JPH1029979A - New pyridine derivative - Google Patents
New pyridine derivativeInfo
- Publication number
- JPH1029979A JPH1029979A JP9378297A JP9378297A JPH1029979A JP H1029979 A JPH1029979 A JP H1029979A JP 9378297 A JP9378297 A JP 9378297A JP 9378297 A JP9378297 A JP 9378297A JP H1029979 A JPH1029979 A JP H1029979A
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- group
- yield
- methoxyphenyl
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は新規なピリジン誘導
体及び医薬品としてのピリジン誘導体の使用に関するも
のである。高血圧症、レイノー病、心筋梗塞、狭心症、
脳梗塞、脳血管攣縮、動脈硬化、冠動脈再狭窄、気管支
喘息、胃潰瘍、急性肝不全、糖尿病、前立腺肥大、エン
ドキシンショック、多臓器不全、播種性血管内凝固、急
性腎不全、シクロスポリン誘発の腎障害等の病態にエン
ドセリンの関与が示されており、本発明の化合物はその
エンドセリンに対する拮抗作用を示し、これにより上記
疾患の治療薬として利用できる。The present invention relates to novel pyridine derivatives and to the use of pyridine derivatives as pharmaceuticals. Hypertension, Raynaud's disease, myocardial infarction, angina,
Cerebral infarction, cerebral vasospasm, arteriosclerosis, coronary artery restenosis, bronchial asthma, gastric ulcer, acute liver failure, diabetes, prostatic hypertrophy, endoxin shock, multiple organ failure, disseminated intravascular coagulation, acute renal failure, cyclosporine-induced kidney The involvement of endothelin in pathological conditions such as disorders has been shown, and the compounds of the present invention exhibit an antagonistic action on the endothelin, whereby they can be used as therapeutics for the above-mentioned diseases.
【0002】[0002]
【従来の技術】エンドセリン(ET)は血管内皮細胞よ
り産生される21個のアミノ酸からなるポリペプチドで
あり、強力な血管収縮作用及び持続的で、強い昇圧作用
を有する生体内因子である。エンドセリンには構造の類
似したイソペプチドとして3種類のエンドセリン(ET
−1,ET−2,ET−3)が存在している事が知ら
れ、その中でもエンドセリンー1は既知の血管収縮因子
の中で最も強く、且つ持続作用を有している。臨床的に
は本態性高血圧症、急性心筋梗塞、肺高血圧症、レイノ
ー病、糖尿病、冠攣縮性狭心症、脳血管攣縮、腎不全、
動脈硬化、PTCA(経皮的冠動脈形成術)後の再狭窄
などの症例において、血中エンドセリン濃度の有意な上
昇が認められている。従ってエンドセリン受容体へのエ
ンドセリンの結合を阻害できる拮抗剤が強く望まれてい
る。2. Description of the Related Art Endothelin (ET) is a polypeptide consisting of 21 amino acids produced from vascular endothelial cells, and is an in vivo factor having a strong vasoconstrictive action and a sustained and strong pressor action. Endothelin has three types of endothelins (ET
-1, ET-2, ET-3) are known to exist, among which endothelin-1 has the strongest and long-lasting action among known vasoconstrictor factors. Clinically, essential hypertension, acute myocardial infarction, pulmonary hypertension, Raynaud's disease, diabetes, coronary vasospasm, cerebral vasospasm, renal failure,
In cases such as arteriosclerosis and restenosis after PTCA (percutaneous coronary angioplasty), a significant increase in blood endothelin concentration has been observed. Therefore, an antagonist capable of inhibiting the binding of endothelin to an endothelin receptor is strongly desired.
【0003】これまでエンドセリン受容体に対する拮抗
作用を有するいくつかのペプチド性または非ペプチド性
の化合物が開示されているが(例えばEP 05105
26A1,WO 930879 A1)、いずれも実際
の薬剤としての使用には至っていない。A number of peptidic or non-peptidic compounds having an antagonistic action on endothelin receptor have been disclosed (for example, EP 05105).
26A1, WO 930879 A1), none of which has been used as an actual drug.
【0004】[0004]
【発明が解決しようとする課題】本発明は優れた活性を
有する新規エンドセリン拮抗剤を提供することにある。SUMMARY OF THE INVENTION An object of the present invention is to provide a novel endothelin antagonist having excellent activity.
【0005】[0005]
【課題を解決するための手段】本発明者らは、上記の課
題を解決するために、種々の誘導体を合成し、そのエン
ドセリン拮抗作用を調べた結果、ある特定の新規ピリジ
ン誘導体が優れたエンドセリン拮抗活性を有することを
見いだし、本発明を完成させるにいたった。すなわち本
発明は、下記一般式(1)で示されるピリジン誘導体ま
たはその医薬的に許容しうる塩、並びにそれらを有効成
分とするエンドセリン拮抗剤である。Means for Solving the Problems In order to solve the above-mentioned problems, the present inventors have synthesized various derivatives and examined their endothelin antagonism. They have found that they have antagonistic activity, and have completed the present invention. That is, the present invention is a pyridine derivative represented by the following general formula (1) or a pharmaceutically acceptable salt thereof, and an endothelin antagonist containing them as an active ingredient.
【0006】[0006]
【化5】 Embedded image
【0007】[式中、R1、R2、R3、R4及びR5はそ
れぞれ同じでも異なっても良く、またいずれか二つが結
合して環を構成しても良く、水素原子、ハロゲン原子、
水酸基、アミノ基、ニトロ基、低級アルキル基、低級ア
ルコキシ基、低級アルケニル基、低級アルキルアミノ
基、低級アルキルチオ基、低級アルカノイル基、ヒドロ
キシ低級アルキル基、ヒドロキシ低級アルコキシ基、ヒ
ドロキシ低級アルケニル基、ハロゲノ低級アルキル基、
ハロゲノ低級アルコキシ基、ハロゲノ低級アルケニル
基、アリール低級アルコキシ基、又はアロイル基のいず
れかを表し、R6は酸性官能基を表し、R7、R8、R9、
R10及びR11はそれぞれ同じでも異なっても良く、また
いずれか二つが結合して環を構成しても良く、水素原
子、ハロゲン原子、水酸基、アミノ基、ニトロ基、低級
アルキル基、低級アルコキシ基、低級アルケニル基、低
級アルキルアミノ基、低級アルキルチオ基、低級アルカ
ノイル基、ヒドロキシ低級アルキル基、ヒドロキシ低級
アルコキシ基、ヒドロキシ低級アルケニル基、ハロゲノ
低級アルキル基、ハロゲノ低級アルコキシ基、ハロゲノ
低級アルケニル基、アリール低級アルコキシ基、又はア
ロイル基のいずれかを表し、R12は水素原子、ハロゲン
原子、水酸基、アミノ基、ニトロ基、低級アルキル基、
低級アルコキシ基、低級アルケニル基、低級アルキルア
ミノ基、低級アルキルチオ基、低級アルカノイル基、ヒ
ドロキシ低級アルキル基、ヒドロキシ低級アルコキシ
基、ヒドロキシ低級アルケニル基、ハロゲノ低級アルキ
ル基、ハロゲノ低級アルコキシ基、ハロゲノ低級アルケ
ニル基、アリール低級アルコキシ基、アロイル基、アリ
ール基、ヘテロアリール基、又はヘテロサイクリルカル
ボニル基のいずれかを表す。また、Xは下式(2)〜
(5)のいずれかを表し、[Wherein, R 1 , R 2 , R 3 , R 4 and R 5 may be the same or different, and any two may be combined to form a ring; atom,
Hydroxyl group, amino group, nitro group, lower alkyl group, lower alkoxy group, lower alkenyl group, lower alkylamino group, lower alkylthio group, lower alkanoyl group, hydroxy lower alkyl group, hydroxy lower alkoxy group, hydroxy lower alkenyl group, halogeno lower Alkyl group,
Represents a halogeno lower alkoxy group, a halogeno lower alkenyl group, an aryl lower alkoxy group, or an aroyl group, R 6 represents an acidic functional group, and R 7 , R 8 , R 9 ,
R 10 and R 11 may be the same or different, and any two of them may combine to form a ring, and include a hydrogen atom, a halogen atom, a hydroxyl group, an amino group, a nitro group, a lower alkyl group, and a lower alkoxy group. Group, lower alkenyl group, lower alkylamino group, lower alkylthio group, lower alkanoyl group, hydroxy lower alkyl group, hydroxy lower alkoxy group, hydroxy lower alkenyl group, halogeno lower alkyl group, halogeno lower alkoxy group, halogeno lower alkenyl group, aryl Represents a lower alkoxy group or an aroyl group, R 12 is a hydrogen atom, a halogen atom, a hydroxyl group, an amino group, a nitro group, a lower alkyl group,
Lower alkoxy group, lower alkenyl group, lower alkylamino group, lower alkylthio group, lower alkanoyl group, hydroxy lower alkyl group, hydroxy lower alkoxy group, hydroxy lower alkenyl group, halogeno lower alkyl group, halogeno lower alkoxy group, halogeno lower alkenyl group , An aryl lower alkoxy group, an aroyl group, an aryl group, a heteroaryl group, or a heterocyclylcarbonyl group. X is the following formula (2)-
(5)
【0008】[0008]
【化6】 Embedded image
【0009】(但し、R13、R14、及びR15はそれぞれ
同じでも異なっていても良く、水素原子又は低級アルキ
ル基を表す。) Yは下式(6)〜(9)のいずれかを表し、(However, R 13 , R 14 and R 15 may be the same or different and each represents a hydrogen atom or a lower alkyl group.) Y is any of the following formulas (6) to (9) Represent
【0010】[0010]
【化7】 Embedded image
【0011】(但し、R16、R17、及びR18はそれぞれ
同じでも異なっていても良く、水素原子又は低級アルキ
ル基のいずれかを表す。) Zは水素原子、水酸基、カルボキシル基、低級アルコキ
シカルボニル基、アリールオキシカルボニル基、ヘテロ
アリールオキシカルボニル基、アルキルカルバモイル
基、アリールカルバモイル基、ヘテロアリールカルバモ
イル基、アミノ基、アルキルアミノ基、アリールアミノ
基、ヘテロアリールアミノ基、アシルアミノ基又は下式
(10)〜(15)のいずれかを表す。(However, R 16 , R 17 , and R 18 may be the same or different and each represents a hydrogen atom or a lower alkyl group.) Z is a hydrogen atom, a hydroxyl group, a carboxyl group, a lower alkoxy group. Carbonyl group, aryloxycarbonyl group, heteroaryloxycarbonyl group, alkylcarbamoyl group, arylcarbamoyl group, heteroarylcarbamoyl group, amino group, alkylamino group, arylamino group, heteroarylamino group, acylamino group or the following formula (10 ) To (15).
【0012】[0012]
【化8】 Embedded image
【0013】(但し、R19、R20、R21、R22、R23、
R24、R25、R26、R27、及びR28はそれぞれ同じでも
異なっていても良く、水素原子、低級アルキル基、アリ
ール基、ヘテロアリール基のいずれかを表す、なお、こ
こでR19及びR20、R21及びR22、R21及びR23、R22
及びR23、又はR25及びR26は結合して環を構成しても
良い。)mは0か1の整数を、nは0〜3の整数を表
す。](However, R 19 , R 20 , R 21 , R 22 , R 23 ,
R 24, R 25, R 26 , R 27, and R 28 may be the same or different and each represents any of a hydrogen atom, a lower alkyl group, an aryl group, a heteroaryl group, Here, R 19 And R 20 , R 21 and R 22 , R 21 and R 23 , R 22
And R 23 or R 25 and R 26 may combine to form a ring. M) represents an integer of 0 or 1, and n represents an integer of 0 to 3. ]
【0014】本発明に於けるハロゲン原子とはフッ素、
塩素、臭素、ヨウ素であり、低級アルキル基、低級アル
コキシ基、低級アルケニル基、低級アルキルアミノ基、
低級アルキルチオ基、低級アルカノイル基、ヒドロキシ
低級アルキル基、ヒドロキシ低級アルコキシ基、ヒドロ
キシ低級アルケニル基、ハロゲノ低級アルキル基、ハロ
ゲノ低級アルコキシ基、ハロゲノ低級アルケニル基、ア
リール低級アルコキシ基における、低級とは、炭素数が
1〜6の基を示すものである。尚、アルキル基、アルコ
キシ基、アルケニル基、アルキルアミノ基、アルキルチ
オ基、アルカノイル基の成分としてのアルキル基は直鎖
でも分岐鎖状であっても構わない。さあらに、ここでい
うアルキル基を具体的に例示するならばメチル基、エチ
ル基、プロピル基、イソプロピル基、ブチル基、セカン
ダリー及びターシャリーブチル基等があげられる。ま
た、アリール低級アルコキシ基におけるアリール基とは
フェニル及び置換されたフェニル基であり、置換基とし
てハロゲン、アルキル及びアルコキシが特に考えられ
る。具体的に例示するならばベンジルオキシ基等が挙げ
られる。アロイル基を具体的に例示するならばベンゾイ
ル基、ピリジルカルボニル基等が挙げられる。The halogen atom in the present invention is fluorine,
Chlorine, bromine, iodine, a lower alkyl group, a lower alkoxy group, a lower alkenyl group, a lower alkylamino group,
In the lower alkylthio group, the lower alkanoyl group, the hydroxy lower alkyl group, the hydroxy lower alkoxy group, the hydroxy lower alkenyl group, the halogeno lower alkyl group, the halogeno lower alkoxy group, the halogeno lower alkenyl group, and the aryl lower alkoxy group, lower is the number of carbon atoms. Represents a group of 1 to 6. The alkyl group as a component of the alkyl group, the alkoxy group, the alkenyl group, the alkylamino group, the alkylthio group, and the alkanoyl group may be linear or branched. Furthermore, the alkyl group mentioned here may be specifically exemplified by a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, a secondary and a tertiary butyl group, and the like. The aryl group in the aryl lower alkoxy group is phenyl or a substituted phenyl group, and halogen, alkyl, and alkoxy are particularly considered as the substituent. Specific examples include a benzyloxy group and the like. Specific examples of the aroyl group include a benzoyl group and a pyridylcarbonyl group.
【0015】本発明に於ける酸性官能基を具体的に例示
するならばカルボキシル基、SO3H、PO3H2、テト
ラゾール−5−イル基、スルホンアミド基、2−オキソ
−3H−1、2、3、5−オキサチアジアゾール−4−
イル基、又は5−オキソ−4H−1、2、4−オキサジ
アゾール−3−イル基をあげることができるが、これら
に限定されるものではない。また、ヘテロアリール基と
は、窒素、酸素または硫黄をヘテロ原子として有してい
る単環式または多環式の5−及び6−員のヘテロ芳香族
基を差し、具体的にはピリジル基、ピリミジル基、フラ
ニル基、チエニル基、キノリル基等が挙げられる。Specific examples of the acidic functional group in the present invention include a carboxyl group, SO 3 H, PO 3 H 2 , tetrazol-5-yl group, sulfonamide group, 2-oxo-3H-1, 2,3,5-oxathiadiazole-4-
Examples thereof include, but are not limited to, an yl group and a 5-oxo-4H-1,2,4-oxadiazol-3-yl group. Further, the heteroaryl group refers to a monocyclic or polycyclic 5- and 6-membered heteroaromatic group having nitrogen, oxygen or sulfur as a hetero atom, specifically, a pyridyl group, Examples include a pyrimidyl group, a furanyl group, a thienyl group, and a quinolyl group.
【0016】なお、本発明の一般式(1)で示される化
合物において、R6がカルボキシル基、又はテトラゾー
ルー5ーイル基であり、m=n=1であり、Yが上記一
般式(9)で示されR17及びR18がいずれも水素原子で
あるピリジン誘導体またはその医薬的に許容しうる塩が
活性が高い。In the compound of the present invention represented by the general formula (1), R 6 is a carboxyl group or a tetrazol-5-yl group, m = n = 1, and Y is the above-mentioned general formula (9) A pyridine derivative or a pharmaceutically acceptable salt thereof, wherein R 17 and R 18 are both hydrogen atoms, has high activity.
【0017】本発明のピリジン誘導体は下記に示した工
程にて製造する事ができる。The pyridine derivative of the present invention can be produced by the following steps.
【0018】[0018]
【化9】 Embedded image
【0019】(式中、R1、R2、R3、R4、R5、R6、
R7、R8、R9、R10、R11、R12及びXは、上記と同
じである。)Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 ,
R 7 , R 8 , R 9 , R 10 , R 11 , R 12 and X are the same as described above. )
【0020】すなわち、不飽和ケトン(16)とシアノ
アセトアミドを酸素気流下、例えばt−ブトキシカリウ
ム等の塩基存在下で処理することにより、ピリドン(1
7)を得ることができる。そして得られたピリドンを例
えばオキシ塩化リン等のクロロ化剤にて処理すると、2
−クロロピリジン環(18)を構築できる。さらに得ら
れた2−クロロピリジン環(18)と、例えばフェノー
ル等(19)を水素化ナトリウムの様な塩基存在下で処
理する事により、化合物(20)を得ることができる。
そして例えばR6がテトラゾール−5−イル基の場合に
は、(20)のシアノ基を例えばアジ化トリブチルスズ
とトルエン中に加熱することにより、本発明の一般式
(1)で示される化合物において、m=n=0でZが水
素原子であるのピリジン誘導体(21)を製造すること
ができる。That is, by treating an unsaturated ketone (16) and cyanoacetamide in an oxygen stream, for example, in the presence of a base such as potassium t-butoxide, the pyridone (1) is obtained.
7) can be obtained. When the obtained pyridone is treated with a chlorinating agent such as phosphorus oxychloride, for example, 2
A chloropyridine ring (18) can be constructed. Further, the compound (20) can be obtained by treating the obtained 2-chloropyridine ring (18) and, for example, phenol (19) in the presence of a base such as sodium hydride.
For example, when R 6 is a tetrazol-5-yl group, the cyano group of (20) is heated in, for example, tributyltin azide and toluene to obtain a compound represented by the general formula (1) of the present invention. A pyridine derivative (21) in which m = n = 0 and Z is a hydrogen atom can be produced.
【0021】出発原料として使用される不飽和ケトン
(16)はそれらが公知でないならば、下式に示す様な
方法等にて製造することができる。例えば、アリールア
ルデヒド(22)とメチルケトン(23)を適当な塩基
にてアルドール型縮合を用いれば製造できる。Unsaturated ketones (16) used as starting materials can be produced by a method as shown in the following scheme if they are not known. For example, the aryl aldehyde (22) and methyl ketone (23) can be produced by using an appropriate base and aldol-type condensation.
【0022】[0022]
【化10】 Embedded image
【0023】(式中、R7、R8、R9、R10、R11、及
びR12は、上記と同じである。)Wherein R 7 , R 8 , R 9 , R 10 , R 11 and R 12 are the same as above.
【0024】またピリジン環の5位に置換基を持つ誘導
体の合成については、例えば上記反応の中間体として得
られたピリドン(17)をN−ブロモコハク酸イミド
(以下NBSと略す)等のハロゲン化剤で処理すると、
下式の様に、ピリドン環の5位が容易にハロゲン化さ
れ、前記と同様の工程にてピリジン環(24)を構築で
きる。As for the synthesis of a derivative having a substituent at the 5-position of the pyridine ring, for example, pyridone (17) obtained as an intermediate in the above reaction is halogenated with N-bromosuccinimide (hereinafter abbreviated as NBS) or the like. When treated with the agent,
As shown in the following formula, the 5-position of the pyridone ring is easily halogenated, and the pyridine ring (24) can be constructed by the same steps as described above.
【0025】[0025]
【化11】 Embedded image
【0026】得られたピリジン環(24)に例えばヘッ
ク反応等の反応を行えば、下式の様にピリジン環の5位
に種々の置換基を導入することができる。その後、置換
基を適当に変換する事により望む誘導体へ導くこともで
きる。そして前記と同様にシアノ基を酸性基に変換する
ことにより特許請求の化合物(1)を得ることができ
る。When a reaction such as Heck reaction is performed on the obtained pyridine ring (24), various substituents can be introduced at the 5-position of the pyridine ring as shown in the following formula. Thereafter, the desired derivative can be obtained by appropriately converting the substituent. Then, the compound (1) of the present invention can be obtained by converting a cyano group into an acidic group in the same manner as described above.
【0027】[0027]
【化12】 Embedded image
【0028】このようにして製造される一般式(1)で
表される本発明の化合物およびその塩は、公知の分離精
製手段、例えば濃縮、減圧濃縮、溶媒抽出、晶析、再結
晶、転溶、クロマトグラフィーなどにより単離精製する
ことができる。The compound of the present invention represented by the general formula (1) and a salt thereof thus produced can be obtained by known separation and purification means, for example, concentration, concentration under reduced pressure, solvent extraction, crystallization, recrystallization, and inversion. It can be isolated and purified by dissolution, chromatography and the like.
【0029】本発明の化合物の塩の形態は医薬的に許容
しうるものであれば良く、例えばアンモニウム塩、ナト
リウム、カリウム等のアルカリ金属との塩、カルシウ
ム、マグネシウム等のアルカリ土類金属との塩、アルミ
ニウム塩、亜鉛塩、モルホリン、ピペリジン等の有機ア
ミンとの塩、アルギニン、リジン等の塩基性アミノ酸と
の塩が挙げることができる。The salt of the compound of the present invention may be in any form as long as it is pharmaceutically acceptable. Examples thereof include salts with organic amines such as salts, aluminum salts, zinc salts, morpholine and piperidine, and salts with basic amino acids such as arginine and lysine.
【0030】本発明の化合物またはその塩は、そのまま
あるいは各種の医薬組成物として投与される。このよう
な医薬組成物の剤形としては、例えば錠剤、散財、丸
剤、顆粒剤、カプセル剤、坐剤、溶液剤、糖衣剤、また
はデボー剤にしてよく、普通の製剤助剤を用いて常法に
従って製造する事ができる。例えば錠剤は、本発明の有
効成分であるピリジン誘導体を既知の補助物質、例えば
乳糖、炭酸カルシウムまたは燐酸カルシウム等の不活性
希釈剤、アラビアゴム、コーンスターチまたはゼラチン
等の結合剤、アルギン酸、コーンスターチまたは前ゼラ
チン化デンプン等の膨化剤、ショ糖、乳糖またはサッカ
リン等の甘味剤、ペパーミント、アカモノ油またはチェ
リー等の香味剤、ステアリン酸マグネシウム、タルクま
たはカルボキシメチルセルロース等の滑湿剤と混合する
ことによって得られる。The compound of the present invention or a salt thereof may be administered as it is or as various pharmaceutical compositions. The dosage form of such a pharmaceutical composition may be, for example, a tablet, sprinkle, pill, granule, capsule, suppository, solution, dragee, or depot, using common formulation auxiliaries. It can be manufactured according to the usual method. For example, tablets may be prepared by converting the pyridine derivative, which is the active ingredient of the present invention, into a known auxiliary substance, such as lactose, an inert diluent such as calcium carbonate or calcium phosphate, a binder such as acacia, corn starch or gelatin, alginic acid, corn starch, or corn starch. It is obtained by mixing with a leavening agent such as gelatinized starch, a sweetening agent such as sucrose, lactose or saccharin, a flavoring agent such as peppermint, reddish oil or cherry, a lubricating agent such as magnesium stearate, talc or carboxymethylcellulose. .
【0031】本発明の化合物またはその塩を有効成分と
するエンドセリン拮抗剤は、高血圧症、レイノー病、心
筋梗塞、狭心症、脳梗塞、脳血管攣縮、動脈硬化、冠動
脈再狭窄、気管支喘息、胃潰瘍、急性肝不全、糖尿病、
前立腺肥大、エンドキシンショック、多臓器不全、播種
性血管内凝固、急性腎不全、シクロスポリン誘発の腎障
害などの治療薬に利用できる。Endothelin antagonists containing the compound of the present invention or a salt thereof as an active ingredient include hypertension, Raynaud's disease, myocardial infarction, angina, cerebral infarction, cerebral vasospasm, arteriosclerosis, coronary artery restenosis, bronchial asthma, Gastric ulcer, acute liver failure, diabetes,
It can be used as a therapeutic agent for prostatic hypertrophy, endoxin shock, multiple organ failure, disseminated intravascular coagulation, acute renal failure, and cyclosporine-induced renal damage.
【0032】上記目的のために用いる投与量は、目的と
する治療効果、投与方法、治療期間、年齢、体重などに
より決定されるが、経口もしくは非経口のルートによ
り、通常成人一日あたりの投与量として経口投与の場合
で1μg〜5g、非経口投与の場合で0.01μg〜1
gを用いる。The dose used for the above purpose is determined depending on the intended therapeutic effect, administration method, treatment period, age, body weight, etc., and is usually administered by the oral or parenteral route per adult day. The amount is 1 μg to 5 g for oral administration and 0.01 μg to 1 for parenteral administration.
Use g.
【0033】[0033]
【実施例】以下の実施例により本発明を詳細に説明す
る。これらは本発明の好ましい実施態様でありこれらの
実施例に限定されるものではない。The present invention will be described in detail with reference to the following examples. These are preferred embodiments of the present invention and are not limited to these examples.
【0034】実施例1 6−ブチル−4−(4−メトキ
シフェニル)−2−(3,4−メチレンジオキシフェニ
ルオキシ)ピリジン−3−カルボン酸の合成 1)1−(4 −メトキシフェニル)−3−オキソ−1
−ヘプタノールの合成 アルゴン雰囲気下、−70℃でリチウムビストリメチル
シリルアミドの1Mヘキサン溶液10mlをテトラヒド
ロフラン(以下THFと略す)20mlに加える。2−
ヘキサノン1.23ml(10.0mmol)のTHF
10ml溶液を滴下し10分間攪拌する。p−アニスア
ルデヒド1.20ml(9.9mmol)を加え30分
攪拌した後に1規定塩酸を加え反応を停止する。酢酸エ
チルで抽出し飽和食塩水で洗浄する。無水硫酸マグネシ
ウムで乾燥し減圧下溶媒を留去する。得られた残渣をシ
リカゲルカラムクロマトグラフィー(酢酸エチル:ヘキ
サン 1:4から1:3)に付し表題化合物を得た。 収量:1.50g、収率:63.5% MS(ESI,m/z) 259.2 (M+Na) H-NMR(CDCl3):0.90 (3H,t)、1.29 (2H, sex)、1.55 (2
H, quint)、2.45 (2H,t)、2.79 (1H, d)、2.80 (1H,
d)、3.22 (1H, d)、3.80 (3H, s)、5.10 (1H, m)、6.86
(2H, d)、7.30 (2H, d)Example 1 Synthesis of 6-butyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) 1- (4-methoxyphenyl) -3-oxo-1
Synthesis of Heptanol Under argon atmosphere, 10 ml of a 1 M hexane solution of lithium bistrimethylsilylamide is added to 20 ml of tetrahydrofuran (hereinafter abbreviated as THF) at -70 ° C. 2-
Hexanone 1.23 ml (10.0 mmol) in THF
10 ml solution is added dropwise and stirred for 10 minutes. After adding 1.20 ml (9.9 mmol) of p-anisaldehyde and stirring for 30 minutes, 1N hydrochloric acid is added to terminate the reaction. Extract with ethyl acetate and wash with saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 4 to 1: 3) to give the title compound. Yield: 1.50 g, Yield: 63.5% MS (ESI, m / z) 259.2 (M + Na) H-NMR (CDCl3): 0.90 (3H, t), 1.29 (2H, sex), 1.55 ( Two
H, quint), 2.45 (2H, t), 2.79 (1H, d), 2.80 (1H,
d), 3.22 (1H, d), 3.80 (3H, s), 5.10 (1H, m), 6.86
(2H, d), 7.30 (2H, d)
【0035】2)1−(4−メトキシフェニル)−1−
ヘプテン−3−オンの合成 1−(4 −メトキシフェニル)−3−オキソ−1−ヘ
プタノール1.50g(6.4mmol)をトルエン1
00mlに溶解し無水硫酸マグネシウム3.0gを加え
2時間加熱環流する。放冷後濾過し減圧下溶媒を留去す
る。得られた残渣をシリカゲルカラムクロマトグラフィ
ー(酢酸エチル:ヘキサン 1:5)に付し表題化合物
を得た。 収量:1.50g、収率:定量的 MS(ESI,m/z) 219 (MH+) H-NMR(CDCl3):0.90 (3H, t)、1.38 (2H, sex)、1.68
(2H, quint)、2.62 (2H,t)、3.82 (3H, s)、6.62 (1H,
d)、6.90 (2H, d)、7.55 (2H, d)、7.56 (1H,d)2) 1- (4-methoxyphenyl) -1-
Synthesis of hepten-3-one 1.50 g (6.4 mmol) of 1- (4-methoxyphenyl) -3-oxo-1-heptanol was added to toluene 1
The mixture was dissolved in 00 ml, and anhydrous magnesium sulfate (3.0 g) was added. After cooling, the mixture is filtered and the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 5) to give the title compound. Yield: 1.50 g, yield: quantitative MS (ESI, m / z) 219 (MH +) H-NMR (CDCl3): 0.90 (3H, t), 1.38 (2H, sex), 1.68
(2H, quint), 2.62 (2H, t), 3.82 (3H, s), 6.62 (1H,
d), 6.90 (2H, d), 7.55 (2H, d), 7.56 (1H, d)
【0036】3)6−ブチル−3−シアノ−4−(4−
メトキシフェニル)−2−ピリドンの合成 1−(4−メトキシフェニル)−1−ヘプテン−3−オ
ン1.20g(5.5mmol)、シアノアセトアミド
510mg(6.1mmol)、t−ブトキシカリウム
2.50g(22.3mmol)のジメチルスルホキシ
ド(以下DMSOと略す)12ml溶液を酸素雰囲気下
2時間室温で攪拌する。反応溶液は発熱し黒色になる。
1規定塩酸で反応を停止し酢酸エチルで抽出する。飽和
食塩水で洗浄し無水硫酸マグネシウムで乾燥し減圧下溶
媒を留去する。得られた残渣をシリカゲルカラムクロマ
トグラフィー(酢酸エチル:ヘキサン 1:1)に付し
得られる結晶を酢酸エチル:ヘキサン 1:1で洗浄し
表題化合物を得た。 収量:340mg、収率:21.9% MS(FAB,m/z) 283 (MH+) H-NMR(CDCl3):0.99 (3H, t)、1.45 (2H, sex)、1.72
(2H, quint)、2.70 (2H,t)、3.86 (3H, s)、6.25 (1H,
s)、7.04 (2H, d)、7.85 (2H, d)3) 6-butyl-3-cyano-4- (4-
Synthesis of 1- (4-methoxyphenyl) -1-hepten-3-one 1.20 g (5.5 mmol), 510 mg (6.1 mmol) of cyanoacetamide, 2.50 g of potassium t-butoxy A solution of (22.3 mmol) in 12 ml of dimethylsulfoxide (hereinafter abbreviated as DMSO) is stirred at room temperature for 2 hours under an oxygen atmosphere. The reaction solution generates heat and turns black.
The reaction is stopped with 1N hydrochloric acid and extracted with ethyl acetate. The extract is washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1), and the obtained crystals were washed with ethyl acetate: hexane 1: 1 to give the title compound. Yield: 340 mg, yield: 21.9% MS (FAB, m / z) 283 (MH +) H-NMR (CDCl3): 0.99 (3H, t), 1.45 (2H, sex), 1.72
(2H, quint), 2.70 (2H, t), 3.86 (3H, s), 6.25 (1H,
s), 7.04 (2H, d), 7.85 (2H, d)
【0037】4)6−ブチル−3−シアノ−4−(4−
メトキシフェニル)−2−(3,4−メチレンジオキシ
フェニルオキシ)ピリジンの合成 6−ブチル−3−シアノ−4−(4−メトキシフェニ
ル)−2−ピリドン240mg(0.85mmol)を
オキシ塩化リン5mlに溶解し80℃で一晩攪拌する。
オキシ塩化リンを減圧下留去し残渣を酢酸エチルに溶解
する。飽和重曹水、飽和食塩水で洗浄し無水硫酸マグネ
シウムで乾燥する。減圧下溶媒を留去し得られた残渣を
ジメエチルホルムアミド(以下DMFと略す)5mlに
溶解し、別にセサモール130mg(0.94mmo
l)、水素化ナトリウム70mg(60%オイルディス
パージョン、1.8mmol)より作成したフェノキシ
ドイオンのDMF5ml溶液に加えアルゴン雰囲気下2
時間攪拌する。氷水を加え反応を停止し、酢酸エチルで
抽出する。水、飽和食塩水で洗浄し無水硫酸マグネシウ
ムで乾燥し減圧下溶媒を留去する。得られた残渣をシリ
カゲルカラムクロマトグラフィー(酢酸エチル:ヘキサ
ン 1:4)に付し、表題化合物50mg(14.6
%)を得た。別にセサモールとの分離困難な混合物とし
て140mg得られる。 収量:50mg、収率:14.6% MS(FAB,m/z) 403 (MH+) H-NMR(CDCl3):0.88 (3H, t)、1.30 (2H, sex)、1.61
(2H, quint)、2.65 (2H,t)、3.88 (3H, s)、6.01 (2H,
s)、6.67 (1H, dd)、6.75 (1H, d)、6.81 (1H,d)、6.95
(1H, s)、7.04 (2H, d)、7.62 (2H, d)4) 6-butyl-3-cyano-4- (4-
Synthesis of methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 6-butyl-3-cyano-4- (4-methoxyphenyl) -2-pyridone 240 mg (0.85 mmol) was added to phosphorus oxychloride Dissolve in 5 ml and stir at 80 ° C. overnight.
The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The residue obtained by evaporating the solvent under reduced pressure was dissolved in 5 ml of dimethylethylformamide (hereinafter abbreviated as DMF), and 130 mg of sesamol (0.94 mmol) was separately added.
l), a solution of phenoxide ion prepared from 70 mg of sodium hydride (60% oil dispersion, 1.8 mmol) in 5 ml of DMF and added under an argon atmosphere.
Stir for hours. Ice water is added to stop the reaction, and the mixture is extracted with ethyl acetate. The extract is washed with water and saturated saline, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 4) to give the title compound (50 mg, 14.6).
%). Separately, 140 mg is obtained as a difficult-to-separate mixture with sesamol. Yield: 50 mg, Yield: 14.6% MS (FAB, m / z) 403 (MH +) H-NMR (CDCl3): 0.88 (3H, t), 1.30 (2H, sex), 1.61
(2H, quint), 2.65 (2H, t), 3.88 (3H, s), 6.01 (2H,
s), 6.67 (1H, dd), 6.75 (1H, d), 6.81 (1H, d), 6.95
(1H, s), 7.04 (2H, d), 7.62 (2H, d)
【0038】5)6−ブチル−4−(4−メトキシフェ
ニル)−2−(3,4−メチレンジオキシフェニルオキ
シ)ピリジン−3−アルデヒドの合成 6−ブチル−3−シアノ−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェニルオキ
シ)ピリジン60mg(0.15mmol)をベンゼン
に溶解しアルゴン雰囲気下室温で水素化ジイソブチルア
ルミニウム1Mヘキサン溶液0.5ml(0.5mmo
l)を滴下する。室温で30分攪拌しメタノールと水で
反応を停止する。室温で1時間攪拌し、不溶物をセライ
トを用いて濾過する。濾液をを減圧下留去し得られた残
渣をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル:ヘキサン 1:3)に付し6−ブチル−4−(4−
メトキシフェニル)−2−(3,4−メチレンジオキシ
フェニルオキシ)ピリジン−3−アルデヒドを得た。こ
のものは分離困難な不純物を含むがこれ以上精製せずに
以下の反応に用いる。 収量:52mg MS(FAB,m/z) 406 (MH+) H-NMR(CDCl3):0.88 (3H, t)、1.30 (2H, sex) 1.60 (2H, quint)、2.63 (2H, t)、3.88 (3H, s)、6.02
(2H, s)、6.63 (1H, dd)、6.73 (1H, d)、6.79 (1H,
s)、6.82 (1H, d)、6.98(2H, d)、7.34 (2H, d)、10.24
(1H, s)5) Synthesis of 6-butyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 6-butyl-3-cyano-4- (4 -Methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine (60 mg, 0.15 mmol) was dissolved in benzene, and 0.5 ml (0.5 mmo) of a 1 M solution of diisobutylaluminum hydride in hexane was added at room temperature under an argon atmosphere.
1) is added dropwise. Stir at room temperature for 30 minutes and terminate the reaction with methanol and water. The mixture is stirred at room temperature for 1 hour, and the insoluble matter is filtered using celite. The filtrate was evaporated under reduced pressure, and the resulting residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to give 6-butyl-4- (4-
Methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde was obtained. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 52 mg MS (FAB, m / z) 406 (MH +) H-NMR (CDCl3): 0.88 (3H, t), 1.30 (2H, sex) 1.60 (2H, quint), 2.63 (2H, t), 3.88 (3H, s), 6.02
(2H, s), 6.63 (1H, dd), 6.73 (1H, d), 6.79 (1H,
s), 6.82 (1H, d), 6.98 (2H, d), 7.34 (2H, d), 10.24
(1H, s)
【0039】6)6−ブチル−4−(4−メトキシフェ
ニル)−2−(3,4−メチレンジオキシフェニルオキ
シ)ピリジン−3−カルボン酸の合成 6−ブチル−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェニルオキシ)ピリジン
−3−アルデヒド52mgを塩化メチレン0.8ml、
水0.4mlに溶解し、0℃で2−メチル−2−ブテン
0.1m(0.94mmol)、アミド硫酸20mg
(0.21mmol)、亜塩素酸ナトリウム50mg
(0.44mmol)を加え室温に戻して10分間攪拌
する。酢酸エチルで抽出し、無水硫酸マグネシウムで乾
燥し減圧下溶媒を留去する。得られた残渣をシリカゲル
薄層クロマトグラフィー(クロロホルム:メタノール
9:1)に付し表題化合物を得た。 収量:17mg、収率:26.9% MS(FAB,m/z):422 (MH+) H-NMR(CDCl3):0.88 (3H, t)、1.30 (2H, sex)、1.59
(2H, quint)、2.62 (2H,t)、3.81 (3H, s)、5.97 (2H,
s)、6.61 (1H, dd)、6.72 (1H, d)、6.75 (1H,d)、6.85
(1H, s)、6.93 (2H, d) 、7.41 (2H, d)6) Synthesis of 6-butyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6-butyl-4- (4-methoxyphenyl) ) -2-
52 mg of (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde was added to 0.8 ml of methylene chloride,
Dissolve in 0.4 ml of water, and at 0 ° C., 0.1 m (0.94 mmol) of 2-methyl-2-butene, 20 mg of amidosulfuric acid
(0.21 mmol), 50 mg sodium chlorite
(0.44 mmol) is added and the mixture is returned to room temperature and stirred for 10 minutes. Extract with ethyl acetate, dry over anhydrous magnesium sulfate and evaporate the solvent under reduced pressure. The obtained residue is subjected to silica gel thin layer chromatography (chloroform: methanol).
9: 1) to give the title compound. Yield: 17 mg, Yield: 26.9% MS (FAB, m / z): 422 (MH +) H-NMR (CDCl3): 0.88 (3H, t), 1.30 (2H, sex), 1.59
(2H, quint), 2.62 (2H, t), 3.81 (3H, s), 5.97 (2H,
s), 6.61 (1H, dd), 6.72 (1H, d), 6.75 (1H, d), 6.85
(1H, s), 6.93 (2H, d), 7.41 (2H, d)
【0040】実施例2 6−ブチル−4−(3,4−メ
チレンジオキシフェニル)−2−(4−メトキシフェノ
キシ)ピリジン−3−カルボン酸の合成 1)1−(3、4 −メチレンジオキシフェニル)−1
−ヘプテン−3−オンの合成 アルゴン雰囲気下、−70℃でリチウムビストリメチル
シリルアミドの1Mヘキサン溶液11.0mlをTHF
20mlに加える。2−ヘキサノン1.23ml(1
0.0mmol)のTHF10ml溶液を滴下し40分
間攪拌する。ピペロナール1.50ml(10.0mm
ol)を加え1時間攪拌した後に水を加え反応を停止す
る。酢酸エチルで抽出し飽和食塩水で洗浄する。無水硫
酸マグネシウムで乾燥し減圧下溶媒を留去する。得られ
た残渣をシリカゲルカラムクロマトグラフィー(酢酸エ
チル:ヘキサン 1:1)にふし1−(3、4 −メチ
レンジオキシフェニル)−3−オキソ−1−ヘプタノー
ルをピペロナールとの混合物として得た。得られたアル
コール体をトルエン20mlに溶解し、無水硫酸マグネ
シウム4gを加え110℃で一晩攪拌する。不溶物を濾
過し減圧下溶媒を留去し得られる結晶を酢酸エチル:ヘ
キサン 1:3で洗浄し表題化合物を得た。 収量:1.00g、収率:43.1% MS(ESI,m/z) 233 (MH+) H-NMR(CDCl3):0.90 (3H, t)、1.38 (2H, sex)、1.66
(2H, quint)、2.62 (2H, t)、6.01 (2H, s)、6.58 (1H,
d)、6.83 (1H, d)、7.05 (2H, m)、7.48 (1H,d)Example 2 Synthesis of 6-butyl-4- (3,4-methylenedioxyphenyl) -2- (4-methoxyphenoxy) pyridine-3-carboxylic acid 1) 1- (3,4-Methylenedioxy) Oxyphenyl) -1
Synthesis of 1-ml of a 1M hexane solution of lithium bistrimethylsilylamide in an argon atmosphere at -70 ° C in THF
Add to 20 ml. 1.23 ml of 2-hexanone (1
(0.0 mmol) in 10 ml of THF is added dropwise and stirred for 40 minutes. Piperonal 1.50ml (10.0mm
ol) and stirred for 1 hour, and then water was added to stop the reaction. Extract with ethyl acetate and wash with saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The resulting residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1) to give 1- (3,4-methylenedioxyphenyl) -3-oxo-1-heptanol as a mixture with piperonal. The obtained alcohol is dissolved in 20 ml of toluene, 4 g of anhydrous magnesium sulfate is added, and the mixture is stirred at 110 ° C. overnight. The insolubles were filtered and the solvent was distilled off under reduced pressure. The obtained crystals were washed with ethyl acetate: hexane 1: 3 to obtain the title compound. Yield: 1.00 g, yield: 43.1% MS (ESI, m / z) 233 (MH +) H-NMR (CDCl3): 0.90 (3H, t), 1.38 (2H, sex), 1.66
(2H, quint), 2.62 (2H, t), 6.01 (2H, s), 6.58 (1H,
d), 6.83 (1H, d), 7.05 (2H, m), 7.48 (1H, d)
【0041】2)6−ブチル−3−シアノ−4−(3、
4 −メチレンジオキシフェニル)−2−ピリドンの合
成 アルゴン雰囲気下、室温でシアノアセトアミド360m
g(4.3mmol)、t−ブトキシカリウム480m
g(4.3mmol)のDMSO10ml溶液に1−
(3、4 −メチレンジオキシフェニル)−1−ヘプテ
ン−3−オン1.0g(4.3mmol)を加え20分
間攪拌する。t−ブトキシカリウム1.45g(12.
9mmol)を加え1分間酸素をバブリングする。酸素
雰囲気下1時間攪拌した後、水、1規定塩酸氷冷下加え
析出した結晶を濾取する。水で洗い減圧下乾燥し表題化
合物を得た。この化合物は精製せずに以下の反応に用い
る。 収量:850mg、収率:66.7% MS(FAB,m/z) 297 (MH+) H-NMR(CDCl3):0.98 (3H, t)、1.45 (2H, sex)、1.73
(2H, quint)、2.70 (2H, t)、6.06 (2H, s)、6.26 (1H,
s)、6.92 (1H, d)、7.10 (1H, d)、7.18 (1H,dd)2) 6-butyl-3-cyano-4- (3,
Synthesis of 4-methylenedioxyphenyl) -2-pyridone Cyanoacetamide 360m at room temperature under argon atmosphere
g (4.3 mmol), potassium tert-butoxide 480 m
g (4.3 mmol) in 10 ml of DMSO
1.0 g (4.3 mmol) of (3,4-methylenedioxyphenyl) -1-hepten-3-one is added and stirred for 20 minutes. 1.45 g of potassium t-butoxide (12.
9 mmol) and bubbling oxygen for 1 minute. After stirring for 1 hour in an oxygen atmosphere, water and 1N hydrochloric acid are added under ice cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 850 mg, 66.7% MS (FAB, m / z) 297 (MH +) H-NMR (CDCl3): 0.98 (3H, t), 1.45 (2H, sex), 1.73
(2H, quint), 2.70 (2H, t), 6.06 (2H, s), 6.26 (1H,
s), 6.92 (1H, d), 7.10 (1H, d), 7.18 (1H, dd)
【0042】3)6−ブチル−3−シアノ−4−(3、
4 −メチレンジオキシフェニル)−2−(4−メトキ
シフェニルオキシ)ピリジンの合成 6−ブチル−3−シアノ−4−(3、4 −メチレンジ
オキシフェニル)−2−ピリドン850mg(2.9m
mol)オキシ塩化リン6mlに溶解し90℃で一晩攪
拌する。減圧下オキシ塩化リンを留去し得られる残渣を
DMF10mlに溶解し別に4−メトキシフェノール3
60mg(2.9mmol)、水素化ナトリウム140
mg(60%オイルディスパージョン、3.5mmo
l)より作成したフェノキシドイオンのDMF5ml溶
液に加えアルゴン雰囲気下1.5時間攪拌する。減圧下
溶媒を留去し、残渣を酢酸エチルに溶解し水、飽和食塩
水で洗浄する。無水硫酸マグネシウムで乾燥し減圧下溶
媒を留去する。得られた残渣をシリカゲルカラムクロマ
トグラフィー(酢酸エチル:ヘキサン 1:3)に付し
表題化合物を得た。 収量:760mg、収率:65.1% MS(ESI,m/z) 403 (MH+) H-NMR(CDCl3):0.85 (3H, t)、1.30 (2H, sex)、1.58
(2H, quint)、2.63 (2H,t)、3.85 (3H, s)、6.06 (2H,
s)、6.78 (1H, s)、6.90 (4H, m)、7.15 (3H, m)3) 6-butyl-3-cyano-4- (3,
Synthesis of 4-methylenedioxyphenyl) -2- (4-methoxyphenyloxy) pyridine 6-butyl-3-cyano-4- (3,4-methylenedioxyphenyl) -2-pyridone 850 mg (2.9 m
mol) dissolved in 6 ml of phosphorus oxychloride and stirred at 90 ° C. overnight. The residue obtained by distilling off phosphorus oxychloride under reduced pressure was dissolved in 10 ml of DMF, and 4-methoxyphenol 3 was separately added.
60 mg (2.9 mmol), sodium hydride 140
mg (60% oil dispersion, 3.5mmo
l) The solution was added to a solution of phenoxide ion prepared in 1) in 5 ml of DMF, and stirred for 1.5 hours under an argon atmosphere. The solvent is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to give the title compound. Yield: 760 mg, yield: 65.1% MS (ESI, m / z) 403 (MH +) H-NMR (CDCl3): 0.85 (3H, t), 1.30 (2H, sex), 1.58
(2H, quint), 2.63 (2H, t), 3.85 (3H, s), 6.06 (2H,
s), 6.78 (1H, s), 6.90 (4H, m), 7.15 (3H, m)
【0043】4)6−ブチル−4−(3,4−メチレン
ジオキシフェニル)−2−(4−メトキシフェノキシ)
ピリジン−3−アルデヒドの合成 6−ブチル−3−シアノ−4−(3,4−メチレンジオ
キシフェニル)−2−(4−メトキシフェノキシ)ピリ
ジン760mg(1。9mmol)をベンゼン20ml
に溶解しアルゴン雰囲気下室温で水素化ジイソブチルア
ルミニウム1Mヘキサン溶液5.0ml(5.0mmo
l)を滴下する。室温で2.5時間攪拌しメタノールと
水で反応を停止する。室温で30分攪拌し、不溶物をセ
ライトを用いて濾過する。濾液をを減圧下留去し得られ
た残渣をシリカゲルカラムクロマトグラフィー(酢酸エ
チル:ヘキサン 1:3)に付し表題化合物を得た。こ
のものは分離困難な不純物を含むがこれ以上精製せずに
以下の反応に用いる。 収量:520mg MS(FAB,m/z) 406 (MH+)4) 6-butyl-4- (3,4-methylenedioxyphenyl) -2- (4-methoxyphenoxy)
Synthesis of pyridine-3-aldehyde 6-butyl-3-cyano-4- (3,4-methylenedioxyphenyl) -2- (4-methoxyphenoxy) pyridine 760 mg (1.9 mmol) in benzene 20 ml
And 5.0 ml of a 1 M solution of diisobutylaluminum hydride in hexane (5.0 mmol) at room temperature under an argon atmosphere.
1) is added dropwise. Stir at room temperature for 2.5 hours and stop the reaction with methanol and water. The mixture is stirred at room temperature for 30 minutes, and the insoluble matter is filtered using Celite. The filtrate was evaporated under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to obtain the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 520 mg MS (FAB, m / z) 406 (MH +)
【0044】5)6−ブチル−4−(3,4−メチレン
ジオキシフェニル)−2−(4−メトキシフェノキシ)
ピリジン−3−カルボン酸の合成 6−ブチル−4−(3,4−メチレンジオキシフェニ
ル)−2−(4−メトキシフェノキシ)ピリジン−3−
アルデヒド520mgを塩化メチレン8ml、水4ml
に溶解し、0℃で2−メチル−2−ブテン0.2m
(1.9mmol)、アミド硫酸760mg(7.8m
mol)、亜塩素酸ナトリウム520mg(4.5mm
ol)を加え室温に戻して30分間攪拌する。酢酸エチ
ルで抽出し、飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥して減圧下溶媒を留去する。得られた残渣をシ
リカゲルカラムクロマトグラフィー(クロロホルム:メ
タノール50:1)に付し表題化合物を得た。 収量:180mg、収率:32.9% MS(FAB,m/z) 422 (MH+) H-NMR(CDCl3):0.83 (3H, t)、1.25 (2H, sex)、1.55
(2H, quint)、2.58 (2H,t)、3.79 (3H, s)、5.90 (2H,
s)、6.65-7.05 (8H, m)5) 6-butyl-4- (3,4-methylenedioxyphenyl) -2- (4-methoxyphenoxy)
Synthesis of pyridine-3-carboxylic acid 6-butyl-4- (3,4-methylenedioxyphenyl) -2- (4-methoxyphenoxy) pyridine-3-
520 mg of aldehyde was added to 8 ml of methylene chloride and 4 ml of water.
Dissolved at 0 ° C. in 0.2 m 2-methyl-2-butene
(1.9 mmol), 760 mg of amidosulfuric acid (7.8 m
mol), 520 mg of sodium chlorite (4.5 mm
ol) and the mixture is returned to room temperature and stirred for 30 minutes. The mixture is extracted with ethyl acetate, washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (chloroform: methanol 50: 1) to give the title compound. Yield: 180 mg, Yield: 32.9% MS (FAB, m / z) 422 (MH +) H-NMR (CDCl3): 0.83 (3H, t), 1.25 (2H, sex), 1.55
(2H, quint), 2.58 (2H, t), 3.79 (3H, s), 5.90 (2H,
s), 6.65-7.05 (8H, m)
【0045】実施例3 6−ブチル−4−(4−メトキ
シフェニル)−2−(4−メトキシフェニルオキシ)ピ
リジン−3−カルボン酸の合成 1)6−ブチル−3−シアノ−4−(4−メトキシフェ
ニル)−2−クロロピリジンの合成 6−ブチル−3−シアノ−4−(4−メトキシフェニ
ル)−2−ピリドン1.0g(3.5mmol)をオキ
シ塩化リン10mlに溶解し100℃で一晩攪拌する。
オキシ塩化リンを減圧下留去し残渣を酢酸エチルに溶解
する。飽和重曹水、飽和食塩水で洗浄し無水硫酸マグネ
シウムで乾燥する。減圧下溶媒を留去し表題化合物を得
た。このものは精製せずに以下の反応に利用した。 収量:1.00g MS(FAB,m/z) 301 (MH+) H-NMR(CDCl3):0.95 (3H, t)、1.45 (2H, sex)、1.75
(2H, quint)、2.85 (2H,t)、3.88 (3H, s)、7.05 (2H,
d)、7.20 (1H, s)、7.58 (2H, d)Example 3 Synthesis of 6-butyl-4- (4-methoxyphenyl) -2- (4-methoxyphenyloxy) pyridine-3-carboxylic acid 1) 6-butyl-3-cyano-4- (4 Synthesis of 6-butyl-3-cyano-4- (4-methoxyphenyl) -2-pyridone 1.0 g (3.5 mmol) in 10 ml of phosphorus oxychloride Stir overnight.
The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound. This was used for the following reaction without purification. Yield: 1.00 g MS (FAB, m / z) 301 (MH +) H-NMR (CDCl3): 0.95 (3H, t), 1.45 (2H, sex), 1.75
(2H, quint), 2.85 (2H, t), 3.88 (3H, s), 7.05 (2H,
d), 7.20 (1H, s), 7.58 (2H, d)
【0046】2)6−ブチル−3−シアノ−4−(4−
メトキシフェニル)−2−(4−メトキシフェニルオキ
シ)ピリジンの合成 セサモール130mg(0.94mmol)、水素化ナ
トリウム70mg(60%オイルディスパージョン、
1.8mmol)より作成したフェノキシドイオンのD
MF5ml溶液に6−ブチル−3−シアノ−4−(4−
メトキシフェニル)−2−クロロピリジン500mgを
DMF10mlに溶解して加えアルゴン雰囲気下2時間
攪拌する。減圧下溶媒を留去し、残渣をエーテルに溶解
し水、1規定水酸化ナトリウム溶液、飽和食塩水で洗浄
する。無水硫酸マグネシウムで乾燥し減圧下溶媒を留去
する。得られた残渣をシリカゲルカラムクロマトグラフ
ィー(酢酸エチル:ヘキサン 1:3)に付し表題化合
物を得た。 収量:420mg、収率:6−ブチル−3−シアノ−4
−(4−メトキシフェニル)−2−ピリドンより61.
8% MS(FAB,m/z) 389 (MH+) H-NMR(CDCl3):0.85 (3H, t)、1.30 (2H, sex)、1.59
(2H, quint) 、2.65 (2H, t)、3.84 (3H, s)、3.88 (3
H, s)、6.92 (2H, d)、6.92 (1H, s)、7.04 (2H,d)、7.
14 (2H, d)、7.61 (2H, d)2) 6-butyl-3-cyano-4- (4-
Synthesis of methoxyphenyl) -2- (4-methoxyphenyloxy) pyridine 130 mg (0.94 mmol) of sesamol, 70 mg of sodium hydride (60% oil dispersion,
D) of phenoxide ion prepared from 1.8 mmol)
6-butyl-3-cyano-4- (4-
(Methoxyphenyl) -2-chloropyridine (500 mg) is dissolved in DMF (10 ml), and the mixture is stirred under an argon atmosphere for 2 hours. The solvent is distilled off under reduced pressure, the residue is dissolved in ether, and washed with water, 1N sodium hydroxide solution and saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to give the title compound. Yield: 420 mg, Yield: 6-butyl-3-cyano-4
From-(4-methoxyphenyl) -2-pyridone 61.
8% MS (FAB, m / z) 389 (MH +) H-NMR (CDCl3): 0.85 (3H, t), 1.30 (2H, sex), 1.59
(2H, quint), 2.65 (2H, t), 3.84 (3H, s), 3.88 (3
H, s), 6.92 (2H, d), 6.92 (1H, s), 7.04 (2H, d), 7.
14 (2H, d), 7.61 (2H, d)
【0047】3)6−ブチル−4−(4−メトキシフェ
ニル)−2−(4−メトキシフェニルオキシ)ピリジン
−3−アルデヒドの合成 6−ブチル−3−シアノ−4−(4−メトキシフェニ
ル)−2−(4−メトキシフェニルオキシ)ピリジン2
00mg(0.51mmol)をベンゼン5mlに溶解
しアルゴン雰囲気下室温で水素化ジイソブチルアルミニ
ウム1Mヘキサン溶液1.5ml(1.5mmol)を
滴下する。室温で2時間攪拌しメタノールと水で反応を
停止する。室温で1時間攪拌し、不溶物をセライトを用
いて濾過する。濾液をを減圧下留去し得られた残渣をシ
リカゲルカラムクロマトグラフィー(酢酸エチル:ヘキ
サン 1:3)に付し表題化合物を得た。このものは分
離困難な不純物を含むがこれ以上精製せずに以下の反応
に用いる。 収量:190mg MS(FAB,m/z) 392 (MH+)3) Synthesis of 6-butyl-4- (4-methoxyphenyl) -2- (4-methoxyphenyloxy) pyridine-3-aldehyde 6-butyl-3-cyano-4- (4-methoxyphenyl) -2- (4-methoxyphenyloxy) pyridine 2
00 mg (0.51 mmol) is dissolved in 5 ml of benzene, and 1.5 ml (1.5 mmol) of a 1M solution of diisobutylaluminum hydride in hexane is added dropwise at room temperature under an argon atmosphere. Stir at room temperature for 2 hours and terminate the reaction with methanol and water. The mixture is stirred at room temperature for 1 hour, and the insoluble matter is filtered using celite. The filtrate was evaporated under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to obtain the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 190 mg MS (FAB, m / z) 392 (MH +)
【0048】4)6−ブチル−4−(4−メトキシフェ
ニル)−2−(4−メトキシフェニルオキシ)ピリジン
−3−カルボン酸の合成 6−ブチル−4−(4−メトキシフェニル)−2−(4
−メトキシフェニルオキシ)ピリジン−3−アルデヒド
190mgを塩化メチレン2ml、水1mlに溶解し、
0℃で2−メチル−2−ブテン0.3m(2.8mmo
l)、アミド硫酸70mg(0.72mmol)、亜塩
素酸ナトリウム200mg(1.8mmol)を加え室
温に戻して30分間攪拌する。酢酸エチルで抽出し、飽
和食塩水で洗浄し、無水硫酸マグネシウムで乾燥して減
圧下溶媒を留去する。得られた残渣をシリカゲルカラム
クロマトグラフィー(クロロホルム:メタノール 9:
1)に付し表題化合物を得た。 収量:85mg、収率:6−ブチル−3−シアノ−4−
(4−メトキシフェニル)−2−(4−メトキシフェニ
ルオキシ)ピリジンより40.9% MS(ESI,m/z) 408 (MH+) H-NMR(CDCl3):0.82 (3H, t)、1.25 (2H, sex)、1.50
(2H, quint)、2.52 (2H, t)、3.60 (3H, s)、3.75 (3H,
d)、6.70 (4H, m)、6.90 (2H, m)、7.35 (3
H,m)4) Synthesis of 6-butyl-4- (4-methoxyphenyl) -2- (4-methoxyphenyloxy) pyridine-3-carboxylic acid 6-butyl-4- (4-methoxyphenyl) -2-carboxylic acid (4
-Methoxyphenyloxy) pyridine-3-aldehyde 190 mg was dissolved in methylene chloride 2 ml and water 1 ml,
At 0 ° C., 0.3 m of 2-methyl-2-butene (2.8 mmol)
l), 70 mg (0.72 mmol) of amidosulfuric acid and 200 mg (1.8 mmol) of sodium chlorite are added, and the mixture is returned to room temperature and stirred for 30 minutes. The mixture is extracted with ethyl acetate, washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (chloroform: methanol 9: 9).
1) to give the title compound. Yield: 85 mg, Yield: 6-butyl-3-cyano-4-
40.9% MS (ESI, m / z) 408 (MH +) H-NMR (CDCl3) from (4-methoxyphenyl) -2- (4-methoxyphenyloxy) pyridine: 0.82 (3H, t), 1.25 ( 2H, sex), 1.50
(2H, quint), 2.52 (2H, t), 3.60 (3H, s), 3.75 (3H,
d), 6.70 (4H, m), 6.90 (2H, m), 7.35 (3
H, m)
【0049】実施例4 4−(4−メトキシフェニル)
−2−(3,4−メチレンジオキシフェノキシ)−6−
ペンチルピリジン−3−カルボン酸の合成 1)1−(4−メトキシフェニル)−3−オキソオクタ
ノールの合成 THF40ml、リチウムビストリメチルシリルアミド
1M−THF溶液24ml(24.0mmol)に−7
8℃でTHF20mlに溶解したヘプタン−2−オン
2.8ml(20.1mmol)を30分間で滴下し
た。滴下終了10分後p−アニスアルデヒド2.45m
l(20.1mmol)を加え−78℃で1.5時間攪
拌した。2規定塩酸15mlで反応を止め、酢酸エチル
で抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃
縮した。残渣をシリカゲルクロマトグラフィー(ヘキサ
ン:酢酸エチル 4:1)で精製し表題化合物を得た。 収量:2.99g(11.9mmol)、収率:59.
4% H−NMR(CDCl3):0.86-0.91(3H,t)、1.21-1.
35(4H,m)、1.53-1.64(2H,m)、2.39-2.46(2H,t)、2.72-
2.90(2H,m)、3.23-3.25(2H,d)、3.80(3H,s)、5.07-5.14
(1H,m)、6.86-6.90(2H,d)、7.26-7.30(2H,d)Example 4 4- (4-methoxyphenyl)
-2- (3,4-methylenedioxyphenoxy) -6-
Synthesis of pentylpyridine-3-carboxylic acid 1) Synthesis of 1- (4-methoxyphenyl) -3-oxooctanol -7 was added to 40 ml of THF and 24 ml (24.0 mmol) of 1M lithium bistrimethylsilylamide in THF solution.
At 8 ° C, 2.8 ml (20.1 mmol) of hept-2-one dissolved in 20 ml of THF was added dropwise over 30 minutes. 10 minutes after completion of the dropwise addition, 2.45 m of p-anisaldehyde
1 (20.1 mmol) was added and the mixture was stirred at -78 ° C for 1.5 hours. The reaction was stopped with 15 ml of 2N hydrochloric acid, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 2.99 g (11.9 mmol), yield: 59.
4% H-NMR (CDCl3): 0.86-0.91 (3H, t), 1.21-1.
35 (4H, m), 1.53-1.64 (2H, m), 2.39-2.46 (2H, t), 2.72-
2.90 (2H, m), 3.23-3.25 (2H, d), 3.80 (3H, s), 5.07-5.14
(1H, m), 6.86-6.90 (2H, d), 7.26-7.30 (2H, d)
【0050】2)1−(4−メトキシフェニル)−1−
オクテン−3−オンの合成 トルエン80ml中、1−(4−メトキシフェニル)−
3−オキソオクタノール2.06g(8.23mmo
l)と無水硫酸マグネシウム4.07g(33.8mm
ol)を3時間還流した。濾過、酢酸エチルで洗浄し濾
液を減圧下濃縮した。残渣をシリカゲルクロマトグラフ
ィー(ヘキサン:酢酸エチル 4:1)で精製し表題化
合物を得た。 収量:1.69g(7.27mmol)、収率:88.
3% MS(ESI,m/z) 233(MH+) H-NMR(CDCl3):0.88-0.93(3H,t)、1.28-1.40(2H,m)、1.
63-1.74(2H,m)、2.60-2.66(2H,t)、3.84(3H,s)、6.60-
6.66(1H,d)、6.89-6.93(2H,d)、7.47-7.55(3H,m)2) 1- (4-methoxyphenyl) -1-
Synthesis of octen-3-one 1- (4-methoxyphenyl)-in 80 ml of toluene
2.06 g of 3-oxooctanol (8.23 mmol
l) and anhydrous magnesium sulfate 4.07 g (33.8 mm
ol) was refluxed for 3 hours. After filtration and washing with ethyl acetate, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 1.69 g (7.27 mmol), Yield: 88.
3% MS (ESI, m / z) 233 (MH +) H-NMR (CDCl3): 0.88-0.93 (3H, t), 1.28-1.40 (2H, m), 1.
63-1.74 (2H, m), 2.60-2.66 (2H, t), 3.84 (3H, s), 6.60-
6.66 (1H, d), 6.89-6.93 (2H, d), 7.47-7.55 (3H, m)
【0051】3)3−シアノ−4−(4−メトキシフェ
ニル)−6−ペンチル−2−ピリドンの合成 DMSO10ml中、シアノアセトアミド506mg
(6.02mmol)にt−ブトキシカリウム669m
g(5.96mmol)ついでDMSO5mlに溶解し
た1−(4−メトキシフェニル)−1−オクテン−3−
オン1.40g(6.01mmol)を加え室温で20
分間攪拌した。t−ブトキシカリウム2.13g(1
9.0mmol)を加えた後、酸素ガスを1分間バブリ
ングしさらに室温常圧酸素雰囲気下で1時間攪拌した。
2規定塩酸を加え析出した結晶を濾取、水、ヘキサンで
洗浄、減圧乾燥し表題化合物を得た。 収量:1.42g(4.79mmol)、収率:79.
7% MS(ESI,m/z) 297(MH+) H-NMR(CDCl3):0.89-0.94(3H,t)、1.37-1.42(4H,m)、1.
71-1.83(2H,m)、2.68-2.73(2H,t)、3.88(3H,s)、6.26(1
H,s)、7.00-7.03(2H,d)、7.60-7.63(2H,d)3) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-pentyl-2-pyridone 506 mg of cyanoacetamide in 10 ml of DMSO.
(6.02 mmol) to 669 m of potassium t-butoxide
g (5.96 mmol) and then 1- (4-methoxyphenyl) -1-octene-3- dissolved in 5 ml of DMSO.
Add 1.40 g (6.01 mmol) of ON and add 20 at room temperature.
Stirred for minutes. 2.13 g of potassium t-butoxide (1
After adding 9.0 mmol), oxygen gas was bubbled for 1 minute, and the mixture was further stirred at room temperature under an atmospheric oxygen atmosphere for 1 hour.
2N Hydrochloric acid was added, and the precipitated crystals were collected by filtration, washed with water and hexane, and dried under reduced pressure to obtain the title compound. Yield: 1.42 g (4.79 mmol), yield: 79.
7% MS (ESI, m / z) 297 (MH +) H-NMR (CDCl3): 0.89-0.94 (3H, t), 1.37-1.42 (4H, m), 1.
71-1.83 (2H, m), 2.68-2.73 (2H, t), 3.88 (3H, s), 6.26 (1
H, s), 7.00-7.03 (2H, d), 7.60-7.63 (2H, d)
【0052】4)2−クロロ−3−シアノ−4−(4−
メトキシフェニル)−6−ペンチルピリジンの合成 3−シアノ−4−(4−メトキシフェニル)−6−ペン
チル−2−ピリドン1.27g(4.29mmol)に
オキシ塩化リン15ml、N,N−ジメチルアニリン
0.55ml(4.34mmol)を加え100℃で4
時間加熱した。オキシ塩化リンを留去後水を加えエーテ
ル抽出し、有機層を無水硫酸ナトリウムで乾燥、減圧下
濃縮した。残渣を精製せずに次の反応に用いた。 収量:1.27g(4.03mmol)、収率:93.
9% MS(ESI,m/z) 315(MH+) H-NMR(CDCl3):0.87-0.94(3H,t)、1.32-1.41(4H,m)、1.
70-1.83(2H,m)、2.80-2.86(2H,t)、3.88(3H,s)、7.02-
7.06(2H,d)、7.18(1H,s)、7.55-7.58(2H,d)4) 2-chloro-3-cyano-4- (4-
Synthesis of (methoxyphenyl) -6-pentylpyridine 3-cyano-4- (4-methoxyphenyl) -6-pentyl-2-pyridone was added to 1.27 g (4.29 mmol) of phosphorus oxychloride in 15 ml and N, N-dimethylaniline. Add 0.55 ml (4.34 mmol) and add 4 at 100 ° C.
Heated for hours. After distilling off phosphorus oxychloride, water was added thereto, and the mixture was extracted with ether. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was used for the next reaction without purification. Yield: 1.27 g (4.03 mmol), yield: 93.
9% MS (ESI, m / z) 315 (MH +) H-NMR (CDCl3): 0.87-0.94 (3H, t), 1.32-1.41 (4H, m), 1.
70-1.83 (2H, m), 2.80-2.86 (2H, t), 3.88 (3H, s), 7.02-
7.06 (2H, d), 7.18 (1H, s), 7.55-7.58 (2H, d)
【0053】5)3−シアノ−4−(4−メトキシフェ
ニル)−2−(3,4−メチレンジオキシフェノキシ)
−6−ペンチルピリジンの合成 DMF15ml中、セサモール322mg(2.33m
mol)に60%水素化ナトリウム120mg(3.0
mmol)を加え室温で15分間攪拌した。2−クロロ
−3−シアノ−4−(4−メトキシフェニル)−6−ペ
ンチルピリジン705mg(2.24mmol)をDM
F1mlに溶解して滴下し、室温で4時間攪拌した。減
圧下でDMFを留去後1規定塩酸を加え、酢酸エチルで
抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮
した。残渣をシリカゲルクロマトグラフィー(ヘキサ
ン:酢酸エチル 4:1)で精製し表題化合物を得た。 収量:0.62g(1.49mmol)、収率:66.
5% MS(FAB,m/z) 417(MH+) H-NMR(CDCl3):0.83-0.89(3H,t)、1.22-1.34(4H,m)、1.
56-1.68(2H,m)、2.62-2.68(2H,t)、3.88(3H,s)、6.01(2
H,s)、6.62-6.82(3H,m)、6.93(1H,s)、7.02-7.05(2H,
d)、7.59-7.62(2H,d)5) 3-cyano-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy)
Synthesis of -6-pentylpyridine Sesamol 322 mg (2.33 m
mol) and 120 mg of 60% sodium hydride (3.0
mmol) and stirred at room temperature for 15 minutes. 705 mg (2.24 mmol) of 2-chloro-3-cyano-4- (4-methoxyphenyl) -6-pentylpyridine was added to DM
The resultant was dissolved in F1 ml and added dropwise, followed by stirring at room temperature for 4 hours. After distilling off DMF under reduced pressure, 1N hydrochloric acid was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 0.62 g (1.49 mmol), yield: 66.
5% MS (FAB, m / z) 417 (MH +) H-NMR (CDCl3): 0.83-0.89 (3H, t), 1.22-1.34 (4H, m), 1.
56-1.68 (2H, m), 2.62-2.68 (2H, t), 3.88 (3H, s), 6.01 (2
H, s), 6.62-6.82 (3H, m), 6.93 (1H, s), 7.02-7.05 (2H,
d), 7.59-7.62 (2H, d)
【0054】6)4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)−6−ペンチ
ルピリジン−3−アルデヒドの合成 3−シアノ−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)−6−ペンチ
ルピリジン210mg(0.50mmol)をベンゼン
5mlに溶解し室温で水素化ジイソブチルアルミニウム
1Mヘキサン溶液1.5ml(1.5mmol)を加え
室温で3時間攪拌した。メタノール0.2ml、水1m
lを加え20分間攪拌した。沈澱を濾過し濾液を減圧下
濃縮した。残渣をシリカゲルクロマトグラフィー(ヘキ
サン:酢酸エチル 4:1)で精製し表題化合物を得
た。 収量:176mg(0.42mmol)、収率:83.
2% H-NMR(CDCl3):0.82-0.90(3H,t)、1.22-1.33(4H,m)、1.
56-1.67(2H,m)、2.56-2.67(2H,m)、3.87(3H,s)、6.00(2
H,s)、6.63-6.84(4H,m)、6.97-7.00(2H,d)、7.30-7.33
(2H,d)、10.24(1H,s,CHO)6) 4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenoxy) -6-pentylpyridine-3-aldehyde 3-cyano-4- (4-methoxyphenyl) -2-
210 mg (0.50 mmol) of (3,4-methylenedioxyphenoxy) -6-pentylpyridine are dissolved in 5 ml of benzene, and 1.5 ml (1.5 mmol) of a 1M solution of diisobutylaluminum hydride in hexane is added at room temperature for 3 hours at room temperature. Stirred. 0.2 ml of methanol, 1 m of water
was added and stirred for 20 minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 176 mg (0.42 mmol), yield: 83.
2% H-NMR (CDCl3): 0.82-0.90 (3H, t), 1.22-1.33 (4H, m), 1.
56-1.67 (2H, m), 2.56-2.67 (2H, m), 3.87 (3H, s), 6.00 (2
H, s), 6.63-6.84 (4H, m), 6.97-7.00 (2H, d), 7.30-7.33
(2H, d), 10.24 (1H, s, CHO)
【0055】7)4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)−6−ペンチ
ルピリジン−3−カルボン酸の合成 塩化メチレン2ml、水1ml中4−(4−メトキシフ
ェニル)−2−(3,4−メチレンジオキシフェノキ
シ)−6−ペンチルピリジン−3−アルデヒド169m
g(0.43mmol)に氷浴下2−メチル−2−ブテ
ン0.3ml(2.83mmol)、アミド硫酸100
mg(1.03mmol)、亜塩素酸ナトリウム205
mg(2.27mmol)を加え室温で20分間攪拌し
た。水を加え、酢酸エチルで抽出し有機層を無水硫酸ナ
トリウムで乾燥、減圧下濃縮した。残渣をシリカゲルク
ロマトグラフィー(クロロホルム:メタノール 9:
1)で精製し表題化合物を得た。 収量:76mg(0.17mmol)、収率:43.1
% MS(ESI,m/z) 436(MH+) H-NMR(CDCl3)、0.80-0.86(3H,t)、1.23-1.32(4H,m)、1.
45-1.60(2H,m)、2.49-2.55(2H,t)、3.55(3H,s)、5.85(2
H,s)、6.36-6.71(6H,m)、7.27-7.34(2H,m)7) 4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenoxy) -6-pentylpyridine-3-carboxylic acid 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) in 2 ml of methylene chloride and 1 ml of water 169 m of -6-pentylpyridine-3-aldehyde
g (0.43 mmol) in an ice bath, 0.3 ml (2.83 mmol) of 2-methyl-2-butene, 100 g of amidosulfuric acid
mg (1.03 mmol), sodium chlorite 205
mg (2.27 mmol) was added and the mixture was stirred at room temperature for 20 minutes. Water was added, the mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was chromatographed on silica gel (chloroform: methanol 9: 9).
Purification in 1) gave the title compound. Yield: 76 mg (0.17 mmol), yield: 43.1
% MS (ESI, m / z) 436 (MH +) H-NMR (CDCl3), 0.80-0.86 (3H, t), 1.23-1.32 (4H, m), 1.
45-1.60 (2H, m), 2.49-2.55 (2H, t), 3.55 (3H, s), 5.85 (2
H, s), 6.36-6.71 (6H, m), 7.27-7.34 (2H, m)
【0056】実施例5 4−(4−メトキシフェニル)
−2−(3,4−メチレンジオキシフェニル)−6−ペ
ンチルピリジン−3−カルボン酸 1)3−シアノ−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェニル)−6−ペンチル
ピリジンの合成 2−クロロ−3−シアノ−4−(4−メトキシフェニ
ル)−6−ペンチルピリジン547mg(1.74mm
ol)にDME5ml、テトラキス(トリフェニルホス
フィン)パラジウム62mg(0.05mmol)を加
え室温で30分間攪拌した。DME3mlに懸濁させた
3,4−メチレンジオキシフェニルホウ酸314mg
(1.89mmol)、2M−炭酸ナトリウム水溶液
2.5mlを加え7.5時間還流した。水、エーテル加
えセライト濾過、濾液をエーテルで抽出、有機層を1規
定水酸化ナトリウム水溶液で洗浄した。有機層を無水硫
酸ナトリウムで乾燥、減圧下濃縮した。残渣をシリカゲ
ルクロマトグラフィー(ヘキサン:酢酸エチル 6:
1)で精製し表題化合物を得た。 収量:659mg(1.65mmol)、収率:94.
6% MS(FAB,m/z) 401(MH+) H-NMR(CDCl3):0.89-0.95(3H,t)、1.35-1.43(4H,m)、1.
75-1.86(2H,m)、2.86-2.94(2H,m)、3.88(3H,s)、6.04(2
H,s)、6.92-6.95(1H,d)、7.03-7.06(2H,d)、7.17(1H,
s)、7.37-7.48(2H,m)、7.57−7.60(2H,
d)Example 5 4- (4-methoxyphenyl)
-2- (3,4-Methylenedioxyphenyl) -6-pentylpyridine-3-carboxylic acid 1) 3-cyano-4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenyl) -6-pentylpyridine 2-chloro-3-cyano-4- (4-methoxyphenyl) -6-pentylpyridine 547 mg (1.74 mm
ol), 5 ml of DME and 62 mg (0.05 mmol) of tetrakis (triphenylphosphine) palladium were added, and the mixture was stirred at room temperature for 30 minutes. 314 mg of 3,4-methylenedioxyphenylboric acid suspended in 3 ml of DME
(1.89 mmol), 2.5 ml of a 2M aqueous solution of sodium carbonate was added, and the mixture was refluxed for 7.5 hours. Water and ether were added, the mixture was filtered through celite, the filtrate was extracted with ether, and the organic layer was washed with a 1N aqueous sodium hydroxide solution. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (hexane: ethyl acetate 6:
Purification in 1) gave the title compound. Yield: 659 mg (1.65 mmol), yield: 94.
6% MS (FAB, m / z) 401 (MH +) H-NMR (CDCl3): 0.89-0.95 (3H, t), 1.35-1.43 (4H, m), 1.
75-1.86 (2H, m), 2.86-2.94 (2H, m), 3.88 (3H, s), 6.04 (2
H, s), 6.92-6.95 (1H, d), 7.03-7.06 (2H, d), 7.17 (1H,
s), 7.37-7.48 (2H, m), 7.57-7.60 (2H,
d)
【0057】2)4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェニル)−6−ペンチル
ピリジン−3−アルデヒドの合成 3−シアノ−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェニル)−6−ペンチル
ピリジン289mg(0.72mmol)をベンゼン7
mlに溶解し室温で水素化ジイソブチルアルミニウム1
Mヘキサン溶液2.2ml(2.2mmol)を加え室
温で3時間攪拌した。メタノール0.3ml、水1.5
mlを加え20分間攪拌した。沈澱を濾過し濾液を減圧
下濃縮した。残渣をシリカゲルクロマトグラフィー(ヘ
キサン:酢酸エチル 4:1)で精製し表題化合物を得
た。 収量:148mg(0.37mmol)、収率:50.
9% MS(ESI,m/z) 404(MH+) H-NMR(CDCl3):0.88-0.96(3H,t)、1.32-1.44(4H,m)、1.
74-1.87(2H,m)、2.86-2.91(2H,m)、3.87(3H,s)、6.03(2
H,s)、6.87-7.00(4H,m)、7.09-7.14(2H,m)、7.29-7.36
(2H,m)、9.95(1H,s)2) 4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenyl) -6-pentylpyridine-3-aldehyde 3-cyano-4- (4-methoxyphenyl) -2-
289 mg (0.72 mmol) of (3,4-methylenedioxyphenyl) -6-pentylpyridine was added to benzene 7
disodium diisobutylaluminum 1 at room temperature
2.2 ml (2.2 mmol) of M hexane solution was added, and the mixture was stirred at room temperature for 3 hours. 0.3 ml of methanol, 1.5 of water
ml was added and stirred for 20 minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 148 mg (0.37 mmol), yield: 50.
9% MS (ESI, m / z) 404 (MH +) H-NMR (CDCl3): 0.88-0.96 (3H, t), 1.32-1.44 (4H, m), 1.
74-1.87 (2H, m), 2.86-2.91 (2H, m), 3.87 (3H, s), 6.03 (2
H, s), 6.87-7.00 (4H, m), 7.09-7.14 (2H, m), 7.29-7.36
(2H, m), 9.95 (1H, s)
【0058】3)4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェニル)−6−ペンチル
ピリジン−3−カルボン酸の合成 塩化メチレン2ml、水1ml中4−(4−メトキシフ
ェニル)−2−(3,4−メチレンジオキシフェニル)
−6−ペンチルピリジン−3−アルデヒド144mg
(0.36mmol)に氷浴下2−メチル−2−ブテン
0.3ml(2.83mmol)、アミド硫酸100m
g(1.03mmol)、亜塩素酸ナトリウム206m
g(2.28mmol)を加え室温で30分間攪拌し
た。水を加え、酢酸エチルで抽出し有機層を無水硫酸ナ
トリウムで乾燥、減圧下濃縮した。残渣をシリカゲルク
ロマトグラフィー(クロロホルム:メタノール 50:
1)で精製し表題化合物を得た。 収量:108mg(0.26mmol)、収率:72.
1% MS(ESI,m/z) 420(MH+) H-NMR(CDCl3):0.88-0.94(3H,t)、1.32-1.43(4H,m)、1.
72-1.85(2H,m)、2.82-2.88(2H,t)、3.85(3H,s)、5.99(2
H,s)、6.80-6.83(1H,d)、6.93-6.96(2H,d)、7.08(1H,
s)、7.09-7.17(2H,m)、7.36-7.39(2H,d)3) 4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenyl) -6-pentylpyridine-3-carboxylic acid 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyl) in 2 ml of methylene chloride and 1 ml of water
144 mg of -6-pentylpyridine-3-aldehyde
(0.36 mmol), 0.3 ml (2.83 mmol) of 2-methyl-2-butene in an ice bath, 100 m of amidosulfuric acid
g (1.03 mmol), sodium chlorite 206 m
g (2.28 mmol) was added and the mixture was stirred at room temperature for 30 minutes. Water was added, the mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (chloroform: methanol 50:
Purification in 1) gave the title compound. Yield: 108 mg (0.26 mmol), yield: 72.
1% MS (ESI, m / z) 420 (MH +) H-NMR (CDCl3): 0.88-0.94 (3H, t), 1.32-1.43 (4H, m), 1.
72-1.85 (2H, m), 2.82-2.88 (2H, t), 3.85 (3H, s), 5.99 (2
H, s), 6.80-6.83 (1H, d), 6.93-6.96 (2H, d), 7.08 (1H,
s), 7.09-7.17 (2H, m), 7.36-7.39 (2H, d)
【0059】実施例6 4−(4−メトキシフェニル)
−2−(3,4−メチレンジオキシフェノキシ)−6−
プロピルピリジン−3−カルボン酸の合成 1)1−(4−メトキシフェニル)−3−オキソヘキサ
ノールの合成 THF30ml、リチウムビストリメチルシリルアミド
1M−THF溶液18mlに−78℃でTHF15ml
に溶解したペンタン−2−オン1.60ml(15.1
mmol)を15分間で滴下した。滴下終了10分後p
−アニスアルデヒド1.80ml(14.8mmol)
を加え−78℃で1.5時間攪拌した。2規定塩酸15
mlで反応を止め、酢酸エチルで抽出し有機層を無水硫
酸ナトリウムで乾燥、減圧下濃縮した。残渣をシリカゲ
ルクロマトグラフィー(ヘキサン:酢酸エチル 6:
1)で精製し表題化合物を得た。 収量:2.40g(10.8mmol)収率:73.0
% H-NMR(CDCl3):0.89-0.94(3H,t)、1.58-1.68(2H,m)、2.
38-2.43(2H,t)、2.71-2.85(2H,m)、3.23-3.24(1H,d)、
3.80(3H,s)、5.08-5.15(1H,m)、6.86-6.89(2H,d)、7.26
-7.29(2H,d)Example 6 4- (4-methoxyphenyl)
-2- (3,4-methylenedioxyphenoxy) -6-
Synthesis of propylpyridine-3-carboxylic acid 1) Synthesis of 1- (4-methoxyphenyl) -3-oxohexanol THF 30 ml, lithium bistrimethylsilylamide 1M-THF solution 18 ml at -78 ° C THF 15 ml
1.60 ml of pentan-2-one (15.1) dissolved in
mmol) was added dropwise over 15 minutes. 10 minutes after the end of dropping
-Anisaldehyde 1.80 ml (14.8 mmol)
Was added and stirred at -78 ° C for 1.5 hours. 2N hydrochloric acid 15
The reaction was quenched with ml, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (hexane: ethyl acetate 6:
Purification in 1) gave the title compound. Yield: 2.40 g (10.8 mmol) Yield: 73.0
% H-NMR (CDCl3): 0.89-0.94 (3H, t), 1.58-1.68 (2H, m), 2.
38-2.43 (2H, t), 2.71-2.85 (2H, m), 3.23-3.24 (1H, d),
3.80 (3H, s), 5.08-5.15 (1H, m), 6.86-6.89 (2H, d), 7.26
-7.29 (2H, d)
【0060】2)1−(4−メトキシフェニル)−1−
ヘキセン−3−オンの合成 トルエン70ml中、1−(4−メトキシフェニル)−
3−オキソヘキサノール2.40g(10.8mmo
l)と無水硫酸マグネシウム3.98g(33.1mm
ol)を2時間還流した。濾過、酢酸エチルで洗浄し濾
液を減圧下濃縮した。残渣を精製せずに次の反応に用い
た。 収量:2.19g(10.7mmol)、収率:99.
1% MS(ESI,m/z) 205(MH+) H-NMR(CDCl3):0.95-1.01(3H,t)、1.64-1.78(2H,m)、2.
59-2.65(2H,t)、3.84(3H,s)、6.60-6.66(1H,d)、6.90-
6.93(2H,d)、7.49-7.54(3H,m)2) 1- (4-methoxyphenyl) -1-
Synthesis of hexen-3-one 1- (4-methoxyphenyl)-in 70 ml of toluene
2.40 g of 3-oxohexanol (10.8 mmol
l) and 3.98 g (33.1 mm) of anhydrous magnesium sulfate
ol) was refluxed for 2 hours. After filtration and washing with ethyl acetate, the filtrate was concentrated under reduced pressure. The residue was used for the next reaction without purification. Yield: 2.19 g (10.7 mmol), yield: 99.
1% MS (ESI, m / z) 205 (MH +) H-NMR (CDCl3): 0.95-1.01 (3H, t), 1.64-1.78 (2H, m), 2.
59-2.65 (2H, t), 3.84 (3H, s), 6.60-6.66 (1H, d), 6.90-
6.93 (2H, d), 7.49-7.54 (3H, m)
【0061】3)3−シアノ−4−(4−メトキシフェ
ニル)−6−プロピル−2−ピリドンの合成 DMSO20ml中、シアノアセトアミド905mg
(10.8mmol)にt−ブトキシカリウム1.20
1g(10.7mmol)ついでDMSO5mlに溶解
した1−(4−メトキシフェニル)−1−ヘキセン−3
−オン2.18g(10.7mmol)を加え室温で2
0分間攪拌した。t−ブトキシカリウム3.71g(3
3.1mmol)を加えた後、酸素ガスを2分間バブリ
ングしさらに室温常圧酸素雰囲気下で1時間攪拌した。
2規定塩酸を加え析出した結晶を濾取、水、ヘキサンで
洗浄、減圧乾燥し表題化合物を得た。 収量:1.80g(6.71mmol)、収率:62.
7% MS(ESI,m/z) 269(MH+) H-NMR(CDCl3):1.01-1.07(3H,t)、1.77-1.85(2H,m)、2.
67-2.73(2H,t)、3.88(3H,s)、6.26(1H,s)、7.00-7.03(2
H,d)、7.60-7.63(2H,d)3) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-propyl-2-pyridone 905 mg of cyanoacetamide in 20 ml of DMSO
(10.8 mmol) to potassium t-butoxide 1.20
1 g (10.7 mmol) and then 1- (4-methoxyphenyl) -1-hexene-3 dissolved in 5 ml of DMSO.
-One (1.88 g, 10.7 mmol) was added at room temperature.
Stirred for 0 minutes. 3.71 g of potassium t-butoxide (3
After adding 3.1 mmol), oxygen gas was bubbled for 2 minutes, and the mixture was further stirred for 1 hour at room temperature under a normal pressure oxygen atmosphere.
2N Hydrochloric acid was added, and the precipitated crystals were collected by filtration, washed with water and hexane, and dried under reduced pressure to obtain the title compound. Yield: 1.80 g (6.71 mmol), yield: 62.
7% MS (ESI, m / z) 269 (MH +) H-NMR (CDCl3): 1.01-1.07 (3H, t), 1.77-1.85 (2H, m), 2.
67-2.73 (2H, t), 3.88 (3H, s), 6.26 (1H, s), 7.00-7.03 (2
H, d), 7.60-7.63 (2H, d)
【0062】4)2−クロロ−3−シアノ−4−(4−
メトキシフェニル)−6−プロピルピリジンの合成 3−シアノ−4−(4−メトキシフェニル)−6−プロ
ピル−2−ピリドン1.78g(6.63mmol)に
オキシ塩化リン30ml、N,N−ジメチルアニリン
0.90ml(7.10mmol)を加え100℃で2
時間加熱した。オキシ塩化リンを留去後水を加えエーテ
ル抽出し、有機層を飽和炭酸水素ナトリウム水溶液で洗
浄、無水硫酸ナトリウムで乾燥、減圧下濃縮した。残渣
を精製せずに次の反応に用いた。 収量:1.59g(5.55mmol)、収率:83.
8% MS(ESI,m/z) 287(MH+) H-NMR(CDCl3):0.97-1.03(3H,t)、1.73-1.87(2H,m)、2.
79-2.84(2H,t)、3.88(3H,s)、7.02-7.05(2H,d)、7.55-
7.58(2H,d)4) 2-chloro-3-cyano-4- (4-
Synthesis of methoxyphenyl) -6-propylpyridine To 1.78 g (6.63 mmol) of 3-cyano-4- (4-methoxyphenyl) -6-propyl-2-pyridone were added 30 ml of phosphorus oxychloride and N, N-dimethylaniline. Add 0.90 ml (7.10 mmol) and add 2 at 100 ° C.
Heated for hours. After distilling off phosphorus oxychloride, water was added thereto, and the mixture was extracted with ether. The organic layer was washed with a saturated aqueous solution of sodium hydrogen carbonate, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was used for the next reaction without purification. Yield: 1.59 g (5.55 mmol), yield: 83.
8% MS (ESI, m / z) 287 (MH +) H-NMR (CDCl3): 0.97-1.03 (3H, t), 1.73-1.87 (2H, m), 2.
79-2.84 (2H, t), 3.88 (3H, s), 7.02-7.05 (2H, d), 7.55-
7.58 (2H, d)
【0063】5)3−シアノ−4−(4−メトキシフェ
ニル)−2−(3,4−メチレンジオキシフェノキシ)
−6−プロピルピリジンの合成 DMF15ml中、セサモール440mg(3.18m
mol)に60%水素化ナトリウム160mg(4.0
mmol)を加え室温で15分間攪拌した。2−クロロ
−3−シアノ−4−(4−メトキシフェニル)−6−プ
ロピルピリジン875mg(3.05mmol)をDM
F3mlに溶解して滴下し、室温で2時間攪拌した。減
圧下でDMFを留去後1規定塩酸を加え、酢酸エチルで
抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮
した。残渣をシリカゲルクロマトグラフィー(ヘキサ
ン:酢酸エチル 4:1)で精製し表題化合物を得た。 収量:872mg(2.24mmol)、収率:70.
6% MS(FAB,m/z) 389(MH+) H-NMR(CDCl3):0.88-0.94(3H,t)、1.58-1.72(2H,m)、2.
61-2.66(2H,t)、3.88(3H,s)、6.01(2H,s)、6.62-6.82(3
H,s)、6.93(1H,s)、7.02-7.05(2H,d)、7.60-7.63(2H,d)5) 3-cyano-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy)
Synthesis of -6-propylpyridine In 15 ml of DMF, 440 mg of sesamol (3.18 m
mol) and 60 mg of sodium hydride (160 mg, 4.0%).
mmol) and stirred at room temperature for 15 minutes. 875 mg (3.05 mmol) of 2-chloro-3-cyano-4- (4-methoxyphenyl) -6-propylpyridine was added to DM
F3ml was dissolved and added dropwise, and the mixture was stirred at room temperature for 2 hours. After distilling off DMF under reduced pressure, 1N hydrochloric acid was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 872 mg (2.24 mmol), yield: 70.
6% MS (FAB, m / z) 389 (MH +) H-NMR (CDCl3): 0.88-0.94 (3H, t), 1.58-1.72 (2H, m), 2.
61-2.66 (2H, t), 3.88 (3H, s), 6.01 (2H, s), 6.62-6.82 (3
H, s), 6.93 (1H, s), 7.02-7.05 (2H, d), 7.60-7.63 (2H, d)
【0064】6)4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)−6−プロピ
ルピリジン−3−アルデヒドの合成 3−シアノ−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)−6−プロピ
ルピリジン389mg(1.00mmol)をベンゼン
10mlに溶解し室温で水素化ジイソブチルアルミニウ
ム1Mヘキサン溶液3.0ml(3.0mmol)を加
え室温で2時間攪拌した。メタノール0.4ml、水2
mlを加え20分間攪拌した。沈澱を濾過し濾液を減圧
下濃縮した。残渣をシリカゲルクロマトグラフィー(ヘ
キサン:酢酸エチル 8:1)で精製し表題化合物を得
た。 収量:279mg(0.71mmol)、収率:71.
3% H-NMR(CDCl3):0.88-0.94(3H,t)、1.60-1.72(2H,m)、2.
60-2.65(2H,t)、3.87(3H,s)、6.00(2H,s)、6.61-6.84(4
H,m)、6.97-7.00(2H,d)、7.30-7.33(2H,d)10.20(1H,s,C
HO)6) 4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenoxy) -6-propylpyridine-3-aldehyde 3-cyano-4- (4-methoxyphenyl) -2-
389 mg (1.00 mmol) of (3,4-methylenedioxyphenoxy) -6-propylpyridine were dissolved in 10 ml of benzene, and 3.0 ml (3.0 mmol) of a 1M solution of diisobutylaluminum hydride in hexane was added at room temperature, followed by 2 hours at room temperature. Stirred. 0.4 ml of methanol, water 2
ml was added and stirred for 20 minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 8: 1) to give the title compound. Yield: 279 mg (0.71 mmol), yield: 71.
3% H-NMR (CDCl3): 0.88-0.94 (3H, t), 1.60-1.72 (2H, m), 2.
60-2.65 (2H, t), 3.87 (3H, s), 6.00 (2H, s), 6.61-6.84 (4
H, m), 6.97-7.00 (2H, d), 7.30-7.33 (2H, d) 10.20 (1H, s, C
HO)
【0065】7)4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)−6−プロピ
ルピリジン−3−カルボン酸の合成 塩化メチレン4ml、水2ml中4−(4−メトキシフ
ェニル)−2−(3,4−メチレンジオキシフェノキ
シ)−6−プロピルピリジン−3−アルデヒド274m
g(0.70mmol)に氷浴下2−メチル−2−ブテ
ン0.6ml(5.66mmol)、アミド硫酸210
mg(2.16mmol)、亜塩素酸ナトリウム480
mg(5.31mmol)を加え室温で20分間攪拌し
た。水を加え、酢酸エチルで抽出し有機層を無水硫酸ナ
トリウムで乾燥、減圧下濃縮した。残渣をシリカゲルク
ロマトグラフィー(クロロホルム:メタノール 30:
1)で精製し表題化合物を得た。 収量:191mg(0.47mmol)、収率:66.
8% MS(ESI,m/z) 408(MH+) H-NMR(CDCl3):0.83-0.88(3H,t)、1.50-1.63(2H,m)、2.
48-2.55(2H,t)、3.60(3H,s)、5.89(2H,s)、6.40-6.45(1
H,m)、6.52-6.59(2H,m)、6.66-6.73(3H,m)、7.30-7.33
(2H,d)7) 4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenoxy) -6-propylpyridine-3-carboxylic acid 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) in 4 ml of methylene chloride and 2 ml of water 274 m of -6-propylpyridine-3-aldehyde
g (0.70 mmol), 0.6 ml (5.66 mmol) of 2-methyl-2-butene in an ice bath, 210 g of amidosulfuric acid
mg (2.16 mmol), sodium chlorite 480
mg (5.31 mmol) was added and the mixture was stirred at room temperature for 20 minutes. Water was added, the mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (chloroform: methanol 30:
Purification in 1) gave the title compound. Yield: 191 mg (0.47 mmol), yield: 66.
8% MS (ESI, m / z) 408 (MH +) H-NMR (CDCl3): 0.83-0.88 (3H, t), 1.50-1.63 (2H, m), 2.
48-2.55 (2H, t), 3.60 (3H, s), 5.89 (2H, s), 6.40-6.45 (1
H, m), 6.52-6.59 (2H, m), 6.66-6.73 (3H, m), 7.30-7.33
(2H, d)
【0066】実施例7 1)1−(3、4 −ジメトキシフェニル)−3−オキ
ソ−1−ヘプタノールの合成 アルゴン雰囲気下、−70℃でt−ブトキシカリウム
1.12gを2−ヘキサノン2.5ml(20.3mm
ol)、ベラトルムアルデヒド1.66g(10.0m
mol)のTHF20ml溶液に加え1時間攪拌する。
1規定塩酸を加え反応を停止する。酢酸エチルで抽出し
飽和食塩水で洗浄する。無水硫酸マグネシウムで乾燥し
減圧下溶媒を留去する。得られた残渣をシリカゲルカラ
ムクロマトグラフィー(酢酸エチル:ヘキサン 1:
2)にふし表題化合物を得た。 収量:1.10g、収率:41.3% MS(ESI,m/z) 249 (MH+ -H2O) H-NMR(CDCl3):0.90 (3H, t)、1.30 (2H, m)、1.59 (2
H, m)、2.42 (2H, t)、2.82 (2H,m)、3.30 (3H, s)、3.
87 (3H, s)、5.12 1H, m)、6.82-6.86 (2H, m)、6.94
(1H, d)Example 7 1) Synthesis of 1- (3,4-dimethoxyphenyl) -3-oxo-1-heptanol 1.12 g of potassium t-butoxide was added to 2.5 ml of 2-hexanone at -70 ° C. under an argon atmosphere. (20.3mm
ol), 1.66 g of veraformaldehyde (10.0 m
mol) in 20 ml of THF and stirred for 1 hour.
The reaction is stopped by adding 1N hydrochloric acid. Extract with ethyl acetate and wash with saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1:
2) to give the title compound. Yield: 1.10 g, Yield: 41.3% MS (ESI, m / z) 249 (MH + -H 2 O) H-NMR (CDCl 3): 0.90 (3H, t), 1.30 (2H, m), 1.59 ( Two
H, m), 2.42 (2H, t), 2.82 (2H, m), 3.30 (3H, s), 3.
87 (3H, s), 5.12 1H, m), 6.82-6.86 (2H, m), 6.94
(1H, d)
【0067】2)1−(3、4−ジメトキシフェニル)
−1−ヘプテン−3−オンの合成 1−(3、4 −ジメトキシフェニル)−3−オキソ−
1−ヘプタノール1.10g(4.1mmol)をトル
エン20mlに溶解し無水硫酸マグネシウム2.0gを
加え100℃で一晩攪拌する。放冷後濾過し減圧下溶媒
を留去する。得られた残渣をシリカゲルカラムクロマト
グラフィー(酢酸エチル:ヘキサン 1:2)に付し表
題化合物を得た。 収量:530mg、収率:52.1% MS(ESI,m/z) 249 (MH+) H-NMR(CDCl3):0.95 (3H, t)、1.39 (2H, sex)、1.68
(2H, quint)、2.66 (2H, t)、3.92 (3H, s)、3.92 (3
H, s)、6.62 (1H, d)、6.88 (1H, d)、7.08 (1H,d)、7.
13 (1H, d)、7.50 (1H, d)2) 1- (3,4-dimethoxyphenyl)
Synthesis of -1-hepten-3-one 1- (3,4-dimethoxyphenyl) -3-oxo-
1.10 g (4.1 mmol) of 1-heptanol is dissolved in 20 ml of toluene, 2.0 g of anhydrous magnesium sulfate is added, and the mixture is stirred at 100 ° C. overnight. After cooling, the mixture is filtered and the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 2) to give the title compound. Yield: 530 mg, Yield: 52.1% MS (ESI, m / z) 249 (MH +) H-NMR (CDCl3): 0.95 (3H, t), 1.39 (2H, sex), 1.68
(2H, quint), 2.66 (2H, t), 3.92 (3H, s), 3.92 (3
H, s), 6.62 (1H, d), 6.88 (1H, d), 7.08 (1H, d), 7.
13 (1H, d), 7.50 (1H, d)
【0068】3)6−ブチル−3−シアノ−4−(3、
4 −ジメトキシフェニル)−2−ピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド180m
g(2.14mmol)、t−ブトキシカリウム240
mg(2.14mmol)のDMSO5ml溶液に1−
(3、4 −ジメトキシフェニル)−1−ヘプテン−3
−オン530mg(2.13mmol)のDMSO10
mlを加え20分間攪拌する。t−ブトキシカリウム7
20mg(6.42mmol)を加え1分間酸素をバブ
リングする。酸素雰囲気下1.5時間攪拌した後、1規
定塩酸氷冷下加え析出した結晶を濾取する。水で洗い減
圧下乾燥し表題化合物を得た。この化合物は精製せずに
以下の反応に用いる。 収量:280mg、収率:42.1% MS(ESI,m/z) 313 (MH+) H-NMR(CDCl3):0.98 (3H, t)、1.43 (2H, sex)、1.75
(2H, quint)、2.72 (2H, t)、3.94 (3H, s)、3.95 (3H,
s)、6.26 (1H, s)、6.98 (1H, d)、7.20-7.30(2H, m)3) 6-butyl-3-cyano-4- (3,
Synthesis of 4-dimethoxyphenyl) -2-pyridone Cyanoacetamide 180m at room temperature under argon atmosphere
g (2.14 mmol), potassium t-butoxide 240
mg (2.14 mmol) in 5 ml of DMSO
(3,4-dimethoxyphenyl) -1-heptene-3
530 mg (2.13 mmol) of DMSO10
Add ml and stir for 20 minutes. potassium t-butoxide 7
20 mg (6.42 mmol) is added and oxygen is bubbled for 1 minute. After stirring for 1.5 hours in an oxygen atmosphere, the mixture is added with 1N hydrochloric acid under ice-cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 280 mg, Yield: 42.1% MS (ESI, m / z) 313 (MH +) H-NMR (CDCl3): 0.98 (3H, t), 1.43 (2H, sex), 1.75
(2H, quint), 2.72 (2H, t), 3.94 (3H, s), 3.95 (3H,
s), 6.26 (1H, s), 6.98 (1H, d), 7.20-7.30 (2H, m)
【0069】4)6−ブチル−3−シアノ−4−(3、
4−ジメトキシフェニル)−2−クロロピリジンの合成 6−ブチル−3−シアノ−4−(3、4−ジメトキシフ
ェニル)−2−ピリドン280mg(0.9mmol)
をオキシ塩化リン5mlに溶解し90℃で一晩攪拌す
る。オキシ塩化リンを減圧下留去し残渣を酢酸エチルに
溶解する。飽和重曹水、飽和食塩水で洗浄し無水硫酸マ
グネシウムで乾燥する。減圧下溶媒を留去し6−ブチル
−3−シアノ−4−(3、4−ジメトキシフェニル)−
2−クロロピリジンを得た。このものは精製せずに以下
の反応に利用した。 収量:280mg MS(ESI,m/z) 331 (MH+) H-NMR(CDCl3):0.96 (3H, t)、1.42 (2H, sex)、1.75
(2H, quint)、2.84 (2H, t)、3.95 (3H, s)、3.96 (3H,
s)、7.00 (1H, s)、7.14 (1H, d)、7.19 (1H,dd)、7.2
0 (1H, s)4) 6-butyl-3-cyano-4- (3,
Synthesis of 4-dimethoxyphenyl) -2-chloropyridine 6-butyl-3-cyano-4- (3,4-dimethoxyphenyl) -2-pyridone 280 mg (0.9 mmol)
Is dissolved in 5 ml of phosphorus oxychloride and stirred at 90 ° C. overnight. The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 6-butyl-3-cyano-4- (3,4-dimethoxyphenyl)-
2-Chloropyridine was obtained. This was used for the following reaction without purification. Yield: 280 mg MS (ESI, m / z) 331 (MH +) H-NMR (CDCl3): 0.96 (3H, t), 1.42 (2H, sex), 1.75
(2H, quint), 2.84 (2H, t), 3.95 (3H, s), 3.96 (3H,
s), 7.00 (1H, s), 7.14 (1H, d), 7.19 (1H, dd), 7.2
0 (1H, s)
【0070】5)6−ブチル−3−シアノ−4−(3、
4−ジメトキシフェニル)−2−(3、4−メチレンジ
オキシフェニルオキシ)ピリジンの合成 セサモール130mg(0.94mmol)、水素化ナ
トリウム70mg(60%オイルディスパージョン、
1.8mmol)より作成したフェノキシドイオンのD
MF5ml溶液に6−ブチル−3−シアノ−4−(3、
4−ジメトキシフェニル)−2−クロロピリジン280
mgをDMF10mlに溶解して加えアルゴン雰囲気下
1時間攪拌する。減圧下溶媒を留去し、残渣をエーテル
に溶解し水、1規定水酸化ナトリウム溶液、飽和食塩水
で洗浄する。無水硫酸マグネシウムで乾燥し減圧下溶媒
を留去する。得られた残渣をシリカゲルカラムクロマト
グラフィー(酢酸エチル:ヘキサン 1:2)に付し表
題化合物を得た。 収量:230mg、収率:6−ブチル−3−シアノ−4
−(3、4−ジメトキシフェニル)−2−ピリドンより
59.1% MS(ESI,m/z) 433 (MH+) H-NMR(CDCl3):0.88 (3H, t)、1.32 (2H, m)、1.62 (2
H, m)、2.68 (2H, t)、3.95 (3H, s)、3.97 (3H, s)、
6.02 (2H, s)、6.65 (1H, dd)、6.20 (2H, m)、6.80 (1
H, d)、6.94 (1H, s)、7.00 (1H, s)5) 6-butyl-3-cyano-4- (3,
Synthesis of 4-dimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 130 mg (0.94 mmol) of sesamol, 70 mg of sodium hydride (60% oil dispersion,
D) of phenoxide ion prepared from 1.8 mmol)
6-butyl-3-cyano-4- (3,
4-dimethoxyphenyl) -2-chloropyridine 280
mg was dissolved in 10 ml of DMF, and the mixture was stirred for 1 hour under an argon atmosphere. The solvent is distilled off under reduced pressure, the residue is dissolved in ether, and washed with water, 1N sodium hydroxide solution and saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 2) to give the title compound. Yield: 230 mg, Yield: 6-butyl-3-cyano-4
59.1% MS (ESI, m / z) 433 (MH +) H-NMR (CDCl3) from-(3,4-dimethoxyphenyl) -2-pyridone: 0.88 (3H, t), 1.32 (2H, m) , 1.62 (2
H, m), 2.68 (2H, t), 3.95 (3H, s), 3.97 (3H, s),
6.02 (2H, s), 6.65 (1H, dd), 6.20 (2H, m), 6.80 (1
H, d), 6.94 (1H, s), 7.00 (1H, s)
【0071】6)6−ブチル−4−(3、4−ジメトキ
シフェニル)−2−(3、4−メチレンジオキシフェニ
ルオキシ)ピリジン−3−アルデヒドの合成 6−ブチル−3−シアノ−4−(3、4−ジメトキシフ
ェニル)−2−(3、4−メチレンジオキシフェニルオ
キシ)ピリジン230mg(0.53mmol)をベン
ゼン5mlに溶解しアルゴン雰囲気下室温で水素化ジイ
ソブチルアルミニウム1Mヘキサン溶液1.6ml
(1.6mmol)を滴下する。室温で1時間攪拌しメ
タノールと水で反応を停止する。室温で30分攪拌し、
不溶物をセライトを用いて濾過する。濾液をを減圧下留
去し得られた残渣をシリカゲルカラムクロマトグラフィ
ー(酢酸エチル:ヘキサン 1:2)に付し表題化合物
を得た。このものは分離困難な不純物を含むがこれ以上
精製せずに以下の反応に用いる。 収量:140mg MS(ESI,m/z) 437 (MH+) H-NMR(CDCl3):0.88 (3H, t)、1.32 (2H, sex)、1.62
(2H, quint)、2.66 (2H, t)、3.91 (3H, s)、3.94 (3H,
s)、6.00 (2H, s)、6.63 (1H, dd)、6.73 (1H,d)、6.8
0 (1H, d)、6.85 (1H, s)、6.88 (1H, br)、6.94 (1H,
d)、6.94 (1H,s)、10.22 (1H, s)6) Synthesis of 6-butyl-4- (3,4-dimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 6-butyl-3-cyano-4-aldehyde 230 mg (0.53 mmol) of (3,4-dimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine are dissolved in 5 ml of benzene, and 1.6 ml of a 1M solution of diisobutylaluminum hydride in hexane at room temperature under an argon atmosphere.
(1.6 mmol) are added dropwise. Stir at room temperature for 1 hour and terminate the reaction with methanol and water. Stir at room temperature for 30 minutes,
The insolubles are filtered using celite. The filtrate was evaporated under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 2) to obtain the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 140 mg MS (ESI, m / z) 437 (MH +) H-NMR (CDCl3): 0.88 (3H, t), 1.32 (2H, sex), 1.62
(2H, quint), 2.66 (2H, t), 3.91 (3H, s), 3.94 (3H,
s), 6.00 (2H, s), 6.63 (1H, dd), 6.73 (1H, d), 6.8
0 (1H, d), 6.85 (1H, s), 6.88 (1H, br), 6.94 (1H,
d), 6.94 (1H, s), 10.22 (1H, s)
【0072】7)6−ブチル−4−(3、4−ジメトキ
シフェニル)−2−(3、4−メチレンジオキシフェニ
ルオキシ)ピリジン−3−カルボン酸の合成 6−ブチル−4−(3、4−ジメトキシフェニル)−2
−(3、4−メチレンジオキシフェニルオキシ)ピリジ
ン−3−アルデヒド140mgを塩化メチレン2ml、
水1mlに溶解し、0℃で2−メチル−2−ブテン0.
2ml(1.9mmol)、アミド硫酸50mg(0.
5mmol)、亜塩素酸ナトリウム130mg(1.1
mmol)を加え室温に戻して1時間攪拌する。酢酸エ
チルで抽出し、飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥して減圧下溶媒を留去する。得られた残渣を
シリカゲルカラムクロマトグラフィー(クロロホルム:
メタノール 9:1)に付し表題化合物を得た。 収量:70mg、収率:6−ブチル−3−シアノ−4−
(3、4−ジメトキシフェニル)−2−(3、4−メチ
レンジオキシフェニルオキシ)ピリジンより29.3% MS(ESI,m/z) 452 (MH+) H-NMR(CDCl3):0.86 (3H, t)、1.28 (2H, m)、1.56 (2
H, quint)、2.58 (2H,t)、3.70 (3H, s)、3.73 (3H,
s)、5.95 (2H, s)、6.46 (1H, br d)、6.57 (2H,m)、6.
68 (1H, m)、6.76 (1H, br s)、6.97 (1H, br s)、6.98
(1H, br d)7) Synthesis of 6-butyl-4- (3,4-dimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 4-dimethoxyphenyl) -2
140 mg of-(3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde was added to 2 ml of methylene chloride,
Dissolve in 1 ml of water, and add 2-methyl-2-butene at 0 ° C.
2 ml (1.9 mmol), amidosulfuric acid 50 mg (0.
5 mmol), 130 mg of sodium chlorite (1.1 mg)
mmol) and the mixture is returned to room temperature and stirred for 1 hour. The mixture is extracted with ethyl acetate, washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (chloroform:
Methanol 9: 1) to give the title compound. Yield: 70 mg, yield: 6-butyl-3-cyano-4-
29.3% MS (ESI, m / z) 452 (MH +) H-NMR (CDCl 3): 0.86 (3H , t), 1.28 (2H, m), 1.56 (2
H, quint), 2.58 (2H, t), 3.70 (3H, s), 3.73 (3H,
s), 5.95 (2H, s), 6.46 (1H, br d), 6.57 (2H, m), 6.
68 (1H, m), 6.76 (1H, br s), 6.97 (1H, br s), 6.98
(1H, br d)
【0073】実施例8 6−ブチル−4−(3、4、5
−トリメトキシフェニル)−2−(3、4−メチレンジ
オキシフェニルオキシ)ピリジン−3−カルボン酸の合
成 1)1−(3、4 、5−トリメトキシフェニル)−3
−オキソ−1−ヘプタノールの合成 アルゴン雰囲気下、−70℃でt−ブトキシカリウム
1.12gを2−ヘキサノン2.5ml(20.3mm
ol)、3、4 、5−トリメトキシベンズアルデヒド
1.96g(10.0mmol)のTHF20ml溶液
に加え2時間攪拌する。1規定塩酸を加え反応を停止す
る。酢酸エチルで抽出し飽和食塩水で洗浄する。無水硫
酸マグネシウムで乾燥し減圧下溶媒を留去する。得られ
た残渣をシリカゲルカラムクロマトグラフィー(酢酸エ
チル:ヘキサン 1:1)にふし表題化合物を得た。 収量:950mg、収率:32.1% MS(ESI,m/z) 389 (M+Na+) H-NMR(CDCl3):0.90 (3H, t)、1.30 (2H, sex)、1.58
(2H, quint)、2.43 (2H, t)、2.80 (2H, m)、3.34 (1H,
d)、3.33 (3H, s)、3.34 (6H, s)、5.11 (1H,dt)、6.5
9 (2H, s)Example 8 6-butyl-4- (3,4,5
Synthesis of -trimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) 1- (3,4,5-trimethoxyphenyl) -3
Synthesis of -oxo-1-heptanol Under argon atmosphere, at -70 ° C, 1.12 g of potassium t-butoxide was added to 2.5 ml of 2-hexanone (20.3 mm
ol), 3,4,5-Trimethoxybenzaldehyde (1.96 g, 10.0 mmol) was added to a THF (20 ml) solution, and the mixture was stirred for 2 hours. The reaction is stopped by adding 1N hydrochloric acid. Extract with ethyl acetate and wash with saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1) to give the title compound. Yield: 950 mg, Yield: 32.1% MS (ESI, m / z) 389 (M + Na +) H-NMR (CDCl3): 0.90 (3H, t), 1.30 (2H, sex), 1.58
(2H, quint), 2.43 (2H, t), 2.80 (2H, m), 3.34 (1H,
d), 3.33 (3H, s), 3.34 (6H, s), 5.11 (1H, dt), 6.5
9 (2H, s)
【0074】2)1−(3、4、5−トリメトキシフェ
ニル)−1−ヘプテン−3−オンの合成 1−(3、4、5−トリメトキシフェニル)−3−オキ
ソ−1−ヘプタノール950mg(3.2mmol)を
トルエン20mlに溶解しp−トルエンスルホン酸30
mgを加え90℃で10分攪拌する。減圧下溶媒を留去
し、得られた残渣をシリカゲルカラムクロマトグラフィ
ー(酢酸エチル:ヘキサン 1:2)に付し表題化合物
を得た。 収量:580mg、収率:65.1% MS(ESI,m/z) 279 (MH+) H-NMR(CDCl3):0.96 (3H, t)、1.39 (2H, sex)、1.68
(2H, quint)、2.67 (2H, t)、3.89 (3H, s)、3.90 (6H,
s)、6.64 (1H, d)、6.78 (2H, s)、7.47 (1H,d)2) Synthesis of 1- (3,4,5-trimethoxyphenyl) -1-hepten-3-one 950 mg of 1- (3,4,5-trimethoxyphenyl) -3-oxo-1-heptanol (3.2 mmol) was dissolved in 20 ml of toluene, and p-toluenesulfonic acid 30 was dissolved.
mg and stirred at 90 ° C. for 10 minutes. The solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 2) to obtain the title compound. Yield: 580 mg, yield: 65.1% MS (ESI, m / z) 279 (MH +) H-NMR (CDCl3): 0.96 (3H, t), 1.39 (2H, sex), 1.68
(2H, quint), 2.67 (2H, t), 3.89 (3H, s), 3.90 (6H,
s), 6.64 (1H, d), 6.78 (2H, s), 7.47 (1H, d)
【0075】3)6−ブチル−3−シアノ−4−(3、
4、5−トリメトキシフェニル)−2−ピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド180m
g(2.14mmol)、t−ブトキシカリウム240
mg(2.14mmol)のDMSO5ml溶液に1−
(3、4、5−トリメトキシフェニル)−1−ヘプテン
−3−オン580mg(2.1mmol)のDMSO1
5mlを加え20分間攪拌する。t−ブトキシカリウム
720mg(6.4mmol)を加え1分間酸素をバブ
リングする。酸素雰囲気下1.5時間攪拌した後、1規
定塩酸氷冷下加え析出した結晶を濾取する。水で洗い減
圧下乾燥し表題化合物を得た。この化合物は精製せずに
以下の反応に用いる。 収量:330mg、収率:45.9% MS(ESI,m/z) 343 (MH+) H-NMR(CDCl3):1.00 (3H, t)、1.47 (2H, sex)、1.77
(2H, quint)、2.74 (2H, t)、3.93 (3H, s)、3.93 (6H,
s)、6.28 (1H, s)、6.85 (2H, s)3) 6-butyl-3-cyano-4- (3,
Synthesis of 4,5-trimethoxyphenyl) -2-pyridone Cyanoacetamide 180m at room temperature under argon atmosphere
g (2.14 mmol), potassium t-butoxide 240
mg (2.14 mmol) in 5 ml of DMSO
580 mg (2.1 mmol) of (3,4,5-trimethoxyphenyl) -1-hepten-3-one in DMSO1
Add 5 ml and stir for 20 minutes. 720 mg (6.4 mmol) of potassium t-butoxide are added, and oxygen is bubbled for 1 minute. After stirring for 1.5 hours in an oxygen atmosphere, the mixture is added with 1N hydrochloric acid under ice-cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 330 mg, Yield: 45.9% MS (ESI, m / z) 343 (MH +) H-NMR (CDCl3): 1.00 (3H, t), 1.47 (2H, sex), 1.77
(2H, quint), 2.74 (2H, t), 3.93 (3H, s), 3.93 (6H,
s), 6.28 (1H, s), 6.85 (2H, s)
【0076】4)6−ブチル−3−シアノ−4−(3、
4、5−トリメトキシフェニル)−2−クロロピリジン
の合成 6−ブチル−3−シアノ−4−(3、4、5−トリメト
キシフェニル)−2−ピリドン320mg(0.9mm
ol)をオキシ塩化リン5mlに溶解し100℃で一晩
攪拌する。オキシ塩化リンを減圧下留去し残渣を酢酸エ
チルに溶解する。飽和重曹水、飽和食塩水で洗浄し無水
硫酸マグネシウムで乾燥する。減圧下溶媒を留去し表題
化合物を得た。このものは精製せずに以下の反応に利用
した。 収量:360mg MS(ESI,m/z) 361 (MH+) H-NMR(CDCl3):0.96 (3H, t)、1.43 (2H, sex)、1.76
(2H, quint)、2.86 (2H, t)、3.93 (3H, s)、3.93 (6H,
s)、6.80 (2H, s)、7.22 (1H, s)4) 6-butyl-3-cyano-4- (3,
Synthesis of 4,5-trimethoxyphenyl) -2-chloropyridine 320 mg of 6-butyl-3-cyano-4- (3,4,5-trimethoxyphenyl) -2-pyridone (0.9 mm
ol) in 5 ml of phosphorus oxychloride and stir at 100 ° C. overnight. The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound. This was used for the following reaction without purification. Yield: 360 mg MS (ESI, m / z) 361 (MH +) H-NMR (CDCl3): 0.96 (3H, t), 1.43 (2H, sex), 1.76
(2H, quint), 2.86 (2H, t), 3.93 (3H, s), 3.93 (6H,
s), 6.80 (2H, s), 7.22 (1H, s)
【0077】5)6−ブチル−3−シアノ−4−(3、
4、5−トリメトキシフェニル)−2−(3、4−メチ
レンジオキシフェニルオキシ)ピリジンの合成 セサモール130mg(0.94mmol)、水素化ナ
トリウム70mg(60%オイルディスパージョン、
1.8mmol)より作成したフェノキシドイオンのD
MF5ml溶液に6−ブチル−3−シアノ−4−(3、
4−ジメトキシフェニル)−2−クロロピリジン360
mgをDMF10mlに溶解して加えアルゴン雰囲気下
室温で2時間攪拌する。減圧下溶媒を留去し、残渣をエ
ーテルに溶解し水、1規定水酸化ナトリウム溶液、飽和
食塩水で洗浄する。無水硫酸マグネシウムで乾燥し減圧
下溶媒を留去する。得られた残渣をシリカゲルカラムク
ロマトグラフィー(酢酸エチル:ヘキサン 1:2)に
付し表題化合物を得た。 収量:160mg、収率:6−ブチル−3−シアノ−4
−(3、4、5−トリメトキシフェニル)−2−ピリド
ンより37.2% MS(ESI,m/z) 463 (MH+) H-NMR(CDCl3):0.89 (3H, t)、1.32 (2H, sex)、1.61
(2H, quint)、2.68 (2H, t)、3.893 (3H, s)、3.94 (6
H, s)、6.02 (2H, s)、6.67 (1H, dd)、6.74 (1H, d)、
6.82 (1H, d)、6.85 (2H, s)、6.95 (1H, s)5) 6-butyl-3-cyano-4- (3,
Synthesis of 4,5-trimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 130 mg (0.94 mmol) of sesamol, 70 mg of sodium hydride (60% oil dispersion,
D) of phenoxide ion prepared from 1.8 mmol)
6-butyl-3-cyano-4- (3,
4-dimethoxyphenyl) -2-chloropyridine 360
mg was dissolved in 10 ml of DMF, and the mixture was stirred at room temperature for 2 hours under an argon atmosphere. The solvent is distilled off under reduced pressure, the residue is dissolved in ether, and washed with water, 1N sodium hydroxide solution and saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 2) to give the title compound. Yield: 160 mg, yield: 6-butyl-3-cyano-4
-(3,4,5-trimethoxyphenyl) -2-pyridone 37.2% MS (ESI, m / z) 463 (MH +) H-NMR (CDCl3): 0.89 (3H, t), 1.32 (2H , sex), 1.61
(2H, quint), 2.68 (2H, t), 3.893 (3H, s), 3.94 (6
H, s), 6.02 (2H, s), 6.67 (1H, dd), 6.74 (1H, d),
6.82 (1H, d), 6.85 (2H, s), 6.95 (1H, s)
【0078】6)6−ブチル−4−(3、4、5−トリ
メトキシフェニル)−2−(3、4−メチレンジオキシ
フェニルオキシ)ピリジン−3−アルデヒドの合成 6−ブチル−3−シアノ−4−(3、4、5−トリメト
キシフェニル)−2−(3、4−メチレンジオキシフェ
ニルオキシ)ピリジン160mg(0.35mmol)
をベンゼン5mlに溶解しアルゴン雰囲気下室温で水素
化ジイソブチルアルミニウム1Mヘキサン溶液1.0m
l(1.0mmol)を滴下する。室温で1時間攪拌し
メタノールと水で反応を停止する。室温で1時間攪拌
し、不溶物をセライトを用いて濾過する。濾液をを減圧
下留去し得られた残渣をシリカゲルカラムクロマトグラ
フィー(酢酸エチル:ヘキサン 1:1)に付し表題化
合物を得た。このものは分離困難な不純物を含むがこれ
以上精製せずに以下の反応に用いる。 収量:60mg MS(ESI,m/z) 466 (MH+)6) Synthesis of 6-butyl-4- (3,4,5-trimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 6-butyl-3-cyano 160 mg (0.35 mmol) of -4- (3,4,5-trimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine
Was dissolved in 5 ml of benzene, and a 1 M solution of diisobutylaluminum hydride in hexane was added at room temperature under an argon atmosphere at room temperature.
1 (1.0 mmol) is added dropwise. Stir at room temperature for 1 hour and terminate the reaction with methanol and water. The mixture is stirred at room temperature for 1 hour, and the insoluble matter is filtered using celite. The filtrate was evaporated under reduced pressure, and the residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1) to give the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 60 mg MS (ESI, m / z) 466 (MH +)
【0079】7)6−ブチル−4−(3、4、5−トリ
メトキシフェニル)−2−(3、4−メチレンジオキシ
フェニルオキシ)ピリジン−3−カルボン酸の合成 6−ブチル−4−(3、4、5−トリメトキシフェニ
ル)−2−(3、4−メチレンジオキシフェニルオキ
シ)ピリジン−3−アルデヒド60mgを塩化メチレン
2ml、水1mlに溶解し、0℃で2−メチル−2−ブ
テン0.1ml(0.94mmol)、アミド硫酸20
mg(0.21mmol)、亜塩素酸ナトリウム50m
g(0.44mmol)を加え室温に戻して1時間攪拌
する。酢酸エチルで抽出し、飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥して減圧下溶媒を留去する。得
られた残渣をシリカゲル薄層クロマトグラフィー(酢酸
エチル:ヘキサン 1:1)に付し表題化合物を得た。 収量:38mg、収率:6−ブチル−3−シアノ−4−
(3、4、5−トリメトキシフェニル)−2−(3、4
−メチレンジオキシフェニルオキシ)ピリジンより2
2.5% MS(ESI,m/z) 482 (MH+) H-NMR(CDCl3):0.88 (3H, t)、1.31 (2H, m)、1.60 (2
H, quint)、2.65 (2H,t)、3.83 (6H, s)、3.86 (3H,
s)、5.99 (2H, s)、6.61 (1H, dd)、6.69 (3H, m)、6.7
6 (1H, d)、6.86 (1H, s)7) Synthesis of 6-butyl-4- (3,4,5-trimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid Dissolve 60 mg of (3,4,5-trimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde in 2 ml of methylene chloride and 1 ml of water, and add 2-methyl-2 at 0 ° C. 0.1 ml (0.94 mmol) of butene, 20 amidosulfuric acid
mg (0.21 mmol), 50 m of sodium chlorite
g (0.44 mmol) was added and the mixture was returned to room temperature and stirred for 1 hour. The mixture is extracted with ethyl acetate, washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel thin layer chromatography (ethyl acetate: hexane 1: 1) to give the title compound. Yield: 38 mg, Yield: 6-butyl-3-cyano-4-
(3,4,5-trimethoxyphenyl) -2- (3,4
-Methylenedioxyphenyloxy) pyridine from 2
2.5% MS (ESI, m / z) 482 (MH +) H-NMR (CDCl3): 0.88 (3H, t), 1.31 (2H, m), 1.60 (2
H, quint), 2.65 (2H, t), 3.83 (6H, s), 3.86 (3H,
s), 5.99 (2H, s), 6.61 (1H, dd), 6.69 (3H, m), 6.7
6 (1H, d), 6.86 (1H, s)
【0080】実施例9 6−イソブチル−4−(4−メ
トキシフェニル)−2−(3、4−メチレンジオキシフ
ェニルオキシ)ピリジン−3−カルボン酸の合成 1)1−(4−メトキシフェニル)−5−メチル−1−
ヘキセン−3−オンの合成 アルゴン雰囲気下、−70℃でt−ブトキシカリウム
4.0g(35.6mmol)をメチルイソブチルケト
ン4.1ml(32.8mmol)、p−アニスアルデ
ヒド2.0ml(16.4mmol)のTHF20ml
溶液に加え−20℃にして1時間攪拌する。1規定塩酸
を加え反応を停止する。酢酸エチルで抽出し飽和食塩水
で洗浄する。無水硫酸マグネシウムで乾燥し減圧下溶媒
を留去する。得られた残渣をシリカゲルカラムクロマト
グラフィー(酢酸エチル:ヘキサン1:3)にふし表題
化合物を得た。 収量:480mg、収率:13.4% MS(ESI,m/z) 219 (MH+) H-NMR(CDCl3):0.98 (6H, d)、2.23 (1H, m)、2.52 (2
H, d)、3.84 (3H, s)、6.63 (1H, d)、6.91 (2H, d)、
7.50 (2H, d)、7.50 (1H, d)Example 9 Synthesis of 6-isobutyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) 1- (4-methoxyphenyl) -5-methyl-1-
Synthesis of hexen-3-one Under an argon atmosphere, at -70 ° C, 4.0 g (35.6 mmol) of potassium t-butoxide was added to 4.1 ml (32.8 mmol) of methyl isobutyl ketone and 2.0 ml of p-anisaldehyde (16. 4 mmol) of THF 20 ml
Add to the solution, bring to -20 ° C and stir for 1 hour. The reaction is stopped by adding 1N hydrochloric acid. Extract with ethyl acetate and wash with saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to give the title compound. Yield: 480 mg, yield: 13.4% MS (ESI, m / z) 219 (MH +) H-NMR (CDCl3): 0.98 (6H, d), 2.23 (1H, m), 2.52 (2
H, d), 3.84 (3H, s), 6.63 (1H, d), 6.91 (2H, d),
7.50 (2H, d), 7.50 (1H, d)
【0081】2)6−イソブチル−3−シアノ−4−
(4−メトキシフェニル)−2−ピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド190m
g(2.3mmol)、t−ブトキシカリウム250m
g(2.2mmol)のDMSO5ml溶液に1−(4
−メトキシフェニル)−5−メチル−1−ヘキセン−3
−オン580mg(2.1mmol)のDMSO15m
lを加え20分間攪拌する。t−ブトキシカリウム75
0mg(6.7mmol)を加え1分間酸素をバブリン
グする。酸素雰囲気下1時間攪拌した後、1規定塩酸氷
冷下加え析出した結晶を濾取する。水で洗い減圧下乾燥
し表題化合物を得た。この化合物は精製せずに以下の反
応に用いる。 収量:400mg、収率:64.4% MS(ESI,m/z) 283 (MH+) H-NMR(CDCl3):1.03 (6H, d)、2.12 (1H, m)、2.56 (2
H, d)、3.88 (3H, s)、6.24 (1H, s)、7.50 (2H, d)、
7.63 (2H, d)2) 6-isobutyl-3-cyano-4-
Synthesis of (4-methoxyphenyl) -2-pyridone Cyanoacetamide 190m at room temperature under argon atmosphere
g (2.3 mmol), potassium t-butoxide 250 m
g (2.2 mmol) in 5 ml of DMSO was added to 1- (4
-Methoxyphenyl) -5-methyl-1-hexene-3
-580 mg (2.1 mmol) of DMSO 15m
Add 1 and stir for 20 minutes. potassium t-butoxide75
Add 0 mg (6.7 mmol) and bubble oxygen for 1 minute. After stirring for 1 hour in an oxygen atmosphere, 1N hydrochloric acid is added under ice-cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 400 mg, Yield: 64.4% MS (ESI, m / z) 283 (MH +) H-NMR (CDCl3): 1.03 (6H, d), 2.12 (1H, m), 2.56 (2
H, d), 3.88 (3H, s), 6.24 (1H, s), 7.50 (2H, d),
7.63 (2H, d)
【0082】3)6−イソブチル−3−シアノ−4−
(4−メトキシフェニル)−2−クロロピリジンの合成 6−イソブチル−3−シアノ−4−(4−メトキシフェ
ニル)−2−ピリドン400mg(1.4mmol)を
オキシ塩化リン5mlに溶解し90℃で一晩攪拌する。
オキシ塩化リンを減圧下留去し残渣を酢酸エチルに溶解
する。飽和重曹水、飽和食塩水で洗浄し無水硫酸マグネ
シウムで乾燥する。減圧下溶媒を留去し表題化合物を得
た。このものは精製せずに以下の反応に利用した。 収量:420mg MS(ESI,m/z) 301 (MH+) H-NMR(CDCl3):0.97 (6H, d)、2.17 (1H, m)、2.70 (2
H, d)、3.88 (3H, s)、7.04 (2H, d)、7.15 (1H, s)、
7.57 (2H, d)3) 6-isobutyl-3-cyano-4-
Synthesis of (4-methoxyphenyl) -2-chloropyridine 400 mg (1.4 mmol) of 6-isobutyl-3-cyano-4- (4-methoxyphenyl) -2-pyridone was dissolved in 5 ml of phosphorus oxychloride and the solution was heated at 90 ° C. Stir overnight.
The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound. This was used for the following reaction without purification. Yield: 420 mg MS (ESI, m / z) 301 (MH +) H-NMR (CDCl3): 0.97 (6H, d), 2.17 (1H, m), 2.70 (2
H, d), 3.88 (3H, s), 7.04 (2H, d), 7.15 (1H, s),
7.57 (2H, d)
【0083】4)6−イソブチル−3−シアノ−4−
(4−メトキシフェニル)−2−(3、4−メチレンジ
オキシフェニルオキシ)ピリジンの合成 セサモール200mg(1.4mmol)、水素化ナト
リウム120mg(60%オイルディスパージョン、
3.0mmol)より作成したフェノキシドイオンのD
MF5ml溶液に6−イソブチル−3−シアノ−4−
(4−メトキシフェニル)−2−クロロピリジン420
mgをDMF10mlに溶解して加えアルゴン雰囲気下
室温で30分攪拌する。減圧下溶媒を留去し、残渣をエ
ーテルに溶解し水、1規定水酸化ナトリウム溶液、飽和
食塩水で洗浄する。無水硫酸マグネシウムで乾燥し減圧
下溶媒を留去する。得られた残渣をシリカゲルカラムク
ロマトグラフィー(酢酸エチル:ヘキサン 1:2)に
付し表題化合物を得た。 収量:390mg、収率:6−イソブチル−3−シアノ
−4−(4−メトキシフェニル)−2−ピリドンより6
8.2% MS(FAB,m/z) 402 (MH+) H-NMR(CDCl3):0.88 (6H, d)、2.01 (1H, m)、2.53 (2
H, d)、3.88 (3H, s)、6.01 (2H, s)、6.66 (1H, dd)、
6.74 (1H, d)、6.81 (1H, d)、6.90 (1H, s)、7.40 (2
H, d)、7.61 (2H, d)4) 6-isobutyl-3-cyano-4-
Synthesis of (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 200 mg (1.4 mmol) of sesamol, 120 mg of sodium hydride (60% oil dispersion,
3.0 mmol) of phenoxide ion prepared from
6-isobutyl-3-cyano-4- was added to a 5 ml MF solution.
(4-methoxyphenyl) -2-chloropyridine 420
mg was dissolved in 10 ml of DMF, and the mixture was stirred at room temperature for 30 minutes under an argon atmosphere. The solvent is distilled off under reduced pressure, the residue is dissolved in ether, and washed with water, 1N sodium hydroxide solution and saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 2) to give the title compound. Yield: 390 mg, Yield: 6 from 6-isobutyl-3-cyano-4- (4-methoxyphenyl) -2-pyridone
8.2% MS (FAB, m / z) 402 (MH +) H-NMR (CDCl3): 0.88 (6H, d), 2.01 (1H, m), 2.53 (2
H, d), 3.88 (3H, s), 6.01 (2H, s), 6.66 (1H, dd),
6.74 (1H, d), 6.81 (1H, d), 6.90 (1H, s), 7.40 (2
H, d), 7.61 (2H, d)
【0084】5)6−イソブチル−4−(4−メトキシ
フェニル)−2−(3、4−メチレンジオキシフェニル
オキシ)ピリジン−3−アルデヒドの合成 6−イソブチル−3−シアノ−4−(4−メトキシフェ
ニル)−2−(3、4−メチレンジオキシフェニルオキ
シ)ピリジン390mg(1.0mmol)をベンゼン
5mlに溶解しアルゴン雰囲気下室温で水素化ジイソブ
チルアルミニウム1Mヘキサン溶液3.0ml(3.0
mmol)を滴下する。室温で1時間攪拌しメタノール
と水で反応を停止する。室温で1時間攪拌し、不溶物を
セライトを用いて濾過する。濾液をを減圧下留去し得ら
れた残渣をシリカゲルカラムクロマトグラフィー(酢酸
エチル:ヘキサン 2:5)に付し表題化合物を得た。
このものは分離困難な不純物を含むがこれ以上精製せず
に以下の反応に用いる。 収量:400mg MS(FAB,m/z) 405 (M+)5) Synthesis of 6-isobutyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 6-isobutyl-3-cyano-4- (4 390 mg (1.0 mmol) of -methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine are dissolved in 5 ml of benzene, and 3.0 ml of a 1M solution of diisobutylaluminum hydride in hexane (3.0 ml) at room temperature under an argon atmosphere.
mmol) is added dropwise. Stir at room temperature for 1 hour and terminate the reaction with methanol and water. The mixture is stirred at room temperature for 1 hour, and the insoluble matter is filtered using celite. The filtrate was evaporated under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 2: 5) to give the title compound.
It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 400 mg MS (FAB, m / z) 405 (M +)
【0085】6)6−イソブチル−4−(4−メトキシ
フェニル)−2−(3、4−メチレンジオキシフェニル
オキシ)ピリジン−3−カルボン酸の合成 6−イソブチル−4−(4−メトキシフェニル)−2−
(3、4−メチレンジオキシフェニルオキシ)ピリジン
−3−アルデヒド400mgを塩化メチレン2ml、水
1mlに溶解し、0℃で2−メチル−2−ブテン0.6
3ml(5.9mmol)、アミド硫酸143mg
(5.9mmol)、亜塩素酸ナトリウム400mg
(1.5mmol)を加え室温に戻して30分間攪拌す
る。酢酸エチルで抽出し、飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥して減圧下溶媒を留去する。得ら
れた残渣をシリカゲルカラムクロマトグラフィー(クロ
ロホルム:メタノール 9:1)に付し、さらにシリカ
ゲル薄層クロマトグラフィー(酢酸エチル:ヘキサン
1:1)により精製すると表題化合物を得た。 収量:120mg、収率:6−イソブチル−3−シアノ
−4−(4−メトキシフェニル)−2−(3、4−メチ
レンジオキシフェニルオキシ)ピリジンより28.5% MS(ESI,m/z) 422 (MH+) H-NMR(CDCl3):0.88 (6H, d)、1.98 (1H, m)、2.52 (2
H, m)、3.83 (3H, s)、5.98 (2H, s)、6.61 (1H, dd)、
6.71 (1H, d)、6.76 (1H, d)、6.82 (1H, s)、6.94 (2
H, d)、7.41 (2H, d)6) Synthesis of 6-isobutyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6-isobutyl-4- (4-methoxyphenyl) ) -2-
400 mg of (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde was dissolved in 2 ml of methylene chloride and 1 ml of water, and 0.6 ml of 2-methyl-2-butene was added at 0 ° C.
3 ml (5.9 mmol), 143 mg of amidosulfuric acid
(5.9 mmol), 400 mg sodium chlorite
(1.5 mmol) was added and the mixture was returned to room temperature and stirred for 30 minutes. The mixture is extracted with ethyl acetate, washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (chloroform: methanol 9: 1), and further subjected to silica gel thin layer chromatography (ethyl acetate: hexane).
Purification by 1: 1) gave the title compound. Yield: 120 mg, Yield: 28.5% MS (ESI, m / z) from 6-isobutyl-3-cyano-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine ) 422 (MH +) H-NMR (CDCl3): 0.88 (6H, d), 1.98 (1H, m), 2.52 (2
H, m), 3.83 (3H, s), 5.98 (2H, s), 6.61 (1H, dd),
6.71 (1H, d), 6.76 (1H, d), 6.82 (1H, s), 6.94 (2
H, d), 7.41 (2H, d)
【0086】実施例10 4−(4−メトキシフェニ
ル)−2−(2−ナフトキシ)−6−プロピルピリジン
−3−カルボン酸の合成 1)3−シアノ−4−(4−メトキシフェニル)−2−
(2−ナフトキシ)−6−プロピルピリジンの合成 DMF5ml中、2−ナフトール122mg(0.85
mmol)に60%水素化ナトリウム50mg(1.2
5mmol)を加え室温で15分間攪拌した。2−クロ
ロ−3−シアノ−4−(4−メトキシフェニル)−6−
プロピルピリジン201mg(0.70mmol)をD
MF2mlに溶解して滴下し、室温で2時間攪拌した。
減圧下でDMFを留去後1規定塩酸を加え、酢酸エチル
で抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃
縮した。残渣をシリカゲルクロマトグラフィー(ヘキサ
ン−クロロホルム=1:2)で精製し表題化合物を得
た。 収量:124mg(0.31mmol)、収率:37.
1% MS(ESI,m/z) 395(MH+) H-NMR(CDCl3):0.85-0.90(3H,t)、1.56-1.68(2H,m)、2.
58-2.63(2H,t)、3.89(3H,s)、6.97(1H,s)、7.04-7.07(2
H,d)、7.35-7.39(1H,m)、7.44-7.53(2H,m)、7.62-7.70
(3H,m)、7.80-7.90(3H,m)Example 10 Synthesis of 4- (4-methoxyphenyl) -2- (2-naphthoxy) -6-propylpyridine-3-carboxylic acid 1) 3-Cyano-4- (4-methoxyphenyl) -2 −
Synthesis of (2-naphthoxy) -6-propylpyridine 122 mg (0.85
mmol) to 50 mg (1.2%) of 60% sodium hydride.
5 mmol) and stirred at room temperature for 15 minutes. 2-chloro-3-cyano-4- (4-methoxyphenyl) -6
201 mg (0.70 mmol) of propylpyridine was added to D
It was dissolved in 2 ml of MF and added dropwise, followed by stirring at room temperature for 2 hours.
After distilling off DMF under reduced pressure, 1N hydrochloric acid was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-chloroform = 1: 2) to obtain the title compound. Yield: 124 mg (0.31 mmol), yield: 37.
1% MS (ESI, m / z) 395 (MH +) H-NMR (CDCl3): 0.85-0.90 (3H, t), 1.56-1.68 (2H, m), 2.
58-2.63 (2H, t), 3.89 (3H, s), 6.97 (1H, s), 7.04-7.07 (2
H, d), 7.35-7.39 (1H, m), 7.44-7.53 (2H, m), 7.62-7.70
(3H, m), 7.80-7.90 (3H, m)
【0087】2)4−(4−メトキシフェニル)−2−
(2−ナフトキシ)−6−プロピルピリジン−3−アル
デヒドの合成 3−シアノ−4−(4−メトキシフェニル)−2−(2
−ナフトキシ)−6−プロピルピリジン118mg
(1.00mmol)をベンゼン7mlに溶解し室温で
水素化ジイソブチルアルミニウム1Mヘキサン溶液0.
95ml(0.95mmol)を加え室温で2時間攪拌
した。メタノール1.0ml、水3mlを加え20分間
攪拌した。沈澱を濾過し濾液を減圧下濃縮した。残渣を
シリカゲルクロマトグラフィー(ヘキサン:酢酸エチル
4:1)で精製し表題化合物を得た。 収量:98mg(0.25mmol)、収率:83.3
% H-NMR(CDCl3):0.85-0.90(3H,t)、1.54-1.68(2H,m)、2.
53-2.63(2H,m)、3.88(3H,s)、6.58-7.02(3H,m)、7.26-
7.88(9H,m)、10.31(1H,s)2) 4- (4-methoxyphenyl) -2-
Synthesis of (2-naphthoxy) -6-propylpyridine-3-aldehyde 3-cyano-4- (4-methoxyphenyl) -2- (2
-Naphthoxy) -6-propylpyridine 118 mg
(1.00 mmol) was dissolved in 7 ml of benzene, and a 1 M solution of diisobutylaluminum hydride in hexane was added at room temperature.
95 ml (0.95 mmol) was added and the mixture was stirred at room temperature for 2 hours. 1.0 ml of methanol and 3 ml of water were added and stirred for 20 minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 98 mg (0.25 mmol), yield: 83.3
% H-NMR (CDCl3): 0.85-0.90 (3H, t), 1.54-1.68 (2H, m), 2.
53-2.63 (2H, m), 3.88 (3H, s), 6.58-7.02 (3H, m), 7.26
7.88 (9H, m), 10.31 (1H, s)
【0088】3)4−(4−メトキシフェニル)−2−
(2−ナフトキシ)−6−プロピルピリジン−3−カル
ボン酸の合成 塩化メチレン1.8ml、水0.9ml中4−(4−メ
トキシフェニル)−2−(2−ナフトキシ)−6−プロ
ピルピリジン−3−アルデヒド98mg(0.25mm
ol)に氷浴下2−メチル−2−ブテン0.21ml
(1.98mmol)、アミド硫酸70mg(0.72
mmol)、亜塩素酸ナトリウム141mg(1.56
mmol)を加え室温で30分間攪拌した。水を加え、
酢酸エチルで抽出し有機層を無水硫酸ナトリウムで乾
燥、減圧下濃縮した。残渣をシリカゲルクロマトグラフ
ィー(クロロホルム:メタノール 50:1)で精製し
表題化合物を得た。 収量:71mg(0.17mmol)、収率:68.7
% MS(ESI,m/z) 414(MH+) H-NMR(CDCl3):0.85-0.90(3H,t)、1.55-1.70(2H,m)、2.
56-2.61(2H,t)、3.81(3H,s)、6.91-6.98(3H,m)、7.28-
7.60(6H,m)、7.71-7.87(3H,m)3) 4- (4-methoxyphenyl) -2-
Synthesis of (2-naphthoxy) -6-propylpyridine-3-carboxylic acid 4- (4-methoxyphenyl) -2- (2-naphthoxy) -6-propylpyridine- in 1.8 ml of methylene chloride and 0.9 ml of water 98 mg of 3-aldehyde (0.25 mm
ol) in an ice bath 0.21 ml of 2-methyl-2-butene
(1.98 mmol), amidosulfuric acid 70 mg (0.72
mmol), 141 mg of sodium chlorite (1.56
mmol) and stirred at room temperature for 30 minutes. Add water,
The mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform: methanol 50: 1) to obtain the title compound. Yield: 71 mg (0.17 mmol), yield: 68.7
% MS (ESI, m / z) 414 (MH +) H-NMR (CDCl3): 0.85-0.90 (3H, t), 1.55-1.70 (2H, m), 2.
56-2.61 (2H, t), 3.81 (3H, s), 6.91-6.98 (3H, m), 7.28-
7.60 (6H, m), 7.71-7.87 (3H, m)
【0089】実施例11 6−エチル−4−(4−メト
キシフェニル)−2−(3,4−メチレンジオキシフェ
ノキシ)ピリジン−3−カルボン酸の合成 1)1−(4−メトキシフェニル)−3−オキソペンタ
ノールの合成 THF30ml、リチウムビストリメチルシリルアミド
1M−THF溶液17mlに−78℃でTHF15ml
に溶解した2−ブタノン1.35ml(15.1mmo
l)を10分間で滴下した。滴下終了20分後p−アニ
スアルデヒド1.80ml(14.8mmol)を加え
−78℃から−30℃まで徐々に温度を上げながら1時
間攪拌した。2規定塩酸15mlで反応を止め、酢酸エ
チルで抽出し有機層を無水硫酸ナトリウムで乾燥、減圧
下濃縮した。残渣をシリカゲルクロマトグラフィー(ヘ
キサン:酢酸エチル 6:1)で精製し表題化合物を得
た。 収量:1.90g(9.12mmol)、収率:61.
6% H-NMR(CDCl3):1.04-1.09(3H,t)、2.41-2.50(2H,qua)、
2.78-2.85(2H,m)、3.21-3.22(1H,d)、3.80(3H,s)、5.08
-5.15(1H,m)、6.87-6.90(2H,d)、7.27-7.30(2H,d)Example 11 Synthesis of 6-ethyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine-3-carboxylic acid 1) 1- (4-methoxyphenyl)- Synthesis of 3-oxopentanol THF (30 ml), lithium bistrimethylsilylamide 1M-THF solution (17 ml) at −78 ° C. in THF (15 ml)
1.35 ml (15.1 mmol) of 2-butanone dissolved in
l) was added dropwise over 10 minutes. 20 minutes after the completion of the dropwise addition, 1.80 ml (14.8 mmol) of p-anisaldehyde was added, and the mixture was stirred for 1 hour while gradually raising the temperature from -78 ° C to -30 ° C. The reaction was stopped with 15 ml of 2N hydrochloric acid, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 6: 1) to give the title compound. Yield: 1.90 g (9.12 mmol), Yield: 61.
6% H-NMR (CDCl3): 1.04-1.09 (3H, t), 2.41-2.50 (2H, qua),
2.78-2.85 (2H, m), 3.21-3.22 (1H, d), 3.80 (3H, s), 5.08
-5.15 (1H, m), 6.87-6.90 (2H, d), 7.27-7.30 (2H, d)
【0090】2)1−(4−メトキシフェニル)−1−
ペンテン−3−オンの合成 トルエン60ml中、1−(4−メトキシフェニル)−
3−オキソペンタノール1.90g(9.12mmo
l)と無水硫酸マグネシウム3.73g(31.0mm
ol)を1晩還流した。濾過、酢酸エチルで洗浄し濾液
を減圧下濃縮した。残渣を精製せずに次の反応に用い
た。 収量:1.67g(8.78mmol)、収率:96.
3% MS(ESI,m/z) 191(MH+) H-NMR(CDCl3):1.14-1.19(3H,t)、2.64-2.72(2H,qua)、
3.84(3H,s)、6.61-6.66(1H,d)、6.90-6.93(2H,d)、7.48
-7.51(2H,d)、7.50-7.55(1H,m)2) 1- (4-methoxyphenyl) -1-
Synthesis of penten-3-one 1- (4-methoxyphenyl)-in 60 ml of toluene
1.90 g of 3-oxopentanol (9.12 mmol
l) and 3.73 g (31.0 mm) of anhydrous magnesium sulfate
ol) was refluxed overnight. After filtration and washing with ethyl acetate, the filtrate was concentrated under reduced pressure. The residue was used for the next reaction without purification. Yield: 1.67 g (8.78 mmol), yield: 96.
3% MS (ESI, m / z) 191 (MH +) H-NMR (CDCl3): 1.14-1.19 (3H, t), 2.64-2.72 (2H, qua),
3.84 (3H, s), 6.61-6.66 (1H, d), 6.90-6.93 (2H, d), 7.48
-7.51 (2H, d), 7.50-7.55 (1H, m)
【0091】3)3−シアノ−6−エチル−4−(4−
メトキシフェニル)−2−ピリドンの合成 DMSO20ml中、シアノアセトアミド743mg
(8.84mmol)にt−ブトキシカリウム992m
g(8.84mmol)ついでDMSO5mlに溶解し
た1−(4−メトキシフェニル)−1−ペンテン−3−
オン1.67g(8.78mmol)を加え室温で30
分間攪拌した。t−ブトキシカリウム2.98g(2
6.6mmol)を加えた後、酸素ガスを1分間バブリ
ングしさらに室温常圧酸素雰囲気下で2時間攪拌した。
2規定塩酸を加え析出した結晶を濾取、水、ヘキサンで
洗浄、減圧乾燥し表題化合物を得た。 収量:1.24g(4.88mmol)、収率:55.
6% MS(ESI,m/z) 255(MH+) H-NMR(CDCl3):1.35-1.40(3H,t)、2.74-2.83(2H,qua)、
3.88(3H,s)、6.28(1H,s)、7.00-7.03(2H,d)、7.59-7.62
(2H,d)3) 3-cyano-6-ethyl-4- (4-
Synthesis of methoxyphenyl) -2-pyridone 743 mg of cyanoacetamide in 20 ml of DMSO
(8.84 mmol) in 992 m of potassium t-butoxide
g (8.84 mmol) and then 1- (4-methoxyphenyl) -1-pentene-3- dissolved in 5 ml of DMSO.
1.67 g (8.78 mmol) was added and the mixture was added at room temperature for 30 minutes.
Stirred for minutes. 2.98 g of potassium t-butoxide (2
(6.6 mmol) was added, oxygen gas was bubbled for 1 minute, and the mixture was further stirred at room temperature under a normal pressure oxygen atmosphere for 2 hours.
2N Hydrochloric acid was added, and the precipitated crystals were collected by filtration, washed with water and hexane, and dried under reduced pressure to obtain the title compound. Yield: 1.24 g (4.88 mmol), yield: 55.
6% MS (ESI, m / z) 255 (MH +) H-NMR (CDCl3): 1.35-1.40 (3H, t), 2.74-2.83 (2H, qua),
3.88 (3H, s), 6.28 (1H, s), 7.00-7.03 (2H, d), 7.59-7.62
(2H, d)
【0092】4)2−クロロ−3−シアノ−6−エチル
−4−(4−メトキシフェニル)ピリジンの合成 3−シアノ−6−エチル−4−(4−メトキシフェニ
ル)−2−ピリドン1.22g(4.80mmol)に
オキシ塩化リン22ml、N,N−ジメチルアニリン
0.61ml(4.81mmol)を加え100℃で
2.5時間加熱した。オキシ塩化リンを留去後水を加え
エーテル抽出し、有機層を飽和炭酸水素ナトリウム水溶
液で洗浄、無水硫酸ナトリウムで乾燥、減圧下濃縮し
た。残渣を精製せずに次の反応に用いた。 収量:795mg(2.91mmol)、収率:60.
6% MS(ESI,m/z) 273(MH+) H-NMR(CDCl3):1.32-1.37(3H,t)、2.84-2.92(2H,qua)、
3.88(3H,s,MeO)、7.03-7.06(2H,d)、7.20(1H,s)、7.55-
7.58(2H,d)4) Synthesis of 2-chloro-3-cyano-6-ethyl-4- (4-methoxyphenyl) pyridine 3-cyano-6-ethyl-4- (4-methoxyphenyl) -2-pyridone To 22 g (4.80 mmol), 22 ml of phosphorus oxychloride and 0.61 ml (4.81 mmol) of N, N-dimethylaniline were added, and the mixture was heated at 100 ° C. for 2.5 hours. After distilling off phosphorus oxychloride, water was added thereto, and the mixture was extracted with ether. The organic layer was washed with a saturated aqueous solution of sodium hydrogen carbonate, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was used for the next reaction without purification. Yield: 795 mg (2.91 mmol), yield: 60.
6% MS (ESI, m / z) 273 (MH +) H-NMR (CDCl3): 1.32-1.37 (3H, t), 2.84-2.92 (2H, qua),
3.88 (3H, s, MeO), 7.03-7.06 (2H, d), 7.20 (1H, s), 7.55-
7.58 (2H, d)
【0093】5)3−シアノ−6−エチル−4−(4−
メトキシフェニル)−2−(3,4−メチレンジオキシ
フェノキシ)ピリジンの合成 DMF7ml中、セサモール221mg(1.60mm
ol)に60%水素化ナトリウム80mg(2.0mm
ol)を加え室温で10分間攪拌した。2−クロロ−3
−シアノ−6−エチル−4−(4−メトキシフェニル)
ピリジン408mg(1.50mmol)をDMF5m
lに溶解して滴下し、室温で2時間攪拌した。減圧下で
DMFを留去後1規定塩酸を加え、酢酸エチルで抽出し
有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮した。
残渣をシリカゲルクロマトグラフィー(ヘキサン:酢酸
エチル 4:1)で精製し表題化合物を得た。 収量:400mg(1.07mmol)、収率:71.
2% MS(ESI,m/z) 375(MH+) H-NMR(CDCl3):1.17-1.22(3H,t)、2.65-2.75(2H,qua)、
3.88(3H,s)、6.01(2H,s,OCH2O)、6.63-6.83(3H,m)、6.9
4(1H,s)、7.02-7.05(2H,d)、7.59−7.62(2
H,d)5) 3-cyano-6-ethyl-4- (4-
Synthesis of methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 221 mg of sesamol (1.60 mm) in 7 ml of DMF
ol) to 80 mg of 60% sodium hydride (2.0 mm
ol) and stirred at room temperature for 10 minutes. 2-chloro-3
-Cyano-6-ethyl-4- (4-methoxyphenyl)
Pyridine (408 mg, 1.50 mmol) in DMF (5 m)
The resulting mixture was added dropwise to the mixture and stirred at room temperature for 2 hours. After distilling off DMF under reduced pressure, 1N hydrochloric acid was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure.
The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 400 mg (1.07 mmol), yield: 71.
2% MS (ESI, m / z) 375 (MH +) H-NMR (CDCl3): 1.17-1.22 (3H, t), 2.65-2.75 (2H, qua),
3.88 (3H, s), 6.01 (2H, s, OCH2O), 6.63-6.83 (3H, m), 6.9
4 (1H, s), 7.02-7.05 (2H, d), 7.59-7.62 (2
H, d)
【0094】6)6−エチル−4−(4−メトキシフェ
ニル)−2−(3,4−メチレンジオキシフェノキシ)
ピリジン−3−アルデヒドの合成 3−シアノ−6−エチル−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)ピ
リジン393mg(1.05mmol)をベンゼン10
mlに溶解し室温で水素化ジイソブチルアルミニウム1
Mヘキサン溶液3.15ml(3.15mmol)を加
え室温で2時間攪拌した。メタノール1ml、水3ml
を加え20分間攪拌した。沈澱を濾過し濾液を減圧下濃
縮した。残渣をシリカゲルクロマトグラフィー(ヘキサ
ン:酢酸エチル 6:1)で精製し表題化合物を得た。 収量:84mg(0.22mmol)、収率:21.1
% H−NMR(CDCl3):1.17-1.22(3H,t)、2.64-2.
72(2H,qua)、3.87(3H,s,MeO)、6.00(2H,s)、6.62-6.82
(3H,m)、6.84(1H,s)、6.97-7.00(2H,d)、7.30-7.33(2H,
d)、10.24(1H,s,CHO)6) 6-ethyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy)
Synthesis of pyridine-3-aldehyde 3-cyano-6-ethyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 393 mg (1.05 mmol) was added to benzene 10
disodium diisobutylaluminum 1 at room temperature
3.15 ml (3.15 mmol) of a M hexane solution was added, and the mixture was stirred at room temperature for 2 hours. 1 ml of methanol, 3 ml of water
Was added and stirred for 20 minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 6: 1) to give the title compound. Yield: 84 mg (0.22 mmol), Yield: 21.1
% H-NMR (CDCl3): 1.17-1.22 (3H, t), 2.64-2.
72 (2H, qua), 3.87 (3H, s, MeO), 6.00 (2H, s), 6.62-6.82
(3H, m), 6.84 (1H, s), 6.97-7.00 (2H, d), 7.30-7.33 (2H,
d), 10.24 (1H, s, CHO)
【0095】7)6−エチル−4−(4−メトキシフェ
ニル)−2−(3,4−メチレンジオキシフェノキシ)
ピリジン−3−カルボン酸の合成 塩化メチレン1.8ml、水0.9ml中6−エチル−
4−(4−メトキシフェニル)−2−(3,4−メチレ
ンジオキシフェノキシ)ピリジン−3−アルデヒド84
mg(0.22mmol)に氷浴下2−メチル−2−ブ
テン0.21ml(1.98mmol)、アミド硫酸7
0mg(0.72mmol)、亜塩素酸ナトリウム14
0mg(1.55mmol)を加え室温で20分間攪拌
した。水を加え、酢酸エチルで抽出し有機層を無水硫酸
ナトリウムで乾燥、減圧下濃縮した。残渣をシリカゲル
クロマトグラフィー(クロロホルム:メタノール 9:
1)で精製し表題化合物を得た。 収量:56mg(0.14mmol)、収率:63.5
% MS(ESI,m/z) 394(MH+) H-NMR(CDCl3):1.08-1.13(3H,t)、2.51-2.61(2H,qua)、
3.60(3H,s,MeO)、5.87(2H,s)、6.38-6.59(3H,m)、6.62-
6.65(2H,d)、6.70(1H,s)、7.27−7.30(2H,
d)7) 6-ethyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy)
Synthesis of pyridine-3-carboxylic acid 6-ethyl- in 1.8 ml of methylene chloride, 0.9 ml of water
4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine-3-aldehyde 84
mg (0.22 mmol) of 0.21 ml (1.98 mmol) of 2-methyl-2-butene in an ice bath,
0 mg (0.72 mmol), sodium chlorite 14
0 mg (1.55 mmol) was added, and the mixture was stirred at room temperature for 20 minutes. Water was added, the mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was chromatographed on silica gel (chloroform: methanol 9: 9).
Purification in 1) gave the title compound. Yield: 56 mg (0.14 mmol), yield: 63.5
% MS (ESI, m / z) 394 (MH +) H-NMR (CDCl3): 1.08-1.13 (3H, t), 2.51-2.61 (2H, qua),
3.60 (3H, s, MeO), 5.87 (2H, s), 6.38-6.59 (3H, m), 6.62
6.65 (2H, d), 6.70 (1H, s), 7.27-7.30 (2H,
d)
【0096】実施例12 6−プロピル−4−(4−イ
ソプロピルオキシフェニル)−2−(3、4−メチレン
ジオキシフェニルオキシ)ピリジン−3−カルボン酸の
合成 1)4−イソプロピルオキシベンズアルデヒドの合成 4−ヒドロキシベンズアルデヒド5.0g(44.6m
mol)、炭酸カリウム6.0g(55.0mmo
l)、イソプロピルブロミド6.0ml(63.9mm
ol)、DMF80mlの混合物を50℃で一晩攪拌す
る。酢酸エチルで薄め不溶物を濾過する。減圧下溶媒を
留去し残渣をエーテルに溶解する。1規定水酸化ナトリ
ウム溶液、水、飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧下溶媒を留去すると表題化合物を得
た。 収量:6.12g、収率:83.6%Example 12 Synthesis of 6-propyl-4- (4-isopropyloxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) Synthesis of 4-isopropyloxybenzaldehyde 5.0 g of 4-hydroxybenzaldehyde (44.6 m
mol), 6.0 g of potassium carbonate (55.0 mmol)
l), 6.0 ml of isopropyl bromide (63.9 mm
ol), a mixture of 80 ml of DMF is stirred at 50 ° C. overnight. Dilute with ethyl acetate and filter the insolubles. The solvent is distilled off under reduced pressure, and the residue is dissolved in ether. After washing with 1N sodium hydroxide solution, water and saturated saline, drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure to obtain the title compound. Yield: 6.12 g, yield: 83.6%
【0097】2)1−(4−イソプロピルオキシフェニ
ル)−3−オキソ−1−ヘキサノールの合成 アルゴン雰囲気下、−70℃でリチウムビストリメチル
シリルアミドの1Mヘキサン溶液22mlをTHF10
mlに加える。2−ヘプタノン2.1ml(19.8m
mol)のTHF10ml溶液を滴下し10分間攪拌す
る。4−ヒドロキシベンズアルデヒド1.64g(1
0.0mmol)を加え1時間攪拌した後に1規定塩酸
を加え反応を停止する。酢酸エチルで抽出し飽和食塩水
で洗浄する。無水硫酸マグネシウムで乾燥し減圧下溶媒
を留去する。得られた残渣をシリカゲルカラムクロマト
グラフィー(酢酸エチル:ヘキサン 1:3)に付し表
題化合物を得た。 収量:1.40g、収率:55.9%2) Synthesis of 1- (4-isopropyloxyphenyl) -3-oxo-1-hexanol In an argon atmosphere, 22 ml of a 1M hexane solution of lithium bistrimethylsilylamide was added to THF10 at -70 ° C.
Add to ml. 2.1 ml of 2-heptanone (19.8 m
mol) in 10 ml of THF, and the mixture is stirred for 10 minutes. 1.64 g of 4-hydroxybenzaldehyde (1
(0.0 mmol) and stirred for 1 hour, and then 1N hydrochloric acid was added to terminate the reaction. Extract with ethyl acetate and wash with saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to give the title compound. Yield: 1.40 g, yield: 55.9%
【0098】3)1−(4−イソプロピルオキシフェニ
ル)−1−ヘキセン−3−オンの合成 1−(4−イソプロピルオキシフェニル)−3−オキソ
−1−ヘキサノール1.40g(5.6mmol)をト
ルエン30mlに溶解し無水硫酸マグネシウム4.0
g、p−トルエンスルホン酸30mgを加え90℃で1
時間攪拌する。濾過し減圧下溶媒を留去して得られた残
渣をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル:ヘキサン 1:4)に付し表題化合物を得た。 収量:1.09g、収率:83.4% MS(ESI,m/z) 233 (MH+) H-NMR(CDCl3):0.95 (3H, t)、1.35 (6H, d)、1.71 (2
H, sex)、2.62 (2H, t)、4.59 (1H, m)、6.62 (1H,
d)、6.88 (2H, d)、7.47 (2H, d)、7.51 (1H, d)3) Synthesis of 1- (4-isopropyloxyphenyl) -1-hexen-3-one 1.40 g (5.6 mmol) of 1- (4-isopropyloxyphenyl) -3-oxo-1-hexanol Dissolved in 30 ml of toluene and dried over anhydrous magnesium sulfate 4.0
g and 30 mg of p-toluenesulfonic acid.
Stir for hours. The residue obtained by filtration and evaporation of the solvent under reduced pressure was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 4) to give the title compound. Yield: 1.09 g, 83.4% MS (ESI, m / z) 233 (MH +) H-NMR (CDCl3): 0.95 (3H, t), 1.35 (6H, d), 1.71 (2
H, sex), 2.62 (2H, t), 4.59 (1H, m), 6.62 (1H,
d), 6.88 (2H, d), 7.47 (2H, d), 7.51 (1H, d)
【0099】4)6−プロピル−3−シアノ−4−(4
−イソプロピルオキシフェニル)−2−ピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド400m
g(4.8mmol)、t−ブトキシカリウム530m
g(4.7mmol)のDMSO10ml溶液に1−
(4−イソプロピルオキシフェニル)−5−メチル−1
−ヘキセン−3−オン1.09g(4.7mmol)の
DMSO20mlを加え15分間攪拌する。t−ブトキ
シカリウム1.58g(14.1mmol)を加え1分
間酸素をバブリングする。酸素雰囲気下1時間攪拌した
後、1規定塩酸氷冷下加え析出した結晶を濾取する。水
で洗い減圧下乾燥し表題化合物を得た。この化合物は精
製せずに以下の反応に用いる。 収量:910mg、収率:65.3% MS(ESI,m/z) 297 (MH+) H-NMR(CDCl3):1.04 (3H, t)、1.38 (6H, d)、2.00 (2
H, sex)、2.68 (2H, t)、4.63 (1H, m)、6.25 (1H,
s)、6.98 (2H, d)、7.59 (2H, d)4) 6-propyl-3-cyano-4- (4
Synthesis of -Isopropyloxyphenyl) -2-pyridone Cyanoacetamide 400m at room temperature under argon atmosphere
g (4.8 mmol), potassium t-butoxide 530 m
g (4.7 mmol) in 10 ml of DMSO
(4-isopropyloxyphenyl) -5-methyl-1
-Hexen-3-one (1.09 g, 4.7 mmol) in 20 ml of DMSO is added, and the mixture is stirred for 15 minutes. 1.58 g (14.1 mmol) of potassium t-butoxide is added, and oxygen is bubbled for 1 minute. After stirring for 1 hour in an oxygen atmosphere, 1N hydrochloric acid is added under ice-cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 910 mg, 65.3% MS (ESI, m / z) 297 (MH +) H-NMR (CDCl3): 1.04 (3H, t), 1.38 (6H, d), 2.00 (2
H, sex), 2.68 (2H, t), 4.63 (1H, m), 6.25 (1H,
s), 6.98 (2H, d), 7.59 (2H, d)
【0100】5)6−プロピル−3−シアノ−4−(4
−イソプロピルオキシフェニル)−2−クロロピリジン
の合成 6−プロピル−3−シアノ−4−(4−イソプロピルオ
キシフェニル)−2−ピリドン910mg(3.1mm
ol)をオキシ塩化リン6mlに溶解し90℃で一晩攪
拌する。オキシ塩化リンを減圧下留去し残渣を酢酸エチ
ルに溶解する。飽和重曹水、飽和食塩水で洗浄し無水硫
酸マグネシウムで乾燥する。減圧下溶媒を留去し表題化
合物を得た。このものは精製せずに以下の反応に利用し
た。 収量:1.10g MS(ESI,m/z) 315 (MH+) H-NMR(CDCl3):1.00 (3H, t)、1.38 (6H, d)、1.70 (2
H, sex)、2.72 (2H, t)、4.64 (1H, m)、7.01 (2H,
d)、7.18 (1H, s)、7.55 (2H, d)5) 6-propyl-3-cyano-4- (4
Synthesis of -isopropyloxyphenyl) -2-chloropyridine 910 mg (3.1 mm) of 6-propyl-3-cyano-4- (4-isopropyloxyphenyl) -2-pyridone
ol) in 6 ml of phosphorus oxychloride and stir at 90 ° C. overnight. The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound. This was used for the following reaction without purification. Yield: 1.10 g MS (ESI, m / z) 315 (MH +) H-NMR (CDCl3): 1.00 (3H, t), 1.38 (6H, d), 1.70 (2
H, sex), 2.72 (2H, t), 4.64 (1H, m), 7.01 (2H,
d), 7.18 (1H, s), 7.55 (2H, d)
【0101】6)6−プロピル−3−シアノ−4−(4
−イソプロピルオキシフェニル)−2−(3、4−メチ
レンジオキシフェニルオキシ)ピリジンの合成 セサモール290mg(2.1mmol)、水素化ナト
リウム170mg(60%オイルディスパージョン、
4.2mmol)より作成したフェノキシドイオンのD
MF5ml溶液に6−プロピル−3−シアノ−4−(4
−イソプロピルオキシフェニル)−2−クロロピリジン
620mgをDMF10mlに溶解して加えアルゴン雰
囲気下室温で2時間攪拌する。減圧下溶媒を留去し、残
渣をエーテルに溶解し1規定水酸化ナトリウム溶液、
水、飽和食塩水で洗浄する。無水硫酸マグネシウムで乾
燥し減圧下溶媒を留去する。得られた残渣をシリカゲル
カラムクロマトグラフィー(酢酸エチル:ヘキサン
1:4)に付し表題化合物を得た。 収量:110mg、収率:6−プロピル−3−シアノ−
4−(4−イソプロピルオキシフェニル)−2−ピリド
ンより15.3% MS(ESI,m/z) 417 (MH+) H-NMR(CDCl3):0.90 (3H, t)、1.38 (6H, d)、2.24 (2
H, sex)、2.62 (2H, t)、4.63 (1H, m)、6.01 (2H,
s)、6.66 (1H, dd)、6.74 (1H, d)、6.80 (1H, d)、6.9
2 (1H, s)、7.00 (2H, d)、7.59 (2H, d)6) 6-propyl-3-cyano-4- (4
Synthesis of -isopropyloxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine sesamol 290 mg (2.1 mmol), sodium hydride 170 mg (60% oil dispersion,
D) of phenoxide ion prepared from 4.2 mmol)
6-propyl-3-cyano-4- (4
-Isopropyloxyphenyl) -2-chloropyridine (620 mg) is dissolved in DMF (10 ml), and the mixture is stirred under an argon atmosphere at room temperature for 2 hours. The solvent was distilled off under reduced pressure, and the residue was dissolved in ether.
Wash with water and saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (ethyl acetate: hexane)
1: 4) to give the title compound. Yield: 110 mg, yield: 6-propyl-3-cyano-
15.3% from 4- (4-isopropyloxyphenyl) -2-pyridone MS (ESI, m / z) 417 (MH +) H-NMR (CDCl3): 0.90 (3H, t), 1.38 (6H, d) , 2.24 (2
H, sex), 2.62 (2H, t), 4.63 (1H, m), 6.01 (2H,
s), 6.66 (1H, dd), 6.74 (1H, d), 6.80 (1H, d), 6.9
2 (1H, s), 7.00 (2H, d), 7.59 (2H, d)
【0102】7)6−プロピル−4−(4−イソプロピ
ルオキシフェニル)−2−(3、4−メチレンジオキシ
フェニルオキシ)ピリジン−3−アルデヒドの合成 6−プロピル−3−シアノ−4−(4−イソプロピルオ
キシフェニル)−2−(3、4−メチレンジオキシフェ
ニルオキシ)ピリジン110mg(0.26mmol)
をベンゼン5mlに溶解しアルゴン雰囲気下室温で水素
化ジイソブチルアルミニウム1Mヘキサン溶液1.0m
l(1.0mmol)を滴下する。室温で1時間攪拌し
メタノールと水で反応を停止する。室温で1時間攪拌
し、不溶物をセライトを用いて濾過する。濾液をを減圧
下留去し得られた残渣をシリカゲルカラムクロマトグラ
フィー(酢酸エチル:ヘキサン 1:4)に付し表題化
合物を得た。このものは分離困難な不純物を含むがこれ
以上精製せずに以下の反応に用いる。 収量:80mg MS(ESI,m/z) 420 (MH+)7) Synthesis of 6-propyl-4- (4-isopropyloxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 6-propyl-3-cyano-4- ( 110 mg (0.26 mmol) of 4-isopropyloxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine
Was dissolved in 5 ml of benzene, and a 1 M solution of diisobutylaluminum hydride in hexane was added at room temperature under an argon atmosphere at room temperature.
1 (1.0 mmol) is added dropwise. Stir at room temperature for 1 hour and terminate the reaction with methanol and water. The mixture is stirred at room temperature for 1 hour, and the insoluble matter is filtered using celite. The filtrate was evaporated under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 4) to obtain the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 80 mg MS (ESI, m / z) 420 (MH +)
【0103】8)6−プロピル−4−(4−イソプロピ
ルオキシフェニル)−2−(3、4−メチレンジオキシ
フェニルオキシ)ピリジン−3−カルボン酸の合成 6−プロピル−4−(4−イソプロピルオキシフェニ
ル)−2−(3、4−メチレンジオキシフェニルオキ
シ)ピリジン−3−アルデヒド80mgを塩化メチレン
2ml、水1mlに溶解し、0℃で2−メチル−2−ブ
テン0.12ml(1,1mmol)、アミド硫酸30
mg(0.31mmol)、亜塩素酸ナトリウム80m
g(0.70mmol)を加え室温に戻して20分間攪
拌する。酢酸エチルで抽出し、飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥して減圧下溶媒を留去する。
得られた残渣をシリカゲル薄層クロマトグラフィー(酢
酸エチル:ヘキサン 1:1)に付し表題化合物を得
た。 収量:13mg、収率:6−プロピル−3−シアノ−4
−(4−イソプロピルオキシフェニル)−2−(3、4
−メチレンジオキシフェニルオキシ)ピリジンより1
1.5% MS(ESI,m/z) 436 (MH+) H-NMR(CDCl3):0.88 (3H, t)、1.34 (6H, d)、1.64 (2
H, sex)、2.60 (2H, t)、4.55 (1H, m)、5.97 (2H,
s)、6.61 (1H, dd)、6.73 (1H, d)、6.75 (1H, d)、6.8
4 (1H, s)、6.88 (2H, d)、7.38 (2H, d)8) Synthesis of 6-propyl-4- (4-isopropyloxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6-propyl-4- (4-isopropyl) Dissolve 80 mg of (oxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde in 2 ml of methylene chloride and 1 ml of water and, at 0 ° C., 0.12 ml of 2-methyl-2-butene (1,2). 1 mmol), amidosulfuric acid 30
mg (0.31 mmol), sodium chlorite 80m
g (0.70 mmol) was added and the mixture was returned to room temperature and stirred for 20 minutes. The mixture is extracted with ethyl acetate, washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure.
The obtained residue was subjected to silica gel thin layer chromatography (ethyl acetate: hexane 1: 1) to give the title compound. Yield: 13 mg, yield: 6-propyl-3-cyano-4
-(4-isopropyloxyphenyl) -2- (3,4
-Methylenedioxyphenyloxy) pyridine
1.5% MS (ESI, m / z) 436 (MH +) H-NMR (CDCl3): 0.88 (3H, t), 1.34 (6H, d), 1.64 (2
H, sex), 2.60 (2H, t), 4.55 (1H, m), 5.97 (2H,
s), 6.61 (1H, dd), 6.73 (1H, d), 6.75 (1H, d), 6.8
4 (1H, s), 6.88 (2H, d), 7.38 (2H, d)
【0104】実施例13 4−(4−メトキシフェニ
ル)−6−メチル−2−(3、4−メチレンジオキシフ
ェノキシ)−ピリジン−3−カルボン酸の合成 1)1−(4−メトキシフェニル)−1−ブテニル−3
−オンの合成 アセトニルトリフェニルホスホニウム クロリド3.9
1g(11.0mmol) をTHF(30ml)に溶
かし60%水素化ナトリウム440mg(11.0mm
ol)を0℃にて加えた。室温に戻し、1時間攪拌した
後、Pーp−アニスアルデヒド1g(7.34mmo
l)を加え1晩攪拌した。反応溶液に水を加え、酢酸エ
チルにて抽出した。有機相を飽和食塩水にて洗浄し、無
水硫酸マグネシウムで乾燥後、減圧下溶媒留去して黄褐
色結晶の粗製生成物を得た。これをシリカゲル上でヘキ
サン/酢酸エチル(5:1)を用いて精製し表題化合物
を得た。 収量:1、15g 、収率:59% MS(ESI. m/z) 177(MH+) H-NMR (CDCl3):2.36 (3H, s)、3.85 (3H, s)、6.61 (1
H, d)、6.92 (2H, d)、7.45-7.51 (3H, m)Example 13 Synthesis of 4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 1) 1- (4-methoxyphenyl) -1-butenyl-3
Synthesis of -one Acetonyltriphenylphosphonium chloride 3.9
1 g (11.0 mmol) was dissolved in THF (30 ml) and 440 mg of 60% sodium hydride (11.0 mm
ol) at 0 ° C. After returning to room temperature and stirring for 1 hour, 1 g of P-p-anisaldehyde (7.34 mmol
l) was added and stirred overnight. Water was added to the reaction solution, and extracted with ethyl acetate. The organic phase was washed with brine, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure to give a crude product of yellow-brown crystals. This was purified on silica gel using hexane / ethyl acetate (5: 1) to give the title compound. Yield: 1,15 g, Yield: 59% MS (ESI. M / z) 177 (MH +) H-NMR (CDCl3): 2.36 (3H, s), 3.85 (3H, s), 6.61 (1
H, d), 6.92 (2H, d), 7.45-7.51 (3H, m)
【0105】2)3−シアノ−4−(4−メトキシフェ
ニル)−6−メチル−2−ピリドンの合成 α−シアノアセトアミド604mg(7.18mmo
l)をDMSO30mlに溶かし、アルゴン雰囲気下、
t−ブトキシカリウム733mg(6.53mmo
l)、1−(4−メトキシフェニル)−1−ブテニル−
3−オン1.15g(6.53mmol)を室温にて順
次加えて、15分間攪拌した。TLCにて原料の消失を
確認した後、t−ブトキシカリウム2.20g(19.
6mmol)を加え、酸素を1分間バブリングし、酸素
雰囲気下1時間攪拌した。反応溶液に3規定 塩酸を2
0ml加えて1時間攪拌すると、黄土色結晶物質が析出
した。この結晶物質を吸引濾過し、水、ヘキサン/酢酸
エチル(1:1)混合液で順次洗浄し、100℃におい
て1晩乾燥させて表題化合物を得た。 収量:990mg、収率:67% H-NMR (CD3OD):2.65 ( 3H, s)、3.87 ( 3H, s)、6.39
( 1H, s)、7.06 ( 2H,d)、7.63 ( 2H, d)2) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-methyl-2-pyridone 604 mg of α-cyanoacetamide (7.18 mmol)
l) was dissolved in 30 ml of DMSO, and under an argon atmosphere,
733 mg of potassium t-butoxide (6.53 mmol
1), 1- (4-methoxyphenyl) -1-butenyl-
1.15 g (6.53 mmol) of 3-one was sequentially added at room temperature, and the mixture was stirred for 15 minutes. After confirming the disappearance of the raw materials by TLC, 2.20 g of potassium t-butoxide (19.
6 mmol) was added, oxygen was bubbled for 1 minute, and the mixture was stirred under an oxygen atmosphere for 1 hour. Add 3N hydrochloric acid to the reaction solution
After 0 ml was added and the mixture was stirred for 1 hour, an ocher crystal substance was deposited. The crystalline material was filtered off with suction, washed successively with water and a hexane / ethyl acetate (1: 1) mixture and dried overnight at 100 ° C. to give the title compound. Yield: 990 mg, yield: 67% H-NMR (CD3OD): 2.65 (3H, s), 3.87 (3H, s), 6.39
(1H, s), 7.06 (2H, d), 7.63 (2H, d)
【0106】3)2−クロロ−3−シアノ−4−(4−
メトキシフェニル)−6−メチルピリジンの合成 3−シアノ−4−(4−メトキシフェニル)−6−メチ
ル−2−ピリドン990mg(4.38mmol)にオ
キシ塩化リン10mlを加え、120℃にて12時間攪
拌した。この後、減圧下にてオキシ塩化リンを留去し、
残渣を酢酸エチル中に加え、水、飽和重曹水、飽和食塩
水で順次洗浄する。無水硫酸マグネシウムで乾燥後、溶
媒を留去して、表題化合物を得た。 収量:900mg、収率:79% MS(ESI. m/z) 259(MH+) H-NMR (CDCl3):2.63 (3H, s)、3.88 (3H, s)、7.06 (2
H, d)、7.04 (1H, s)、7.56 (2H, d)3) 2-Chloro-3-cyano-4- (4-
Synthesis of methoxyphenyl) -6-methylpyridine To 990 mg (4.38 mmol) of 3-cyano-4- (4-methoxyphenyl) -6-methyl-2-pyridone was added 10 ml of phosphorus oxychloride, and the mixture was heated at 120 ° C for 12 hours. Stirred. Thereafter, phosphorus oxychloride was distilled off under reduced pressure,
The residue is added to ethyl acetate, and washed successively with water, saturated aqueous sodium hydrogen carbonate and saturated saline. After drying over anhydrous magnesium sulfate, the solvent was distilled off to obtain the title compound. Yield: 900 mg, 79% MS (ESI. M / z) 259 (MH +) H-NMR (CDCl3): 2.63 (3H, s), 3.88 (3H, s), 7.06 (2
H, d), 7.04 (1H, s), 7.56 (2H, d)
【0107】4)3−シアノ−4−(4−メトキシフェ
ニル)−6−メチル−2−(3、4−メチレンジオキシ
フェノキシ)−ピリジンの合成 アルゴン雰囲気下、セサモール400mg(2.90m
mol)をDMF10mlに溶かし、60%水素化ナト
リウム116mg(2.90mmol)を0℃にて加
え、1時間攪拌した。この後、2−クロロ−3−シアノ
−4−(4−メトキシフェニル)−6−メチル−ピリジ
ン500mg(1.93mmol)を加え、80℃にて
3時間攪拌した。反応溶液を水にあけ、酢酸エチルで有
機層を抽出し、無水硫酸マグネシウムで乾燥後溶媒を減
圧留去し、得られた残渣をカラムクロマトグラフィー
(溶離液 ヘキサン:酢酸エチル 3:1)に付し、表
題化合物を得た。 収量:260mg、収率:37% MS(ESI. m/z) 361(MH+) H-NMR (CDCl3):2.44 (3H, s)、3.88 (3H, s)、6.01 (2
H, s)、6.62-6.74 (3H, m)、6.81 (1H, d)、6.95 (1H,
s)、7.03 (2H, d)、7.60 (2H, d)4) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine Under an argon atmosphere, 400 mg of sesamol (2.90 m
mol) was dissolved in 10 ml of DMF, 116 mg (2.90 mmol) of 60% sodium hydride was added at 0 ° C., and the mixture was stirred for 1 hour. Thereafter, 500 mg (1.93 mmol) of 2-chloro-3-cyano-4- (4-methoxyphenyl) -6-methyl-pyridine was added, and the mixture was stirred at 80 ° C for 3 hours. The reaction solution was poured into water, the organic layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography (eluent hexane: ethyl acetate 3: 1). To give the title compound. Yield: 260 mg, Yield: 37% MS (ESI. M / z) 361 (MH +) H-NMR (CDCl3): 2.44 (3H, s), 3.88 (3H, s), 6.01 (2
H, s), 6.62 to 6.74 (3H, m), 6.81 (1H, d), 6.95 (1H,
s), 7.03 (2H, d), 7.60 (2H, d)
【0108】5)4−(4−メトキシフェニル)−6−
メチル−2−(3、4−メチレンジオキシフェノキシ)
−ピリジン−3−アルデヒドの合成 アルゴン雰囲気下、塩化メチレン10ml中、3−シア
ノ−4−(4−メトキシフェニル)−6−メチル−2−
(3、4−メチレンジオキシフェノキシ)−ピリジン2
60mg(0.722mmol)を溶かし、水素化ジイ
ソブチルアルミニウム1Mヘキサン溶液2.16mlを
0℃にて加え、室温にて1晩攪拌した。この後水1ml
を加え1時間攪拌した後、セライト濾過し残渣を酢酸エ
チルにて洗浄した。濾液を減圧下にて溶媒留去し、得ら
れた残渣をカラムクロマトグラフィー(溶離液 ヘキサ
ン:酢酸エチル 5:1)に付し、表題化合物を得た。 収量:190mg、収率:72% MS(ESI. m/z) 364(MH+) H-NMR (CDCl3):2.42 (3H, s)、3.87 (3H, s)、6.00 (2
H, s)、6.61-6.85 (3H, m)、6.98 (2H, d)、7.30 (2H,
d)、10.2 (1H, s)5) 4- (4-methoxyphenyl) -6
Methyl-2- (3,4-methylenedioxyphenoxy)
Synthesis of -pyridine-3-aldehyde 3-cyano-4- (4-methoxyphenyl) -6-methyl-2-in methylene chloride 10 ml under argon atmosphere
(3,4-methylenedioxyphenoxy) -pyridine 2
60 mg (0.722 mmol) was dissolved, 2.16 ml of a 1M solution of diisobutylaluminum hydride in hexane was added at 0 ° C., and the mixture was stirred at room temperature overnight. Then 1 ml of water
After stirring for 1 hour, the mixture was filtered through celite and the residue was washed with ethyl acetate. The solvent was distilled off from the filtrate under reduced pressure, and the obtained residue was subjected to column chromatography (eluent: hexane: ethyl acetate 5: 1) to obtain the title compound. Yield: 190 mg, yield: 72% MS (ESI. M / z) 364 (MH +) H-NMR (CDCl3): 2.42 (3H, s), 3.87 (3H, s), 6.00 (2
H, s), 6.61-6.85 (3H, m), 6.98 (2H, d), 7.30 (2H,
d), 10.2 (1H, s)
【0109】6)4−(4−メトキシフェニル)−6−
メチル−2−(3、4−メチレンジオキシフェノキシ)
−ピリジン−3−カルボン酸の合成 4−(4−メトキシフェニル)−6−メチル−2−
(3、4−メチレンジオキシフェノキシ)−ピリジン−
3−アルデヒド190mg(0.523mmol)を水
5ml,塩化メチレン10mlに溶かし、氷冷下、2−
メチル−ブテン213mg(3.03mmol),アミ
ド硫酸76mg(0.785mmol),亜塩素酸ナト
リウム165mg(1.83mmol)を加え、室温に
て2時間攪拌した。反応溶液に水を加え、塩化メチレン
にて抽出し、無水硫酸マグネシウムで乾燥後、減圧下に
て溶媒留去した。得られた残渣をカラムクロマトグラフ
ィー(溶離液 クロロホルム:メタノール 9:1)に
て精製し、表題化合物を得た。 収量:45mg、収率:23% MS(ESI. m/z) 380(MH+) H-NMR (CDCl3):2.37 (3H, s)、3.77 (3H, s)、5.95 (2
H, s)、6.55-6.73 (3H, m)、6.85 (3H, t)、7.38 (2H,
d)6) 4- (4-methoxyphenyl) -6
Methyl-2- (3,4-methylenedioxyphenoxy)
Synthesis of -pyridine-3-carboxylic acid 4- (4-methoxyphenyl) -6-methyl-2-
(3,4-methylenedioxyphenoxy) -pyridine-
Dissolve 190 mg (0.523 mmol) of 3-aldehyde in 5 ml of water and 10 ml of methylene chloride, and cool under ice-cooling.
213 mg (3.03 mmol) of methyl-butene, 76 mg (0.785 mmol) of amidosulfuric acid and 165 mg (1.83 mmol) of sodium chlorite were added, and the mixture was stirred at room temperature for 2 hours. Water was added to the reaction solution, extracted with methylene chloride, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 45 mg, Yield: 23% MS (ESI. M / z) 380 (MH +) H-NMR (CDCl3): 2.37 (3H, s), 3.77 (3H, s), 5.95 (2
H, s), 6.55-6.73 (3H, m), 6.85 (3H, t), 7.38 (2H,
d)
【0110】実施例14 4−(4−メトキシフェニ
ル)−2−(1−ナフトキシ)−6−プロピルピリジン
−3−カルボン酸の合成 1) 3−シアノ−4−(4−メトキシフェニル)−2
−(1−ナフトキシ)−6−プロピルピリジンの合成 DMF5ml中、1−ナフトール123mg(0.85
mmol)に60%水素化ナトリウム50mg(1.2
5mmol)を加え室温で15分間攪拌した。2−クロ
ロ−3−シアノ−4−(4−メトキシフェニル)−6−
プロピルピリジン202mg(0.70mmol)をD
MF2mlに溶解して滴下し、室温で2時間攪拌した。
減圧下でDMFを留去後1規定塩酸を加え、酢酸エチル
で抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃
縮した。残渣をシリカゲルクロマトグラフィー(ヘキサ
ン−クロロホルム=1:2)で精製し表題化合物を得
た。 収量:193mg(0.49mmol)、収率:69.
6% MS(ESI,m/z) 395(MH+) H-NMR(CDCl3):0.85-0.90(3H,t)、1.45-1.55(2H,m)、2.
48-2.56(2H,m)、3.90(3H,s)、6.94(1H,s)、7.05-7.08(2
H,d)、7.26-7.53(7H,m)、7.65-7.68(2H,d)Example 14 Synthesis of 4- (4-methoxyphenyl) -2- (1-naphthoxy) -6-propylpyridine-3-carboxylic acid 1) 3-Cyano-4- (4-methoxyphenyl) -2
Synthesis of-(1-Naphthoxy) -6-propylpyridine 123 mg of 1-naphthol (0.85
mmol) to 50 mg (1.2%) of 60% sodium hydride.
5 mmol) and stirred at room temperature for 15 minutes. 2-chloro-3-cyano-4- (4-methoxyphenyl) -6
Propyl pyridine 202 mg (0.70 mmol)
It was dissolved in 2 ml of MF and added dropwise, followed by stirring at room temperature for 2 hours.
After distilling off DMF under reduced pressure, 1N hydrochloric acid was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-chloroform = 1: 2) to obtain the title compound. Yield: 193 mg (0.49 mmol), yield: 69.
6% MS (ESI, m / z) 395 (MH +) H-NMR (CDCl3): 0.85-0.90 (3H, t), 1.45-1.55 (2H, m), 2.
48-2.56 (2H, m), 3.90 (3H, s), 6.94 (1H, s), 7.05-7.08 (2
H, d), 7.26-7.53 (7H, m), 7.65-7.68 (2H, d)
【0111】2)4−(4−メトキシフェニル)−2−
(1−ナフトキシ)−6−プロピルピリジン−3−カル
ボン酸の合成 3−シアノ−4−(4−メトキシフェニル)−2−(1
−ナフトキシ)−6−プロピルピリジン193mg
(0.49mmol)をベンゼン5mlに溶解し室温で
水素化ジイソブチルアルミニウム1Mヘキサン溶液1.
50ml(1.50mmol)を加え室温で2時間攪拌
した。メタノール1.0ml、水3mlを加え20分間
攪拌した。沈澱を濾過し濾液を減圧下濃縮した。残渣を
シリカゲルクロマトグラフィー(ヘキサン:酢酸エチル
6:1)で精製し対応するピリジンアルデヒドを得
た。これを塩化メチレン2ml、水1mlに溶解し、氷
浴下2−メチル−2−ブテン0.22ml(2.08m
mol)、アミド硫酸90mg(0.93mmol)、
亜塩素酸ナトリウム160mg(1.77mmol)を
加え室温で40分間攪拌した。水を加え、酢酸エチルで
抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮
した。残渣をシリカゲルクロマトグラフィー(クロロホ
ルム:メタノール 30:1)で精製し表題化合物を得
た。 収量:25mg(0.06mmol)、収率:12.2
% MS(ESI,m/z) 414(MH+) H-NMR(CDCl3):0.73-0.78(3H,t)、1.38-1.54(2H,m)、2.
42-2.48(2H,t)、3.59(3H,s)、6.70-6.79(3H,m)、7.14-
7.43(6H,m)、7.60-7.63(1H,d)、7.77-7.80(1H,d)、7.99
-8.02(1H,d)2) 4- (4-methoxyphenyl) -2-
Synthesis of (1-naphthoxy) -6-propylpyridine-3-carboxylic acid 3-cyano-4- (4-methoxyphenyl) -2- (1
-Naphthoxy) -6-propylpyridine 193 mg
(0.49 mmol) was dissolved in 5 ml of benzene.
50 ml (1.50 mmol) was added, and the mixture was stirred at room temperature for 2 hours. 1.0 ml of methanol and 3 ml of water were added and stirred for 20 minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 6: 1) to give the corresponding pyridine aldehyde. This was dissolved in 2 ml of methylene chloride and 1 ml of water, and 0.22 ml of 2-methyl-2-butene (2.08 m
mol), amidosulfuric acid 90 mg (0.93 mmol),
160 mg (1.77 mmol) of sodium chlorite was added, and the mixture was stirred at room temperature for 40 minutes. Water was added, the mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform: methanol 30: 1) to obtain the title compound. Yield: 25 mg (0.06 mmol), yield: 12.2
% MS (ESI, m / z) 414 (MH +) H-NMR (CDCl3): 0.73-0.78 (3H, t), 1.38-1.54 (2H, m), 2.
42-2.48 (2H, t), 3.59 (3H, s), 6.70-6.79 (3H, m), 7.14-
7.43 (6H, m), 7.60-7.63 (1H, d), 7.77-7.80 (1H, d), 7.99
-8.02 (1H, d)
【0112】実施例15 4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)ピ
リジン−3−カルボン酸の合成 1)3−シアノ−4−(4−メトキシフェニル)−2−
ピリドンの合成 DMSO40ml中、シアノアセトアミド1.75g
(20.8mmol)にt−ブトキシカリウム2.35
g(20.9mmol)ついでDMSO10mlに溶解
した4−メトキシケイ皮アルデヒド3.37g(20.
8mmol)を加え室温で30分間攪拌した。t−ブト
キシカリウム7.05g(62.8mmol)を加えた
後、酸素ガスを2分間バブリングしさらに室温常圧酸素
雰囲気下で2時間攪拌した。2規定塩酸を加え析出した
結晶を濾取、水、ヘキサンで洗浄、減圧乾燥し表題化合
物を得た。 収量:3.58g(15.8mmol)、収率:76.
0% MS(ESI,m/z) 227(MH+) H-NMR(CDCl3+CD3OD):3.89(3H,s,MeO)、6.43-6.46(1H,
d)、7.02-7.05(2H,d)、7.53-7.55(1H,d)、7.61-7.64(2
H,d)Example 15 Synthesis of 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine-3-carboxylic acid 1) 3-Cyano-4- (4-methoxyphenyl)- 2-
Synthesis of pyridone 1.75 g of cyanoacetamide in 40 ml of DMSO
(20.8 mmol) to 2.35 potassium t-butoxide.
g (20.9 mmol) and then 3.37 g of 4-methoxycinnamic aldehyde dissolved in 10 ml of DMSO (20.
8 mmol) and stirred at room temperature for 30 minutes. After addition of 7.05 g (62.8 mmol) of potassium t-butoxide, oxygen gas was bubbled for 2 minutes, and the mixture was further stirred for 2 hours at room temperature under a normal pressure oxygen atmosphere. 2N Hydrochloric acid was added, and the precipitated crystals were collected by filtration, washed with water and hexane, and dried under reduced pressure to obtain the title compound. Yield: 3.58 g (15.8 mmol), yield: 76.
0% MS (ESI, m / z) 227 (MH +) H-NMR (CDCl3 + CD3OD): 3.89 (3H, s, MeO), 6.43-6.46 (1H,
d), 7.02-7.05 (2H, d), 7.53-7.55 (1H, d), 7.61-7.64 (2
H, d)
【0113】2)2−クロロ−3−シアノ−4−(4−
メトキシフェニル)ピリジンの合成 3−シアノ−4−(4−メトキシフェニル)−2−ピリ
ドン3.50g(15.5mmol)にオキシ塩化リン
60ml、N,N−ジメチルアニリン2.05ml(1
6.2mmol)を加え100℃で1.5時間加熱し
た。オキシ塩化リンを留去後水を加えエーテル抽出し、
有機層を飽和炭酸水素ナトリウム水溶液で洗浄、無水硫
酸ナトリウムで乾燥、減圧下濃縮した。残渣を精製せず
に次の反応に用いた。 収量:2.46g(10.0mmol)、収率:64.
8% MS(ESI,m/z) 245(MH+) H-NMR(CDCl3):3.89(3H,s,MeO)、7.04-7.07(2H,d)、7.3
5-7.37(1H,d)、7.57-7.60(2H,d)、8.51−8.53
(1H,d)2) 2-chloro-3-cyano-4- (4-
Synthesis of methoxyphenyl) pyridine To 3.50 g (15.5 mmol) of 3-cyano-4- (4-methoxyphenyl) -2-pyridone was added 60 ml of phosphorus oxychloride and 2.05 ml of N, N-dimethylaniline (1
6.2 mmol) and heated at 100 ° C. for 1.5 hours. After distilling off phosphorus oxychloride, water was added and extracted with ether.
The organic layer was washed with a saturated aqueous solution of sodium hydrogen carbonate, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was used for the next reaction without purification. Yield: 2.46 g (10.0 mmol), yield: 64.
8% MS (ESI, m / z) 245 (MH +) H-NMR (CDCl3): 3.89 (3H, s, MeO), 7.04-7.07 (2H, d), 7.3
5-7.37 (1H, d), 7.57-7.60 (2H, d), 8.51-8.53
(1H, d)
【0114】3)3−シアノ−4−(4−メトキシフェ
ニル)−2−(3,4−メチレンジオキシフェノキシ)
ピリジンの合成 DMF10ml中、セサモール298mg(2.16m
mol)に60%水素化ナトリウム100mg(2.5
0mmol)を加え室温で20分間攪拌した。2−クロ
ロ−3−シアノ−4−(4−メトキシフェニル)ピリジ
ン489mg(2.0mmol)をDMF2mlに溶解
して滴下し、室温で5.5時間攪拌した。減圧下でDM
Fを留去後2規定 塩酸を加え析出した結晶を濾過、酢
酸エチルで洗浄、減圧乾燥し表題化合物を得た。 収量:406mg(1.17mmol)、収率:58.
6% MS(FAB,m/z) 347(MH+) H-NMR(CDCl3):3.89(3H,s,MeO)、6.02(2H,s)、6.65-6.8
6(3H,m)、7.03-7.12(3H,m)、7.62-7.65(2H,d)、8.25-8.
26(1H,d)3) 3-cyano-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy)
Synthesis of pyridine Sesamol 298 mg (2.16 m
mol) and 60 mg of sodium hydride (100 mg, 2.5 mg).
0 mmol) and stirred at room temperature for 20 minutes. 489 mg (2.0 mmol) of 2-chloro-3-cyano-4- (4-methoxyphenyl) pyridine was dissolved in 2 ml of DMF and added dropwise, followed by stirring at room temperature for 5.5 hours. DM under reduced pressure
After evaporating F, 2N hydrochloric acid was added, and the precipitated crystals were filtered, washed with ethyl acetate, and dried under reduced pressure to obtain the title compound. Yield: 406 mg (1.17 mmol), yield: 58.
6% MS (FAB, m / z) 347 (MH +) H-NMR (CDCl3): 3.89 (3H, s, MeO), 6.02 (2H, s), 6.65-6.8
6 (3H, m), 7.03-7.12 (3H, m), 7.62-7.65 (2H, d), 8.25-8.
26 (1H, d)
【0115】4)4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)ピリジン−3
−カルボン酸の合成 3−シアノ−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)ピリジン20
5mg(0.59mmol)を塩化メチレン15mlに
溶解し室温で水素化ジイソブチルアルミニウム1Mヘキ
サン溶液1.8ml(1.8mmol)を加え室温で3
時間攪拌した。メタノール0.5ml、水1mlを加え
20分間攪拌した。沈澱を濾過し濾液を減圧下濃縮し
た。残渣を塩化メチレン10ml、水5mlに溶解し氷
浴下2−メチル−2−ブテン0.45ml(4.25m
mol)、アミド硫酸190mg(1.96mmo
l)、亜塩素酸ナトリウム350mg(3.87mmo
l)を加え室温で30分間攪拌した。水を加え、クロロ
ホルムで抽出し有機層を無水硫酸ナトリウムで乾燥、減
圧下濃縮した。得られた結晶をクロロホルムで洗浄し表
題化合物を得た。 収量:98mg(0.27mmol)、収率:45.4
% MS(ESI,m/z) 366(MH+) H-NMR(DMSO-d6):3.82(3H,s,MeO)、6.06(2H,s)、6.56-
6.60(1H,m)、6.78-6.79(1H,d)、6.90-6.93(1H,d)、7.06
-7.09(2H,d)、7.17-7.19(1H,d)、7.48-7.51(2H,d)、8.1
4-8.16(1H,d)4) 4- (4-methoxyphenyl) -2-
(3,4-methylenedioxyphenoxy) pyridine-3
Synthesis of carboxylic acid 3-cyano-4- (4-methoxyphenyl) -2-
(3,4-methylenedioxyphenoxy) pyridine 20
5 mg (0.59 mmol) was dissolved in 15 ml of methylene chloride, and 1.8 ml (1.8 mmol) of a 1 M solution of diisobutylaluminum hydride in hexane was added at room temperature.
Stirred for hours. 0.5 ml of methanol and 1 ml of water were added and stirred for 20 minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was dissolved in 10 ml of methylene chloride and 5 ml of water, and 0.45 ml of 2-methyl-2-butene (4.25 m
mol), 190 mg of amidosulfuric acid (1.96 mmol)
l), 350 mg (3.87 mmol) of sodium chlorite
l) was added and the mixture was stirred at room temperature for 30 minutes. Water was added, extracted with chloroform, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained crystals were washed with chloroform to obtain the title compound. Yield: 98 mg (0.27 mmol), yield: 45.4
% MS (ESI, m / z) 366 (MH +) H-NMR (DMSO-d6): 3.82 (3H, s, MeO), 6.06 (2H, s), 6.56-
6.60 (1H, m), 6.78-6.79 (1H, d), 6.90-6.93 (1H, d), 7.06
-7.09 (2H, d), 7.17-7.19 (1H, d), 7.48-7.51 (2H, d), 8.1
4-8.16 (1H, d)
【0116】実施例16 6−エチル−2−(3,4−
ジメトキシフェノキシ)−4−(4−メトキシフェニ
ル)ピリジン−3−カルボン酸の合成 1)3−シアノ−6−エチル−2−(3,4−ジメトキ
シフェノキシ)−4−(4−メトキシフェニル)ピリジ
ンの合成 DMF5ml中、3,4−ジメトキシフェノール157
mg(1.02mmol)に60%水素化ナトリウム6
0mg(1.5mmol)を加え室温で10分間攪拌し
た。2−クロロ−3−シアノ−6−エチル−4−(4−
メトキシフェニル)ピリジン191mg(0.70mm
ol)をDMF3mlに溶解して滴下し、室温で11時
間攪拌した。減圧下でDMFを留去後1規定塩酸を加
え、酢酸エチルで抽出し有機層を無水硫酸ナトリウムで
乾燥、減圧下濃縮した。残渣をシリカゲルクロマトグラ
フィー(ヘキサン:酢酸エチル 3:1)で精製し表題
化合物を得た。 収量:176mg(0.45mmol)、収率:64.
3% MS(ESI,m/z) 391(MH+) H-NMR(CDCl3):1.17-1.22(3H,t)、2.65-2.73(2H,qua)、
3.87(3H,s)、3.88(3H,s)、3.91(3H,s)、6.78-6.90(3H,
m)、6.95(1H,m)、7.03-7.06(2H,d)、7.60-7.63(2H,d)Example 16 6-ethyl-2- (3,4-
Synthesis of dimethoxyphenoxy) -4- (4-methoxyphenyl) pyridine-3-carboxylic acid 1) 3-cyano-6-ethyl-2- (3,4-dimethoxyphenoxy) -4- (4-methoxyphenyl) pyridine Synthesis of 3,4-dimethoxyphenol 157 in 5 ml of DMF
mg (1.02 mmol) to 60% sodium hydride 6
0 mg (1.5 mmol) was added and the mixture was stirred at room temperature for 10 minutes. 2-chloro-3-cyano-6-ethyl-4- (4-
Methoxyphenyl) pyridine 191 mg (0.70 mm
ol) was dissolved in 3 ml of DMF and added dropwise, followed by stirring at room temperature for 11 hours. After distilling off DMF under reduced pressure, 1N hydrochloric acid was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 3: 1) to obtain the title compound. Yield: 176 mg (0.45 mmol), yield: 64.
3% MS (ESI, m / z) 391 (MH +) H-NMR (CDCl3): 1.17-1.22 (3H, t), 2.65-2.73 (2H, qua),
3.87 (3H, s), 3.88 (3H, s), 3.91 (3H, s), 6.78-6.90 (3H,
m), 6.95 (1H, m), 7.03-7.06 (2H, d), 7.60-7.63 (2H, d)
【0117】2)6−エチル−2−(3,4−ジメトキ
シフェノキシ)−4−(4−メトキシフェニル)ピリジ
ン−3−アルデヒドの合成 3−シアノ−6−エチル−2−(3,4−ジメトキシフ
ェノキシ)−4−(4−メトキシフェニル)ピリジン1
75mg(0.45mmol)をベンゼン8mlに溶解
し室温で水素化ジイソブチルアルミニウム1Mヘキサン
溶液1.35ml(1.35mmol)を加え室温で3
時間攪拌した。メタノール1ml、水2mlを加え15
分間攪拌した。沈澱を濾過し濾液を減圧下濃縮した。残
渣をシリカゲルクロマトグラフィー(ヘキサン:酢酸エ
チル 4:1)で精製し表題化合物を得た。 収量:86mg(0.22mmol)、収率:48.4
% H-NMR(CDCl3):1.16-1.22(3H,t)、2.64-2.72(2H,qua)、
3.87(3H,s)、3.88(3H,s)、3.91(3H,s)、6.73-6.90(4H,
m)、6.98-7.01(2H,d)、7.31-7.34(2H,d)、10.26(1H,s,C
HO)2) Synthesis of 6-ethyl-2- (3,4-dimethoxyphenoxy) -4- (4-methoxyphenyl) pyridine-3-aldehyde 3-cyano-6-ethyl-2- (3,4- Dimethoxyphenoxy) -4- (4-methoxyphenyl) pyridine 1
75 mg (0.45 mmol) was dissolved in 8 ml of benzene, and 1.35 ml (1.35 mmol) of a 1M solution of diisobutylaluminum hydride in hexane was added at room temperature.
Stirred for hours. 1 ml of methanol and 2 ml of water were added and 15
Stirred for minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 86 mg (0.22 mmol), Yield: 48.4
% H-NMR (CDCl3): 1.16-1.22 (3H, t), 2.64-2.72 (2H, qua),
3.87 (3H, s), 3.88 (3H, s), 3.91 (3H, s), 6.73-6.90 (4H,
m), 6.98-7.01 (2H, d), 7.31-7.34 (2H, d), 10.26 (1H, s, C
HO)
【0118】3)6−エチル−2−(3,4−ジメトキ
シフェノキシ)−4−(4−メトキシフェニル)ピリジ
ン−3−カルボン酸の合成 塩化メチレン2ml、水1ml中6−エチル−2−
(3,4−ジメトキシフェノキシ)−4−(4−メトキ
シフェニル)ピリジン−3−アルデヒド110mg
(0.28mmol)に氷浴下2−メチル−2−ブテン
0.22ml(2.08mmol)、アミド硫酸80m
g(0.82mmol)、亜塩素酸ナトリウム160m
g(1.77mmol)を加え室温で4時間攪拌した。
水を加え、酢酸エチルで抽出し有機層を無水硫酸ナトリ
ウムで乾燥、減圧下濃縮した。残渣をシリカゲルクロマ
トグラフィー(クロロホルム:メタノール 9:1)で
精製し表題化合物を得た。 収量:17mg(0.04mmol)、収率:20.2
% MS(ESI,m/z) 410(MH+) H-NMR(CDCl3):1.09-1.14(3H,t)、2.52-2.60(2H,qua)、
3.60(3H,s)、3.62(3H,s)、3.80(3H,s)、6.52-6.80(6H,
m)、7.32-7.35(2H,d)3) Synthesis of 6-ethyl-2- (3,4-dimethoxyphenoxy) -4- (4-methoxyphenyl) pyridine-3-carboxylic acid 6 ml of methylene chloride in 1 ml of water
(3,4-dimethoxyphenoxy) -4- (4-methoxyphenyl) pyridine-3-aldehyde 110 mg
(0.28 mmol), 0.22 ml (2.08 mmol) of 2-methyl-2-butene in an ice bath, 80 m of amidosulfuric acid
g (0.82 mmol), sodium chlorite 160 m
g (1.77 mmol) was added and the mixture was stirred at room temperature for 4 hours.
Water was added, the mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform: methanol 9: 1) to give the title compound. Yield: 17 mg (0.04 mmol), yield: 20.2
% MS (ESI, m / z) 410 (MH +) H-NMR (CDCl3): 1.09-1.14 (3H, t), 2.52-2.60 (2H, qua),
3.60 (3H, s), 3.62 (3H, s), 3.80 (3H, s), 6.52-6.80 (6H,
m), 7.32-7.35 (2H, d)
【0119】実施例17 6−エチル−4−(4−メト
キシフェニル)−2−フェノキシピリジン−3−カルボ
ン酸の合成 1)3−シアノ−6−エチル−4−(4−メトキシフェ
ニル)−2−フェノキシピリジンの合成 DMF5ml中、フェノール82mg(0.87mmo
l)に60%水素化ナトリウム55mg(1.38mm
ol)を加え室温で15分間攪拌した。2−クロロ−3
−シアノ−6−エチル−4−(4−メトキシフェニル)
ピリジン171mg(0.63mmol)をDMF3m
lに溶解して滴下し、室温で1晩攪拌した。減圧下でD
MFを留去後1規定塩酸を加え、酢酸エチルで抽出し有
機層を無水硫酸ナトリウムで乾燥、減圧下濃縮した。残
渣をシリカゲルクロマトグラフィー(ヘキサン:酢酸エ
チル 6:1)で精製し表題化合物を得た。 収量:74mg(0.22mmol)、収率:35.8
% MS(ESI,m/z) 331(MH+) H-NMR(CDCl3):1.16-1.21(3H,t)、2.65-2.72(2H,qua)、
3.88(3H,s)、6.95(1H,s)、7.03-7.06(2H,d)、7.20-7.28
(3H,m)、7.38-7.44(2H,m)、7.61-7.64(2H,d)Example 17 Synthesis of 6-ethyl-4- (4-methoxyphenyl) -2-phenoxypyridine-3-carboxylic acid 1) 3-Cyano-6-ethyl-4- (4-methoxyphenyl) -2 Synthesis of phenoxypyridine 82 mg (0.87 mmol) of phenol in 5 ml of DMF
l) to 55 mg of 60% sodium hydride (1.38 mm
ol) and stirred at room temperature for 15 minutes. 2-chloro-3
-Cyano-6-ethyl-4- (4-methoxyphenyl)
171 mg (0.63 mmol) of pyridine in 3 m of DMF
1 and added dropwise, and stirred at room temperature overnight. D under reduced pressure
After evaporating MF, 1N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 6: 1) to give the title compound. Yield: 74 mg (0.22 mmol), yield: 35.8
% MS (ESI, m / z) 331 (MH +) H-NMR (CDCl3): 1.16-1.21 (3H, t), 2.65-2.72 (2H, qua),
3.88 (3H, s), 6.95 (1H, s), 7.03-7.06 (2H, d), 7.20-7.28
(3H, m), 7.38-7.44 (2H, m), 7.61-7.64 (2H, d)
【0120】2)6−エチル−4−(4−メトキシフェ
ニル)−2−フェノキシピリジン−3−カルボン酸の合
成 3−シアノ−6−エチル−4−(4−メトキシフェニ
ル)−2−フェノキシピリジン74mg(0.22mm
ol)をベンゼン5mlに溶解し室温で水素化ジイソブ
チルアルミニウム1Mヘキサン溶液0.7ml(0.7
mmol)を加え室温で2時間攪拌した。メタノール
0.5ml、水1mlを加え15分間攪拌した。沈澱を
濾過し濾液を減圧下濃縮した。残渣を塩化メチレン3m
l、水1mlに溶解し氷浴下2−メチル−2−ブテン
0.2ml(1.89mmol)、アミド硫酸75mg
(0.77mmol)、亜塩素酸ナトリウム151mg
(1.67mmol)を加え室温で40分間攪拌した。
水を加え、クロロホルムで抽出し有機層を無水硫酸ナト
リウムで乾燥、減圧下濃縮した。残渣をシリカゲルクロ
マトグラフィー(クロロホルム:メタノール 9:1)
で精製し表題化合物を得た。 収量:32mg(0.09mmol)、収率:40.9
% MS(ESI,m/z) 350(MH+) H-NMR(CDCl3):1.09-1.14(3H,t)、2.52-2.63(2H,qua)、
3.62(3H,s)、6.68-6.77(3H,m)、6.97-7.06(3H,m)、7.13
-7.22(2H,m)、7.33-7.36(2H,d)2) Synthesis of 6-ethyl-4- (4-methoxyphenyl) -2-phenoxypyridine-3-carboxylic acid 3-cyano-6-ethyl-4- (4-methoxyphenyl) -2-phenoxypyridine 74mg (0.22mm
was dissolved in 5 ml of benzene, and 0.7 ml (0.7 ml) of a 1M solution of diisobutylaluminum hydride in hexane at room temperature.
mmol) and stirred at room temperature for 2 hours. 0.5 ml of methanol and 1 ml of water were added and stirred for 15 minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was methylene chloride 3m
1, dissolved in 1 ml of water, 0.2 ml (1.89 mmol) of 2-methyl-2-butene in an ice bath, 75 mg of amidosulfuric acid
(0.77 mmol), 151 mg of sodium chlorite
(1.67 mmol) and the mixture was stirred at room temperature for 40 minutes.
Water was added, extracted with chloroform, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. Silica gel chromatography of the residue (chloroform: methanol 9: 1)
And the title compound was obtained. Yield: 32 mg (0.09 mmol), yield: 40.9
% MS (ESI, m / z) 350 (MH +) H-NMR (CDCl3): 1.09-1.14 (3H, t), 2.52-2.63 (2H, qua),
3.62 (3H, s), 6.68-6.77 (3H, m), 6.97-7.06 (3H, m), 7.13
-7.22 (2H, m), 7.33-7.36 (2H, d)
【0121】実施例18 6−メチル−4−(3,5−
ジメトキシフェニル)−2−(3、4−メチレンジオキ
シフェニルオキシ)ピリジン−3−カルボン酸の合成 1)1−(3,5−ジメトキシフェニル)−1−ブテン
−3−オンの合成 3,5−ジメトキシベンズアルデヒド1.0g(6.0
mmol)、アセトニルトリフェニルホスホニウム ク
ロリド2.6g(7.3mmol)、ナトリウムエトキ
シド500mg(7.3mmol)をエタノール10m
lに溶解し、アルゴン雰囲気下室温で、1.5時間攪拌
する。エタノールを減圧下に留去し得られる残渣を酢酸
エチルで抽出する。水、飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥する。減圧下溶媒を留去し得られる
残渣をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル:ヘキサン 1:3から1:1)に付し表題化合物を
得た。 収量:1.00g、収率:80.0% MS(ESI,m/z) 207 (MH+) H-NMR(CDCl3):2.38 (3H, s)、3.82 (6H, s)、6.52 (1
H, m)、6.66 (2H, m)、6.65 (1H, d)、7.42 (1H, d)Example 18 6-methyl-4- (3,5-
Synthesis of dimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) Synthesis of 1- (3,5-dimethoxyphenyl) -1-buten-3-one 3,5 1.0 g of dimethoxybenzaldehyde (6.0
mmol), 2.6 g (7.3 mmol) of acetonyltriphenylphosphonium chloride, 500 mg (7.3 mmol) of sodium ethoxide and 10 m of ethanol.
and stirred for 1.5 hours at room temperature under an argon atmosphere. Ethanol is distilled off under reduced pressure, and the obtained residue is extracted with ethyl acetate. Wash with water and saturated saline, and dry over anhydrous magnesium sulfate. The residue obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3 to 1: 1) to obtain the title compound. Yield: 1.00 g, yield: 80.0% MS (ESI, m / z) 207 (MH +) H-NMR (CDCl3): 2.38 (3H, s), 3.82 (6H, s), 6.52 (1
H, m), 6.66 (2H, m), 6.65 (1H, d), 7.42 (1H, d)
【0122】2)6−メチル−3−シアノ−4−(3,
5−ジメトキシフェニル)−2−ピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド410m
g(4.9mmol)、t−ブトキシカリウム550m
g(4.9mmol)のDMSO5ml溶液に1−
(3,5−ジメトキシフェニル)−1−ブテン−3−オ
ン1.0g(4.8mmol)のDMSO10mlを加
え15分間攪拌する。t−ブトキシカリウム1.63g
(13.3mmol)を加え1分間酸素をバブリングす
る。酸素雰囲気下1時間攪拌した後、1規定塩酸を氷冷
下加え析出した結晶を濾取する。水で洗い減圧下乾燥し
表題化合物を得た。この化合物は精製せずに以下の反応
に用いる。 収量:960mg、収率:74.0% MS(ESI,m/z) 271 (MH+) H-NMR(CDCl3):2.50 (3H, s)、3.84 (6H, s)、6.28 (1
H, s)、6.58 (1H, s)、6.71 (2H, s)2) 6-methyl-3-cyano-4- (3,
Synthesis of 5-dimethoxyphenyl) -2-pyridone at room temperature under argon atmosphere.
g (4.9 mmol), potassium tert-butoxide 550 m
g (4.9 mmol) in 5 ml of DMSO
(3,5-Dimethoxyphenyl) -1-buten-3-one 1.0 g (4.8 mmol) of DMSO (10 ml) is added, and the mixture is stirred for 15 minutes. 1.63 g of potassium t-butoxide
(13.3 mmol) and bubbling oxygen for 1 minute. After stirring for 1 hour in an oxygen atmosphere, 1N hydrochloric acid is added under ice cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 960 mg, yield: 74.0% MS (ESI, m / z) 271 (MH +) H-NMR (CDCl3): 2.50 (3H, s), 3.84 (6H, s), 6.28 (1
H, s), 6.58 (1H, s), 6.71 (2H, s)
【0123】3)6−メチル−3−シアノ−4−(3,
5−ジメトキシフェニル)−2−クロロピリジンの合成 6−メチル−3−シアノ−4−(3,5−ジメトキシフ
ェニル)−2−ピリドン960mg(3.6mmol)
をオキシ塩化リン10mlに溶解し100℃で一晩攪拌
する。オキシ塩化リンを減圧下留去し残渣を酢酸エチル
に溶解する。飽和重曹水、飽和食塩水で洗浄し無水硫酸
マグネシウムで乾燥する。減圧下溶媒を留去し表題化合
物を得た。このものは精製せずに以下の反応に利用し
た。 収量:860mg MS(ESI,m/z) 289 (MH+) H-NMR(CDCl3):2.65 (3H, s)、3.85 (6H, s)、6.60 (1
H, t)、6.68 (2H, d)、7.23 (1H, s)3) 6-methyl-3-cyano-4- (3,
Synthesis of 5-dimethoxyphenyl) -2-chloropyridine 960 mg (3.6 mmol) of 6-methyl-3-cyano-4- (3,5-dimethoxyphenyl) -2-pyridone
Is dissolved in 10 ml of phosphorus oxychloride and stirred at 100 ° C. overnight. The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound. This was used for the following reaction without purification. Yield: 860 mg MS (ESI, m / z) 289 (MH +) H-NMR (CDCl3): 2.65 (3H, s), 3.85 (6H, s), 6.60 (1
H, t), 6.68 (2H, d), 7.23 (1H, s)
【0124】4)6−メチル−3−シアノ−4−(3,
5−ジメトキシフェニル)−2−(3、4−メチレンジ
オキシフェニルオキシ)ピリジンの合成 セサモール490mg(3.5mmol)、水素化ナト
リウム280mg(60%オイルディスパージョン、
7.0mmol)より作成したフェノキシドイオンのD
MF10ml溶液に6−メチル−3−シアノ−4−
(3,5−ジメトキシフェニル)−2−クロロピリジン
860mgをDMF10mlに溶解して加えアルゴン雰
囲気下室温で1時間攪拌する。減圧下溶媒を留去し、残
渣を酢酸エチルに溶解し、水、飽和食塩水で洗浄する。
無水硫酸マグネシウムで乾燥し減圧下溶媒を留去する。
得られた残渣をシリカゲルカラムクロマトグラフィー
(酢酸エチル:ヘキサン 1:3)に付し表題化合物を
得た。 収量:70mg、収率:6−メチル−3−シアノ−4−
(3,5−ジメトキシフェニル)−2−ピリドンより4
9.8% MS(ESI,m/z) 391 (MH+) H-NMR(CDCl3):2.45 (3H, s)、3.86 (6H, s)、6.02 (2
H, s)、6.59 (1H, t)、6.67 (1H, dd)、6.74 (3H, m)、
6.82 (1H, d)、6.97 (1H, s)4) 6-methyl-3-cyano-4- (3,
Synthesis of 5-dimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine Sesamol 490 mg (3.5 mmol), sodium hydride 280 mg (60% oil dispersion,
7.0 mmol) of phenoxide ion prepared from
6-methyl-3-cyano-4- was added to a 10 ml MF solution.
860 mg of (3,5-dimethoxyphenyl) -2-chloropyridine is dissolved in 10 ml of DMF, and the mixture is stirred for 1 hour at room temperature under an argon atmosphere. The solvent is distilled off under reduced pressure, the residue is dissolved in ethyl acetate, and washed with water and saturated saline.
After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure.
The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to give the title compound. Yield: 70 mg, yield: 6-methyl-3-cyano-4-
4 from (3,5-dimethoxyphenyl) -2-pyridone
9.8% MS (ESI, m / z) 391 (MH +) H-NMR (CDCl3): 2.45 (3H, s), 3.86 (6H, s), 6.02 (2
H, s), 6.59 (1H, t), 6.67 (1H, dd), 6.74 (3H, m),
6.82 (1H, d), 6.97 (1H, s)
【0125】5)6−メチル−4−(3,5−ジメトキ
シフェニル)−2−(3、4−メチレンジオキシフェニ
ルオキシ)ピリジン−3−アルデヒドの合成 6−メチル−3−シアノ−4−(3,5−ジメトキシフ
ェニル)−2−(3、4−メチレンジオキシフェニルオ
キシ)ピリジン70mg(0.18mmol)をベンゼ
ン10mlに溶解しアルゴン雰囲気下室温で水素化ジイ
ソブチルアルミニウム1Mヘキサン溶液0.55ml
(0.55mmol)を滴下する。室温で2時間攪拌し
メタノールと水で反応を停止する。室温で1時間攪拌
し、不溶物をセライトを用いて濾過する。濾液をを減圧
下留去し得られた残渣をシリカゲルカラムクロマトグラ
フィー(酢酸エチル:ヘキサン 1:3)に付し表題化
合物を得た。このものは分離困難な不純物を含むがこれ
以上精製せずに以下の反応に用いる。 収量:60mg5) Synthesis of 6-methyl-4- (3,5-dimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 6-methyl-3-cyano-4- 70 mg (0.18 mmol) of (3,5-dimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine is dissolved in 10 ml of benzene, and 0.55 ml of a 1M solution of diisobutylaluminum hydride in hexane at room temperature under an argon atmosphere.
(0.55 mmol) is added dropwise. Stir at room temperature for 2 hours and terminate the reaction with methanol and water. The mixture is stirred at room temperature for 1 hour, and the insoluble matter is filtered using celite. The filtrate was evaporated under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to obtain the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 60mg
【0126】6)6−メチル−4−(3,5−ジメトキ
シフェニル)−2−(3、4−メチレンジオキシフェニ
ルオキシ)ピリジン−3−カルボン酸の合成 6−メチル−4−(3,5−ジメトキシフェニル)−2
−(3、4−メチレンジオキシフェニルオキシ)ピリジ
ン−3−アルデヒド60mgを塩化メチレン2ml、水
1mlに溶解し、0℃で2−メチル−2−ブテン0.1
ml(0.94mmol)、アミド硫酸20mg(0.
21mmol)、亜塩素酸ナトリウム60mg(0.5
2mmol)を加え室温に戻して30分間攪拌する。酢
酸エチルで抽出し無水硫酸マグネシウムで乾燥して減圧
下溶媒を留去する。得られた残渣をシリカゲル薄層クロ
マトグラフィー(酢酸エチル:ヘキサン 1:1)に付
し表題化合物を得た。 収量:6mg、収率:6−メチル−3−シアノ−4−
(3,5−ジメトキシフェニル)−2−(3、4−メチ
レンジオキシフェニルオキシ)ピリジンより8.1% MS(ESI,m/z) 410 (MH+) H-NMR(CDCl3):2.41 (3H, s)、3.77 (6H, s)、5.98 (2
H, s)、6.48 (1H, br)、6.58-6.62 (3H, m)、6.70 (1H,
m)、6.76 (1H, d)、7.89 (1H, s)6) Synthesis of 6-methyl-4- (3,5-dimethoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 5-dimethoxyphenyl) -2
Dissolve 60 mg of-(3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde in 2 ml of methylene chloride and 1 ml of water, and add 0.1 g of 2-methyl-2-butene at 0 ° C.
ml (0.94 mmol), 20 mg of amidosulfuric acid (0.
21 mmol), 60 mg of sodium chlorite (0.5 mg)
2 mmol) and the mixture is returned to room temperature and stirred for 30 minutes. Extract with ethyl acetate, dry over anhydrous magnesium sulfate and evaporate the solvent under reduced pressure. The obtained residue was subjected to silica gel thin layer chromatography (ethyl acetate: hexane 1: 1) to give the title compound. Yield: 6 mg, yield: 6-methyl-3-cyano-4-
8.1% MS (ESI, m / z) 410 (MH +) H-NMR (CDCl3): 2.41 (3H , s), 3.77 (6H, s), 5.98 (2
H, s), 6.48 (1H, br), 6.58-6.62 (3H, m), 6.70 (1H,
m), 6.76 (1H, d), 7.89 (1H, s)
【0127】実施例19 6−メチル−4−(4−(2
−ベンジルオキシエトキシ)−3−メトキシフェニル)
−2−(3、4−メチレンジオキシフェニルオキシ)ピ
リジン−3−カルボン酸の合成 1)4−(2−ヒドロキシエトキシ)−3−メトキシベ
ンズアルデヒドの合成 バニリン1.52g(10.0mmol)、エチレンカ
ーボネート0.7ml(10.5mmol)、炭酸カリ
ウム1.38g(10.0mmol)のDMF10ml
溶液をアルゴン雰囲気下90℃で2日間攪拌する。減圧
下DMFを留去し残渣をクロロホルムに溶解し不溶物を
セライトを用いて濾過する。減圧下溶媒を留去し得られ
る結晶を酢酸エチル:ヘキサン1:1で洗浄し表題化合
物を得た。 収量:1.17g、収率:59.6% MS(ESI,m/z) 197 (MH+) H-NMR(CDCl3):2.35 (1H, br)、3.93 (3H, s)、4.06 (2
H, br t)、4.24 (2H,t)、7.11 (1H, d)、7.43-7.47 (3
H, m)、9.85 (1H, s)Example 19 6-methyl-4- (4- (2
-Benzyloxyethoxy) -3-methoxyphenyl)
Synthesis of -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) Synthesis of 4- (2-hydroxyethoxy) -3-methoxybenzaldehyde 1.52 g (10.0 mmol) of vanillin, ethylene 0.7 ml (10.5 mmol) of carbonate and 1.38 g (10.0 mmol) of potassium carbonate in 10 ml of DMF
The solution is stirred at 90 ° C. for 2 days under an argon atmosphere. The DMF is distilled off under reduced pressure, the residue is dissolved in chloroform, and the insoluble matter is filtered using Celite. The crystals obtained by evaporating the solvent under reduced pressure were washed with ethyl acetate: hexane 1: 1 to obtain the title compound. Yield: 1.17 g, 59.6% MS (ESI, m / z) 197 (MH +) H-NMR (CDCl3): 2.35 (1H, br), 3.93 (3H, s), 4.06 (2
H, br t), 4.24 (2H, t), 7.11 (1H, d), 7.43-7.47 (3
H, m), 9.85 (1H, s)
【0128】2)4−(2−ベンジルオキシエトキシ)
−3−メトキシベンズアルデヒドの合成 4−(2−ヒドロキシエトキシ)−3−メトキシベンズ
アルデヒド1.17g(6.0mmol)をDMF10
mlに溶解し、アルゴン雰囲気下、0℃で水素化ナトリ
ウム290mg(60%オイルディスパージョン、7.
3mmol)、臭化ベンジル0.85ml(7.1mm
ol)を加え20分攪拌する。減圧下溶媒を留去し水を
加える。酢酸エチルで抽出し水、飽和食塩水で洗浄す
る。無水硫酸マグネシウムで乾燥し減圧下溶媒を留去す
る。得られる残渣をシリカゲルカラムクロマトグラフィ
ーに付し表題化合物を得た。 収量:1.56g、収率:90.8% MS(ESI,m/z) 287 (MH+) H-NMR(CDCl3):3.90 (2H, m)、3.93 (3H, s)、4.29 (2
H, t)、4.64 (2H, s)、7.01 (1H, d)、7.25-7.36 (5H,
m)、7.40-7.45 (2H, m)、9.85 (1H, s)2) 4- (2-benzyloxyethoxy)
Synthesis of -3-methoxybenzaldehyde 1.17 g (6.0 mmol) of 4- (2-hydroxyethoxy) -3-methoxybenzaldehyde was added to DMF10
290 mg of sodium hydride (60% oil dispersion, 7.degree. C.) at 0.degree. C. under an argon atmosphere.
3 mmol), 0.85 ml of benzyl bromide (7.1 mm
ol) and stirred for 20 minutes. The solvent is distilled off under reduced pressure, and water is added. Extract with ethyl acetate and wash with water and saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography to give the title compound. Yield: 1.56 g, 90.8% MS (ESI, m / z) 287 (MH +) H-NMR (CDCl3): 3.90 (2H, m), 3.93 (3H, s), 4.29 (2
H, t), 4.64 (2H, s), 7.01 (1H, d), 7.25-7.36 (5H,
m), 7.40-7.45 (2H, m), 9.85 (1H, s)
【0129】3)4−(4−(2−ベンジルオキシエト
キシ)−3−メトキシフェニル)−1−ブテン−3−オ
ンの合成 4−(2−ベンジルオキシエトキシ)−3−メトキシベ
ンズアルデヒド1.56g(5.4mmol)、アセト
ニルトリフェニルホスホニウム クロリド2.32g
(6.5mmol)、ナトリウムエトキシド450mg
(6.6mmol)をエタノール10mlに溶解し、ア
ルゴン雰囲気下室温で、2日間攪拌する。エタノールを
減圧下に留去し得られる残渣を酢酸エチルで抽出する。
水、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
する。減圧下溶媒を留去し得られる残渣をシリカゲルカ
ラムクロマトグラフィー(酢酸エチル:ヘキサン 1:
2)に付し表題化合物を得た。 収量:1.30g、収率:73.8% MS(ESI、m/z) 327 (MH+) H-NMR(CDCl3):2.37 (3H, s)、3.85-3.90 (2H, m)、3.9
0 (3H, s)、4.25 (2H,t)、4.64 (2H, s)、6.60 (1H,
d)、6.91 (1H, d)、7.08 (1H, s)、7.09 (1H, dd)、7.2
5-7.38 (5H, m)、7.45 (1H, d)3) Synthesis of 4- (4- (2-benzyloxyethoxy) -3-methoxyphenyl) -1-buten-3-one 1.56 g of 4- (2-benzyloxyethoxy) -3-methoxybenzaldehyde (5.4 mmol), acetonyltriphenylphosphonium chloride 2.32 g
(6.5 mmol), 450 mg of sodium ethoxide
(6.6 mmol) was dissolved in 10 ml of ethanol, and the mixture was stirred at room temperature under an argon atmosphere for 2 days. Ethanol is distilled off under reduced pressure, and the obtained residue is extracted with ethyl acetate.
Wash with water and saturated saline, and dry over anhydrous magnesium sulfate. The residue obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1).
2) The title compound was obtained. Yield: 1.30 g, Yield: 73.8% MS (ESI, m / z) 327 (MH +) H-NMR (CDCl3): 2.37 (3H, s), 3.85-3.90 (2H, m), 3.9
0 (3H, s), 4.25 (2H, t), 4.64 (2H, s), 6.60 (1H,
d), 6.91 (1H, d), 7.08 (1H, s), 7.09 (1H, dd), 7.2
5-7.38 (5H, m), 7.45 (1H, d)
【0130】4)6−メチル−3−シアノ−4−(4−
(2−ベンジルオキシエトキシ)−3−メトキシフェニ
ル)−2−ピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド340m
g(4.0mmol)、t−ブトキシカリウム450m
g(4.0mmol)のDMSO5ml溶液に4−
((2−ベンジルオキシエトキシ)−3−メトキシフェ
ニル)−1−ブテン−3−オン1.30g(4.0mm
ol)のDMSO10mlを加え15分間攪拌する。t
−ブトキシカリウム1.35g(12.0mmol)を
加え1分間酸素をバブリングする。酸素雰囲気下1時間
攪拌した後、1規定塩酸を氷冷下加え析出した結晶を濾
取する。水で洗い減圧下乾燥し表題化合物を得た。この
化合物は精製せずに以下の反応に用いる。 収量:1.25g、収率:80.0% MS(ESI,m/z) 391 (MH+) H-NMR(CDCl3):2.48 (3H, s)、3.86-4.00 (2H, m)、3.9
4 (3H, s)、4.28 (2H,t)、4.65 (2H, s)、6.28 (1H,
s)、7.00 (1H, d)、7.20 (1H, m)、7.20-7.40 (6H, m)4) 6-methyl-3-cyano-4- (4-
Synthesis of (2-benzyloxyethoxy) -3-methoxyphenyl) -2-pyridone Cyanoacetamide 340 m at room temperature under argon atmosphere
g (4.0 mmol), potassium t-butoxide 450 m
g (4.0 mmol) in 5 ml of DMSO
1.30 g of ((2-benzyloxyethoxy) -3-methoxyphenyl) -1-buten-3-one (4.0 mm
ol) of DMSO (10 ml) and stirred for 15 minutes. t
Add 1.35 g (12.0 mmol) of potassium butoxide and bubble oxygen for 1 minute. After stirring for 1 hour in an oxygen atmosphere, 1N hydrochloric acid is added under ice cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 1.25 g, 80.0% MS (ESI, m / z) 391 (MH +) H-NMR (CDCl3): 2.48 (3H, s), 3.86-4.00 (2H, m), 3.9
4 (3H, s), 4.28 (2H, t), 4.65 (2H, s), 6.28 (1H,
s), 7.00 (1H, d), 7.20 (1H, m), 7.20-7.40 (6H, m)
【0131】5)6−メチル−3−シアノ−4−(4−
(2−ベンジルオキシエトキシ)−3−メトキシフェニ
ル)−2−クロロピリジンの合成 6−メチル−3−シアノ−4−(4−(2−ベンジルオ
キシエトキシ)−3−メトキシフェニル)−2−ピリド
ン1.25g(3.2mmol)をオキシ塩化リン10
mlに溶解し100℃で5時間攪拌する。オキシ塩化リ
ンを減圧下留去し残渣を酢酸エチルに溶解する。飽和重
曹水、飽和食塩水で洗浄し無水硫酸マグネシウムで乾燥
する。減圧下溶媒を留去し表題化合物を得た。このもの
は精製せずに以下の反応に利用した。 収量:870mg MS(ESI,m/z) 409 (MH+) H-NMR(CDCl3):2.64 (3H, s)、3.94 (3H, s)、3.80-4.0
0 (2H, m)、4.28 (2H,t)、4.66 (2H, s)、7.03 (1H,
d)、7.10-7.40 (8H, m)5) 6-methyl-3-cyano-4- (4-
Synthesis of (2-benzyloxyethoxy) -3-methoxyphenyl) -2-chloropyridine 6-methyl-3-cyano-4- (4- (2-benzyloxyethoxy) -3-methoxyphenyl) -2-pyridone 1.25 g (3.2 mmol) of phosphorus oxychloride 10
Dissolve in 100 ml and stir at 100 ° C. for 5 hours. The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound. This was used for the following reaction without purification. Yield: 870 mg MS (ESI, m / z) 409 (MH +) H-NMR (CDCl3): 2.64 (3H, s), 3.94 (3H, s), 3.80-4.0
0 (2H, m), 4.28 (2H, t), 4.66 (2H, s), 7.03 (1H,
d), 7.10-7.40 (8H, m)
【0132】6)6−メチル−3−シアノ−4−(4−
(2−ベンジルオキシエトキシ)−3−メトキシフェニ
ル)−2−(3、4−メチレンジオキシフェニルオキ
シ)ピリジンの合成 セサモール440mg(3.2mmol)、水素化ナト
リウム250mg(60%オイルディスパージョン、
6.2mmol)より作成したフェノキシドイオンのD
MF10ml溶液に6−メチル−3−シアノ−4−(4
−(2−ベンジルオキシエトキシ)−3−メトキシフェ
ニル)−2−クロロピリジン870mgをDMF10m
lに溶解して加えアルゴン雰囲気下室温で2時間攪拌す
る。減圧下溶媒を留去し、残渣を酢酸エチルに溶解し、
水、飽和食塩水で洗浄する。無水硫酸マグネシウムで乾
燥し減圧下溶媒を留去する。得られた残渣をシリカゲル
カラムクロマトグラフィー(酢酸エチル:ヘキサン
1:1)に付し表題化合物を得た。 収量:260mg、収率:6−メチル−3−シアノ−4
−(4−(2−ベンジルオキシエトキシ)−3−メトキ
シフェニル)−2−ピリドンより15.9% MS(ESI,m/z) 511 (MH+) H-NMR(CDCl3):2.45 (3H, s)、3.90 (2H, t)、3.95 (3
H, s)、4.28 (2H, t)、4.65 (2H, s)、6.02 (2H, s)、
6.67 (1H, dd)、6.74 (1H, d)、6.82 (1H, d)、6.96 (1
H, s)、7.05 (1H, d)、7.19 (1H, dd)、7.20 (1H, d)、
7.28-7.40 (5H, m)6) 6-methyl-3-cyano-4- (4-
Synthesis of (2-benzyloxyethoxy) -3-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine Sesamol 440 mg (3.2 mmol), sodium hydride 250 mg (60% oil dispersion,
D) of phenoxide ion prepared from 6.2 mmol)
6-methyl-3-cyano-4- (4
870 mg of-(2-benzyloxyethoxy) -3-methoxyphenyl) -2-chloropyridine is added to 10 m of DMF.
and stirred for 2 hours at room temperature under an argon atmosphere. The solvent was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate.
Wash with water and saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (ethyl acetate: hexane)
1: 1) to give the title compound. Yield: 260 mg, Yield: 6-methyl-3-cyano-4
-(4- (2-Benzyloxyethoxy) -3-methoxyphenyl) -2-pyridone 15.9% MS (ESI, m / z) 511 (MH +) H-NMR (CDCl3): 2.45 (3H, s) ), 3.90 (2H, t), 3.95 (3
H, s), 4.28 (2H, t), 4.65 (2H, s), 6.02 (2H, s),
6.67 (1H, dd), 6.74 (1H, d), 6.82 (1H, d), 6.96 (1
H, s), 7.05 (1H, d), 7.19 (1H, dd), 7.20 (1H, d),
7.28-7.40 (5H, m)
【0133】7)6−メチル−4−(4−(2−ベンジ
ルオキシエトキシ)−3−メトキシフェニル)−2−
(3、4−メチレンジオキシフェニルオキシ)ピリジン
−3−アルデヒドの合成 6−メチル−3−シアノ−4−(4−(2−ベンジルオ
キシエトキシ)−3−メトキシフェニル)−2−(3、
4−メチレンジオキシフェニルオキシ)ピリジン260
mg(0.51mmol)をベンゼン3mlに溶解しア
ルゴン雰囲気下室温で水素化ジイソブチルアルミニウム
1Mヘキサン溶液1.5ml(1.5mmol)を滴下
する。室温で2時間攪拌しメタノールと水で反応を停止
する。室温で30分攪拌し、不溶物をセライトを用いて
濾過する。濾液をを減圧下留去し得られた残渣をシリカ
ゲルカラムクロマトグラフィー(酢酸エチル:ヘキサン
1:1)に付し表題化合物を得た。このものは分離困難
な不純物を含むがこれ以上精製せずに以下の反応に用い
る。 収量:160mg MS(ESI,m/z) 514 (MH+)7) 6-methyl-4- (4- (2-benzyloxyethoxy) -3-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 6-methyl-3-cyano-4- (4- (2-benzyloxyethoxy) -3-methoxyphenyl) -2- (3,
4-Methylenedioxyphenyloxy) pyridine 260
mg (0.51 mmol) is dissolved in 3 ml of benzene, and 1.5 ml (1.5 mmol) of a 1 M solution of diisobutylaluminum hydride in hexane is added dropwise at room temperature under an argon atmosphere. Stir at room temperature for 2 hours and terminate the reaction with methanol and water. The mixture is stirred at room temperature for 30 minutes, and the insoluble matter is filtered using Celite. The filtrate was evaporated under reduced pressure, and the resulting residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1) to give the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 160 mg MS (ESI, m / z) 514 (MH +)
【0134】8)6−メチル−4−(4−(2−ベンジ
ルオキシエトキシ)−3−メトキシフェニル)−2−
(3、4−メチレンジオキシフェニルオキシ)ピリジン
−3−カルボン酸の合成 6−メチル−4−(4−(2−ベンジルオキシエトキ
シ)−3−メトキシフェニル)−2−(3、4−メチレ
ンジオキシフェニルオキシ)ピリジン−3−アルデヒド
160mgを塩化メチレン2ml、水1mlに溶解し、
0℃で2−メチル−2−ブテン0.23ml(2.2m
mol)、アミド硫酸45mg(0.46mmol)、
亜塩素酸ナトリウム125mg(1.1mmol)を加
え室温に戻して1時間攪拌する。酢酸エチルで抽出し無
水硫酸マグネシウムで乾燥して減圧下溶媒を留去する。
得られた残渣をシリカゲル薄層クロマトグラフィー(酢
酸エチル:ヘキサン 1:1)に付し表題化合物を得
た。 収量:105mg、収率:6−メチル−3−シアノ−4
−(4−(2−ベンジルオキシエトキシ)−3−メトキ
シフェニル)−2−(3、4−メチレンジオキシフェニ
ルオキシ)ピリジンより38.9% MS(ESI,m/z) 530 (MH+) H-NMR(CDCl3):2.40 (3H, s)、3.80 (3H, s)、3.80-3.9
0 (2H, m)、4.18 (2H,br t)、4.62 (2H, s)、5.98 (2H,
s)、6.62 (1H, dd)、6.72 (1H, d)、6.76 (1H, d)、6.
88 (1H, s)、6.90-6.94 (1H, m)、6.98-7.02 (2H, s)、
7.20-7.40 (5H, m)8) 6-methyl-4- (4- (2-benzyloxyethoxy) -3-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6-methyl-4- (4- (2-benzyloxyethoxy) -3-methoxyphenyl) -2- (3,4-methylene 160 mg of dioxyphenyloxy) pyridine-3-aldehyde was dissolved in 2 ml of methylene chloride and 1 ml of water,
At 0 ° C., 0.23 ml of 2-methyl-2-butene (2.2 m
mol), 45 mg (0.46 mmol) of amidosulfuric acid,
125 mg (1.1 mmol) of sodium chlorite is added and the mixture is returned to room temperature and stirred for 1 hour. Extract with ethyl acetate, dry over anhydrous magnesium sulfate and evaporate the solvent under reduced pressure.
The obtained residue was subjected to silica gel thin layer chromatography (ethyl acetate: hexane 1: 1) to give the title compound. Yield: 105 mg, Yield: 6-methyl-3-cyano-4
38.9% MS (ESI, m / z) 530 (MH +) H from-(4- (2-benzyloxyethoxy) -3-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine -NMR (CDCl3): 2.40 (3H, s), 3.80 (3H, s), 3.80-3.9
0 (2H, m), 4.18 (2H, br t), 4.62 (2H, s), 5.98 (2H,
s), 6.62 (1H, dd), 6.72 (1H, d), 6.76 (1H, d), 6.
88 (1H, s), 6.90-6.94 (1H, m), 6.98-7.02 (2H, s),
7.20-7.40 (5H, m)
【0135】実施例20 6−メチル−4−(4−(2
−ヒドロキシエトキシ)−3−メトキシフェニル)−2
−(3、4−メチレンジオキシフェニルオキシ)ピリジ
ン−3−カルボン酸の合成 6−メチル−4−(4−(2−ベンジルオキシエトキ
シ)−3−メトキシフェニル)−2−(3、4−メチレ
ンジオキシフェニルオキシ)ピリジン−3−カルボン酸
80mg(0.15mmol)をエタノールに溶解し1
0%パラジウム炭素50mgを加え水素雰囲気下、室
温、1気圧で一晩攪拌する。セライトを用いて触媒をの
ぞき、減圧下溶媒を留去する。残渣をシリカゲル薄層ク
ロマトグラフィー(クロロホルム:メタノール 9:1
2回展開)に付し表題化合物を得た。 収量:20mg、収率:30.1% MS(ESI,m/z) 440 (MH+) H-NMR(CDCl3):2.38 (3H, s)、3.46 (1H, s)、3.62 (3
H, s)、3.98 (2H, br)、4.14 (2H, br)、5.95 (2H,
s)、6.62 (1H, dd)、6.70 (1H, d)、6.73 (1H, d)、6.8
6 (1H, s)、6.92 (1H, d)、7.02 (2H, m)Example 20 6-methyl-4- (4- (2
-Hydroxyethoxy) -3-methoxyphenyl) -2
Synthesis of-(3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6-methyl-4- (4- (2-benzyloxyethoxy) -3-methoxyphenyl) -2- (3,4- Dissolve 80 mg (0.15 mmol) of methylenedioxyphenyloxy) pyridine-3-carboxylic acid in ethanol
50 mg of 0% palladium carbon is added, and the mixture is stirred overnight at room temperature and 1 atm under a hydrogen atmosphere. The catalyst is removed using celite, and the solvent is distilled off under reduced pressure. The residue was subjected to silica gel thin layer chromatography (chloroform: methanol 9: 1).
(Twice development) to give the title compound. Yield: 20 mg, yield: 30.1% MS (ESI, m / z) 440 (MH +) H-NMR (CDCl3): 2.38 (3H, s), 3.46 (1H, s), 3.62 (3
H, s), 3.98 (2H, br), 4.14 (2H, br), 5.95 (2H, br)
s), 6.62 (1H, dd), 6.70 (1H, d), 6.73 (1H, d), 6.8
6 (1H, s), 6.92 (1H, d), 7.02 (2H, m)
【0136】実施例21 4−(2−(2−ベンジルオ
キシエトキシ)−4−メトキシフェニル)−2−(3,
4−メチレンジオキシフェノキシ)−6−メチルピリジ
ン−3−カルボン酸の合成 1)2−(2−ベンジルオキシエトキシ)−4−メトキ
シベンズアルデヒドの合成 塩化メチレン100ml中、2−ベンジルオキシエタノ
ール3.83g(25.2mmol)、メタンスルホン
酸クロライド3.9ml(50.4mmol)、トリエ
チルアミン7.7ml(55.2mmol)を室温で1
晩攪拌した。2規定 塩酸を加え、クロロホルムで抽出
し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮し
た。残渣をDMF5mlに溶解し、DMF50ml中で
2−ヒドロキシ−4−メトキシベンズアルデヒド3.1
0g(20.4mmol)と60%水素化ナトリウム8
88mg(22.2mmol)を室温で20分間攪拌し
た溶液に加えた。室温で1晩攪拌した後、80℃で4時
間加熱攪拌した。減圧下でDMFを留去後2規定 塩酸
を加え、酢酸エチルで抽出し有機層を無水硫酸ナトリウ
ムで乾燥、減圧下濃縮した。残渣をシリカゲルクロマト
グラフィー(ヘキサン:酢酸エチル 4:1)で精製し
表題化合物を得た。 収量:3.86g(13.5mmol)、収率:66.
2% H-NMR(CDCl3):3.84(3H,s)、3.86-3.90(2H,m)、4.22-4.
26(2H,m)、4.63(2H,s)、6.44-6.58(2H,m)、7.26-7.39(5
H,m)、7.81-7.84(1H,d)、10.34-10.35(1H,d)Example 21 4- (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -2- (3
Synthesis of 4-methylenedioxyphenoxy) -6-methylpyridine-3-carboxylic acid 1) Synthesis of 2- (2-benzyloxyethoxy) -4-methoxybenzaldehyde 3.83 g of 2-benzyloxyethanol in 100 ml of methylene chloride (25.2 mmol), 3.9 ml (50.4 mmol) of methanesulfonic acid chloride, and 7.7 ml (55.2 mmol) of triethylamine at room temperature.
Stirred overnight. 2N Hydrochloric acid was added, extracted with chloroform, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was dissolved in 5 ml of DMF and 2-hydroxy-4-methoxybenzaldehyde 3.1 in 50 ml of DMF.
0 g (20.4 mmol) and 60% sodium hydride 8
88 mg (22.2 mmol) were added to the solution stirred at room temperature for 20 minutes. After stirring at room temperature overnight, the mixture was heated and stirred at 80 ° C. for 4 hours. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 3.86 g (13.5 mmol), yield: 66.
2% H-NMR (CDCl3): 3.84 (3H, s), 3.86-3.90 (2H, m), 4.22-4.
26 (2H, m), 4.63 (2H, s), 6.44-6.58 (2H, m), 7.26-7.39 (5
H, m), 7.81-7.84 (1H, d), 10.34-10.35 (1H, d)
【0137】2)1−(2−(2−ベンジルオキシエト
キシ)−4−メトキシ)フェニル−1−ブテン−3−オ
ンの合成 アセトニルトリフェニルホスホニウム クロリド6.2
5g(17.6mmol)、ナトリウムエトキシド1.
20g(17.6mmol)と2−(2−ベンジルオキ
シエトキシ)−4−メトキシベンズアルデヒド3.86
g(13.5mmol)をエタノール140ml中で3
日間還流した。減圧下でエタノールを留去後2規定 塩
酸を加え、酢酸エチルで抽出し有機層を無水硫酸ナトリ
ウムで乾燥、減圧下濃縮した。残渣をシリカゲルクロマ
トグラフィー(ヘキサン:酢酸エチル 4:1)で精製
し表題化合物を得た。 収量:3.70g(11.3mmol)、収率:83.
9% MS(ESI,m/z) 327(MH+) H-NMR(CDCl3):2.31(3H,s)、3.81(3H,s)、3.88-3.92(2
H,m)、4.20-4.24(2H,m)、4.65(2H,s)、6.47-6.56(2H,
m)、6.68-6.73(1H,d)、7.26-7.39(5H,m)、7.47-7.50(1
H,d)、7.81-7.86(1H,d)2) Synthesis of 1- (2- (2-benzyloxyethoxy) -4-methoxy) phenyl-1-buten-3-one Acetonyltriphenylphosphonium chloride 6.2
5 g (17.6 mmol), sodium ethoxide
20 g (17.6 mmol) and 2- (2-benzyloxyethoxy) -4-methoxybenzaldehyde 3.86
g (13.5 mmol) in 140 ml of ethanol
Refluxed for days. After distilling off ethanol under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 3.70 g (11.3 mmol), yield: 83.
9% MS (ESI, m / z) 327 (MH +) H-NMR (CDCl3): 2.31 (3H, s), 3.81 (3H, s), 3.88-3.92 (2
H, m), 4.20-4.24 (2H, m), 4.65 (2H, s), 6.47-6.56 (2H,
m), 6.68-6.73 (1H, d), 7.26-7.39 (5H, m), 7.47-7.50 (1
H, d), 7.81-7.86 (1H, d)
【0138】3)4−(2−(2−ベンジルオキシエト
キシ)−4−メトキシフェニル)−3−シアノ−6−メ
チル−2−ピリドンの合成 DMSO20ml中、シアノアセトアミド953mg
(11.3mmol)にt−ブトキシカリウム1.27
g(11.3mmol)ついでDMSO10mlに溶解
した1−(2−(2−ベンジルオキシエトキシ)−4−
メトキシ)フェニル−1−ブテン−3−オン3.70g
(11.3mmol)を加え室温で30分間攪拌した。
t−ブトキシカリウム3.90g(34.8mmol)
を加えた後、酸素ガスを2分間バブリングしさらに室温
常圧酸素雰囲気下で3時間攪拌した。2規定塩酸を加
え、酢酸エチルで抽出し有機層を無水硫酸ナトリウムで
乾燥、減圧下濃縮した。 収量:4.05g(10.4mmol)、収率:92.
0% MS(ESI,m/z) 391(MH+) H-NMR(CDCl3):2.62(3H,s)、3.75-3.90(5H,m)、4.21-4.
25(2H,m)、4.56(2H,s)、6.44-6.68(3H,m)、7.24-7.42(6
H,m)3) Synthesis of 4- (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-6-methyl-2-pyridone 953 mg of cyanoacetamide in 20 ml of DMSO
(11.3 mmol) to potassium t-butoxide 1.27
g (11.3 mmol) and then 1- (2- (2-benzyloxyethoxy) -4-) dissolved in 10 ml of DMSO.
3.70 g of methoxy) phenyl-1-buten-3-one
(11.3 mmol) was added and stirred at room temperature for 30 minutes.
3.90 g (34.8 mmol) of potassium t-butoxide
Was added, oxygen gas was bubbled for 2 minutes, and the mixture was further stirred at room temperature under an atmosphere of normal pressure oxygen for 3 hours. 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. Yield: 4.05 g (10.4 mmol);
0% MS (ESI, m / z) 391 (MH +) H-NMR (CDCl3): 2.62 (3H, s), 3.75 to 3.90 (5H, m), 4.21-4.
25 (2H, m), 4.56 (2H, s), 6.44-6.68 (3H, m), 7.24-7.42 (6
H, m)
【0139】4)4−(2−(2−ベンジルオキシエト
キシ)−4−メトキシフェニル)−2 −クロロ−3−シアノ−6−メチルピリジンの合成4−
(2−(2−ベンジルオキシエトキシ)−4−メトキシ
フェニル)−3−シアノ−6−メチル−2−ピリドン
4.05g(10.4mmol)にオキシ塩化リン30
ml、N,N−ジメチルアニリン1.3ml(10.3
mmol)を加え100℃で2時間加熱した。オキシ塩
化リンを留去後水を加えエーテルついで酢酸エチルで抽
出し、有機層を飽和炭酸水素ナトリウム水溶液で洗浄、
無水硫酸ナトリウムで乾燥、減圧下濃縮した。残渣を精
製せずに次の反応に用いた。 収量:3.02g(7.38mmol)、収率:71.
0% MS(ESI,m/z) 409(MH+) H-NMR(CDCl3):2.55(3H,s)、3.76-3.88(5H,m)、4.20-4.
24(2H,m)、4.52(2H,s)、6.59-6.79(3H,m)、7.19-7.40(6
H,m)4) Synthesis of 4- (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -2-chloro-3-cyano-6-methylpyridine
Phosphorus oxychloride was added to 4.05 g (10.4 mmol) of (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-6-methyl-2-pyridone.
ml, N, N-dimethylaniline 1.3 ml (10.3
mmol) and heated at 100 ° C. for 2 hours. After distilling off phosphorus oxychloride, water was added, and the mixture was extracted with ether and ethyl acetate.The organic layer was washed with a saturated aqueous solution of sodium hydrogen carbonate,
The extract was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was used for the next reaction without purification. Yield: 3.02 g (7.38 mmol), yield: 71.
0% MS (ESI, m / z) 409 (MH +) H-NMR (CDCl3): 2.55 (3H, s), 3.76-3.88 (5H, m), 4.20-4.
24 (2H, m), 4.52 (2H, s), 6.59-6.79 (3H, m), 7.19-7.40 (6
H, m)
【0140】5)4−(2−(2−ベンジルオキシエト
キシ)−4−メトキシフェニル)−3−シアノ−2−
(3,4−メチレンジオキシフェノキシ)−6−メチル
ピリジンの合成 DMF30ml中、セサモール1.14g(8.25m
mol)に60%水素化ナトリウム280mg(7.0
mmol)を加え室温で15分間攪拌した。4−(2−
(2−ベンジルオキシエトキシ)−4−メトキシフェニ
ル)−2−クロロ−3−シアノ−6−メチルピリジン
3.02g(7.38mmol)をDMF20mlに溶
解して滴下し、室温で7時間攪拌した。60%水素化ナ
トリウム250mg(6.25mmol)を追加しさら
に2時間攪拌した。減圧下でDMFを留去後2規定 塩
酸を加え、酢酸エチルで抽出し有機層を無水硫酸ナトリ
ウムで乾燥、減圧下濃縮した。残渣をシリカゲルクロマ
トグラフィー(ヘキサン:酢酸エチル 4:1)で精製
し表題化合物を得た。 収量:546mg(1.07mmol)、収率:14.
5% MS(ESI,m/z) 511(MH+) H-NMR(CDCl3):2.38(3H,s)、3.84(3H,s)、3.81-3.87(2
H,m)、4.22-4.26(2H,m)、4.54(2H,s)、6.00(2H,s)、6.5
8-6.64(3H,m)、6.70-6.72(1H,d)、6.77-6.80(1H,d)、6.
96(1H,s)、7.23-7.30(6H,m)5) 4- (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-2-
Synthesis of (3,4-methylenedioxyphenoxy) -6-methylpyridine 1.14 g (8.25 m) of sesamol in 30 ml of DMF
mol) to 280 mg (7.0 mg) of 60% sodium hydride.
mmol) and stirred at room temperature for 15 minutes. 4- (2-
3.02 g (7.38 mmol) of (2-benzyloxyethoxy) -4-methoxyphenyl) -2-chloro-3-cyano-6-methylpyridine was dissolved in 20 ml of DMF, added dropwise, and stirred at room temperature for 7 hours. 250 mg (6.25 mmol) of 60% sodium hydride was added, and the mixture was further stirred for 2 hours. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 4: 1) to obtain the title compound. Yield: 546 mg (1.07 mmol), yield: 14.
5% MS (ESI, m / z) 511 (MH +) H-NMR (CDCl3): 2.38 (3H, s), 3.84 (3H, s), 3.81-3.87 (2
H, m), 4.22-4.26 (2H, m), 4.54 (2H, s), 6.00 (2H, s), 6.5
8-6.64 (3H, m), 6.70-6.72 (1H, d), 6.77-6.80 (1H, d), 6.
96 (1H, s), 7.23-7.30 (6H, m)
【0141】6)4−(2−(2−ベンジルオキシエト
キシ)−4−メトキシフェニル)−2−(3,4−メチ
レンジオキシフェノキシ)−6−メチルピリジン−3−
アルデヒドの合成 4−(2−(2−ベンジルオキシエトキシ)−4−メト
キシフェニル)−3−シアノ−2−(3,4−メチレン
ジオキシフェノキシ)−6−メチルピリジン540mg
(1.06mmol)をベンゼン10mlに溶解し室温
で水素化ジイソブチルアルミニウム1Mヘキサン溶液
3.2ml(3.2mmol)を加え室温で2.5時間
攪拌した。メタノール1ml、水2mlを加え15分間
攪拌した。沈澱を濾過し濾液を減圧下濃縮した。残渣を
シリカゲルクロマトグラフィー(ヘキサン:酢酸エチル
3:1)で精製し表題化合物を得た。 収量:242mg(0.47mmol)、収率:44.
5% H-NMR(CDCl3):2.39(3H,s)、3.69-3.72(2H,t)、3.83(3
H,s)、4.09-4.13(2H,m)、4.49(2H,s)、5.99(2H,s)、6.5
3-6.62(3H,m)、6.67-6.68(1H,d)、6.75-6.78(1H,d)、6.
81(1H,s)、7.13-7.16(1H,d)、7.21-7.32(5H,m)、10.18
(1H,s)6) 4- (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) -6-methylpyridine-3-
Synthesis of aldehyde 540 mg of 4- (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-2- (3,4-methylenedioxyphenoxy) -6-methylpyridine
(1.06 mmol) was dissolved in 10 ml of benzene, and 3.2 ml (3.2 mmol) of a 1 M solution of diisobutylaluminum hydride in hexane was added at room temperature, followed by stirring at room temperature for 2.5 hours. 1 ml of methanol and 2 ml of water were added and stirred for 15 minutes. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate 3: 1) to obtain the title compound. Yield: 242 mg (0.47 mmol), yield: 44.
5% H-NMR (CDCl3): 2.39 (3H, s), 3.69-3.72 (2H, t), 3.83 (3
H, s), 4.09-4.13 (2H, m), 4.49 (2H, s), 5.99 (2H, s), 6.5
3-6.62 (3H, m), 6.67-6.68 (1H, d), 6.75-6.78 (1H, d), 6.
81 (1H, s), 7.13-7.16 (1H, d), 7.21-7.32 (5H, m), 10.18
(1H, s)
【0142】7)4−(2−(2−ベンジルオキシエト
キシ)−4−メトキシフェニル)−2−(3,4−メチ
レンジオキシフェノキシ)−6−メチルピリジン−3−
カルボン酸の合成 塩化メチレン4ml、水2ml中4−(2−(2−ベン
ジルオキシエトキシ)−4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)−6−メチル
ピリジン−3−アルデヒド238mg(0.46mmo
l)に氷浴下2−メチル−2−ブテン0.45ml
(4.25mmol)、アミド硫酸150mg(1.5
4mmol)、亜塩素酸ナトリウム300mg(3.3
2mmol)を加え室温で30分間攪拌した。水を加
え、クロロホルムで抽出し有機層を無水硫酸ナトリウム
で乾燥、減圧下濃縮した。残渣をシリカゲルクロマトグ
ラフィー(クロロホルム:メタノール 25:1)で精
製し表題化合物を得た。 収量:202mg(0.38mmol)、収率:82.
3% MS(ESI,m/z) 530(MH+) H-NMR(CDCl3):2.38(3H,s)、3.70-3.73(2H,t)、3.78(3
H,s)、4.07-4.09(2H,t)、4.52(2H,s)、5.96(2H,s)、6.4
7-6.57(3H,m)、6.63-6.64(1H,d)、6.70-6.73(1H,d)、6.
83(1H,s)、7.17-7.30(6H,m)7) 4- (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) -6-methylpyridine-3-
Synthesis of carboxylic acid 4- (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -2-in 4 ml of methylene chloride and 2 ml of water
238 mg of (3,4-methylenedioxyphenoxy) -6-methylpyridine-3-aldehyde (0.46 mmol
1) 0.45 ml of 2-methyl-2-butene in an ice bath
(4.25 mmol), 150 mg (1.5 mg) of amidosulfuric acid
4 mmol), 300 mg of sodium chlorite (3.3
2 mmol) and stirred at room temperature for 30 minutes. Water was added, extracted with chloroform, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform: methanol 25: 1) to give the title compound. Yield: 202 mg (0.38 mmol), yield: 82.
3% MS (ESI, m / z) 530 (MH +) H-NMR (CDCl3): 2.38 (3H, s), 3.70-3.73 (2H, t), 3.78 (3
H, s), 4.07-4.09 (2H, t), 4.52 (2H, s), 5.96 (2H, s), 6.4
7-6.57 (3H, m), 6.63-6.64 (1H, d), 6.70-6.73 (1H, d), 6.
83 (1H, s), 7.17-7.30 (6H, m)
【0143】実施例22 4−(2−(2−ヒドロキシ
エトキシ)−4−メトキシフェニル)−2−(3,4−
メチレンジオキシフェノキシ)−6−メチルピリジン−
3−カルボン酸の合成 4−(2−(2−ベンジルオキシエトキシ)−4−メト
キシフェニル)−2−(3,4−メチレンジオキシフェ
ノキシ)−6−メチルピリジン−3−カルボン酸178
mg(0.34mmol)を10%Pd−C存在下、メ
タノール10ml中常圧水素雰囲気下室温で1晩攪拌し
た。通常の後処理後表題化合物を得た。 収量:112mg(0.26mmol)、収率:76.
1% MS(ESI,m/z) 440(MH+) H-NMR(CDCl3+CD3OD):2.40(3H,s)、3.36-3.39(2H,m)、
3.84(3H,s)、4.01-4.07(2H,m)、5.97(2H,s)、6.48-6.64
(3H,m)、6.70(1H,s)、6.76-6.79(1H,d)、6.82-6.83(1H,
d)、7.19-7.22(1H,d)Example 22 4- (2- (2-hydroxyethoxy) -4-methoxyphenyl) -2- (3,4-
Methylenedioxyphenoxy) -6-methylpyridine-
Synthesis of 3-carboxylic acid 4- (2- (2-benzyloxyethoxy) -4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) -6-methylpyridine-3-carboxylic acid 178
mg (0.34 mmol) was stirred in the presence of 10% Pd-C in 10 ml of methanol at room temperature under an atmosphere of hydrogen at normal pressure overnight. The title compound was obtained after usual work-up. Yield: 112 mg (0.26 mmol), yield: 76.
1% MS (ESI, m / z) 440 (MH +) H-NMR (CDCl3 + CD3OD): 2.40 (3H, s), 3.36 to 3.39 (2H, m),
3.84 (3H, s), 4.01-4.07 (2H, m), 5.97 (2H, s), 6.48-6.64
(3H, m), 6.70 (1H, s), 6.76-6.79 (1H, d), 6.82-6.83 (1H,
d), 7.19-7.22 (1H, d)
【0144】実施例23 6−(2−フリル)−4−
(4−メトキシフェニル)−2−(3、4−メチレンジ
オキシフェニルオキシ)ピリジン−3−カルボン酸 1)2−(3−(4−メトキシフェニル)−2−プロペ
ノイル)フランの合成 2−アセチルフラン1.10g(10.0mmol)、
p−アニスアルデヒド1.22ml(10.0mmo
l)のTHF20ml溶液に1規定水酸化ナトリウム溶
液10mlを加え室温で2日間攪拌する。酢酸エチルで
抽出し、水、1規定塩酸、飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧下溶媒を留去し残渣をシリ
カゲルカラムクロマトグラフィー(酢酸エチル:ヘキサ
ン 1:3)に付し表題化合物を得た。 収量:1.10g、収率:48.2% MS(ESI,m/z) 229 (MH+) H-NMR(CDCl3):3.86 (3H, s)、6.58 (1H, dd)、7.31-7.
34 (2H, m)、7.61 (2H, d)、7.64 (1H, m)、7.85 (1H,
d)Example 23 6- (2-furyl) -4-
(4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) Synthesis of 2- (3- (4-methoxyphenyl) -2-propenoyl) furan 2-acetyl 1.10 g (10.0 mmol) of furan,
1.22 ml of p-anisaldehyde (10.0 mmol
10 ml of a 1N sodium hydroxide solution is added to a solution of 1) in 20 ml of THF, and the mixture is stirred at room temperature for 2 days. After extraction with ethyl acetate, washing with water, 1N hydrochloric acid and saturated saline, drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3). The title compound was obtained. Yield: 1.10 g, Yield: 48.2% MS (ESI, m / z) 229 (MH +) H-NMR (CDCl3): 3.86 (3H, s), 6.58 (1H, dd), 7.31-7.
34 (2H, m), 7.61 (2H, d), 7.64 (1H, m), 7.85 (1H,
d)
【0145】2)3−シアノ−6−(2−フリル)−4
−(4−メトキシフェニル)−2−ピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド410m
g(4.9mmol)、t−ブトキシカリウム540m
g(4.8mmol)のDMSO5ml溶液に2−(3
−(4−メトキシフェニル)−2−プロペンノイル)フ
ラン1.10g(4.8mmol)のDMSO15ml
を加え15分間攪拌する。t−ブトキシカリウム1.6
2g(14.4mmol)を加え1分間酸素をバブリン
グする。酸素雰囲気下1時間攪拌した後、1規定塩酸を
氷冷下加え析出した結晶を濾取する。水で洗い減圧下乾
燥し表題化合物を得た。この化合物は精製せずに以下の
反応に用いる。 収量:1.18g、収率:84.1% MS(ESI,m/z) 311 (MH+) H-NMR(CDCl3):3.89 (3H, s)、6.69 (1H, m)、6.83 (1
H, s)、7.06 (2H, d)、7.55-7.72 (4H, m)2) 3-cyano-6- (2-furyl) -4
Synthesis of-(4-methoxyphenyl) -2-pyridone Cyanoacetamide 410m at room temperature under argon atmosphere
g (4.9 mmol), potassium tert-butoxide 540 m
g (4.8 mmol) in 5 ml of DMSO was added to 2- (3
-(4-methoxyphenyl) -2-propenyl) furan 1.10 g (4.8 mmol) of DMSO in 15 ml
And stir for 15 minutes. potassium t-butoxide 1.6
Add 2 g (14.4 mmol) and bubble oxygen for 1 minute. After stirring for 1 hour in an oxygen atmosphere, 1N hydrochloric acid is added under ice cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 1.18 g, yield: 84.1% MS (ESI, m / z) 311 (MH +) H-NMR (CDCl3): 3.89 (3H, s), 6.69 (1H, m), 6.83 (1
H, s), 7.06 (2H, d), 7.55-7.72 (4H, m)
【0146】3)6−(2−フリル)−3−シアノ−4
−(4−メトキシフェニル)−2−クロロピリジンの合
成 3−シアノ−6−(2−フリル)−4−(4−メトキシ
フェニル)−2−ピリドン1.18g(4.0mmo
l)をオキシ塩化リン10mlに溶解し90℃で一晩攪
拌する。オキシ塩化リンを減圧下留去し残渣を酢酸エチ
ルに溶解する。飽和重曹水、飽和食塩水で洗浄し無水硫
酸マグネシウムで乾燥する。減圧下溶媒を留去し得られ
る結晶を酢酸エチルで洗浄し表題化合物を得た。このも
のはこれ以上精製せずに以下の反応に利用した。 収量:720mg MS(ESI,m/z) 311 (MH+) H-NMR(CDCl3):3.89 (3H, s)、6.61 (1H, dd)、7.06 (2
H, d)、7.31 (1H, dd)、7.61 (1H, m)、7.63 (2H, d)、
7.68 (1H, s)3) 6- (2-furyl) -3-cyano-4
Synthesis of-(4-methoxyphenyl) -2-chloropyridine 1.18 g (4.0 mmol) of 3-cyano-6- (2-furyl) -4- (4-methoxyphenyl) -2-pyridone
l) is dissolved in 10 ml of phosphorus oxychloride and stirred at 90 ° C. overnight. The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The crystals obtained by evaporating the solvent under reduced pressure were washed with ethyl acetate to obtain the title compound. This was used for the following reaction without further purification. Yield: 720 mg MS (ESI, m / z) 311 (MH +) H-NMR (CDCl3): 3.89 (3H, s), 6.61 (1H, dd), 7.06 (2
H, d), 7.31 (1H, dd), 7.61 (1H, m), 7.63 (2H, d),
7.68 (1H, s)
【0147】4)6−(2−フリル)−3−シアノ−4
−(4−メトキシフェニル)−2−(3、4−メチレン
ジオキシフェニルオキシ)ピリジンの合成 セサモール320mg(2.3mmol)、水素化ナト
リウム190mg(60%オイルディスパージョン、
4.8mmol)より作成したフェノキシドイオンのD
MF10ml溶液に6−(2−フリル)−3−シアノ−
4−((2−ベンジルオキシエトキシ)−3−メトキシ
フェニル)−2−クロロピリジン720mgを加えアル
ゴン雰囲気下室温で30分間攪拌する。減圧下溶媒を留
去し、残渣をクロロホルムに溶解し、水、飽和食塩水で
洗浄する。無水硫酸マグネシウムで乾燥し減圧下溶媒を
留去して得られる結晶を酢酸エチルで洗浄し、表題化合
物を得た。 収量:340mg、収率:3−シアノ−6−(2−フリ
ル)−4−(4−メトキシフェニル)−2−ピリドンよ
り17.2% MS(ESI,m/z) 413 (MH+) H-NMR(CDCl3):3.89 (3H, s)、6.03 (2H, s)、6.58 (1
H, dd)、6.72 (1H, dd)、6.81 (1H, d)、6.83 (1H,
d)、6.92 (1H, d)、7.06 (2H, d)、7.47 (1H, s)、7.52
(1H, m)、7.68 (2H, d)4) 6- (2-furyl) -3-cyano-4
Synthesis of-(4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine Sesamol 320 mg (2.3 mmol), sodium hydride 190 mg (60% oil dispersion,
4.8 mmol) of phenoxide ion prepared from
6- (2-furyl) -3-cyano-
720 mg of 4-((2-benzyloxyethoxy) -3-methoxyphenyl) -2-chloropyridine is added, and the mixture is stirred at room temperature for 30 minutes under an argon atmosphere. The solvent is distilled off under reduced pressure, the residue is dissolved in chloroform, and washed with water and saturated saline. The crystals obtained by drying over anhydrous magnesium sulfate and evaporating the solvent under reduced pressure were washed with ethyl acetate to obtain the title compound. Yield: 340 mg, Yield: 17.2% MS (ESI, m / z) 413 (MH +) H- from 3-cyano-6- (2-furyl) -4- (4-methoxyphenyl) -2-pyridone. NMR (CDCl3): 3.89 (3H, s), 6.03 (2H, s), 6.58 (1
H, dd), 6.72 (1H, dd), 6.81 (1H, d), 6.83 (1H,
d), 6.92 (1H, d), 7.06 (2H, d), 7.47 (1H, s), 7.52
(1H, m), 7.68 (2H, d)
【0148】5)6−(2−フリル)−4−(4−メト
キシフェニル)−2−(3、4−メチレンジオキシフェ
ニルオキシ)ピリジン−3−アルデヒドの合成 6−(2−フリル)−3−シアノ−4−(4−メトキシ
フェニル)−2−(3、4−メチレンジオキシフェニル
オキシ)ピリジン340mg(0.82mmol)を塩
化メチレン10mlに溶解しアルゴン雰囲気下室温で水
素化ジイソブチルアルミニウム1Mヘキサン溶液2.5
ml(2.5mmol)を滴下する。室温で1時間攪拌
しメタノールと水で反応を停止する。室温で30分攪拌
し、不溶物をセライトを用いて濾過する。濾液をを減圧
下留去し得られた残渣をシリカゲルカラムクロマトグラ
フィー(クロロホルム:メタノール 100:1)に付
し表題化合物を得た。このものは分離困難な不純物を含
むがこれ以上精製せずに以下の反応に用いる。 収量:180mg MS(ESI,m/z) 416 (MH+)5) Synthesis of 6- (2-furyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 6- (2-furyl)- 340 mg (0.82 mmol) of 3-cyano-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine is dissolved in 10 ml of methylene chloride and diisobutylaluminum hydride 1M is added at room temperature under an argon atmosphere. Hexane solution 2.5
ml (2.5 mmol) are added dropwise. Stir at room temperature for 1 hour and terminate the reaction with methanol and water. The mixture is stirred at room temperature for 30 minutes, and the insoluble matter is filtered using Celite. The filtrate was evaporated under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (chloroform: methanol 100: 1) to obtain the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 180 mg MS (ESI, m / z) 416 (MH +)
【0149】6)6−(2−フリル)−4−(4−メト
キシフェニル)−2−(3、4−メチレンジオキシフェ
ニルオキシ)ピリジン−3−カルボン酸の合成 6−(2−フリル)−4−(4−メトキシフェニル)−
2−(3、4−メチレンジオキシフェニルオキシ)ピリ
ジン−3−アルデヒド180mgを塩化メチレン4m
l、水2mlに溶解し、0℃で2−メチル−2−ブテン
0.3ml(2.8mmol)、アミド硫酸60mg
(0.62mmol)、亜塩素酸ナトリウム170mg
(1.5mmol)を加え室温に戻して1時間攪拌す
る。塩化メチレンで抽出し無水硫酸マグネシウムで乾燥
して減圧下溶媒を留去する。得られた残渣をシリカゲル
薄層クロマトグラフィー(酢酸エチル:ヘキサン 1:
1 2回展開)に付し表題化合物を得た。 収量:50mg、収率:6−(2−フリル)−3−シア
ノ−4−(4−メトキシフェニル)−2−(3、4−メ
チレンジオキシフェニルオキシ)ピリジンより27.0
% MS(ESI,m/z) 432 (MH+) H-NMR(CDCl3):3.81 (3H, s)、5.99 (2H, s)、6.45 (1
H, dd)、6.67 (1H, dd)、6.76 (1H, d)、6.78 (1H,
s)、6.83 (1H, d)、6.94 (2H, d)、7.38 (1H, s)、7.46
(2H, d)、7.47 (1H, m)6) Synthesis of 6- (2-furyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6- (2-furyl) -4- (4-methoxyphenyl)-
180 mg of 2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde was added to 4 m of methylene chloride.
l, dissolved in 2 ml of water, 0.3 ml (2.8 mmol) of 2-methyl-2-butene at 0 ° C., 60 mg of amidosulfuric acid
(0.62 mmol), 170 mg of sodium chlorite
(1.5 mmol) was added and the mixture was returned to room temperature and stirred for 1 hour. Extract with methylene chloride, dry over anhydrous magnesium sulfate and evaporate the solvent under reduced pressure. The obtained residue is subjected to silica gel thin layer chromatography (ethyl acetate: hexane 1: 1:
(12 developments) to give the title compound. Yield: 50 mg, Yield: 27.0 from 6- (2-furyl) -3-cyano-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine
% MS (ESI, m / z) 432 (MH +) H-NMR (CDCl3): 3.81 (3H, s), 5.99 (2H, s), 6.45 (1
H, dd), 6.67 (1H, dd), 6.76 (1H, d), 6.78 (1H,
s), 6.83 (1H, d), 6.94 (2H, d), 7.38 (1H, s), 7.46
(2H, d), 7.47 (1H, m)
【0150】実施例24 5−ブロモ−4−(4−メト
キシフェニル)−6−メチル−2−(3、4−メチレン
ジオキシフェノキシ)−ピリジン−3−カルボン酸の合
成 1)5−ブロモ−3−シアノ−4−(4−メトキシフェ
ニル)−6−メチル−2−ピリドンの合成 アルゴン雰囲気下、3−シアノ−4−(4−メトキシフ
ェニル)−6−メチル−2−ピリドン1g(4.42m
mol)を四塩化炭素10mlに溶かし、NBS1.5
7g(8.84mmol),AIBN1.45g(8.
84mmol)を加えて、100℃にて、12時間攪拌
した。反応溶液に水を加え、クロロホルムで抽出、無水
硫酸マグネシウムで乾燥後溶媒を減圧留去した。残渣黄
色結晶をクロロホルム、ヘキサンから再結晶させ、表題
化合物を得た。 収量:370mg、収率:26% MS(ESI. m/z) 319(MH+) H-NMR (CDCl3):2.65 (3H, s)、3.88 (3H, s)、7.03 (2
H, d)、7.32 (2H, d)Example 24 Synthesis of 5-bromo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 1) 5-Bromo- Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-methyl-2-pyridone 1 g of 3-cyano-4- (4-methoxyphenyl) -6-methyl-2-pyridone (4. 42m
mol) was dissolved in 10 ml of carbon tetrachloride, and NBS 1.5
7 g (8.84 mmol), AIBN 1.45 g (8.8.
84 mmol) and stirred at 100 ° C. for 12 hours. Water was added to the reaction solution, extracted with chloroform, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residual yellow crystals were recrystallized from chloroform and hexane to give the title compound. Yield: 370 mg, Yield: 26% MS (ESI. M / z) 319 (MH +) H-NMR (CDCl3): 2.65 (3H, s), 3.88 (3H, s), 7.03 (2
H, d), 7.32 (2H, d)
【0151】2)5−ブロモ−2−クロロ−3−シアノ
−4−(4−メトキシフェニル)−6−メチル−ピリジ
ンの合成 5−ブロモ−3−シアノ−4−(4−メトキシフェニ
ル)−6−メチル−2−ピリドン370mg(1.16
mmol)にオキシ塩化リン5mlを加え、120℃に
て24時間攪拌した。この後、減圧下にてオキシ塩化リ
ンを留去し、残渣を酢酸エチル中に加え、水、飽和重曹
水、飽和食塩水で順次洗浄する。無水硫酸マグネシウム
で乾燥後、溶媒を留去して、表題化合物を得た。 収量:380mg、収率:97% MS(ESI. m/z) 338(MH+) H-NMR (CDCl3):2.66 (3H, s)、3.88 (3H, s)、7.02-7.
05 (2H, m)、7.27-7.30 (2H, m)2) Synthesis of 5-bromo-2-chloro-3-cyano-4- (4-methoxyphenyl) -6-methyl-pyridine 5-bromo-3-cyano-4- (4-methoxyphenyl)- 370 mg of 6-methyl-2-pyridone (1.16
(mmol), and the mixture was stirred at 120 ° C for 24 hours. Thereafter, phosphorus oxychloride is distilled off under reduced pressure, the residue is added to ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated brine in that order. After drying over anhydrous magnesium sulfate, the solvent was distilled off to obtain the title compound. Yield: 380 mg, yield: 97% MS (ESI. M / z) 338 (MH +) H-NMR (CDCl3): 2.66 (3H, s), 3.88 (3H, s), 7.02-7.
05 (2H, m), 7.27-7.30 (2H, m)
【0152】3)5−ブロモ−3−シアノ−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−ピリジンの合成 アルゴン雰囲気下、セサモール187mg(1.36m
mol)をDMF10mlに溶かし、60%水素化ナト
リウム54mg(1.36mmol)を0℃にて加え、
1時間攪拌した。この後、5−ブロモ−2−クロロ−3
−シアノ−4−(4−メトキシフェニル)−6−メチル
−ピリジン380mg(1.13mmol)を加え、8
0℃にて12時間攪拌した。反応溶液を水にあけ、酢酸
エチルで有機層を抽出し、無水硫酸マグネシウムで乾燥
後溶媒を減圧留去し、得られた残渣をカラムクロマトグ
ラフィー(溶離液 ヘキサン:酢酸エチル 3:1)に
付し、表題化合物を得た。 収量:200mg、収率:40% MS(ESI. m/z) 439(MH+) H-NMR (CDCl3):2.60 (3H, s)、3.88 (3H, s)、6.02 (2
H, s)、6.62-6.73 (3H, m)、6.81 (1H, d)、7.04 (2H,
d)、7.33 (2H, d)3) 5-Bromo-3-cyano-4- (4-
Synthesis of methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine Under an argon atmosphere, 187 mg of sesamol (1.36 m
mol) was dissolved in 10 ml of DMF, and 54 mg (1.36 mmol) of 60% sodium hydride was added at 0 ° C.
Stir for 1 hour. This is followed by 5-bromo-2-chloro-3
-Cyano-4- (4-methoxyphenyl) -6-methyl-pyridine (380 mg, 1.13 mmol) was added, and 8
The mixture was stirred at 0 ° C for 12 hours. The reaction solution was poured into water, the organic layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography (eluent hexane: ethyl acetate 3: 1). To give the title compound. Yield: 200 mg, yield: 40% MS (ESI. M / z) 439 (MH +) H-NMR (CDCl3): 2.60 (3H, s), 3.88 (3H, s), 6.02 (2
H, s), 6.62 to 6.73 (3H, m), 6.81 (1H, d), 7.04 (2H,
d), 7.33 (2H, d)
【0153】4)5−ブロモ−4−(4−メトキシフェ
ニル)−6−メチル−2−(3、4−メチレンジオキシ
フェノキシ)−ピリジン−3−アルデヒドの合成 アルゴン雰囲気下、塩化メチレン10ml中、5−ブロ
モ−3−シアノ−4−(4−メトキシフェニル)−6−
メチル−2−(3、4−メチレンジオキシフェノキシ)
−ピリジン200mg(0.455mmol)を溶か
し、水素化ジイソブチルアルミニウム1Mヘキサン溶液
2.78mlを0℃にて加え、室温にて1晩攪拌した。
この後水1mlを加え1時間攪拌した後、セライト濾過
し残渣を酢酸エチルにて洗浄した。濾液を減圧下にて溶
媒留去し、表題化合物 の粗生成物を得た。精製困難に
つき未精製のまま次の反応を行った。 収量:80mg、収率:40%4) Synthesis of 5-bromo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-aldehyde In 10 ml of methylene chloride under an argon atmosphere , 5-bromo-3-cyano-4- (4-methoxyphenyl) -6
Methyl-2- (3,4-methylenedioxyphenoxy)
-200 mg (0.455 mmol) of pyridine was dissolved, 2.78 ml of a 1 M solution of diisobutylaluminum hydride in hexane was added at 0 ° C, and the mixture was stirred at room temperature overnight.
Thereafter, 1 ml of water was added and the mixture was stirred for 1 hour, filtered through celite, and the residue was washed with ethyl acetate. The filtrate was evaporated under reduced pressure to give a crude product of the title compound. Due to difficulty in purification, the following reaction was performed without purification. Yield: 80 mg, yield: 40%
【0154】5)5−ブロモ−4−(4−メトキシフェ
ニル)−6−メチル−2−(3、4−メチレンジオキシ
フェノキシ)−ピリジン−3−カルボン酸の合成 5−ブロモ−4−(4−メトキシフェニル)−6−メチ
ル−2−(3、4−メチレンジオキシフェノキシ)−ピ
リジン−3−アルデヒド80mg(0.181mmo
l)を水5ml,塩化メチレン10mlに溶かし、氷冷
下、2−メチル−ブテン76mg(1.09mmo
l),アミド硫酸26mg(0.272mmol),亜
塩素酸ナトリウム57mg(0.634mmol)を加
え、室温にて2時間攪拌した。反応溶液に水を加え、塩
化メチレンにて抽出し、無水硫酸マグネシウムで乾燥
後、減圧下にて溶媒留去した。得られた残渣をカラムク
ロマトグラフィー(溶離液 クロロホルム:メタノール
9:1)にて精製し、表題化合物を得た。 収量:14mg、収率:17% MS(ESI.m/z) 458(MH+) H-NMR (CDCl3):2.53 (3H, s)、3.78 (3H, s)、5.97 (2
H, s)、6.55-6.75 (3H, m)、6.88 (2H, d)、7.17 (2H,
d)5) Synthesis of 5-bromo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 5-bromo-4- ( 4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-aldehyde 80 mg (0.181 mmol
l) was dissolved in 5 ml of water and 10 ml of methylene chloride, and 76 mg (1.09 mmol) of 2-methyl-butene was added under ice-cooling.
l), 26 mg (0.272 mmol) of amidosulfuric acid and 57 mg (0.634 mmol) of sodium chlorite were added, and the mixture was stirred at room temperature for 2 hours. Water was added to the reaction solution, extracted with methylene chloride, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 14 mg, Yield: 17% MS (ESI.m / z) 458 (MH +) H-NMR (CDCl3): 2.53 (3H, s), 3.78 (3H, s), 5.97 (2
H, s), 6.55-6.75 (3H, m), 6.88 (2H, d), 7.17 (2H,
d)
【0155】実施例25 6−メチル−4−(3−(2
−ベンジルオキシエトキシ)−5−メトキシフェニル)
−2−(3、4−メチレンジオキシフェニルオキシ)ピ
リジン−3−カルボン酸の合成 1)3−ヒドロキシ−5−メトキシ安息香酸メチルの合
成 3,5−ジヒドロキシ安息香酸メチル5.5g(32.
7mmol)、ヨウ化メチル2.2ml(35.3mm
ol)、炭酸カリウム4.5g(32.6mmol)の
DMF30ml溶液を室温で一晩攪拌する。DMFを減
圧下留去し残渣を酢酸エチルに溶解し不溶物を濾過す
る。溶媒を減圧下留去し残渣をシリカゲルカラムクロマ
トグラフィー(酢酸エチル:ヘキサン 1:3)に付し
表題化合物2.23g(37.4%)を得た。このとき
3,5−ジメトキシ安息香酸メチル1.88gも得られ
る。 収量:2.23g、収率:37.4% H-NMR(CDCl3):3.82 (3H, s)、3.91 (3H, s)、4.90-5.3
0 (1H, br)、6.62 (1H, m)、7.15 (1H, m)、7.18 (1H,
m)Example 25 6-methyl-4- (3- (2
-Benzyloxyethoxy) -5-methoxyphenyl)
Synthesis of 2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) Synthesis of methyl 3-hydroxy-5-methoxybenzoate 5.5 g of methyl 3,5-dihydroxybenzoate (32.
7 mmol), 2.2 ml of methyl iodide (35.3 mm
ol) and 4.5 g (32.6 mmol) of potassium carbonate in 30 ml of DMF are stirred at room temperature overnight. DMF is distilled off under reduced pressure, the residue is dissolved in ethyl acetate, and the insoluble matter is filtered. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to obtain 2.23 g (37.4%) of the title compound. At this time, 1.88 g of methyl 3,5-dimethoxybenzoate is also obtained. Yield: 2.23 g, Yield: 37.4% H-NMR (CDCl3): 3.82 (3H, s), 3.91 (3H, s), 4.90-5.3
0 (1H, br), 6.62 (1H, m), 7.15 (1H, m), 7.18 (1H,
m)
【0156】2)3−(2−ベンジルオキシ)−5−メ
トキシベンジルアルコールの合成 3−ヒドロキシ−5−メトキシ安息香酸メチル1.0g
(5.5mmol)をDMF10mlに溶解し、水素化
ナトリウム250mg(60%オイルディスパージョ
ン、6.3mmol)、2−ベンジルオキシエチル メ
タンスルホネート1.9g(8.3mmol)を加え一
晩攪拌する。DMFを減圧下留去し残渣を酢酸エチルに
溶解し、1規定水酸化ナトリウム、水、飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧下溶媒を留去
し、3−(2−ベンジルオキシ)−5−メトキシ安息香
酸メチル2.23gを得た。このものは精製せずに以下
の反応に利用する。3−(2−ベンジルオキシ)−5−
メトキシ安息香酸メチル2.23gをTHF20mlに
溶解し、0℃で水素化リチウムアルミニウム300mg
(7.9mmol)を加え室温に戻して一晩攪拌する。
0℃で飽和アンモニア水を加え反応を停止し、セライト
を用いて濾過する。減圧下溶媒を留去し、残渣をシリカ
ゲルカラムクロマトグラフィー(酢酸エチル:ヘキサン
1:1)に付し表題化合物を得た。 収量:1.41g、収率:88.9% MS(ESI,m/z) 311 (M+Na) H-NMR(CDCl3):3.78 (3H, s)、3.82(2H, dd)、4.15 (2
H, dd)、4.60 (2H, m)、4.63 (2H, s)、6.42 (1H, t)、
6.53 (2H, m)、7.25−7.40 (5H, m)2) Synthesis of 3- (2-benzyloxy) -5-methoxybenzyl alcohol 1.0 g of methyl 3-hydroxy-5-methoxybenzoate
(5.5 mmol) is dissolved in 10 ml of DMF, 250 mg of sodium hydride (60% oil dispersion, 6.3 mmol) and 1.9 g (8.3 mmol) of 2-benzyloxyethyl methanesulfonate are added, and the mixture is stirred overnight. DMF was distilled off under reduced pressure, the residue was dissolved in ethyl acetate, washed with 1N sodium hydroxide, water and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to give 3- (2-benzyl) 2.23 g of methyl oxy) -5-methoxybenzoate were obtained. This is used for the following reaction without purification. 3- (2-benzyloxy) -5
2.23 g of methyl methoxybenzoate was dissolved in 20 ml of THF, and 300 mg of lithium aluminum hydride was added at 0 ° C.
(7.9 mmol) was added and the mixture was returned to room temperature and stirred overnight.
The reaction was stopped by adding saturated aqueous ammonia at 0 ° C., and the mixture was filtered using Celite. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1) to obtain the title compound. Yield: 1.41 g, Yield: 88.9% MS (ESI, m / z) 311 (M + Na) H-NMR (CDCl3): 3.78 (3H, s), 3.82 (2H, dd), 4.15 ( Two
H, dd), 4.60 (2H, m), 4.63 (2H, s), 6.42 (1H, t),
6.53 (2H, m), 7.25-7.40 (5H, m)
【0157】3)3−(2−ベンジルオキシ)−5−メ
トキシベンズアルデヒドの合成 3−(2−ベンジルオキシ)−5−メトキシベンジルア
ルコール1.41g(4.9mmol)をクロロホルム
10mlに溶解し、活性化二酸化マンガン2.0gを加
え2日間攪拌する。活性化二酸化マンガン2.0gをさ
らに加えて一晩攪拌しセライトを用いて濾過する。減圧
下溶媒を留去し、残渣をシリカゲルカラムクロマトグラ
フィー(酢酸エチル:ヘキサン 1:2)に付し表題化
合物を得た。 収量:1.04g、収率:74.1% MS(ESI,m/z) 309 (M+Na) H-NMR(CDCl3):3.84 (3H, s)、3.85 (2H, m)、4.20 (2
H, m)、4.64 (2H, s)、6.75 (1H, t)、7.02 (2H, m)、
7.25-7.40 (5H, m)、9.90(1H, s)3) Synthesis of 3- (2-benzyloxy) -5-methoxybenzaldehyde 1.41 g (4.9 mmol) of 3- (2-benzyloxy) -5-methoxybenzyl alcohol was dissolved in 10 ml of chloroform. 2.0 g of manganese dioxide are added and stirred for 2 days. Further add 2.0 g of activated manganese dioxide, stir overnight, and filter using celite. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 2) to obtain the title compound. Yield: 1.04 g, Yield: 74.1% MS (ESI, m / z) 309 (M + Na) H-NMR (CDCl3): 3.84 (3H, s), 3.85 (2H, m), 4.20 ( Two
H, m), 4.64 (2H, s), 6.75 (1H, t), 7.02 (2H, m),
7.25-7.40 (5H, m), 9.90 (1H, s)
【0158】4)1−(3−(2−ベンジルオキシエト
キシ)−5−メトキシフェニル)−1−ブテン−3−オ
ンの合成 3−(2−ベンジルオキシ)−5−メトキシベンズアル
デヒド1.04g(3.6mmol)、アセトニルトリ
フェニルホスホニウム クロリド1.55g(4.4m
mol)、ナトリウムエトキシド0.3g(4.4mm
ol)をエタノール20mlに溶解し5時間加熱環流す
る。エタノールを減圧下留挙し、酢酸エチルで抽出す
る。水、1規定塩酸、飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧下溶媒を留去する。残渣をシリ
カゲルカラムクロマトグラフィー(酢酸エチル:ヘキサ
ン 1:1)に付し表題化合物を得た。 収量:1.0g、収率:定量的 MS(ESI,m/z) 349 (M+Na) H-NMR(CDCl3):2.37 (3H, s)、3.80 (3H, s)、3.83 (2
H, dd)、4.16 (2H, dd)、4.64 (2H, s)、6.55 (1H,
t)、6.65 (1H, d)、6.67-6.72 (2H, m)、7.26-7.36(5H,
m)、7.40 (1H, d)4) Synthesis of 1- (3- (2-benzyloxyethoxy) -5-methoxyphenyl) -1-buten-3-one 1.04 g of 3- (2-benzyloxy) -5-methoxybenzaldehyde ( 3.6 mmol), 1.55 g of acetonyltriphenylphosphonium chloride (4.4 m
mol), 0.3 g of sodium ethoxide (4.4 mm
ol) in 20 ml of ethanol and reflux under heating for 5 hours. The ethanol is distilled off under reduced pressure and extracted with ethyl acetate. After washing with water, 1N hydrochloric acid and saturated saline, drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1) to obtain the title compound. Yield: 1.0 g, Yield: quantitative MS (ESI, m / z) 349 (M + Na) H-NMR (CDCl3): 2.37 (3H, s), 3.80 (3H, s), 3.83 (2
H, dd), 4.16 (2H, dd), 4.64 (2H, s), 6.55 (1H,
t), 6.65 (1H, d), 6.67-6.72 (2H, m), 7.26-7.36 (5H,
m), 7.40 (1H, d)
【0159】5)6−メチル−3−シアノ−4−(3−
(2−ベンジルオキシエトキシ)−5−メトキシフェニ
ル)−2−ピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド580m
g(6.9mmol)、t−ブトキシカリウム780m
g(6.2mmol)のDMSO5ml溶液に4−(3
−(2−ベンジルオキシエトキシ)−5−メトキシフェ
ニル)−1−ブテン−3−オン1.0g(3.6mmo
l)のDMSO10mlを加え15分間攪拌する。t−
ブトキシカリウム2.32g(20.7mmol)を加
え1分間酸素をバブリングする。酸素雰囲気下1時間攪
拌した後、1規定塩酸を氷冷下加え析出した粘凋な物質
をデカンテーションでとる。酢酸エチルに溶解し無水硫
酸マグネシウムで乾燥後減圧下溶媒を留去する。得られ
る物質を酢酸エチル:ヘキサン 1:1で洗浄し表題化
合物を得た。この化合物はこれ以上精製せずに以下の反
応に用いる。 収量:940mg、収率:66.9% MS(ESI,m/z) 413 (M+Na) H-NMR(CDCl3):2.49 (3H, s)、3.83 (3H, s)、3.84 (2
H, m)、4.20 (2H, m)、4.62 (2H, s)、6.24 (1H, s)、
6.62 (1H, m)、6.72 (2H, m)、7.25-7.40 (5H, m)5) 6-methyl-3-cyano-4- (3-
Synthesis of (2-benzyloxyethoxy) -5-methoxyphenyl) -2-pyridone Cyanoacetamide 580m at room temperature under argon atmosphere
g (6.9 mmol), potassium tert-butoxide 780 m
g (6.2 mmol) in DMSO (5 ml) was added to 4- (3
-(2-benzyloxyethoxy) -5-methoxyphenyl) -1-buten-3-one 1.0 g (3.6 mmol)
l) 10 ml of DMSO is added and stirred for 15 minutes. t-
2.32 g (20.7 mmol) of potassium butoxide is added and oxygen is bubbled for 1 minute. After stirring for 1 hour in an oxygen atmosphere, 1N hydrochloric acid is added under ice cooling, and the precipitated viscous substance is removed by decantation. After dissolving in ethyl acetate and drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained substance was washed with ethyl acetate: hexane 1: 1 to obtain the title compound. This compound is used for the following reaction without further purification. Yield: 940 mg, Yield: 66.9% MS (ESI, m / z) 413 (M + Na) H-NMR (CDCl3): 2.49 (3H, s), 3.83 (3H, s), 3.84 (2
H, m), 4.20 (2H, m), 4.62 (2H, s), 6.24 (1H, s),
6.62 (1H, m), 6.72 (2H, m), 7.25-7.40 (5H, m)
【0160】6)6−メチル−3−シアノ−4−(3−
(2−ベンジルオキシエトキシ)−5−メトキシフェニ
ル)−2−クロロピリジンの合成 6−メチル−3−シアノ−4−(3−(2−ベンジルオ
キシエトキシ)−5−メトキシフェニル)−2−ピリド
ン940mg(2.4mmol)をオキシ塩化リン10
mlに溶解し90℃で一晩攪拌する。オキシ塩化リンを
減圧下留去し残渣をクロロホルムに溶解する。飽和重曹
水、飽和食塩水で洗浄し無水硫酸マグネシウムで乾燥す
る。減圧下溶媒を留去し表題化合物を得た。このものは
精製せずに以下の反応に利用した。 収量:1.0g MS(ESI,m/z) 431 (M+Na) H-NMR(CDCl3):2.62 (3H, s)、3.82 (3H, s)、3.85 (2
H, m)、4.20 (2H, m)、4.64 (2H, s)、6.62 (1H, m)、
6.70 (2H, m)、7.22 (1H, s)、7.25-7.40 (5H, m)6) 6-methyl-3-cyano-4- (3-
Synthesis of (2-benzyloxyethoxy) -5-methoxyphenyl) -2-chloropyridine 6-methyl-3-cyano-4- (3- (2-benzyloxyethoxy) -5-methoxyphenyl) -2-pyridone 940 mg (2.4 mmol) of phosphorus oxychloride 10
Dissolve in the solution and stir at 90 ° C overnight. The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in chloroform. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound. This was used for the following reaction without purification. Yield: 1.0 g MS (ESI, m / z) 431 (M + Na) H-NMR (CDCl3): 2.62 (3H, s), 3.82 (3H, s), 3.85 (2
H, m), 4.20 (2H, m), 4.64 (2H, s), 6.62 (1H, m),
6.70 (2H, m), 7.22 (1H, s), 7.25-7.40 (5H, m)
【0161】7)6−メチル−3−シアノ−4−(3−
(2−ベンジルオキシエトキシ)−5−メトキシフェニ
ル)−2−(3、4−メチレンジオキシフェニルオキ
シ)ピリジンの合成 セサモール330mg(2.4mmol)、水素化ナト
リウム190mg(60%オイルディスパージョン、
4.7mmol)より作成したフェノキシドイオンのD
MF5ml溶液に6−メチル−3−シアノ−4−(3−
(2−ベンジルオキシエトキシ)−5−メトキシフェニ
ル)−2−クロロピリジン1.0gをDMF15mlに
溶解して加えアルゴン雰囲気下室温で30分間攪拌す
る。減圧下溶媒を留去し、残渣をクロロホルムに溶解
し、飽和食塩水で洗浄する。無水硫酸マグネシウムで乾
燥し減圧下溶媒を留去する。得られた残渣をシリカゲル
カラムクロマトグラフィー(酢酸エチル:ヘキサン
1:2)に付し表題化合物を得た。このもの分離困難な
不純物を含むがこれ以上精製せずに以下の反応に用い
る。 収量:530mg MS(ESI,m/z) 533 (M+Na)7) 6-methyl-3-cyano-4- (3-
Synthesis of (2-benzyloxyethoxy) -5-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 330 mg (2.4 mmol) of sesamol, 190 mg of sodium hydride (60% oil dispersion,
D) of phenoxide ion prepared from 4.7 mmol)
6-Methyl-3-cyano-4- (3-
1.0 g of (2-benzyloxyethoxy) -5-methoxyphenyl) -2-chloropyridine is dissolved in 15 ml of DMF, and the mixture is stirred at room temperature for 30 minutes under an argon atmosphere. The solvent is distilled off under reduced pressure, the residue is dissolved in chloroform, and washed with saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (ethyl acetate: hexane)
1: 2) to give the title compound. This contains impurities which are difficult to separate, but is used for the following reaction without further purification. Yield: 530 mg MS (ESI, m / z) 533 (M + Na)
【0162】8)6−メチル−4−(3−(2−ベンジ
ルオキシエトキシ)−5−メトキシフェニル)−2−
(3、4−メチレンジオキシフェニルオキシ)ピリジン
−3−アルデヒドの合成 6−メチル−3−シアノ−4−(3−(2−ベンジルオ
キシエトキシ)−5−メトキシフェニル)−2−(3、
4−メチレンジオキシフェニルオキシ)ピリジン530
mg(1.0mmol)をベンゼン10mlに溶解しア
ルゴン雰囲気下室温で水素化ジイソブチルアルミニウム
1Mヘキサン溶液4.0ml(4.0mmol)を滴下
する。室温で2時間攪拌しメタノールと水で反応を停止
する。室温で30分攪拌し、不溶物をセライトを用いて
濾過する。濾液をを減圧下留去し得られた残渣をシリカ
ゲルカラムクロマトグラフィー(酢酸エチル:ヘキサン
1:1)に付し表題化合物を得た。このものは分離困難
な不純物を含むがこれ以上精製せずに以下の反応に用い
る。 収量:280mg MS(ESI,m/z) 536 (M+Na) H-NMR(CDCl3)、2.41 (3H, s)、3.80 (3H, s)、3.83 (2
H, m)、4.18 (2H, m)、4.64 (2H, s)、6.02 (2H, s)、
6.48 (2H, m)、6.57 (1H, m)、6.63 (1H, dd)、6.72 (1
H, d)、6.80 (1H, d)、6.85 (1H, s)、7.20-7.40 (5H,
m)、10.19 (1H, s)8) 6-methyl-4- (3- (2-benzyloxyethoxy) -5-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 6-methyl-3-cyano-4- (3- (2-benzyloxyethoxy) -5-methoxyphenyl) -2- (3,
4-Methylenedioxyphenyloxy) pyridine 530
mg (1.0 mmol) is dissolved in 10 ml of benzene, and 4.0 ml (4.0 mmol) of a 1 M solution of diisobutylaluminum hydride in hexane is added dropwise at room temperature under an argon atmosphere. Stir at room temperature for 2 hours and terminate the reaction with methanol and water. The mixture is stirred at room temperature for 30 minutes, and the insoluble matter is filtered using Celite. The filtrate was evaporated under reduced pressure, and the resulting residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1) to give the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 280 mg MS (ESI, m / z) 536 (M + Na) H-NMR (CDCl3), 2.41 (3H, s), 3.80 (3H, s), 3.83 (2
H, m), 4.18 (2H, m), 4.64 (2H, s), 6.02 (2H, s),
6.48 (2H, m), 6.57 (1H, m), 6.63 (1H, dd), 6.72 (1
H, d), 6.80 (1H, d), 6.85 (1H, s), 7.20-7.40 (5H,
m), 10.19 (1H, s)
【0163】9)6−メチル−4−(3−(2−ベンジ
ルオキシエトキシ)−5−メトキシフェニル)−2−
(3、4−メチレンジオキシフェニルオキシ)ピリジン
−3−カルボン酸の合成 6−メチル−4−(3−(2−ベンジルオキシエトキ
シ)−5−メトキシフェニル)−2−(3、4−メチレ
ンジオキシフェニルオキシ)ピリジン−3−アルデヒド
280mgを塩化メチレン4ml、水2mlに溶解し、
0℃で2−メチル−2−ブテン0.40ml(3.8m
mol)、アミド硫酸80mg(0.82mmol)、
亜塩素酸ナトリウム220mg(1.9mmol)を加
え室温に戻して1時間攪拌する。塩化メチレンで抽出し
無水硫酸マグネシウムで乾燥して減圧下溶媒を留去す
る。得られた残渣をシリカゲル薄層クロマトグラフィー
(酢酸エチル:ヘキサン 1:1 2回展開)に付し表
題化合物を得た。 収量:140mg、収率:6−メチル−3−シアノ−4
−(3−(2−ベンジルオキシエトキシ)−5−メトキ
シフェニル)−2−ピリドンより11.0% MS(ESI,m/z) 530 (MH+) H-NMR(CDCl3):2.38 (3H, s)、3.74 (5H, m)、4.08 (2
H, m)、4.57 (2H, s)、5.95 (2H, s)、6.47 (1H, m)、
6.54-6.76 (4H, m)、6.85 (1H, s)、6.90-6.94 (1H,
m)、7.25-7.40 (5H, m)9) 6-methyl-4- (3- (2-benzyloxyethoxy) -5-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6-methyl-4- (3- (2-benzyloxyethoxy) -5-methoxyphenyl) -2- (3,4-methylene 280 mg of dioxyphenyloxy) pyridine-3-aldehyde was dissolved in 4 ml of methylene chloride and 2 ml of water,
At 0 ° C, 0.40 ml of 2-methyl-2-butene (3.8 m
mol), 80 mg (0.82 mmol) of amidosulfuric acid,
After adding 220 mg (1.9 mmol) of sodium chlorite, the mixture is returned to room temperature and stirred for 1 hour. Extract with methylene chloride, dry over anhydrous magnesium sulfate and evaporate the solvent under reduced pressure. The obtained residue was subjected to silica gel thin layer chromatography (developed twice with ethyl acetate: hexane 1: 1) to give the title compound. Yield: 140 mg, Yield: 6-methyl-3-cyano-4
11.0% from-(3- (2-benzyloxyethoxy) -5-methoxyphenyl) -2-pyridone MS (ESI, m / z) 530 (MH +) H-NMR (CDCl3): 2.38 (3H, s) ), 3.74 (5H, m), 4.08 (2
H, m), 4.57 (2H, s), 5.95 (2H, s), 6.47 (1H, m),
6.54-6.76 (4H, m), 6.85 (1H, s), 6.90-6.94 (1H,
m), 7.25-7.40 (5H, m)
【0164】実施例26 6−メチル−4−(3−(2
−ヒドロキシエトキシ)−5−メトキシフェニル)−2
−(3、4−メチレンジオキシフェニルオキシ)ピリジ
ン−3−カルボン酸の合成 6−メチル−4−(3−(2−ベンジルオキシエトキ
シ)−5−メトキシフェニル)−2−(3、4−メチレ
ンジオキシフェニルオキシ)ピリジン−3−カルボン酸
120mg(0.23mmol)をエタノール5mlに
溶解し10%パラジウム炭素50mgを加え水素雰囲気
下、室温、1気圧で一晩攪拌する。セライトを用いて触
媒をのぞき、減圧下溶媒を留去する。残渣をシリカゲル
薄層クロマトグラフィー(クロロホルム:メタノール
10:1 4回展開)に付し表題化合物()を得た。 収量:30mg、収率:29.7% MS(ESI,m/z) 440 (MH+) H-NMR(CDCl3):2.40 (3H, s)、3.77 (3H, s)、3.90 (2
H, m)、4.05 (2H, m)、5.97 (2H, s)、6.49 (1H, m)、
6.57-6.77 (5H, m)、6.87 (1H, s)Example 26 6-methyl-4- (3- (2
-Hydroxyethoxy) -5-methoxyphenyl) -2
Synthesis of-(3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6-methyl-4- (3- (2-benzyloxyethoxy) -5-methoxyphenyl) -2- (3,4- 120 mg (0.23 mmol) of methylenedioxyphenyloxy) pyridine-3-carboxylic acid is dissolved in 5 ml of ethanol, 50 mg of 10% palladium on carbon is added, and the mixture is stirred under a hydrogen atmosphere at room temperature and 1 atm overnight. The catalyst is removed using celite, and the solvent is distilled off under reduced pressure. The residue is purified by silica gel thin layer chromatography (chloroform: methanol).
10: 1 four times) to give the title compound (). Yield: 30 mg, Yield: 29.7% MS (ESI, m / z) 440 (MH +) H-NMR (CDCl3): 2.40 (3H, s), 3.77 (3H, s), 3.90 (2
H, m), 4.05 (2H, m), 5.97 (2H, s), 6.49 (1H, m),
6.57-6.77 (5H, m), 6.87 (1H, s)
【0165】実施例27 4−[3−(2−ヒドロキシ
エトキシ)−4−メトキシ−フェニル]−6−メチル−
2−(3、4−メチレンジオキシフェノキシ)−ピリジ
ン−3−カルボン酸の合成 1)3−ベンジルオキシエトキシ−4ーメトキシ−ベン
ズアルデヒドの合成 アルゴン雰囲気下、イソバニリン2g(13.1mmo
l)をDMF20mlに溶かし、60%水素化ナトリウ
ム632mg(15.8mmol)を加え室温にて1時
間攪拌した。その後メタンスルホン酸ベンジルオキシエ
チルエステル3.64g(15.8mmol)を室温に
て加え、100℃にて4時間攪拌した。反応溶液に水を
加え酢酸エチルにて抽出し、無水硫酸マグネシウムで乾
燥後溶媒を減圧留去し、得られた残渣をカラムクロマト
グラフィー(溶離液 ヘキサン:酢酸エチル 3:1)
に付し、表題化合物を得た。 収量:3.45g、収率:92% MS(ESI.m/z) 287(MH+) H-NMR (CDCl3):3.87 (2H, t)、3.93 (3H, s)、4.26 (2
H, t)、4.64 (2H, s)、6.96 (1H, s)、7.24-7.47 (7H,
m)、9.82 (1H, s)Example 27 4- [3- (2-hydroxyethoxy) -4-methoxy-phenyl] -6-methyl-
Synthesis of 2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 1) Synthesis of 3-benzyloxyethoxy-4-methoxy-benzaldehyde 2 g (13.1 mmol) of isovanillin under an argon atmosphere
1) was dissolved in 20 ml of DMF, 632 mg (15.8 mmol) of 60% sodium hydride was added, and the mixture was stirred at room temperature for 1 hour. Thereafter, 3.64 g (15.8 mmol) of benzylsulfonic acid benzyloxyethyl ester was added at room temperature, and the mixture was stirred at 100 ° C. for 4 hours. Water was added to the reaction solution, the mixture was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
To give the title compound. Yield: 3.45 g, yield: 92% MS (ESI.m / z) 287 (MH +) H-NMR (CDCl3): 3.87 (2H, t), 3.93 (3H, s), 4.26 (2
H, t), 4.64 (2H, s), 6.96 (1H, s), 7.24-7.47 (7H,
m), 9.82 (1H, s)
【0166】2)1−(3−ベンジルオキシエトキシ−
4−メトキシ−フェニル)−1−ブテニル−3−オンの
合成 アセトニルトリフェニルホスホニウム クロリド3.7
3g(10.5mmol) をエタノール(20ml)
に溶かしナトリウムエトキシド715mg(10.5m
mol)を0℃にて加えた。室温に戻し、1時間攪拌し
た後、3−ベンジルオキシエトキシ−4ーメトキシ−ベ
ンズアルデヒド2.00g(6.99mmol)を加え
1晩攪拌した。反応溶液を減圧下溶媒留去し、残渣に水
を加え、酢酸エチルにて抽出した。有機相を飽和食塩水
にて洗浄し、無水硫酸マグネシウムで乾燥、減圧下溶
媒留去して粗製生成物を得た。これをシリカゲル上でヘ
キサン/酢酸エチル(3:1)を用いて精製し表題化合
物を得た。 収量:1.72g、収率:75% MS(ESI.m/z) 327(MH+) H-NMR (CDCl3):2.34(3H,s)、3.86-3.90(5H,m)、4.24(2
H,t)、4.64(2H,s)、6.56(1H,d)、6.88(1H d)、7.12-7.4
6(8H,m)2) 1- (3-benzyloxyethoxy-)
Synthesis of 4-methoxy-phenyl) -1-butenyl-3-one acetonyltriphenylphosphonium chloride 3.7
3 g (10.5 mmol) of ethanol (20 ml)
Sodium ethoxide 715mg (10.5m
mol) was added at 0 ° C. After returning to room temperature and stirring for 1 hour, 2.00 g (6.99 mmol) of 3-benzyloxyethoxy-4-methoxy-benzaldehyde was added, and the mixture was stirred overnight. The solvent was distilled off from the reaction solution under reduced pressure, water was added to the residue, and the mixture was extracted with ethyl acetate. The organic phase was washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain a crude product. This was purified on silica gel using hexane / ethyl acetate (3: 1) to give the title compound. Yield: 1.72 g, Yield: 75% MS (ESI.m / z) 327 (MH +) H-NMR (CDCl3): 2.34 (3H, s), 3.86-3.90 (5H, m), 4.24 (2
H, t), 4.64 (2H, s), 6.56 (1H, d), 6.88 (1H d), 7.12-7.4
6 (8H, m)
【0167】3)4−(3−ベンジルオキシエトキシ−
4−メトキシ−フェニル)−3−シアノ−6−メチル−
2−ピリドンの合成 α−シアノアセトアミド486mg(5.78mmo
l)をDMSO20mlに溶かし、アルゴン雰囲気下、
t−ブトキシカリウム590mg(5.26mmo
l)、1−(3−ベンジルオキシエトキシ−4−メトキ
シ−フェニル)−1−ブテニル−3−オン1.72g
(5.26mmol)を室温にて順次加えて、15分間
攪拌した。TLCにて原料の消失を確認した後、t−ブ
トキシカリウム1.77g(15.8mmol)を加
え、酸素を1分間バブリングし、酸素雰囲気下1時間攪
拌した。反応溶液に3規定 塩酸を20ml加えて1時
間攪拌すると、黄褐色の結晶物質が析出した。この結晶
を吸引濾過し、水、ヘキサン/酢酸エチル(1:1)混
合液で順次洗浄し、100℃において1晩乾燥させて表
題化合物を得た。 収量:1.62g、収率:79% MS(ESI.m/z) 391 (MH+) H-NMR (CDCl3):2.47(3H,s)、3.88-3.92(5H,m)、4.27-
4.29(2H,m)、4.64(2H s)、6.23(1H,s)、6.95-6.98(1H,
m)、7.22−7.35(8H,m)3) 4- (3-benzyloxyethoxy-)
4-methoxy-phenyl) -3-cyano-6-methyl-
Synthesis of 2-pyridone α-cyanoacetamide 486 mg (5.78 mmol)
l) in 20 ml of DMSO, and
590 mg of potassium t-butoxide (5.26 mmol
l), 1.72 g of 1- (3-benzyloxyethoxy-4-methoxy-phenyl) -1-butenyl-3-one
(5.26 mmol) was sequentially added at room temperature, and the mixture was stirred for 15 minutes. After confirming the disappearance of the raw materials by TLC, 1.77 g (15.8 mmol) of potassium t-butoxide was added, oxygen was bubbled for 1 minute, and the mixture was stirred under an oxygen atmosphere for 1 hour. When 20 ml of 3N hydrochloric acid was added to the reaction solution and stirred for 1 hour, a yellow-brown crystalline substance was deposited. The crystals were filtered off with suction, washed successively with a mixture of water and hexane / ethyl acetate (1: 1) and dried at 100 ° C. overnight to give the title compound. Yield: 1.62 g, yield: 79% MS (ESI.m / z) 391 (MH +) H-NMR (CDCl3): 2.47 (3H, s), 3.88-3.92 (5H, m), 4.27-
4.29 (2H, m), 4.64 (2H s), 6.23 (1H, s), 6.95-6.98 (1H,
m), 7.22-7.35 (8H, m)
【0168】4)4−(3−ベンジルオキシエトキシ−
4−メトキシ−フェニル)−2−クロロ−3−シアノ−
6−メチル−ピリジンの合成 4−(3−ベンジルオキシエトキシ−4−メトキシ−フ
ェニル)−3−シアノ−6−メチル−2−ピリドン1.
62g(4.15mmol)にオキシ塩化リン10ml
を加え、100℃にて4時間攪拌した。この後、減圧下
にてオキシ塩化リンを留去し、残渣を酢酸エチル中に加
え、水、飽和重曹水、飽和食塩水で順次洗浄する。無水
硫酸マグネシウムで乾燥後、溶媒を留去して、表題化合
物を得た。 収量:1.66g、収率:98% MS(FAB.m/z) 409(MH+) H-NMR (CDCl3):2.61 (3H, s)、3.88-3.93 (5H, m)、4.
28-4.32 (2H, t)、4.64 (2H, s)、7.00 (1H, d)、7.17-
7.35 (8H, m)4) 4- (3-benzyloxyethoxy-)
4-methoxy-phenyl) -2-chloro-3-cyano-
Synthesis of 6-methyl-pyridine 4- (3-benzyloxyethoxy-4-methoxy-phenyl) -3-cyano-6-methyl-2-pyridone
10 ml of phosphorus oxychloride in 62 g (4.15 mmol)
Was added and stirred at 100 ° C. for 4 hours. Thereafter, phosphorus oxychloride is distilled off under reduced pressure, the residue is added to ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated brine in that order. After drying over anhydrous magnesium sulfate, the solvent was distilled off to obtain the title compound. Yield: 1.66 g, 98% MS (FAB. M / z) 409 (MH +) H-NMR (CDCl3): 2.61 (3H, s), 3.88-3.93 (5H, m), 4.
28-4.32 (2H, t), 4.64 (2H, s), 7.00 (1H, d), 7.17-
7.35 (8H, m)
【0169】5)4−(3−ベンジルオキシエトキシ−
4−メトキシ−フェニル)−3−シアノ−6−メチル−
2−(3、4−メチレンジオキシフェノキシ)−ピリジ
ンの合成 アルゴン雰囲気下、セサモール459mg(3.32m
mol)をDMF10mlに溶かし、60%水素化ナト
リウム133mg(3.32mmol)を0℃にて加
え、1時間攪拌した。この後、4−(3−ベンジルオキ
シエトキシ−4−メトキシ−フェニル)−2−クロロ−
3−シアノ−6−メチル−ピリジン1.13g(2.7
6mmol)を加え、80℃にて24時間攪拌した。反
応溶液を水にあけ、酢酸エチルで有機層を抽出し、無水
硫酸マグネシウムで乾燥後溶媒を減圧留去し、得られた
残渣をカラムクロマトグラフィー(溶離液 ヘキサン:
酢酸エチル 3:1)に付し、表題化合物を得た。 収量:200mg、収率:14% MS(ESI.m/z) 511(MH+) H-NMR (CDCl3):2.42 (3H, s)、3.89-3.93 (5H, m)、4.
31 (2H, t)、4.65 (2H, s)、6.01 (2H, s)、6.64-7.01
(5H, m)、7.23−7.36 (7H, m)5) 4- (3-benzyloxyethoxy-
4-methoxy-phenyl) -3-cyano-6-methyl-
Synthesis of 2- (3,4-methylenedioxyphenoxy) -pyridine Under an argon atmosphere, 459 mg of sesamol (3.32 m
mol) was dissolved in 10 ml of DMF, 133 mg (3.32 mmol) of 60% sodium hydride was added at 0 ° C., and the mixture was stirred for 1 hour. This is followed by 4- (3-benzyloxyethoxy-4-methoxy-phenyl) -2-chloro-
1.13 g of 3-cyano-6-methyl-pyridine (2.7
6 mmol) and stirred at 80 ° C. for 24 hours. The reaction solution was poured into water, the organic layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography (eluent: hexane:
Ethyl acetate (3: 1) gave the title compound. Yield: 200 mg, Yield: 14% MS (ESI.m / z) 511 (MH +) H-NMR (CDCl3): 2.42 (3H, s), 3.89-3.93 (5H, m), 4.
31 (2H, t), 4.65 (2H, s), 6.01 (2H, s), 6.64-7.01
(5H, m), 7.23-7.36 (7H, m)
【0170】6)4−(3−ベンジルオキシエトキシ−
4−メトキシ−フェニル)−6−メチル−2−(3、4
−メチレンジオキシフェノキシ)−ピリジン−3−アル
デヒドの合成 アルゴン雰囲気下、塩化メチレン10ml中、4−(3
−ベンジルオキシエトキシ−4−メトキシ−フェニル)
−3−シアノ−6−メチル−2−(3、4−メチレンジ
オキシフェノキシ)−ピリジン200mg(0.392
mmol)を溶かし、水素化ジイソブチルアルミニウム
1Mヘキサン溶液1.18mlを0℃にて加え、室温に
て1晩攪拌した。この後、水1mlを加え1時間攪拌し
た後、セライト濾過し残渣を酢酸エチルにて洗浄した。
濾液を減圧下にて溶媒留去し、得られた残渣をカラムク
ロマトグラフィー(溶離液 クロロホルム)に付し、表
題化合物を得た。 収量:160mg、収率:79% MS(ESI.m/z) 514(MH+) H-NMR (CDCl3):2.40 (3H,s)、3.86-3.92 (5H,m)、4.25
(2H,t)、4.64 (1H,s)、5.99 (2H,s)、6.61-6.96 (7H,
m)、7.25-7.38 (5H,m)、10.2 (1H,s)6) 4- (3-benzyloxyethoxy-)
4-methoxy-phenyl) -6-methyl-2- (3,4
Synthesis of 4- (3) -methylenedioxyphenoxy) -pyridine-3-aldehyde in 10 ml of methylene chloride under an argon atmosphere
-Benzyloxyethoxy-4-methoxy-phenyl)
-3-cyano-6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine 200 mg (0.392
mmol), and 1.18 ml of a 1M hexane solution of diisobutylaluminum hydride was added at 0 ° C., followed by stirring at room temperature overnight. Thereafter, 1 ml of water was added and the mixture was stirred for 1 hour, filtered through celite, and the residue was washed with ethyl acetate.
The solvent was distilled off from the filtrate under reduced pressure, and the obtained residue was subjected to column chromatography (eluent: chloroform) to obtain the title compound. Yield: 160 mg, 79% MS (ESI.m / z) 514 (MH +) H-NMR (CDCl3): 2.40 (3H, s), 3.86-3.92 (5H, m), 4.25
(2H, t), 4.64 (1H, s), 5.99 (2H, s), 6.61-6.96 (7H,
m), 7.25-7.38 (5H, m), 10.2 (1H, s)
【0171】7)4−[3−(2−ヒドロキシエトキ
シ)−4−メトキシ−フェニル]−6−メチル−2−
(3、4−メチレンジオキシフェノキシ)−ピリジン−
3−カルボン酸の合成 4−(3−ベンジルオキシエトキシ−4−メトキシ−フ
ェニル)−6−メチル−2−(3、4−メチレンジオキ
シフェノキシ)−ピリジン−3−アルデヒド160mg
(0.312mmol)を水5ml,塩化メチレン10
mlに溶かし、氷冷下、2−メチル−ブテン131mg
(1.87mmol),アミド硫酸45mg(0.46
8mmol),亜塩素酸ナトリウム99mg(1.09
mmol)を加え、室温にて1時間攪拌した。反応溶液
に水を加え、クロロホルムにて抽出し、無水硫酸マグネ
シウムで乾燥後、減圧下にて溶媒留去した。得られた残
渣をカラムクロマトグラフィー(溶離液 ヘキサン:酢
酸エチル 1:1)にて精製し、表題化合物を得た。 収量:20mg、収率:15% MS(ESI.m/z) 440(MH+) H-NMR (CDCl3):3.70 (5H, br s)、4.03 (2H, br s)、
5.94 (2H, s)、6.53-6.70 (3H, m)、6.82-7.13 (4H, m)7) 4- [3- (2-Hydroxyethoxy) -4-methoxy-phenyl] -6-methyl-2-
(3,4-methylenedioxyphenoxy) -pyridine-
Synthesis of 3-carboxylic acid 4- (3-benzyloxyethoxy-4-methoxy-phenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-aldehyde 160 mg
(0.312 mmol) in 5 ml of water, 10 methylene chloride
dissolved in ice-cold water, and ice-cooled, 2-methyl-butene 131 mg
(1.87 mmol), amidosulfuric acid 45 mg (0.46 mmol)
8 mmol), 99 mg of sodium chlorite (1.09
mmol) and stirred at room temperature for 1 hour. Water was added to the reaction solution, extracted with chloroform, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent hexane: ethyl acetate 1: 1) to give the title compound. Yield: 20 mg, Yield: 15% MS (ESI.m / z) 440 (MH +) H-NMR (CDCl3): 3.70 (5H, br s), 4.03 (2H, br s),
5.94 (2H, s), 6.53-6.70 (3H, m), 6.82-7.13 (4H, m)
【0172】実施例28 4−(2−ベンジルオキシエ
トキシ−5−メトキシ−フェニル)−6−メチル−2−
(3、4−メチレンジオキシフェノキシ)−ピリジン−
3−カルボン酸の合成 1)2−ベンジルオキシエトキシ−5ーメトキシ−ベン
ズアルデヒドの合成 アルゴン雰囲気下、2−ヒドロキシ−5−メトキシベン
ズアルデヒド2g(13.1mmol)をDMF20m
lに溶かし、60%水素化ナトリウム632mg(1
5.8mmol)を加え室温にて1時間攪拌した。その
後メタンスルホン酸ベンジルオキシエチルエステル3.
64g(15.8mmol)を室温にて加え、100℃
にて4時間攪拌した。反応溶液に水を加え酢酸エチルに
て抽出し、無水硫酸マグネシウムで乾燥後溶媒を減圧留
去し、得られた残渣をカラムクロマトグラフィー(溶離
液 ヘキサン:酢酸エチル 3:1)に付し、表題化合
物を得た。 収量:3.41g、収率:91% MS(ESI.m/z) 287(MH+) H-NMR (CDCl3):3.80 (3H, s)、3.85 (2H, t)、4.23 (2
H, t)、4.62 (2H, s)、6.94-7.13 (2H, m)、7.26-7.36
(6H, m)、10.5 (1H, s)Example 28 4- (2-benzyloxyethoxy-5-methoxy-phenyl) -6-methyl-2-
(3,4-methylenedioxyphenoxy) -pyridine-
Synthesis of 3-carboxylic acid 1) Synthesis of 2-benzyloxyethoxy-5-methoxy-benzaldehyde Under an argon atmosphere, 2 g (13.1 mmol) of 2-hydroxy-5-methoxybenzaldehyde was added to 20 m of DMF.
and 632 mg of 60% sodium hydride (1
(5.8 mmol) and stirred at room temperature for 1 hour. Thereafter, methanesulfonic acid benzyloxyethyl ester3.
64 g (15.8 mmol) was added at room temperature,
For 4 hours. Water was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography (eluent: hexane: ethyl acetate 3: 1) to give the title. The compound was obtained. Yield: 3.41 g, yield: 91% MS (ESI.m / z) 287 (MH +) H-NMR (CDCl3): 3.80 (3H, s), 3.85 (2H, t), 4.23 (2
H, t), 4.62 (2H, s), 6.94-7.13 (2H, m), 7.26-7.36
(6H, m), 10.5 (1H, s)
【0173】2)1−(2−ベンジルオキシエトキシ−
5−メトキシ−フェニル)−1−ブテニル−3−オンの
合成 アセトニルトリフェニルホスホニウム クロリド6.3
5g(11.9mmol) をエタノール(30ml)
に溶かしナトリウムエトキシド1.21g(17.9m
mol)を0℃にて加えた。室温に戻し、1時間攪拌し
た後、2−ベンジルオキシエトキシ−5ーメトキシ−ベ
ンズアルデヒド3.41g(11.9mmol)を加え
1晩攪拌した。反応溶液を減圧下溶媒留去し、残渣に水
を加え、酢酸エチルにて抽出した。有機相を飽和食塩水
にて洗浄し、無水硫酸マグネシウムで乾燥、減圧下溶媒
留去して粗製生成物を得た。これをシリカゲル上でヘキ
サン/酢酸エチル(3:1)を用いて精製し表題化合物
を得た。 収量:3.53g、収率:91% H-NMR (CDCl3):2.28 (3H, s)、3.73 (3H, s)、3.79-3.
82 (2H, m)、4.11-4.14 (2H, m)、4.58 (2H, d)、6.69-
6.86 (3H, m)、7.04-7.10 (1H, m)、7.24-7.35(5H,
m)、7.75 ( 1H, d )2) 1- (2-benzyloxyethoxy-)
Synthesis of 5-methoxy-phenyl) -1-butenyl-3-one acetonyltriphenylphosphonium chloride 6.3
5 g (11.9 mmol) of ethanol (30 ml)
Sodium ethoxide 1.21g (17.9m
mol) was added at 0 ° C. After returning to room temperature and stirring for 1 hour, 3.41 g (11.9 mmol) of 2-benzyloxyethoxy-5-methoxy-benzaldehyde was added, and the mixture was stirred overnight. The solvent was distilled off from the reaction solution under reduced pressure, water was added to the residue, and the mixture was extracted with ethyl acetate. The organic phase was washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain a crude product. This was purified on silica gel using hexane / ethyl acetate (3: 1) to give the title compound. Yield: 3.53 g, yield: 91% H-NMR (CDCl3): 2.28 (3H, s), 3.73 (3H, s), 3.79-3.
82 (2H, m), 4.11-4.14 (2H, m), 4.58 (2H, d), 6.69-
6.86 (3H, m), 7.04-7.10 (1H, m), 7.24-7.35 (5H, m
m), 7.75 (1H, d)
【0174】3)4−(2−ベンジルオキシエトキシ−
5−メトキシ−フェニル)−3−シアノ−6−メチル−
2−ピリドンの合成 α−シアノアセトアミド999mg(11.9mmo
l)をDMSO20mlに溶かし、アルゴン雰囲気下、
t−ブトキシカリウム1.21g(10.8mmo
l)、1−(2−ベンジルオキシエトキシ−5−メトキ
シ−フェニル)−1−ブテニル−3−オン3.53g
(10.8mmol)を室温にて順次加えて、15分間
攪拌した。TLCにて原料の消失を確認した後、t−ブ
トキシカリウム3.64g(32.4mmol)を加
え、酸素を1分間バブリングし、酸素雰囲気下1時間攪
拌した。反応溶液に3規定 塩酸を20ml加えて1時
間攪拌すると、黄褐色の結晶物質が析出した。この結晶
を吸引濾過し、水、ヘキサン/酢酸エチル(1:1)混
合液で順次洗浄し、100℃において1晩乾燥させて表
題化合物を得た。 収量:4.00g、収率:94% MS(ESI.m/z) 391 (MH+) H-NMR (CDCl3):2.36 (3H, s)、3.78-3.81 (5H, m)、4.
17 (2H, t)、4.54 (2H, s)、6.27 (1H, s)、6.85-6.97
(3H, m)、7.25-7.34 ( 6H, m )3) 4- (2-benzyloxyethoxy-)
5-methoxy-phenyl) -3-cyano-6-methyl-
Synthesis of 2-pyridone α-cyanoacetamide 999 mg (11.9 mmol)
l) in 20 ml of DMSO, and
1.21 g (10.8 mmol) of potassium t-butoxide
l), 3.53 g of 1- (2-benzyloxyethoxy-5-methoxy-phenyl) -1-butenyl-3-one
(10.8 mmol) were sequentially added at room temperature, and the mixture was stirred for 15 minutes. After confirming the disappearance of the raw materials by TLC, 3.64 g (32.4 mmol) of potassium t-butoxide was added, oxygen was bubbled for 1 minute, and the mixture was stirred under an oxygen atmosphere for 1 hour. When 20 ml of 3N hydrochloric acid was added to the reaction solution and stirred for 1 hour, a yellow-brown crystalline substance was deposited. The crystals were filtered off with suction, washed successively with a mixture of water and hexane / ethyl acetate (1: 1) and dried at 100 ° C. overnight to give the title compound. Yield: 4.00 g, yield: 94% MS (ESI.m / z) 391 (MH +) H-NMR (CDCl3): 2.36 (3H, s), 3.78-3.81 (5H, m), 4.
17 (2H, t), 4.54 (2H, s), 6.27 (1H, s), 6.85-6.97
(3H, m), 7.25-7.34 (6H, m)
【0175】4)4−(2−ベンジルオキシエトキシ−
5−メトキシ−フェニル)−2−クロロ−3−シアノ−
6−メチル−ピリジンの合成 4−(2−ベンジルオキシエトキシ−5−メトキシ−フ
ェニル)−3−シアノ−6−メチル−2−ピリドン1.
27g(3.25mmol)にオキシ塩化リン10ml
を加え、100℃にて12時間攪拌した。この後、減圧
下にてオキシ塩化リンを留去し、残渣を酢酸エチル中に
加え、水、飽和重曹水、飽和食塩水で順次洗浄する。無
水硫酸マグネシウムで乾燥後、溶媒を留去して、表題化
合物を得た。 収量:1.07g、収率:81% MS(ESI.m/z) 409(MH+) H-NMR (CDCl3):2.57 (3H, s)、3.74-3.81 (5H, m)、4.
18 (2H, t )、4.44 (2H, s)、6.80-7.38 (9H, m)4) 4- (2-benzyloxyethoxy-)
5-methoxy-phenyl) -2-chloro-3-cyano-
Synthesis of 6-methyl-pyridine 4- (2-benzyloxyethoxy-5-methoxy-phenyl) -3-cyano-6-methyl-2-pyridone
10 g of phosphorus oxychloride in 27 g (3.25 mmol)
Was added and stirred at 100 ° C. for 12 hours. Thereafter, phosphorus oxychloride is distilled off under reduced pressure, the residue is added to ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated brine in that order. After drying over anhydrous magnesium sulfate, the solvent was distilled off to obtain the title compound. Yield: 1.07 g, 81% MS (ESI.m / z) 409 (MH +) H-NMR (CDCl3): 2.57 (3H, s), 3.74-3.81 (5H, m), 4.
18 (2H, t), 4.44 (2H, s), 6.80-7.38 (9H, m)
【0176】5)4−(2−ベンジルオキシエトキシ−
5−メトキシ−フェニル)−3−シアノ−6−メチル−
2−(3、4−メチレンジオキシフェノキシ)−ピリジ
ンの合成 アルゴン雰囲気下、セサモール459mg(3.32m
mol)をDMF10mlに溶かし、60%水素化ナト
リウム133mg(3.32mmol)を0℃にて加
え、1時間攪拌した。この後、4−(2−ベンジルオキ
シエトキシ−5−メトキシ−フェニル)−2−クロロ−
3−シアノ−6−メチル−ピリジン1.13g(2.7
6mmol)を加え、80℃にて2時間攪拌した。反応
溶液を水にあけ、酢酸エチルで有機層を抽出し、無水硫
酸マグネシウムで乾燥後溶媒を減圧留去し、得られた残
渣をカラムクロマトグラフィー(溶離液 ヘキサン:酢
酸エチル 3:1)に付し、表題化合物を得た。 収量:640mg、収率:48% H-NMR (CDCl3):2.39 (3H, s)、3.78-3.81 (5H, m)、4.
19 (2H, t)、4.52 (2H, s)、6.00 (2H, s)、6.60-6.86
(4H, m)、6.96-6.99 (3H, m)、7.24-7.29 (5H,m)5) 4- (2-benzyloxyethoxy-)
5-methoxy-phenyl) -3-cyano-6-methyl-
Synthesis of 2- (3,4-methylenedioxyphenoxy) -pyridine Under an argon atmosphere, 459 mg of sesamol (3.32 m
mol) was dissolved in 10 ml of DMF, 133 mg (3.32 mmol) of 60% sodium hydride was added at 0 ° C., and the mixture was stirred for 1 hour. This is followed by 4- (2-benzyloxyethoxy-5-methoxy-phenyl) -2-chloro-
1.13 g of 3-cyano-6-methyl-pyridine (2.7
6 mmol) and stirred at 80 ° C. for 2 hours. The reaction solution was poured into water, the organic layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography (eluent hexane: ethyl acetate 3: 1). To give the title compound. Yield: 640 mg, yield: 48% H-NMR (CDCl3): 2.39 (3H, s), 3.78-3.81 (5H, m), 4.
19 (2H, t), 4.52 (2H, s), 6.00 (2H, s), 6.60-6.86
(4H, m), 6.96-6.99 (3H, m), 7.24-7.29 (5H, m)
【0177】6)4−(2−ベンジルオキシエトキシ−
5−メトキシ−フェニル)−6−メチル−2−(3、4
−メチレンジオキシフェノキシ)−ピリジン−3−アル
デヒドの合成 アルゴン雰囲気下、塩化メチレン10ml中、4−(2
−ベンジルオキシエトキシ−5−メトキシ−フェニル)
−3−シアノ−6−メチル−2−(3、4−メチレンジ
オキシフェノキシ)−ピリジン300mg(0.588
mmol)を溶かし、水素化ジイソブチルアルミニウム
1Mヘキサン溶液1.76mlを0℃にて加え、室温に
て1晩攪拌した。この後水1mlを加え1時間攪拌した
後、セライト濾過し残渣を酢酸エチルにて洗浄した。濾
液を減圧下にて溶媒留去し、得られた残渣をカラムクロ
マトグラフィー(溶離液 クロロホルム)に付し、表題
化合物を得た。 収量:110mg、収率:36% MS(ESI.m/z) 514(MH+) H-NMR (CDCl3):2.40 (3H, s)、3.67 (2H, t)、3.80 (3
H, s)、4.06 (2H, t)、4.48 (2H, s)、5.99 (2H, s)、
6.55-6.91 (7H, m)、7.22-7.30 (5H, m)6) 4- (2-benzyloxyethoxy-)
5-methoxy-phenyl) -6-methyl-2- (3,4
Synthesis of 4- (2) -methylenedioxyphenoxy) -pyridine-3-aldehyde in 10 ml of methylene chloride under an argon atmosphere
-Benzyloxyethoxy-5-methoxy-phenyl)
300 mg (0.588) of -3-cyano-6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine
mmol), and 1.76 ml of a 1M solution of diisobutylaluminum hydride in hexane was added at 0 ° C., followed by stirring at room temperature overnight. Thereafter, 1 ml of water was added and the mixture was stirred for 1 hour, filtered through celite, and the residue was washed with ethyl acetate. The solvent was distilled off from the filtrate under reduced pressure, and the obtained residue was subjected to column chromatography (eluent: chloroform) to obtain the title compound. Yield: 110 mg, yield: 36% MS (ESI.m / z) 514 (MH +) H-NMR (CDCl3): 2.40 (3H, s), 3.67 (2H, t), 3.80 (3
H, s), 4.06 (2H, t), 4.48 (2H, s), 5.99 (2H, s),
6.55-6.91 (7H, m), 7.22-7.30 (5H, m)
【0178】7)4−(2−ベンジルオキシエトキシ−
5−メトキシ−フェニル)−6−メチル−2−(3、4
−メチレンジオキシフェノキシ)−ピリジン−3−カル
ボン酸の合成 4−(2−ベンジルオキシエトキシ−5−メトキシ−フ
ェニル)−6−メチル−2−(3、4−メチレンジオキ
シフェノキシ)−ピリジン−3−アルデヒド210mg
(0.409mmol)を水5ml,塩化メチレン10
mlに溶かし、氷冷下、2−メチル−ブテン172mg
(2.45mmol),アミド硫酸60mg(0.61
4mmol),亜塩素酸ナトリウム129mg(1.4
3mmol)を加え、室温にて2時間攪拌した。反応溶
液に水を加え、クロロホルムにて抽出し、無水硫酸マグ
ネシウムで乾燥後、減圧下にて溶媒留去した。得られた
残渣をカラムクロマトグラフィー(溶離液 クロロホル
ム:メタノール 9:1)にて精製し、表題化合物を得
た。 収量:90mg、収率:42% MS(ESI.m/z) 530(MH+) H-NMR (CDCl3):2.39 (3H, s)、3.67 (2H, t)、3.76 (3
H, s)、4.02 (2H, t)、4.51 (2H, s)、5.96 (2H, s)、
6.53-6.85 (7H, m)、7.02−7.29 (5H,
m)7) 4- (2-benzyloxyethoxy-)
5-methoxy-phenyl) -6-methyl-2- (3,4
Synthesis of -methylenedioxyphenoxy) -pyridine-3-carboxylic acid 4- (2-benzyloxyethoxy-5-methoxy-phenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine- 210 mg of 3-aldehyde
(0.409 mmol) in 5 ml of water, 10 methylene chloride
172 mg of 2-methyl-butene under ice-cooling.
(2.45 mmol), amidosulfuric acid 60 mg (0.61 mmol)
4 mmol) and 129 mg of sodium chlorite (1.4 mg).
3 mmol) and stirred at room temperature for 2 hours. Water was added to the reaction solution, extracted with chloroform, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 90 mg, Yield: 42% MS (ESI.m / z) 530 (MH +) H-NMR (CDCl3): 2.39 (3H, s), 3.67 (2H, t), 3.76 (3
H, s), 4.02 (2H, t), 4.51 (2H, s), 5.96 (2H, s),
6.53-6.85 (7H, m), 7.02-7.29 (5H,
m)
【0179】実施例29 4−[2−(2−ヒドロキシ
エトキシ)−5−メトキシ−フェニル]−6−メチル−
2−(3、4−メチレンジオキシフェノキシ)−ピリジ
ン−3−カルボン酸の合成 4−(2−ベンジルオキシエトキシ−5−メトキシ−フ
ェニル)−6−メチル−2−(3、4−メチレンジオキ
シフェノキシ)−ピリジン−3−カルボン酸70mg
(0.132mmol)をエタノール5mlに溶かし、
10%パラジウム炭素を触媒量加えて、水素雰囲気下
(1atm)室温にて18時間攪拌した。反応溶液を濾
過しエタノールで洗浄後、濾液を減圧下溶媒留去した。
得られた残渣をクロロホルム、ヘキサンから再結晶して
表題化合物を得た。 収量:50mg、収率:86% MS(ESI.m/z) 440(MH+) H-NMR (CD3OD):2.34 (3H, s)、3.69-3.72 (5H, m)、3.
93 (2H, t)、5.92 (2H, s)、6.51-6.98 (7H, m)Example 29 4- [2- (2-hydroxyethoxy) -5-methoxy-phenyl] -6-methyl-
Synthesis of 2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 4- (2-benzyloxyethoxy-5-methoxy-phenyl) -6-methyl-2- (3,4-methylenedi (Oxyphenoxy) -pyridine-3-carboxylic acid 70 mg
(0.132 mmol) in 5 ml of ethanol,
A catalytic amount of 10% palladium carbon was added, and the mixture was stirred at room temperature under a hydrogen atmosphere (1 atm) for 18 hours. After the reaction solution was filtered and washed with ethanol, the filtrate was evaporated under reduced pressure.
The obtained residue was recrystallized from chloroform and hexane to give the title compound. Yield: 50 mg, yield: 86% MS (ESI. M / z) 440 (MH +) H-NMR (CD3OD): 2.34 (3H, s), 3.69-3.72 (5H, m), 3.
93 (2H, t), 5.92 (2H, s), 6.51-6.98 (7H, m)
【0180】実施例30 3−シアノ−4−(2−(3
−クロロプロピルオキシ)−4−メトキシフェニル)−
6−メチルピリジン−3−カルボン酸の合成 1)2−(3−ベンジルオキシプロピルオキシ)−4−
メトキシベンズアルデヒドの合成 2−ヒドロキシ−4−メトキシベンズアルデヒド1.5
2g(10.0mmol)をDMF10mlに溶解し、
水素化ナトリウム500mg(60%オイルディスパー
ジョン、12.5mmol)、3−ベンジルオキシプロ
ピル メタンスルホネート2.7g(11.1mmo
l)を加え60℃で6時間攪拌する。DMFを減圧下留
去し残渣を酢酸エチルに溶解し、1規定水酸化ナトリウ
ム、水、飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後減圧下溶媒を留去し残渣をシリカゲルカラムクロ
マトグラフィー(酢酸エチル:ヘキサン 1:4)に付
し表題化合物を得た。 収量:1.13g、収率:37.6% MS(ESI,m/z) 301 (MH+) H-NMR(CDCl3):2.17 (2H, quint)、3.67 (2H, t)、3.85
(3H, s)、4.18 (2H,t)、4.52 (2H, s)、6.46 (1H,
d)、6.54 (1H, dd)、7.25-7.38 (5H, m)、7.80 (1H,
d)、10.26 (1H, s)Example 30 3-cyano-4- (2- (3
-Chloropropyloxy) -4-methoxyphenyl)-
Synthesis of 6-methylpyridine-3-carboxylic acid 1) 2- (3-benzyloxypropyloxy) -4-
Synthesis of methoxybenzaldehyde 2-hydroxy-4-methoxybenzaldehyde 1.5
2 g (10.0 mmol) is dissolved in 10 ml of DMF,
500 mg of sodium hydride (60% oil dispersion, 12.5 mmol), 2.7 g of 3-benzyloxypropyl methanesulfonate (11.1 mmol)
1) and stirred at 60 ° C. for 6 hours. DMF is distilled off under reduced pressure, the residue is dissolved in ethyl acetate, washed with 1N sodium hydroxide, water and saturated saline, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. Ethyl acetate: hexane 1: 4) to give the title compound. Yield: 1.13 g, yield: 37.6% MS (ESI, m / z) 301 (MH +) H-NMR (CDCl3): 2.17 (2H, quint), 3.67 (2H, t), 3.85
(3H, s), 4.18 (2H, t), 4.52 (2H, s), 6.46 (1H,
d), 6.54 (1H, dd), 7.25-7.38 (5H, m), 7.80 (1H,
d), 10.26 (1H, s)
【0181】2)1−(2−(3−ベンジルオキシプロ
ピルオキシ)−4−メトキシフェニル)−1−ブテン−
3−オンの合成 2−(3−ベンジルオキシプロピルオキシ)−4−メト
キシベンズアルデヒド1.13g(3.8mmol)、
アセトニルトリフェニルホスホニウム クロリド1.6
g(4.5mmol)、ナトリウムエトキシド0.31
g(4.6mmol)をエタノール30mlに溶解し一
晩加熱環流する。エタノールを減圧下留挙し、酢酸エチ
ルに溶解し不溶物を濾過し減圧下溶媒を留去する。残渣
をシリカゲルカラムクロマトグラフィー(酢酸エチル:
ヘキサン 1:3)に付し表題化合物を得た。 収量:1.07g、収率:82.7% MS(ESI,m/z) 341 (MH+) H-NMR(CDCl3):2.15 (2H, quint)、2.30 (3H, s)、3.68
(2H, t)、3.83 (3H,s)、4.15 (2H, t)、4.53 (2H,
s)、6.47 (1H, d)、6.52 (1H, dd)、6.66 (1H, d)、7.2
5-7.35 (5H, m)、7.48 (1H, d)、7.76 (1H, d)2) 1- (2- (3-benzyloxypropyloxy) -4-methoxyphenyl) -1-butene-
Synthesis of 3-one 1.13 g (3.8 mmol) of 2- (3-benzyloxypropyloxy) -4-methoxybenzaldehyde,
Acetonyltriphenylphosphonium chloride 1.6
g (4.5 mmol), sodium ethoxide 0.31
g (4.6 mmol) is dissolved in 30 ml of ethanol and heated under reflux overnight. Ethanol is distilled off under reduced pressure, dissolved in ethyl acetate, insoluble matter is filtered, and the solvent is distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (ethyl acetate:
Hexane 1: 3) to give the title compound. Yield: 1.07 g, 82.7% MS (ESI, m / z) 341 (MH +) H-NMR (CDCl3): 2.15 (2H, quint), 2.30 (3H, s), 3.68
(2H, t), 3.83 (3H, s), 4.15 (2H, t), 4.53 (2H,
s), 6.47 (1H, d), 6.52 (1H, dd), 6.66 (1H, d), 7.2
5-7.35 (5H, m), 7.48 (1H, d), 7.76 (1H, d)
【0182】3)3−シアノ−4−(2−(3−クロロ
プロピルオキシ)−4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェニルオキシ)ピリジン
の合成 アルゴン雰囲気下、室温でシアノアセトアミド270m
g(3.2mmol)、t−ブトキシカリウム350m
g(3.1mmol)のDMSO5ml溶液に1−(2
−(3−ベンジルオキシプロピルオキシ)−4−メトキ
シフェニル)−1−ブテン−3−オン1.07g(3.
1mmol)のDMSO15mlを加え15分間攪拌す
る。t−ブトキシカリウム1.06g(9.4mmo
l)を加え1分間酸素をバブリングする。酸素雰囲気下
1時間攪拌した後、1規定塩酸を氷冷下加え析出した粘
凋な物質をデカンテーションでとる。酢酸エチルに溶解
し無水硫酸マグネシウムで乾燥後減圧下溶媒を留去す
る。残渣をオキシ塩化リン10mlに溶解し100℃で
一晩攪拌する。減圧下オキシ塩化リンを留去し残渣をク
ロロホルムで抽出する。飽和重曹水で洗浄し、無水硫酸
マグネシウムで乾燥後減圧下溶媒を留去する。得られる
残渣をDMFに溶解し、別にセサモール430mg
(3.1mmol)、水素化ナトリウム250mg(6
0%オイルディスパージョン、6.2mmol)より作
成したフェノキシドイオンのDMF溶液に加え、アルゴ
ン雰囲気下、室温で4時間攪拌する。減圧下溶媒を留去
し、残渣を酢酸エチルに溶解し、水、飽和食塩水で洗浄
する。無水硫酸マグネシウムで乾燥し減圧下溶媒を留去
する。得られた残渣をシリカゲルカラムクロマトグラフ
ィー(酢酸エチル:ヘキサン 1:3)に付し表題化合
物を得た。このものは分離困難な不純物を含むがこれ以
上精製せずに以下の反応に用いる。 収量:90mg、収率:1−(2−(3−ベンジルオキ
シプロピルオキシ)−4−メトキシフェニル)−1−ブ
テン−3−オンより6.4%3) 3-Cyano-4- (2- (3-chloropropyloxy) -4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenyloxy) pyridine Cyanoacetamide 270m at room temperature under argon atmosphere
g (3.2 mmol), 350 m potassium t-butoxide
g (3.1 mmol) in 5 ml of DMSO was added to 1- (2
1.07 g of-(3-benzyloxypropyloxy) -4-methoxyphenyl) -1-buten-3-one (3.
(1 mmol) in 15 ml of DMSO and stirred for 15 minutes. 1.06 g (9.4 mmol) of potassium t-butoxide
Add l) and bubble oxygen for 1 minute. After stirring for 1 hour in an oxygen atmosphere, 1N hydrochloric acid is added under ice cooling, and the precipitated viscous substance is removed by decantation. After dissolving in ethyl acetate and drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The residue is dissolved in 10 ml of phosphorus oxychloride and stirred at 100 ° C. overnight. The phosphorus oxychloride is distilled off under reduced pressure, and the residue is extracted with chloroform. The extract is washed with saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The obtained residue was dissolved in DMF, and 430 mg of sesamol was separately added.
(3.1 mmol), 250 mg of sodium hydride (6
(0% oil dispersion, 6.2 mmol) to a DMF solution of phenoxide ion, and the mixture is stirred at room temperature for 4 hours under an argon atmosphere. The solvent is distilled off under reduced pressure, the residue is dissolved in ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to give the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 90 mg, Yield: 6.4% from 1- (2- (3-benzyloxypropyloxy) -4-methoxyphenyl) -1-buten-3-one
【0183】4)3−シアノ−4−(2−(3−クロロ
プロピルオキシ)−4−メトキシフェニル)−6−メチ
ルピリジン−3−アルデヒドの合成 3−シアノ−4−(2−(3−クロロプロピルオキシ)
−4−メトキシフェニル)−2−(3,4−メチレンジ
オキシフェニルオキシ)ピリジン90mg(0.21m
mol)をベンゼン5mlに溶解しアルゴン雰囲気下室
温で水素化ジイソブチルアルミニウム1Mヘキサン溶液
1.0ml(1.0mmol)を滴下する。室温で3時
間攪拌しメタノールと水で反応を停止する。室温で1時
間攪拌し、不溶物をセライトを用いて濾過する。濾液を
を減圧下留去し得られた残渣をシリカゲルカラムクロマ
トグラフィー(酢酸エチル:ヘキサン 1:3 ついで
1:2)に付し表題化合物を得た。このものは分離困難
な不純物を含むがこれ以上精製せずに以下の反応に用い
る。 収量:30mg MS(ESI,m/z) 456 (MH+) H-NMR(CDCl3):2.31 (2H, quint)、2.42 (3H, s)、3.53
(2H, t)、3.86 (3H,s)、4.08 (2H, t)、6.00 (2H,
s)、6.54-6.64 (3H, m)、6.72 (1H, d)、6.79-6.81 (2
H, m)、7.14 (1H, d)、10.16 (1H, s)4) Synthesis of 3-cyano-4- (2- (3-chloropropyloxy) -4-methoxyphenyl) -6-methylpyridine-3-aldehyde 3-cyano-4- (2- (3- Chloropropyloxy)
-4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 90 mg (0.21 m
mol) was dissolved in 5 ml of benzene, and 1.0 ml (1.0 mmol) of a 1M solution of diisobutylaluminum hydride in hexane was added dropwise at room temperature under an argon atmosphere. Stir at room temperature for 3 hours and stop the reaction with methanol and water. The mixture is stirred at room temperature for 1 hour, and the insoluble matter is filtered using celite. The filtrate was evaporated under reduced pressure, and the residue obtained was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3 then 1: 2) to give the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 30 mg MS (ESI, m / z) 456 (MH +) H-NMR (CDCl3): 2.31 (2H, quint), 2.42 (3H, s), 3.53
(2H, t), 3.86 (3H, s), 4.08 (2H, t), 6.00 (2H, t)
s), 6.54-6.64 (3H, m), 6.72 (1H, d), 6.79-6.81 (2
H, m), 7.14 (1H, d), 10.16 (1H, s)
【0184】5)3−シアノ−4−(2−(3−クロロ
プロピルオキシ)−4−メトキシフェニル)−6−メチ
ルピリジン−3−カルボン酸の合成 3−シアノ−4−(2−(3−クロロプロピルオキシ)
−4−メトキシフェニル)−6−メチルピリジン−3−
アルデヒド30mgを塩化メチレン2ml、水1mlに
溶解し、0℃で2−メチル−2−ブテン0.05ml
(0.47mmol)、アミド硫酸10mg(0.10
mmol)、亜塩素酸ナトリウム30mg(0.26m
mol)を加え室温に戻して2時間攪拌する。塩化メチ
レンで抽出し無水硫酸マグネシウムで乾燥して減圧下溶
媒を留去する。得られた残渣をシリカゲル薄層クロマト
グラフィー(酢酸エチル:ヘキサン 1:1 2回展
開)に付し表題化合物()を得た。 収量:12mg、収率:3−シアノ−4−(2−(3−
クロロプロピルオキシ)−4−メトキシフェニル)−2
−(3,4−メチレンジオキシフェニルオキシ)ピリジ
ンより12.1% MS(ESI,m/z) 472 (MH+) H-NMR(CDCl3):2.42 (2H, quint)、2.41 (3H, s)、3.54
(2H, t)、3.83 (3H,s)、4.04 (2H, t)、5.99 (2H,
s)、6.50 (1H, d)、6.55 (1H, dd)、6.62 (1H, dd)、6.
71 (1H, d)、6.78 (1H, d)、6.84 (1H, s)、7.16 (1H,
d)5) Synthesis of 3-cyano-4- (2- (3-chloropropyloxy) -4-methoxyphenyl) -6-methylpyridine-3-carboxylic acid 3-cyano-4- (2- (3 -Chloropropyloxy)
-4-methoxyphenyl) -6-methylpyridine-3-
30 mg of aldehyde was dissolved in 2 ml of methylene chloride and 1 ml of water, and 0.05 ml of 2-methyl-2-butene was added at 0 ° C.
(0.47 mmol), amidosulfuric acid 10 mg (0.10
mmol), 30 mg of sodium chlorite (0.26 m
mol), and the mixture is returned to room temperature and stirred for 2 hours. Extract with methylene chloride, dry over anhydrous magnesium sulfate and evaporate the solvent under reduced pressure. The obtained residue was subjected to silica gel thin layer chromatography (developed twice with ethyl acetate: hexane 1: 1) to give the title compound (). Yield: 12 mg, Yield: 3-cyano-4- (2- (3-
Chloropropyloxy) -4-methoxyphenyl) -2
12.1% MS (ESI, m / z) 472 (MH +) H-NMR (CDCl3): 2.42 (2H, quint), 2.41 (3H, s) from-(3,4-methylenedioxyphenyloxy) pyridine , 3.54
(2H, t), 3.83 (3H, s), 4.04 (2H, t), 5.99 (2H,
s), 6.50 (1H, d), 6.55 (1H, dd), 6.62 (1H, dd), 6.
71 (1H, d), 6.78 (1H, d), 6.84 (1H, s), 7.16 (1H,
d)
【0185】実施例31 4−(3−ベンジルオキシプ
ロポキシ−4−メトキシ−フェニル)−6−メチル−2
−(3、4−メチレンジオキシフェノキシ)−ピリジン
−3−カルボン酸の合成 1)3−ベンジルオキシプロポキシ−4ーメトキシ−ベ
ンズアルデヒドの合成 アルゴン雰囲気下、イソバニリン2g(13.1mmo
l)をDMF20mlに溶かし、60%水素化ナトリウ
ム632mg(15.8mmol)を加え室温にて1時
間攪拌した。その後メタンスルホン酸ベンジルオキシプ
ロピルエステル3.64g(15.8mmol)を室温
にて加え、80℃にて6時間攪拌した。反応溶液に水を
加え酢酸エチルにて抽出し、無水硫酸マグネシウムで乾
燥後溶媒を減圧留去し、得られた残渣をカラムクロマト
グラフィー(溶離液 ヘキサン:酢酸エチル 5:1)
に付し、表題化合物を得た。 収量:3.45g、収率:88% MS(ESI.m/z) 301(MH+) H-NMR (CDCl3):2.17 (2H, quint)、3.68 (2H, t)、3.9
3-3.97 (3H, m)、4.21(2H, t)、4.53 (2H, s)、6.95-6.
98 (1H, m)、7.26-7.46 (7H, m)、9.84 (1H,s)Example 31 4- (3-benzyloxypropoxy-4-methoxy-phenyl) -6-methyl-2
Synthesis of-(3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 1) Synthesis of 3-benzyloxypropoxy-4-methoxy-benzaldehyde 2 g (13.1 mmol) of isovanillin under an argon atmosphere
1) was dissolved in 20 ml of DMF, 632 mg (15.8 mmol) of 60% sodium hydride was added, and the mixture was stirred at room temperature for 1 hour. Thereafter, 3.64 g (15.8 mmol) of benzylsulfonic acid methanesulfonate was added at room temperature, and the mixture was stirred at 80 ° C. for 6 hours. Water was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The resulting residue was subjected to column chromatography (eluent: hexane: ethyl acetate 5: 1).
To give the title compound. Yield: 3.45 g, yield: 88% MS (ESI.m / z) 301 (MH +) H-NMR (CDCl3): 2.17 (2H, quint), 3.68 (2H, t), 3.9
3-3.97 (3H, m), 4.21 (2H, t), 4.53 (2H, s), 6.95-6.
98 (1H, m), 7.26-7.46 (7H, m), 9.84 (1H, s)
【0186】2)1−(3−ベンジルオキシプロポキシ
−4−メトキシ−フェニル)−1−ブテニル−3−オン
の合成 アセトニルトリフェニルホスホニウム クロリド5.1
8g(14.6mmol) をエタノール(30ml)
に溶かしナトリウムエトキシド994mg(14.6m
mol)を0℃にて加えた。室温に戻し、1時間攪拌し
た後、3−ベンジルオキシプロポキシ−4ーメトキシ−
ベンズアルデヒド3.45g(9.72mmol)を加
え1晩攪拌した。反応溶液を減圧下溶媒留去し、残渣に
水を加え、酢酸エチルにて抽出した。有機相を飽和食塩
水 にて洗浄し、無水硫酸マグネシウムで乾燥、減圧下
溶媒留去して粗製生成物を得た。これをシリカゲル上で
ヘキサン/酢酸エチル(5:1)を用いて精製し表題化
合物を得た。 収量:2.28g、収率:69% MS(ESI.m/z) 363(M+Na+) H-NMR (CDCl3):2.16 (2H, quint)、2.35 (3H, s)、3.6
9 (2H, t)、3.88 (3H,s)、4.18 (2H, t)、4.53 (2H,
s)、6.59 (1H, d)、6.87 (1H, d)、7.11-7.33 (5H,
m)、7.44 (1H, d)2) Synthesis of 1- (3-benzyloxypropoxy-4-methoxy-phenyl) -1-butenyl-3-one Acetonyltriphenylphosphonium chloride 5.1
8 g (14.6 mmol) of ethanol (30 ml)
Sodium ethoxide 994mg (14.6m
mol) was added at 0 ° C. After returning to room temperature and stirring for 1 hour, 3-benzyloxypropoxy-4-methoxy-
3.45 g (9.72 mmol) of benzaldehyde was added and stirred overnight. The solvent was distilled off from the reaction solution under reduced pressure, water was added to the residue, and the mixture was extracted with ethyl acetate. The organic phase was washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain a crude product. This was purified on silica gel using hexane / ethyl acetate (5: 1) to give the title compound. Yield: 2.28 g, 69% MS (ESI.m / z) 363 (M + Na +) H-NMR (CDCl3): 2.16 (2H, quint), 2.35 (3H, s), 3.6
9 (2H, t), 3.88 (3H, s), 4.18 (2H, t), 4.53 (2H, t)
s), 6.59 (1H, d), 6.87 (1H, d), 7.11-7.33 (5H,
m), 7.44 (1H, d)
【0187】3)4−(3−ベンジルオキシプロポキシ
−4−メトキシ−フェニル)−3−シアノ−6−メチル
−2−ピリドンの合成 α−シアノアセトアミド620mg(7.37mmo
l)をDMSO20mlに溶かし、アルゴン雰囲気下、
t−ブトキシカリウム752mg(6.70mmo
l)、1−(3−ベンジルオキシプロポキシ−4−メト
キシ−フェニル)−1−ブテニル−3−オン2.28g
(6.70mmol)を室温にて順次加えて、15分間
攪拌した。TLCにて原料の消失を確認した後、t−ブ
トキシカリウム2.26g(20.1mmol)を加
え、酸素を1分間バブリングし、酸素雰囲気下1時間攪
拌した。反応溶液に3規定 塩酸を20ml加えて1時
間攪拌すると、黄褐色の結晶物質が析出した。この結晶
を吸引濾過し、水、ヘキサン/酢酸エチル(1:1)混
合液で順次洗浄し、100℃において1晩乾燥させて表
題化合物を得た。 収量:2.13g、収率:79% MS(ESI.m/z) 427 (M+Na+) H-NMR (CDCl3):2.18 (2H, quint)、2.48 (3H, s)、3.7
0 (2H, t)、3.91 (3H,s)、4.22 (2H, t)、4.53 (2H,
s)、6.26 (1H, s)、6.96 (1H, d)、7.18-7.32 (8H, m)3) Synthesis of 4- (3-benzyloxypropoxy-4-methoxy-phenyl) -3-cyano-6-methyl-2-pyridone 620 mg of α-cyanoacetamide (7.37 mmol)
l) in 20 ml of DMSO, and
752 mg (6.70 mmol) of potassium t-butoxide
l), 2.28 g of 1- (3-benzyloxypropoxy-4-methoxy-phenyl) -1-butenyl-3-one
(6.70 mmol) was sequentially added at room temperature, and the mixture was stirred for 15 minutes. After confirming the disappearance of the raw materials by TLC, 2.26 g (20.1 mmol) of potassium t-butoxide was added, oxygen was bubbled for 1 minute, and the mixture was stirred under an oxygen atmosphere for 1 hour. When 20 ml of 3N hydrochloric acid was added to the reaction solution and stirred for 1 hour, a yellow-brown crystalline substance was deposited. The crystals were filtered off with suction, washed successively with a mixture of water and hexane / ethyl acetate (1: 1) and dried at 100 ° C. overnight to give the title compound. Yield: 2.13 g, 79% MS (ESI.m / z) 427 (M + Na +) H-NMR (CDCl3): 2.18 (2H, quint), 2.48 (3H, s), 3.7
0 (2H, t), 3.91 (3H, s), 4.22 (2H, t), 4.53 (2H, t)
s), 6.26 (1H, s), 6.96 (1H, d), 7.18-7.32 (8H, m)
【0188】4)4−(3−ベンジルオキシプロポキシ
−4−メトキシ−フェニル)−2−クロロ−3−シアノ
−6−メチル−ピリジンの合成 4−(3−ベンジルオキシプロポキシ−4−メトキシ−
フェニル)−3−シアノ−6−メチル−2−ピリドン
2.13g(5.27mmol)にオキシ塩化リン10
mlを加え、100℃にて5時間攪拌した。この後、減
圧下にてオキシ塩化リンを留去し、残渣を酢酸エチル中
に加え、水、飽和重曹水、飽和食塩水で順次洗浄する。
無水硫酸マグネシウムで乾燥後、溶媒を留去して、表題
化合物を得た。 収量:2.05g、収率:92% MS(ESI.m/z) 445(M+Na+) H-NMR (CDCl3):2.18 (2H, quint)、2.62 (3H, s)、3.7
0 (2H, t)、3.91 (3H,s)、4.23 (2H, t)、4.52 (2H,
s)、6.97-7.32 (9H, m)4) Synthesis of 4- (3-benzyloxypropoxy-4-methoxy-phenyl) -2-chloro-3-cyano-6-methyl-pyridine 4- (3-benzyloxypropoxy-4-methoxy-pyridine)
Phenyl) -3-cyano-6-methyl-2-pyridone
2.13 g (5.27 mmol) of phosphorus oxychloride 10
Then, the mixture was stirred at 100 ° C. for 5 hours. Thereafter, phosphorus oxychloride is distilled off under reduced pressure, the residue is added to ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated brine in that order.
After drying over anhydrous magnesium sulfate, the solvent was distilled off to obtain the title compound. Yield: 2.05 g, 92% MS (ESI.m / z) 445 (M + Na +) H-NMR (CDCl3): 2.18 (2H, quint), 2.62 (3H, s), 3.7
0 (2H, t), 3.91 (3H, s), 4.23 (2H, t), 4.52 (2H, t)
s), 6.97-7.32 (9H, m)
【0189】5)4−(3−ベンジルオキシプロポキシ
−4−メトキシ−フェニル)−3−シアノ−6−メチル
−2−(3、4−メチレンジオキシフェノキシ)−ピリ
ジンの合成 アルゴン雰囲気下、セサモール936mg(6.78m
mol)をDMF10mlに溶かし、60%水素化ナト
リウム271mg(6.78mmol)を0℃にて加
え、1時間攪拌した。この後、4−(3−ベンジルオキ
シプロポキシ−4−メトキシ−フェニル)−2−クロロ
−3−シアノ−6−メチル−ピリジン2.39g(5.
65mmol)を加え、80℃にて12時間攪拌した。
反応溶液を水にあけ、酢酸エチルで有機層を抽出し、無
水硫酸マグネシウムで乾燥後溶媒を減圧留去し、得られ
た残渣をカラムクロマトグラフィー(溶離液 ヘキサ
ン:酢酸エチル 3:1)に付し、表題化合物を得た。 収量:1.24g、収率:42% MS(ESI.m/z) 547(M+Na+) H-NMR (CDCl3):2.19 (2H, quint)、2.43 (3H, s)、3.7
1 (2H, t)、3.91 (3H,s)、4.24 (2H, t)、4.53 (2H,
s)、6.01 (2H, s)、6.64-7.00 (5H, m)、7.18-7.32 (7
H, m)5) Synthesis of 4- (3-benzyloxypropoxy-4-methoxy-phenyl) -3-cyano-6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine Sesamol under argon atmosphere 936 mg (6.78 m
mol) was dissolved in 10 ml of DMF, 271 mg (6.78 mmol) of 60% sodium hydride was added at 0 ° C, and the mixture was stirred for 1 hour. Thereafter, 2.39 g of 4- (3-benzyloxypropoxy-4-methoxy-phenyl) -2-chloro-3-cyano-6-methyl-pyridine (5.
65 mmol) and stirred at 80 ° C. for 12 hours.
The reaction solution was poured into water, the organic layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography (eluent hexane: ethyl acetate 3: 1). To give the title compound. Yield: 1.24 g, yield: 42% MS (ESI.m / z) 547 (M + Na +) H-NMR (CDCl3): 2.19 (2H, quint), 2.43 (3H, s), 3.7
1 (2H, t), 3.91 (3H, s), 4.24 (2H, t), 4.53 (2H, t)
s), 6.01 (2H, s), 6.64-7.00 (5H, m), 7.18-7.32 (7
H, m)
【0190】6)4−(3−ベンジルオキシプロポキシ
−4−メトキシ−フェニル)−6−メチル−2−(3、
4−メチレンジオキシフェノキシ)−ピリジン−3−ア
ルデヒドの合成 アルゴン雰囲気下、塩化メチレン10ml中、4−(3
−ベンジルオキシプロポキシ−4−メトキシ−フェニ
ル)−3−シアノ−6−メチル−2−(3、4−メチレ
ンジオキシフェノキシ)−ピリジン550mg(1.0
5mmol)を溶かし、水素化ジイソブチルアルミニウ
ム1Mヘキサン溶液3.15mlを0℃にて加え、室温
にて1 時間攪拌した。この後水1mlを加え1時間攪
拌した後、セライト濾過し残渣を酢酸エチルにて洗浄し
た。濾液を減圧下にて溶媒留去し、得られた残渣をカラ
ムクロマトグラフィー(溶離液 クロロホルム)に付
し、表題化合物を得た。 収量:550mg、収率:99% MS(ESI.m/z) 550(M+Na+) H-NMR (CDCl3):2.14-2.20 (2H, m)、2.41 (3H, d)、3.
67-3.72 (2H, m)、3.89 (3H, d)、4.15-4.24 (2H, m)、
4.52 (2H, d)、5.98 (2H, d)、6.60-6.99 (7H,m)、7.19
-7.32 (5H, m)、10.2 (1H, s)6) 4- (3-benzyloxypropoxy-4-methoxy-phenyl) -6-methyl-2- (3,
Synthesis of 4-methylenedioxyphenoxy) -pyridine-3-aldehyde In an argon atmosphere, 4- (3
Benzyloxypropoxy-4-methoxy-phenyl) -3-cyano-6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine 550 mg (1.0 mg)
5mmol), and 3.15 ml of a 1M solution of diisobutylaluminum hydride in hexane was added at 0 ° C, followed by stirring at room temperature for 1 hour. Thereafter, 1 ml of water was added and the mixture was stirred for 1 hour, filtered through celite, and the residue was washed with ethyl acetate. The solvent was distilled off from the filtrate under reduced pressure, and the obtained residue was subjected to column chromatography (eluent: chloroform) to obtain the title compound. Yield: 550 mg, yield: 99% MS (ESI.m / z) 550 (M + Na +) H-NMR (CDCl3): 2.14-2.20 (2H, m), 2.41 (3H, d), 3.
67-3.72 (2H, m), 3.89 (3H, d), 4.15-4.24 (2H, m),
4.52 (2H, d), 5.98 (2H, d), 6.60-6.99 (7H, m), 7.19
-7.32 (5H, m), 10.2 (1H, s)
【0191】7)4−(3−ベンジルオキシプロポキシ
−4−メトキシ−フェニル)−6−メチル−2−(3、
4−メチレンジオキシフェノキシ)−ピリジン−3−カ
ルボン酸の合成 4−(3−ベンジルオキシプロポキシ−4−メトキシ−
フェニル)−6−メチル−2−(3、4−メチレンジオ
キシフェノキシ)−ピリジン−3−アルデヒド550m
g(1.04mmol)を水5ml,塩化メチレン10
mlに溶かし、氷冷下、2−メチル−ブテン439mg
(6.26mmol),アミド硫酸151mg(1.5
6mmol),亜塩素酸ナトリウム329mg(3.6
4mmol)を加え、室温にて1時間攪拌した。反応溶
液に水を加え、クロロホルムにて抽出し、無水硫酸マグ
ネシウムで乾燥後、減圧下にて溶媒留去した。得られた
残渣をカラムクロマトグラフィー(溶離液 クロロホル
ム:メタノール 9:1)にて精製し、表題化合物を得
た。 収量:268mg、収率:47% MS(ESI.m/z) 544(MH+) H-NMR (CDCl3):2.07 (2H, quint)、2.37 (3H, s)、3.6
3 (2H, t)、3.78 (3H,s)、4.14 (2H, t)、4.49 (2H,
s)、5.94 (2H, s)、6.53-7.10 (7H, m)、7.24-7.29 (5
H, m)7) 4- (3-benzyloxypropoxy-4-methoxy-phenyl) -6-methyl-2- (3,
Synthesis of 4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 4- (3-benzyloxypropoxy-4-methoxy-
Phenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-aldehyde 550 m
g (1.04 mmol) in 5 ml of water and 10 ml of methylene chloride.
The mixture was dissolved in ice-cold water and cooled under ice-cooling, 439 mg of 2-methyl-butene.
(6.26 mmol), 151 mg of amidosulfuric acid (1.5 mg)
6 mmol), 329 mg of sodium chlorite (3.6
4 mmol) and stirred at room temperature for 1 hour. Water was added to the reaction solution, extracted with chloroform, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 268 mg, Yield: 47% MS (ESI.m / z) 544 (MH +) H-NMR (CDCl3): 2.07 (2H, quint), 2.37 (3H, s), 3.6
3 (2H, t), 3.78 (3H, s), 4.14 (2H, t), 4.49 (2H, t)
s), 5.94 (2H, s), 6.53-7.10 (7H, m), 7.24-7.29 (5
H, m)
【0192】実施例32 4−[3−(2−ヒドロキシ
プロポキシ)−4−メトキシ−フェニル]−6−メチル
−2−(3、4−メチレンジオキシフェノキシ)−ピリ
ジン−3−カルボン酸の合成 4−(3−ベンジルオキシプロポキシ−4−メトキシ−
フェニル)−6−メチル−2−(3、4−メチレンジオ
キシフェノキシ)−ピリジン−3−カルボン酸130m
g(0.239mmol)をエタノール5ml、クロロ
ホルム2mlに溶かし、10%パラジウム炭素を触媒量
加えて、水素雰囲気下(1atm)室温にて5時間攪拌
した。反応溶液を濾過しエタノールで洗浄後、濾液を減
圧下溶媒留去した。得られた残渣をクロロホルム、ヘキ
サンから再結晶して表題化合物を得た。 収量:60mg、収率:55% MS(ESI.m/z) 454(MH+) H-NMR (CDCl3):2.04 (2H, t)、2.41 (3H, s)、3.84-3.
88 (5H, m)、4.23 (2H, t)、5.98 (2H, s)、6.60-7.15
(7H, m)Example 32 Synthesis of 4- [3- (2-hydroxypropoxy) -4-methoxy-phenyl] -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 4- (3-benzyloxypropoxy-4-methoxy-
Phenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 130 m
g (0.239 mmol) was dissolved in 5 ml of ethanol and 2 ml of chloroform, a catalytic amount of 10% palladium carbon was added, and the mixture was stirred at room temperature under a hydrogen atmosphere (1 atm) for 5 hours. After the reaction solution was filtered and washed with ethanol, the filtrate was evaporated under reduced pressure. The obtained residue was recrystallized from chloroform and hexane to give the title compound. Yield: 60 mg, Yield: 55% MS (ESI.m / z) 454 (MH +) H-NMR (CDCl3): 2.04 (2H, t), 2.41 (3H, s), 3.84-3.
88 (5H, m), 4.23 (2H, t), 5.98 (2H, s), 6.60-7.15
(7H, m)
【0193】実施例33 4−(2−ベンジルオキシプ
ロポキシ−5−メトキシ−フェニル)−6−メチル−2
−(3、4−メチレンジオキシフェノキシ)−ピリジン
−3−カルボン酸の合成 1)2−ベンジルオキシプロポキシ−5ーメトキシ−ベ
ンズアルデヒドの合成 アルゴン雰囲気下、2−ヒドロキシ−5−メトキシベン
ズアルデヒド2.00g(13.1mmol)をDMF
20mlに溶かし、60%水素化ナトリウム632mg
(15.8mmol)を加え室温にて1時間攪拌した。
その後メタンスルホン酸ベンジルオキシプロピルエステ
ル3.86g(15.8mmol)を室温にて加え、8
0℃にて8時間攪拌した。反応溶液に水を加え酢酸エチ
ルにて抽出し、無水硫酸マグネシウムで乾燥後溶媒を減
圧留去し、得られた残渣をカラムクロマトグラフィー
(溶離液 ヘキサン:酢酸エチル 10:1)に付し、
表題化合物を得た。 収量:1.97g、収率:50% H-NMR (CDCl3):2.12 (2H, quint)、3.67 (2H, t)、3.8
0 (3H, s)、4.15 (2H,t)、4.52 (2H, s)、6.93-7.32 (8
H, m)、10.4 (1H, s)Example 33 4- (2-benzyloxypropoxy-5-methoxy-phenyl) -6-methyl-2
Synthesis of-(3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 1) Synthesis of 2-benzyloxypropoxy-5-methoxy-benzaldehyde Under an argon atmosphere, 2.00 g of 2-hydroxy-5-methoxybenzaldehyde ( 13.1 mmol) in DMF
Dissolve in 20 ml, 632 mg of 60% sodium hydride
(15.8 mmol) and the mixture was stirred at room temperature for 1 hour.
Thereafter, 3.86 g (15.8 mmol) of benzylsulfonic acid methanesulfonate was added at room temperature to give 8
Stirred at 0 ° C. for 8 hours. Water was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography (eluent hexane: ethyl acetate 10: 1),
The title compound was obtained. Yield: 1.97 g, 50% H-NMR (CDCl3): 2.12 (2H, quint), 3.67 (2H, t), 3.8
0 (3H, s), 4.15 (2H, t), 4.52 (2H, s), 6.93-7.32 (8
H, m), 10.4 (1H, s)
【0194】2)1−(2−ベンジルオキシプロポキシ
−5−メトキシ−フェニル)−1−ブテニル−3−オン
の合成 アセトニルトリフェニルホスホニウム クロリド3.4
9g(9.84mmol) をエタノール(30ml)
に溶かしナトリウムエトキシド670mg(9.84m
mol)を0℃にて加えた。室温に戻し、1時間攪拌し
た後、2−ベンジルオキシプロポキシ−5ーメトキシ−
ベンズアルデヒド1.97g(6.56mmol)を加
え1晩攪拌した。反応溶液を減圧下溶媒留去し、残渣に
水を加え、酢酸エチルにて抽出した。有機相を飽和食塩
水 にて洗浄し、無水硫酸マグネシウムで乾燥、減圧下
溶媒留去して粗製生成物を得た。これをシリカゲル上で
ヘキサン/酢酸エチル(3:1)を用いて精製し表題化
合物を得た。 収量:1.82g、収率:82% MS(ESI. m/z) 363(M+Na+) H-NMR (CDCl3):2.13 (2H, quint)、2.32 (3H, s)、3.6
9 (2H, t)、3.79 (3H,s)、4.12 (2H, t)、4.53 (2H,
s)、6.69 (1H, d)、6.85-6.94 (2H, m)、7.07 (1H,
d)、7.24-7.32 (5H, m)、7.82 (1H, d)2) Synthesis of 1- (2-benzyloxypropoxy-5-methoxy-phenyl) -1-butenyl-3-one Acetonyltriphenylphosphonium chloride 3.4
9 g (9.84 mmol) of ethanol (30 ml)
Sodium ethoxide 670mg (9.84m
mol) was added at 0 ° C. After returning to room temperature and stirring for 1 hour, 2-benzyloxypropoxy-5-methoxy-
1.97 g (6.56 mmol) of benzaldehyde was added and stirred overnight. The solvent was distilled off from the reaction solution under reduced pressure, water was added to the residue, and the mixture was extracted with ethyl acetate. The organic phase was washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain a crude product. This was purified on silica gel using hexane / ethyl acetate (3: 1) to give the title compound. Yield: 1.82 g, yield: 82% MS (ESI. M / z) 363 (M + Na +) H-NMR (CDCl3): 2.13 (2H, quint), 2.32 (3H, s), 3.6
9 (2H, t), 3.79 (3H, s), 4.12 (2H, t), 4.53 (2H,
s), 6.69 (1H, d), 6.85-6.94 (2H, m), 7.07 (1H,
d), 7.24-7.32 (5H, m), 7.82 (1H, d)
【0195】3)4−(2−ベンジルオキシプロポキシ
−5−メトキシ−フェニル)−3−シアノ−6−メチル
−2−ピリドンの合成 α−シアノアセトアミド495mg(589mmol)
をDMSO20mlに溶かし、アルゴン雰囲気下、t−
ブトキシカリウム600g(5.35mmol)、1−
(2−ベンジルオキシプロポキシ−5−メトキシ−フェ
ニル)−1−ブテニル−3−オン1.82g(5.35
mmol)を室温にて順次加えて、15分間攪拌した。
TLCにて原料の消失を確認した後、t−ブトキシカリ
ウム1.80g(16.1mmol)を加え、酸素を1
分間バブリングし、酸素雰囲気下1時間攪拌した。反応
溶液に3規定 塩酸を20ml加えて1時間攪拌する
と、黄褐色の結晶物質が析出した。この結晶を吸引濾過
し、水、ヘキサン/酢酸エチル(1:1)混合液で順次
洗浄し、100℃において1晩乾燥させて表題化合物を
得た。 収量:1.73g、収率:80% MS(ESI.m/z) 427(M+Na+) H-NMR (CDCl3):2.04 (2H, quint)、2.40 (3H, s)、3.5
7 (2H, t)、3.80 (3H,s)、4.10 (2H, t)、4.49 (2H,
s)、6.18 (1H, s)、6.82-6.96 (2H, m)、7.25-7.31 (7
H, m)3) Synthesis of 4- (2-benzyloxypropoxy-5-methoxy-phenyl) -3-cyano-6-methyl-2-pyridone 495 mg (589 mmol) of α-cyanoacetamide
Was dissolved in 20 ml of DMSO, and t-
600 g (5.35 mmol) of potassium butoxy, 1-
1.82 g of (2-benzyloxypropoxy-5-methoxy-phenyl) -1-butenyl-3-one (5.35
(mmol) at room temperature and stirred for 15 minutes.
After confirming the disappearance of the raw materials by TLC, 1.80 g (16.1 mmol) of potassium t-butoxide was added, and oxygen was added to 1%.
The mixture was bubbled for 1 minute and stirred for 1 hour under an oxygen atmosphere. When 20 ml of 3N hydrochloric acid was added to the reaction solution and stirred for 1 hour, a yellow-brown crystalline substance was deposited. The crystals were filtered off with suction, washed successively with a mixture of water and hexane / ethyl acetate (1: 1) and dried at 100 ° C. overnight to give the title compound. Yield: 1.73 g, 80% MS (ESI.m / z) 427 (M + Na +) H-NMR (CDCl3): 2.04 (2H, quint), 2.40 (3H, s), 3.5
7 (2H, t), 3.80 (3H, s), 4.10 (2H, t), 4.49 (2H, t)
s), 6.18 (1H, s), 6.82-6.96 (2H, m), 7.25-7.31 (7
H, m)
【0196】4)4−(2−ベンジルオキシプロポキシ
−5−メトキシ−フェニル)−2−クロロ−3−シアノ
−6−メチル−ピリジンの合成 4−(2−ベンジルオキシプロポキシ−5−メトキシ−
フェニル)−3−シアノ−6−メチル−2−ピリドン
1.73g(4.28mmol)にオキシ塩化リン10
mlを加え、100℃にて5時間攪拌した。この後、減
圧下にてオキシ塩化リンを留去し、残渣を酢酸エチル中
に加え、水、飽和重曹水、飽和食塩水で順次洗浄する。
無水硫酸マグネシウムで乾燥後、溶媒を留去して、表題
化合物を得た。 収量:1.36g、収率:75% MS(ESI.m/z) 445(M+Na+) H-NMR (CDCl3):2.01 (2H, quint)、2.60 (3H, s)、3.5
3 (2H, t)、3.80 (3H,s)、4.10 (2H, t)、4.48 (2H,
s)、6.79-7.32 (9H, m)4) Synthesis of 4- (2-benzyloxypropoxy-5-methoxy-phenyl) -2-chloro-3-cyano-6-methyl-pyridine 4- (2-benzyloxypropoxy-5-methoxy-pyridine)
Phosphorous oxychloride was added to 1.73 g (4.28 mmol) of phenyl) -3-cyano-6-methyl-2-pyridone.
Then, the mixture was stirred at 100 ° C. for 5 hours. Thereafter, phosphorus oxychloride is distilled off under reduced pressure, the residue is added to ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated brine in that order.
After drying over anhydrous magnesium sulfate, the solvent was distilled off to obtain the title compound. Yield: 1.36 g, yield: 75% MS (ESI.m / z) 445 (M + Na +) H-NMR (CDCl3): 2.01 (2H, quint), 2.60 (3H, s), 3.5
3 (2H, t), 3.80 (3H, s), 4.10 (2H, t), 4.48 (2H, t)
s), 6.79-7.32 (9H, m)
【0197】5)4−(2−ベンジルオキシプロポキシ
−5−メトキシ−フェニル)−3−シアノ−6−メチル
−2−(3、4−メチレンジオキシフェノキシ)−ピリ
ジンの合成 アルゴン雰囲気下、セサモール533mg(3.86m
mol)をDMF10mlに溶かし、60%水素化ナト
リウム154mg(3.86mmol)を0℃にて加
え、1時間攪拌した。この後、4−(2−ベンジルオキ
シプロポキシ−5−メトキシ−フェニル)−2−クロロ
−3−シアノ−6−メチル−ピリジン1.36g(3.
22mmol)を加え、80℃にて12時間攪拌した。
反応溶液を水にあけ、酢酸エチルで有機層を抽出し、無
水硫酸マグネシウムで乾燥後溶媒を減圧留去し、得られ
た残渣をカラムクロマトグラフィー(溶離液 ヘキサ
ン:酢酸エチル 3:1)に付し、表題化合物を得た。 収量:550mg、収率:33% MS(ESI.m/z) 547(M+Na+) H-NMR (CDCl3):2.03 (2H, quint)、2.41 (3H, s)、3.5
6 (2H, t)、3.80 (3H,s)、4.11 (2H, t)、4.48 (2H,
s)、5.99 (2H, s)、6.63-6.97 (7H, m)、7.22-7.31 (5
H, m)5) Synthesis of 4- (2-benzyloxypropoxy-5-methoxy-phenyl) -3-cyano-6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine Sesamol under argon atmosphere 533mg (3.86m
mol) was dissolved in 10 ml of DMF, 154 mg (3.86 mmol) of 60% sodium hydride was added at 0 ° C., and the mixture was stirred for 1 hour. This was followed by 1.36 g of 4- (2-benzyloxypropoxy-5-methoxy-phenyl) -2-chloro-3-cyano-6-methyl-pyridine (3.
22 mmol) and stirred at 80 ° C. for 12 hours.
The reaction solution was poured into water, the organic layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography (eluent hexane: ethyl acetate 3: 1). To give the title compound. Yield: 550 mg, yield: 33% MS (ESI.m / z) 547 (M + Na +) H-NMR (CDCl3): 2.03 (2H, quint), 2.41 (3H, s), 3.5
6 (2H, t), 3.80 (3H, s), 4.11 (2H, t), 4.48 (2H, t)
s), 5.99 (2H, s), 6.63-6.97 (7H, m), 7.22-7.31 (5
H, m)
【0198】6)4−(2−ベンジルオキシプロポキシ
−5−メトキシ−フェニル)−6−メチル−2−(3、
4−メチレンジオキシフェノキシ)−ピリジン−3−ア
ルデヒドの合成 アルゴン雰囲気下、塩化メチレン10ml中、4−(2
−ベンジルオキシプロポキシ−5−メトキシ−フェニ
ル)−3−シアノ−6−メチル−2−(3、4−メチレ
ンジオキシフェノキシ)−ピリジン550mg(1.0
5mmol)を溶かし、水素化ジイソブチルアルミニウ
ム1Mヘキサン溶液3.15mlを0℃にて加え、室温
にて1晩攪拌した。水1mlを加え1時間攪拌した後、
セライト濾過し残渣を酢酸エチルにて洗浄した。濾液を
減圧下にて溶媒留去し、得られた残渣をカラムクロマト
グラフィー(溶離液 クロロホルム)に付し、表題化合
物を得た。 収量:430mg、収率:78% MS(ESI.m/z) 550(M+Na+) H-NMR (CDCl3):2.03 (2H, quint)、2.41 (3H, s)、3.5
6 (2H, t)、3.80 (3H,s)、4.11 (2H, t)、4.48 (2H,
s)、5.99 (2H, s)、6.63-6.97 (7H, m)、7.25-7.31 (5
H, m)、10.2 (1H, s)6) 4- (2-benzyloxypropoxy-5-methoxy-phenyl) -6-methyl-2- (3,
Synthesis of 4-methylenedioxyphenoxy) -pyridine-3-aldehyde In an argon atmosphere, 4- (2
Benzyloxypropoxy-5-methoxy-phenyl) -3-cyano-6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine 550 mg (1.0 mg)
5 mmol) was dissolved, and 3.15 ml of a 1M solution of diisobutylaluminum hydride in hexane was added at 0 ° C., followed by stirring at room temperature overnight. After adding 1 ml of water and stirring for 1 hour,
After filtration through celite, the residue was washed with ethyl acetate. The solvent was distilled off from the filtrate under reduced pressure, and the obtained residue was subjected to column chromatography (eluent: chloroform) to obtain the title compound. Yield: 430 mg, Yield: 78% MS (ESI.m / z) 550 (M + Na +) H-NMR (CDCl3): 2.03 (2H, quint), 2.41 (3H, s), 3.5
6 (2H, t), 3.80 (3H, s), 4.11 (2H, t), 4.48 (2H, t)
s), 5.99 (2H, s), 6.63-6.97 (7H, m), 7.25-7.31 (5
H, m), 10.2 (1H, s)
【0199】7)4−(2−ベンジルオキシプロポキシ
−5−メトキシ−フェニル)−6−メチル−2−(3、
4−メチレンジオキシフェノキシ)−ピリジン−3−カ
ルボン酸の合成 4−(2−ベンジルオキシプロポキシ−5−メトキシ−
フェニル)−6−メチル−2−(3、4−メチレンジオ
キシフェノキシ)−ピリジン−3−アルデヒド430m
g(0.815mmol)を水5ml,塩化メチレン1
0mlに溶かし、氷冷下、2−メチル−ブテン343m
g(4.89mmol),アミド硫酸118mg(1.
22mmol),亜塩素酸ナトリウム258mg(2.
85mmol)を加え、室温にて2時間攪拌した。反応
溶液に水を加え、クロロホルムにて抽出し、無水硫酸マ
グネシウムで乾燥後、減圧下にて溶媒留去した。得られ
た残渣をカラムクロマトグラフィー(溶離液 クロロホ
ルム:メタノール 9:1)にて精製し、表題化合物を
得た。 収量:34mg、収率:8% MS(ESI.m/z) 544(MH+) H-NMR (CDCl3):1.90 (2H, quint)、2.35 (3H, quin
t)、3.44 (2H, t)、3.71(3H, s)、3.93 (2H, t)、4.39
(2H, s)、5.94 (2H, s)、6.55-6.83 (7H, m)、7.22-7.2
8 (5H, m)7) 4- (2-benzyloxypropoxy-5-methoxy-phenyl) -6-methyl-2- (3,
Synthesis of 4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 4- (2-benzyloxypropoxy-5-methoxy-
Phenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-aldehyde 430 m
g (0.815 mmol) in 5 ml of water, methylene chloride 1
0 ml, and cooled under ice-cooling, 343 m 2-methyl-butene
g (4.89 mmol), 118 mg of amidosulfuric acid (1.
22 mmol), 258 mg of sodium chlorite (2.
85 mmol) and stirred at room temperature for 2 hours. Water was added to the reaction solution, extracted with chloroform, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 34 mg, Yield: 8% MS (ESI.m / z) 544 (MH +) H-NMR (CDCl3): 1.90 (2H, quint), 2.35 (3H, quin)
t), 3.44 (2H, t), 3.71 (3H, s), 3.93 (2H, t), 4.39
(2H, s), 5.94 (2H, s), 6.55-6.83 (7H, m), 7.22-7.2
8 (5H, m)
【0200】実施例34 4−[2−(2−ヒドロキシ
プロポキシ)−5−メトキシ−フェニル]−6−メチル
−2−(3、4−メチレンジオキシフェノキシ)−ピリ
ジン−3−カルボン酸の合成 4−(2−ベンジルオキシプロポキシ−5−メトキシ−
フェニル)−6−メチル−2−(3、4−メチレンジオ
キシフェノキシ)−ピリジン−3−カルボン酸26mg
(0.0478mmol)をエタノール5mlに溶か
し、10%パラジウム炭素を触媒量加えて、水素雰囲気
下(1atm)室温にて48時間攪拌した。反応溶液を
濾過しエタノールで洗浄後、濾液を減圧下溶媒留去し
た。得られた残渣をクロロホルム、ヘキサンから再結晶
して表題化合物を得た。 収量:18mg、収率:83% MS(ESI.m/z) 454(MH+) H-NMR (CDCl3):1.88 (2H, br s)、2.41 (3H, s)、3.65
(2H, br s)、3.78 (3H, s)、4.01 (2H, br s)、5.98
(2H, s)、6.61-6.87 (7H, m)Example 34 Synthesis of 4- [2- (2-hydroxypropoxy) -5-methoxy-phenyl] -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 4- (2-benzyloxypropoxy-5-methoxy-
26 mg of phenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid
(0.0478 mmol) was dissolved in 5 ml of ethanol, a catalytic amount of 10% palladium carbon was added, and the mixture was stirred under a hydrogen atmosphere (1 atm) at room temperature for 48 hours. After the reaction solution was filtered and washed with ethanol, the filtrate was evaporated under reduced pressure. The obtained residue was recrystallized from chloroform and hexane to give the title compound. Yield: 18 mg, Yield: 83% MS (ESI.m / z) 454 (MH +) H-NMR (CDCl3): 1.88 (2H, br s), 2.41 (3H, s), 3.65
(2H, br s), 3.78 (3H, s), 4.01 (2H, br s), 5.98
(2H, s), 6.61-6.87 (7H, m)
【0201】実施例35 6−(2−(5−メチルフリ
ル))−4−(4−メトキシフェニル)−2−(3、4
−メチレンジオキシフェニルオキシ)ピリジン−3−カ
ルボン酸の合成 1)2−(3−(4−メトキシフェニル)−2−プロペ
ノイル)−5−メチルフランの合成 2−アセチル−5−メチルフラン2.48g(20.0
mmol)、p−アニスアルデヒド2.43ml(2
0.0mmol)のTHF50ml溶液に1規定水酸化
ナトリウム溶液20mlを加え室温で4日間攪拌する。
酢酸エチルで抽出し、水、1規定塩酸、飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧下溶媒を留去
し残渣をシリカゲルカラムクロマトグラフィー(酢酸エ
チル:ヘキサン 1:5ついで1:1)に付し表題化合
物を得た。 収量:2.45g、収率:50.5% MS(ESI,m/z) 243 (MH+) H-NMR(CDCl3):2.44 (3H, s)、3.85 (3H, s)、6.21 (1
H, dd)、6.93 (2H, d)、7.23 (1H, d)、7.25 (1H, d)、
7.60 (2H, d)、7.83 (1H, d)Example 35 6- (2- (5-Methylfuryl))-4- (4-methoxyphenyl) -2- (3,4
Synthesis of -methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) Synthesis of 2- (3- (4-methoxyphenyl) -2-propenoyl) -5-methylfuran 2-acetyl-5-methylfuran 48 g (20.0
mmol), 2.43 ml of p-anisaldehyde (2
(0.0 mmol) in THF (50 ml) is added with 1N sodium hydroxide solution (20 ml) and stirred at room temperature for 4 days.
After extraction with ethyl acetate, washing with water, 1N hydrochloric acid and saturated saline, drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 5, then 1: 1). ) To give the title compound. Yield: 2.45 g, 50.5% MS (ESI, m / z) 243 (MH +) H-NMR (CDCl3): 2.44 (3H, s), 3.85 (3H, s), 6.21 (1
H, dd), 6.93 (2H, d), 7.23 (1H, d), 7.25 (1H, d),
7.60 (2H, d), 7.83 (1H, d)
【0202】2)3−シアノ−4−(4−メトキシフェ
ニル)−6−(2−(5−メチルフリル))ピリドンの
合成 アルゴン雰囲気下、室温でシアノアセトアミド850m
g(10.1mmol)、t−ブトキシカリウム1.1
3g(10.1mmol)のDMSO10ml溶液に2
−(3−(4−メトキシフェニル)−2−プロペノイ
ル)−5−メチルフラン2.45g(10.1mmo
l)のDMSO20mlを加え15分間攪拌する。t−
ブトキシカリウム3.40g(30.3mmol)を加
え1分間酸素をバブリングする。酸素雰囲気下1時間攪
拌した後、1規定塩酸を氷冷下加え析出した結晶を濾取
する。水で洗い減圧下乾燥し表題化合物を得た。この化
合物は精製せずに以下の反応に用いる。 収量:2.66g、収率:86.0% MS(ESI,m/z) 282 (MH+) H-NMR(CDCl3):2.44 (3H, s)、3.89 (3H, s)、6.25 (1
H, s)、6.74 (1H, s)、7.04 (2H, d)、7.67-7.70 (3H,
m)2) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6- (2- (5-methylfuryl)) pyridone Cyanoacetamide (850 m) at room temperature under an argon atmosphere.
g (10.1 mmol), potassium t-butoxide 1.1
3 g (10.1 mmol) of DMSO in 10 ml
2.45 g of (-(3- (4-methoxyphenyl) -2-propenoyl) -5-methylfuran (10.1 mmol
1) 20 ml of DMSO is added and stirred for 15 minutes. t-
3.40 g (30.3 mmol) of potassium butoxide is added and oxygen is bubbled for 1 minute. After stirring for 1 hour in an oxygen atmosphere, 1N hydrochloric acid is added under ice cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 2.66 g, yield: 86.0% MS (ESI, m / z) 282 (MH +) H-NMR (CDCl3): 2.44 (3H, s), 3.89 (3H, s), 6.25 (1
H, s), 6.74 (1H, s), 7.04 (2H, d), 7.67-7.70 (3H,
m)
【0203】3)2−クロロ−3−シアノ−4−(4−
メトキシフェニル)−6−(2−(5−メチルフリ
ル))ピリジンの合成 3−シアノ−4−(4−メトキシフェニル)−6−(5
−メチルフリル)ピリドン2.66g(8.7mmo
l)をオキシ塩化リン15mlに溶解し90℃で一晩攪
拌する。オキシ塩化リンを減圧下留去し残渣を酢酸エチ
ルに溶解する。飽和重曹水、飽和食塩水で洗浄し無水硫
酸マグネシウムで乾燥する。減圧下溶媒を留去し得られ
る結晶を酢酸エチルで洗浄し表題化合物を得た。このも
のはこれ以上精製せずに以下の反応に利用した。 収量:2.60g H-NMR(CDCl3):2.42 (3H, s)、3.90 (3H, s)、6.21 (1
H, d)、7.05 (2H, d)、7.22 (1H, d)、7.60 (1H, s)、
7.684 (2H, d)3) 2-chloro-3-cyano-4- (4-
Synthesis of methoxyphenyl) -6- (2- (5-methylfuryl)) pyridine 3-cyano-4- (4-methoxyphenyl) -6- (5
-Methylfuryl) pyridone 2.66 g (8.7 mmo
1) is dissolved in 15 ml of phosphorus oxychloride and stirred at 90 ° C. overnight. The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The crystals obtained by evaporating the solvent under reduced pressure were washed with ethyl acetate to obtain the title compound. This was used for the following reaction without further purification. Yield: 2.60 g H-NMR (CDCl3): 2.42 (3H, s), 3.90 (3H, s), 6.21 (1
H, d), 7.05 (2H, d), 7.22 (1H, d), 7.60 (1H, s),
7.684 (2H, d)
【0204】4)3−シアノ−4−(4−メトキシフェ
ニル)−6−(2−(5−メチルフリル))−2−
(3、4−メチレンジオキシフェニルオキシ)ピリジン
の合成 セサモール1.20g(8.7mmol)、水素化ナト
リウム700mg(60%オイルディスパージョン、1
7.5mmol)より作成したフェノキシドイオンのD
MF20ml溶液に2−クロロ−3−シアノ−4−(4
−メトキシフェニル)−6−(2−(5−メチルフリ
ル))ピリジン2.60gを加えアルゴン雰囲気下室温
で1時間攪拌する。減圧下溶媒を留去し、残渣を酢酸エ
チルに溶解し、水、飽和食塩水で洗浄する。無水硫酸マ
グネシウムで乾燥し減圧下溶媒を留去して得られる残渣
をシリカゲルカラムクロマトグラフィー(酢酸エチル:
ヘキサン 1:3)に付し得られる結晶をさらに酢酸エ
チル:ヘキサン 1:1で洗浄すると、表題化合物を得
た。 収量:750mg、収率:3−シアノ−4−(4−メト
キシフェニル)−6−(5−メチルフリル)ピリドンよ
り20.2% MS(ESI,m/z) 427 (MH+) H-NMR(CDCl3):2.37 (3H, s)、3.89 (3H, s)、6.03 (2
H, s)、6.10 (1H, d)、6.72 (1H, dd)、6.80-84 (3H,
m)、7.06 (2H, d)、7.39 (1H, s)、7.68 (2H, d)4) 3-Cyano-4- (4-methoxyphenyl) -6- (2- (5-methylfuryl))-2-
Synthesis of (3,4-methylenedioxyphenyloxy) pyridine 1.20 g (8.7 mmol) of sesamol, 700 mg of sodium hydride (60% oil dispersion, 1
7.5 mmol) of phenoxide ion prepared from
2-chloro-3-cyano-4- (4
2.60 g of -methoxyphenyl) -6- (2- (5-methylfuryl)) pyridine are added, and the mixture is stirred at room temperature for 1 hour under an argon atmosphere. The solvent is distilled off under reduced pressure, the residue is dissolved in ethyl acetate, and washed with water and saturated saline. The residue obtained by drying over anhydrous magnesium sulfate and evaporating the solvent under reduced pressure is subjected to silica gel column chromatography (ethyl acetate:
The crystals obtained by hexane 1: 3) were further washed with ethyl acetate: hexane 1: 1 to give the title compound. Yield: 750 mg, Yield: 20.2% from 3-cyano-4- (4-methoxyphenyl) -6- (5-methylfuryl) pyridone MS (ESI, m / z) 427 (MH +) H-NMR ( CDCl3): 2.37 (3H, s), 3.89 (3H, s), 6.03 (2
H, s), 6.10 (1H, d), 6.72 (1H, dd), 6.80-84 (3H,
m), 7.06 (2H, d), 7.39 (1H, s), 7.68 (2H, d)
【0205】5)6−(2−(5−メチルフリル))−
4−(4−メトキシフェニル)−2−(3、4−メチレ
ンジオキシフェニルオキシ)ピリジン−3−アルデヒド
の合成 3−シアノ−4−(4−メトキシフェニル)−6−(2
−(5−メチルフリル))−2−(3、4−メチレンジ
オキシフェニルオキシ)ピリジン300mg(0.7m
mol)をベンゼン10mlに溶解しアルゴン雰囲気下
室温で水素化ジイソブチルアルミニウム1Mヘキサン溶
液2.8ml(2.8mmol)を滴下する。室温で2
時間攪拌しメタノールと水で反応を停止する。室温で3
0分攪拌し、不溶物をセライトを用いて濾過する。濾液
をを減圧下留去し得られた残査をシリカゲルカラムクロ
マトグラフィー(酢酸エチル:ヘキサン 1:3)に付
し表題化合物を得た。このものは分離困難な不純物を含
むがこれ以上精製せずに以下の反応に用いる。 収量:90mg5) 6- (2- (5-methylfuryl))-
Synthesis of 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 3-cyano-4- (4-methoxyphenyl) -6- (2
-(5-methylfuryl))-2- (3,4-methylenedioxyphenyloxy) pyridine 300 mg (0.7 m
mol) was dissolved in 10 ml of benzene, and 2.8 ml (2.8 mmol) of a 1 M solution of diisobutylaluminum hydride in hexane was added dropwise at room temperature under an argon atmosphere. 2 at room temperature
Stir for an hour and terminate the reaction with methanol and water. 3 at room temperature
After stirring for 0 minutes, the insoluble matter is filtered using Celite. The filtrate was evaporated under reduced pressure, and the resulting residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to give the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 90mg
【0206】6)6−(2−(5−メチルフリル))−
4−(4−メトキシフェニル)−2−(3、4−メチレ
ンジオキシフェニルオキシ)ピリジン−3−カルボン酸
の合成 6−(2−(5−メチルフリル))−4−(4−メトキ
シフェニル)−2−(3、4−メチレンジオキシフェニ
ルオキシ)ピリジン−3−アルデヒド90mgを塩化メ
チレン2ml、水1mlに溶解し、0℃で2−メチル−
2−ブテン0.2ml(1.9mmol)、アミド硫酸
30mg(0.31mmol)、亜塩素酸ナトリウム9
0mg(0.78mmol)を加え室温に戻して1時間
攪拌する。塩化メチレンで抽出し無水硫酸マグネシウム
で乾燥して減圧下溶媒を留去する。得られた残渣をシリ
カゲル薄層クロマトグラフィー(酢酸エチル:ヘキサン
1:1)に付し表題化合物を得た。 収量:13mg、収率:3−シアノ−4−(4−メトキ
シフェニル)−6−(2−(5−メチルフリル))−2
−(3、4−メチレンジオキシフェニルオキシ)ピリジ
ンより4.2% MS(ESI,m/z) 446 (MH+) H-NMR(CDCl3):2.35 (3H, s)、3.85 (3H, s)、6.00 (2
H, s)、6.05 (1H, dd)、6.69 (1H, dd)、6.75 (1H,
d)、6.79 (1H, d)、6.80 (1H, d)、6.97 (2H, d)、7.34
(1H, s)、7.48 (2H, d)6) 6- (2- (5-methylfuryl))-
Synthesis of 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6- (2- (5-methylfuryl))-4- (4-methoxyphenyl) ) -2- (3,4-Methylenedioxyphenyloxy) pyridine-3-aldehyde (90 mg) was dissolved in methylene chloride (2 ml) and water (1 ml).
0.2 ml (1.9 mmol) of 2-butene, 30 mg (0.31 mmol) of amidosulfuric acid, sodium chlorite 9
0 mg (0.78 mmol) was added, and the mixture was returned to room temperature and stirred for 1 hour. Extract with methylene chloride, dry over anhydrous magnesium sulfate and evaporate the solvent under reduced pressure. The obtained residue was subjected to silica gel thin layer chromatography (ethyl acetate: hexane 1: 1) to give the title compound. Yield: 13 mg, yield: 3-cyano-4- (4-methoxyphenyl) -6- (2- (5-methylfuryl))-2
4.2% MS (ESI, m / z) 446 (MH +) H-NMR (CDCl3) from-(3,4-methylenedioxyphenyloxy) pyridine: 2.35 (3H, s), 3.85 (3H, s) , 6.00 (2
H, s), 6.05 (1H, dd), 6.69 (1H, dd), 6.75 (1H,
d), 6.79 (1H, d), 6.80 (1H, d), 6.97 (2H, d), 7.34
(1H, s), 7.48 (2H, d)
【0207】実施例36 6−(2−チオフェニル)−
4−(4−メトキシフェニル)−2−(3、4−メチレ
ンジオキシフェニルオキシ)ピリジン−3−カルボン酸
の合成 1)2−(3−(4−メトキシフェニル)−2−プロペ
ノイル)チオフェンの合成 2−アセチルチオフェン2.5g(19.8mmo
l)、p−アニスアルデヒド2.43ml(20.0m
mol)のTHF50ml溶液に1規定水酸化ナトリウ
ム溶液20mlを加え室温で4日間攪拌する。酢酸エチ
ルで抽出し、水、1規定塩酸、飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧下溶媒を留去し残渣を
シリカゲルカラムクロマトグラフィー(酢酸エチル:ヘ
キサン 1:3)に付し表題化合物を得た。 収量:2.76g、収率:57.1% MS(ESI,m/z) 245 (MH+) H-NMR(CDCl3):3.86 (3H, s)、6.94 (2H, d)、7.18 (1
H, dd)、7.31 (1H, d)、7.60 (2H, d)、7.66 (1H, d
d)、7.83 (1H, d)、7.85 (1H, m)Example 36 6- (2-thiophenyl)-
Synthesis of 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) Synthesis of 2- (3- (4-methoxyphenyl) -2-propenoyl) thiophene Synthesis 2-acetylthiophene 2.5 g (19.8 mmol)
l), p-anisaldehyde 2.43 ml (20.0 m
mol) in 50 ml of THF, 20 ml of a 1N sodium hydroxide solution is added, and the mixture is stirred at room temperature for 4 days. After extraction with ethyl acetate, washing with water, 1N hydrochloric acid and saturated saline, drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3). The title compound was obtained. Yield: 2.76 g, 57.1% MS (ESI, m / z) 245 (MH +) H-NMR (CDCl3): 3.86 (3H, s), 6.94 (2H, d), 7.18 (1
H, dd), 7.31 (1H, d), 7.60 (2H, d), 7.66 (1H, d
d), 7.83 (1H, d), 7.85 (1H, m)
【0208】2)3−シアノ−4−(4−メトキシフェ
ニル)−6−(2−チオフェニル)ピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド950m
g(11.3mmol)、t−ブトキシカリウム1.2
7g(11.3mmol)のDMSO10ml溶液に2
−(3−(4−メトキシフェニル)−2−プロペノイ
ル)チオフェン2.76g(11.3mmol)のDM
SO20mlを加え15分間攪拌する。t−ブトキシカ
リウム3.80g(33.9mmol)を加え1分間酸
素をバブリングする。酸素雰囲気下1時間攪拌した後、
1規定塩酸を氷冷下加え析出した結晶を濾取する。水で
洗い減圧下乾燥し表題化合物を得た。この化合物は精製
せずに以下の反応に用いる。 収量:3.87g、収率:定量的 MS(ESI,m/z) 309 (MH+)2) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6- (2-thiophenyl) pyridone Cyanoacetamide (950 m) at room temperature under an argon atmosphere.
g (11.3 mmol), potassium t-butoxide 1.2
7 g (11.3 mmol) of DMSO in 10 ml
2.76 g (11.3 mmol) of-(3- (4-methoxyphenyl) -2-propenoyl) thiophene in DM
Add 20 ml of SO and stir for 15 minutes. 3.80 g (33.9 mmol) of potassium t-butoxide are added, and oxygen is bubbled for 1 minute. After stirring for 1 hour in an oxygen atmosphere,
1N hydrochloric acid is added under ice cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 3.87 g, yield: quantitative MS (ESI, m / z) 309 (MH +)
【0209】3)2−クロロ−3−シアノ−4−(4−
メトキシフェニル)−6−(2−チオフェニル)ピリジ
ンの合成 3−シアノ−4−(4−メトキシフェニル)−6−チオ
フェニルピリドン3.87g(12.6mmol)をオ
キシ塩化リン15mlに溶解し70℃で一晩攪拌する。
オキシ塩化リンを減圧下留去し残渣を酢酸エチルに溶解
する。飽和重曹水、飽和食塩水で洗浄し無水硫酸マグネ
シウムで乾燥する。減圧下溶媒を留去し得られる結晶を
酢酸エチルで洗浄し表題化合物を得た。このものはこれ
以上精製せずに以下の反応に利用した。 収量:2.21g MS(ESI,m/z) 284 (MH+) H-NMR(CDCl3):3.89 (3H, s)、6.96 (2H, d)、7.17 (1
H, dd)、7.56 (1H, dd)、7.58 (1H, s)、7.61 (2H,
d)、7.77 (1H, dd)3) 2-chloro-3-cyano-4- (4-
Synthesis of methoxyphenyl) -6- (2-thiophenyl) pyridine 3.87 g (12.6 mmol) of 3-cyano-4- (4-methoxyphenyl) -6-thiophenylpyridone was dissolved in 15 ml of phosphorus oxychloride and the temperature was 70 ° C. And stir overnight.
The phosphorus oxychloride is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate. The extract is washed with saturated aqueous sodium hydrogen carbonate and saturated saline and dried over anhydrous magnesium sulfate. The crystals obtained by evaporating the solvent under reduced pressure were washed with ethyl acetate to obtain the title compound. This was used for the following reaction without further purification. Yield: 2.21 g MS (ESI, m / z) 284 (MH +) H-NMR (CDCl3): 3.89 (3H, s), 6.96 (2H, d), 7.17 (1
H, dd), 7.56 (1H, dd), 7.58 (1H, s), 7.61 (2H,
d), 7.77 (1H, dd)
【0210】4)3−シアノ−4−(4−メトキシフェ
ニル)−6−(2−チオフェニル)−2−(3、4−メ
チレンジオキシフェニルオキシ)ピリジンの合成 セサモール940mg(6.8mmol)、水素化ナト
リウム540mg(60%オイルディスパージョン、1
3.5mmol)より作成したフェノキシドイオンのD
MF10ml溶液に2−クロロ−3−シアノ−4−(4
−メトキシフェニル)−6−(2−チオフェニル)ピリ
ジン2.21gをDMF20mlに溶解して加え、アル
ゴン雰囲気下室温で2時間攪拌する。減圧下溶媒を留去
し、得られる結晶を水、酢酸エチルで洗浄し表題化合物
を得た。 収量:1.82g、収率:2−(3−(4−メトキシフ
ェニル)−2−プロペノイル)チオフェンより37.6
% MS(ESI,m/z) 331 (M+Na) H-NMR(CDCl3):3.90 (3H, s)、6.04 (2H, s)、6.75 (1
H, dd)、6.84 (1H, d)、6.86 (1H, d)、7.05-7.10 (3H,
m)、7.37 (1H, s)、7.42 (1H, dd)、7.60 (1H, dd)、
7.66 (2H, d)4) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6- (2-thiophenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 940 mg (6.8 mmol) of sesamol, 540 mg of sodium hydride (60% oil dispersion, 1
D) of phenoxide ion prepared from 3.5 mmol)
2-chloro-3-cyano-4- (4
-Methoxyphenyl) -6- (2-thiophenyl) pyridine (2.21 g) dissolved in DMF (20 ml) was added, and the mixture was stirred at room temperature for 2 hours under an argon atmosphere. The solvent was distilled off under reduced pressure, and the obtained crystals were washed with water and ethyl acetate to obtain the title compound. Yield: 1.82 g, Yield: 37.6 from 2- (3- (4-methoxyphenyl) -2-propenoyl) thiophene
% MS (ESI, m / z) 331 (M + Na) H-NMR (CDCl3): 3.90 (3H, s), 6.04 (2H, s), 6.75 (1
H, dd), 6.84 (1H, d), 6.86 (1H, d), 7.05-7.10 (3H,
m), 7.37 (1H, s), 7.42 (1H, dd), 7.60 (1H, dd),
7.66 (2H, d)
【0211】5)6−(2−チオフェニル)−4−(4
−メトキシフェニル)−2−(3、4−メチレンジオキ
シフェニルオキシ)ピリジン−3−アルデヒドの合成 3−シアノ−4−(4−メトキシフェニル)−6−(2
−チオフェニル)−2−(3、4−メチレンジオキシフ
ェニルオキシ)ピリジン860mg(2.0mmol)
をベンゼン20mlに溶解しアルゴン雰囲気下室温で水
素化ジイソブチルアルミニウム1Mヘキサン溶液8.0
ml(8.0mmol)を滴下する。室温で2時間攪拌
しメタノールと水で反応を停止する。室温で30分攪拌
し、1規定塩酸を加え塩化メチレンで抽出し無水硫酸マ
グネシウムで乾燥する。溶媒をを減圧下留去し得られた
残渣をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル:ヘキサン 1:3)に付し表題化合物を得た。この
ものは分離困難な不純物を含むがこれ以上精製せずに以
下の反応に用いる。 収量:40mg MS(ESI,m/z) 432 (MH+) H-NMR(CDCl3):3.88 (3H, s)、6.03 (2H, s)、6.72 (1
H, dd)、6.82 (1H, d)、6.84 (1H, d)、7.02 (2H, d)、
7.06 (1H, dd)、7.27 (1H, s)、7.36 (2H, d)、7.40 (1
H, dd)、7.57 (1H, dd)、10.25 (1H, s)5) 6- (2-thiophenyl) -4- (4
Synthesis of -methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 3-cyano-4- (4-methoxyphenyl) -6- (2
-Thiophenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 860 mg (2.0 mmol)
Was dissolved in 20 ml of benzene, and a 1M solution of diisobutylaluminum hydride in hexane 8.0 at room temperature under an argon atmosphere.
ml (8.0 mmol) are added dropwise. Stir at room temperature for 2 hours and terminate the reaction with methanol and water. Stir at room temperature for 30 minutes, add 1N hydrochloric acid, extract with methylene chloride, and dry with anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to obtain the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 40 mg MS (ESI, m / z) 432 (MH +) H-NMR (CDCl3): 3.88 (3H, s), 6.03 (2H, s), 6.72 (1
H, dd), 6.82 (1H, d), 6.84 (1H, d), 7.02 (2H, d),
7.06 (1H, dd), 7.27 (1H, s), 7.36 (2H, d), 7.40 (1
H, dd), 7.57 (1H, dd), 10.25 (1H, s)
【0212】6)6−(2−チオフェニル)−4−(4
−メトキシフェニル)−2−(3、4−メチレンジオキ
シフェニルオキシ)ピリジン−3−カルボン酸の合成 6−(2−チオフェニル)−4−(4−メトキシフェニ
ル)−2−(3、4−メチレンジオキシフェニルオキ
シ)ピリジン−3−アルデヒド40mgを塩化メチレン
2ml、水1mlに溶解し、0℃で2−メチル−2−ブ
テン0.1ml(0.9mmol)、アミド硫酸20m
g(0.21mmol)、亜塩素酸ナトリウム40mg
(0.56mmol)を加え室温に戻して30分間攪拌
する。塩化メチレンで抽出し無水硫酸マグネシウムで乾
燥して減圧下溶媒を留去する。得られた残渣をシリカゲ
ル薄層クロマトグラフィー(酢酸エチル:ヘキサン
1:1)に付し表題化合物を得た。 収量:40mg、収率:3−シアノ−4−(4−メトキ
シフェニル)−6−(2−チオフェニル)−2−(3、
4−メチレンジオキシフェニルオキシ)ピリジンより
4.5% MS(ESI,m/z) 448 (MH+) H-NMR(CDCl3):3.79 (3H, s)、5.98 (2H, s)、6.68 (1
H, br)、6.74-6.82 (2H, m)、6.90-6.98 (2H, m)、7.04
(1H, dd)、7.28 (1H, m)、7.34 (1H, br d)、7.40-7.4
8 (2H, m)、7.50 (1H, d)6) 6- (2-thiophenyl) -4- (4
Synthesis of -methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6- (2-thiophenyl) -4- (4-methoxyphenyl) -2- (3,4- Methylenedioxyphenyloxy) pyridine-3-aldehyde (40 mg) was dissolved in methylene chloride (2 ml) and water (1 ml), and 0.1 ml (0.9 mmol) of 2-methyl-2-butene was added at 0 ° C.
g (0.21 mmol), 40 mg of sodium chlorite
(0.56 mmol) was added and the mixture was returned to room temperature and stirred for 30 minutes. Extract with methylene chloride, dry over anhydrous magnesium sulfate and evaporate the solvent under reduced pressure. The obtained residue is subjected to silica gel thin layer chromatography (ethyl acetate: hexane).
1: 1) to give the title compound. Yield: 40 mg, Yield: 3-cyano-4- (4-methoxyphenyl) -6- (2-thiophenyl) -2- (3,
4.5% MS (ESI, m / z) 448 (MH +) H-NMR (CDCl3) from 4-methylenedioxyphenyloxy) pyridine: 3.79 (3H, s), 5.98 (2H, s), 6.68 (1
H, br), 6.74-6.82 (2H, m), 6.90-6.98 (2H, m), 7.04
(1H, dd), 7.28 (1H, m), 7.34 (1H, br d), 7.40-7.4
8 (2H, m), 7.50 (1H, d)
【0213】実施例37 5−ヨード−4−(4−メト
キシフェニル)−6−メチル−2−(3、4−メチレン
ジオキシフェノキシ)−ピリジン−3−カルボン酸の合
成 1)3−シアノ−5−ヨード−4−(4−メトキシフェ
ニル)−6−メチル−2−ピリドンの合成 アルゴン雰囲気下、3−シアノ−4−(4−メトキシフ
ェニル)−6−メチル−2−ピリドン1g(4.42m
mol)をアセトニトリル10mlに溶かし、N−ヨウ
化コハク酸イミド(以下NISと略す)1.99g
(8.84mmol)を加えて、100℃にて、1時間
攪拌した。反応溶液に水を加え、酢酸エチルで抽出、無
水硫酸マグネシウムで乾燥後溶媒を減圧留去した。残渣
の結晶物をクロロホルム、ヘキサンから再結晶させ、表
題化合物を得た。 収量:940mg、収率:48% MS(ESI.m/z) 389(M+Na+) H-NMR (CDCl3):2.73 (3H, s)、3.88 (3H, s)、7.02 (2
H, d)、7.23 (2H, d)Example 37 Synthesis of 5-iodo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 1) 3-Cyano- Synthesis of 5-iodo-4- (4-methoxyphenyl) -6-methyl-2-pyridone 1 g of 3-cyano-4- (4-methoxyphenyl) -6-methyl-2-pyridone under an argon atmosphere (4. 42m
mol) was dissolved in 10 ml of acetonitrile, and 1.99 g of N-iodosuccinimide (hereinafter abbreviated as NIS) was dissolved.
(8.84 mmol), and the mixture was stirred at 100 ° C. for 1 hour. Water was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue crystal was recrystallized from chloroform and hexane to give the title compound. Yield: 940 mg, yield: 48% MS (ESI.m / z) 389 (M + Na +) H-NMR (CDCl3): 2.73 (3H, s), 3.88 (3H, s), 7.02 (2
H, d), 7.23 (2H, d)
【0214】2)2−クロロ−3−シアノ−5−ヨード
−4−(4−メトキシフェニル)−6−メチル−ピリジ
ンの合成 3−シアノ−5−ヨード−4−(4−メトキシフェニ
ル)−6−メチル−2−ピリドン940mg(2.57
mmol)にオキシ塩化リン30mlを加え、100℃
にて4時間攪拌した。この後、減圧下にてオキシ塩化リ
ンを留去し、残渣を酢酸エチル中に加え、水、飽和重曹
水、飽和食塩水で順次洗浄する。無水硫酸マグネシウム
で乾燥後、溶媒を留去して、表題化合物を得た。 収量:730mg、収率:74% H-NMR (CDCl3):2.90 ( 3H, s )、3.88 ( 3H, s )、7.0
3 ( 2H, d )、7.19 (2H, d )2) Synthesis of 2-chloro-3-cyano-5-iodo-4- (4-methoxyphenyl) -6-methyl-pyridine 3-cyano-5-iodo-4- (4-methoxyphenyl)- 940 mg of 6-methyl-2-pyridone (2.57
mmol), add 30 ml of phosphorus oxychloride, and add
For 4 hours. Thereafter, phosphorus oxychloride is distilled off under reduced pressure, the residue is added to ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated brine in that order. After drying over anhydrous magnesium sulfate, the solvent was distilled off to obtain the title compound. Yield: 730 mg, Yield: 74% H-NMR (CDCl3): 2.90 (3H, s), 3.88 (3H, s), 7.0
3 (2H, d), 7.19 (2H, d)
【0215】3)3−シアノ−5−ヨード−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−ピリジンの合成 アルゴン雰囲気下、セサモール313mg(1.89m
mol)をDMF20mlに溶かし、60%水素化ナト
リウム91mg(2.27mmol)を0℃にて加え、
1時間攪拌した。この後、2−クロロ−3−シアノ−5
−ヨード−4−(4−メトキシフェニル)−6−メチル
−ピリジン730mg(1.89mmol)を加え、室
温にて24時間攪拌した。反応溶液を水にあけ、酢酸エ
チルで有機層を抽出し、無水硫酸マグネシウムで乾燥後
溶媒を減圧留去し、得られた残渣をカラムクロマトグラ
フィー(溶離液 ヘキサン:酢酸エチル 3:1)に付
し、表題化合物を得た。 収量:400mg、収率:44% MS(ESI.m/z) 487(MH+) H-NMR (CDCl3):2.71 (3H, s)、3.88 (3H, s)、6.02 (2
H, s)、6.63-6.82 (3H, m)、7.04 (2H, d)、7.24 (2H,
d)3) 3-Cyano-5-iodo-4- (4-
Synthesis of methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine Under an argon atmosphere, 313 mg of sesamol (1.89 m
mol) was dissolved in 20 ml of DMF, and 91 mg (2.27 mmol) of 60% sodium hydride was added at 0 ° C.
Stir for 1 hour. This is followed by 2-chloro-3-cyano-5
-Iodo-4- (4-methoxyphenyl) -6-methyl-pyridine (730 mg, 1.89 mmol) was added, and the mixture was stirred at room temperature for 24 hours. The reaction solution was poured into water, the organic layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography (eluent hexane: ethyl acetate 3: 1). To give the title compound. Yield: 400 mg, Yield: 44% MS (ESI.m / z) 487 (MH +) H-NMR (CDCl3): 2.71 (3H, s), 3.88 (3H, s), 6.02 (2
H, s), 6.63-6.82 (3H, m), 7.04 (2H, d), 7.24 (2H,
d)
【0216】4)5−ヨード−4−(4−メトキシフェ
ニル)−6−メチル−2−(3、4−メチレンジオキシ
フェノキシ)−ピリジン−3−アルデヒドの合成 アルゴン雰囲気下、塩化メチレン3ml中、5−ヨード
−3−シアノ−4−(4−メトキシフェニル)−6−メ
チル−2−(3、4−メチレンジオキシフェノキシ)−
ピリジン183mg(0.376mmol)を溶かし、
水素化ジイソブチルアルミニウム1Mヘキサン溶液1.
13mlを0℃にて加え、室温にて1晩攪拌した。この
後水1mlを加え1時間攪拌した後、セライト濾過し残
渣を酢酸エチルにて洗浄した。濾液を減圧下にて溶媒留
去し、得られた残渣をカラムクロマトグラフィー(溶離
液 クロロホルム)に付し、表題化合物を得た。 収量:170mg、収率:92% MS(ESI.m/z) 490(MH+) H-NMR (CDCl3):2.70 (3H, s)、3.88 (3H, s)、6.02 (2
H, s)、6.63-6.82 (3H, m)、7.03 (2H, d)、7.24 (2H,
d)、9.91 (1H, s)4) Synthesis of 5-iodo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-aldehyde In 3 ml of methylene chloride under an argon atmosphere , 5-Iodo-3-cyano-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy)-
Dissolve 183 mg (0.376 mmol) of pyridine,
Diisobutylaluminum hydride 1M hexane solution
13 ml was added at 0 ° C., and the mixture was stirred at room temperature overnight. Thereafter, 1 ml of water was added and the mixture was stirred for 1 hour, filtered through celite, and the residue was washed with ethyl acetate. The solvent was distilled off from the filtrate under reduced pressure, and the obtained residue was subjected to column chromatography (eluent: chloroform) to obtain the title compound. Yield: 170 mg, yield: 92% MS (ESI.m / z) 490 (MH +) H-NMR (CDCl3): 2.70 (3H, s), 3.88 (3H, s), 6.02 (2
H, s), 6.63-6.82 (3H, m), 7.03 (2H, d), 7.24 (2H,
d), 9.91 (1H, s)
【0217】5)5−ヨード−4−(4−メトキシフェ
ニル)−6−メチル−2−(3、4−メチレンジオキシ
フェノキシ)−ピリジン−3−カルボン酸の合成 5−ヨード−4−(4−メトキシフェニル)−6−メチ
ル−2−(3、4−メチレンジオキシフェノキシ)−ピ
リジン−3−アルデヒド170mg(0.347mmo
l)を水5ml,塩化メチレン10mlに溶かし、氷冷
下、2−メチル−ブテン146mg(2.08mmo
l),アミド硫酸51mg(0.521mmol),亜
塩素酸ナトリウム110mg(1.21mmol)を加
え、室温にて2時間攪拌した。反応溶液に水を加え、塩
化メチレンにて抽出し、無水硫酸マグネシウムで乾燥
後、減圧下にて溶媒留去した。得られた残渣をカラムク
ロマトグラフィー(溶離液 クロロホルム:メタノール
9:1)にて精製し、表題化合物を得た。 収量:10mg、収率:6% MS(ESI.m/z) 506(MH+) H-NMR (CDCl3):2.66 (3H, s)、3.83 (3H, s)、5.99 (2
H, s)、6.58-6.78 (3H, m)、6.92 (2H, d)、7.14 (2H,
d)5) Synthesis of 5-iodo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 5-iodo-4- ( 170 mg (0.347 mmol of 4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-aldehyde
l) was dissolved in 5 ml of water and 10 ml of methylene chloride, and 146 mg (2.08 mmol) of 2-methyl-butene was added under ice-cooling.
l), 51 mg (0.521 mmol) of amidosulfuric acid and 110 mg (1.21 mmol) of sodium chlorite were added, and the mixture was stirred at room temperature for 2 hours. Water was added to the reaction solution, extracted with methylene chloride, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 10 mg, Yield: 6% MS (ESI.m / z) 506 (MH +) H-NMR (CDCl3): 2.66 (3H, s), 3.83 (3H, s), 5.99 (2
H, s), 6.58-6.78 (3H, m), 6.92 (2H, d), 7.14 (2H,
d)
【0218】実施例38 5−(3−ヒドロキシ−1−
プロペニル)−4−(4−メトキシフェニル)−6−メ
チル−2−(3、4−メチレンジオキシフェノキシ)−
ピリジン−3−カルボン酸の合成 1)3−[3−シアノ−4−メトキシフェニル−6−メ
チル−2−(3、4−メチレンジオキシフェノキシ−ピ
リジン−5−イル]−2−プロペン酸 エチルエステル
の合成 3−シアノ−5−ヨード−4−(4−メトキシフェニ
ル)−6−メチル−2−(3、4−メチレンジオキシフ
ェノキシ)−ピリジン520mg(1.07mmol)
をDMF5mlに溶かし、アクリル酸エチル134mg
(1.34mmol),Pd(OAc)212mg
(0.0535mmol),トリフェニルホスフィン2
8mg(0.107mmol),トリエチルアミン5m
lを加え、100℃にて24時間攪拌した。反応溶液に
水を加え、酢酸エチルにて抽出し、無水硫酸マグネシウ
ムで乾燥後、減圧下にて溶媒留去した。得られた残渣を
カラムクロマトグラフィー(溶離液 ヘキサン:酢酸エ
チル 5:1)にて精製し、表題化合物を得た。 収量:340mg、収率:69% MS(ESI.m/z) 459(MH+) H-NMR (CDCl3):1.25 (3H, t)、2.53 (3H, s)、3.87 (3
H, s)、4.17 (2H, q)、5.81 (1H, d)、6.01 (2H, s)、
6.65-6.83 (3H, m)、7.13 (2H, d)、7.27 (2H,d)、7.42
(1H, d)Example 38 5- (3-hydroxy-1-)
Propenyl) -4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy)-
Synthesis of pyridine-3-carboxylic acid 1) Ethyl 3- [3-cyano-4-methoxyphenyl-6-methyl-2- (3,4-methylenedioxyphenoxy-pyridin-5-yl] -2-propenoate Synthesis of ester 520 mg (1.07 mmol) of 3-cyano-5-iodo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine
Was dissolved in DMF (5 ml), and ethyl acrylate (134 mg) was dissolved.
(1.34 mmol), 212 mg of Pd (OAc)
(0.0535 mmol), triphenylphosphine 2
8 mg (0.107 mmol), triethylamine 5 m
was added and stirred at 100 ° C. for 24 hours. Water was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent hexane: ethyl acetate 5: 1) to give the title compound. Yield: 340 mg, yield: 69% MS (ESI.m / z) 459 (MH +) H-NMR (CDCl3): 1.25 (3H, t), 2.53 (3H, s), 3.87 (3
H, s), 4.17 (2H, q), 5.81 (1H, d), 6.01 (2H, s),
6.65-6.83 (3H, m), 7.13 (2H, d), 7.27 (2H, d), 7.42
(1H, d)
【0219】2)5−(3−ヒドロキシ−1−プロペニ
ル)−4−(4−メトキシフェニル)−6−メチル−2
−(3、4−メチレンジオキシフェノキシ)−ピリジン
−3−アルデヒドの合成 アルゴン雰囲気下、塩化メチレン10ml中、3−[3
−シアノ−4−メトキシフェニル−6−メチル−2−
(3、4−メチレンジオキシフェノキシ−ピリジン−5
−イル]−2−プロペン酸 エチルエステル340mg
(0.742mmol)を溶かし、水素化ジイソブチル
アルミニウム1Mヘキサン溶液5.19mlを0℃にて
加え、室温にて1晩攪拌した。水1mlを加え1時間攪
拌した後、セライト濾過し残渣を酢酸エチルにて洗浄し
た。濾液を減圧下にて溶媒留去し、得られた残渣をカラ
ムクロマトグラフィー(溶離液 ヘキサン:酢酸エチル
5:1)に付し、表題化合物を得た。 収量:120mg、収率:39% MS(ESI.m/z) 420(MH+) H-NMR (CDCl3):2.46 (3H, s)、3.86 (3H, s)、4.09 (2
H, br s)、5.58-5.68(1H, m)、6.01 (2H, s)、6.16-6.2
9 (1H, m)、6.62-7.26 (7H, m)、9.99 (1H, s)2) 5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -6-methyl-2
Synthesis of-(3,4-methylenedioxyphenoxy) -pyridine-3-aldehyde In an argon atmosphere, 3- [3
-Cyano-4-methoxyphenyl-6-methyl-2-
(3,4-methylenedioxyphenoxy-pyridine-5
-Yl] -2-propenoic acid ethyl ester 340 mg
(0.742 mmol) was dissolved, 5.19 ml of a 1M solution of diisobutylaluminum hydride in hexane was added at 0 ° C., and the mixture was stirred at room temperature overnight. After adding 1 ml of water and stirring for 1 hour, the mixture was filtered through celite and the residue was washed with ethyl acetate. The solvent was distilled off from the filtrate under reduced pressure, and the obtained residue was subjected to column chromatography (eluent: hexane: ethyl acetate 5: 1) to obtain the title compound. Yield: 120 mg, Yield: 39% MS (ESI.m / z) 420 (MH +) H-NMR (CDCl3): 2.46 (3H, s), 3.86 (3H, s), 4.09 (2
H, br s), 5.58-5.68 (1H, m), 6.01 (2H, s), 6.16-6.2
9 (1H, m), 6.62-7.26 (7H, m), 9.99 (1H, s)
【0220】3)5−(3−ヒドロキシ−1−プロペニ
ル)−4−(4−メトキシフェニル)−6−メチル−2
−(3、4−メチレンジオキシフェノキシ)−ピリジン
−3−カルボン酸の合 5−(3−ヒドロキシ−1−プロペニル)−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−ピリジン−3−アルデヒド
120mg(0.286mmol)を水5ml,塩化メ
チレン10mlに溶かし、氷冷下、2−メチル−ブテン
120mg(1.72mmol),アミド硫酸42mg
(0.429mmol),亜塩素酸ナトリウム90.5
mg(1.00mmol)を加え、室温にて3時間攪拌
した。反応溶液に水を加え、クロロホルムにて抽出し、
無水硫酸マグネシウムで乾燥後、減圧下にて溶媒留去し
た。得られた残渣をカラムクロマトグラフィー(溶離液
クロロホルム:メタノール 9:1)にて精製し、表
題化合物を得た。 収量:42mg、収率:34% MS(ESI.m/z) 436(MH+) H-NMR (CDCl3):2.41 (3H, s)、3.79 (3H, s)、5.58 (1
H, dt)、5.97 (2H, s)、6.21 (1H, d)、6.59-6.88 (5H,
m)、7.11-7.14 (2H, m)3) 5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -6-methyl-2
-(3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid combined 5- (3-hydroxy-1-propenyl) -4- (4-
Dissolve 120 mg (0.286 mmol) of methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-aldehyde in 5 ml of water and 10 ml of methylene chloride. Butene 120mg (1.72mmol), Amidosulfuric acid 42mg
(0.429 mmol), sodium chlorite 90.5
mg (1.00 mmol) was added, and the mixture was stirred at room temperature for 3 hours. Water was added to the reaction solution, extracted with chloroform,
After drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 42 mg, yield: 34% MS (ESI.m / z) 436 (MH +) H-NMR (CDCl3): 2.41 (3H, s), 3.79 (3H, s), 5.58 (1
H, dt), 5.97 (2H, s), 6.21 (1H, d), 6.59-6.88 (5H,
m), 7.11-7.14 (2H, m)
【0221】実施例39 6−フェニル−4−(4−メ
トキシフェニル)−2−(3、4−メチレンジオキシフ
ェニルオキシ)ピリジン−3−カルボン酸の合成 1)3−(4−メトキシフェニル)−1−オキソ−1−
フェニル−2−プロペンの合成 アセトフェノン2.4g(20.0mmol)、p−ア
ニスアルデヒド2.43ml(20.0mmol)のメ
タノール20ml溶液にナトリウム50mgを加え室温
で2日間攪拌する。メタノールを減圧下留去し、酢酸エ
チルで抽出し、水、1規定塩酸、飽和食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後減圧下溶媒を留去し残渣
をシリカゲルカラムクロマトグラフィー(酢酸エチル:
ヘキサン1:3)に付し表題化合物を得た。 収量:3.0g、収率:62.9% MS(ESI,m/z) 239 (MH+) H-NMR(CDCl3):3.85 (3H, s)、6.94 (2H, d)、7.40 (1
H, d)、7.45-7.60 (5H,m)、7.78 (1H, d)、8.01 (2H,
m)Example 39 Synthesis of 6-phenyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 1) 3- (4-methoxyphenyl) -1-oxo-1-
Synthesis of phenyl-2-propene 50 mg of sodium was added to a solution of 2.4 g (20.0 mmol) of acetophenone and 2.43 ml (20.0 mmol) of p-anisaldehyde in 20 ml of methanol, and the mixture was stirred at room temperature for 2 days. The methanol was distilled off under reduced pressure, extracted with ethyl acetate, washed with water, 1N hydrochloric acid and saturated saline,
After drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure, and the residue is subjected to silica gel column chromatography (ethyl acetate:
Hexane 1: 3) to give the title compound. Yield: 3.0 g, Yield: 62.9% MS (ESI, m / z) 239 (MH +) H-NMR (CDCl3): 3.85 (3H, s), 6.94 (2H, d), 7.40 (1
H, d), 7.45-7.60 (5H, m), 7.78 (1H, d), 8.01 (2H,
m)
【0222】2)3−シアノ−4−(4−メトキシフェ
ニル)−6−フェニルピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド1.06
g(12.6mmol)、t−ブトキシカリウム1.4
1g(12.6mmol)のDMSO10ml溶液に3
−(4−メトキシフェニル)−1−オキソ−1−フェニ
ル−2−プロペン3.00g(12.6mmol)のD
MSO20ml溶液を加え20分間攪拌する。t−ブト
キシカリウム4.24g(37.8mmol)を加え1
分間酸素をバブリングする。酸素雰囲気下1時間攪拌し
た後、1規定塩酸を氷冷下加え析出した結晶を濾取す
る。水で洗い減圧下乾燥し表題化合物を得た。この化合
物は精製せずに以下の反応に用いる。 収量:3.12g、収率:81.9% MS(ESI,m/z) 303 (MH+) H-NMR(CDCl3):3.84 (3H, s)、6.60-7.10 (5H, m)、7.4
0-7.90 (5H, m)2) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-phenylpyridone Cyanoacetamide 1.06 at room temperature under an argon atmosphere.
g (12.6 mmol), potassium t-butoxide 1.4
1 g (12.6 mmol) in 10 ml of DMSO
3.00 g (12.6 mmol) of-(4-methoxyphenyl) -1-oxo-1-phenyl-2-propene D
Add 20 ml of MSO solution and stir for 20 minutes. 4.24 g (37.8 mmol) of potassium t-butoxide was added, and 1
Bubble oxygen for minutes. After stirring for 1 hour in an oxygen atmosphere, 1N hydrochloric acid is added under ice cooling, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 3.12 g, 81.9% MS (ESI, m / z) 303 (MH +) H-NMR (CDCl3): 3.84 (3H, s), 6.60-7.10 (5H, m), 7.4
0-7.90 (5H, m)
【0223】3)2−クロロ−3−シアノ−4−(4−
メトキシフェニル)−6−フェニルピリジンの合成 3−シアノ−4−(4−メトキシフェニル)−6−フェ
ニルピリドン1.32g(4.4mmol)をオキシ塩
化リン20mlに溶解し100℃で一晩攪拌する。オキ
シ塩化リンを減圧下留去し得られる結晶を酢酸エチルで
洗浄し表題化合物を得た。このものはこれ以上精製せず
に以下の反応に利用した。 収量:770mg MS(ESI,m/z) 321 (MH+) H-NMR(CDCl3):3.90 (3H, s)、7.08 (2H, d)、7.52 (3
H, m)、7.63 (2H, d)、7.76 (1H, s)、8.06-8.10 (2H,
m)3) 2-chloro-3-cyano-4- (4-
Synthesis of (methoxyphenyl) -6-phenylpyridine 1.32 g (4.4 mmol) of 3-cyano-4- (4-methoxyphenyl) -6-phenylpyridone is dissolved in 20 ml of phosphorus oxychloride and stirred at 100 ° C. overnight. . The crystals obtained by evaporating phosphorus oxychloride under reduced pressure were washed with ethyl acetate to obtain the title compound. This was used for the following reaction without further purification. Yield: 770 mg MS (ESI, m / z) 321 (MH +) H-NMR (CDCl3): 3.90 (3H, s), 7.08 (2H, d), 7.52 (3
H, m), 7.63 (2H, d), 7.76 (1H, s), 8.06-8.10 (2H,
m)
【0224】4)3−シアノ−4−(4−メトキシフェ
ニル)−6−フェニル−2−(3、4−メチレンジオキ
シフェニルオキシ)ピリジンの合成 セサモール330mg(2.4mmol)、水素化ナト
リウム200mg(60%オイルディスパージョン、
5.0mmol)より作成したフェノキシドイオンのD
MF10ml溶液に2−クロロ−3−シアノ−4−(4
−メトキシフェニル)−6−フェニルピリジン770m
gを加え、アルゴン雰囲気下室温で2時間攪拌する。減
圧下溶媒を留去し、得られる残渣を酢酸エチルで抽出
し、水、飽和食塩水で洗浄し減圧下溶媒を留去する。得
られる結晶を酢酸エチル:ヘキサン1:3で洗浄し、表
題化合物を得た。 収量:780mg、収率:3−シアノ−4−(4−メト
キシフェニル)−6−フェニルピリドンより42.0% H-NMR(CDCl3):3.90 (3H, s)、6.04 (2H, s)、6.75 (1
H, dd)、6.83 (1H, d)、6.85 (1H, d)、7.08 (2H, d)、
7.42 (3H, m)、7.54 (1H, s)、7.68 (2H, d)、7.88 (2
H, m)4) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-phenyl-2- (3,4-methylenedioxyphenyloxy) pyridine Sesamol 330 mg (2.4 mmol), sodium hydride 200 mg (60% oil dispersion,
5.0 mmol) of phenoxide ion prepared from
2-chloro-3-cyano-4- (4
-Methoxyphenyl) -6-phenylpyridine 770 m
g, and stirred at room temperature for 2 hours under an argon atmosphere. The solvent is distilled off under reduced pressure, the obtained residue is extracted with ethyl acetate, washed with water and saturated saline, and the solvent is distilled off under reduced pressure. The obtained crystals were washed with ethyl acetate: hexane 1: 3 to give the title compound. Yield: 780 mg, Yield: 42.0% from 3-cyano-4- (4-methoxyphenyl) -6-phenylpyridone H-NMR (CDCl3): 3.90 (3H, s), 6.04 (2H, s), 6.75 (1
H, dd), 6.83 (1H, d), 6.85 (1H, d), 7.08 (2H, d),
7.42 (3H, m), 7.54 (1H, s), 7.68 (2H, d), 7.88 (2
H, m)
【0225】5)6−フェニル−4−(4−メトキシフ
ェニル)−2−(3、4−メチレンジオキシフェニルオ
キシ)ピリジン−3−アルデヒドの合成 3−シアノ−4−(4−メトキシフェニル)−6−フェ
ニル−2−(3、4−メチレンジオキシフェニルオキ
シ)ピリジン100mg(0.24mmol)を塩化メ
チレンに溶解しアルゴン雰囲気下0℃で水素化ジイソブ
チルアルミニウム1Mヘキサン溶液1.0ml(1.0
mmol)を滴下する。室温に戻し一晩攪拌し、メタノ
ールと水で反応を停止する。室温で30分攪拌し、セラ
イトを用いて濾過し溶媒を減圧下留去して得られた残渣
をシリカゲルカラムクロマトグラフィー(酢酸エチル:
ヘキサン 1:1)に付し表題化合物を得た。このもの
は分離困難な不純物を含むがこれ以上精製せずに以下の
反応に用いる。 収量:60mg MS(ESI,m/z) 58 (M+MeOH)5) Synthesis of 6-phenyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde 3-cyano-4- (4-methoxyphenyl) 100 mg (0.24 mmol) of -6-phenyl-2- (3,4-methylenedioxyphenyloxy) pyridine is dissolved in methylene chloride, and 1.0 ml of a 1M solution of diisobutylaluminum hydride in hexane (1. 0
mmol) is added dropwise. After returning to room temperature and stirring overnight, the reaction is stopped with methanol and water. The mixture was stirred at room temperature for 30 minutes, filtered using Celite, and the solvent was distilled off under reduced pressure. The resulting residue was subjected to silica gel column chromatography (ethyl acetate:
Hexane 1: 1) to give the title compound. It contains impurities which are difficult to separate, but is used in the following reaction without further purification. Yield: 60 mg MS (ESI, m / z) 58 (M + MeOH)
【0226】6)6−フェニル−4−(4−メトキシフ
ェニル)−2−(3、4−メチレンジオキシフェニルオ
キシ)ピリジン−3−カルボン酸の合成 6−フェニル−4−(4−メトキシフェニル)−2−
(3、4−メチレンジオキシフェニルオキシ)ピリジン
−3−アルデヒド60mgを塩化メチレン4ml、水2
mlに溶解し、0℃で2−メチル−2−ブテン0.1m
l(0.9mmol)、アミド硫酸20mg(0.21
mmol)、亜塩素酸ナトリウム50mg(0.70m
mol)を加え室温に戻して20分間攪拌する。塩化メ
チレンで抽出し無水硫酸マグネシウムで乾燥して減圧下
溶媒を留去する。得られた残渣をシリカゲル薄層クロマ
トグラフィー(酢酸エチル:ヘキサン 1:1 2回展
開)に付し表題化合物を得た。 収量:15mg、収率:3−シアノ−4−(4−メトキ
シフェニル)−6−フェニル−2−(3、4−メチレン
ジオキシフェニルオキシ)ピリジンより14.2% MS(ESI,m/z) 442 (MH+) H-NMR(CDCl3):3.83 (3H, s)、6.00 (2H, s)、6.70 (1
H, m)、6.80 (2H, m)、6.97 (2H, br d)、7.34-7.42 (3
H, m)、7.44-7.52 (3H, m)、7.84-7.90 (2H, m)6) Synthesis of 6-phenyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine-3-carboxylic acid 6-phenyl-4- (4-methoxyphenyl) ) -2-
(3,4-methylenedioxyphenyloxy) pyridine-3-aldehyde (60 mg) was treated with methylene chloride (4 ml) and water (2).
dissolved in 0 ml at 0 ° C.
1 (0.9 mmol), amidosulfuric acid 20 mg (0.21
mmol), 50 mg of sodium chlorite (0.70 m
mol), and the mixture is returned to room temperature and stirred for 20 minutes. Extract with methylene chloride, dry over anhydrous magnesium sulfate and evaporate the solvent under reduced pressure. The obtained residue was subjected to silica gel thin layer chromatography (developed twice with ethyl acetate: hexane 1: 1) to give the title compound. Yield: 15 mg, Yield: 14.2% MS (ESI, m / z) from 3-cyano-4- (4-methoxyphenyl) -6-phenyl-2- (3,4-methylenedioxyphenyloxy) pyridine ) 442 (MH +) H-NMR (CDCl3): 3.83 (3H, s), 6.00 (2H, s), 6.70 (1
H, m), 6.80 (2H, m), 6.97 (2H, br d), 7.34-7.42 (3
H, m), 7.44-7.52 (3H, m), 7.84-7.90 (2H, m)
【0227】実施例40 5−(3−ヒドロキシ−1−
プロピル)−4−(4−メトキシフェニル)−6−メチ
ル−2−(3、4−メチレンジオキシフェノキシ)−ピ
リジン−3−カルボン酸の合成 5−(3−ヒドロキシ−1−プロペニル)−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−ピリジン−3−カルボン酸
10mg(0.0230mmol)をエタノール5ml
に溶かし、10%パラジウム炭素を触媒量加えて、水素
雰囲気下(1atm)室温にて1時間攪拌した。反応溶
液を濾過しエタノールで洗浄後、濾液を減圧下溶媒留去
した。得られた残渣をクロロホルム、ヘキサンから再結
晶して表題化合物を得た。 収量:8mg、収率:78% MS(ESI.m/z) 438(MH+) 1H-NMR (CDCl3):1.50-1.59 (2H, m)、2.45-2.52 (5H,
m)、3.45 (2H, t)、3.83 (3H, s)、5.98 (2H, s)、6.60
-6.78 (3H, m)、6.93 (2H, d)、7.17 (2H, d)Example 40 5- (3-hydroxy-1-)
Synthesis of propyl) -4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 5- (3-hydroxy-1-propenyl) -4 − (4-
Methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 10 mg (0.0230 mmol) in ethanol 5 ml
, And a catalytic amount of 10% palladium carbon was added, and the mixture was stirred at room temperature under a hydrogen atmosphere (1 atm) for 1 hour. After the reaction solution was filtered and washed with ethanol, the filtrate was evaporated under reduced pressure. The obtained residue was recrystallized from chloroform and hexane to give the title compound. Yield: 8 mg, Yield: 78% MS (ESI.m / z) 438 (MH +) 1H-NMR (CDCl3): 1.50-1.59 (2H, m), 2.45-2.52 (5H,
m), 3.45 (2H, t), 3.83 (3H, s), 5.98 (2H, s), 6.60
-6.78 (3H, m), 6.93 (2H, d), 7.17 (2H, d)
【0228】実施例41 3−(5−テトラゾイル)−
4−(4−メトキシフェニル)−6−(2−チオフェニ
ル)−2−(3、4−メチレンジオキシフェニルオキ
シ)ピリジンの合成 3−シアノ−4−(4−メトキシフェニル)−6−(2
−チオフェニル)−2−(3、4−メチレンジオキシフ
ェニルオキシ)ピリジン100mg(0.23mmo
l)をトルエン10mlに溶解しアジ化ナトリウム10
0mg(1.5mmol)、塩化トリ−n−ブチルスズ
0.27ml(1.0mmol)から作成したアジ化ト
リ−n−ブチルスズを加え一晩加熱環流する。1規定塩
酸を加え、酢酸エチルで抽出し、無水硫酸マグネシウム
で乾燥する。減圧下溶媒を留去し、得られる結晶を塩化
メチレンで洗浄し表題化合物を得た。 収量:20mg、収率:18.4% MS(ESI,m/z) 472 (MH+) H-NMR(DMSO-d6):3.76 (3H, s)、6.63 (1H, dd)、6.86
(1H, dd)、6.88-6.96(3H, m)、7.13-7.20 (3H, m)、7.6
6 (1H, d)、7.79 (1H, s)、7.95 (1H, d)Example 41 3- (5-tetrazoyl)-
Synthesis of 4- (4-methoxyphenyl) -6- (2-thiophenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 3-cyano-4- (4-methoxyphenyl) -6- (2
-Thiophenyl) -2- (3,4-methylenedioxyphenyloxy) pyridine 100 mg (0.23 mmol
l) was dissolved in 10 ml of toluene, and sodium azide 10
Tri-n-butyltin azide prepared from 0 mg (1.5 mmol) and 0.27 ml (1.0 mmol) of tri-n-butyltin chloride is added, and the mixture is heated under reflux overnight. 1N hydrochloric acid is added, extracted with ethyl acetate, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained crystals were washed with methylene chloride to obtain the title compound. Yield: 20 mg, Yield: 18.4% MS (ESI, m / z) 472 (MH +) H-NMR (DMSO-d6): 3.76 (3H, s), 6.63 (1H, dd), 6.86
(1H, dd), 6.88-6.96 (3H, m), 7.13-7.20 (3H, m), 7.6
6 (1H, d), 7.79 (1H, s), 7.95 (1H, d)
【0229】実施例42 3−[3−カルボキシル−4
−メトキシフェニル−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−ピリジン−5−イル]−2
−プロペン酸 エチルエステルの合成 5−ヨード−4−(4−メトキシフェニル)−6−メチ
ル−2−(3、4−メチレンジオキシフェノキシ)−ピ
リジン−3−カルボン酸40mg(0.0419mmo
l)をDMF3mlに溶かし、アクリル酸エチル12m
g(0.119mmol),Pd(OAc)20.88
9mg(0.00396mmol),トリフェニルホス
フィン2.1mg(0.00792mmol),トリエ
チルアミン3mlを加え、100℃にて3日間攪拌し
た。反応溶液に水を加え、酢酸エチルにて抽出し、無水
硫酸マグネシウムで乾燥後、減圧下にて溶媒留去した。
得られた残渣をカラムクロマトグラフィー(溶離液 ク
ロロホルム:メタノール 9:1)にて精製し、表題化
合物を得た。 収量:20mg、収率:53% MS(ESI.m/z) 478(MH+) 1H-NMR (CDCl3):1.24 (3H, t)、2.48 (3H, s)、3.79
(3H, s)、4.15 (2H, q)、5.76 (1H, d)、5.99 (2H,
s)、6.59-7.14 (7H, m)、7.41 (2H, d)Example 42 3- [3-carboxyl-4
-Methoxyphenyl-6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridin-5-yl] -2
Synthesis of ethyl propene acid 5-iodo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -pyridine-3-carboxylic acid 40 mg (0.0419 mmol)
1) was dissolved in DMF (3 ml), and ethyl acrylate (12 m) was dissolved.
g (0.119 mmol), Pd (OAc) 20.88
9 mg (0.00396 mmol), 2.1 mg (0.00792 mmol) of triphenylphosphine and 3 ml of triethylamine were added, and the mixture was stirred at 100 ° C. for 3 days. Water was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 20 mg, Yield: 53% MS (ESI.m / z) 478 (MH +) 1H-NMR (CDCl3): 1.24 (3H, t), 2.48 (3H, s), 3.79
(3H, s), 4.15 (2H, q), 5.76 (1H, d), 5.99 (2H,
s), 6.59-7.14 (7H, m), 7.41 (2H, d)
【0230】実施例43 5−(3−ヒドロキシ−1−
プロペニル)−4−(4−メトキシフェニル)−6−メ
チル−2−(3,4−メチレンジオキシフェニル)−3
−(5−テトラゾイル)ピリジンの合成 1)1−(4−メトキシフェニル)−1−ブテン−3−
オンの合成 p−アニスアルデヒド50ml(411mmol)をア
セトン300mlに溶解し1規定水酸化ナトリウム溶液
50mlを加え室温で一晩攪拌する。アセトンを減圧下
留去しられる結晶を、水、エタノールで洗浄し表題化合
物を得た。 収量:57.4g、収率:79.3% MS(ESI,m/z) 177 (MH+) H-NMR(DMSO-d6):2.36 (3H, s)、3.85 (3H, s)、6.72
(1H, d)、6.93 (2H, d)、7.48 (1H, d)、7.50 (2H, d)Example 43 5- (3-hydroxy-1-)
Propenyl) -4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenyl) -3
Synthesis of-(5-tetrazoyl) pyridine 1) 1- (4-methoxyphenyl) -1-butene-3-
Synthesis of ON 50 ml (411 mmol) of p-anisaldehyde is dissolved in 300 ml of acetone, 50 ml of 1N sodium hydroxide solution is added, and the mixture is stirred at room temperature overnight. The crystals from which acetone was distilled off under reduced pressure were washed with water and ethanol to give the title compound. Yield: 57.4 g, 79.3% MS (ESI, m / z) 177 (MH +) H-NMR (DMSO-d6): 2.36 (3H, s), 3.85 (3H, s), 6.72
(1H, d), 6.93 (2H, d), 7.48 (1H, d), 7.50 (2H, d)
【0231】2)3−シアノ−4−(4−メトキシフェ
ニル)−6−メチルピリドンの合成 アルゴン雰囲気下、室温でシアノアセトアミド27.4
g(326mmol)、t−ブトキシカリウム36.6
g(326mmol)のDMSO600ml溶液に1−
(4−メトキシフェニル)−1−ブテン−3−オン5
7.42g(326mmol)を加え15分間攪拌す
る。t−ブトキシカリウム110g(980mmol)
を加え1分間酸素をバブリングする。酸素雰囲気下1時
間攪拌した後、氷水にあけ濃塩酸、水を加え析出した結
晶を濾取する。水で洗い減圧下乾燥し表題化合物を得
た。この化合物は精製せずに以下の反応に用いる。 収量:58.5g、収率:74.7% MS(ESI,m/z) 241 (MH+) H-NMR(CDCl3):2.50 (3H, s)、3.88 (3H, s)、6.28 (1
H, s)、7.01 (2H, d)、7.60 (2H, d)2) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-methylpyridone Cyanoacetamide 27.4 at room temperature under an argon atmosphere.
g (326 mmol), potassium t-butoxide 36.6
g (326 mmol) in DMSO 600 ml solution
(4-methoxyphenyl) -1-buten-3-one 5
Add 7.42 g (326 mmol) and stir for 15 minutes. 110 g (980 mmol) of potassium t-butoxide
And bubbling oxygen for 1 minute. After stirring for 1 hour in an oxygen atmosphere, the mixture is poured into ice water, concentrated hydrochloric acid and water are added, and the precipitated crystals are collected by filtration. After washing with water and drying under reduced pressure, the title compound was obtained. This compound is used for the following reaction without purification. Yield: 58.5 g, yield: 74.7% MS (ESI, m / z) 241 (MH +) H-NMR (CDCl3): 2.50 (3H, s), 3.88 (3H, s), 6.28 (1
H, s), 7.01 (2H, d), 7.60 (2H, d)
【0232】3)3−シアノ−4−(4−メトキシフェ
ニル)−6−メチル−5−ヨード−2−ピリドンの合成 3−シアノ−4−(4−メトキシフェニル)−6−メチ
ルピリドン7.86g(32.7mmol)をアセトニ
トリル100mlに溶解し、N−ヨウ化コハク酸イミド
14.7g(65.3mmol)を加え、一晩加熱環流
する。放冷後沈殿をろ取し、酢酸エチルで洗浄し表題化
合物を得た。 収量:8.42g、収率:70.3% MS(ESI,m/z) 367 (MH+) H-NMR(DMSO-d6):2.53 (3H, s)、3.88 (3H, s)、7.07
(2H, d)、7.22 (2H, d)3) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-methyl-5-iodo-2-pyridone 3-cyano-4- (4-methoxyphenyl) -6-methylpyridone 86 g (32.7 mmol) is dissolved in 100 ml of acetonitrile, 14.7 g (65.3 mmol) of N-iodosuccinimide is added, and the mixture is heated under reflux overnight. After cooling, the precipitate was collected by filtration and washed with ethyl acetate to give the title compound. Yield: 8.42 g, 70.3% MS (ESI, m / z) 367 (MH +) H-NMR (DMSO-d6): 2.53 (3H, s), 3.88 (3H, s), 7.07
(2H, d), 7.22 (2H, d)
【0233】4)2−クロロ−3−シアノ−4−(4−
メトキシフェニル)−6−メチル−5−ヨードピリジン
の合成 3−シアノ−4−(4−メトキシフェニル)−6−メチ
ル−5−ヨード−2−ピリドン8.42g(23.0m
mol)をオキシ塩化リン100mlに溶解し100℃
で一晩攪拌する。オキシ塩化リンを減圧下留去し得られ
る結晶を酢酸エチルで洗浄し、表題化合物を得た。この
ものはこれ以上精製せずに以下の反応に利用した。 収量:6.76g、収率:76.5% H-NMR(CDCl3):2.90 (3H, s)、3.88 (3H, s)、7.03 (2
H, d)、7.24 (2H, d)4) 2-Chloro-3-cyano-4- (4-
Synthesis of methoxyphenyl) -6-methyl-5-iodopyridine 3-cyano-4- (4-methoxyphenyl) -6-methyl-5-iodo-2-pyridone 8.42 g (23.0 m
mol) in 100 ml of phosphorus oxychloride
And stir overnight. The crystals obtained by evaporating phosphorus oxychloride under reduced pressure were washed with ethyl acetate to obtain the title compound. This was used for the following reaction without further purification. Yield: 6.76 g, 76.5% H-NMR (CDCl3): 2.90 (3H, s), 3.88 (3H, s), 7.03 (2
H, d), 7.24 (2H, d)
【0234】5)3−シアノ−4−(4−メトキシフェ
ニル)−6−メチル−2−(3,4−メチレンジオキシ
フェニル)−5−ヨードピリジンの合成 セサモール2.56g(18.5mmol)、水素化ナ
トリウム890mg(60%オイルディスパージョン、
22.3mmol)より作成したフェノキシドイオンの
DMF50ml溶液に2−クロロ−3−シアノ−4−
(4−メトキシフェニル)−6−メチル−5−ヨードピ
リジン7.12g(18.5mmol)を0℃で加え、
アルゴン雰囲気下室温に戻して30分間攪拌する。減圧
下溶媒を留去し、得られる結晶を水、酢酸エチルで洗浄
し、表題化合物6.47gを得た。洗浄液を無水硫酸マ
グネシウムで乾燥し減圧下溶媒を留去した残渣をシリカ
ゲルカラムクロマトグラフィー(酢酸エチル:ヘキサン
1:3)に付しさらに0.72gを得た。 収量:7.19g、収率:79.9% MS(ESI,m/z) 487 (MH+) H-NMR(CDCl3):2.71 (3H, s)、3.89 (3H, s)、6.65 (1
H, dd)、6.72 (1H, d)、6.81 (1H, d)、7.04 (2H, d)、
7.24 (2H, d)5) Synthesis of 3-cyano-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenyl) -5-iodopyridine 2.56 g (18.5 mmol) of sesamol , 890 mg of sodium hydride (60% oil dispersion,
22.3 mmol) was added to a 50 ml solution of phenoxide ion in DMF to give 2-chloro-3-cyano-4-.
7.12 g (18.5 mmol) of (4-methoxyphenyl) -6-methyl-5-iodopyridine was added at 0 ° C,
The mixture is returned to room temperature under an argon atmosphere and stirred for 30 minutes. The solvent was distilled off under reduced pressure, and the obtained crystals were washed with water and ethyl acetate to obtain 6.47 g of the title compound. The washed solution was dried over anhydrous magnesium sulfate, and the residue obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 3) to obtain a further 0.72 g. Yield: 7.19 g, 79.9% MS (ESI, m / z) 487 (MH +) H-NMR (CDCl3): 2.71 (3H, s), 3.89 (3H, s), 6.65 (1
H, dd), 6.72 (1H, d), 6.81 (1H, d), 7.04 (2H, d),
7.24 (2H, d)
【0235】6)3−シアノ−5−(2−エトキシカル
ボニルエテニル)−4−(4−メトキシフェニル)−6
−メチル−2−(3,4−メチレンジオキシフェニル)
ピリジンの合成 3−シアノ−4−(4−メトキシフェニル)−6−メチ
ル−2−(3,4−メチレンジオキシフェニル)−5−
ヨードピリジン2.0g(4.1mmol)、アクリル
酸メチル10ml(92mmol)、トリ−n−ブチル
アミン3.0ml(13mmol)、酢酸パラジウム2
0mg(0.09mmol)をDMF20mlに溶解し
150℃で10時間加熱環流する。不溶解物を濾過し、
減圧か溶媒を留去し、酢酸エチルで抽出する。1規定塩
酸、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧下溶媒を留去し得られる結晶を酢酸エチル、ヘキ
サンで洗浄し表題化合物を得た。 収量:1.90g、収率:定量的 MS(ESI,m/z) 459 (MH+) H-NMR(CDCl3):1.26 (3H, t)、2.53 (3H, s)、3.87 (3
H, s)、4.18 (2H, q)、5.81 (1H, d)、6.03 (2H, s)、
6.67 (1H, dd)、6.75 (1H, d)、6.82 (1H, d)、7.02 (2
H, d)、7.26 (2H, d)、7.43 (1H, d)6) 3-cyano-5- (2-ethoxycarbonylethenyl) -4- (4-methoxyphenyl) -6
-Methyl-2- (3,4-methylenedioxyphenyl)
Synthesis of pyridine 3-cyano-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenyl) -5
2.0 g (4.1 mmol) of iodopyridine, 10 ml (92 mmol) of methyl acrylate, 3.0 ml (13 mmol) of tri-n-butylamine, palladium acetate 2
0 mg (0.09 mmol) is dissolved in DMF (20 ml) and refluxed by heating at 150 ° C. for 10 hours. Filter the insolubles,
Evaporate the solvent under reduced pressure and extract with ethyl acetate. The crystals were washed with 1N hydrochloric acid and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crystals were washed with ethyl acetate and hexane to give the title compound. Yield: 1.90 g, Yield: quantitative MS (ESI, m / z) 459 (MH +) H-NMR (CDCl3): 1.26 (3H, t), 2.53 (3H, s), 3.87 (3
H, s), 4.18 (2H, q), 5.81 (1H, d), 6.03 (2H, s),
6.67 (1H, dd), 6.75 (1H, d), 6.82 (1H, d), 7.02 (2
H, d), 7.26 (2H, d), 7.43 (1H, d)
【0236】7)3−シアノ−5−(3−ヒドロキシ−
1−プロペニル)−4−(4−メトキシフェニル)−6
−メチル−2−(3,4−メチレンジオキシフェニル)
ピリジンの合成 3−シアノ−5−(2−エトキシカルボニルエテニル)
−4−(4−メトキシフェニル)−6−メチル−2−
(3,4−メチレンジオキシフェニル)ピリジン1.5
7g(3.4mmol)を塩化メチレン20mlに溶解
しアルゴン雰囲気下−78度で水素化ジイソブチルアル
ミニウム1Mヘキサン溶液13.7ml(13.7mm
ol)を滴下する。−78度で1時間攪拌し、メタノー
ルと水で反応を停止する。室温で2時間攪拌し、セライ
トを用いて濾過する。溶媒を減圧下留去して得られた残
渣をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル:ヘキサン 1:1)に付し表題化合物を得た。 収量:1.17g、収率:82.6% MS(ESI,m/z) 417 (MH+) H-NMR(CDCl3):2.47 (3H, s)、3.86 (3H, s)、4.11 (2
H, m)、5.64 (1H, dt)、6.02 (2H, s)、6.28 (1H, d
t)、6.67 (1H, dd)、6.75 (1H, d)、6.81 (1H, d)、6.9
8 (2H, d)、7.26 (2H, d)7) 3-cyano-5- (3-hydroxy-
1-propenyl) -4- (4-methoxyphenyl) -6
-Methyl-2- (3,4-methylenedioxyphenyl)
Synthesis of pyridine 3-cyano-5- (2-ethoxycarbonylethenyl)
-4- (4-methoxyphenyl) -6-methyl-2-
(3,4-methylenedioxyphenyl) pyridine 1.5
7 g (3.4 mmol) was dissolved in 20 ml of methylene chloride and 13.7 ml (13.7 mm
ol). Stir at -78 degrees for 1 hour and stop the reaction with methanol and water. Stir at room temperature for 2 hours and filter using celite. The residue obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 1) to obtain the title compound. Yield: 1.17 g, yield: 82.6% MS (ESI, m / z) 417 (MH +) H-NMR (CDCl3): 2.47 (3H, s), 3.86 (3H, s), 4.11 (2
H, m), 5.64 (1H, dt), 6.02 (2H, s), 6.28 (1H, d
t), 6.67 (1H, dd), 6.75 (1H, d), 6.81 (1H, d), 6.9
8 (2H, d), 7.26 (2H, d)
【0237】8)5−(3−ヒドロキシ−1−プロペニ
ル)−4−(4−メトキシフェニル)−6−メチル−2
−(3,4−メチレンジオキシフェニル)−3−(5−
テトラゾイル)ピリジンの合成 3−シアノ−5−(3−ヒドロキシ−1−プロペニル)
−4−(4−メトキシフェニル)−6−メチル−2−
(3,4−メチレンジオキシフェニル)ピリジン300
mg(0.72mmol)をトルエン10mlに溶解し
アジ化ナトリウム300mg(4.6mmol)、塩化
トリ−n−ブチルスズ0.81ml(3.0mmol)
から作成したアジ化トリ−n−ブチルスズを加え一晩加
熱環流する。1規定塩酸を加え、酢酸エチルで抽出し、
無水硫酸マグネシウムで乾燥する。減圧下溶媒を留去
し、得られる結晶を塩化メチレンで洗浄し表題化合物を
得た。 収量:200mg、収率:60.5% MS(ESI,m/z) 460 (MH+) HRMS(FAB) 460.1599 (C24H22N5O5 460.1621) H-NMR(DMSO-d6):2.45 (3H, s)、3.71 (3H, s)、3.88
(2H, m)、4.73 (1H, m)、5.63 (1H, dt)、6.05 (2H,
s)、6.20 (1H, dt)、6.53 (1H, dd)、6.75 (1H, d)、6.
81 (2H, d)、6.89 (1H, d)、6.93 (2H, d)8) 5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -6-methyl-2
-(3,4-methylenedioxyphenyl) -3- (5-
Synthesis of tetrazoyl) pyridine 3-cyano-5- (3-hydroxy-1-propenyl)
-4- (4-methoxyphenyl) -6-methyl-2-
(3,4-methylenedioxyphenyl) pyridine 300
mg (0.72 mmol) was dissolved in 10 ml of toluene, 300 mg (4.6 mmol) of sodium azide, and 0.81 ml (3.0 mmol) of tri-n-butyltin chloride.
And the mixture is heated under reflux overnight. Add 1N hydrochloric acid, extract with ethyl acetate,
Dry over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained crystals were washed with methylene chloride to obtain the title compound. Yield: 200 mg, Yield: 60.5% MS (ESI, m / z) 460 (MH +) HRMS (FAB) 460.1599 (C24H22N5O5 460.1621) H-NMR (DMSO-d6): 2.45 (3H, s), 3.71 ( 3H, s), 3.88
(2H, m), 4.73 (1H, m), 5.63 (1H, dt), 6.05 (2H, m
s), 6.20 (1H, dt), 6.53 (1H, dd), 6.75 (1H, d), 6.
81 (2H, d), 6.89 (1H, d), 6.93 (2H, d)
【0238】実施例44 3−(2−(3,4−メチレ
ンジオキシフェニルオキシ)−3−(5−テトラゾイ
ル)−4−(4−メトキシフェニル)−6−メチルピリ
ジン−5−イル)プロペノイックアシド モルホリンア
ミドの合成 1)3−シアノ−5−(2−カルボキシエテニル)−4
−(4−メトキシフェニル)−6−メチル−2−(3,
4−メチレンジオキシフェニル)ピリジンの合成 3−シアノ−4−(4−メトキシフェニル)−6−メチ
ル−2−(3,4−メチレンジオキシフェニル)−5−
ヨードピリジン720mg(1.5mmol)、アクリ
ル酸1.0ml(14.7mmol)、トリ−n−ブチ
ルアミン5.0ml(21mmol)、酢酸パラジウム
10mg(0.04mmol)をDMF10mlに溶解
し150℃で2時間加熱環流する。不溶解物を濾過し、
減圧下溶媒を留去し、酢酸エチルで抽出する。1規定塩
酸、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧下溶媒を留去し得られる結晶を酢酸エチル、ヘキ
サンで洗浄し表題化合物を得た。 収量:450mg、収率:70.6% MS(ESI,m/z) 431 (MH+) H-NMR(DMSO-d6):2.45 (3H, s)、3.75 (3H, s)、5.82
(1H, d)、6.10 (2H, s)、6.72 (1H, dd)、6.96 (1H,
s)、6.98 (1H, d)、7.12 (2H, d)、7.26 (1H, d)、7.34
(2H, d)Example 44 3- (2- (3,4-Methylenedioxyphenyloxy) -3- (5-tetrazoyl) -4- (4-methoxyphenyl) -6-methylpyridin-5-yl) prope Synthesis of Neuacacid morpholinamide 1) 3-Cyano-5- (2-carboxyethenyl) -4
-(4-methoxyphenyl) -6-methyl-2- (3,
Synthesis of 4-methylenedioxyphenyl) pyridine 3-cyano-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenyl) -5
720 mg (1.5 mmol) of iodopyridine, 1.0 ml (14.7 mmol) of acrylic acid, 5.0 ml (21 mmol) of tri-n-butylamine, and 10 mg (0.04 mmol) of palladium acetate are dissolved in 10 ml of DMF, and the mixture is dissolved at 150 ° C. for 2 hours. Heat to reflux. Filter the insolubles,
The solvent is distilled off under reduced pressure, and the mixture is extracted with ethyl acetate. The crystals were washed with 1N hydrochloric acid and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crystals were washed with ethyl acetate and hexane to give the title compound. Yield: 450 mg, yield: 70.6% MS (ESI, m / z) 431 (MH +) H-NMR (DMSO-d6): 2.45 (3H, s), 3.75 (3H, s), 5.82
(1H, d), 6.10 (2H, s), 6.72 (1H, dd), 6.96 (1H,
s), 6.98 (1H, d), 7.12 (2H, d), 7.26 (1H, d), 7.34
(2H, d)
【0239】2)3−(2−(3,4−メチレンジオキ
シフェニルオキシ)−3−シアノ−4−(4−メトキシ
フェニル)−6−メチルピリジン−5−イル)プロペノ
イックアシド モルホリンアミドの合成 3−シアノ−5−(2−カルボキシエテニル)−4−
(4−メトキシフェニル)−6−メチル−2−(3,4
−メチレンジオキシフェニル)ピリジン100mg
(0.23mmol)、モルホリン0.1ml(1.1
mmol)を塩化メチレン5mlに溶解しWSC100
mg(0.52mmol)、ジメチルアミノピリジン5
mgを加え室温で4時間攪拌する。酢酸エチルで抽出
し、1規定水酸化ナトリウム、1規定塩酸、飽和食塩水
で洗浄し無水硫酸マグネシウムで乾燥後減圧下溶媒を留
去し、表題化合物を得た。この化合物はこれ以上精製せ
ずに以下の反応に用いる。 収量:120mg、収率:定量的 MS(ESI,m/z) 500 (MH+) H-NMR(CDCl3):2.51 (3H, s)、2.96-3.04 (2H, m)、3.4
0-3.50 (2H, m)、3.54-3.68 (4H, m)、3.85 (3H, s)、
5.91 (1H, d)、6.03 (2H, s)、6.66 (1H, dd)、6.74 (1
H, d)、6.82 (1H, d)、7.01 (2H, d)、7.26 (2H, d)、
7.46 (1H, d)2) 3- (2- (3,4-methylenedioxyphenyloxy) -3-cyano-4- (4-methoxyphenyl) -6-methylpyridin-5-yl) propenoic acid morpholinamide Synthesis of 3-cyano-5- (2-carboxyethenyl) -4-
(4-methoxyphenyl) -6-methyl-2- (3,4
-Methylenedioxyphenyl) pyridine 100mg
(0.23 mmol), morpholine 0.1 ml (1.1
mmol) in 5 ml of methylene chloride, and
mg (0.52 mmol), dimethylaminopyridine 5
mg and stirred at room temperature for 4 hours. The mixture was extracted with ethyl acetate, washed with 1N sodium hydroxide, 1N hydrochloric acid and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the title compound. This compound is used for the following reaction without further purification. Yield: 120 mg, Yield: quantitative MS (ESI, m / z) 500 (MH +) H-NMR (CDCl3): 2.51 (3H, s), 2.96-3.04 (2H, m), 3.4
0-3.50 (2H, m), 3.54-3.68 (4H, m), 3.85 (3H, s),
5.91 (1H, d), 6.03 (2H, s), 6.66 (1H, dd), 6.74 (1
H, d), 6.82 (1H, d), 7.01 (2H, d), 7.26 (2H, d),
7.46 (1H, d)
【0240】3)3−(2−(3,4−メチレンジオキ
シフェニルオキシ)−3−(5−テトラゾイル)−4−
(4−メトキシフェニル)−6−メチルピリジン−5−
イル)プロペノイックアシド モルホリンアミドの合成 3−(2−(3,4−メチレンジオキシフェニルオキ
シ)−3−シアノ−4−(4−メトキシフェニル)−6
−メチルピリジン−5−イル)プロペノイックアシド
モルホリンアミド120mg(0.24mmol)をト
ルエン5mlに溶解し、アジ化ナトリウム100mg
(1.5mmol)、塩化トリ−n−ブチルスズ0.2
7ml(1.0mmol)から作成したアジ化トリ−n
−ブチルスズを加え一晩加熱環流する。4規定塩酸ジオ
キサン溶液を加え、得られる結晶を酢酸エチルで洗浄し
表題化合物を得た。 収量:70mg、収率:53.8% MS(ESI,m/z) 543 (MH+) HRMS(FAB) 543.2004 (C28H27N6O6 543.1992 M
H+) H-NMR(DMSO-d6):2.48 (3H, s)、3.16-3.27 (2H, m)、
3.36-3.60 (6H, m)、3.72 (3H, s)、6.07 (2H, s)、6.3
4 (1H, d)、6.55 (1H, dd)、6.77 (1H, d)、6.86 (2H,
d)、6.92 (1H, d)、6.97 (2H, d)、7.22 (1H, d)3) 3- (2- (3,4-Methylenedioxyphenyloxy) -3- (5-tetrazoyl) -4-
(4-methoxyphenyl) -6-methylpyridine-5
Synthesis of yl) propenoic acid morpholinamide 3- (2- (3,4-methylenedioxyphenyloxy) -3-cyano-4- (4-methoxyphenyl) -6
-Methylpyridin-5-yl) propenoic acid
Dissolve 120 mg (0.24 mmol) of morpholinamide in 5 ml of toluene and add 100 mg of sodium azide.
(1.5 mmol), tri-n-butyltin chloride 0.2
Tri-n-azide prepared from 7 ml (1.0 mmol)
Add butyltin and heat to reflux overnight. A 4N hydrochloric acid-dioxane solution was added, and the obtained crystals were washed with ethyl acetate to give the title compound. Yield: 70 mg, Yield: 53.8% MS (ESI, m / z) 543 (MH +) HRMS (FAB) 543.2004 (C28H27N6O6 543.1992 M
H +) H-NMR (DMSO-d6): 2.48 (3H, s), 3.16-3.27 (2H, m),
3.36-3.60 (6H, m), 3.72 (3H, s), 6.07 (2H, s), 6.3
4 (1H, d), 6.55 (1H, dd), 6.77 (1H, d), 6.86 (2H,
d), 6.92 (1H, d), 6.97 (2H, d), 7.22 (1H, d)
【0241】実施例45 4−(4−メトキシフェニ
ル)−6−メチル−2−(3,4−メチレンジオキシフ
ェニル)−5−(3−(2−ピリジルオキシ)−1−プ
ロペニル)−3−(5−テトラゾリル)ピリジンの合成 1)2−アリルオキシピリジンの合成 DMF20ml中2−ヒドロキシピリジン0.96g
(10.1mmol)に60%水素化ナトリウム0.4
4g(11.0mmol)、臭化アリル2.6ml(3
0.0mmol)を室温で4時間攪拌した。減圧下でD
MFを留去後水を加え、酢酸エチルで抽出し有機層を無
水硫酸ナトリウムで乾燥、減圧下濃縮した。残渣をシリ
カゲルクロマトグラフィー(クロロホルム:メタノール
50:1)で精製し表題化合物を得た。 収量:1.12g(8.26mmol)、収率:81.
9% H-NMR(CDCl3):4.55-4.60(2H,m)、5.14-5.29(2H,m)、5.
89-6.03(1H,m)、6.15-6.20(1H,t)、6.57-6.60(1H,d)、
7.22-7.36(2H,m)Example 45 4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenyl) -5- (3- (2-pyridyloxy) -1-propenyl) -3 Synthesis of-(5-tetrazolyl) pyridine 1) Synthesis of 2-allyloxypyridine 0.96 g of 2-hydroxypyridine in 20 ml of DMF
(10.1 mmol) in 60% sodium hydride 0.4
4 g (11.0 mmol), 2.6 ml of allyl bromide (3
0.0 mmol) was stirred at room temperature for 4 hours. D under reduced pressure
After evaporating MF, water was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform: methanol 50: 1) to obtain the title compound. Yield: 1.12 g (8.26 mmol), yield: 81.
9% H-NMR (CDCl3): 4.55-4.60 (2H, m), 5.14-5.29 (2H, m), 5.
89-6.03 (1H, m), 6.15-6.20 (1H, t), 6.57-6.60 (1H, d),
7.22-7.36 (2H, m)
【0242】2)3−シアノ−4−(4−メトキシフェ
ニル)−6−メチル−2−(3,4−メチレンジオキシ
フェニル)−5−(3−(2−ピリジルオキシ)−1−
プロペニル)ピリジンの合成 DMF6ml中3−シアノ−5−ヨード−4−(4−メ
トキシフェニル)−6−メチル−2−(3,4−メチレ
ンジオキシフェニル)ピリジン284mg(0.58m
mol)、2−アリルオキシピリジン121mg(0.
89mmol)、酢酸パラジウム15mg(0.07m
mol)とトリブチルアミン0.42ml(1.76m
mol)を150℃で3.5時間加熱攪拌した。減圧下
でDMFを留去後水を加え、酢酸エチルで抽出し有機層
を無水硫酸ナトリウムで乾燥、減圧下濃縮した。残渣を
シリカゲルクロマトグラフィー(クロロホルム:メタノ
ール 100:1)で精製し表題化合物を得た。 収量:212mg(0.43mmol)、収率:73.
5% MS(ESI,m/z) 494(MH+) H-NMR(CDCl3):2.43(3H,s,Me)、3.86(3H,s,MeO)、4.50-
4.52(2H,d)、5.52-5.62(1H,dt)、6.02(2H,s)、6.04-6.1
0(1H,dt)、6.21-6.27(1H,d)、6.51-6.55(1H,d)、6.63-
6.83(3H,m)、6.86-6.90(1H,m)、6.92-6.95(2H,d)、7.18
-7.21(2H,d)、7.28-7.32(1H,m)2) 3-cyano-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenyl) -5- (3- (2-pyridyloxy) -1-
Synthesis of propenyl) pyridine 284 mg (0.58 m) of 3-cyano-5-iodo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenyl) pyridine in 6 ml of DMF
mol), 121 mg of 2-allyloxypyridine (0.
89 mmol), 15 mg of palladium acetate (0.07 m
mol) and 0.42 ml of tributylamine (1.76 m
mol) was heated and stirred at 150 ° C. for 3.5 hours. After evaporating DMF under reduced pressure, water was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform: methanol 100: 1) to give the title compound. Yield: 212 mg (0.43 mmol), yield: 73.
5% MS (ESI, m / z) 494 (MH +) H-NMR (CDCl3): 2.43 (3H, s, Me), 3.86 (3H, s, MeO), 4.50-
4.52 (2H, d), 5.52-5.62 (1H, dt), 6.02 (2H, s), 6.04-6.1
0 (1H, dt), 6.21-6.27 (1H, d), 6.51-6.55 (1H, d), 6.63
6.83 (3H, m), 6.86-6.90 (1H, m), 6.92-6.95 (2H, d), 7.18
-7.21 (2H, d), 7.28-7.32 (1H, m)
【0243】3)3−シアノ−4−(4−メトキシフェ
ニル)−6−メチル−2−(3,4−メチレンジオキシ
フェニル)−5−(3−(2−ピリジルオキシ)−1−
プロペニル)ピリジンの合成 アジ化ナトリウム215mg(3.31mmol)と塩
化トリブチルスズ0.54ml(1.99mmol)を
水10ml中氷浴下で4時間攪拌した。塩化メチレンで
抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮
した。残渣にトルエン15ml、3−シアノ−4−(4
−メトキシフェニル)−6−メチル−2−(3,4−メ
チレンジオキシフェニル)−5−(3−(2−ピリジル
オキシ)−1−プロペニル)ピリジン212mg(0.
43mmol)を加え4日間還流した。室温で2規定
塩酸、次に酢酸エチルを加えた。沈澱物を濾過、酢酸エ
チルで洗浄、乾燥し表題化合物を得た。 収量:127mg(0.24mmol)、収率:55.
2% MS(ESI,m/z) 537(MH+) H-NMR(DMSO-d6):2.40(3H,s,Me)、3.70(3H,s,MeO)、4.4
4-4.47(2H,d)、5.51-5.61(1H,dt)、6.05(2H,s)、6.06-
6.13(1H,dt)、6.20-6.33(2H,m)、6.51-6.55(1H,m)、6.7
1-6.91(6H,m)、7.24-7.28(1H,m)、7.31-7.38(1H,m)3) 3-Cyano-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenyl) -5- (3- (2-pyridyloxy) -1-
Synthesis of propenyl) pyridine 215 mg (3.31 mmol) of sodium azide and 0.54 ml (1.99 mmol) of tributyltin chloride were stirred in 10 ml of water in an ice bath for 4 hours. After extraction with methylene chloride, the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. To the residue, 15 ml of toluene and 3-cyano-4- (4
-Methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenyl) -5- (3- (2-pyridyloxy) -1-propenyl) pyridine 212 mg (0.
43 mmol) and refluxed for 4 days. 2 room temperature
Hydrochloric acid and then ethyl acetate were added. The precipitate was filtered, washed with ethyl acetate and dried to give the title compound. Yield: 127 mg (0.24 mmol), yield: 55.
2% MS (ESI, m / z) 537 (MH +) H-NMR (DMSO-d6): 2.40 (3H, s, Me), 3.70 (3H, s, MeO), 4.4
4-4.47 (2H, d), 5.51-5.61 (1H, dt), 6.05 (2H, s), 6.06-
6.13 (1H, dt), 6.20-6.33 (2H, m), 6.51-6.55 (1H, m), 6.7
1-6.91 (6H, m), 7.24-7.28 (1H, m), 7.31-7.38 (1H, m)
【0244】実施例46 3−(2−(3,4−メチレ
ンジオキシフェニルオキシ)−3−(5−テトラゾイ
ル)−4−(4−メトキシフェニル)−6−メチルピリ
ジン−5−イル)プロパノイックアシド モルホリンア
ミドの合成 3−(2−(3,4−メチレンジオキシフェニルオキ
シ)−3−(5−テトラゾイル)−4−(4−メトキシ
フェニル)−6−メチルピリジン−5−イル)プロペノ
イックアシド モルホリンアミド30mg(0.06m
mol)をDMF10mlに溶解し、10%パラジウム
炭素10mgを加え、水素圧4kg/m2、室温で一晩
攪拌する。セライトを用いて触媒を除き減圧下溶媒を留
去する。残渣を酢酸エチルで抽出し無水硫酸マグネシウ
ムで乾燥後減圧下溶媒を留去する。得られる結晶を酢酸
エチル:ヘキサン 1:1で洗浄し表題化合物を得た。 収量:20mg、収率:66.8% MS(ESI,m/z) 545 (MH+) HRMS(FAB) 545.2139 (C28H27N6O6 545.2149 M
H+) H-NMR(DMSO-d6):2.22-2.32 (2H, m)、2.45 (3H, s)、
2.58-2.68 (2H, m)、3.02-3.08 (2H, m)、3.24-3.38 (4
H, m)、3.42-3.50 (2H, m)、3.73 (3H, s)、6.05 (2H,
s)、6.51 (1H, dd)、6.72 (1H, d)、6.83-6.92 (3H,
m)、7.04 (2H, d)Example 46 3- (2- (3,4-Methylenedioxyphenyloxy) -3- (5-tetrazoyl) -4- (4-methoxyphenyl) -6-methylpyridin-5-yl) propa Synthesis of Neuacacid morpholinamide 3- (2- (3,4-methylenedioxyphenyloxy) -3- (5-tetrazoyl) -4- (4-methoxyphenyl) -6-methylpyridin-5-yl) 30 mg of propenoic acid morpholinamide (0.06m
mol) was dissolved in 10 ml of DMF, 10 mg of 10% palladium on carbon was added, and the mixture was stirred overnight at a hydrogen pressure of 4 kg / m2 at room temperature. The solvent is removed under reduced pressure by removing the catalyst using celite. The residue is extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent is distilled off under reduced pressure. The obtained crystals were washed with ethyl acetate: hexane 1: 1 to give the title compound. Yield: 20 mg, yield: 66.8% MS (ESI, m / z) 545 (MH +) HRMS (FAB) 545.2139 (C28H27N6O6 545.2149 M
H +) H-NMR (DMSO-d6): 2.22-2.32 (2H, m), 2.45 (3H, s),
2.58-2.68 (2H, m), 3.02-3.08 (2H, m), 3.24-3.38 (4
H, m), 3.42-3.50 (2H, m), 3.73 (3H, s), 6.05 (2H,
s), 6.51 (1H, dd), 6.72 (1H, d), 6.83-6.92 (3H,
m), 7.04 (2H, d)
【0245】実施例47 ピリジン−2−カルバミン酸
3−[4−(4−メトキシフェニル)−6−メチル−
2−(3、4−メチレンジオキシフェノキシ)−3−
(1H−テトラゾール−5−イル)ピリジン−5−イ
ル]−2−プロピレンエステルの合成 ピコリン酸81mg(0.654mmol)をトルエン
5mlに溶かし、アジ化ジフェニルホスホリル198m
g(0.718mmol),トリエチルアミン73mg
(0.718mmol)を加え、80℃にて2時間攪拌
した。その後5−(3−ヒドロキシ−1−プロペニル)
−4−(4−メトキシフェニル)−6−メチル−2−
(3、4−メチレンジオキシフェノキシ)−3−(1H
−テトラゾール−5−イル)−ピリジン100mg
(0.218mmol)を80℃にて加え、さらに12
時間攪拌した。反応終了後、反応溶液に1規定塩酸を2
ml加え、30分間攪拌した後、反応溶液に水を加え、
酢酸エチルにて抽出し、無水硫酸マグネシウムで乾燥
後、減圧下にて溶媒留去した。得られた残渣をカラムク
ロマトグラフィー(溶離液 クロロホルム:メタノール
9:1)にて精製し、表題化合物を得た。 収量:60mg、収率:48% MS(ESI.m/z) 580(MH+) 1H-H-NMR(DMSO-d6):2.45 (3H, s)、3.61 (3H, s)、4.5
6 (2H, d)、5.66 (2H,dt)、6.05 (2H, s)、6.40 (1H,
d)、6.52-7.06 (7H, m)、7.74-7.77 (2H, m)、8.24 (1
H, d)Example 47 3- [4- (4-Methoxyphenyl) -6-methyl-pyridine-2-carbamic acid
2- (3,4-methylenedioxyphenoxy) -3-
Synthesis of (1H-tetrazol-5-yl) pyridin-5-yl] -2-propylene ester 81 mg (0.654 mmol) of picolinic acid was dissolved in 5 ml of toluene, and 198 m of diphenylphosphoryl azide was obtained.
g (0.718 mmol), triethylamine 73 mg
(0.718 mmol), and the mixture was stirred at 80 ° C. for 2 hours. Then 5- (3-hydroxy-1-propenyl)
-4- (4-methoxyphenyl) -6-methyl-2-
(3,4-methylenedioxyphenoxy) -3- (1H
-Tetrazol-5-yl) -pyridine 100 mg
(0.218 mmol) at 80 ° C. and an additional 12
Stirred for hours. After completion of the reaction, 1N hydrochloric acid was added to the reaction solution for 2 hours.
After stirring for 30 minutes, water was added to the reaction solution,
After extraction with ethyl acetate and drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 60 mg, Yield: 48% MS (ESI.m / z) 580 (MH +) 1H-H-NMR (DMSO-d6): 2.45 (3H, s), 3.61 (3H, s), 4.5
6 (2H, d), 5.66 (2H, dt), 6.05 (2H, s), 6.40 (1H,
d), 6.52-7.06 (7H, m), 7.74-7.77 (2H, m), 8.24 (1
H, d)
【0246】実施例48 フラン−2−カルバミン酸
3−[4−(4−メトキシフェニル)−6−メチル−2
−(3、4−メチレンジオキシフェノキシ)−3−(1
H−テトラゾール−5−イル)ピリジン−5−イル]−
2−プロピレンエステルの合成 2ーフランカルボン酸146mg(1.31mmol)
をトルエン5mlに溶かし、アジ化ジフェニルホスホリ
ル419mg(1.52mmol),トリエチルアミン
154mg(1.52mmol)を加え、80℃にて2
時間攪拌した。その後5−(3−ヒドロキシ−1−プロ
ペニル)−4−(4−メトキシフェニル)−6−メチル
−2−(3、4−メチレンジオキシフェノキシ)−3−
(1H−テトラゾール−5−イル)−ピリジン200m
g(0.435mmol)を80℃にて加え、さらに4
8時間攪拌した。反応終了後、反応溶液に1規定塩酸を
2ml加え、30分間攪拌した後、反応溶液に水を加
え、酢酸エチルにて抽出し、無水硫酸マグネシウムで乾
燥後、減圧下にて溶媒留去した。得られた残渣をカラム
クロマトグラフィー(溶離液 クロロホルム:メタノー
ル 9:1)にて精製し、表題化合物を得た。 収量:160mg、収率:65% MS(ESI.m/z) 569(MH+) 1H-NMR (CDCl3):2.49 (3H, s)、3.69 (3H, s)、4.57
(2H, d)、5.65 (1H, dt)、5.96 (3H, br s)、6.34-7.14
(10H, m)Example 48 Furan-2-carbamic acid
3- [4- (4-methoxyphenyl) -6-methyl-2
-(3,4-methylenedioxyphenoxy) -3- (1
H-tetrazol-5-yl) pyridin-5-yl]-
Synthesis of 2-propylene ester 146 mg (1.31 mmol) of 2-furancarboxylic acid
Was dissolved in 5 ml of toluene, and 419 mg (1.52 mmol) of diphenylphosphoryl azide and 154 mg (1.52 mmol) of triethylamine were added.
Stirred for hours. Then, 5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -3-
(1H-tetrazol-5-yl) -pyridine 200 m
g (0.435 mmol) at 80 ° C.
Stir for 8 hours. After completion of the reaction, 2 ml of 1N hydrochloric acid was added to the reaction solution, and the mixture was stirred for 30 minutes. Water was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 160 mg, Yield: 65% MS (ESI.m / z) 569 (MH +) 1H-NMR (CDCl3): 2.49 (3H, s), 3.69 (3H, s), 4.57
(2H, d), 5.65 (1H, dt), 5.96 (3H, br s), 6.34-7.14
(10H, m)
【0247】実施例49 フラン−2−イルカルボン酸
3−[4−(4−メトキシフェニル)−6−メチル−
2−(3、4−メチレンジオキシフェノキシ)−3−
(1H−テトラゾール−5−イル)ピリジン−5−イ
ル」−2−プロピレンエステルの合成 5−(3−ヒドロキシ−1−プロペニル)−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−3−(1H−テトラゾール
−5−イル)−ピリジン100mg(0.218mmo
l)をピリジン5mlに溶かし、2−フロイルクロライ
ド43mg(0.326mmol)を室温にて加え4時
間攪拌した。反応溶液に1規定塩酸を3ml加え、酢酸
エチルにて抽出し、無水硫酸マグネシウムで乾燥後、減
圧下にて溶媒留去した。得られた残渣をカラムクロマト
グラフィー(溶離液 クロロホルム:メタノール 9:
1)にて精製し、表題化合物を得た。 収量:70mg、収率:59% MS(ESI.m/z) 554(MH+) 1H-NMR (CDCl3):2.45 (3H, s)、3.66 (3H, s)、4.70
(2H, d) 、5.60 (1H, dt)、5.92 (2H, s)、6.32-7.54
(11H, m)Example 49 Furan-2-ylcarboxylic acid 3- [4- (4-methoxyphenyl) -6-methyl-
2- (3,4-methylenedioxyphenoxy) -3-
Synthesis of (1H-tetrazol-5-yl) pyridin-5-yl "-2-propylene ester 5- (3-hydroxy-1-propenyl) -4- (4-
Methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) -pyridine 100 mg (0.218 mmol)
l) was dissolved in 5 ml of pyridine, 43 mg (0.326 mmol) of 2-furoyl chloride was added at room temperature, and the mixture was stirred for 4 hours. The reaction solution was added with 3 ml of 1N hydrochloric acid, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is subjected to column chromatography (eluent: chloroform: methanol 9:
Purification in 1) gave the title compound. Yield: 70 mg, Yield: 59% MS (ESI.m / z) 554 (MH +) 1H-NMR (CDCl3): 2.45 (3H, s), 3.66 (3H, s), 4.70
(2H, d), 5.60 (1H, dt), 5.92 (2H, s), 6.32-7.54
(11H, m)
【0248】実施例50 3−(2−(3,4−メチレ
ンジオキシフェニルオキシ)−3−(5−テトラゾイ
ル)−4−(4−メトキシフェニル)−6−メチルピリ
ジン−5−イル)プロペノイックアシド アニリンアミ
ドの合成 1)3−(2−(3,4−メチレンジオキシフェニルオ
キシ)−3−シアノ−4−(4−メトキシフェニル)−
6−メチルピリジン−5−イル)プロペノイックアシド
アニリンアミドの合成 3−シアノ−5−(2−カルボキシエテニル)−4−
(4−メトキシフェニル)−6−メチル−2−(3,4
−メチレンジオキシフェニル)ピリジン90mg(0.
21mmol)、アニリン0.1g(1.0mmol)
を塩化メチレン5mlに溶解しWSC80mg(0.4
2mmol)を加え室温で3時間攪拌する。酢酸エチル
で抽出し、1規定水酸化ナトリウム、1規定塩酸、飽和
食塩水で洗浄し無水硫酸マグネシウムで乾燥後減圧下溶
媒を留去し、表題化合物を得た。この化合物はこれ以上
精製せずに以下の反応に用いる。 収量:40mg、収率:37.7% MS(ESI,m/Z) 506 (MH+) H-NMR(CDCl3):2.52 (3H, s)、3.86 (3H, s)、5.79 (1
H, d)、6.02 (2H, s)、6.66 (1H, dd)、6.74 (1H, d)、
6.82 (1H, d)、7.00 (2H, d)、7.50 (1H, m)、7.54 (1
H, d)Example 50 3- (2- (3,4-Methylenedioxyphenyloxy) -3- (5-tetrazoyl) -4- (4-methoxyphenyl) -6-methylpyridin-5-yl) propane Synthesis of Neuacacid anilinamide 1) 3- (2- (3,4-Methylenedioxyphenyloxy) -3-cyano-4- (4-methoxyphenyl)-
Synthesis of 6-methylpyridin-5-yl) propenoic acid anilinamide 3-cyano-5- (2-carboxyethenyl) -4-
(4-methoxyphenyl) -6-methyl-2- (3,4
-Methylenedioxyphenyl) pyridine 90 mg (0.
21 mmol), aniline 0.1 g (1.0 mmol)
Was dissolved in 5 ml of methylene chloride, and 80 mg of WSC (0.4 mg) was dissolved.
2 mmol) and stir at room temperature for 3 hours. The mixture was extracted with ethyl acetate, washed with 1N sodium hydroxide, 1N hydrochloric acid and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the title compound. This compound is used for the following reaction without further purification. Yield: 40 mg, Yield: 37.7% MS (ESI, m / Z) 506 (MH +) H-NMR (CDCl3): 2.52 (3H, s), 3.86 (3H, s), 5.79 (1
H, d), 6.02 (2H, s), 6.66 (1H, dd), 6.74 (1H, d),
6.82 (1H, d), 7.00 (2H, d), 7.50 (1H, m), 7.54 (1
H, d)
【0249】2)3−(2−(3,4−メチレンジオキ
シフェニルオキシ)−3−(5−テトラゾイル)−4−
(4−メトキシフェニル)−6−メチルピリジン−5−
イル)プロペノイックアシド アニリンアミドの合成 3−(2−(3,4−メチレンジオキシフェニルオキ
シ)−3−シアノ−4−(4−メトキシフェニル)−6
−メチルピリジン−5−イル)プロペノイックアシド
アニホリンアミド40mgをトルエン10mlに溶解
し、アジ化ナトリウム100mg(1.5mmol)、
塩化トリ−n−ブチルスズ0.27ml(1.0mmo
l)から作成したアジ化トリ−n−ブチルスズを加え3
日間加熱環流する。4規定塩酸ジオキサン溶液を加え、
得られる結晶を酢酸エチルで洗浄し表題化合物を得た。 収量:35mg、収率:80.1% MS(ESI,m/z) 549 (MH+) H-NMR(DMSO-d6):2.55 (3H, s)、3.73 (3H, s)、6.07
(2H, s)、6.36 (1H, d)、6.58 (1H, dd)、6.80-7.10 (8
H, m)、7.20-7.38 (3H, m)、7.62 (2H, d)、10.12 (1H,
br)2) 3- (2- (3,4-methylenedioxyphenyloxy) -3- (5-tetrazoyl) -4-
(4-methoxyphenyl) -6-methylpyridine-5
Synthesis of yl) propenoic acid anilinamide 3- (2- (3,4-methylenedioxyphenyloxy) -3-cyano-4- (4-methoxyphenyl) -6
-Methylpyridin-5-yl) propenoic acid
Anifolinamide (40 mg) was dissolved in toluene (10 ml), sodium azide (100 mg, 1.5 mmol),
0.27 ml of tri-n-butyltin chloride (1.0 mmol
l) Add tri-n-butyltin azide prepared from 1) and add 3
Heat to reflux for days. Add 4N dioxane hydrochloride solution,
The obtained crystals were washed with ethyl acetate to give the title compound. Yield: 35 mg, Yield: 80.1% MS (ESI, m / z) 549 (MH +) H-NMR (DMSO-d6): 2.55 (3H, s), 3.73 (3H, s), 6.07
(2H, s), 6.36 (1H, d), 6.58 (1H, dd), 6.80-7.10 (8
H, m), 7.20-7.38 (3H, m), 7.62 (2H, d), 10.12 (1H,
br)
【0250】実施例51 5−[3−(ピリミジン−2
−イロキシ)−1−プロペニル]−4−(4−メトキシ
フェニル)−6−メチル−2−(3、4−メチレンジオ
キシフェノキシ)−3−(1H−テトラゾール−5−イ
ル)−ピリジンの合成 アルゴン雰囲気下、5−(3−ヒドロキシ−1−プロペ
ニル)−4−(4−メトキシフェニル)−6−メチル−
2−(3、4−メチレンジオキシフェノキシ)−3−
(1H−テトラゾール−5−イル)−ピリジン60mg
(0.131mmol)をDMF5mlに溶かし、60
%水素化ナトリウム11mg(0.261mmol)を
室温にて加えて1時間攪拌した。その後2ークロロピリ
ミジン30mg(0.261mmol)を室温にて加え
て、80℃にて12時間攪拌した。反応溶液に飽和食塩
水を加え、酢酸エチルにて抽出、無水硫酸マグネシウム
で乾燥後、減圧下にて溶媒留去した。得られた残渣をカ
ラムクロマトグラフィー(溶離液 クロロホルム:メタ
ノール 9:1)にて精製し、表題化合物を得た。 収量:60mg、収率:87% MS(ESI.m/z) 538(MH+) 1H-NMR (CDCl3):2.39 (3H, s)、3.69 (3H, s)、4.78
(2H, d)、5.62 (1H, dt)、5.93 (2H, s)、6.26-6.98 (9
H, m)、8.46 (2H, d)Example 51 5- [3- (pyrimidine-2)
Synthesis of-(yloxy) -1-propenyl] -4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) -pyridine Under an argon atmosphere, 5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -6-methyl-
2- (3,4-methylenedioxyphenoxy) -3-
(1H-tetrazol-5-yl) -pyridine 60 mg
(0.131 mmol) was dissolved in 5 ml of DMF.
% Sodium hydride (11 mg, 0.261 mmol) was added at room temperature, and the mixture was stirred for 1 hour. Thereafter, 30 mg (0.261 mmol) of 2-chloropyrimidine was added at room temperature, and the mixture was stirred at 80 ° C. for 12 hours. Saturated saline was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 60 mg, Yield: 87% MS (ESI.m / z) 538 (MH +) 1H-NMR (CDCl3): 2.39 (3H, s), 3.69 (3H, s), 4.78
(2H, d), 5.62 (1H, dt), 5.93 (2H, s), 6.26-6.98 (9
H, m), 8.46 (2H, d)
【0251】実施例52 4−(4−メトキシフェニ
ル)−6−メチル−2−(3,4−メチレンジオキシフ
ェノキシ)−5−(3−(2−キノリルオキシ)−1−
プロペニル)−3−(5−テトラゾリル)ピリジンの合
成 1)2−アリルオキシキノリンの合成 DMF40ml中2−ヒドロキシキノリン3.08g
(21.2mmol)に60%水素化ナトリウム0.9
0g(22.5mmol)、臭化アリル10ml(11
6mmol)を室温で1晩攪拌した。減圧下でDMFを
留去後水を加え、酢酸エチルで抽出し有機層を無水硫酸
ナトリウムで乾燥、減圧下濃縮した。残渣をシリカゲル
クロマトグラフィー(ヘキサン:酢酸エチル 4:1)
で精製し表題化合物を得た。 収量:3.13g(16.9mmol)、収率:79.
7% H-NMR(CDCl3):4.94-4.98(2H,m)、5.06-5.26(2H,m)、5.
91-6.04(1H,m)、6.73(1H,d)、7.22(1H,t)、7.33(1H,
d)、7.50-7.59(2H,m)、7.70(1H,d)Example 52 4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -5- (3- (2-quinolyloxy) -1-
Synthesis of propenyl) -3- (5-tetrazolyl) pyridine 1) Synthesis of 2-allyloxyquinoline 3.08 g of 2-hydroxyquinoline in 40 ml of DMF
(21.2 mmol) in 60% sodium hydride 0.9
0 g (22.5 mmol), allyl bromide 10 ml (11
6 mmol) was stirred overnight at room temperature. After evaporating DMF under reduced pressure, water was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. Silica gel chromatography of the residue (hexane: ethyl acetate 4: 1)
And the title compound was obtained. Yield: 3.13 g (16.9 mmol), yield: 79.
7% H-NMR (CDCl3): 4.94 to 4.98 (2H, m), 5.06-5.26 (2H, m), 5.
91-6.04 (1H, m), 6.73 (1H, d), 7.22 (1H, t), 7.33 (1H,
d), 7.50-7.59 (2H, m), 7.70 (1H, d)
【0252】2)3−シアノ−4−(4−メトキシフェ
ニル)−6−メチル−2−(3,4−メチレンジオキシ
フェノキシ)−5−(3−(2−キノリルオキシ)−1
−プロペニル)ピリジンの合成 DMF6ml中3−シアノ−5−ヨード−4−(4−メ
トキシフェニル)−6−メチル−2−(3,4−メチレ
ンジオキシフェノキシ)ピリジン285mg(0.59
mmol)、2−アリルオキシキノリン163mg
(0.88mmol)、酢酸パラジウム17mg(0.
07mmol)とトリブチルアミン0.42ml(1.
76mmol)を150℃で4時間加熱攪拌した。減圧
下でDMFを留去後1規定塩酸を加え、酢酸エチルで抽
出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮し
た。残渣をシリカゲルクロマトグラフィー(ヘキサン:
酢酸エチル 2:1)で精製し表題化合物を得た。 収量:240mg(0.44mmol)、収率:75.
5% MS(ESI,m/z) 544(MH+) H-NMR(CDCl3):2.40(3H,s,Me)、3.80(3H,s,MeO)、4.89
(2H,d)、5.59(1H,dt)、6.00(2H,s)、6.14(1H,d)、6.61-
6.81(6H,m)、7.02-7.09(3H,m)、6.63-6.83(3H,m)、7.19
-7.27(1H,m)、7.47(1H,t)、7.56(1H,d)、7.66(1H,d)2) 3-Cyano-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -5- (3- (2-quinolyloxy) -1
Synthesis of -propenyl) pyridine 285 mg (0.59) of 3-cyano-5-iodo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) pyridine in 6 ml of DMF
mmol), 163 mg of 2-allyloxyquinoline
(0.88 mmol), 17 mg of palladium acetate (0.
07 mmol) and 0.42 ml of tributylamine (1.
(76 mmol) was heated and stirred at 150 ° C. for 4 hours. After distilling off DMF under reduced pressure, 1N hydrochloric acid was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was chromatographed on silica gel (hexane:
Purification with ethyl acetate (2: 1) gave the title compound. Yield: 240 mg (0.44 mmol), yield: 75.
5% MS (ESI, m / z) 544 (MH +) H-NMR (CDCl3): 2.40 (3H, s, Me), 3.80 (3H, s, MeO), 4.89
(2H, d), 5.59 (1H, dt), 6.00 (2H, s), 6.14 (1H, d), 6.61
6.81 (6H, m), 7.02-7.09 (3H, m), 6.63-6.83 (3H, m), 7.19
-7.27 (1H, m), 7.47 (1H, t), 7.56 (1H, d), 7.66 (1H, d)
【0253】3)4−(4−メトキシフェニル)−6−
メチル−2−(3,4−メチレンジオキシフェノキシ)
−5−(3−(2−キノリルオキシ)−1−プロペニ
ル)−3−(5−テトラゾリル)ピリジンの合成 アジ化ナトリウム408mg(6.28mmol)と塩
化トリブチルスズ1.0ml(3.69mmol)を水
20ml中氷浴下で4時間攪拌した。塩化メチレンで抽
出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮し
た。残渣にトルエン5ml、3−シアノ−4−(4−メ
トキシフェニル)−6−メチル−2−(3,4−メチレ
ンジオキシフェノキシ)−5−(3−(2−キノリルオ
キシ)−1−プロペニル)ピリジン235mg(0.4
3mmol)を加え1晩還流した。室温で2規定 塩酸
を加え、酢酸エチルで抽出し有機層を無水硫酸ナトリウ
ムで乾燥、減圧下濃縮した。残渣を酢酸エチルで洗浄、
乾燥し表題化合物を得た。 収量:158mg(0.27mmol)、収率:62.
3% MS(ESI,m/z) 587(MH+) H-NMR(DMSO-d6):2.39(3H,s,Me)、3.64(3H,s,MeO)、4.8
4(2H,d)、5.58(1H,dt)、6.04(2H,s)、6.10(1H,d)、6.43
-6.56(4H,m)、6.66-6.74(3H,m)、6.88(1H,d)、7.22-7.2
8(2H,m)、7.48-7.55(1H,m)、7.66-7.71(1H,m)、7.86(1
H,d)3) 4- (4-methoxyphenyl) -6
Methyl-2- (3,4-methylenedioxyphenoxy)
Synthesis of -5- (3- (2-quinolyloxy) -1-propenyl) -3- (5-tetrazolyl) pyridine 408 mg (6.28 mmol) of sodium azide and 1.0 ml (3.69 mmol) of tributyltin chloride were added to 20 ml of water. The mixture was stirred for 4 hours under a medium ice bath. After extraction with methylene chloride, the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. To the residue was added 5 ml of toluene, 3-cyano-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -5- (3- (2-quinolyloxy) -1-propenyl). 235 mg of pyridine (0.4 mg
3 mmol) and refluxed overnight. At room temperature, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was washed with ethyl acetate,
Dry to obtain the title compound. Yield: 158 mg (0.27 mmol), yield: 62.
3% MS (ESI, m / z) 587 (MH +) H-NMR (DMSO-d6): 2.39 (3H, s, Me), 3.64 (3H, s, MeO), 4.8
4 (2H, d), 5.58 (1H, dt), 6.04 (2H, s), 6.10 (1H, d), 6.43
-6.56 (4H, m), 6.66-6.74 (3H, m), 6.88 (1H, d), 7.22-7.2
8 (2H, m), 7.48-7.55 (1H, m), 7.66-7.71 (1H, m), 7.86 (1
H, d)
【0254】実施例53 シクロヘキサンカルボン酸
3−[4−メトキシフェニル−6−メチル−2−(3、
4−メチレンジオキシフェノキシ)−3−(1H−テト
ラゾール−5−イル)ピリジン−5−イル」−2−プロ
ピレンエステルの合成 5−(3−ヒドロキシ−1−プロペニル)−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−3−(1H−テトラゾール
−5−イル)−ピリジン100mg(0.218mmo
l)をピリジン5mlに溶かし、シクロヘキサンカルボ
ニルクロライド48mg(0.326mmol)を室温
にて加え12時間攪拌した。反応溶液に1規定塩酸を3
ml加え、酢酸エチルにて抽出し、無水硫酸マグネシウ
ムで乾燥後、減圧下にて溶媒留去した。得られた残渣を
カラムクロマトグラフィー(溶離液 クロロホルム:メ
タノール 9:1)にて精製し、表題化合物を得た。 収量:40mg、収率:32% MS(ESI.m/z) 570(MH+) 1H-NMR (CDCl3):1.23-2.30 (11H, m)、2.48 (3H, s)、
3.76 (3H, s)、4.51 (2H, d)、5.59 (1H, dt)、5.97 (2
H, s)、6.25 (1H, d)、6.53-6.96 (7H, m)Example 53 Cyclohexanecarboxylic acid
3- [4-methoxyphenyl-6-methyl-2- (3,
Synthesis of 4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) pyridin-5-yl "-2-propylene ester 5- (3-hydroxy-1-propenyl) -4- (4-
Methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) -pyridine 100 mg (0.218 mmol)
l) was dissolved in 5 ml of pyridine, 48 mg (0.326 mmol) of cyclohexanecarbonyl chloride was added at room temperature, and the mixture was stirred for 12 hours. Add 1N hydrochloric acid to the reaction solution
The mixture was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 40 mg, Yield: 32% MS (ESI.m / z) 570 (MH +) 1H-NMR (CDCl3): 1.23-2.30 (11H, m), 2.48 (3H, s),
3.76 (3H, s), 4.51 (2H, d), 5.59 (1H, dt), 5.97 (2
H, s), 6.25 (1H, d), 6.53-6.96 (7H, m)
【0255】実施例54 5−(3−ヒドロキシ−1−
プロペニル)−4−(4−メトキシフェニル)−6−メ
チル−2−(2−クロロ−4,5−メチレンジオキシフ
ェノキシ)−3−(5−テトラゾイル)ピリジンの合成 実施例43と同様に行った。 MS(ESI,m/z) 494(MH+) H-NMR(DMSO-d6):2.16(3H,s)、3.45(3H,s)、3.62(2H,
m)、5.37(1H,dt)、5.86(2H,s)、5.94(1H,d)、6.55(2H,
d)、6.68(2H,d)、6.71(1H,s)、6.88(1H,s)Example 54 5- (3-hydroxy-1-)
Synthesis of propenyl) -4- (4-methoxyphenyl) -6-methyl-2- (2-chloro-4,5-methylenedioxyphenoxy) -3- (5-tetrazoyl) pyridine Performed in the same manner as in Example 43. Was. MS (ESI, m / z) 494 (MH +) H-NMR (DMSO-d6): 2.16 (3H, s), 3.45 (3H, s), 3.62 (2H,
m), 5.37 (1H, dt), 5.86 (2H, s), 5.94 (1H, d), 6.55 (2H,
d), 6.68 (2H, d), 6.71 (1H, s), 6.88 (1H, s)
【0256】実施例55 4−モルホリンカルボン酸
3−[4−(4−メトキシフェニル)−6−メチル−2
−(3、4−メチレンジオキシフェノキシ)−3−(1
H−テトラゾール−5−イル)ピリジン−5−イル」−
2−プロピレンエステルの合成 5−(3−ヒドロキシ−1−プロペニル)−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−3−(1H−テトラゾール
−5−イル)−ピリジン200mg(0.435mmo
l)をピリジン5mlに溶かし、4−モルホリンカルボ
ニルクロリド98mg(0.653mmol)を室温に
て加え48時間攪拌した。反応溶液に1規定塩酸を3m
l加え、酢酸エチルにて抽出し、無水硫酸マグネシウム
で乾燥後、減圧下にて溶媒留去した。得られた残渣をカ
ラムクロマトグラフィー(溶離液 クロロホルム:メタ
ノール 9:1)にて精製し、表題化合物を得た。 収量:124mg、収率:51% MS(ESI.m/z) 573(MH+) 1H-NMR (CDCl3):2.47 (3H, s)、3.24-3.76 (11H, m)、
4.09 (2H, d)、5.66 (1H, dt)、6.00 (2H, s)、6.27 (1
H, d)、6.47-7.07 (7H, m)Example 55 4-morpholinecarboxylic acid
3- [4- (4-methoxyphenyl) -6-methyl-2
-(3,4-methylenedioxyphenoxy) -3- (1
H-tetrazol-5-yl) pyridin-5-yl "-
Synthesis of 2-propylene ester 5- (3-hydroxy-1-propenyl) -4- (4-
Methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) -pyridine 200 mg (0.435 mmol)
l) was dissolved in 5 ml of pyridine, 98 mg (0.653 mmol) of 4-morpholinecarbonyl chloride was added at room temperature, and the mixture was stirred for 48 hours. 3m of 1N hydrochloric acid in the reaction solution
l, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 124 mg, Yield: 51% MS (ESI.m / z) 573 (MH +) 1H-NMR (CDCl3): 2.47 (3H, s), 3.24-3.76 (11H, m),
4.09 (2H, d), 5.66 (1H, dt), 6.00 (2H, s), 6.27 (1
H, d), 6.47-7.07 (7H, m)
【0257】実施例56 3−(2−(3,4−メチレ
ンジオキシフェニルオキシ)−3−(5−テトラゾイ
ル)−4−(4−メトキシフェニル)−6−メチルピリ
ジン−5−イル)プロペノイックアシド ジブチルアミ
ドの合成 実施例44と同様に行った。 MS(ESI,m/z) 585(MH+) H-NMR(DMSO-d6):0.85(6H,t)、1.08-1.44(8H,m)、2.48
(3H,s)、3.00(2H,m)、3.22(2H,m)、3.71(3H,s)、6.06(2
H,s)、6.22(1H,d)、6.55(1H,dd)、6.72(1H,d)、6.84(2
H,d)、6.91(1H,d)、6.97(2H,d)、7.28(1H,d)Example 56 3- (2- (3,4-Methylenedioxyphenyloxy) -3- (5-tetrazoyl) -4- (4-methoxyphenyl) -6-methylpyridin-5-yl) propane Synthesis of Neuacacid dibutylamide The same procedure was performed as in Example 44. MS (ESI, m / z) 585 (MH +) H-NMR (DMSO-d6): 0.85 (6H, t), 1.08-1.44 (8H, m), 2.48
(3H, s), 3.00 (2H, m), 3.22 (2H, m), 3.71 (3H, s), 6.06 (2
H, s), 6.22 (1H, d), 6.55 (1H, dd), 6.72 (1H, d), 6.84 (2
H, d), 6.91 (1H, d), 6.97 (2H, d), 7.28 (1H, d)
【0258】実施例57 3−(2−(3,4−メチレ
ンジオキシフェニルオキシ)−3−(5−テトラゾイ
ル)−4−(4−メトキシフェニル)−6−メチルピリ
ジン−5−イル)プロペノイックアシド 3,4,5−
トリメトキシアニリンアミドの合成 実施例44と同様に行った。 MS(ESI,m/z) 639(MH+) H-NMR(DMSO-d6):2.55(3H,s)、3.61(3H,s)、3.73(6H,
s)、3.74(3H,s)、6.07(2H,s)、6.34(1H,d)、6.58(1H,d
d)、6.80-7.02(8H,m)、7.24(1H,d)Example 57 3- (2- (3,4-Methylenedioxyphenyloxy) -3- (5-tetrazoyl) -4- (4-methoxyphenyl) -6-methylpyridin-5-yl) prope Neuk Acid 3,4,5-
Synthesis of trimethoxyanilinamide It was carried out in the same manner as in Example 44. MS (ESI, m / z) 639 (MH +) H-NMR (DMSO-d6): 2.55 (3H, s), 3.61 (3H, s), 3.73 (6H,
s), 3.74 (3H, s), 6.07 (2H, s), 6.34 (1H, d), 6.58 (1H, d
d), 6.80-7.02 (8H, m), 7.24 (1H, d)
【0259】実施例58 4−(4−メトキシフェニ
ル)−6−メチル−2−(3,4−メチレンジオキシフ
ェノキシ)−5−(3−(6−フェニル−3−ピリダジ
ルオキシ)−1−プロペニル)−3−(5−テトラゾリ
ル)ピリジンの合成 DMF5ml中5−(3−ヒドロキシ−1−プロペニ
ル)−4−(4−メトキシフェニル)−6−メチル−2
−(3,4−メチレンジオキシフェノキシ)−3−(5
−テトラゾイル)ピリジン58mg(0.13mmo
l)に60%水素化ナトリウム40mg(1.0mmo
l)、3−クロロ−6−フェニルピリダジン40mg
(0.21mmol)を80℃で3時間加熱した。減圧
下でDMFを留去後2規定 塩酸を加え、酢酸エチルで
抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮
した。残渣をシリカゲルクロマトグラフィー(クロロホ
ルム:メタノール 9:1)で精製し表題化合物を得
た。 収量:32mg(0.05mmol)、収率:41.3
% MS(ESI,m/z) 614(MH+) H-NMR(CDCl3):2.47(3H,s,Me)、3.68(3H,s,MeO)、4.92
(2H,d)、5.76(1H,dt)、5.97(2H,s)、6.35-6.95(8H,m)、
7.00(1H,d)、7.46-7.53(3H,m)、7.80(1H,d)、7.93-7.99
(2H,m)Example 58 4- (4-Methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -5- (3- (6-phenyl-3-pyridazyloxy) -1-propenyl Synthesis of) -3- (5-tetrazolyl) pyridine 5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -6-methyl-2 in 5 ml of DMF
-(3,4-methylenedioxyphenoxy) -3- (5
-Tetrazoyl) pyridine 58 mg (0.13 mmol
l) to 40 mg of 60% sodium hydride (1.0 mmo
l), 3-chloro-6-phenylpyridazine 40 mg
(0.21 mmol) was heated at 80 ° C. for 3 hours. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform: methanol 9: 1) to give the title compound. Yield: 32 mg (0.05 mmol), yield: 41.3
% MS (ESI, m / z) 614 (MH +) H-NMR (CDCl3): 2.47 (3H, s, Me), 3.68 (3H, s, MeO), 4.92
(2H, d), 5.76 (1H, dt), 5.97 (2H, s), 6.35-6.95 (8H, m),
7.00 (1H, d), 7.46-7.53 (3H, m), 7.80 (1H, d), 7.93-7.99
(2H, m)
【0260】実施例59 ピリジン−2−イルカルボン
酸 3−[4−メトキシフェニル−6−メチル−2−
(3、4−メチレンジオキシフェノキシ)−3−(1H
−テトラゾール−5−イル)ピリジン−5−イル」−2
−プロピレンエステルの合成 5−(3−ヒドロキシ−1−プロペニル)−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−3−(1H−テトラゾール
−5−イル)−ピリジン200mg(0.435mmo
l)をピリジン5mlに溶かし、ピリジンー2−カルボ
ニルクロライド ヒドロクロリド116mg(0.65
3mmol)を室温にて加え48時間攪拌した。反応溶
液に1規定塩酸を3ml加え、酢酸エチルにて抽出し、
無水硫酸マグネシウムで乾燥後、減圧下にて溶媒留去し
た。得られた残渣をカラムクロマトグラフィー(溶離液
クロロホルム:メタノール 9:1)にて精製し、表題
化合物を得た。 収量:30mg、収率:13% MS(ESI.m/z) 565(MH+) 1H-NMR (CDCl3):2.40 (3H, s)、3.60 (3H, s)、4.76
(2H, d)、5.57 (1H, dt)、5.94 (2H, s)、6.33-6.88 (8
H, m)、7.48-8.03 (3H, m)、8.67 (1H, d)Example 59 3- [4-Methoxyphenyl-6-methyl-2-pyridin-2-ylcarboxylic acid
(3,4-methylenedioxyphenoxy) -3- (1H
-Tetrazol-5-yl) pyridin-5-yl "-2
Synthesis of propylene ester 5- (3-hydroxy-1-propenyl) -4- (4-
Methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) -pyridine 200 mg (0.435 mmol)
l) was dissolved in 5 ml of pyridine, and 116 mg of pyridine-2-carbonyl chloride hydrochloride (0.65
3 mmol) at room temperature and stirred for 48 hours. 3N hydrochloric acid was added to the reaction solution, and extracted with ethyl acetate.
After drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 30 mg, Yield: 13% MS (ESI.m / z) 565 (MH +) 1H-NMR (CDCl3): 2.40 (3H, s), 3.60 (3H, s), 4.76
(2H, d), 5.57 (1H, dt), 5.94 (2H, s), 6.33-6.88 (8
H, m), 7.48-8.03 (3H, m), 8.67 (1H, d)
【0261】実施例60 4−ブトキシ安息香酸 3−
[4−メトキシフェニル−6−メチル−2−(3、4−
メチレンジオキシフェノキシ)−3−(1H−テトラゾ
ール−5−イル)ピリジン−5−イル」−2−プロピレ
ンエステルの合成 5−(3−ヒドロキシ−1−プロペニル)−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−3−(1H−テトラゾール
−5−イル)−ピリジン200mg(0.435mmo
l)をピリジン5mlに溶かし、4−ブトキシベンゾイ
ルクロライド139mg(0.653mmol)を室温
にて加え24時間攪拌した。反応溶液に1規定塩酸を3
ml加え、酢酸エチルにて抽出し、無水硫酸マグネシウ
ムで乾燥後、減圧下にて溶媒留去した。得られた残渣を
カラムクロマトグラフィー(溶離液 クロロホルム:メ
タノール 9:1)にて精製し、表題化合物を得た。 収量:120mg、収率:43% MS(ESI.m/z) 636(MH+) 1H-NMR (CDCl3):0.99 (3H, t)、1.50 (2H, sext)、1.7
9 (2H, quint)、2.48(3H, s)、3.68 (3H, s)、4.01 (2
H, t)、4.71 (2H, d)、5.67 (1H, dt)、5.96 (2H, s)、
5.96-6.93 (10H, m)、7.84 (2H, d)Example 60 4-butoxybenzoic acid 3-
[4-methoxyphenyl-6-methyl-2- (3,4-
Synthesis of methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) pyridin-5-yl "-2-propylene ester 5- (3-hydroxy-1-propenyl) -4- (4-
Methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) -pyridine 200 mg (0.435 mmol)
l) was dissolved in 5 ml of pyridine, 139 mg (0.653 mmol) of 4-butoxybenzoyl chloride was added at room temperature, and the mixture was stirred for 24 hours. Add 1N hydrochloric acid to the reaction solution
The mixture was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 120 mg, Yield: 43% MS (ESI.m / z) 636 (MH +) 1H-NMR (CDCl3): 0.99 (3H, t), 1.50 (2H, sext), 1.7
9 (2H, quint), 2.48 (3H, s), 3.68 (3H, s), 4.01 (2
H, t), 4.71 (2H, d), 5.67 (1H, dt), 5.96 (2H, s),
5.96-6.93 (10H, m), 7.84 (2H, d)
【0262】実施例61 5−[3−(5−ブロモピリ
ジン−2−イロキシ)−1−プロペニル]−4−(4−
メトキシフェニル)−6−メチル−2−(3、4−メチ
レンジオキシフェノキシ)−3−(1H−テトラゾール
−5−イル)−ピリジンの合成 アルゴン雰囲気下、5−(3−ヒドロキシ−1−プロペ
ニル)−4−(4−メトキシフェニル)−6−メチル−
2−(3、4−メチレンジオキシフェノキシ)−3−
(1H−テトラゾール−5−イル)−ピリジン200m
g(0.435mmol)をDMF10mlに溶かし、
60%水素化ナトリウム52mg(1.31mmol)
を室温にて加えて1時間攪拌した。その後2、5−ジブ
ロモピリジン309mg(1.31mmol)を室温に
て加えて、80℃にて12時間攪拌した。反応溶液に1
規定塩酸を3ml加え、酢酸エチルにて抽出後、飽和食
塩水で洗浄、無水硫酸マグネシウムで乾燥後、減圧下に
て溶媒留去した。得られた残渣をカラムクロマトグラフ
ィー(溶離液 クロロホルム:メタノール 9:1)に
て精製し、表題化合物を得た。 収量:80mg、収率:30% MS(ESI.m/z) 616(MH+) 1H-NMR (CDCl3):2.43 (3H, s)、3.69 (3H, s)、4.69
(2H, d)、5.66 (1H, dt)、5.90 (2H, s)、6.26-6.81 (9
H, m)、7.60 (1H, q)、8.07 (1H, d)Example 61 5- [3- (5-bromopyridine-2-yloxy) -1-propenyl] -4- (4-
Synthesis of methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) -pyridine 5- (3-hydroxy-1-propenyl) under an argon atmosphere ) -4- (4-Methoxyphenyl) -6-methyl-
2- (3,4-methylenedioxyphenoxy) -3-
(1H-tetrazol-5-yl) -pyridine 200 m
g (0.435 mmol) in 10 ml of DMF,
52 mg (1.31 mmol) of 60% sodium hydride
Was added at room temperature and stirred for 1 hour. Thereafter, 309 mg (1.31 mmol) of 2,5-dibromopyridine was added at room temperature, and the mixture was stirred at 80 ° C. for 12 hours. 1 in the reaction solution
After adding 3 ml of normal hydrochloric acid, the mixture was extracted with ethyl acetate, washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 80 mg, 30% MS (ESI.m / z) 616 (MH +) 1H-NMR (CDCl3): 2.43 (3H, s), 3.69 (3H, s), 4.69
(2H, d), 5.66 (1H, dt), 5.90 (2H, s), 6.26-6.81 (9
H, m), 7.60 (1H, q), 8.07 (1H, d)
【0263】実施例62 3、4、5−トリメトキシフ
ェニル−1−カルバミン酸 3−[4−メトキシフェニ
ル−6−メチル−2−(3、4−メチレンジオキシフェ
ノキシ)−3−(1H−テトラゾール−5−イル)ピリ
ジン−5−イル]−2−プロピレンエステルの合成 3、4、5−トリメトキシ安息香酸278mg(1.3
1mmol)をトルエン5mlに溶かし、アジ化ジフェ
ニルホスホリル418mg(1.52mmol),トリ
エチルアミン154mg(1.52mmol)を加え、
80℃にて2時間攪拌した。その後5−(3−ヒドロキ
シ−1−プロペニル)−4−(4−メトキシフェニル)
−6−メチル−2−(3、4−メチレンジオキシフェノ
キシ)−3−(1H−テトラゾール−5−イル)−ピリ
ジン200mg(0.435mmol)を80℃にて加
え、さらに12時間攪拌した。反応終了後、反応溶液に
1規定塩酸を2ml加え、30分間攪拌した後、反応溶
液に水を加え、酢酸エチルにて抽出し、無水硫酸マグネ
シウムで乾燥後、減圧下にて溶媒留去した。得られた残
渣をカラムクロマトグラフィー(溶離液 クロロホル
ム:メタノール 9:1)にて精製し、表題化合物を得
た。 収量:120mg、収率:41% MS(ESI.m/z) 669(MH+) 1H-NMR (CDCl3):2.45 (3H, s)、3.67 (3H, s)、3.79
(9H, s)、4.55 (2H, d)、5.56 (1H, dt)、5.95 (2H,
s)、6.25-6.87 (10H, m)Example 62 3,4,5-Trimethoxyphenyl-1-carbamic acid 3- [4-methoxyphenyl-6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H- Synthesis of tetrazol-5-yl) pyridin-5-yl] -2-propylene ester 278 mg of 3,4,5-trimethoxybenzoic acid (1.3 mg)
1 mmol) was dissolved in 5 ml of toluene, and 418 mg (1.52 mmol) of diphenylphosphoryl azide and 154 mg (1.52 mmol) of triethylamine were added.
The mixture was stirred at 80 ° C for 2 hours. Then 5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl)
200 mg (0.435 mmol) of -6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) -pyridine was added at 80 ° C, and the mixture was further stirred for 12 hours. After completion of the reaction, 2 ml of 1N hydrochloric acid was added to the reaction solution, and the mixture was stirred for 30 minutes. Water was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: chloroform: methanol 9: 1) to give the title compound. Yield: 120 mg, Yield: 41% MS (ESI.m / z) 669 (MH +) 1H-NMR (CDCl3): 2.45 (3H, s), 3.67 (3H, s), 3.79
(9H, s), 4.55 (2H, d), 5.56 (1H, dt), 5.95 (2H,
s), 6.25-6.87 (10H, m)
【0264】実施例63 4−(4−メトキシフェニ
ル)−6−メチル−2−(3,4−メチレンジオキシフ
ェノキシ)−5−(3−ピラジルオキシ−1−プロペニ
ル)−3−(1H−テトラゾール−5−イル)ピリジン
の合成 DMF5ml中、実施例43の化合物227mg(0.
49mmol)に60%水素化ナトリウム90mg
(2.25mmol)、クロロピラジン0.05ml
(0.56mmol)を100℃で3時間加熱した。減
圧下でDMFを留去後2N塩酸を加え、酢酸エチルで抽
出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮し
た。残渣を酢酸エチルで洗浄、減圧乾燥し表題化合物を
得た。 収量 110mg(0.21mmol) 収率 41.
4% MS (ESI, m/z) 538 (MH+) 1H-NMR (CDCl3):2.49 (3H, s), 3.76 (3H, s), 4.79
(2H, d), 5.77-5.79 (1H, m), 5.98 (2H, s), 6.37 (1
H, d), 6.50-6.77 (5H, m), 6.90 (2H, d), 7.99-8.17
(3H, m)Example 63 4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -5- (3-pyrazyloxy-1-propenyl) -3- (1H-tetrazole Synthesis of -5-yl) pyridine In 5 ml of DMF, 227 mg of the compound of Example 43 (0.
49 mmol) to 90 mg of 60% sodium hydride
(2.25 mmol), 0.05 ml of chloropyrazine
(0.56 mmol) was heated at 100 ° C. for 3 hours. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was washed with ethyl acetate and dried under reduced pressure to obtain the title compound. Yield 110 mg (0.21 mmol) Yield
4% MS (ESI, m / z) 538 (MH +) 1H-NMR (CDCl3): 2.49 (3H, s), 3.76 (3H, s), 4.79
(2H, d), 5.77-5.79 (1H, m), 5.98 (2H, s), 6.37 (1
H, d), 6.50-6.77 (5H, m), 6.90 (2H, d), 7.99-8.17
(3H, m)
【0265】実施例64 4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)−
5−(3−ヒドロキシ−1−プロペニル)−3−(1H
−テトラゾール−5−イル)ピリジンの合成 1)3−シアノ−5−ヨード−4−(4−メトキシフェ
ニル)−2−ピリドンの合成 アセトニトリル430ml中、3−シアノ−4−(4−
メトキシフェニル)−2−ピリドン13.38g(5
9.1mmol)にN−ヨードコハク酸イミド13.4
5g(59.8mmol)を加え8.5時間加熱還流し
た。冷却後結晶を濾過、アセトニトリルで洗浄、減圧乾
燥し表題化合物を得た。 収量 12.35g(35.1mmol) 収率 5
9.4% 1H-NMR (DMSO-d6): 3.83 (3H, s), 7.08 (2H, d), 7.28
(2H, d), 8.20 (1H, sExample 64 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy)-
5- (3-hydroxy-1-propenyl) -3- (1H
Synthesis of -tetrazol-5-yl) pyridine 1) Synthesis of 3-cyano-5-iodo-4- (4-methoxyphenyl) -2-pyridone In 430 ml of acetonitrile, 3-cyano-4- (4-
13.38 g of (methoxyphenyl) -2-pyridone (5
9.1 mmol) to 13.4 N-iodosuccinimide.
5 g (59.8 mmol) was added, and the mixture was heated under reflux for 8.5 hours. After cooling, the crystals were filtered, washed with acetonitrile, and dried under reduced pressure to obtain the title compound. Yield 12.35 g (35.1 mmol) Yield 5
9.4% 1H-NMR (DMSO-d6): 3.83 (3H, s), 7.08 (2H, d), 7.28
(2H, d), 8.20 (1H, s
【0266】2)2−クロロ−3−シアノ−5−ヨード
−4−(4−メトキシフェニル)ピリジンの合成 3−シアノ−5−ヨード−4−(4−メトキシフェニ
ル)−2−ピリドン12.35g(35.1mmol)
にオキシ塩化リン200mlを加え100℃で1晩加熱
した。オキシ塩化リンを留去後水を加え結晶を濾過、
水、ヘキサン、ヘキサン−酢酸エチル(1:1)で洗
浄、減圧乾燥し表題化合物を得た。。 収量 12.00g(32.4mmol) 収率 9
2.3% MS (ESI, m/z) 371 (MH+) 1H-NMR (CDCl3): 3.89 (3H, s), 7.05 (2H, d), 7.27
(2H, d), 8.94 (1H, s)2) Synthesis of 2-chloro-3-cyano-5-iodo-4- (4-methoxyphenyl) pyridine 3-cyano-5-iodo-4- (4-methoxyphenyl) -2-pyridone 35 g (35.1 mmol)
To the mixture was added 200 ml of phosphorus oxychloride, and the mixture was heated at 100 ° C. overnight. After distilling off phosphorus oxychloride, water was added and the crystals were filtered,
Washing with water, hexane, hexane-ethyl acetate (1: 1) and drying under reduced pressure gave the title compound. . Yield 12.00 g (32.4 mmol) Yield 9
2.3% MS (ESI, m / z) 371 (MH +) 1H-NMR (CDCl3): 3.89 (3H, s), 7.05 (2H, d), 7.27
(2H, d), 8.94 (1H, s)
【0267】3)3−シアノ−5−ヨード−4−(4−
メトキシフェニル)−2−(3,4−メチレンジオキシ
フェノキシ)ピリジンの合成 DMF150ml中、セサモール4.71g(34.1
mmol)、60%水素化ナトリウム1.37g(3
4.3mmol)、2−クロロ−3−シアノ−5−ヨー
ド−4−(4−メトキシフェニル)ピリジン12.00
g(32.4mmol)を室温で4時間攪拌した。減圧
下でDMFを留去後結晶を水、ヘキサン、ヘキサン−酢
酸エチル(1:1)で洗浄、減圧乾燥し表題化合物を得
た。。 収量 14.52g(30.8mmol) 収率 9
4.9% MS (ESI, m/z) 473 (MH+) 1H−NMR (CDCl3): 3.89 (3H,
s), 6.02 (2H, s), 6.63−
6.85 (3H, m), 7.05 (2H,
d), 7.32 (2H, d), 8.65 (1
H, s)3) 3-Cyano-5-iodo-4- (4-
Synthesis of methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 4.71 g (34.1) of sesamol in 150 ml of DMF
mmol), 1.37 g of 60% sodium hydride (3
4.3 mmol), 2-chloro-3-cyano-5-iodo-4- (4-methoxyphenyl) pyridine 12.00
g (32.4 mmol) was stirred at room temperature for 4 hours. After evaporating DMF under reduced pressure, the crystals were washed with water, hexane, hexane-ethyl acetate (1: 1) and dried under reduced pressure to obtain the title compound. . Yield 14.52 g (30.8 mmol) Yield 9
4.9% MS (ESI, m / z) 473 (MH +) 1H-NMR (CDCl3): 3.89 (3H,
s), 6.02 (2H, s), 6.63-
6.85 (3H, m), 7.05 (2H,
d), 7.32 (2H, d), 8.65 (1
H, s)
【0268】4)3−シアノ−5−(2−エトキシカル
ボニルエテニル)−4−(4−メトキシフェニル)−2
−(3,4−メチレンジオキシフェノキシ)ピリジンの
合成 3−シアノ−5−ヨード−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)ピ
リジン443mg(0.94mmol)をDMF8ml
に溶解し、酢酸パラジウム15mg(0.07mmo
l)とアクリル酸エチル1ml(9.23mmol)、
トリエチルアミン1ml(7.21mmol)を100
℃で1晩加熱攪拌した。減圧下でDMFを留去後2N塩
酸を加え、酢酸エチルで抽出し有機層を無水硫酸ナトリ
ウムで乾燥、減圧下濃縮した。残渣をシリカゲルクロマ
トグラフィー(ヘキサン−酢酸エチル=2:1)で精製
し表題化合物を得た。 収量 320mg(0.72mmol) 収率 76.
6% MS (ESI, m/z) 445 (MH+) 1H-NMR(CDCl3): 1.28 (3H, t), 3.90 (3H, s), 4.20 (2
H, qua), 6.03 (2H, s), 6.29 (1H, d), 6.65-6.87 (3
H, m), 7.07 (2H, d), 7.33 (2H, d), 7.43 (1H, d),
8.52 (1H, s)4) 3-Cyano-5- (2-ethoxycarbonylethenyl) -4- (4-methoxyphenyl) -2
Synthesis of-(3,4-methylenedioxyphenoxy) pyridine 3-cyano-5-iodo-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 443 mg (0.94 mmol) 8 ml of DMF
And dissolved in 15 mg of palladium acetate (0.07 mmol
1) and 1 ml (9.23 mmol) of ethyl acrylate,
1 ml (7.21 mmol) of triethylamine in 100
The mixture was heated and stirred at ℃ overnight. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 2: 1) to obtain the title compound. Yield 320 mg (0.72 mmol) Yield
6% MS (ESI, m / z) 445 (MH +) 1H-NMR (CDCl3): 1.28 (3H, t), 3.90 (3H, s), 4.20 (2
H, qua), 6.03 (2H, s), 6.29 (1H, d), 6.65-6.87 (3
H, m), 7.07 (2H, d), 7.33 (2H, d), 7.43 (1H, d),
8.52 (1H, s)
【0269】5)3−シアノ−5−(3−ヒドロキシ−
1−プロペニル)−4−(4−メトキシフェニル)−2
−(3,4−メチレンジオキシフェノキシ)ピリジンの
合成 3−シアノ−5−(2−エトキシカルボニルエテニル)
−4−(4−メトキシフェニル)−2−(3,4−メチ
レンジオキシフェノキシ)ピリジン234mg(0.5
3mmol)を塩化メチレン8mlに溶解し−78℃に
冷却後水素化ジイソブチルアルミニウム1Mヘキサン溶
液1.1ml(1.1mmol)を8分間で加えた。1
時間20分間攪拌後さらに水素化ジイソブチルアルミニ
ウム1Mヘキサン溶液0.5ml(0.5mmol)を
5分間で加えた。1時間攪拌後さらに水素化ジイソブチ
ルアルミニウム1Mヘキサン溶液0.5ml(0.5m
mol)を5分間で加えた。20分後、メタノール0.
8ml、水0.8mlを加えた。沈澱を濾過し濾液を減
圧下濃縮した。残渣をシリカゲルクロマトグラフィー
(ヘキサン−酢酸エチル=1:1)で精製し表題化合物
を得た。 収量 150mg(0.37mmol) 収率 70.
3% MS (ESI, m/z) 403 (MH+) 1H-NMR (CDCl3): 3.89 (3H, s), 4.22 (2H, d), 6.02
(2H, s), 6.20 (1H, dt), 6.35 (1H, d), 6.65-6.86 (3
H, m), 7.04 (2H, d), 7.33 (2H, d), 8.43 (1H, s)5) 3-cyano-5- (3-hydroxy-
1-propenyl) -4- (4-methoxyphenyl) -2
Synthesis of-(3,4-methylenedioxyphenoxy) pyridine 3-cyano-5- (2-ethoxycarbonylethenyl)
234 mg of 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine (0.5 mg)
3 mmol) was dissolved in 8 ml of methylene chloride, cooled to -78 ° C, and 1.1 ml (1.1 mmol) of a 1M hexane solution of diisobutylaluminum hydride was added over 8 minutes. 1
After stirring for 20 minutes, 0.5 ml (0.5 mmol) of a 1M hexane solution of diisobutylaluminum hydride was further added over 5 minutes. After stirring for one hour, 0.5 ml of a 1 M diisobutylaluminum hexane solution (0.5 m
mol) was added over 5 minutes. After 20 minutes, methanol 0.1.
8 ml and 0.8 ml of water were added. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 1: 1) to give the title compound. Yield 150 mg (0.37 mmol) Yield 70.
3% MS (ESI, m / z) 403 (MH +) 1H-NMR (CDCl3): 3.89 (3H, s), 4.22 (2H, d), 6.02
(2H, s), 6.20 (1H, dt), 6.35 (1H, d), 6.65-6.86 (3
H, m), 7.04 (2H, d), 7.33 (2H, d), 8.43 (1H, s)
【0270】6)4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)−5−(3−
ヒドロキシ−1−プロペニル)−3−(1H−テトラゾ
ール−5−イル)ピリジンの合成 アジ化ナトリウム436mg(6.71mmol)と塩
化トリブチルスズ1.0ml(3.69mmol)より
調製したトリブチルチンアジドと3−シアノ−5−(3
−ヒドロキシ−1−プロペニル)−4−(4−メトキシ
フェニル)−2−(3,4−メチレンジオキシフェノキ
シ)ピリジン145mg(0.36mmol)をトルエ
ン5ml、110℃で2日間加熱した。室温で2N塩酸
を加え、結晶を濾過、クロロホルムで洗浄した。得られ
た結晶をシリカゲルクロマトグラフィー(クロロホルム
−メタノール=9:1)で精製、さらにTLC(クロロ
ホルム−メタノール=9:1)で精製し表題化合物を得
た。 収量 8.5mg(0.02mmol) 収率 5.3
% MS (ESI, m/z) 446 (MH+) 1H-NMR (DMSO-d6): 3.74 (3H, s), 4.00 (2H, m), 6.05
(2H, s), 6.19 (1H,d), 6.36 (1H, dt), 6.51-7.07 (7
H, m), 7.33 (2H, d), 8.57 (1H, s)6) 4- (4-methoxyphenyl) -2-
(3,4-methylenedioxyphenoxy) -5- (3-
Synthesis of hydroxy-1-propenyl) -3- (1H-tetrazol-5-yl) pyridine Tributyltin azide prepared from 436 mg (6.71 mmol) of sodium azide and 1.0 ml (3.69 mmol) of tributyltin chloride and 3-butyltin Cyano-5- (3
145 mg (0.36 mmol) of -hydroxy-1-propenyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine was heated in 5 ml of toluene at 110 ° C for 2 days. At room temperature, 2N hydrochloric acid was added, and the crystals were filtered and washed with chloroform. The obtained crystals were purified by silica gel chromatography (chloroform-methanol = 9: 1), and further purified by TLC (chloroform-methanol = 9: 1) to obtain the title compound. Yield 8.5 mg (0.02 mmol) Yield 5.3
% MS (ESI, m / z) 446 (MH +) 1H-NMR (DMSO-d6): 3.74 (3H, s), 4.00 (2H, m), 6.05
(2H, s), 6.19 (1H, d), 6.36 (1H, dt), 6.51-7.07 (7
H, m), 7.33 (2H, d), 8.57 (1H, s)
【0271】実施例65 5−(3−ヒドロキシ−2−
メチレンプロピル)−4−(4−メトキシフェニル)−
2−(3,4−メチレンジオキシフェニル)−3−(1
H−テトラゾール−5−イル)ピリジンの合成 1)5−メチレン−2−フェニル−[1,3]ジオキサ
ンの合成 ベンゼン60ml中で2−メチレン−1,3−プロパン
ジオール2.65g(30.1mmol)とベンズアル
デヒド3.05ml(30.0mmol)をベンゼン6
0ml中で水を除きながら1晩加熱還流した。減圧下で
ベンゼンを留去後酢酸エチルを加え、有機層を飽和炭酸
水素ナトリウム水溶液で洗浄、無水硫酸ナトリウムで乾
燥、減圧下濃縮し表題化合物を得た。 収量 4.65g(26.4mmol) 収率 88.
0% 1H-NMR(CDCl3): 4.52 (4H, s), 5.00 (2H, s), 5.62 (1
H, s), 7.32-7.52 (5H, m)Example 65 5- (3-hydroxy-2-
Methylenepropyl) -4- (4-methoxyphenyl)-
2- (3,4-methylenedioxyphenyl) -3- (1
Synthesis of H-tetrazol-5-yl) pyridine 1) Synthesis of 5-methylene-2-phenyl- [1,3] dioxane 2.65 g (30.1 mmol) of 2-methylene-1,3-propanediol in 60 ml of benzene ) And benzaldehyde (3.05 ml, 30.0 mmol) in benzene 6
The mixture was refluxed overnight while removing water in 0 ml. After distilling off benzene under reduced pressure, ethyl acetate was added, and the organic layer was washed with a saturated aqueous solution of sodium hydrogen carbonate, dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain the title compound. Yield 4.65 g (26.4 mmol) Yield
0% 1H-NMR (CDCl3): 4.52 (4H, s), 5.00 (2H, s), 5.62 (1
H, s), 7.32-7.52 (5H, m)
【0272】2)3−シアノ−5−(2−ホルミル−2
−プロペニル)−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)ピリジンの合
成 3−シアノ−5−ヨード−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)ピ
リジン491mg(1.01mmol)をDMF10m
lに溶解し、酢酸パラジウム25mg(0.11mmo
l)と5−メチレン−2−フェニル−[1,3]ジオキ
サン1.70g(9.65mmol)、トリエチルアミ
ン1ml(7.21mmol)を100℃で1晩加熱攪
拌した。減圧下でDMFを留去後2N塩酸を加え、酢酸
エチルで抽出し有機層を無水硫酸ナトリウムで乾燥、減
圧下濃縮した。残渣をシリカゲルクロマトグラフィー
(ヘキサン−酢酸エチル=2:1)で精製し表題化合物
を得た。 収量 392mg(0.91mmol) 収率 90.
5% MS (ESI, m/z) 429 (MH+) 1H-NMR(CDCl3): 2.31 (3H, s), 3.40 (2H, m), 3.84 (3
H, s), 5.74 (1H, t),6.02 (2H, s), 6.04 (1H, t), 6.
66-6.83 (3H, m), 6.96 (2H, d), 7.15 (2H, d), 9.55
(1H, s, CHO)2) 3-cyano-5- (2-formyl-2)
-Propenyl) -4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenoxy) pyridine 491 mg (1.01 mmol) of 3-cyano-5-iodo-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine DMF10m
and 25 mg (0.11 mmol) of palladium acetate
l), 1.70 g (9.65 mmol) of 5-methylene-2-phenyl- [1,3] dioxane and 1 ml (7.21 mmol) of triethylamine were heated and stirred at 100 ° C. overnight. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 2: 1) to obtain the title compound. Yield 392 mg (0.91 mmol) Yield 90.
5% MS (ESI, m / z) 429 (MH +) 1H-NMR (CDCl3): 2.31 (3H, s), 3.40 (2H, m), 3.84 (3
H, s), 5.74 (1H, t), 6.02 (2H, s), 6.04 (1H, t), 6.
66-6.83 (3H, m), 6.96 (2H, d), 7.15 (2H, d), 9.55
(1H, s, CHO)
【0273】3)3−シアノ−5−(3−ヒドロキシ−
2−メチレンプロピル)−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェニル)ピリ
ジンの合成 3−シアノ−5−(2−ホルミル−2−プロペニル)−
4−(4−メトキシフェニル)−2−(3,4−メチレ
ンジオキシフェノキシ)ピリジン392mg(0.91
mmol)にエタノール10ml、メタノール10m
l、THF10mlを加え氷浴後、水素化ホウ素ナトリ
ウム130mg(3.44mmol)を加えた。2時間
攪拌後2N塩酸を加えて反応を止め、減圧下で反応溶媒
を留去、酢酸エチルで抽出し有機層を無水硫酸ナトリウ
ムで乾燥、減圧下濃縮した。残渣を精製せずに次の反応
に用いた。 収量 402mg(0.94mmol) 粗収率 10
0% MS (ESI, m/z) 431 (MH+) 1H-NMR(CDCl3): 2.39 (3H, s), 3.16 (2H, s), 3.86 (3
H, s), 3.98 (2H, s),4.45 (1H, s), 5.12 (1H, s), 6.
02 (2H, s), 6.65-6.84 (3H, m), 6.98 (2H,d), 7.24
(2H, d)3) 3-cyano-5- (3-hydroxy-
Synthesis of 2-methylenepropyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyl) pyridine 3-cyano-5- (2-formyl-2-propenyl)-
392 mg of 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine (0.91
mmol), ethanol 10ml, methanol 10m
1, 10 ml of THF was added, and after ice bath, 130 mg (3.44 mmol) of sodium borohydride was added. After stirring for 2 hours, 2N hydrochloric acid was added to stop the reaction, the reaction solvent was distilled off under reduced pressure, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was used for the next reaction without purification. Yield 402 mg (0.94 mmol) Crude yield 10
0% MS (ESI, m / z) 431 (MH +) 1H-NMR (CDCl3): 2.39 (3H, s), 3.16 (2H, s), 3.86 (3
H, s), 3.98 (2H, s), 4.45 (1H, s), 5.12 (1H, s), 6.
02 (2H, s), 6.65-6.84 (3H, m), 6.98 (2H, d), 7.24
(2H, d)
【0274】4)5−(3−ヒドロキシ−2−メチレン
プロピル)−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェニル)−3−(1H−
テトラゾール−5−イル)ピリジンの合成 アジ化ナトリウム698mg(10.7mmol)と塩
化トリブチルスズ1.5ml(5.53mmol)より
調製したトリブチルチンアジドと3−シアノ−5−(3
−ヒドロキシ−2−メチレンプロピル)−4−(4−メ
トキシフェニル)−2−(3,4−メチレンジオキシフ
ェニル)ピリジン395mg(0.86mmol)をト
ルエン5ml、120℃で2日間加熱した。室温で2N
塩酸を加え、酢酸エチルで抽出し有機層を無水硫酸ナト
リウムで乾燥、減圧下濃縮した。残渣をシリカゲルクロ
マトグラフィー(クロロホルム−メタノール=9:1)
で精製し表題化合物を得た。 収量 53mg(0.11mmol) 収率 12.8
% MS (ESI, m/z) 474 (MH+) 1H-NMR(CDCl3): 2.33 (3H, s), 3.05 (2H, s), 3.71 (3
H, s), 3.74 (2H, s),4.31 (1H, s), 4.85 (1H, brd),
5.03 (1H, s), 6.04 (2H, s), 6.50-6.96 (7H, m)4) 5- (3-hydroxy-2-methylenepropyl) -4- (4-methoxyphenyl) -2-
(3,4-methylenedioxyphenyl) -3- (1H-
Synthesis of tetrazol-5-yl) pyridine Tributyltin azide prepared from 698 mg (10.7 mmol) of sodium azide and 1.5 ml (5.53 mmol) of tributyltin chloride and 3-cyano-5- (3
395 mg (0.86 mmol) of -hydroxy-2-methylenepropyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenyl) pyridine were heated in 5 ml of toluene at 120 ° C for 2 days. 2N at room temperature
Hydrochloric acid was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. Silica gel chromatography of the residue (chloroform-methanol = 9: 1)
And the title compound was obtained. Yield 53 mg (0.11 mmol) Yield 12.8
% MS (ESI, m / z) 474 (MH +) 1H-NMR (CDCl3): 2.33 (3H, s), 3.05 (2H, s), 3.71 (3
H, s), 3.74 (2H, s), 4.31 (1H, s), 4.85 (1H, brd),
5.03 (1H, s), 6.04 (2H, s), 6.50-6.96 (7H, m)
【0275】実施例66 6−エチル−5−(3−ヒド
ロキシ−1−プロペニル)−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)−
3−(1H−テトラゾール−5−イル)ピリジンの合成 1)3−シアノ−6−エチル−5−ヨード−4−(4−
メトキシフェニル)−2−ピリドンの合成 アセトニトリル250ml中、3−シアノ−6−エチル
−4−(4−メトキシフェニル)−2−ピリドン7.0
7g(27.8mmol)にN−ヨードコハク酸イミド
8.20g(36.4mmol)を加え1晩加熱還流し
た。アセトニトリルを減圧下留去、残渣をヘキサン、ア
セトニトリルで洗浄、減圧乾燥し表題化合物を得た。 収量 5.30g(13.9mmol) 収率 50.
1% MS (ESI, m/z) 381 (MH+)Example 66 6-Ethyl-5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy)-
Synthesis of 3- (1H-tetrazol-5-yl) pyridine 1) 3-cyano-6-ethyl-5-iodo-4- (4-
Synthesis of methoxyphenyl) -2-pyridone 3-cyano-6-ethyl-4- (4-methoxyphenyl) -2-pyridone 7.0 in 250 ml of acetonitrile.
7.20 g (36.4 mmol) of N-iodosuccinimide was added to 7 g (27.8 mmol), and the mixture was heated under reflux overnight. Acetonitrile was distilled off under reduced pressure, and the residue was washed with hexane and acetonitrile and dried under reduced pressure to obtain the title compound. Yield 5.30 g (13.9 mmol) Yield 50.
1% MS (ESI, m / z) 381 (MH +)
【0276】2)2−クロロ−3−シアノ−6−エチル
−5−ヨード−4−(4−メトキシフェニル)ピリジン
の合成 3−シアノ−6−エチル−5−ヨード−4−(4−メト
キシフェニル)−2−ピリドン5.30g(13.9m
mol)にオキシ塩化リン70mlを加え100℃で1
晩加熱した。オキシ塩化リンを留去後、残渣をシリカゲ
ルクロマトグラフィー(クロロホルム−ヘキサン=4:
1)で精製し表題化合物を得た。 収量 4.81g(12.1mmol) 収率 86.
6% MS (ESI, m/z) 399 (MH+) 1H-NMR(CDCl3): 1.34 (3H, t), 3.14 (2H, qua), 3.88
(3H, s), 7.03 (2H, d), 7.19 (2H, d)2) Synthesis of 2-chloro-3-cyano-6-ethyl-5-iodo-4- (4-methoxyphenyl) pyridine 3-cyano-6-ethyl-5-iodo-4- (4-methoxy) 5.30 g of phenyl) -2-pyridone (13.9 m
mol), and add 70 ml of phosphorus oxychloride at 100 ° C.
Heated overnight. After the phosphorus oxychloride was distilled off, the residue was subjected to silica gel chromatography (chloroform-hexane = 4:
Purification in 1) gave the title compound. Yield 4.81 g (12.1 mmol) Yield
6% MS (ESI, m / z) 399 (MH +) 1H-NMR (CDCl3): 1.34 (3H, t), 3.14 (2H, qua), 3.88
(3H, s), 7.03 (2H, d), 7.19 (2H, d)
【0277】3)3−シアノ−6−エチル−5−ヨード
−4−(4−メトキシフェニル)−2−(3,4−メチ
レンジオキシフェノキシ)ピリジンの合成 DMF70ml中、セサモール1.86g(13.5m
mol)、60%水素化ナトリウム0.57g(14.
3mmol)、2−クロロ−3−シアノ−6−エチル−
5−ヨード−4−(4−メトキシフェニル)ピリジン
4.81g(12.1mmol)を室温で5時間攪拌し
た。減圧下でDMFを留去後水を加え濾過、水、ヘキサ
ンで洗浄、減圧乾燥し表題化合物を得た。 収量 6.36g(12.7mmol) 収率 94.
1% MS (ESI, m/z) 501 (MH+) 1H-NMR(CDCl3): 1.13 (3H, t), 2.95 (2H, m), 3.88 (3
H, s), 6.02 (2H, s),6.64-6.83 (3H, m), 7.03 (2H,
d), 7.24 (2H, d)3) Synthesis of 3-cyano-6-ethyl-5-iodo-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 1.86 g (13) of sesamol in 70 ml of DMF .5m
mol), 0.57 g of 60% sodium hydride (14.
3 mmol), 2-chloro-3-cyano-6-ethyl-
4.81 g (12.1 mmol) of 5-iodo-4- (4-methoxyphenyl) pyridine was stirred at room temperature for 5 hours. After evaporating DMF under reduced pressure, water was added, and the mixture was filtered, washed with water and hexane, and dried under reduced pressure to obtain the title compound. Yield 6.36 g (12.7 mmol) Yield
1% MS (ESI, m / z) 501 (MH +) 1H-NMR (CDCl3): 1.13 (3H, t), 2.95 (2H, m), 3.88 (3
H, s), 6.02 (2H, s), 6.64-6.83 (3H, m), 7.03 (2H,
d), 7.24 (2H, d)
【0278】4)3−シアノ−5−(2−エトキシカル
ボニルエテニル)−6−エチル−4−(4−メトキシフ
ェニル)−2−(3,4−メチレンジオキシフェノキ
シ)ピリジンの合成 3−シアノ−6−エチル−5−ヨード−4−(4−メト
キシフェニル)−2−(3,4−メチレンジオキシフェ
ノキシ)ピリジン6.35g(12.7mmol)をD
MF100mlに溶解し、酢酸パラジウム128mg
(0.57mmol)とアクリル酸エチル10ml(9
2.3mmol)、トリエチルアミン10ml(72.
1mmol)を100℃で5日間加熱攪拌した。減圧下
でDMFを留去後2N塩酸を加え、酢酸エチルで抽出し
有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮した。
残渣をシリカゲルクロマトグラフィー(ヘキサン−酢酸
エチル=2:1)で精製し表題化合物を得た。 収量 3.69g(7.80mmol) 収率 61.
4% MS (ESI, m/z) 473 (MH+) 1H-NMR(CDCl3): 1.14 (3H, t), 1.25 (3H, t), 2.80 (2
H, qua), 3.87 (3H, s), 4.17 (2H, qua), 5.74 (1H,
d), 6.02 (2H, s), 6.66-6.83 (3H, m), 6.70 (2H, d),
7.25 (2H, d), 7.44 (1H, d)4) Synthesis of 3-cyano-5- (2-ethoxycarbonylethenyl) -6-ethyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 6.35 g (12.7 mmol) of cyano-6-ethyl-5-iodo-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine was added to D
Dissolved in 100 ml of MF, 128 mg of palladium acetate
(0.57 mmol) and 10 ml of ethyl acrylate (9
2.3 mmol), 10 ml of triethylamine (72.
(1 mmol) was heated and stirred at 100 ° C. for 5 days. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure.
The residue was purified by silica gel chromatography (hexane-ethyl acetate = 2: 1) to obtain the title compound. Yield 3.69 g (7.80 mmol) Yield
4% MS (ESI, m / z) 473 (MH +) 1H-NMR (CDCl3): 1.14 (3H, t), 1.25 (3H, t), 2.80 (2
H, qua), 3.87 (3H, s), 4.17 (2H, qua), 5.74 (1H,
d), 6.02 (2H, s), 6.66-6.83 (3H, m), 6.70 (2H, d),
7.25 (2H, d), 7.44 (1H, d)
【0279】5)3−シアノ−6−エチル−5−(3−
ヒドロキシ−1−プロペニル)−4−(4−メトキシフ
ェニル)−2−(3,4−メチレンジオキシフェノキ
シ)ピリジンの合成 3−シアノ−5−(2−エトキシカルボニルエテニル)
−6−エチル−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)ピリジン3.
68g(7.79mmol)を塩化メチレン90mlに
溶解し−78℃に冷却後水素化ジイソブチルアルミニウ
ム1Mヘキサン溶液16.0ml(16.0mmol)
を55分間で加えた。そのままの温度で攪拌し、滴下終
了1.5時間後、3.5時間後、4.5時間後にさらに
水素化ジイソブチルアルミニウム1Mヘキサン溶液計1
8.0ml(18.0mmol)をそれぞれ10分間で
加えた。−78℃で1時間攪拌後、メタノール2.0m
l、水2mlを加えた。沈澱を濾過し濾液を減圧下濃縮
し表題化合物を得た。 収量 3.14g(7.29mmol) 収率 93.
6% MS (ESI, m/z) 431 (MH+) 1H-NMR(CDCl3): 1.12 (3H, t), 2.77 (2H, qua), 3.86
(3H, s), 4.09 (2H, m), 5.58 (1H, dt), 6.01 (2H,
s), 6.29 (1H, dt), 6.66-6.82 (3H, m), 6.98 (2H,
d), 7.24 (2H, d)5) 3-Cyano-6-ethyl-5- (3-
Synthesis of hydroxy-1-propenyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 3-cyano-5- (2-ethoxycarbonylethenyl)
-6-ethyl-4- (4-methoxyphenyl) -2-
(3,4-methylenedioxyphenoxy) pyridine3.
68 g (7.79 mmol) was dissolved in 90 ml of methylene chloride, cooled to -78 ° C, and then 16.0 ml (16.0 mmol) of a 1M hexane solution of diisobutylaluminum hydride.
Was added over 55 minutes. The mixture was stirred at the same temperature, and 1.5 hours, 3.5 hours, and 4.5 hours after the completion of the dropwise addition. Further, a 1 M hexane solution of diisobutylaluminum hydride was added.
8.0 ml (18.0 mmol) were added over 10 minutes each. After stirring at -78 ° C for 1 hour, methanol 2.0m
1 and 2 ml of water. The precipitate was filtered and the filtrate was concentrated under reduced pressure to obtain the title compound. Yield 3.14 g (7.29 mmol) Yield
6% MS (ESI, m / z) 431 (MH +) 1H-NMR (CDCl3): 1.12 (3H, t), 2.77 (2H, qua), 3.86
(3H, s), 4.09 (2H, m), 5.58 (1H, dt), 6.01 (2H,
s), 6.29 (1H, dt), 6.66-6.82 (3H, m), 6.98 (2H,
d), 7.24 (2H, d)
【0280】6)6−エチル−5−(3−ヒドロキシ−
1−プロペニル)−4−(4−メトキシフェニル)−2
−(3,4−メチレンジオキシフェノキシ)−3−(1
H−テトラゾール−5−イル)ピリジンの合成 アジ化ナトリウム737mg(11.3mmol)と塩
化トリブチルスズ1.5ml(5.53mmol)より
調製したトリブチルチンアジドと3−シアノ−6−エチ
ル−5−(3−ヒドロキシ−1−プロペニル)−4−
(4−メトキシフェニル)−2−(3,4−メチレンジ
オキシフェノキシ)ピリジン440mg(1.02mm
ol)をトルエン5ml、120℃で3日間加熱した。
室温で2N塩酸を加え濾過、結晶をトルエン、酢酸エチ
ルで洗浄、減圧乾燥し表題化合物を得た。 収量 258mg(0.55mmol) 収率 53.
3% MS (ESI, m/z) 474 (MH+) 1H-NMR (DMSO-d6): 1.09 (3H, t), 2.77 (2H, qua), 3.
71 (3H, s), 3.87 (2H, t), 5.55 (1H, dt), 6.05 (2H,
s), 6.24 (1H, dt), 6.54 (1H, dd), 6.76-6.96 (6H,
m)6) 6-ethyl-5- (3-hydroxy-
1-propenyl) -4- (4-methoxyphenyl) -2
-(3,4-methylenedioxyphenoxy) -3- (1
Synthesis of H-tetrazol-5-yl) pyridine Tributyltin azide prepared from 737 mg (11.3 mmol) of sodium azide and 1.5 ml (5.53 mmol) of tributyltin chloride and 3-cyano-6-ethyl-5- (3 -Hydroxy-1-propenyl) -4-
440 mg of (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine (1.02 mm
ol) was heated in 5 ml of toluene at 120 ° C. for 3 days.
2N Hydrochloric acid was added at room temperature, followed by filtration. The crystals were washed with toluene and ethyl acetate, and dried under reduced pressure to obtain the title compound. Yield 258 mg (0.55 mmol) Yield 53.
3% MS (ESI, m / z) 474 (MH +) 1H-NMR (DMSO-d6): 1.09 (3H, t), 2.77 (2H, qua), 3.
71 (3H, s), 3.87 (2H, t), 5.55 (1H, dt), 6.05 (2H,
s), 6.24 (1H, dt), 6.54 (1H, dd), 6.76-6.96 (6H,
m)
【0281】実施例67 6−ブチル−4−(4−メト
キシフェニル)−2−(3,4−メチレンジオキシフェ
ノキシ)−5−(3−ヒドロキシ−1−プロペニル)−
3−(1H−テトラゾール−5−イル)ピリジンの合成 1)6−ブチル−3−シアノ−5−ヨード−4−(4−
メトキシフェニル)−2−ピリドンの合成 アセトニトリル250ml中、6−ブチル−3−シアノ
−4−(4−メトキシフェニル)−2−ピリドン7.4
0g(26.2mmol)にN−ヨードコハク酸イミド
8.13g(36.1mmol)を加え1晩加熱還流し
た。アセトニトリルを減圧下留去、残渣をヘキサン、ア
セトニトリルで洗浄、減圧乾燥し表題化合物を得た。 収量 5.23g(12.8mmol) 収率 48.
9% MS (ESI, m/z) 409 (MH+)Example 67 6-butyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) -5- (3-hydroxy-1-propenyl)-
Synthesis of 3- (1H-tetrazol-5-yl) pyridine 1) 6-butyl-3-cyano-5-iodo-4- (4-
Synthesis of methoxyphenyl) -2-pyridone 6-butyl-3-cyano-4- (4-methoxyphenyl) -2-pyridone 7.4 in 250 ml of acetonitrile.
8.13 g (36.1 mmol) of N-iodosuccinimide was added to 0 g (26.2 mmol), and the mixture was heated under reflux overnight. Acetonitrile was distilled off under reduced pressure, and the residue was washed with hexane and acetonitrile and dried under reduced pressure to obtain the title compound. Yield 5.23 g (12.8 mmol) Yield
9% MS (ESI, m / z) 409 (MH +)
【0282】2)6−ブチル−2−クロロ−3−シアノ
−5−ヨード−4−(4−メトキシフェニル)ピリジン
の合成 6−ブチル−3−シアノ−5−ヨード−4−(4−メト
キシフェニル)−2−ピリドン5.23g(12.8m
mol)にオキシ塩化リン70mlを加え100℃で8
時間加熱した。オキシ塩化リンを留去後、ヘキサン、水
を加え結晶を濾過、水で洗浄、減圧乾燥し表題化合物を
得た。 収量 2.40g(5.63mmol) 収率 44.
0% MS (ESI, m/z) 427 (MH+)2) Synthesis of 6-butyl-2-chloro-3-cyano-5-iodo-4- (4-methoxyphenyl) pyridine 6-butyl-3-cyano-5-iodo-4- (4-methoxy) 5.23 g (12.8 m) of phenyl) -2-pyridone
mol) and add 70 ml of phosphorus oxychloride
Heated for hours. After phosphorus oxychloride was distilled off, hexane and water were added, and the crystals were filtered, washed with water, and dried under reduced pressure to obtain the title compound. Yield 2.40 g (5.63 mmol) Yield
0% MS (ESI, m / z) 427 (MH +)
【0283】3)6−ブチル−3−シアノ−5−(2−
エトキシカルボニルエテニル)−4−(4−メトキシフ
ェニル)−2−(3,4−メチレンジオキシフェノキ
シ)ピリジンの合成 DMF70ml中、セサモール1.76g(12.7m
mol)、60%水素化ナトリウム0.52g(13.
0mmol)、6−ブチル−2−クロロ−3−シアノ−
5−ヨード−4−(4−メトキシフェニル)ピリジン
4.85g(11.4mmol)を室温で6時間攪拌し
た。減圧下でDMFを留去後水を加え酢酸エチルで抽出
した。有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮
した。残渣をDMF70mlに溶解し、酢酸パラジウム
150mg(0.67mmol)とアクリル酸エチル1
0ml(92.3mmol)、トリエチルアミン10m
l(72.1mmol)を120℃で1晩加熱攪拌し
た。減圧下でDMFを留去後2N塩酸を加え、酢酸エチ
ルで抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下
濃縮した。残渣をシリカゲルクロマトグラフィー(ヘキ
サン−酢酸エチル=3:1)で精製し表題化合物を得
た。 収量 4.64g(9.27mmol) 収率 73.
0% MS (ESI, m/z) 501 (MH+) 1H-NMR(CDCl3): 0.85 (3H, t), 1.22-1.32 (5H, m), 1.
52-1.62 (2H, m), 2.76 (2H, t), 3.87 (3H, s), 4.08-
4.20 (2H, m), 5.70 (1H, d), 6.02 (2H, s),6.64-6.83
(3H, m), 7.00 (2H, d), 7.24 (2H, d), 7.45 (1H, d)3) 6-Butyl-3-cyano-5- (2-
Synthesis of ethoxycarbonylethenyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 1.76 g (12.7 m) of sesamol in 70 ml of DMF
mol), 0.52 g of 60% sodium hydride (13.
0 mmol), 6-butyl-2-chloro-3-cyano-
4.85 g (11.4 mmol) of 5-iodo-4- (4-methoxyphenyl) pyridine was stirred at room temperature for 6 hours. After evaporating DMF under reduced pressure, water was added and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was dissolved in DMF (70 ml), palladium acetate (150 mg, 0.67 mmol) and ethyl acrylate (1).
0 ml (92.3 mmol), triethylamine 10 m
1 (72.1 mmol) was heated and stirred at 120 ° C. overnight. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 3: 1) to obtain the title compound. Yield 4.64 g (9.27 mmol) Yield 73.
0% MS (ESI, m / z) 501 (MH +) 1H-NMR (CDCl3): 0.85 (3H, t), 1.22-1.32 (5H, m), 1.
52-1.62 (2H, m), 2.76 (2H, t), 3.87 (3H, s), 4.08-
4.20 (2H, m), 5.70 (1H, d), 6.02 (2H, s), 6.64-6.83
(3H, m), 7.00 (2H, d), 7.24 (2H, d), 7.45 (1H, d)
【0284】4)6−ブチル−3−シアノ−5−(3−
ヒドロキシ−1−プロペニル)−4−(4−メトキシフ
ェニル)−2−(3,4−メチレンジオキシフェノキ
シ)ピリジンの合成 6−ブチル−3−シアノ−5−(2−エトキシカルボニ
ルエテニル)−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)ピリジン4.
64g(9.27mmol)を塩化メチレン100ml
に溶解し−78℃に冷却後水素化ジイソブチルアルミニ
ウム1Mヘキサン溶液18.0ml(18.0mmo
l)を50分間で加えた。40分間攪拌後さらに水素化
ジイソブチルアルミニウム1Mヘキサン溶液10.0m
l(10.0mmol)を25分間で加えた。−78℃
で2時間攪拌後、メタノール2.0ml、水2mlを加
えた。沈澱を濾過し濾液を減圧下濃縮した。残渣をシリ
カゲルクロマトグラフィー(ヘキサン−酢酸エチル=
1:1)で精製し表題化合物を得た。 収量 2.86g(6.23mmol) 収率 67.
2% MS (ESI, m/z) 459 (MH+) 1H-NMR(CDCl3): 0.85 (3H, t), 1.22-1.33 (2H, m), 1.
50-1.62 (2H, m), 2.73 (2H, t), 3.86 (3H, s), 4.09
(2H, t), 5.55 (1H, dt), 6.01 (2H, s), 6.29(1H, d),
6.64-6.83 (3H, m), 6.97 (2H, d), 7.24 (2H, d)4) 6-butyl-3-cyano-5- (3-
Synthesis of hydroxy-1-propenyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 6-butyl-3-cyano-5- (2-ethoxycarbonylethenyl)- 4- (4-methoxyphenyl) -2-
(3,4-methylenedioxyphenoxy) pyridine4.
64 g (9.27 mmol) of methylene chloride in 100 ml
And cooled to -78 ° C, and then 18.0 ml of a 1M solution of diisobutylaluminum hydride in hexane (18.0 mmo).
l) was added over 50 minutes. After stirring for 40 minutes, further diisobutylaluminum hydride 1M hexane solution 10.0m
1 (10.0 mmol) was added over 25 minutes. -78 ° C
After stirring for 2 hours, methanol (2.0 ml) and water (2 ml) were added. The precipitate was filtered and the filtrate was concentrated under reduced pressure. The residue was subjected to silica gel chromatography (hexane-ethyl acetate =
1: 1) to give the title compound. Yield 2.86 g (6.23 mmol) Yield 67.
2% MS (ESI, m / z) 459 (MH +) 1H-NMR (CDCl3): 0.85 (3H, t), 1.22-1.33 (2H, m), 1.
50-1.62 (2H, m), 2.73 (2H, t), 3.86 (3H, s), 4.09
(2H, t), 5.55 (1H, dt), 6.01 (2H, s), 6.29 (1H, d),
6.64-6.83 (3H, m), 6.97 (2H, d), 7.24 (2H, d)
【0285】5)6−ブチル−4−(4−メトキシフェ
ニル)−2−(3,4−メチレンジオキシフェノキシ)
−5−(3−ヒドロキシ−1−プロペニル)−3−(1
H−テトラゾール−5−イル)ピリジンの合成 アジ化ナトリウム756mg(11.6mmol)と塩
化トリブチルスズ1.5ml(5.53mmol)より
調製したトリブチルチンアジドと6−ブチル−3−シア
ノ−5−(3−ヒドロキシ−1−プロペニル)−4−
(4−メトキシフェニル)−2−(3,4−メチレンジ
オキシフェノキシ)ピリジン569mg(1.24mm
ol)をトルエン5ml、120℃で4日間加熱した。
室温で2N塩酸を加え、結晶を濾過、トルエンついで酢
酸エチル−ヘキサン(1:3)で洗浄、減圧乾燥し表題
化合物を得た。 収量 514mg(1.03mmol) 収率 83.
1% MS (ESI, m/z) 502 (MH+) 1H-NMR (DMSO-d6): 0.82 (3H, t), 1.22-1.33 (2H, m),
1.48-1.62 (2H, m),2.75 (2H, t), 3.71 (3H, s), 3.8
6 (2H, m), 4.72 (1H, t), 5.53 (1H, dt),6.04 (2H,
s), 6.23 (1H, dt), 6.53 (1H, dd), 6.73-6.95 (6H,
m)5) 6-butyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy)
-5- (3-hydroxy-1-propenyl) -3- (1
Synthesis of H-tetrazol-5-yl) pyridine Tributyltin azide prepared from 756 mg (11.6 mmol) of sodium azide and 1.5 ml (5.53 mmol) of tributyltin chloride and 6-butyl-3-cyano-5- (3 -Hydroxy-1-propenyl) -4-
569 mg of (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine (1.24 mm
ol) was heated in 5 ml of toluene at 120 ° C. for 4 days.
At room temperature, 2N hydrochloric acid was added, the crystals were filtered, washed with toluene and then with ethyl acetate-hexane (1: 3), and dried under reduced pressure to obtain the title compound. Yield 514 mg (1.03 mmol) Yield
1% MS (ESI, m / z) 502 (MH +) 1H-NMR (DMSO-d6): 0.82 (3H, t), 1.22-1.33 (2H, m),
1.48-1.62 (2H, m), 2.75 (2H, t), 3.71 (3H, s), 3.8
6 (2H, m), 4.72 (1H, t), 5.53 (1H, dt), 6.04 (2H,
s), 6.23 (1H, dt), 6.53 (1H, dd), 6.73-6.95 (6H,
m)
【0286】実施例68 6−エチル−5−(3−(2
−メトキシアセチル)アミノ−1−プロペニル)−4−
(4−メトキシフェニル)−2−(3,4−メチレンジ
オキシフェノキシ)−3−(1H−テトラゾール−5−
イル)ピリジンの合成 1)5−(3−クロロ−1−プロペニル)−3−シアノ
−6−エチル−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)ピリジンの合
成 3−シアノ−6−エチル−5−(3−クロロ−1−プロ
ペニル)−4−(4−メトキシフェニル)−2−(3,
4−メチレンジオキシフェノキシ)ピリジン2.06g
(4.78mmol)をクロロホルム50mlに溶解し
氷浴下で塩化チオニル3.0ml(41.3mmol)
を滴下した。室温で2時間攪拌後減圧下濃縮した。残渣
をシリカゲルクロマトグラフィー(ヘキサン−酢酸エチ
ル=1:1)で精製し表題化合物を得た。 収量 2.11g(4.70mmol) 収率 98.
3% MS (ESI, m/z) 449 (MH+) 1H-NMR(CDCl3): 1.13 (3H, t), 2.76 (2H, qua), 3.87
(3H, s), 4.00 (2H, d), 5.54-5.64 (1H, m), 6.02 (2
H, s), 6.33 (1H, d), 6.65-6.83 (3H, m), 6.99 (2H,
d), 7.25 (2H, d)Example 68 6-ethyl-5- (3- (2
-Methoxyacetyl) amino-1-propenyl) -4-
(4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazole-5
Synthesis of yl) pyridine 1) 5- (3-chloro-1-propenyl) -3-cyano-6-ethyl-4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenoxy) pyridine 3-cyano-6-ethyl-5- (3-chloro-1-propenyl) -4- (4-methoxyphenyl) -2- (3
4-methylenedioxyphenoxy) pyridine 2.06 g
(4.78 mmol) was dissolved in 50 ml of chloroform, and 3.0 ml (41.3 mmol) of thionyl chloride was dissolved in an ice bath.
Was added dropwise. After stirring at room temperature for 2 hours, the mixture was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 1: 1) to give the title compound. Yield 2.11 g (4.70 mmol) Yield
3% MS (ESI, m / z) 449 (MH +) 1H-NMR (CDCl3): 1.13 (3H, t), 2.76 (2H, qua), 3.87
(3H, s), 4.00 (2H, d), 5.54-5.64 (1H, m), 6.02 (2
H, s), 6.33 (1H, d), 6.65-6.83 (3H, m), 6.99 (2H,
d), 7.25 (2H, d)
【0287】2)N−(tert−ブトキシカルボニ
ル)−N−(3−(3−シアノ−6−エチル−4−(4
−メトキシフェニル)−2−(3,4−メチレンジオキ
シフェノキシ)ピリジン−5−イル)−2−プロペニ
ル)ホスホロアミド酸ジエチルの合成 ベンゼン50ml中、N−(tert−ブトキシカルボ
ニル)ホスホロアミド酸ジエチル2.30g(9.08
mmol)に60%水素化ナトリウム0.36g(9.
0mmol)を加えた後、ベンゼン40mlに溶解した
5−(3−クロロ−1−プロペニル)−3−シアノ−6
−エチル−4−(4−メトキシフェニル)−2−(3,
4−メチレンジオキシフェノキシ)ピリジン2.11g
(4.70mmol)を滴下した。ついで臭化テトラブ
チルアンモニウム0.28gを加え1晩加熱還流した。
減圧下濃縮し残渣をシリカゲルクロマトグラフィー(ヘ
キサン−酢酸エチル=1:1)で精製し表題化合物を得
た。 収量 2.97g(4.46mmol) 収率 94.
9% MS (ESI, m/z) 666 (MH+) 1H-NMR(CDCl3): 1.13 (3H, t), 1.23-1.33 (6H, m), 1.
45 (9H, s), 2.76 (2H, qua), 3.85 (3H, s), 3.98-4.1
3 (6H, m), 5.46-5.58 (1H, m), 6.01 (2H, s), 6.28
(1H, d), 6.65-6.82 (3H, m), 6.97 (2H, d), 7.25 (2
H, d)2) N- (tert-butoxycarbonyl) -N- (3- (3-cyano-6-ethyl-4- (4
Synthesis of diethyl -methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridin-5-yl) -2-propenyl) phosphoramidate Diethyl N- (tert-butoxycarbonyl) phosphoramidate in 50 ml of benzene. 30 g (9.08
mmol) in 0.36 g of 60% sodium hydride (9.
After addition of 5- (3-chloro-1-propenyl) -3-cyano-6 dissolved in 40 ml of benzene.
-Ethyl-4- (4-methoxyphenyl) -2- (3,
4-methylenedioxyphenoxy) pyridine 2.11 g
(4.70 mmol) was added dropwise. Then, 0.28 g of tetrabutylammonium bromide was added, and the mixture was heated under reflux overnight.
After concentration under reduced pressure, the residue was purified by silica gel chromatography (hexane-ethyl acetate = 1: 1) to obtain the title compound. Yield 2.97 g (4.46 mmol) Yield 94.
9% MS (ESI, m / z) 666 (MH +) 1H-NMR (CDCl3): 1.13 (3H, t), 1.23-1.33 (6H, m), 1.
45 (9H, s), 2.76 (2H, qua), 3.85 (3H, s), 3.98-4.1
3 (6H, m), 5.46-5.58 (1H, m), 6.01 (2H, s), 6.28
(1H, d), 6.65-6.82 (3H, m), 6.97 (2H, d), 7.25 (2
H, d)
【0288】3)5−(3−アミノ−1−プロペニル)
−3−シアノ−6−エチル−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)ピ
リジンの合成 N−(tert−ブトキシカルボニル)−N−(3−
(3−シアノ−6−エチル−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)ピ
リジン−5−イル)−2−プロペニル)ホスホロアミド
酸ジエチル2.97g(4.46mmol)に氷浴下で
36wt%塩化水素−エタノール溶液を加えた。9時間
攪拌後減圧下濃縮した。飽和炭酸水素ナトリウム水溶液
でアルカリ性にし、酢酸エチルで抽出した。有機層を無
水硫酸ナトリウムで乾燥、減圧下濃縮した。 収量 1.80g(4.20mmol) 収率 94.
2% MS (ESI, m/z) 430 (MH+) 1H-NMR(CDCl3): 1.12 (3H, t), 2.76 (2H, qua), 3.25
(2H, d), 3.86 (3H, s), 5.48-5.58 (1H, m), 6.01 (2
H, s), 6.15 (1H, d), 6.66-6.82 (3H, m), 6.97 (2H,
d), 7.25 (2H, d)3) 5- (3-amino-1-propenyl)
Synthesis of -3-cyano-6-ethyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine N- (tert-butoxycarbonyl) -N- (3-
2.97 g of diethyl (3-cyano-6-ethyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridin-5-yl) -2-propenyl) phosphoramidate (4. To 46 mmol) was added a 36 wt% hydrogen chloride-ethanol solution in an ice bath. After stirring for 9 hours, the mixture was concentrated under reduced pressure. The mixture was made alkaline with a saturated aqueous sodium hydrogen carbonate solution and extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. Yield 1.80 g (4.20 mmol) Yield 94.
2% MS (ESI, m / z) 430 (MH +) 1H-NMR (CDCl3): 1.12 (3H, t), 2.76 (2H, qua), 3.25
(2H, d), 3.86 (3H, s), 5.48-5.58 (1H, m), 6.01 (2
H, s), 6.15 (1H, d), 6.66-6.82 (3H, m), 6.97 (2H,
d), 7.25 (2H, d)
【0289】4)3−シアノ−6−エチル−5−(3−
(2−メトキシアセチル)アミノ−1−プロペニル)−
4−(4−メトキシフェニル)−2−(3,4−メチレ
ンジオキシフェノキシ)ピリジンの合成 5−(3−アミノ−1−プロペニル)−3−シアノ−6
−エチル−4−(4−メトキシフェニル)−2−(3,
4−メチレンジオキシフェノキシ)ピリジン559mg
(1.30mmol)をピリジン5mlに溶解しメトキ
シアセチルクロライド0.15ml(1.64mmo
l)を滴下した。室温で3.5時間攪拌後減圧下濃縮し
た。残渣をシリカゲルクロマトグラフィー(クロロホル
ム−メタノール=100:1)で精製し表題化合物を得
た。 収量 512mg(1.02mmol) 収率 78.
5% MS (ESI, m/z) 502 (MH+) 1H-NMR(CDCl3): 1.11 (3H, t), 2.73 (2H, qua), 3.39
(3H, s), 3.83 (2H, s), 3.84-3.89 (2H, m), 3.87 (3
H, s), 5.40 (1H, dt), 6.01 (2H, s), 6.22 (1H, dt),
6.66-6.82 (3H, m), 6.98 (2H, d), 7.23 (2H, d)4) 3-Cyano-6-ethyl-5- (3-
(2-methoxyacetyl) amino-1-propenyl)-
Synthesis of 4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine 5- (3-amino-1-propenyl) -3-cyano-6
-Ethyl-4- (4-methoxyphenyl) -2- (3,
4-methylenedioxyphenoxy) pyridine 559 mg
(1.30 mmol) was dissolved in 5 ml of pyridine, and 0.15 ml (1.64 mmol) of methoxyacetyl chloride was dissolved.
l) was added dropwise. After stirring at room temperature for 3.5 hours, the mixture was concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform-methanol = 100: 1) to obtain the title compound. Yield 512 mg (1.02 mmol) Yield 78.
5% MS (ESI, m / z) 502 (MH +) 1H-NMR (CDCl3): 1.11 (3H, t), 2.73 (2H, qua), 3.39
(3H, s), 3.83 (2H, s), 3.84-3.89 (2H, m), 3.87 (3
H, s), 5.40 (1H, dt), 6.01 (2H, s), 6.22 (1H, dt),
6.66-6.82 (3H, m), 6.98 (2H, d), 7.23 (2H, d)
【0290】5)6−エチル−5−(3−(2−メトキ
シアセチル)アミノ−1−プロペニル)−4−(4−メ
トキシフェニル)−2−(3,4−メチレンジオキシフ
ェノキシ)−3−(1H−テトラゾール−5−イル)ピ
リジンの合成 アジ化ナトリウム758mg(11.7mmol)と塩
化トリブチルスズ1.5ml(5.53mmol)より
調製したトリブチルチンアジドと3−シアノ−6−エチ
ル−5−(3−(2−メトキシアセチル)アミノ−1−
プロペニル)−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)ピリジン50
8mg(1.01mmol)をトルエン10ml中、1
20℃で3日間加熱した。室温で2N塩酸を加え、結晶
を濾過、トルエンついで酢酸エチルで洗浄、減圧乾燥し
表題化合物を得た。 収量 110mg(0.20mmol) 収率 20.
0% MS (ESI, m/z) 545 (MH+) 1H-NMR (DMSO-d6): 1.06 (3H, t), 2.72 (2H, qua), 3.
24 (3H, s), 3.64 (2H, t), 3.70 (2H, s), 3.71 (3H,
s), 5.42 (1H, dt), 6.05 (2H, s), 6.16 (1H,dt), 6.5
0-6.96 (7H, m), 7.75 (1H, t)5) 6-ethyl-5- (3- (2-methoxyacetyl) amino-1-propenyl) -4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) -3 Synthesis of-(1H-tetrazol-5-yl) pyridine Tributyltin azide prepared from 758 mg (11.7 mmol) of sodium azide and 1.5 ml (5.53 mmol) of tributyltin chloride, and 3-cyano-6-ethyl-5- (3- (2-methoxyacetyl) amino-1-
Propenyl) -4- (4-methoxyphenyl) -2-
(3,4-methylenedioxyphenoxy) pyridine 50
8 mg (1.01 mmol) in 10 ml of toluene
Heat at 20 ° C. for 3 days. 2N Hydrochloric acid was added at room temperature, and the crystals were filtered, washed with toluene and then with ethyl acetate, and dried under reduced pressure to obtain the title compound. Yield 110 mg (0.20 mmol) Yield 20.
0% MS (ESI, m / z) 545 (MH +) 1H-NMR (DMSO-d6): 1.06 (3H, t), 2.72 (2H, qua), 3.
24 (3H, s), 3.64 (2H, t), 3.70 (2H, s), 3.71 (3H,
s), 5.42 (1H, dt), 6.05 (2H, s), 6.16 (1H, dt), 6.5
0-6.96 (7H, m), 7.75 (1H, t)
【0291】実施例69 5−(3−ヒドロキシ−1−
プロペニル)−4−(2,4−ジメトキシフェニル)−
6−メチル−2−(3,4−メチレンジオキシフェノキ
シ)−3−(1H−テトラゾール−5−イル)ピリジン
の合成 1)4−(2,4−ジメトキシフェニル)−3−ブテン
−2−オンの合成 2,4−ジメトキシベンズアルデヒド20.8g(12
5.2mmol)にアセトン150ml、1N水酸化ナ
トリウム水溶液25mlを加え室温で1晩攪拌した。減
圧濃縮後結晶を濾過、水で洗浄、減圧乾燥し表題化合物
を得た。 収量 25.2g(122.2mmol) 収率 9
7.6% 1H-NMR (DMSO-d6): 2.27 (3H, s), 3.82 (3H, s), 3.87
(3H, s), 6.58-6.65(2H, m), 6.75 (1H, d), 7.63-7.7
5 (2H, m)Example 69 5- (3-hydroxy-1-)
Propenyl) -4- (2,4-dimethoxyphenyl)-
Synthesis of 6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) pyridine 1) 4- (2,4-dimethoxyphenyl) -3-butene-2- Synthesis of 2,4-dimethoxybenzaldehyde 20.8 g (12
To 5.2 mmol), 150 ml of acetone and 25 ml of a 1N aqueous sodium hydroxide solution were added, followed by stirring at room temperature overnight. After concentration under reduced pressure, the crystals were filtered, washed with water, and dried under reduced pressure to obtain the title compound. Yield 25.2 g (122.2 mmol) Yield 9
7.6% 1H-NMR (DMSO-d6): 2.27 (3H, s), 3.82 (3H, s), 3.87
(3H, s), 6.58-6.65 (2H, m), 6.75 (1H, d), 7.63-7.7
5 (2H, m)
【0292】2)3−シアノ−4−(2,4−ジメトキ
シフェニル)−6−メチル−2−ピリドンの合成 DMSO250ml中、シアノ酢酸アミド10.2g
(122mmol)にt−ブトキシカリウム13.7g
(122mmol)、4−(2,4−ジメトキシフェニ
ル)−3−ブテン−2−オン25.2g(122mmo
l)を加え室温で15分間攪拌した。t−ブトキシカリ
ウム41.0g(367mmol)を加えた後、酸素ガ
スを1分間バブリングしさらに室温常圧酸素雰囲気下で
1時間攪拌した。2規定塩酸を加え析出した結晶を濾
取、水で洗浄、減圧乾燥し表題化合物を得た。 収量 12.9g(47.7mmol) 収率 39.
1% 1H-NMR (DMSO-d6): 2.27 (3H, s), 3.79 (3H, s), 3.83
(3H, s), 6.18 (1H,s), 6.63-6.73 (2H, m), 7.22 (1
H, d)2) Synthesis of 3-cyano-4- (2,4-dimethoxyphenyl) -6-methyl-2-pyridone 10.2 g of cyanoacetamide in 250 ml of DMSO
(122 mmol) 13.7 g of potassium t-butoxide
(122 mmol), 25.2 g of 4- (2,4-dimethoxyphenyl) -3-buten-2-one (122 mmol)
l) was added and the mixture was stirred at room temperature for 15 minutes. After adding 41.0 g (367 mmol) of potassium t-butoxide, oxygen gas was bubbled for 1 minute, and the mixture was further stirred at room temperature under an atmosphere of normal pressure oxygen for 1 hour. 2N Hydrochloric acid was added and the precipitated crystals were collected by filtration, washed with water, and dried under reduced pressure to give the title compound. Yield 12.9 g (47.7 mmol) Yield 39.
1% 1H-NMR (DMSO-d6): 2.27 (3H, s), 3.79 (3H, s), 3.83
(3H, s), 6.18 (1H, s), 6.63-6.73 (2H, m), 7.22 (1
H, d)
【0293】3)3−シアノ−5−ヨード−4−(2,
4−ジメトキシフェニル)−6−メチル−2−ピリドン
の合成 アセトニトリル50ml中、3−シアノ−4−(2,4
−ジメトキシフェニル)−6−メチル−2−ピリドン
3.10g(12.9mmol)にN−ヨードコハク酸
イミド3.48g(15.5mmol)を加え3時間加
熱還流した。 さらにN−ヨードコハク酸イミド1.1
0g(4.89mmol)を加え1.5時間加熱還流し
た。アセトニトリルを減圧下留去、残渣をヘキサン、ア
セトニトリルで洗浄、減圧乾燥し表題化合物を得た。 収量 1.40g(3.83mmol) 収率 29.
7%3) 3-cyano-5-iodo-4- (2,
Synthesis of 4-dimethoxyphenyl) -6-methyl-2-pyridone 3-cyano-4- (2,4) in 50 ml of acetonitrile
3.48 g (15.5 mmol) of N-iodosuccinimide was added to 3.10 g (12.9 mmol) of -dimethoxyphenyl) -6-methyl-2-pyridone, and the mixture was heated under reflux for 3 hours. Further, N-iodosuccinimide 1.1
0 g (4.89 mmol) was added, and the mixture was heated under reflux for 1.5 hours. Acetonitrile was distilled off under reduced pressure, and the residue was washed with hexane and acetonitrile and dried under reduced pressure to obtain the title compound. Yield 1.40 g (3.83 mmol) Yield 29.
7%
【0294】4)2−クロロ−3−シアノ−5−ヨード
−4−(2,4−ジメトキシフェニル)−6−メチルピ
リジンの合成 3−シアノ−5−ヨード−4−(2,4−ジメトキシフ
ェニル)−6−メチル−2−ピリドン5.10g(1
3.9mmol)にオキシ塩化リン50mlを加え10
0℃で1晩加熱攪拌した。オキシ塩化リンを留去後水を
加え酢酸エチルで抽出し、有機層を水で洗浄、無水硫酸
マグネシウムで乾燥、減圧下濃縮した。 収量 3.00g(7.25mmol) 収率 52.
2%4) Synthesis of 2-chloro-3-cyano-5-iodo-4- (2,4-dimethoxyphenyl) -6-methylpyridine 3-cyano-5-iodo-4- (2,4-dimethoxy 5.10 g of phenyl) -6-methyl-2-pyridone (1
3.9 mmol), add 50 ml of phosphorus oxychloride and add 10
The mixture was heated and stirred at 0 ° C. overnight. After phosphorus oxychloride was distilled off, water was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. Yield 3.00 g (7.25 mmol) Yield 52.
2%
【0295】5)3−シアノ−5−ヨード−4−(2,
4−ジメトキシフェニル)−6−メチル−2−(3,4
−メチレンジオキシフェノキシ)ピリジンの合成 DMF30ml中、セサモール1.0g(7.20mm
ol)に60%水素化ナトリウム0.40g(10.0
mmol)を加えた。2−クロロ−3−シアノ−4−
(2,4−ジメトキシフェニル)−6−メチルピリジン
3.00g(7.20mmol)を加え、室温で3時間
攪拌した。減圧下でDMFを留去後酢酸エチルで抽出し
有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮した。
残渣をシリカゲルクロマトグラフィー(ヘキサン−酢酸
エチル=3:1)で精製し表題化合物を得た。 収量 1.80g(3.49mmol) 収率 48.
4% 1H-NMR(CDCl3): 2.70 (3H, s), 3.82 (3H, s), 3.88 (3
H, s), 6.02 (2H, s),6.57-6.83 (5H, m), 7.04 (1H,
d)5) 3-Cyano-5-iodo-4- (2,
4-dimethoxyphenyl) -6-methyl-2- (3,4
Synthesis of -methylenedioxyphenoxy) pyridine In 30 ml of DMF, 1.0 g of sesamol (7.20 mm
ol) to 0.40 g (10.0%) of 60% sodium hydride.
mmol). 2-chloro-3-cyano-4-
3.00 g (7.20 mmol) of (2,4-dimethoxyphenyl) -6-methylpyridine was added, and the mixture was stirred at room temperature for 3 hours. After evaporating DMF under reduced pressure, the mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure.
The residue was purified by silica gel chromatography (hexane-ethyl acetate = 3: 1) to obtain the title compound. Yield 1.80 g (3.49 mmol) Yield 48.
4% 1H-NMR (CDCl3): 2.70 (3H, s), 3.82 (3H, s), 3.88 (3
H, s), 6.02 (2H, s), 6.57-6.83 (5H, m), 7.04 (1H,
d)
【0296】6)3−シアノ−5−(2−エトキシカル
ボニルエテニル)−4−(2,4−ジメトキシフェニ
ル)−6−メチル−2−(3,4−メチレンジオキシフ
ェノキシ)ピリジンの合成 3−シアノ−5−ヨード−4−(2,4−ジメトキシフ
ェニル)−6−メチル−2−(3,4−メチレンジオキ
シフェノキシ)ピリジン2.0g(3.87mmol)
をDMF80mlに溶解し、酢酸パラジウム43mg
(0.19mmol)とアクリル酸エチル8.4ml
(77.4mmol)、トリエチルアミン10.8ml
(77.4mmol)を100℃で4日間加熱攪拌し
た。減圧下でDMFを留去後2N塩酸を加え、酢酸エチ
ルで抽出し有機層を無水硫酸マグネシウムで乾燥、減圧
下濃縮した。残渣をシリカゲルクロマトグラフィー(ヘ
キサン−酢酸エチル=3:1)で精製し表題化合物を得
た。 収量 796mg(1.63mmol) 収率 42.
1% 1H-NMR(CDCl3): 1.25 (3H, t), 2.51 (3H, s), 3.78 (3
H, s), 3.87 (3H, s),4.17 (2H, qua), 5.75 (1H, d),
6.02 (2H, s), 6.53-6.83 (5H, m), 7.03 (1H, d), 7.4
5 (1H, d)6) Synthesis of 3-cyano-5- (2-ethoxycarbonylethenyl) -4- (2,4-dimethoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) pyridine 2.0 g (3.87 mmol) of 3-cyano-5-iodo-4- (2,4-dimethoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) pyridine
Was dissolved in DMF (80 ml), and palladium acetate (43 mg) was dissolved.
(0.19 mmol) and 8.4 ml of ethyl acrylate
(77.4 mmol), 10.8 ml of triethylamine
(77.4 mmol) was heated and stirred at 100 ° C. for 4 days. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 3: 1) to obtain the title compound. Yield 796 mg (1.63 mmol) Yield 42.
1% 1H-NMR (CDCl3): 1.25 (3H, t), 2.51 (3H, s), 3.78 (3
H, s), 3.87 (3H, s), 4.17 (2H, qua), 5.75 (1H, d),
6.02 (2H, s), 6.53-6.83 (5H, m), 7.03 (1H, d), 7.4
5 (1H, d)
【0297】7)3−シアノ−5−(3−ヒドロキシ−
1−プロペニル)−4−(2,4−ジメトキシフェニ
ル)−6−メチル−2−(3,4−メチレンジオキシフ
ェノキシ)ピリジンの合成 3−シアノ−5−(2−エトキシカルボニルエテニル)
−4−(2,4−ジメトキシフェニル)−6−メチル−
2−(3,4−メチレンジオキシフェノキシ)ピリジン
796mg(1.63mmol)を1N水酸化ナトリウ
ム水溶液20ml、THF10ml中で1晩攪拌した。
ジクロロメタン抽出、1N塩酸で洗浄、有機層を無水硫
酸マグネシウムで乾燥し、減圧下濃縮した。残渣にTH
F5ml、トリエチルアミン0.34ml(2.45m
mol)を加え、氷浴後クロロギ酸エチル0.23ml
(2.45mmol)を滴下した。20分間攪拌後、水
素化ホウ素ナトリウム154mg(4.08mmol)
を加え1時間攪拌した。ジクロロメタン抽出、1N塩
酸、飽和塩化ナトリウム水溶液で洗浄、有機層を無水硫
酸マグネシウムで乾燥し、減圧下濃縮した。残渣をシリ
カゲルクロマトグラフィー(ヘキサン−酢酸エチル=
1:1)で精製し表題化合物を得た。 収量 326mg(0.73mmol) 収率 44.
8% 1H-NMR(CDCl3): 2.46 (3H, s), 3.80 (3H, s), 3.86 (3
H, s), 4.07 (2H, t),5.59 (1H, dt), 6.01 (2H, s),
6.08 (1H, d), 6.53-6.85 (5H, m), 7.03 (1H, d)7) 3-cyano-5- (3-hydroxy-
Synthesis of 1-propenyl) -4- (2,4-dimethoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) pyridine 3-cyano-5- (2-ethoxycarbonylethenyl)
-4- (2,4-dimethoxyphenyl) -6-methyl-
796 mg (1.63 mmol) of 2- (3,4-methylenedioxyphenoxy) pyridine was stirred in 20 ml of 1N aqueous sodium hydroxide solution and 10 ml of THF overnight.
The mixture was extracted with dichloromethane, washed with 1N hydrochloric acid, and the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. TH in the residue
F5 ml, triethylamine 0.34 ml (2.45 m
mol), and after cooling with ice, 0.23 ml of ethyl chloroformate was added.
(2.45 mmol) was added dropwise. After stirring for 20 minutes, 154 mg (4.08 mmol) of sodium borohydride
Was added and stirred for 1 hour. The mixture was extracted with dichloromethane, washed with 1N hydrochloric acid and a saturated aqueous solution of sodium chloride, and the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (hexane-ethyl acetate =
1: 1) to give the title compound. Yield 326 mg (0.73 mmol) Yield
8% 1H-NMR (CDCl3): 2.46 (3H, s), 3.80 (3H, s), 3.86 (3
H, s), 4.07 (2H, t), 5.59 (1H, dt), 6.01 (2H, s),
6.08 (1H, d), 6.53-6.85 (5H, m), 7.03 (1H, d)
【0298】8)5−(3−ヒドロキシ−1−プロペニ
ル)−4−(2,4−ジメトキシフェニル)−6−メチ
ル−2−(3,4−メチレンジオキシフェノキシ)−3
−(1H−テトラゾール−5−イル)ピリジンの合成 アジ化ナトリウム285mg(4.39mmol)と塩
化トリブチルスズ0.79ml(2.92mmol)よ
り調製したトリブチルチンアジドと3−シアノ−5−
(3−ヒドロキシ−1−プロペニル)−4−(2,4−
ジメトキシフェニル)−6−メチル−2−(3,4−メ
チレンジオキシフェノキシ)ピリジン326mg(0.
73mmol)をトルエン5ml、2日間加熱還流し
た。冷却後4N塩酸−ジオキサンを加え濾過、結晶をト
ルエン、で洗浄、シリカゲルクロマトグラフィー(クロ
ロホルム−メタノール=9:1)で精製した。さらに再
結晶(クロロホルム−酢酸エチル−ヘキサン)を行い表
題化合物を得た。 収量 180mg(0.37mmol) 収率 50.
4% MS (ESI, m/z) 490 (MH+) 1H-NMR (DMSO-d6): 2.42 (3H, s), 3.56 (3H, s), 3.73
(3H, s), 3.85 (2H,t), 4.69 (1H, t),5.57 (1H, dt),
6.05 (2H, s), 6.19 (1H, d), 6.40-6.92 (6H, m)8) 5- (3-Hydroxy-1-propenyl) -4- (2,4-dimethoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -3
Synthesis of-(1H-tetrazol-5-yl) pyridine Tributyltin azide prepared from 285 mg (4.39 mmol) of sodium azide and 0.79 ml (2.92 mmol) of tributyltin chloride and 3-cyano-5
(3-hydroxy-1-propenyl) -4- (2,4-
326 mg of dimethoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) pyridine (0.
73 mmol) was heated at reflux for 5 days in 5 ml of toluene. After cooling, 4N hydrochloric acid-dioxane was added, the mixture was filtered, the crystals were washed with toluene, and purified by silica gel chromatography (chloroform-methanol = 9: 1). Further recrystallization (chloroform-ethyl acetate-hexane) gave the title compound. Yield 180 mg (0.37 mmol) Yield 50.
4% MS (ESI, m / z) 490 (MH +) 1H-NMR (DMSO-d6): 2.42 (3H, s), 3.56 (3H, s), 3.73
(3H, s), 3.85 (2H, t), 4.69 (1H, t), 5.57 (1H, dt),
6.05 (2H, s), 6.19 (1H, d), 6.40-6.92 (6H, m)
【0299】実施例70 4−(3−(2−ベンジルオ
キシエトキシ)−4−メトキシフェニル)−6−メチル
−2−(3,4−メチレンジオキシフェノキシ)−5−
(3−ヒドロキシ−1−プロペニル)−3−(1H−テ
トラゾール−5−イル)ピリジンの合成 1)4−(3−(2−ベンジルオキシエトキシ)−4−
メトキシフェニル)−3−シアノ−5−ヨード−6−メ
チル−2−ピリドンの合成 アセトニトリル250ml中、4−(3−(2−ベンジ
ルオキシエトキシ)−4−メトキシフェニル)−3−シ
アノ−6−メチル−2−ピリドン4.60g(11.8
mmol)にN−ヨードコハク酸イミド4.06g(1
8.0mmol)を加え1晩加熱還流した。さらに N
−ヨードコハク酸イミド4.78g(21.2mmo
l)を加え1晩加熱還流した。アセトニトリルを減圧下
留去、残渣をヘキサン、アセトニトリルで洗浄、減圧乾
燥し表題化合物を得た。 収量 4.90g(9.49mmol) 収率 80.
4% MS (ESI, m/z) 517 (MH+)Example 70 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -5
Synthesis of (3-hydroxy-1-propenyl) -3- (1H-tetrazol-5-yl) pyridine 1) 4- (3- (2-benzyloxyethoxy) -4-
Synthesis of methoxyphenyl) -3-cyano-5-iodo-6-methyl-2-pyridone 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-6 in 250 ml of acetonitrile. 4.60 g of methyl-2-pyridone (11.8
mmol) in 4.06 g of N-iodosuccinimide (1
8.0 mmol) and heated to reflux overnight. And N
4.78 g of iodosuccinimide (21.2 mmol
l) was added and the mixture was heated under reflux overnight. Acetonitrile was distilled off under reduced pressure, and the residue was washed with hexane and acetonitrile and dried under reduced pressure to obtain the title compound. Yield 4.90 g (9.49 mmol) Yield
4% MS (ESI, m / z) 517 (MH +)
【0300】2)4−(3−(2−ベンジルオキシエト
キシ)−4−メトキシフェニル)−2−クロロ−3−シ
アノ−5−ヨード−6−メチルピリジンの合成 4−(3−(2−ベンジルオキシエトキシ)−4−メト
キシフェニル)−3−シアノ−5−ヨード−6−メチル
−2−ピリドン4.90g(9.49mmol)にオキ
シ塩化リン50ml、N,N−ジメチルアニリン1.5
ml(11.9mmol)を加え110℃で2.5時間
加熱した。オキシ塩化リンを留去後、水を加え酢酸エチ
ルで抽出し有機層を無水硫酸ナトリウムで乾燥、減圧下
濃縮した。残渣をシリカゲルクロマトグラフィー(ヘキ
サン−酢酸エチル=3:1)で精製し表題化合物を得
た。 収量 1.64g(3.06mmol) 収率 32.
2% MS (ESI, m/z) 534 (MH+) 1H-NMR(CDCl3): 2.89 (3H, s), 3.87 (2H, t), 3.94 (3
H, s), 4.25 (2H, t),4.64 (2H, s), 6.78-7.01 (3H,
m), 7.24-7.39 (5H, m)2) Synthesis of 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -2-chloro-3-cyano-5-iodo-6-methylpyridine To 4.90 g (9.49 mmol) of benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-5-iodo-6-methyl-2-pyridone were added 50 ml of phosphorus oxychloride and 1.5 ml of N, N-dimethylaniline.
ml (11.9 mmol) and heated at 110 ° C. for 2.5 hours. After phosphorus oxychloride was distilled off, water was added and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 3: 1) to obtain the title compound. Yield 1.64 g (3.06 mmol) Yield 32.
2% MS (ESI, m / z) 534 (MH +) 1H-NMR (CDCl3): 2.89 (3H, s), 3.87 (2H, t), 3.94 (3
H, s), 4.25 (2H, t), 4.64 (2H, s), 6.78-7.01 (3H,
m), 7.24-7.39 (5H, m)
【0301】3)4−(3−(2−ベンジルオキシエト
キシ)−4−メトキシフェニル)−3−シアノ−5−ヨ
ード−6−メチル−2−(3,4−メチレンジオキシフ
ェノキシ)ピリジンの合成 DMF12ml中、セサモール469mg(3.40m
mol)、60%水素化ナトリウム145mg(3.6
3mmol)、4−(3−(2−ベンジルオキシエトキ
シ)−4−メトキシフェニル)−2−クロロ−3−シア
ノ−5−ヨード−6−メチルピリジン1.64g(3.
06mmol)を室温で4.5時間攪拌した。減圧下で
DMFを留去後水を加え酢酸エチルで抽出し有機層を無
水硫酸ナトリウムで乾燥、減圧下濃縮した。残渣をシリ
カゲルクロマトグラフィー(ヘキサン−酢酸エチル=
3:1)で精製し表題化合物を得た。 収量 1.10g(1.73mmol) 収率 56.
7% MS (ESI, m/z) 659 (M+Na+) 1H-NMR(CDCl3): 2.70 (3H, s), 3.88 (2H, t), 3.94 (3
H, s), 4.27 (2H, t),4.65 (2H, s), 6.62-03 (2H, s),
6.21 (1H, d), 6.64-6.84 (3H, m), 6.86-7.00 (3H,
m), 7.25-7.39 (5H, m), 7.43 (1H, d)3) 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-5-iodo-6-methyl-2- (3,4-methylenedioxyphenoxy) pyridine Synthesis 469 mg of sesamol (3.40 m) in 12 ml of DMF
mol), 145 mg (3.6%) of 60% sodium hydride.
3 mmol), 1.64 g of 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -2-chloro-3-cyano-5-iodo-6-methylpyridine (3.
06 mmol) was stirred at room temperature for 4.5 hours. After distilling off DMF under reduced pressure, water was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (hexane-ethyl acetate =
3: 1) to give the title compound. Yield 1.10 g (1.73 mmol) Yield
7% MS (ESI, m / z) 659 (M + Na +) 1H-NMR (CDCl3): 2.70 (3H, s), 3.88 (2H, t), 3.94 (3
H, s), 4.27 (2H, t), 4.65 (2H, s), 6.62-03 (2H, s),
6.21 (1H, d), 6.64-6.84 (3H, m), 6.86-7.00 (3H,
m), 7.25-7.39 (5H, m), 7.43 (1H, d)
【0302】4)4−(3−(2−ベンジルオキシエト
キシ)−4−メトキシフェニル)−3−シアノ−5−
(2−エトキシカルボニルエテニル)−6−メチル−2
−(3,4−メチレンジオキシフェノキシ)ピリジンの
合成 4−(3−(2−ベンジルオキシエトキシ)−4−メト
キシフェニル)−3−シアノ−5−ヨード−6−メチル
−2−(3,4−メチレンジオキシフェノキシ)ピリジ
ン644mg(1.01mmol)をDMF10mlに
溶解し、酢酸パラジウム43mg(0.19mmol)
とアクリル酸エチル1ml(9.23mmol)、トリ
エチルアミン1ml(7.21mmol)を100℃で
1晩加熱攪拌した。減圧下でDMFを留去後2N塩酸を
加え、酢酸エチルで抽出し有機層を無水硫酸ナトリウム
で乾燥、減圧下濃縮した。残渣をシリカゲルクロマトグ
ラフィー(ヘキサン−酢酸エチル=2:1)で精製し表
題化合物を得た。 収量 553mg(0.91mmol) 収率 90.
0% MS (ESI, m/z) 609 (MH+) 1H-NMR(CDCl3): 1.24 (3H, t), 2.52 (3H, s), 3.86 (2
H, t), 3.93 (3H, s), 4.18 (2H, qua), 4.21 (2H,
t), 4.63 (2H, s), 5.79 (1H, d), 6.03 (2H, s), 6.21
(1H, d), 6.64-6.84 (3H, m), 6.86-7.00 (3H, m), 7.
25-7.39 (5H, m),7.43 (1H, d)4) 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-5
(2-ethoxycarbonylethenyl) -6-methyl-2
Synthesis of-(3,4-methylenedioxyphenoxy) pyridine 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-5-iodo-6-methyl-2- (3, 644 mg (1.01 mmol) of 4-methylenedioxyphenoxy) pyridine was dissolved in 10 ml of DMF, and 43 mg (0.19 mmol) of palladium acetate was dissolved.
And 1 ml (9.23 mmol) of ethyl acrylate and 1 ml (7.21 mmol) of triethylamine were heated and stirred at 100 ° C. overnight. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 2: 1) to obtain the title compound. Yield 553 mg (0.91 mmol) Yield 90.
0% MS (ESI, m / z) 609 (MH +) 1H-NMR (CDCl3): 1.24 (3H, t), 2.52 (3H, s), 3.86 (2
H, t), 3.93 (3H, s), 4.18 (2H, qua), 4.21 (2H,
t), 4.63 (2H, s), 5.79 (1H, d), 6.03 (2H, s), 6.21
(1H, d), 6.64-6.84 (3H, m), 6.86-7.00 (3H, m), 7.
25-7.39 (5H, m), 7.43 (1H, d)
【0303】5)4−(3−(2−ベンジルオキシエト
キシ)−4−メトキシフェニル)−3−シアノ−6−メ
チル−2−(3,4−メチレンジオキシフェノキシ)−
5−(3−ヒドロキシ−1−プロペニル)ピリジン 4−(3−(2−ベンジルオキシエトキシ)−4−メト
キシフェニル)−3−シアノ−5−(2−エトキシカル
ボニルエテニル)−6−メチル−2−(3,4−メチレ
ンジオキシフェノキシ)ピリジン449mg(0.74
mmol)を塩化メチレン10mlに溶解し−78℃に
冷却後水素化ジイソブチルアルミニウム1Mヘキサン溶
液1.5ml(1.5mmol)を10分間で加えた。
そのままの温度で攪拌し、滴下終了1.5時間後と3時
間後にさらに水素化ジイソブチルアルミニウム1Mヘキ
サン溶液計3.0ml(3.0mmol)をそれぞれ1
0分間で加えた。−78℃で1時間攪拌後、メタノール
1.0ml、水1mlを加えた。沈澱を濾過し濾液を減
圧下濃縮、残渣をシリカゲルクロマトグラフィー(ヘキ
サン−酢酸エチル=2:1)で精製し表題化合物を得
た。 収量 385mg(0.68mmol) 収率 92.
2% MS (ESI, m/z) 567 (MH+) 1H-NMR(CDCl3): 2.45 (3H, s), 3.87 (2H, t), 3.92
(3H, s), 4.05 (2H, t), 4.23 (2H, t), 4.63 (2H, s),
5.61 (1H, dt), 6.01 (2H, s), 6.21 (1H, d),6.64-6.
83 (3H, m), 6.89-6.97 (3H, m), 7.23-7.37 (5H, m)5) 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-6-methyl-2- (3,4-methylenedioxyphenoxy)-
5- (3-hydroxy-1-propenyl) pyridine 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-5- (2-ethoxycarbonylethenyl) -6-methyl- 449 mg of 2- (3,4-methylenedioxyphenoxy) pyridine (0.74
mmol) was dissolved in 10 ml of methylene chloride, cooled to -78 ° C, and 1.5 ml (1.5 mmol) of a 1 M solution of diisobutylaluminum hydride in hexane was added over 10 minutes.
The mixture was stirred at the same temperature, and 1.5 hours and 3 hours after the completion of the dropwise addition, a total of 3.0 ml (3.0 mmol) of a 1M solution of diisobutylaluminum hydride in hexane was added.
Added at 0 minutes. After stirring at -78 ° C for 1 hour, 1.0 ml of methanol and 1 ml of water were added. The precipitate was filtered, the filtrate was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (hexane-ethyl acetate = 2: 1) to obtain the title compound. Yield 385 mg (0.68 mmol) Yield
2% MS (ESI, m / z) 567 (MH +) 1H-NMR (CDCl3): 2.45 (3H, s), 3.87 (2H, t), 3.92
(3H, s), 4.05 (2H, t), 4.23 (2H, t), 4.63 (2H, s),
5.61 (1H, dt), 6.01 (2H, s), 6.21 (1H, d), 6.64-6.
83 (3H, m), 6.89-6.97 (3H, m), 7.23-7.37 (5H, m)
【0304】6) 4−(3−(2−ベンジルオキシエ
トキシ)−4−メトキシフェニル)−6−メチル−2−
(3,4−メチレンジオキシフェノキシ)−5−(3−
ヒドロキシ−1−プロペニル)−3−(1H−テトラゾ
ール−5−イル)ピリジンの合成 トリブチルチンアジド1.12g(3.37mmol)
と4−(3−(2−ベンジルオキシエトキシ)−4−メ
トキシフェニル)−3−シアノ−6−メチル−2−
(3,4−メチレンジオキシフェノキシ)−5−(3−
ヒドロキシ−1−プロペニル)ピリジン380mg
(0.67mmol)をトルエン5ml中、140℃で
1晩加熱した。室温で4N塩酸−ジオキサンを加え濾
過、結晶をトルエンで洗浄後シリカゲルクロマトグラフ
ィー(クロロホルム−メタノール=30:1)で精製し
表題化合物を得た。 収量 195mg(0.32mmol) 収率 47.
8% MS (ESI, m/z) 610 (MH+) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.70 (2H, brd), 3.
72 (3H, s), 3.90 (2H, t), 3.97 (2H, brd), 4.55 (2
H, s), 4.74 (1H, t), 5.67 (1H, dt), 6.05 (2H, s),
6.23 (1H, d), 6.48-6.76 (3H, m), 6.81-6.92 (3H,
m),7.23-7.38 (5H, m)6) 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -6-methyl-2-
(3,4-methylenedioxyphenoxy) -5- (3-
Synthesis of hydroxy-1-propenyl) -3- (1H-tetrazol-5-yl) pyridine 1.12 g (3.37 mmol) of tributyltin azide
And 4- (3- (2-benzyloxyethoxy) -4-methoxyphenyl) -3-cyano-6-methyl-2-
(3,4-methylenedioxyphenoxy) -5- (3-
380 mg of (hydroxy-1-propenyl) pyridine
(0.67 mmol) was heated in 5 ml of toluene at 140 ° C. overnight. At room temperature, 4N hydrochloric acid-dioxane was added, followed by filtration. The crystals were washed with toluene and purified by silica gel chromatography (chloroform-methanol = 30: 1) to obtain the title compound. Yield 195 mg (0.32 mmol) Yield
8% MS (ESI, m / z) 610 (MH +) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.70 (2H, brd), 3.
72 (3H, s), 3.90 (2H, t), 3.97 (2H, brd), 4.55 (2
H, s), 4.74 (1H, t), 5.67 (1H, dt), 6.05 (2H, s),
6.23 (1H, d), 6.48-6.76 (3H, m), 6.81-6.92 (3H,
m), 7.23-7.38 (5H, m)
【0305】実施例71 5−(3−ヒドロキシ−1−
プロペニル)−4−(4−メトキシフェニル)−6−メ
チル−2−(3,4−メチレンジオキシフェノキシ)−
3−(2,5−ジヒドロ−5−オキソ−4H−1,2,
4−オキサジアゾール−3−イル)ピリジンの合成 1) N−ヒドロキシ−5−(3−ヒドロキシ−1−プ
ロペニル)−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)−6−メチル
ニコチンアミジンの合成 ヒドロキシアミン塩酸塩3.03g(43.6mmo
l)にDMSO25ml、トリエチルアミン6.1ml
(44.0mmol)を加え、析出した沈殿を濾過、T
HFで洗浄した。濾液のTHFを減圧留去後、3−シア
ノ−5−(3−ヒドロキシ−1−プロペニル)−4−
(4−メトキシフェニル)−6−メチル−2−(3,4
−メチレンジオキシフェノキシ)ピリジン2.51g
(6.03mmol)を加え70℃で4日間加熱した。
冷却後水を加え析出した結晶を濾過、酢酸エチルで洗浄
し表題化合物をアミド体の混合物として得た。 収量 1.56g (3.76mmol) 収率 6
2.4% MS (ESI, m/z) 450 (MH+) 1H-NMR (DMS0-d6): 2.36 (3H, s), 3.77 (3H, s), 3.86
(2H, d), 4.67 (1H,t), 5.54 (1H, m), 6.05 (2H, s),
6.12 (1H, d), 6.53-7.18 (7H, m)Example 71 5- (3-hydroxy-1-)
Propenyl) -4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy)-
3- (2,5-dihydro-5-oxo-4H-1,2,2
Synthesis of 4-oxadiazol-3-yl) pyridine 1) N-hydroxy-5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenoxy) -6-methylnicotinamidine Hydroxyamine hydrochloride 3.03 g (43.6 mmol)
l) to 25 ml of DMSO and 6.1 ml of triethylamine
(44.0 mmol), and the precipitated precipitate was filtered and T
Washed with HF. After the THF of the filtrate was distilled off under reduced pressure, 3-cyano-5- (3-hydroxy-1-propenyl) -4-.
(4-methoxyphenyl) -6-methyl-2- (3,4
-Methylenedioxyphenoxy) pyridine 2.51 g
(6.03 mmol) and heated at 70 ° C. for 4 days.
After cooling, water was added, and the precipitated crystals were filtered and washed with ethyl acetate to give the title compound as a mixture of amides. Yield 1.56 g (3.76 mmol) Yield 6
2.4% MS (ESI, m / z) 450 (MH +) 1H-NMR (DMS0-d6): 2.36 (3H, s), 3.77 (3H, s), 3.86
(2H, d), 4.67 (1H, t), 5.54 (1H, m), 6.05 (2H, s),
6.12 (1H, d), 6.53-7.18 (7H, m)
【0306】2)5−(3−ヒドロキシ−1−プロペニ
ル)−4−(4−メトキシフェニル)−6−メチル−2
−(3,4−メチレンジオキシフェノキシ)−3−
(2,5−ジヒドロ−5−オキソ−4H−1,2,4−
オキサジアゾール−3−イル)ピリジンの合成 N−ヒドロキシ−5−(3−ヒドロキシ−1−プロペニ
ル)−4−(4−メトキシフェニル)−2−(3,4−
メチレンジオキシフェノキシ)−6−メチルニコチンア
ミジン455mg(1.01mmol)にDMF20m
l、ピリジン0.5mlとクロロギ酸フェニル0.26
ml(2.07mmol)を加え室温で1晩攪拌した。
減圧下でDMFを留去後2N塩酸を加え酢酸エチルで抽
出した。有機層を無水硫酸ナトリウムで乾燥、減圧下濃
縮した。残渣をシリカゲルクロマトグラフィー(ヘキサ
ン−酢酸エチル=1:1)で精製した。この化合物をキ
シレン20ml中140℃で1晩加熱攪拌後減圧下濃縮
した。残渣に1M水酸化カリウム−メタノール溶液を加
え室温で2時間攪拌した。2N塩酸を加え減圧下濃縮、
酢酸エチルで抽出し有機層を無水硫酸ナトリウムで乾
燥、減圧下濃縮した。残渣をシリカゲルクロマトグラフ
ィー(クロロホルム−メタノール=100:1)で精製
し表題化合物を得た。 収量 98mg(0.21mmol) 収率 61.9
% MS (ESI, m/z) 476 (MH+) 1H-NMR(CDCl3): 2.46 (3H, s), 3.44 (1H, t), 3.81 (3
H, s), 4.07 (2H, d),5.55-5.66 (1H, m), 5.99 (2H,
s), 6.20 (1H, d), 6.55-6.82 (3H, m), 6.84-6.93 (3
H, m), 7.01-7.08 (2H, m)2) 5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -6-methyl-2
-(3,4-methylenedioxyphenoxy) -3-
(2,5-dihydro-5-oxo-4H-1,2,4-
Synthesis of oxadiazol-3-yl) pyridine N-hydroxy-5- (3-hydroxy-1-propenyl) -4- (4-methoxyphenyl) -2- (3,4-
Methylenedioxyphenoxy) -6-methylnicotinamidine (455 mg, 1.01 mmol) in DMF 20m
1, pyridine 0.5 ml and phenyl chloroformate 0.26
ml (2.07 mmol) was added and the mixture was stirred at room temperature overnight.
After distilling off DMF under reduced pressure, 2N hydrochloric acid was added and extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 1: 1). This compound was heated and stirred at 140 ° C. overnight in 20 ml of xylene and then concentrated under reduced pressure. A 1 M potassium hydroxide-methanol solution was added to the residue, and the mixture was stirred at room temperature for 2 hours. Add 2N hydrochloric acid and concentrate under reduced pressure.
The mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform-methanol = 100: 1) to obtain the title compound. Yield 98 mg (0.21 mmol) Yield 61.9
% MS (ESI, m / z) 476 (MH +) 1H-NMR (CDCl3): 2.46 (3H, s), 3.44 (1H, t), 3.81 (3
H, s), 4.07 (2H, d), 5.55-5.66 (1H, m), 5.99 (2H,
s), 6.20 (1H, d), 6.55-6.82 (3H, m), 6.84-6.93 (3
H, m), 7.01-7.08 (2H, m)
【0307】実施例72 4−(4−トリフルオロメト
キシフェニル)−6−メチル−2−(3,4−メチレン
ジオキシフェノキシ)−5−(3−ヒドロキシ−1−プ
ロペニル)−3−(1H−テトラゾール−5−イル)ピ
リジンの合成 実施例43と同様にして合成した。 MS (ESI, m/z) 514 (MH+) 1H-NMR (DMSO-d6): 2.48 (3H, s), 3.85 (2H, d), 5.54
(1H, dt), 6.05 (2H,s), 6.21 (1H, d), 6.52-6.95 (3
H, m), 7.10-7.32 (4H, m)Example 72 4- (4-Trifluoromethoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -5- (3-hydroxy-1-propenyl) -3- (1H Synthesis of -tetrazol-5-yl) pyridine It was synthesized in the same manner as in Example 43. MS (ESI, m / z) 514 (MH +) 1H-NMR (DMSO-d6): 2.48 (3H, s), 3.85 (2H, d), 5.54
(1H, dt), 6.05 (2H, s), 6.21 (1H, d), 6.52-6.95 (3
H, m), 7.10-7.32 (4H, m)
【0308】実施例73 ピリジン−2−カルボン酸
(3−(6−(3,4−メチレンジオキシフェニルオキ
シ)−4−(4−メトキシフェニル)−2−メチル−5
−(1H−テトラゾ−5−イル)−ピリジン−3−イ
ル)−アリル)−アミドの合成 1)5−(3−クロロ−1−プロペニル)−3−シアノ
−6−メチル−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)ピリジンの合
成 3−シアノ−6−メチル−5−(3−ヒドロキシ−1−
プロペニル)−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシフェノキシ)ピリジン9.
20g(22.1mmol)をジクロロメタン100m
lに溶解し氷浴下で塩化チオニル2.5ml(34.2
mmol)を滴下した。同温で20分攪拌後減圧下濃縮
した。残渣をシリカゲルクロマトグラフィー(ヘキサン
−酢酸エチル=1:1)で精製し表題化合物を得た。 収量 9.39g(21.6mmol) 収率 97.
7% MS (ESI, m/z) 435 (MH+) 1H-NMR(CDCl3): 2.46 (3/2H,s), 2.59 (3/2H, s), 3.86
(3/2H, s), 3.89 (3/2H, s), 4.05 (2/2H, d) 5.15-5.
30 (1H, m), 5.58-5.70 (1H, m), 6.02 (2H, s), 6.30
(1/2H, d), 6.64 (1H, dd), 6.75 (1H, d), 6.83 (1H,
d), 6.95-7.10(2H, m), 7.15-7.30 (2H, m), 7.38 (1/2
H, dd)Example 73: Pyridine-2-carboxylic acid
(3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5
Synthesis of-(1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide 1) 5- (3-chloro-1-propenyl) -3-cyano-6-methyl-4- (4 -Methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxyphenoxy) pyridine 3-cyano-6-methyl-5- (3-hydroxy-1-
Propenyl) -4- (4-methoxyphenyl) -2-
(3,4-methylenedioxyphenoxy) pyridine 9.
20 g (22.1 mmol) in dichloromethane 100 m
and 2.5 ml of thionyl chloride (34.2) in an ice bath.
mmol) was added dropwise. After stirring at the same temperature for 20 minutes, the mixture was concentrated under reduced pressure. The residue was purified by silica gel chromatography (hexane-ethyl acetate = 1: 1) to give the title compound. Yield 9.39 g (21.6 mmol) Yield
7% MS (ESI, m / z) 435 (MH +) 1H-NMR (CDCl3): 2.46 (3 / 2H, s), 2.59 (3 / 2H, s), 3.86
(3 / 2H, s), 3.89 (3 / 2H, s), 4.05 (2 / 2H, d) 5.15-5.
30 (1H, m), 5.58-5.70 (1H, m), 6.02 (2H, s), 6.30
(1 / 2H, d), 6.64 (1H, dd), 6.75 (1H, d), 6.83 (1H,
d), 6.95-7.10 (2H, m), 7.15-7.30 (2H, m), 7.38 (1/2
H, dd)
【0309】2)N−(tert−ブトキシカルボニ
ル)−N−(3−(3−シアノ−6−メチル−4−(4
−メトキシフェニル)−2−(3,4−メチレンジオキ
シフェノキシ)ピリジン−5−イル)−2−プロペニ
ル)ホスホロアミド酸ジエチルの合成 5−(3−クロロ−1−プロペニル)−3−シアノ−6
−メチル−4−(4−メトキシフェニル)−2−(3,
4−メチレンジオキシフェノキシ)ピリジン9.39g
(21,6mmol)をベンゼン100mlに溶解し、
N−(tert−ブトキシカルボニル)ホスホロアミド
酸ジエチル6.56g(25.9mmol)、臭化テト
ラブチルアンモニウム0.7g(2.2mmol)、6
0%水素化ナトリウム1.04g(26mmol)を加
えた後、1晩加熱還流した。放冷後水を加え反応を停止
し、酢酸エチルで抽出した。飽和食塩水で洗浄し無水硫
酸マグネシウムで乾燥後、減圧下濃縮し残渣をシリカゲ
ルクロマトグラフィー(ヘキサン−酢酸エチル=1:1
から1:3)で精製し表題化合物を得た。 収量 9.12g(14.0mmol) 収率 64.
8% MS (ESI, m/z) 652 (MH+) 1H-NMR(CDCl3): 1.30 (6H, t), 1.47 (9H, s), 2.46 (3
H, s), 3.85 (3H, s),4.10 (6H, m), 5.56 (1H, dt),
6.01 (2H, s), 6.25 (1H, d), 6.66 (1H, dd),6.74 (1
H, d), 6.80 (1H, d), 6.97 (2H, d), 7.25 (2H, d)2) N- (tert-Butoxycarbonyl) -N- (3- (3-cyano-6-methyl-4- (4
Synthesis of diethyl -methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridin-5-yl) -2-propenyl) phospholoamidate 5- (3-chloro-1-propenyl) -3-cyano-6
-Methyl-4- (4-methoxyphenyl) -2- (3,
9.39 g of 4-methylenedioxyphenoxy) pyridine
(21.6 mmol) was dissolved in 100 ml of benzene,
6.56 g (25.9 mmol) of diethyl N- (tert-butoxycarbonyl) phosphoramidate, 0.7 g (2.2 mmol) of tetrabutylammonium bromide, 6
After adding 1.04 g (26 mmol) of 0% sodium hydride, the mixture was heated and refluxed overnight. After cooling, water was added to stop the reaction, and the mixture was extracted with ethyl acetate. The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and the residue was subjected to silica gel chromatography (hexane-ethyl acetate = 1: 1).
To 1: 3) to give the title compound. Yield 9.12 g (14.0 mmol) Yield
8% MS (ESI, m / z) 652 (MH +) 1H-NMR (CDCl3): 1.30 (6H, t), 1.47 (9H, s), 2.46 (3
H, s), 3.85 (3H, s), 4.10 (6H, m), 5.56 (1H, dt),
6.01 (2H, s), 6.25 (1H, d), 6.66 (1H, dd), 6.74 (1
H, d), 6.80 (1H, d), 6.97 (2H, d), 7.25 (2H, d)
【0310】3)5−(3−アミノ−1−プロペニル)
−3−シアノ−6−メチル−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)ピ
リジンの合成 N−(tert−ブトキシカルボニル)−N−(3−
(3−シアノ−6−メチル−4−(4−メトキシフェニ
ル)−2−(3,4−メチレンジオキシフェノキシ)ピ
リジン−5−イル)−2−プロペニル)ホスホロアミド
酸ジエチル9.12g(14.0mmol)に氷浴下で
36wt%塩化水素−エタノール溶液を加えた。室温に
戻し9時間攪拌後減圧下濃縮した。残渣に酢酸エチルを
加え生じた沈殿を濾取し酢酸エチルで洗浄し表題化合物
を得た。 収量 4.77g(10.4mmol) 収率 74.
3% 1H−NMR (DMSO−d6): 2.44 (3
H, s), 3.40 (2H, br), 3.8
2 (3H, s), 5.60 (1H,dt),
6.10 (2H, s), 6.39 (1H,
d), 6.72 (1H, dd), 6.96
(2H, m), 7.06 (2H,d), 7.3
6 (2H, d), 8.08 (3H, br)3) 5- (3-amino-1-propenyl)
Synthesis of -3-cyano-6-methyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridine N- (tert-butoxycarbonyl) -N- (3-
9.12 g of diethyl (3-cyano-6-methyl-4- (4-methoxyphenyl) -2- (3,4-methylenedioxyphenoxy) pyridin-5-yl) -2-propenyl) phosphoramidate (14. 0 mmol) was added with a 36 wt% hydrogen chloride-ethanol solution in an ice bath. After returning to room temperature and stirring for 9 hours, the mixture was concentrated under reduced pressure. Ethyl acetate was added to the residue, and the resulting precipitate was collected by filtration and washed with ethyl acetate to give the title compound. Yield 4.77 g (10.4 mmol) Yield 74.
3% 1H-NMR (DMSO-d6): 2.44 (3
H, s), 3.40 (2H, br), 3.8
2 (3H, s), 5.60 (1H, dt),
6.10 (2H, s), 6.39 (1H,
d), 6.72 (1H, dd), 6.96
(2H, m), 7.06 (2H, d), 7.3
6 (2H, d), 8.08 (3H, br)
【0310】4)ピリジン−2−カルボン酸 (3−
(6−(3,4−メチレンジオキシフェニルオキシ)−
4−(4−メトキシフェニル)−2−メチル−5−シア
ノピリジン−3−イル)−アリル)−アミドの合成 5−(3−アミノ−1−プロペニル)−3−シアノ−6
−メチル−4−(4−メトキシフェニル)−2−(3,
4−メチレンジオキシフェノキシ)ピリジン480mg
(1.16mmol)をジクロロメタン10mlに溶解
し塩化ピリジン−2−カルボニル 塩酸塩220mg
(1.24mmol)、トリエチルアミン0.5ml
(3.59mmol)を加え室温で1時間攪拌した。溶
媒を減圧下留去し酢酸エチルで抽出した。1規定塩酸、
飽和重曹水で洗浄し、無水硫酸マグネシウムで乾燥し
た。溶媒を減圧下留去し、得られた残渣をシリカゲルク
ロマトグラフィー(酢酸エチル:ヘキサン=1:1から
2:1)で精製し表題化合物を得た。 収量 160mg(0.31mmol) 収率 22.
4% MS (ESI, m/z) 521 (MH+) 1H-NMR(CDCl3): 2.47 (3H, s), 3.78 (3H, s), 4.05 (2
H, t), 5.78 (1H, dt), 6.02 (2H, s), 6.28 (1H, d),
6.67 (1H, dd), 6.75 (1H, d), 6.81 (1H, d),6.94 (2
H, d), 7.25 (2H, d), 7.46 (1H, m), 7.86 (1H, dt),
7.95 (1H, br),8.18 (1H, d), 8.56 (1H, d)4) Pyridine-2-carboxylic acid (3-
(6- (3,4-methylenedioxyphenyloxy)-
Synthesis of 4- (4-methoxyphenyl) -2-methyl-5-cyanopyridin-3-yl) -allyl) -amide 5- (3-amino-1-propenyl) -3-cyano-6
-Methyl-4- (4-methoxyphenyl) -2- (3,
480 mg of 4-methylenedioxyphenoxy) pyridine
(1.16 mmol) was dissolved in 10 ml of dichloromethane, and 220 mg of pyridine-2-carbonyl chloride hydrochloride was dissolved.
(1.24 mmol), 0.5 ml of triethylamine
(3.59 mmol) was added and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off under reduced pressure and extracted with ethyl acetate. 1N hydrochloric acid,
The extract was washed with saturated aqueous sodium hydrogen carbonate and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (ethyl acetate: hexane = 1: 1 to 2: 1) to obtain the title compound. Yield 160 mg (0.31 mmol) Yield 22.
4% MS (ESI, m / z) 521 (MH +) 1H-NMR (CDCl3): 2.47 (3H, s), 3.78 (3H, s), 4.05 (2
H, t), 5.78 (1H, dt), 6.02 (2H, s), 6.28 (1H, d),
6.67 (1H, dd), 6.75 (1H, d), 6.81 (1H, d), 6.94 (2
H, d), 7.25 (2H, d), 7.46 (1H, m), 7.86 (1H, dt),
7.95 (1H, br), 8.18 (1H, d), 8.56 (1H, d)
【0311】5)ピリジン−2−カルボン酸 (3−
(6−(3,4−メチレンジオキシフェニルオキシ)−
4−(4−メトキシフェニル)−2−メチル−5−(1
H−テトラゾ−5−イル)−ピリジン−3−イル)−ア
リル)−アミドの合成 塩化トリブチルスズ1,0ml、アジ化ナトリウム36
0mgから合成したアジ化トリブチルスズとピリジン−
2−カルボン酸 (3−(6−(3,4−メチレンジオ
キシフェニルオキシ)−4−(4−メトキシフェニル)
−2−メチル−5−シアノピリジン−3−イル)−アリ
ル)−アミド160mg(0.31mmol)をトルエ
ン中2日間加熱環流した。放冷後4規定塩酸ジオキサン
を加え室温で30分攪拌し沈殿を濾取し、トルエン、酢
酸エチルで洗浄した。 収量 150mg(0.27mmol) 収率 85.
9% MS (ESI, m/z) 564 (MH+) 1H-NMR (DMSO-d6): 2.44 (3H, s), 3.58 (3H, s), 3.85
(2H, t), 5.61 (1H,dt), 6.05 (2H, s), 6.20 (1H,
d), 6.53 (1H, dd), 6.68 (2H, d), 6.48 (1H,d), 6.79
(2H, d), 7.69 (1H, m), 7.98 (2H, m), 8.62 (1H,
d), 8.75 (1H, t)5) Pyridine-2-carboxylic acid (3-
(6- (3,4-methylenedioxyphenyloxy)-
4- (4-methoxyphenyl) -2-methyl-5- (1
Synthesis of H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide 1,0 ml of tributyltin chloride, sodium azide 36
Tributyltin azide and pyridine
2-carboxylic acid (3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl)
160 mg (0.31 mmol) of 2-methyl-5-cyanopyridin-3-yl) -allyl) -amide were refluxed with heating in toluene for 2 days. After allowing to cool, 4N dioxane hydrochloride was added, the mixture was stirred at room temperature for 30 minutes, and the precipitate was collected by filtration and washed with toluene and ethyl acetate. Yield 150 mg (0.27 mmol) Yield
9% MS (ESI, m / z) 564 (MH +) 1H-NMR (DMSO-d6): 2.44 (3H, s), 3.58 (3H, s), 3.85
(2H, t), 5.61 (1H, dt), 6.05 (2H, s), 6.20 (1H,
d), 6.53 (1H, dd), 6.68 (2H, d), 6.48 (1H, d), 6.79
(2H, d), 7.69 (1H, m), 7.98 (2H, m), 8.62 (1H,
d), 8.75 (1H, t)
【0312】実施例74 (3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−ベンズアミド
の合成 1)(3−(6−(3,4−メチレンジオキシフェニル
オキシ)−4−(4−メトキシフェニル)−2−メチル
−5−シアノピリジン−3−イル)−アリル)−ベンズ
アミドの合成 ピリジン−2−カルボン酸(3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−シアノピリジン−3−イ
ル)−アリル)−アミドの合成に準じて行った。 収率 56.9% MS (ESI, m/z) 520 (MH+) 1H-NMR(CDCl3): 2.46 (3H, s), 3.75 (3H, s), 4.03 (2
H, t), 5.52 (1H, dt), 5.66 (1H, dd), 5.86 (1H, b
r), 6.01 (2H, s), 6.29 (1H, d), 6.74 (1H, d), 6.81
(1H, d), 6.95 (2H, d), 7.24 (2H, d), 7.40-7.55 (3
H, m), 7.64 (2H, m)Example 74 (3- (6- (3,4-Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl) -pyridine Synthesis of -3-yl) -allyl) -benzamide 1) (3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5-cyanopyridine- Synthesis of 3-yl) -allyl) -benzamide pyridine-2-carboxylic acid (3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- This was carried out according to the synthesis of cyanopyridin-3-yl) -allyl) -amide. Yield 56.9% MS (ESI, m / z) 520 (MH +) 1H-NMR (CDCl3): 2.46 (3H, s), 3.75 (3H, s), 4.03 (2
H, t), 5.52 (1H, dt), 5.66 (1H, dd), 5.86 (1H, b
r), 6.01 (2H, s), 6.29 (1H, d), 6.74 (1H, d), 6.81
(1H, d), 6.95 (2H, d), 7.24 (2H, d), 7.40-7.55 (3
H, m), 7.64 (2H, m)
【0313】2)(3−(6−(3,4−メチレンジオ
キシフェニルオキシ)−4−(4−メトキシフェニル)
−2−メチル−5−(1H−テトラゾ−5−イル)−ピ
リジン−3−イル)−アリル)−ベンズアミドの合成 ピリジンカルボン酸 (3−(6−(3,4−メチレン
ジオキシフェニルオキシ)−4−(4−メトキシフェニ
ル)−2−メチル−5−(1H−テトラゾ−5−イル)
−ピリジン−3−イル)−アリル)−アミドの合成に準
じて行った。 収率 30.7% MS (ESI, m/z) 563 (MH+) 1H-NMR (DMSO-d6): 2.46 (3H, s), 3.60 (3H, s), 3.84
(2H, t), 5.72 (1H,dt), 6.05 (2H, s), 6.20 (1H, d
d), 6.70-6.75 (3H, m), 6.86-6.96 (3H, m),7.40-7.56
(3H, m), 7.79 (2H, d), 8.50 (1H, t)2) (3- (6- (3,4-Methylenedioxyphenyloxy) -4- (4-methoxyphenyl)
Synthesis of -2-methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -benzamide pyridinecarboxylic acid (3- (6- (3,4-methylenedioxyphenyloxy)) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl)
-Pyridin-3-yl) -allyl) -amide. Yield 30.7% MS (ESI, m / z) 563 (MH +) 1H-NMR (DMSO-d6): 2.46 (3H, s), 3.60 (3H, s), 3.84
(2H, t), 5.72 (1H, dt), 6.05 (2H, s), 6.20 (1H, d
d), 6.70-6.75 (3H, m), 6.86-6.96 (3H, m), 7.40-7.56
(3H, m), 7.79 (2H, d), 8.50 (1H, t)
【0314】実施例75 3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−(2−メトキ
シ)アセトアミドの合成 1)3−(6−(3,4−メチレンジオキシフェニルオ
キシ)−4−(4−メトキシフェニル)−2−メチル−
5−シアノピリジン−3−イル)−アリル)−(2−メ
トキシ)アセトアミドの合成 ピリジンカルボン酸 (3−(6−(3,4−メチレン
ジオキシフェニルオキシ)−4−(4−メトキシフェニ
ル)−2−メチル−5−シアノピリジン−3−イル)−
アリル)−アミドの合成に準じて行った。 収率 定量的 MS (ESI, m/z) 488 (MH+) 1H-NMR(CDCl3): 2.45 (3H, s), 3.38 (3H, s), 3.82 (2
H, s), 3.87 (3H, s),3.85 (2H, m), 5.46 (1H, dt),
6.01 (2H, s), 6.18 (1H, d), 6.40 (1H, br),6.66 (1
H, dd),6.74 (1H, d), 6.81 (1H, d), 6.98 (2H, d),
7.24 (2H, d)Example 75 3- (6- (3,4-Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl) -pyridin- Synthesis of 3-yl) -allyl)-(2-methoxy) acetamide 1) 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-
Synthesis of 5-cyanopyridin-3-yl) -allyl)-(2-methoxy) acetamide pyridinecarboxylic acid (3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5-cyanopyridin-3-yl)-
Allyl) -amide was synthesized. Yield Quantitative MS (ESI, m / z) 488 (MH +) 1H-NMR (CDCl3): 2.45 (3H, s), 3.38 (3H, s), 3.82 (2
H, s), 3.87 (3H, s), 3.85 (2H, m), 5.46 (1H, dt),
6.01 (2H, s), 6.18 (1H, d), 6.40 (1H, br), 6.66 (1
H, dd), 6.74 (1H, d), 6.81 (1H, d), 6.98 (2H, d),
7.24 (2H, d)
【0315】2)3−(6−(3,4−メチレンジオキ
シフェニルオキシ)−4−(4−メトキシフェニル)−
2−メチル−5−(1H−テトラゾ−5−イル)−ピリ
ジン−3−イル)−アリル)−(2−メトキシ)アセト
アミドの合成 ピリジンカルボン酸 (3−(6−(3,4−メチレン
ジオキシフェニルオキシ)−4−(4−メトキシフェニ
ル)−2−メチル−5−(1H−テトラゾ−5−イル)
−ピリジン−3−イル)−アリル)−アミドの合成に準
じて行った。 収率 52.6% MS (ESI, m/z) 531 (MH+) 1H-NMR (DMSO-d6): 2.43 (3H, s), 3.23 (3H, s), 3.66
(2H, t), 3.71 (2H,s), 3.72 (2H, s), 5.52 (1H, d
t), 6.05 (2H, s), 6.11 (1H, d), 6.52 (1H, dt), 6.7
5 (1H, d), 6.80 (2H, d), 6.86-6.94 (3H, m), 7.78
(1H, brt)2) 3- (6- (3,4-Methylenedioxyphenyloxy) -4- (4-methoxyphenyl)-
Synthesis of 2-methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl)-(2-methoxy) acetamide pyridinecarboxylic acid (3- (6- (3,4-methylenedi) Oxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl)
-Pyridin-3-yl) -allyl) -amide. Yield 52.6% MS (ESI, m / z) 531 (MH +) 1H-NMR (DMSO-d6): 2.43 (3H, s), 3.23 (3H, s), 3.66
(2H, t), 3.71 (2H, s), 3.72 (2H, s), 5.52 (1H, d
t), 6.05 (2H, s), 6.11 (1H, d), 6.52 (1H, dt), 6.7
5 (1H, d), 6.80 (2H, d), 6.86-6.94 (3H, m), 7.78
(1H, brt)
【0316】実施例76 3−(6−(3,4−メチレ
ンジオキシフェニルオキシ)−4−(4−メトキシフェ
ニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−4−メトキシ
ベンズ−アミドの合成 1)3−(6−(3,4−メチレンジオキシフェニルオ
キシ)−4−(4−メトキシフェニル)−2−メチル−
5−シアノピリジン−3−イル)−アリル)−4−メト
キシベンズアミドの合成 ピリジン−2−カルボン酸 3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−アミドの合成
に準じて行った。 収率 54.8% MS (ESI, m/z) 550 (MH+) 1H-NMR(CDCl3): 2.46(3H, s), 3.78 (3H, s), 3.86 (3
H, s), 4.02 (2H, t),5.52 (1H, dt), 5.72 (1H, br),
6.02 (2H, s), 6.28 (1H, d), 6.66 (1H, dd),6.74 (1
H, d), 6.81 (1H, d), 6.90-6.98 (4H, m), 7.25 (2H,
d), 7.62 (2H,d)Example 76 3- (6- (3,4-Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl) -pyridin- Synthesis of 3-yl) -allyl) -4-methoxybenz-amide 1) 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-
Synthesis of 5-cyanopyridin-3-yl) -allyl) -4-methoxybenzamide pyridine-2-carboxylic acid 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-Methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide was synthesized. Yield 54.8% MS (ESI, m / z) 550 (MH +) 1H-NMR (CDCl3): 2.46 (3H, s), 3.78 (3H, s), 3.86 (3
H, s), 4.02 (2H, t), 5.52 (1H, dt), 5.72 (1H, br),
6.02 (2H, s), 6.28 (1H, d), 6.66 (1H, dd), 6.74 (1
H, d), 6.81 (1H, d), 6.90-6.98 (4H, m), 7.25 (2H,
d), 7.62 (2H, d)
【0317】2)3−(6−(3,4−メチレンジオキ
シフェニルオキシ)−4−(4−メトキシフェニル)−
2−メチル−5−(1H−テトラゾ−5−イル)−ピリ
ジン−3−イル)−アリル)−4−メトキシベンズ−ア
ミドの合成 ピリジン−2−カルボン酸 3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−アミドの合成
に準じて行った。 収率 54.5% MS (ESI, m/z) 593 (MH+) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.62 (3H, s), 3.80
(3H, s), 3.82 (2H,m), 5.62 (1H, dt), 6.05 (2H,
s), 6.18 (1H, d), 6.54 (1H, d), 6.70-6.78 (3H, m),
6.86-7.00(5H, m), 7.73 (2H, d), 8.36 (1H, br)2) 3- (6- (3,4-Methylenedioxyphenyloxy) -4- (4-methoxyphenyl)-
Synthesis of 2-methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -4-methoxybenz-amide pyridine-2-carboxylic acid 3- (6- (3,4- Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide was synthesized. . Yield 54.5% MS (ESI, m / z) 593 (MH +) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.62 (3H, s), 3.80
(3H, s), 3.82 (2H, m), 5.62 (1H, dt), 6.05 (2H,
s), 6.18 (1H, d), 6.54 (1H, d), 6.70-6.78 (3H, m),
6.86-7.00 (5H, m), 7.73 (2H, d), 8.36 (1H, br)
【0318】実施例77 3−(6−(3,4−メチレ
ンジオキシフェニルオキシ)−4−(4−メトキシフェ
ニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−2−メトキシ
ベンズアミドの合成 1)3−(6−(3,4−メチレンジオキシフェニルオ
キシ)−4−(4−メトキシフェニル)−2−メチル−
5−シアノピリジン−3−イル)−アリル)−2−メト
キシベンズアミドの合成 ピリジン−2−カルボン酸 3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−アミドの合成
に準じて行った。 収率 79.6% MS (ESI, m/z) 550 (MH+) 1H-NMR(CDCl3): 2.47 (3H, s), 3.72 (3H, s), 3.89 (3
H, s), 4.10 (2H, m),5.62 (1H, dt), 6.01 (2H, s),
6.25 (1H, d), 6.66 (1H, dd), 6.74 (1H, d),6.81 (1
H, d), 6.90 (2H, d), 6.96 (1H, d), 7.09 (1H, t),
7.25 (2H, d), 7.45 (1H, m), 7.75 (1H, br), 8.16 (1
H, dd)Example 77 3- (6- (3,4-Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl) -pyridin- Synthesis of 3-yl) -allyl) -2-methoxybenzamide 1) 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-
Synthesis of 5-cyanopyridin-3-yl) -allyl) -2-methoxybenzamide pyridine-2-carboxylic acid 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-Methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide was synthesized. Yield 79.6% MS (ESI, m / z) 550 (MH +) 1H-NMR (CDCl3): 2.47 (3H, s), 3.72 (3H, s), 3.89 (3
H, s), 4.10 (2H, m), 5.62 (1H, dt), 6.01 (2H, s),
6.25 (1H, d), 6.66 (1H, dd), 6.74 (1H, d), 6.81 (1
H, d), 6.90 (2H, d), 6.96 (1H, d), 7.09 (1H, t),
7.25 (2H, d), 7.45 (1H, m), 7.75 (1H, br), 8.16 (1
H, dd)
【0319】2)3−(6−(3,4−メチレンジオキ
シフェニルオキシ)−4−(4−メトキシフェニル)−
2−メチル−5−(1H−テトラゾ−5−イル)−ピリ
ジン−3−イル)−アリル)−2−メトキシベンズ−ア
ミドの合成 ピリジン−2−カルボン酸 3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−アミドの合成
に準じて行った。 収率 60.0% MS (ESI, m/z) 593 (MH+) 1H-NMR (DMSO-d6): 2.46 (3H, s), 3.60 (3H, s), 3.81
(3H, s), 3.88 (2H,m), 5.62 (1H, dt), 6.05 (2H,
s), 6.20 (1H, d), 6.50 (1H, dd), 6.70-6.76(3H, m),
6.88-6.94 (3H, m), 7.00 (1H, t), 7.10 (1H, d), 7.
44 (1H, t), 7.63 (1H, dd), 8.14 (1H, brt)2) 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl)-
Synthesis of 2-methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -2-methoxybenz-amide pyridine-2-carboxylic acid 3- (6- (3,4- Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide was synthesized. . Yield 60.0% MS (ESI, m / z) 593 (MH +) 1H-NMR (DMSO-d6): 2.46 (3H, s), 3.60 (3H, s), 3.81
(3H, s), 3.88 (2H, m), 5.62 (1H, dt), 6.05 (2H,
s), 6.20 (1H, d), 6.50 (1H, dd), 6.70-6.76 (3H, m),
6.88-6.94 (3H, m), 7.00 (1H, t), 7.10 (1H, d), 7.
44 (1H, t), 7.63 (1H, dd), 8.14 (1H, brt)
【0320】実施例78 フラン−2−カルボン酸 3
−(6−(3,4−メチレンジオキシフェニルオキシ)
−4−(4−メトキシフェニル)−2−メチル−5−
(1H−テトラゾ−5−イル)−ピリジン−3−イル)
−アリル)−アミドの合成 1)フラン−2−カルボン酸 3−(6−(3,4−メ
チレンジオキシフェニルオキシ)−4−(4−メトキシ
フェニル)−2−メチル−5−シアノピリジン−3−イ
ル)−アリル)−アミドの合成 ピリジン−2−カルボン酸 3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−アミドの合成
に準じて行った。 収率 87.2% MS (ESI, m/z) 510 (MH+) 1H-NMR(CDCl3): 2.45 (3H, s), 3.81 (3H, s), 3.98 (2
H, t), 5.50 (1H, dt), 6.02 (2H, s), 6.13 (1H, br),
6.25 (1H, d), 6.52 (1H, dd), 6.66 (1H, dd), 6.74
(1H, d), 6.81 (1H, d), 6.96 (2H, d), 7.09 (1H, d),
7.24 (2H, d),7.45 (1H, m)Example 78 Furan-2-carboxylic acid 3
-(6- (3,4-methylenedioxyphenyloxy)
-4- (4-methoxyphenyl) -2-methyl-5-
(1H-tetrazo-5-yl) -pyridin-3-yl)
Synthesis of -allyl) -amide 1) Furan-2-carboxylic acid 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5-cyanopyridine- Synthesis of 3-yl) -allyl) -amide pyridine-2-carboxylic acid 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- ( This was performed according to the synthesis of 1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide. Yield 87.2% MS (ESI, m / z) 510 (MH +) 1H-NMR (CDCl3): 2.45 (3H, s), 3.81 (3H, s), 3.98 (2
H, t), 5.50 (1H, dt), 6.02 (2H, s), 6.13 (1H, br),
6.25 (1H, d), 6.52 (1H, dd), 6.66 (1H, dd), 6.74
(1H, d), 6.81 (1H, d), 6.96 (2H, d), 7.09 (1H, d),
7.24 (2H, d), 7.45 (1H, m)
【0321】2)フラン−2−カルボン酸3−(6−
(3,4−メチレンジオキシフェニルオキシ)−4−
(4−メトキシフェニル)−2−メチル−5−(1H−
テトラゾ−5−イル)−ピリジン−3−イル)−アリ
ル)−アミドの合成 ピリジン−2−カルボン酸 3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−アミドの合成
に準じて行った。 収率 43.8% MS (ESI, m/z) 553 (MH+) 1H-NMR (DMSO-d6): 2.44 (3H, s), 3.65 (3H, s), 3.78
(2H, t), 5.59 (1H,dt), 6.05 (2H, s), 6.18 (1H,
d), 6.52 (1H, dd), 6.59 (1H, dd), 6.74 (3H,m), 6.8
8-6.94 (3H, m), 7.03 (1H, d), 7.79 (1H, m), 8.37
(1H, brt)2) Furan-2-carboxylic acid 3- (6-)
(3,4-methylenedioxyphenyloxy) -4-
(4-methoxyphenyl) -2-methyl-5- (1H-
Synthesis of tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide pyridine-2-carboxylic acid 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) ) -2-Methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide. Yield 43.8% MS (ESI, m / z) 553 (MH +) 1H-NMR (DMSO-d6): 2.44 (3H, s), 3.65 (3H, s), 3.78
(2H, t), 5.59 (1H, dt), 6.05 (2H, s), 6.18 (1H,
d), 6.52 (1H, dd), 6.59 (1H, dd), 6.74 (3H, m), 6.8
8-6.94 (3H, m), 7.03 (1H, d), 7.79 (1H, m), 8.37
(1H, brt)
【0322】実施例79 3−(6−(3,4−メチレ
ンジオキシフェニルオキシ)−4−(4−メトキシフェ
ニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−3−メトキシ
ベンズアミドの合成 1)3−(6−(3,4−メチレンジオキシフェニルオ
キシ)−4−(4−メトキシフェニル)−2−メチル−
5−シアノピリジン−3−イル)−アリル)−2−メト
キシベンズアミドの合成 ピリジン−2−カルボン酸 3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−アミドの合成
に準じて行った。 収率 80.9% MS (ESI, m/z) 550 (MH+) 1H-NMR(CDCl3): 2.46 (3H, s), 3.75 (3H, s), 3.85 (3
H, s), 4.03 (2H, t),5.54 (1H, dt), 6.02 (2H, s),
6.28 (1H, d), 6.56 (1H, dd), 6.74 (1H, d),6.81 (1
H, d), 6.94 (2H, d), 7.05 (1H, dd), 7.11 (1H, d),
7.24 (2H, d),7.29 (1H, m), 7.33 (1H, t)Example 79 3- (6- (3,4-Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl) -pyridin- Synthesis of 3-yl) -allyl) -3-methoxybenzamide 1) 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-
Synthesis of 5-cyanopyridin-3-yl) -allyl) -2-methoxybenzamide pyridine-2-carboxylic acid 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-Methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide was synthesized. Yield 80.9% MS (ESI, m / z) 550 (MH +) 1H-NMR (CDCl3): 2.46 (3H, s), 3.75 (3H, s), 3.85 (3
H, s), 4.03 (2H, t), 5.54 (1H, dt), 6.02 (2H, s),
6.28 (1H, d), 6.56 (1H, dd), 6.74 (1H, d), 6.81 (1
H, d), 6.94 (2H, d), 7.05 (1H, dd), 7.11 (1H, d),
7.24 (2H, d), 7.29 (1H, m), 7.33 (1H, t)
【0323】2)3−(6−(3,4−メチレンジオキ
シフェニルオキシ)−4−(4−メトキシフェニル)−
2−メチル−5−(1H−テトラゾ−5−イル)−ピリ
ジン−3−イル)−アリル)−3−メトキシベンズ−ア
ミドの合成 ピリジン−2−カルボン酸 3−(6−(3,4−メチ
レンジオキシフェニルオキシ)−4−(4−メトキシフ
ェニル)−2−メチル−5−(1H−テトラゾ−5−イ
ル)−ピリジン−3−イル)−アリル)−アミドの合成
に準じて行った。 収率 17.5% MS (ESI, m/z) 593 (MH+) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.60 (3H, s), 3.79
(3H, s), 3.82 (2H,t), 5.60 (1H, dt), 6.05 (2H.,
s), 6.19 (1H, d), 6.54 (1H, dd), 6.70-6.76(3H, m),
6.86-6.94 (3H, m), 7.07 (1H, m), 7.30-7.38 (3H,
m), 8.50 (1H,t)2) 3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl)-
Synthesis of 2-methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -3-methoxybenz-amide pyridine-2-carboxylic acid 3- (6- (3,4- Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl) -pyridin-3-yl) -allyl) -amide was synthesized. . Yield 17.5% MS (ESI, m / z) 593 (MH +) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.60 (3H, s), 3.79
(3H, s), 3.82 (2H, t), 5.60 (1H, dt), 6.05 (2H.,
s), 6.19 (1H, d), 6.54 (1H, dd), 6.70-6.76 (3H, m),
6.86-6.94 (3H, m), 7.07 (1H, m), 7.30-7.38 (3H,
m), 8.50 (1H, t)
【0324】実施例80 1−(3−(6−(3,4−
メチレンジオキシフェニルオキシ)−4−(4−メトキ
シフェニル)−2−メチル−5−(1H−テトラゾ−5
−イル)−ピリジン−3−イル)−アリル)−ピロリジ
ン−2,5−ジオンの合成 1)1−(3−(6−(3,4−メチレンジオキシフェ
ニルオキシ)−4−(4−メトキシフェニル)−2−メ
チル−5−シアノピリジン−3−イル)−アリル)−ピ
ロリジン−2,5−ジオンの合成 5−(3−クロロ−1−プロペニル)−3−シアノ−6
−メチル−4−(4−メトキシフェニル)−2−(3,
4−メチレンジオキシフェノキシ)ピリジン530mg
(1.2mmol)をTHF10mlに溶解し、コハク
酸イミド240mg(2.42mmol)、60%水素
化ナトリウム100mg(2.5mmol)、臭化テト
ラブチルアンモニウム80mg(0.25mmol)を
加え、室温で1晩攪拌する。水を加え酢酸エチルで抽出
する。飽和食塩水で洗浄し、無水硫酸マグネシウムで乾
燥後、減圧下溶媒を留去する。残渣をシリカゲルカラム
クロマトグラフィー(酢酸エチル:ヘキサン 1:2か
ら酢酸エチルのみ)にふし、表題化合物を得た。 収量 380mg(0.76mmol) 収率 63.
7% MS (ESI, m/z) 498 (MH+) 1H-NMR (CDCl3): 2.42 (3H, s), 2.61 (4H, s), 3.87
(3H, s), 4.05 (2H, d), 5.30 (1H, dt), 6.01 (2H,
s), 6.27 (1H, d), 6.65 (1H, dd), 6.74 (1H, d), 6.8
1 (1H, d), 6.95 (2H, d), 7.18 (2H, d)Example 80 1- (3- (6- (3,4-
Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5
Synthesis of -yl) -pyridin-3-yl) -allyl) -pyrrolidine-2,5-dione 1) 1- (3- (6- (3,4-methylenedioxyphenyloxy) -4- (4- Synthesis of methoxyphenyl) -2-methyl-5-cyanopyridin-3-yl) -allyl) -pyrrolidine-2,5-dione 5- (3-chloro-1-propenyl) -3-cyano-6
-Methyl-4- (4-methoxyphenyl) -2- (3,
530 mg of 4-methylenedioxyphenoxy) pyridine
(1.2 mmol) was dissolved in 10 ml of THF, 240 mg (2.42 mmol) of succinimide, 100 mg (2.5 mmol) of 60% sodium hydride, and 80 mg (0.25 mmol) of tetrabutylammonium bromide were added. Stir overnight. Add water and extract with ethyl acetate. After washing with saturated saline and drying over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (ethyl acetate: hexane 1: 2 to ethyl acetate only) to obtain the title compound. Yield 380 mg (0.76 mmol) Yield 63.
7% MS (ESI, m / z) 498 (MH +) 1H-NMR (CDCl3): 2.42 (3H, s), 2.61 (4H, s), 3.87
(3H, s), 4.05 (2H, d), 5.30 (1H, dt), 6.01 (2H,
s), 6.27 (1H, d), 6.65 (1H, dd), 6.74 (1H, d), 6.8
1 (1H, d), 6.95 (2H, d), 7.18 (2H, d)
【0325】2)1−(3−(6−(3,4−メチレン
ジオキシフェニルオキシ)−4−(4−メトキシフェニ
ル)−2−メチル−5−(1H−テトラゾ−5−イル)
−ピリジン−3−イル)−アリル)−ピロリジン−2,
5−ジオンの合成 ピリジンカルボン酸 (3−(6−(3,4−メチレン
ジオキシフェニルオキシ)−4−(4−メトキシフェニ
ル)−2−メチル−5−シアノピリジン−3−イル)−
アリル)−アミドの合成に準じて行った。 収率 17.0% MS (ESI, m/z) 541 (MH+) 1H-NMR (DMSO-d6): 2.39 (3H, s), 2.54 (4H, s), 3.73
(3H, s), 3.90 (2H,d), 5.32 (1H, dt), 6.05 (2H,
s), 6.19 (1H, d), 6.53 (1H, dd), 6.76 (1H,), 6.76-
6.92 (5H, m)2) 1- (3- (6- (3,4-Methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-yl)
-Pyridin-3-yl) -allyl) -pyrrolidine-2,
Synthesis of 5-dione pyridinecarboxylic acid (3- (6- (3,4-methylenedioxyphenyloxy) -4- (4-methoxyphenyl) -2-methyl-5-cyanopyridin-3-yl)-
Allyl) -amide was synthesized. Yield 17.0% MS (ESI, m / z) 541 (MH +) 1H-NMR (DMSO-d6): 2.39 (3H, s), 2.54 (4H, s), 3.73
(3H, s), 3.90 (2H, d), 5.32 (1H, dt), 6.05 (2H,
s), 6.19 (1H, d), 6.53 (1H, dd), 6.76 (1H,), 6.76-
6.92 (5H, m)
【0326】実施例81 1−(3−(6−(3,4−
メチレンジオキシフェニルオキシ)−4−(4メトキシ
フェニル)−2−メチル−5−(1H−テトラゾ−5−
イル)−ピリジン−3−イル)−3−ピリジン−2−イ
ル−ウレアの合成 1−(3−(6−(3,4−メチレンジオキシフェニル
オキシ)−4−(4メトキシフェニル)−2−メチル−
5−(1H−テトラゾ−5−イル)−ピリジン−3−イ
ル−アリルアミン50mg(0.11mmol)、ピリ
ジン−2−イルカルバミン酸 フェニルエステル30m
g(0.14mmol)をジオキサン中100℃で加熱
環流する。放冷後溶媒を減圧下留去し、残渣を逆相HP
LC(0.1%TFA水:アセトニトリル 95:5か
ら20:80)にふし表題化合物を得た。 収量 20mg(0.03mmol) 収率 31.4
% MS (ESI, m/z) 579 (MH+) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.61 (3H, s), 3.78
(2H, t), 5.61 (1H,dt), 6.04 (2H, s), 6.20 (1H,
d), 6.52 (1H, dd), 6.72 (3H, m), 6.80 (3H,m), 7.26
(1H, d), 7.70 (1H, brt), 8.10 (1H, d), 8.22 (1H,
d), 9.33 (1H,br)Example 81 1- (3- (6- (3,4-
Methylenedioxyphenyloxy) -4- (4methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-
Synthesis of yl) -pyridin-3-yl) -3-pyridin-2-yl-urea 1- (3- (6- (3,4-methylenedioxyphenyloxy) -4- (4methoxyphenyl) -2 -Methyl-
5- (1H-tetrazo-5-yl) -pyridin-3-yl-allylamine 50 mg (0.11 mmol), pyridine-2-ylcarbamic acid phenyl ester 30 m
g (0.14 mmol) are refluxed with heating at 100 ° C. in dioxane. After cooling, the solvent was distilled off under reduced pressure.
LC (0.1% TFA water: acetonitrile 95: 5 to 20:80) gave the title compound. Yield 20 mg (0.03 mmol) Yield 31.4
% MS (ESI, m / z) 579 (MH +) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.61 (3H, s), 3.78
(2H, t), 5.61 (1H, dt), 6.04 (2H, s), 6.20 (1H,
d), 6.52 (1H, dd), 6.72 (3H, m), 6.80 (3H, m), 7.26
(1H, d), 7.70 (1H, brt), 8.10 (1H, d), 8.22 (1H,
d), 9.33 (1H, br)
【0327】実施例82 1−(3−(6−(3,4−
メチレンジオキシフェニルオキシ)−4−(4メトキシ
フェニル)−2−メチル−5−(1H−テトラゾ−5−
イル)−ピリジン−3−イル)−3−チアゾール−2−
イル−ウレアの合成 1−(3−(6−(3,4−メチレンジオキシフェニル
オキシ)−4−(4メトキシフェニル)−2−メチル−
5−(1H−テトラゾ−5−イル)−ピリジン−3−イ
ル)−3−ピリジン−2−イル−ウレアの合成に準じて
行った。 収率 62.2% MS (ESI, m/z) 521 (MH+) 1H-NMR (DMSO-d6): 2.43 (3H, s), 3.63 (3H, s), 3.72
(2H, m), 5.58 (1H,dt), 6.05 (2H, s), 6.18 (1H,
d), 6.54 (1H, dd), 6.62 (1H, br), 6.73-6.80(2H,
m), 6.86-6.94 (4H, m), 7.02 (1H, d), 7.25 (1H, d),
7.30 (1H, d)Example 82 1- (3- (6- (3,4-
Methylenedioxyphenyloxy) -4- (4methoxyphenyl) -2-methyl-5- (1H-tetrazo-5-
Yl) -pyridin-3-yl) -3-thiazol-2-
Synthesis of il-urea 1- (3- (6- (3,4-methylenedioxyphenyloxy) -4- (4methoxyphenyl) -2-methyl-
It carried out according to synthesis of 5- (1H-tetrazo-5-yl) -pyridin-3-yl) -3-pyridin-2-yl-urea. Yield 62.2% MS (ESI, m / z) 521 (MH +) 1H-NMR (DMSO-d6): 2.43 (3H, s), 3.63 (3H, s), 3.72
(2H, m), 5.58 (1H, dt), 6.05 (2H, s), 6.18 (1H,
d), 6.54 (1H, dd), 6.62 (1H, br), 6.73-6.80 (2H,
m), 6.86-6.94 (4H, m), 7.02 (1H, d), 7.25 (1H, d),
7.30 (1H, d)
【0328】実施例83 5−(3−ヒドロキシ−1−
プロペニル)−4−(3,5−ジメトキシフェニル)−
6−メチル−2−(3,4−メチレンジオキシフェノキ
シ)−3−(1H−テトラゾール−5−イル)ピリジン
の合成 アジ化ナトリウム420mg(6.5mmol)と塩化
トリブチルスズ0.9ml(3.25mmol)より調
製したトリブチルチンアジドと3−シアノ−5−(3−
ヒドロキシ−1−プロペニル)−4−(3,5−ジメト
キシフェニル)−6−メチル−2−(3,4−メチレン
ジオキシフェノキシ)ピリジン290mg(0.65m
mol)をトルエン5ml、3日間加熱還流した。冷却
後4N塩酸−ジオキサンを加え濾過、結晶をトルエン、
で洗浄、シリカゲルクロマトグラフィー(クロロホルム
−メタノール=9:1)で精製した。さらにHPLC精
製を行い表題化合物を得た。 収量 55mg(0.37mmol) 収率 17.3
% MS (ESI, m/z) 490 (MH+) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.65 (6H, s), 3.92
(2H, brd), 5.71 (1H, dt), 6.05 (2H, s), 6.16 (2H,
d), 6.25 (1H, d), 6.36 (1H, t), 6.53 (1H,dd), 6.7
5 (1H, d), 6.89 (1H, d)Example 83 5- (3-hydroxy-1-)
Propenyl) -4- (3,5-dimethoxyphenyl)-
Synthesis of 6-methyl-2- (3,4-methylenedioxyphenoxy) -3- (1H-tetrazol-5-yl) pyridine 420 mg (6.5 mmol) of sodium azide and 0.9 ml (3.25 mmol) of tributyltin chloride )) And 3-cyano-5- (3-
290 mg (0.65 m) of hydroxy-1-propenyl) -4- (3,5-dimethoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) pyridine
mol) was heated under reflux for 3 days. After cooling, 4N hydrochloric acid-dioxane was added and the mixture was filtered.
And purified by silica gel chromatography (chloroform-methanol = 9: 1). Further purification by HPLC yielded the title compound. Yield 55 mg (0.37 mmol) Yield 17.3
% MS (ESI, m / z) 490 (MH +) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.65 (6H, s), 3.92
(2H, brd), 5.71 (1H, dt), 6.05 (2H, s), 6.16 (2H,
d), 6.25 (1H, d), 6.36 (1H, t), 6.53 (1H, dd), 6.7
5 (1H, d), 6.89 (1H, d)
【0329】実施例84 4−(4−メトキシフェニ
ル)−6−メチル−2−(3,4−メチレンジオキシフ
ェノキシ)−5−(3−(6−ブロモピリジン−2−イ
ルオキシ)−1−プロペニル)−3−(1H−テトラゾ
ール−5−イル)ピリジンの合成 DMF5ml中実施例43の化合物226mg(0.4
9mmol)に60%水素化ナトリウム90mg(2.
25mmol)、2,6−ジブロモピリジン241mg
(1.02mmol)を100℃で3時間加熱した。減
圧下でDMFを留去後2N塩酸を加え、酢酸エチルで抽
出し有機層を無水硫酸ナトリウムで乾燥、減圧下濃縮し
た。残渣をシリカゲルクロマトグラフィー(クロロホル
ム−メタノール=50:1)で精製し表題化合物を得
た。 収量 234mg(0.38mmol) 収率 77.
6% MS (ESI, m/z) 617 (MH+) 1H-NMR(CDCl3): 2.49 (3H, s), 3.77 (3H, s), 4.75 (2
H, d), 5.66-5.76 (1H, d), 5.98 (2H, s), 6.36 (1H,
d), 6.52-6.80 (5H, m), 6.92 (2H, d), 7.04(1H, d),
7.39 (1H, t)Example 84 4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxyphenoxy) -5- (3- (6-bromopyridin-2-yloxy) -1- Synthesis of propenyl) -3- (1H-tetrazol-5-yl) pyridine 226 mg (0.4 mg) of the compound of Example 43 in 5 ml of DMF
9 mmol) and 90 mg of 60% sodium hydride (2.
25 mmol), 241 mg of 2,6-dibromopyridine
(1.02 mmol) was heated at 100 ° C. for 3 hours. After distilling off DMF under reduced pressure, 2N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (chloroform-methanol = 50: 1) to obtain the title compound. Yield 234 mg (0.38 mmol) Yield 77.
6% MS (ESI, m / z) 617 (MH +) 1H-NMR (CDCl3): 2.49 (3H, s), 3.77 (3H, s), 4.75 (2
H, d), 5.66-5.76 (1H, d), 5.98 (2H, s), 6.36 (1H,
d), 6.52-6.80 (5H, m), 6.92 (2H, d), 7.04 (1H, d),
7.39 (1H, t)
【0330】実施例85 5−ニトロ−ピリジン−2−
イル 3−〔4−(4−メトキシフェニル)−2−メチ
ル−6−(3,4−メチレンジオキシ−フェノキシ)−
5−(1H−テトラゾール−5−イル)−ピリジン−3
−イル〕−2−プロペニルエーテルの合成 3−〔4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル〕−プロプ−2−エン−1−オール200mg(0.
435mmol)、60%水素化ナトリウム35mg
(0.870mmol)より作成したアルコキシドイオ
ンのDMF5ml溶液に2−ブロモ−5−ニトロピリジ
ン177mg(0.870mmol)を0℃で加え、ア
ルゴン雰囲気下80℃にて24時間攪拌した。反応終了
後酢酸エチルで抽出し、無水硫酸マグネシウムで乾燥し
た。減圧下溶媒を留去した残渣をシリカゲルカラムクロ
マトグラフィー(クロロホルム−メタノール=9:1)
で精製し表題化合物を得た。 収量 35mg(0.0602mmol) 収率 14
% MS (ESI, m/z) 582 (MH+) 1H-NMR(CDCl3): 2.49 (2H, s), 3.73 (3H, s), 4.90 (2
H, d), 5.73 (1H, dt), 5.98 (2H, s), 6.48 (1H, d),
6.52 (1H, d), 6.63-6.75 (5H, m), 6.89 (2H,d), 8.33
(1H, dd), 8.96 (1H, d)Example 85 5-Nitro-pyridine-2-
Yl 3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy)-
5- (1H-tetrazol-5-yl) -pyridine-3
Synthesis of -yl] -2-propenyl ether 3- [4- (4-methoxyphenyl) -2-methyl-6
-(3,4-methylenedioxy-phenoxy) -5-
(1H-tetrazol-5-yl) -pyridin-3-yl] -prop-2-en-1-ol 200 mg (0.
435 mmol), 35 mg of 60% sodium hydride
177 mg (0.870 mmol) of 2-bromo-5-nitropyridine was added at 0 ° C to a 5 ml solution of the alkoxide ion in DMF prepared from (0.870 mmol), and the mixture was stirred at 80 ° C under an argon atmosphere for 24 hours. After completion of the reaction, the mixture was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The residue obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography (chloroform-methanol = 9: 1).
And the title compound was obtained. Yield 35 mg (0.0602 mmol) Yield 14
% MS (ESI, m / z) 582 (MH +) 1H-NMR (CDCl3): 2.49 (2H, s), 3.73 (3H, s), 4.90 (2
H, d), 5.73 (1H, dt), 5.98 (2H, s), 6.48 (1H, d),
6.52 (1H, d), 6.63-6.75 (5H, m), 6.89 (2H, d), 8.33
(1H, dd), 8.96 (1H, d)
【0331】実施例86 2,4−ジフルオロフェニル
−カルバミン酸 3−〔4−(4−メトキシフェニル)
−2−メチル−6−(3,4−メチレンジオキシ−フェ
ノキシ)−5−(1H−テトラゾール−5−イル)−ピ
リジン−5−イル〕−2−プロピレンエステルの合成 2,4−ジフルオロ安息香酸228mg(1.44mm
ol)をトルエン5mlに溶かし、アジ化ジフェニルホ
スホリル195mg(1.58mmol),トリエチル
アミン160mg(1.58mmol)を加え、80℃
にて2時間攪拌した。その後3−〔4−(4−メトキシ
フェニル)−2−メチル−6−(3,4−メチレンジオ
キシ−フェノキシ)−5−(1H−テトラゾール−5−
イル)−ピリジン−3−イル〕−プロプ−2−エン−1
−オール200mg(0.480mmol)を80℃に
て加え、さらに12時間攪拌した。反応終了後、反応溶
液に3規定塩酸を2ml加え、30分間攪拌した。反応
溶液に水を加え、酢酸エチルにて抽出し有機層を無水硫
酸マグネシウムで乾燥、減圧下濃縮した。残渣をカラム
クロマトグラフィー(クロロホルム−メタノール=9:
1)にて精製し、表題化合物を得た。 収量 250mg(0.407mmol) 収率 48
% MS (ESI, m/z) 615 (MH+) 1H-NMR(CDCl3): 2.43 (3H, s), 3.62 (3H, s), 4.55 (2
H, d), 5.54 (1H, dt), 5.89 (2H, s), 6.26-6.51 (3H,
m), 6.60-6.65 (3H, m),6.79-6.86 (3H, m),7.88 (1H,
br s)Example 86 2,4-Difluorophenyl-carbamic acid 3- [4- (4-methoxyphenyl)
Synthesis of 2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-5-yl] -2-propylene ester 2,4-difluorobenzoate 228 mg of acid (1.44 mm
ol) was dissolved in 5 ml of toluene, and 195 mg (1.58 mmol) of diphenylphosphoryl azide and 160 mg (1.58 mmol) of triethylamine were added.
For 2 hours. Thereafter, 3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazole-5-
Yl) -pyridin-3-yl] -prop-2-ene-1
200 mg (0.480 mmol) of -ol was added at 80 ° C., and the mixture was further stirred for 12 hours. After completion of the reaction, 2 ml of 3N hydrochloric acid was added to the reaction solution, and the mixture was stirred for 30 minutes. Water was added to the reaction solution, extracted with ethyl acetate, and the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was subjected to column chromatography (chloroform-methanol = 9:
Purification in 1) gave the title compound. Yield 250 mg (0.407 mmol) Yield 48
% MS (ESI, m / z) 615 (MH +) 1H-NMR (CDCl3): 2.43 (3H, s), 3.62 (3H, s), 4.55 (2
H, d), 5.54 (1H, dt), 5.89 (2H, s), 6.26-6.51 (3H,
m), 6.60-6.65 (3H, m), 6.79-6.86 (3H, m), 7.88 (1H,
br s)
【0332】実施例87 3−〔4−(4−メトキシフ
ェニル)−2−メチル−6−(3,4−メチレンジオキ
シ−フェノキシ)−5−(1H−テトラゾール−5−イ
ル)−ピリジン−3−イル〕−プロパノールの合成 3−〔4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル〕−プロプ−2−エン−1−オール100mg(0.
218mmol)を酢酸エチル10mlに溶解し、10
%パラジウム炭素を触媒量加え、水素常圧下、室温で一
晩攪拌した。セライトを用いて触媒を除き減圧下溶媒を
留去した。残渣をカラムクロマトグラフィー(クロロホ
ルム100%)にて精製し、表題化合物を得た。 収量 90mg(0.195mmol) 収率 89% MS (ESI, m/z) 462 (MH+) 1H-NMR(CD3OD): 1.50-1.62 (2H, m), 2.48-2.58 (5H,
m), 3.37 (2H, t), 3.76 (3H, s), 5.95 (2H, s), 6.45
-6.61 (2H, m), 6.75 (1H, d), 6.85 (2H, d),7.02 (2
H, d)Example 87 3- [4- (4-Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridine- Synthesis of 3-yl] -propanol 3- [4- (4-methoxyphenyl) -2-methyl-6
-(3,4-methylenedioxy-phenoxy) -5-
(1H-tetrazol-5-yl) -pyridin-3-yl] -prop-2-en-1-ol 100 mg (0.
218 mmol) was dissolved in 10 ml of ethyl acetate, and 10
% Palladium carbon was added in a catalytic amount, and the mixture was stirred overnight at room temperature under normal pressure of hydrogen. The catalyst was removed using celite, and the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (chloroform 100%) to obtain the title compound. Yield 90 mg (0.195 mmol) Yield 89% MS (ESI, m / z) 462 (MH +) 1H-NMR (CD3OD): 1.50-1.62 (2H, m), 2.48-2.58 (5H,
m), 3.37 (2H, t), 3.76 (3H, s), 5.95 (2H, s), 6.45
-6.61 (2H, m), 6.75 (1H, d), 6.85 (2H, d), 7.02 (2
H, d)
【0333】実施例88 4−(4−メトキシフェニ
ル)−6−メチル−2−(3,4−メチレンジオキシ−フ
ェノキシ)−5−プロピル−3−(1H−テトラゾール
−5−イル)−ピリジンの合成 3−〔4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル〕−プロプ−2−エン−1−オール160mg(0.
348mmol)をメタノール−クロロホルム溶液
(5:1)10mlに溶解し、塩化パラジウムを触媒量
加え、水素常圧下、室温で一晩攪拌した。セライトを用
いて触媒を除き減圧下溶媒を留去した。残渣をカラムク
ロマトグラフィー(クロロホルム100%)にて精製
し、表題化合物を得た。 収量 120mg(0.269mmol) 収率 77
% MS (ESI, m/z) 446 (MH+) 1H−NMR(DMSO−d6): 0.72 (3
H, t), 1.24−1.35 (2H, m),
2.33−2.39 (2H, m), 2.43
(3H, s), 3.73 (3H, s), 6.
04 (2H, s), 6.49−6.53 (1
H, m), 6.72−6.73 (1H, m),
6.84−6.90 (3H, m), 6.99
(2H, d)Example 88 4- (4-Methoxyphenyl) -6-methyl-2- (3,4-methylenedioxy-phenoxy) -5-propyl-3- (1H-tetrazol-5-yl) -pyridine 3- [4- (4-methoxyphenyl) -2-methyl-6
-(3,4-methylenedioxy-phenoxy) -5-
160 mg of (1H-tetrazol-5-yl) -pyridin-3-yl] -prop-2-en-1-ol (0.
348 mmol) was dissolved in 10 ml of a methanol-chloroform solution (5: 1), a catalytic amount of palladium chloride was added, and the mixture was stirred overnight at room temperature under hydrogen normal pressure. The catalyst was removed using celite, and the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (chloroform 100%) to obtain the title compound. Yield 120 mg (0.269 mmol) Yield 77
% MS (ESI, m / z) 446 (MH +) 1H-NMR (DMSO-d6): 0.72 (3
H, t), 1.24-1.35 (2H, m),
2.33-2.39 (2H, m), 2.43
(3H, s), 3.73 (3H, s), 6.
04 (2H, s), 6.49-6.53 (1
H, m), 6.72-6.73 (1H, m),
6.84-6.90 (3H, m), 6.99
(2H, d)
【0334】実施例89 3−[2−フラン−2−イル
−4−(4−メトキシフェニル)−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−プロプ−2−
エン−1−オールの合成 1)3−シアノ−6−フラン−2−イル−5−ヨード−
4−(4−メトキシフェニル)−2−ピリドンの合成 3−シアノ−6−フラン−2−イル−4−(4−メトキ
シフェニル)−2−ピリドン2.00g(6.84mm
ol)をアセトニトリル50mlに溶解し、N−ヨウ化
コハク酸イミド3.08g(13.7mmol)を加
え、一晩加熱環流した。放冷後沈殿をろ取し、酢酸エチ
ルで洗浄し表題化合物を得た。 収量 1.57g(3.75mmol) 収率 55% MS (ESI, m/z) 419 (MH+) 1H-NMR(DMSO-d6): 0.72 (3H, t), 1.24-1.35 (2H, m),
2.33-2.39 (2H, m), 2.43 (3H, s), 3.73 (3H, s), 6.0
4 (2H, s), 6.49-7.01 (7H, m)Example 89 3- [2-furan-2-yl-4- (4-methoxyphenyl) -6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl ) -Pyridin-3-yl] -prop-2-
Synthesis of en-1-ol 1) 3-cyano-6-furan-2-yl-5-iodo-
Synthesis of 4- (4-methoxyphenyl) -2-pyridone 3-cyano-6-furan-2-yl-4- (4-methoxyphenyl) -2-pyridone 2.00 g (6.84 mm
ol) was dissolved in 50 ml of acetonitrile, 3.08 g (13.7 mmol) of N-iodosuccinimide was added, and the mixture was refluxed overnight. After cooling, the precipitate was collected by filtration and washed with ethyl acetate to give the title compound. Yield 1.57 g (3.75 mmol) Yield 55% MS (ESI, m / z) 419 (MH +) 1H-NMR (DMSO-d6): 0.72 (3H, t), 1.24-1.35 (2H, m),
2.33-2.39 (2H, m), 2.43 (3H, s), 3.73 (3H, s), 6.0
4 (2H, s), 6.49-7.01 (7H, m)
【0335】2)2−クロロ−3−シアノ−6−フラン
−2−イル−5−ヨード−4−(4−メトキシフェニ
ル)−ピリジンの合成 3−シアノ−6−フラン−2−イル−5−ヨード−4−
(4−メトキシフェニル)−2−ピリドン1.57g
(3.75mmol)をオキシ塩化リン30mlに溶解
し100℃で一晩攪拌した。オキシ塩化リンを減圧下留
去し得られる結晶を酢酸エチルで洗浄し、表題化合物を
得た。このものはこれ以上精製せずに以下の反応に利用
した。 収量 800g(1.88mmol) 収率 50% MS (ESI, m/z) 437 (MH+) 1H-NMR(CDCl3): 3.89 (3H, s), 6.62-6.63 (1H, m), 7.
04-7.31 (5H, m), 7.67-7.70 (1H, m)2) Synthesis of 2-chloro-3-cyano-6-furan-2-yl-5-iodo-4- (4-methoxyphenyl) -pyridine 3-cyano-6-furan-2-yl-5 -Iodine-4-
1.57 g of (4-methoxyphenyl) -2-pyridone
(3.75 mmol) was dissolved in 30 ml of phosphorus oxychloride and stirred at 100 ° C. overnight. The crystals obtained by evaporating phosphorus oxychloride under reduced pressure were washed with ethyl acetate to obtain the title compound. This was used for the following reaction without further purification. Yield 800 g (1.88 mmol) Yield 50% MS (ESI, m / z) 437 (MH +) 1H-NMR (CDCl3): 3.89 (3H, s), 6.62-6.63 (1H, m), 7.
04-7.31 (5H, m), 7.67-7.70 (1H, m)
【0336】3)3−シアノ−6−フラン−2−イル−
5−ヨード−4−(4−メトキシフェニル)−2−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
の合成 セサモール1.09g(7.88mmol)、60%水
素化ナトリウム420mg(10.5mmol)より作
成したフェノキシドイオンのDMF10ml溶液に2−
クロロ−3−シアノ−6−フラン−2−イル−5−ヨー
ド−4−(4−メトキシフェニル)−ピリジン2.23
g(5.25mmol)を0℃で加え、アルゴン雰囲気
下室温に戻して30分間攪拌した。減圧下溶媒を留去
し、得られた結晶をシリカゲルカラムクロマトグラフィ
ー(ヘキサン−酢酸エチル=3:1)で精製し表題化合
物を得た。 収量 2.14g(3.98mmol) 収率 60% 1H-NMR(CDCl3): 3.89 (3H, t), 6.03 (2H, s), 6.52 (1
H, dd), 6.70-6.85 (3H, m), 7.59 (1H, q)3) 3-cyano-6-furan-2-yl-
5-Iodo-4- (4-methoxyphenyl) -2-
Synthesis of (3,4-methylenedioxy-phenoxy) -pyridine
Chloro-3-cyano-6-furan-2-yl-5-iodo-4- (4-methoxyphenyl) -pyridine 2.23
g (5.25 mmol) was added at 0 ° C., and the mixture was returned to room temperature under an argon atmosphere and stirred for 30 minutes. The solvent was distilled off under reduced pressure, and the obtained crystals were purified by silica gel column chromatography (hexane-ethyl acetate = 3: 1) to obtain the title compound. Yield 2.14 g (3.98 mmol) Yield 60% 1H-NMR (CDCl3): 3.89 (3H, t), 6.03 (2H, s), 6.52 (1
H, dd), 6.70-6.85 (3H, m), 7.59 (1H, q)
【0337】4)3−[5−シアノ−2−フラン−2−
イル−4−(4−メトキシフェニル)−6−(3,4−
メチレンジオキシ−フェノキシ)−ピリジン−3−イ
ル]−アクリル酸 エチルエステルの合成 3−シアノ−6−フラン−2−イル−5−ヨード−4−
(4−メトキシフェニル)−2−(3,4−メチレンジ
オキシ−フェノキシ)−ピリジン2.14g(3.98
mmol)、アクリル酸エチル598mg(5.98m
mol)、トリエチルアミン403mg(3.98mm
ol)、酢酸パラジウム89mg(0.398mmo
l)をDMF20mlに溶解し150℃で5時間加熱環
流した。不溶解物を濾過した後減圧下溶媒を留去し、酢
酸エチルで抽出した。有機層を3規定塩酸、飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧下溶媒を
留去した。得られた結晶をシリカゲルカラムクロマトグ
ラフィー(ヘキサン−酢酸エチル=3:1)で精製し表
題化合物を得た。 収量 500mg(0.979mmol) 収率 25
% MS (ESI, m/z) 511 (MH+) 1H−NMR(CDCl3): 1.24 (3H,
t), 3.87 (3H, s), 4.15 (2
H, q), 5.45 (3H, m),6.03
(2H, s), 6.47−6.49 (1H,
m), 6.71−6.92 (4H, m), 6.
97 (2H, d), 7.25(1H, d),
7.55 (1H, s), 7.88 (1H,
d)4) 3- [5-Cyano-2-furan-2-
Yl-4- (4-methoxyphenyl) -6- (3,4-
Synthesis of methylenedioxy-phenoxy) -pyridin-3-yl] -acrylic acid ethyl ester 3-cyano-6-furan-2-yl-5-iodo-4-
2.14 g of (4-methoxyphenyl) -2- (3,4-methylenedioxy-phenoxy) -pyridine (3.98
mmol), 598 mg of ethyl acrylate (5.98 m
mol), 403 mg of triethylamine (3.98 mm
ol), 89 mg of palladium acetate (0.398 mmol)
1) was dissolved in DMF (20 ml) and heated under reflux at 150 ° C. for 5 hours. After filtering the insoluble matter, the solvent was distilled off under reduced pressure, and the mixture was extracted with ethyl acetate. The organic layer was washed with 3N hydrochloric acid and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crystals were purified by silica gel column chromatography (hexane-ethyl acetate = 3: 1) to give the title compound. Yield 500 mg (0.979 mmol) Yield 25
% MS (ESI, m / z) 511 (MH +) 1H-NMR (CDCl3): 1.24 (3H,
t), 3.87 (3H, s), 4.15 (2
H, q), 5.45 (3H, m), 6.03
(2H, s), 6.47-6.49 (1H,
m), 6.71-6.92 (4H, m), 6.
97 (2H, d), 7.25 (1H, d),
7.55 (1H, s), 7.88 (1H,
d)
【0338】5)3−[5−シアノ−2−フラン−2−
イル−4−(4−メトキシフェニル)−6−(3,4−
メチレンジオキシ−フェノキシ)−ピリジン−3−イ
ル]−プロプ−2−エン−1−オールの合成 3−[5−シアノ−2−フラン−2−イル−4−(4−
メトキシフェニル)−6−(3,4−メチレンジオキシ
−フェノキシ)−ピリジン−3−イル]−アクリル酸
エチルエステル500mg(0.979mmol)を塩
化メチレン20mlに溶解しアルゴン雰囲気下−60度
で水素化ジイソブチルアルミニウム1Mヘキサン溶液
1.96ml(1.96mmol)を滴下した。−60
度で4時間攪拌し、メタノールと水で反応を停止した。
室温で2時間攪拌し、セライトを用いて濾過した。溶媒
を減圧下留去して得られた残渣をシリカゲルカラムクロ
マトグラフィー(ヘキサン−酢酸エチル=3:1)で精
製し表題化合物を得た。 収量 120mg(0.256mmol) 収率 26
% MS (ESI, m/z) 469 (MH+) 1H-NMR(CDCl3): 3.86 (3H, s), 4.04 (2H, br d), 5.37
(1H, dt), 6.03 (2H,s), 6.45-6.47 (1H, m), 6.69-7.
00 (7H, m), 7.25 (2H, d), 7.52 (1H, s),5) 3- [5-cyano-2-furan-2-
Yl-4- (4-methoxyphenyl) -6- (3,4-
Synthesis of methylenedioxy-phenoxy) -pyridin-3-yl] -prop-2-en-1-ol 3- [5-cyano-2-furan-2-yl-4- (4-
Methoxyphenyl) -6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -acrylic acid
500 mg (0.979 mmol) of ethyl ester was dissolved in 20 ml of methylene chloride, and 1.96 ml (1.96 mmol) of a 1M solution of diisobutylaluminum hydride in hexane was added dropwise at −60 ° C. in an argon atmosphere. -60
And the reaction was stopped with methanol and water.
The mixture was stirred at room temperature for 2 hours and filtered using Celite. The residue obtained by evaporating the solvent under reduced pressure was purified by silica gel column chromatography (hexane-ethyl acetate = 3: 1) to obtain the title compound. Yield 120 mg (0.256 mmol) Yield 26
% MS (ESI, m / z) 469 (MH +) 1H-NMR (CDCl3): 3.86 (3H, s), 4.04 (2H, br d), 5.37
(1H, dt), 6.03 (2H, s), 6.45-6.47 (1H, m), 6.69-7.
00 (7H, m), 7.25 (2H, d), 7.52 (1H, s),
【0339】6)3−[2−フラン−2−イル−4−
(4−メトキシフェニル)−6−(3,4−メチレンジ
オキシ−フェノキシ)−5−(1H−テトラゾール−5
−イル)−ピリジン−3−イル]−プロプ−2−エン−
1−オールの合成 3−[5−シアノ−2−フラン−2−イル−4−(4−
メトキシフェニル)−6−(3,4−メチレンジオキシ
−フェノキシ)−ピリジン−3−イル]−プロプ−2−
エン−1−オール150mg(0.320mmol)を
トルエン10mlに溶解しアジ化ナトリウム125mg
(1.92mmol)、塩化トリ−n−ブチルスズ41
7mg(1.28mmol)から作成したアジ化トリ−
n−ブチルスズを加え一晩加熱環流した。1規定塩酸を
加え、酢酸エチルで抽出し、無水硫酸マグネシウムで乾
燥した。減圧下溶媒を留去し、得られる結晶をシリカゲ
ルカラムクロマトグラフィー(クロロホルム−メタノー
ル=100:1から30:1)で精製し表題化合物を得
た。 収量 35mg(0.0684mmol) 収率 21
% MS (ESI, m/z) 512 (MH+) 1H-NMR(CDCl3): 3.72 (3H, s), 3.80 (2H, br), 5.28
(1H, dt), 6.06 (2H, s), 6.45-6.63 (3H, m), 6.80-6.
99 (7H, m), 7.82-7.83 (1H, m)6) 3- [2-furan-2-yl-4-
(4-methoxyphenyl) -6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazole-5
-Yl) -pyridin-3-yl] -prop-2-ene-
Synthesis of 1-ol 3- [5-cyano-2-furan-2-yl-4- (4-
Methoxyphenyl) -6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -prop-2-
Dissolve 150 mg (0.320 mmol) of ene-1-ol in 10 ml of toluene and 125 mg of sodium azide
(1.92 mmol), tri-n-butyltin chloride 41
Triazide prepared from 7 mg (1.28 mmol)
n-Butyltin was added and heated under reflux overnight. 1N Hydrochloric acid was added, extracted with ethyl acetate, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained crystals were purified by silica gel column chromatography (chloroform-methanol = 100: 1 to 30: 1) to obtain the title compound. Yield 35 mg (0.0684 mmol) Yield 21
% MS (ESI, m / z) 512 (MH +) 1H-NMR (CDCl3): 3.72 (3H, s), 3.80 (2H, br), 5.28
(1H, dt), 6.06 (2H, s), 6.45-6.63 (3H, m), 6.80-6.
99 (7H, m), 7.82-7.83 (1H, m)
【0340】実施例90 5−[3−(5−ブロモピリ
ジン−2−イロキシ)−プロピル]−4−(4−メトキ
シフェニル)−6−メチル−2−(3,4−メチレンジ
オキシ−フェノキシ)−3−(1H−テトラゾール−5
−イル)−ピリジンの合成 3−〔4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル〕−プロパノール120mg(0.260mmo
l)、60%水素化ナトリウム31mg(0.780m
mol)より作成したアルコキシドイオンのDMF5m
l溶液に2、5−ジブロモピリジン185mg(0.7
80mmol)を0℃で加え、アルゴン雰囲気下100
℃にて24時間攪拌した。反応終了後3規定塩酸にて反
応を停止し、酢酸エチルで抽出した。有機層を無水硫酸
マグネシウムで乾燥後、減圧下濃縮し残渣をシリカゲル
カラムクロマトグラフィー(クロロホルム−メタノール
=100:1)で精製し表題化合物を得た。 収量 80mg(0.130mmol) 収率 50% MS (ESI, m/z) 617 (MH+) 1H-NMR(CD3OD): 1.75-1.85 (2H, m), 2.49 (3H, s), 2.
65-2.70 (2H, m), 3.74 (3H, s), 4.09 (2H, t), 5.95
(2H, s), 6.46-6.61 (3H, m), 6.73-6.77 (3H,m), 6.97
(2H, d), 7.67-8.10 (2H, m)Example 90 5- [3- (5-bromopyridine-2-yloxy) -propyl] -4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxy-phenoxy ) -3- (1H-Tetrazole-5
Synthesis of -yl) -pyridine 3- [4- (4-methoxyphenyl) -2-methyl-6
-(3,4-methylenedioxy-phenoxy) -5-
(1H-tetrazol-5-yl) -pyridin-3-yl] -propanol 120 mg (0.260 mmol
l), 31 mg of 60% sodium hydride (0.780 m
mol) from DMF 5m
185 mg of 2,5-dibromopyridine (0.7 mg)
80 mmol) at 0 ° C. and 100
Stirred at C for 24 hours. After completion of the reaction, the reaction was stopped with 3N hydrochloric acid and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (chloroform-methanol = 100: 1) to obtain the title compound. Yield 80 mg (0.130 mmol) Yield 50% MS (ESI, m / z) 617 (MH +) 1H-NMR (CD3OD): 1.75-1.85 (2H, m), 2.49 (3H, s), 2.
65-2.70 (2H, m), 3.74 (3H, s), 4.09 (2H, t), 5.95
(2H, s), 6.46-6.61 (3H, m), 6.73-6.77 (3H, m), 6.97
(2H, d), 7.67-8.10 (2H, m)
【0341】実施例91 N−(2−ヒドロキシ−エ
チル)−4−(4−メトキシフェニル)−2−メチル−
6−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ニコチン酸アミド
の合成 1)N−(2−ヒドロキシ−エチル)−5−シアノ−4
−(4−メトキシフェニル)−2−メチル−6−(3,
4−メチレンジオキシ−フェノキシ)−ニコチン酸アミ
ドの合成 3−シアノ−5−ヨード−4−(4−メトキシフェニ
ル)−6−メチル−2−(3,4−メチレンジオキシ−
フェノキシ)−ピリジン1.00g(2.06mmo
l)、2−アミノエタノール629mg(10.3mm
ol)、トリエチルアミン1.04g(10.3mmo
l)、酢酸パラジウム46mg(0.206mmol)
をDMF10mlに溶解し、一酸化炭素常圧下100℃
で24時間加熱環流した。放冷後、不溶解物を濾過し、
減圧下溶媒を留去し、酢酸エチルで抽出した。有機層を
3規定塩酸、飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧下溶媒を留去した。得られた結晶をシリ
カゲルカラムクロマトグラフィー(クロロホルム100
%)で精製し表題化合物を得た。 収量 570mg(1.27mmol) 収率 62% MS (ESI, m/z) 448 (MH+) 1H-NMR(CDCl3): 2.42 (3H, s), 3.10-3.38 (4H, m), 3.
83 (3H, s), 5.99 (2H, s), 6.30 (2H, s), 6.30 (1H,
br), 6.58-6.80 (3H, m), 6.98 (2H, d), 7.37(2H, d)Example 91 N- (2-hydroxy-ethyl) -4- (4-methoxyphenyl) -2-methyl-
6- (3,4-methylenedioxy-phenoxy) -5
Synthesis of (1H-tetrazol-5-yl) -nicotinamide 1) N- (2-hydroxy-ethyl) -5-cyano-4
-(4-methoxyphenyl) -2-methyl-6- (3,
Synthesis of 4-methylenedioxy-phenoxy) -nicotinamide 3-cyano-5-iodo-4- (4-methoxyphenyl) -6-methyl-2- (3,4-methylenedioxy-
Phenoxy) -pyridine 1.00 g (2.06 mmol
l), 629 mg of 2-aminoethanol (10.3 mm
ol), 1.04 g of triethylamine (10.3 mmol)
1) palladium acetate 46 mg (0.206 mmol)
Was dissolved in 10 ml of DMF, and carbon
For 24 hours. After standing to cool, insoluble matter was filtered,
The solvent was distilled off under reduced pressure, and extracted with ethyl acetate. The organic layer was washed with 3N hydrochloric acid and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crystals are subjected to silica gel column chromatography (chloroform 100
%) To give the title compound. Yield 570 mg (1.27 mmol) Yield 62% MS (ESI, m / z) 448 (MH +) 1H-NMR (CDCl3): 2.42 (3H, s), 3.10-3.38 (4H, m), 3.
83 (3H, s), 5.99 (2H, s), 6.30 (2H, s), 6.30 (1H,
br), 6.58-6.80 (3H, m), 6.98 (2H, d), 7.37 (2H, d)
【0342】2)N−(2−ヒドロキシ−エチル)−4
−(4−メトキシフェニル)−2−メチル−6−(3,
4−メチレンジオキシ−フェノキシ)−5−(1H−テ
トラゾール−5−イル)−ニコチン酸アミドの合成 N−(2−ヒドロキシ−エチル)−5−シアノ−4−
(4−メトキシフェニル)−2−メチル−6−(3,4
−メチレンジオキシ−フェノキシ)−ニコチン酸アミド
570mg(1.27mmol)をトルエン10mlに
溶解しアジ化ナトリウム495mg(7.62mmo
l)、塩化トリ−n−ブチルスズ1.66mg(5.0
9mmol)から作成したアジ化トリ−n−ブチルスズ
を加え24時間加熱環流した。反応終了後1規定塩酸、
酢酸エチルを加え析出した結晶を濾過し酢酸エチルで洗
浄した。得られた結晶をシリカゲルカラムクロマトグラ
フィー(クロロホルム−メタノール=100:1から1
0:1)で精製し表題化合物を得た。 収量 155mg(0.316mmol) 収率 25
% MS (ESI, m/z) 491 (MH+) 1H-NMR(CD3OD): 2.44 (3H, s), 3.18-3.32 (4H, m), 3.
74 (3H, s), 5.96 (2H, s), 6.50-6.79 (5H, m), 7.08
(2H, d)2) N- (2-hydroxy-ethyl) -4
-(4-methoxyphenyl) -2-methyl-6- (3,
Synthesis of 4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -nicotinamide N- (2-hydroxy-ethyl) -5-cyano-4-
(4-methoxyphenyl) -2-methyl-6- (3,4
-Methylenedioxy-phenoxy) -nicotinamide (570 mg, 1.27 mmol) was dissolved in toluene (10 ml), and sodium azide (495 mg, 7.62 mmol) was dissolved.
l), 1.66 mg of tri-n-butyltin chloride (5.0
9 mmol), and refluxed with heating for 24 hours. After completion of the reaction, 1N hydrochloric acid,
Ethyl acetate was added, and the precipitated crystals were filtered and washed with ethyl acetate. The obtained crystals are subjected to silica gel column chromatography (chloroform-methanol = 100: 1 to 1).
0: 1) to give the title compound. Yield 155 mg (0.316 mmol) Yield 25
% MS (ESI, m / z) 491 (MH +) 1H-NMR (CD3OD): 2.44 (3H, s), 3.18-3.32 (4H, m), 3.
74 (3H, s), 5.96 (2H, s), 6.50-6.79 (5H, m), 7.08
(2H, d)
【0343】実施例92 {3−[4−(4−メトキシ
フェニル)−2−メチル−6−(3,4−メチレンジオ
キシ−フェノキシ)−5−(1H−テトラゾール−5−
イル)−ピリジン−3−イル]−アリル}−アセトアミ
ドの合成 1){3−[5−シアノ−4−(4−メトキシフェニ
ル)−2−メチル−6−(3,4−メチレンジオキシ−
フェノキシ)−ピリジン−3−イル]−アリル}−アセ
トアミドの合成 3−[5−シアノ−4−(4−メトキシフェニル)−2
−メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−ピリジン−3−イル]−アリル}−プロプ−2−
エン−1−アミン180mg(0.433mmol)を
THF10mlに溶解し、トリエチルアミン88mg
(0.867mmol)、無水酢酸66mg(0.65
0mmol)を加え、室温にて1時間攪拌した。反応溶
液に飽和塩化アンモニウム水溶液を加え、酢酸エチルに
て抽出した。有機層を飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧下溶媒を留去した。得られた残
渣をシリカゲルカラムクロマトグラフィー(ヘキサン−
酢酸エチル=1:1)で精製し表題化合物を得た。 収量 130mg(0.284mmol) 収率 66
% MS (ESI, m/z) 458 (MH+) 1H-NMR(CDCl3): 1.91 (3H, s), 2.44 (3H, s), 3.80 (2
H, t), 3.86 (3H, s),5.31 (1H, br), 5.42 (1H, br),
6.01 (2H, s), 6.16 (1H, d), 6.63-6.82 (3H, m), 6.9
9 (2H, d), 7.23 (2H, d)Example 92 {3- [4- (4-Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazole-5
Synthesis of yl) -pyridin-3-yl] -allyl} -acetamide 1) {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-
Synthesis of phenoxy) -pyridin-3-yl] -allyl} -acetamide 3- [5-cyano-4- (4-methoxyphenyl) -2
-Methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -prop-2-
180 mg (0.433 mmol) of ene-1-amine was dissolved in 10 ml of THF, and 88 mg of triethylamine was dissolved.
(0.867 mmol), 66 mg of acetic anhydride (0.65
0 mmol) and stirred at room temperature for 1 hour. A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (hexane-
Purification with ethyl acetate = 1: 1) gave the title compound. Yield 130 mg (0.284 mmol) Yield 66
% MS (ESI, m / z) 458 (MH +) 1H-NMR (CDCl3): 1.91 (3H, s), 2.44 (3H, s), 3.80 (2
H, t), 3.86 (3H, s), 5.31 (1H, br), 5.42 (1H, br),
6.01 (2H, s), 6.16 (1H, d), 6.63-6.82 (3H, m), 6.9
9 (2H, d), 7.23 (2H, d)
【0344】2){3−[4−(4−メトキシフェニ
ル)−2−メチル−6−(3,4−メチレンジオキシ−
フェノキシ)−5−(1H−テトラゾール−5−イル)
−ピリジン−3−イル]−アリル}−アセトアミドの合
成 {3−[5−シアノ−4−(4−メトキシフェニル)−
2−メチル−6−(3,4−メチレンジオキシ−フェノ
キシ)−ピリジン−3−イル]−アリル}−アセトアミ
ド130mg(0.284mmol)をトルエン10m
lに溶解しアジ化ナトリウム110mg(1.70mm
ol)、塩化トリ−n−ブチルスズ370mg(1.1
4mmol)から作成したアジ化トリ−n−ブチルスズ
を加え2日間加熱環流した。反応終了後1規定塩酸、酢
酸エチルを加え析出した結晶を濾過しヘキサン−酢酸エ
チル溶液(1:1)で洗浄した。得られた結晶をシリカ
ゲルカラムクロマトグラフィー(クロロホルム−メタノ
ール=100:1から50:1)で精製し表題化合物を
得た。 収量 60mg(0.120mmol) 収率 42% MS (ESI, m/z) 501 (MH+) 1H-NMR(CD3OD): 1.85 (3H, s), 2.48 (3H, s), 3.73 (2
H, d), 3.75 (3H, s),5.51 (1H, dt), 5.96(2H, s) 6.2
2 (1H, d), 6.50 (1H, dd), 6.62 (1H, d), 6.75-6.83
(3H, m), 6.94 (2H, d)2) {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-
Phenoxy) -5- (1H-tetrazol-5-yl)
Synthesis of -pyridin-3-yl] -allyl} -acetamide {3- [5-cyano-4- (4-methoxyphenyl)-
130 mg (0.284 mmol) of 2-methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -acetamide was added to 10 m of toluene.
1 mg of sodium azide (1.70 mm
ol), 370 mg of tri-n-butyltin chloride (1.1
4 mmol), and refluxed with heating for 2 days. After completion of the reaction, 1N hydrochloric acid and ethyl acetate were added, and the precipitated crystals were filtered and washed with a hexane-ethyl acetate solution (1: 1). The obtained crystals were purified by silica gel column chromatography (chloroform-methanol = 100: 1 to 50: 1) to give the title compound. Yield 60 mg (0.120 mmol) Yield 42% MS (ESI, m / z) 501 (MH +) 1H-NMR (CD3OD): 1.85 (3H, s), 2.48 (3H, s), 3.73 (2
H, d), 3.75 (3H, s), 5.51 (1H, dt), 5.96 (2H, s) 6.2
2 (1H, d), 6.50 (1H, dd), 6.62 (1H, d), 6.75-6.83
(3H, m), 6.94 (2H, d)
【0345】実施例93 3−[4−(4−メトキシフ
ェニル)−2−メチル−6−(3,4−メチレンジオキ
シ−フェノキシ)−5−(1H−テトラゾール−5−イ
ル)−ピリジン−3−イル] −プロプ−2−エン−1−
アミンの合成 3−[5−シアノ−4−(4−メトキシフェニル)−2
−メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−ピリジン−3−イル]−アリル}−プロプ−2−
エン−1−アミン1.44g(3.47mmol)をト
ルエン10mlに溶解しアジ化トリ−n−ブチルスズ
4.60g(13.9mmol)を加え130℃にて2
日間加熱環流する。10%塩酸ーエタノール溶液3ml
を加えて反応を停止させ、減圧下溶媒を留去した。得ら
れた残渣を酢酸エチルで洗浄し、得られた残留物をオク
タドデシル(ODS)基化学結合型シリカゲルを充填剤
とする逆相高速液体クロマトグラフィーに付し、トリフ
ルオロ酢酸を0.1%含有する(v/v)水−アセトニ
トリルの混合溶媒で溶出し、目的物のフラクションを凍
結乾燥することにより表題化合物を得た。 収量 1.04g(2.27mmol) 収率 65% MS (ESI, m/z) 459 (MH+) 1H-NMR(CD3OD): 2.53 (3H, s), 3.50 (2H, d), 3.76 (3
H, s), 5.60 (1H, dt), 5.97 (2H, s), 6.50-6.64 (3H,
m), 6.77-6.86 (3H, m), 6.97 (2H, d)Example 93 3- [4- (4-Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridine- 3-yl] -prop-2-ene-1-
Synthesis of amine 3- [5-cyano-4- (4-methoxyphenyl) -2
-Methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -prop-2-
1.44 g (3.47 mmol) of ene-1-amine was dissolved in 10 ml of toluene, and 4.60 g (13.9 mmol) of tri-n-butyltin azide was added.
Heat to reflux for days. 3 ml of 10% hydrochloric acid-ethanol solution
Was added to stop the reaction, and the solvent was distilled off under reduced pressure. The obtained residue was washed with ethyl acetate, and the obtained residue was subjected to reversed-phase high-performance liquid chromatography using octadodecyl (ODS) group chemically bonded silica gel as a filler to give trifluoroacetic acid in an amount of 0.1%. The mixture was eluted with a mixed solvent of (v / v) water-acetonitrile, and the target compound fraction was lyophilized to give the title compound. Yield 1.04 g (2.27 mmol) Yield 65% MS (ESI, m / z) 459 (MH +) 1H-NMR (CD3OD): 2.53 (3H, s), 3.50 (2H, d), 3.76 (3
H, s), 5.60 (1H, dt), 5.97 (2H, s), 6.50-6.64 (3H,
m), 6.77-6.86 (3H, m), 6.97 (2H, d)
【0346】実施例94 1−{3−[4−(4−メト
キシフェニル)−2−メチル−6−(3,4−メチレン
ジオキシ−フェノキシ)−5−(1H−テトラゾール−
5−イル)−ピリジン−3−イル]−アリル}−ウレア
の合成 1)1−{3−[5−シアノ−4−(4−メトキシフェ
ニル)−2−メチル−6−(3,4−メチレンジオキシ
−フェノキシ)−ピリジン−3−イル]−アリル}−ウ
レアの合成 3−[5−シアノ−4−(4−メトキシフェニル)−2
−メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−ピリジン−3−イル]−アリル}−プロプ−2−
エン−1−アミン200mg(3.47mmol)を氷
酢酸−水(1:2)液10mlに溶解し、シアン酸ナト
リウム63mg(0.963mmol)を加え室温にて
1時間攪拌した。不溶解物を濾過して除き、濾液を減圧
下溶媒留去した。得られた結晶を再結晶(再結晶溶媒:
酢酸エチル−ヘキサン)にて精製して表題化合物を得
た。 収量 130mg(0.284mmol) 収率 59
% MS (ESI, m/z) 458 (MH+) 1H-NMR(CDCl3): 2.43 (3H, s), 3.78 (2H, t), 3.85 (3
H, s), 5.41 (1H, dt), 5.51 (1H, br), 6.00 (2H, s),
6.15 (1H, d), 6.63-6.81 (3H, m), 6.97 (2H, d), 7.
22 (2H, d)Example 94 1- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazole-
Synthesis of 5-yl) -pyridin-3-yl] -allyl} -urea 1) 1- {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4- Synthesis of methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -urea 3- [5-cyano-4- (4-methoxyphenyl) -2
-Methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -prop-2-
200 mg (3.47 mmol) of ene-1-amine was dissolved in 10 ml of glacial acetic acid-water (1: 2) solution, and 63 mg (0.963 mmol) of sodium cyanate was added, followed by stirring at room temperature for 1 hour. The insolubles were removed by filtration, and the filtrate was evaporated under reduced pressure. Recrystallize the obtained crystals (recrystallization solvent:
Purification by ethyl acetate-hexane) gave the title compound. Yield 130 mg (0.284 mmol) Yield 59
% MS (ESI, m / z) 458 (MH +) 1H-NMR (CDCl3): 2.43 (3H, s), 3.78 (2H, t), 3.85 (3
H, s), 5.41 (1H, dt), 5.51 (1H, br), 6.00 (2H, s),
6.15 (1H, d), 6.63-6.81 (3H, m), 6.97 (2H, d), 7.
22 (2H, d)
【0347】2)1−{3−[4−(4−メトキシフェ
ニル)−2−メチル−6−(3,4−メチレンジオキシ
−フェノキシ)−5−(1H−テトラゾール−5−イ
ル)−ピリジン−3−イル]−アリル}−ウレアの合成 1−{3−[5−シアノ−4−(4−メトキシフェニ
ル)−2−メチル−6−(3,4−メチレンジオキシ−
フェノキシ)−ピリジン−3−イル]−アリル}−ウレ
ア130mg(0.284mmol)をトルエン10m
lに溶解しアジ化ナトリウム111mg(1.70mm
ol)、塩化トリ−n−ブチルスズ369mg(1.1
3mmol)から作成したアジ化トリ−n−ブチルスズ
を加え2日間加熱環流した。反応終了後1規定塩酸、酢
酸エチルを加え析出した結晶を濾過した。得られた結晶
をヘキサン−酢酸エチル溶液(1:1)で洗浄し表題化
合物を得た。 収量 130mg(0.259mmol) 収率 91
% MS (ESI, m/z) 501 (MH+) 1H-NMR(DMSO-d6): 2.44 (3H, s), 3.60 (2H, t), 3.72
(3H, s), 5.48 (1H, dt), 6.05 (2H, s), 6.11 (1H, d)
6.53 (1H, dd), 6.75-6.93 (6H, m), 7.85 (1H, br t)2) 1- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl)- Synthesis of pyridin-3-yl] -allyl} -urea 1- {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-
Phenoxy) -pyridin-3-yl] -allyl} -urea 130 mg (0.284 mmol) in toluene 10 m
1 mg of sodium azide (1.70 mm
ol), 369 mg of tri-n-butyltin chloride (1.1
3 mmol), and the mixture was refluxed under heating for 2 days. After completion of the reaction, 1N hydrochloric acid and ethyl acetate were added, and the precipitated crystals were filtered. The obtained crystals were washed with a hexane-ethyl acetate solution (1: 1) to obtain the title compound. Yield 130 mg (0.259 mmol) Yield 91
% MS (ESI, m / z) 501 (MH +) 1H-NMR (DMSO-d6): 2.44 (3H, s), 3.60 (2H, t), 3.72
(3H, s), 5.48 (1H, dt), 6.05 (2H, s), 6.11 (1H, d)
6.53 (1H, dd), 6.75-6.93 (6H, m), 7.85 (1H, br t)
【0348】実施例95 2−アミノ−N−{3−[4
−(4−メトキシフェニル)−2−メチル−6−(3,
4−メチレンジオキシ−フェノキシ)−5−(1H−テ
トラゾール−5−イル)−ピリジン−3−イル]−アリ
ル}−アセトアミド 塩酸塩の合成 1)2−[N−(t−ブトキシカルボニル)]−アミノ−
N−{3−[5−シアノ−4−(4−メトキシフェニ
ル)−2−メチル−6−(3,4−メチレンジオキシ−
フェノキシ)−ピリジン−3−イル]−アリル}−アセ
トアミドの合成 3−[5−シアノ−4−(4−メトキシフェニル)−2
−メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−ピリジン−3−イル]−アリル}−プロプ−2−
エン−1−アミン220g(0.530mmol)、N
−(t−ブトキシカルボニル)−グリシン186mg
(1.06mmol)を塩化メチレン10mlに溶解
し、WSC186mg(1.06mmol)を加え室温
にて1時間攪拌した。減圧下溶媒を留去し、残渣を酢酸
エチルに溶解し水、飽和食塩水で洗浄する。有機層を無
水硫酸マグネシウムで乾燥し減圧下溶媒を留去した。得
られた残渣をシリカゲルカラムクロマトグラフィー(ク
ロロホルム100%)で精製し表題化合物を得た。 収量 220mg(0.384mmol) 収率 72
% MS (ESI, m/z) 573 (MH+) 1H-NMR(CDCl3): 1.45 (9H, s), 2.43 (3H, s), 3.20 (2
H, d), 3.82 (2H, t),3.88 (3H, s), 5.40 (1H, dt) 6.
01 (2H, s), 6.17 (1H, d), 6.64-6.82 (3H,m), 6.99
(2H, d), 7.23 (2H, d)Example 95 2-amino-N- {3- [4
-(4-methoxyphenyl) -2-methyl-6- (3,
Synthesis of 4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -acetamide hydrochloride 1) 2- [N- (t-butoxycarbonyl)] -Amino-
N- {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-
Synthesis of phenoxy) -pyridin-3-yl] -allyl} -acetamide 3- [5-cyano-4- (4-methoxyphenyl) -2
-Methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -prop-2-
220 g (0.530 mmol) of ene-1-amine, N
-(T-butoxycarbonyl) -glycine 186 mg
(1.06 mmol) was dissolved in 10 ml of methylene chloride, 186 mg (1.06 mmol) of WSC was added, and the mixture was stirred at room temperature for 1 hour. The solvent is distilled off under reduced pressure, and the residue is dissolved in ethyl acetate and washed with water and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (chloroform 100%) to obtain the title compound. Yield 220 mg (0.384 mmol) Yield 72
% MS (ESI, m / z) 573 (MH +) 1H-NMR (CDCl3): 1.45 (9H, s), 2.43 (3H, s), 3.20 (2
H, d), 3.82 (2H, t), 3.88 (3H, s), 5.40 (1H, dt) 6.
01 (2H, s), 6.17 (1H, d), 6.64-6.82 (3H, m), 6.99
(2H, d), 7.23 (2H, d)
【0349】2)2−アミノ−N−{3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
セトアミド 塩酸塩の合成 2−[N−(t−ブトキシカルボニル)]−アミノ−N−
{3−[5−シアノ−4−(4−メトキシフェニル)−
2−メチル−6−(3,4−メチレンジオキシ−フェノ
キシ)−ピリジン−3−イル]−アリル}−アセトアミ
ド220mg(0.384mmol)をトルエン10m
lに溶解しアジ化ナトリウム150mg(2.30mm
ol)、塩化トリ−n−ブチルスズ500mg(1.5
4mmol)から作成したアジ化トリ−n−ブチルスズ
を加え1日間加熱環流した。反応終了後トルエン層を取
り除き、4規定塩酸−ジオキサンを5ml加えて1時間
攪拌した。減圧下溶媒を留去し、残渣を酢酸エチルで洗
浄した。得られた結晶を再結晶(再結晶溶媒:メタノー
ル−酢酸エチル)にて精製して表題化合物を得た。 収量 95mg(0.184mmol) 収率 48% MS (ESI, m/z) 516 (MH+) 1H-NMR(CD3OD): 2.48 (3H, s), 3.61 (2H, s), 3.76 (3
H, s), 3.80 (2H, d),5.52 (1H, dt), 5.96 (2H, s),
6.29 (1H, d), 6.49-6.85 (5H, m), 6.95 (2H,d)2) 2-amino-N- {3- [4- (4-
Synthesis of methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -acetamide hydrochloride 2 -[N- (t-butoxycarbonyl)]-amino-N-
{3- [5-cyano-4- (4-methoxyphenyl)-
2-methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -acetamide 220 mg (0.384 mmol) in toluene 10 m
and dissolved in sodium azide 150 mg (2.30 mm
ol), 500 mg of tri-n-butyltin chloride (1.5
4 mmol), and refluxed with heating for 1 day. After completion of the reaction, the toluene layer was removed, and 5 ml of 4N hydrochloric acid-dioxane was added, followed by stirring for 1 hour. The solvent was distilled off under reduced pressure, and the residue was washed with ethyl acetate. The obtained crystals were purified by recrystallization (recrystallization solvent: methanol-ethyl acetate) to obtain the title compound. Yield 95 mg (0.184 mmol) Yield 48% MS (ESI, m / z) 516 (MH +) 1H-NMR (CD3OD): 2.48 (3H, s), 3.61 (2H, s), 3.76 (3
H, s), 3.80 (2H, d), 5.52 (1H, dt), 5.96 (2H, s),
6.29 (1H, d), 6.49-6.85 (5H, m), 6.95 (2H, d)
【0350】実施例96 DL−ピログルタミン酸
{3−[4−(4−メトキシフェニル)−2−メチル−
6−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル]−アリル}−アミド の合成 1)DL−ピログルタミン酸 {3−[5−シアノ−4
−(4−メトキシフェニル)−2−メチル−6−(3,
4−メチレンジオキシ−フェノキシ)−ピリジン−3−
イル]−アリル}−アミドの合成 3−[5−シアノ−4−(4−メトキシフェニル)−2
−メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−ピリジン−3−イル]−アリル}−プロプ−2−
エン−1−アミン300g(0.722mmol)、D
L−ピログルタミン酸140mg(1.08mmol)
を塩化メチレン10mlに溶解し、WSC277mg
(1.44mmol)を加え室温にて1時間攪拌した。
減圧下溶媒を留去し、残渣を酢酸エチルに溶解し水、飽
和食塩水で洗浄した。有機層を無水硫酸マグネシウムで
乾燥し減圧下溶媒を留去した。得られた残渣をシリカゲ
ルカラムクロマトグラフィー(クロロホルム100%)
で精製し表題化合物を得た。 収量 260mg(0.494mmol) 収率 68
% MS (ESI, m/z) 527 (MH+) 1H-NMR(CDCl3): 2.00-2.10 (1H, m), 2.30 (1H, t), 2.
44 (3H, s), 3.75-4.10 (7H, m), 5.38 (1H, dt), 6.02
(2H, s), 6.05-6.22 (2H, m), 6.64-6.82 (3H, m), 6.
99 (2H, d), 7.23 (2H, d)Example 96 DL-pyroglutamic acid
{3- [4- (4-methoxyphenyl) -2-methyl-
6- (3,4-methylenedioxy-phenoxy) -5
Synthesis of (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide 1) DL-pyroglutamic acid {3- [5-cyano-4]
-(4-methoxyphenyl) -2-methyl-6- (3,
4-Methylenedioxy-phenoxy) -pyridine-3-
Synthesis of yl] -allyl} -amide 3- [5-cyano-4- (4-methoxyphenyl) -2
-Methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -prop-2-
300 g (0.722 mmol) of ene-1-amine, D
140 mg (1.08 mmol) of L-pyroglutamic acid
Was dissolved in 10 ml of methylene chloride, and 277 mg of WSC was dissolved.
(1.44 mmol) and the mixture was stirred at room temperature for 1 hour.
The solvent was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate and washed with water and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (chloroform 100%).
And the title compound was obtained. Yield 260 mg (0.494 mmol) Yield 68
% MS (ESI, m / z) 527 (MH +) 1H-NMR (CDCl3): 2.00-2.10 (1H, m), 2.30 (1H, t), 2.
44 (3H, s), 3.75-4.10 (7H, m), 5.38 (1H, dt), 6.02
(2H, s), 6.05-6.22 (2H, m), 6.64-6.82 (3H, m), 6.
99 (2H, d), 7.23 (2H, d)
【0351】2)DL−ピログルタミン酸 {3−[4
−(4−メトキシフェニル)−2−メチル−6−(3,
4−メチレンジオキシ−フェノキシ)−5−(1H−テ
トラゾール−5−イル)−ピリジン−3−イル]−アリ
ル}−アミド の合成 DL−ピログルタミン酸 {3−[5−シアノ−4−
(4−メトキシフェニル)−2−メチル−6−(3,4
−メチレンジオキシ−フェノキシ)−ピリジン−3−イ
ル]−アリル}−アミド260mg(0.494mmo
l)をトルエン10mlに溶解しアジ化ナトリウム19
3mg(2.96mmol)、塩化トリ−n−ブチルス
ズ643mg(1.98mmol)から作成したアジ化
トリ−n−ブチルスズを加え3日間加熱環流した。反応
終了後3規定塩酸、酢酸エチル加えて析出してくる結晶
を濾過した。得られた結晶を再結晶(再結晶溶媒:メタ
ノール−酢酸エチル)にて精製して表題化合物を得た。 収量 120mg(0.211mmol) 収率 43
% MS (ESI, m/z) 570 (MH+) 1H-NMR(DMSO-d6): 2.04-2.15 (2H, m), 2.44 (3H, s),
3.61-3.93 (7H, m), 5.54 (1H, dt), 6.05-6.14 (3H,
m), 6.51 (1H, d), 6.75-6.90 (5H, m), 7.72 (1H, s),
8.03 (1H, br s)2) DL-pyroglutamic acid {3- [4
-(4-methoxyphenyl) -2-methyl-6- (3,
Synthesis of 4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4-]
(4-methoxyphenyl) -2-methyl-6- (3,4
-Methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide 260 mg (0.494 mmol
l) was dissolved in 10 ml of toluene, and sodium azide 19 was dissolved.
Tri-n-butyltin azide prepared from 3 mg (2.96 mmol) and 643 mg (1.98 mmol) of tri-n-butyltin chloride was added, and the mixture was heated under reflux for 3 days. After completion of the reaction, 3N hydrochloric acid and ethyl acetate were added, and the precipitated crystals were filtered. The obtained crystals were purified by recrystallization (recrystallization solvent: methanol-ethyl acetate) to obtain the title compound. Yield 120 mg (0.211 mmol) Yield 43
% MS (ESI, m / z) 570 (MH +) 1H-NMR (DMSO-d6): 2.04-2.15 (2H, m), 2.44 (3H, s),
3.61-3.93 (7H, m), 5.54 (1H, dt), 6.05-6.14 (3H,
m), 6.51 (1H, d), 6.75-6.90 (5H, m), 7.72 (1H, s),
8.03 (1H, br s)
【0352】実施例97 ピラジン−2−カルボン酸
{3−[4−(4−メトキシフェニル)−2−メチル
−6−(3,4−メチレンジオキシ−フェノキシ)−5
−(1H−テトラゾール−5−イル)−ピリジン−3−
イル]−アリル}−アミド の合成 1)ピラジン−2−カルボン酸 {3−[5−シアノ−
4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 522 (MH+) 1H-NMR(CDCl3): 2.46 (3H, s), 3.75 (3H, s), 4.03-4.
08 (2H, br), 5.54 (1H, dt), 6.00 (2H, s), 6.27 (1
H, d), 6.62-6.81 (3H, m), 6.91 (2H, d), 7.23 (2H,
d), 7.71 (1H, br), 8.52 (1H, s), 8.75 (1H, s), 9.3
6 (1H, s)Example 97 Pyrazine-2-carboxylic acid {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5
-(1H-tetrazol-5-yl) -pyridin-3-
Synthesis of yl] -allyl} -amide 1) pyrazine-2-carboxylic acid {3- [5-cyano-
4- (4-methoxyphenyl) -2-methyl-6-
Synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl) -2 of Example] -Methyl-6-
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 522 (MH +) 1H-NMR (CDCl3): 2.46 (3H, s), 3.75 (3H, s), 4.03-4.
08 (2H, br), 5.54 (1H, dt), 6.00 (2H, s), 6.27 (1
H, d), 6.62-6.81 (3H, m), 6.91 (2H, d), 7.23 (2H,
d), 7.71 (1H, br), 8.52 (1H, s), 8.75 (1H, s), 9.3
6 (1H, s)
【0353】2)ピラジン−2−カルボン酸 {3−
[4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−5−(1
H−テトラゾール−5−イル)−ピリジン−3−イル]
−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミドの合成に準じて合成した。 MS (ESI, m/z) 565 (MH+) 1H-NMR(CDCl3): 2.49 (3H, s), 3.58 (3H, s), 4.00 (2
H, br), 5.62 (1H, dt), 5.96 (2H, s), 6.31 (1H, d),
6.48-6.90 (7H, m), 8.65 (1H, t), 8.77 (1H, d), 8.
80 (1H, br), 9.17 (1H, s)2) pyrazine-2-carboxylic acid {3-
[4- (4-methoxyphenyl) -2-methyl-6-
(3,4-methylenedioxy-phenoxy) -5- (1
H-tetrazol-5-yl) -pyridin-3-yl]
Synthesis of -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
According to the synthesis of methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide. Synthesized. MS (ESI, m / z) 565 (MH +) 1H-NMR (CDCl3): 2.49 (3H, s), 3.58 (3H, s), 4.00 (2
H, br), 5.62 (1H, dt), 5.96 (2H, s), 6.31 (1H, d),
6.48-6.90 (7H, m), 8.65 (1H, t), 8.77 (1H, d), 8.
80 (1H, br), 9.17 (1H, s)
【0354】実施例98 N−{3−[4−(4−メト
キシフェニル)−2−メチル−6−(3,4−メチレン
ジオキシ−フェノキシ)−5−(1H−テトラゾール−
5−イル)−ピリジン−3−イル]−アリル}−2−ヒ
ドロキシ−アセトアミドの合成 1)o−メトキシメチル−エチルグリコレートの合成 エチルグリコレート3.0g(28.8mmol)、ジ
−イソプロピル−エチルアミン7.44g(57.6m
mol)を塩化メチレンに溶解させ室温にて1時間攪拌
した。氷冷下、メトキシメチルクロライド3.48g
(43.2mmol)を加え、室温にて2日間攪拌し
た。減圧下溶媒を留去し、残渣を酢酸エチルに溶解し
水、飽和食塩水で洗浄した。有機層を無水硫酸マグネシ
ウムで乾燥し減圧下溶媒を留去した。得られた残渣をシ
リカゲルカラムクロマトグラフィー(クロロホルム10
0%)で精製し表題化合物を得た。 収量 3.35g(22.6mmol) 収率 79% MS (ESI, m/z) 171 (MH+) 1H-NMR(CDCl3): 1.29 (3H, t), 3.41 (3H, s), 4.16 (2
H, s), 4.23 (2H, q),4.71 (2H, s)Example 98 N- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazole-
Synthesis of 5-yl) -pyridin-3-yl] -allyl-2-hydroxy-acetamide 1) Synthesis of o-methoxymethyl-ethyl glycolate 3.0 g (28.8 mmol) of ethyl glycolate, di-isopropyl- 7.44 g of ethylamine (57.6 m
mol) was dissolved in methylene chloride and stirred at room temperature for 1 hour. Under ice cooling, 3.48 g of methoxymethyl chloride
(43.2 mmol), and the mixture was stirred at room temperature for 2 days. The solvent was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate and washed with water and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (chloroform 10
0%) to give the title compound. Yield 3.35 g (22.6 mmol) Yield 79% MS (ESI, m / z) 171 (MH +) 1H-NMR (CDCl3): 1.29 (3H, t), 3.41 (3H, s), 4.16 (2
H, s), 4.23 (2H, q), 4.71 (2H, s)
【0355】2)o−メトキシメチル−グリコール酸の
合成 o−メトキシメチル−エチルグリコレート3.35g
(22.6mmol)をエタノール50mlに溶解し、
3規定水酸化ナトリウム水溶液10ml(30.0mm
ol)を加えて、4日間攪拌した。減圧下溶媒を留去
し、残渣を水に溶解し酢酸エチルで抽出した。有機層を
無水硫酸マグネシウムで乾燥し減圧下溶媒を留去して表
題化合物を得た。 収量 850mg(7.08mmol) 収率 31% 1H-NMR(CDCl3): 3.42 (3H, s), 4.24 (2H, s), 4.73 (2
H, s)2) Synthesis of o-methoxymethyl-glycolic acid 3.35 g of o-methoxymethyl-ethyl glycolate
(22.6 mmol) dissolved in 50 ml of ethanol,
10 ml of 3N sodium hydroxide aqueous solution (30.0 mm
ol) and stirred for 4 days. The solvent was distilled off under reduced pressure, and the residue was dissolved in water and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the title compound. Yield 850 mg (7.08 mmol) Yield 31% 1H-NMR (CDCl3): 3.42 (3H, s), 4.24 (2H, s), 4.73 (2
H, s)
【0356】3) N−{3−[5−シアノ−4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−ピリジン−3−イル]−
アリル}−2−メトキシメチル−アセトアミドの合成 3−[5−シアノ−4−(4−メトキシフェニル)−2
−メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−ピリジン−3−イル]−アリル}−プロプ−2−
エン−1−アミン565g(1.36mmol)、o−
メトキシメチル−グリコール酸245mg(2.04m
mol)を塩化メチレン10mlに溶解し、WSC52
1mg(2.72mmol)を加え室温にて3時間攪拌
した。減圧下溶媒を留去し、残渣を酢酸エチルに溶解し
水、飽和食塩水で洗浄した。有機層を無水硫酸マグネシ
ウムで乾燥し減圧下溶媒を留去した。得られた残渣をシ
リカゲルカラムクロマトグラフィー(クロロホルム10
0%)で精製し表題化合物を得た。 収量 540mg(1.04mmol) 収率 76% MS (ESI, m/z) 518 (MH+) 1H-NMR(CDCl3): 2.45 (3H, s), 3.35 (3H, s), 3.86-3.
88 (5H, m), 3.98 (2H, s), 4.62 (2H, s), 5.48 (1H,
dt), 6.00 (2H, s), 6.18 (1H, d), 6.50 (1H,br), 6.6
3-6.81 (3H, m), 6.98 (2H, d), 7.24 (2H, d)3) N- {3- [5-cyano-4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl]-
Synthesis of allyl {-2-methoxymethyl-acetamide 3- [5-cyano-4- (4-methoxyphenyl) -2
-Methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -prop-2-
565 g (1.36 mmol) of ene-1-amine, o-
245 mg of methoxymethyl-glycolic acid (2.04 m
mol) was dissolved in 10 ml of methylene chloride, and
1 mg (2.72 mmol) was added, and the mixture was stirred at room temperature for 3 hours. The solvent was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate and washed with water and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (chloroform 10
0%) to give the title compound. Yield 540 mg (1.04 mmol) Yield 76% MS (ESI, m / z) 518 (MH +) 1H-NMR (CDCl3): 2.45 (3H, s), 3.35 (3H, s), 3.86-3.
88 (5H, m), 3.98 (2H, s), 4.62 (2H, s), 5.48 (1H,
dt), 6.00 (2H, s), 6.18 (1H, d), 6.50 (1H, br), 6.6
3-6.81 (3H, m), 6.98 (2H, d), 7.24 (2H, d)
【0357】4) N−{3−[4−(4−メトキシフェ
ニル)−2−メチル−6−(3,4−メチレンジオキシ
−フェノキシ)−5−(1H−テトラゾール−5−イ
ル)−ピリジン−3−イル]−アリル}−2−ヒドロキ
シ−アセトアミドの合成 N−{3−[5−シアノ−4−(4−メトキシフェニ
ル)−2−メチル−6−(3,4−メチレンジオキシ−
フェノキシ)−ピリジン−3−イル]−アリル}−2−
メトキシメチル−アセトアミド540mg(1.04m
mol)をトルエン10mlに溶解しアジ化ナトリウム
406mg(6.24mmol)、塩化トリ−n−ブチ
ルスズ1.36mg(4.17mmol)から作成した
アジ化トリ−n−ブチルスズを加え2日間加熱環流し
た。反応終了後30%塩酸−エタノールを加えさらに室
温にて3時間攪拌した。減圧下溶媒を留去し、残渣を酢
酸エチルに溶解し飽和食塩水で洗浄した。有機層を無水
硫酸マグネシウムで乾燥し減圧下溶媒を留去した。得ら
れた残渣をシリカゲルカラムクロマトグラフィー(クロ
ロホルム−メタノール=50:1から9:1)で精製し
表題化合物を得た。 収量 80mg(0.155mmol) 収率 15% MS (ESI, m/z) 570 (MH+) 1H−NMR(CD3OD): 2.48 (3H,
s), 3.76 (3H, s), 3.80 (2
H, t), 3.89 (2H, s),5.53
(1H, dt), 5.96 (2H, s),
6.25 (1H, d), 6.48−6.96
(7H, m)4) N- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl)- Synthesis of pyridin-3-yl] -allyl} -2-hydroxy-acetamide N- {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy) −
Phenoxy) -pyridin-3-yl] -allyl {-2-
540 mg of methoxymethyl-acetamide (1.04 m
mol) was dissolved in 10 ml of toluene, and tri-n-butyltin azide prepared from 406 mg (6.24 mmol) of sodium azide and 1.36 mg (4.17 mmol) of tri-n-butyltin chloride was added, and the mixture was heated under reflux for 2 days. After completion of the reaction, 30% hydrochloric acid-ethanol was added, and the mixture was further stirred at room temperature for 3 hours. The solvent was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate and washed with saturated saline. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (chloroform-methanol = 50: 1 to 9: 1) to obtain the title compound. Yield 80 mg (0.155 mmol) Yield 15% MS (ESI, m / z) 570 (MH +) 1H-NMR (CD3OD): 2.48 (3H,
s), 3.76 (3H, s), 3.80 (2
H, t), 3.89 (2H, s), 5.53
(1H, dt), 5.96 (2H, s),
6.25 (1H, d), 6.48-6.96
(7H, m)
【0358】実施例99 ピリジン−3−カルボン
酸{3−[4−(4−メトキシフェニル)−2−メチル
−6−(3,4−メチレンジオキシ−フェノキシ)−5
−(1H−テトラゾール−5−イル)−ピリジン−3−
イル]−アリル}−アミド の合成 1)ピリジン−3−カルボン酸 {3−[5−シアノ−
4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 521 (MH+) 1H-NMR(CDCl3): 2.44 (3H, s), 3.74 (3H, s), 4.01 (2
H, t), 5.51 (1H, dt), 6.00 (2H, s), 6.27 (1H, br)
, 6.62-6.93 (5H, m), 7.22 (2H, d), 7.36 (1H, q),
7.99 (1H, dt), 8.71 (1H, d), 8.86 (1H, d)Example 99 Pyridine-3-carboxylic acid {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5
-(1H-tetrazol-5-yl) -pyridin-3-
Synthesis of yl] -allyl} -amide 1) Pyridine-3-carboxylic acid {3- [5-cyano-
4- (4-methoxyphenyl) -2-methyl-6-
Synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl) -2 of Example] -Methyl-6-
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 521 (MH +) 1H-NMR (CDCl3): 2.44 (3H, s), 3.74 (3H, s), 4.01 (2
H, t), 5.51 (1H, dt), 6.00 (2H, s), 6.27 (1H, br)
, 6.62-6.93 (5H, m), 7.22 (2H, d), 7.36 (1H, q),
7.99 (1H, dt), 8.71 (1H, d), 8.86 (1H, d)
【0359】2)ピリジン−3−カルボン酸 {3−
[4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−5−(1
H−テトラゾール−5−イル)−ピリジン−3−イル]
−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミドの合成に準じて合成した。 MS (ESI, m/z) 564 (MH+) 1H-NMR(CD3OD): 2.55 (3H, s), 3.60 (3H, s), 4.02 (2
H, br), 5.69 (1H, brd), 5.95 (2H, s), 6.34 (1H,
d), 6.49-6.95 (7H, m), 8.25 (1H, br), 8.95(1H, br
d), 9.06 (1H, br), 9.23 (1H, s)2) Pyridine-3-carboxylic acid {3-
[4- (4-methoxyphenyl) -2-methyl-6-
(3,4-methylenedioxy-phenoxy) -5- (1
H-tetrazol-5-yl) -pyridin-3-yl]
Synthesis of -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
According to the synthesis of methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide. Synthesized. MS (ESI, m / z) 564 (MH +) 1H-NMR (CD3OD): 2.55 (3H, s), 3.60 (3H, s), 4.02 (2
H, br), 5.69 (1H, brd), 5.95 (2H, s), 6.34 (1H,
d), 6.49-6.95 (7H, m), 8.25 (1H, br), 8.95 (1H, br)
d), 9.06 (1H, br), 9.23 (1H, s)
【0360】実施例100 6−ヒドロキシ−ピリジ
ン−3−カルボン酸{3−[4−(4−メトキシフェニ
ル)−2−メチル−6−(3,4−メチレンジオキシ−
フェノキシ)−5−(1H−テトラゾール−5−イル)
−ピリジン−3−イル]−アリル}−アミド の合成 1)6−ヒドロキシ−ピリジン−3−カルボン酸 {3
−[5−シアノ−4−(4−メトキシフェニル)−2−
メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−ピリジン−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 537 (MH+) 1H-NMR(CD3OD): 2.44 (3H, s), 3.75 (3H, s), 3.88 (2
H, br), 5.58 (1H, dt), 6.00 (2H, s), 6.24 (1H, d),
6.50-6.95 (6H, m), 7.23 (2H, d), 7.83-7.94 (2H,
m), 8.35 (1H, br)Example 100 6-Hydroxy-pyridine-3-carboxylic acid {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-
Phenoxy) -5- (1H-tetrazol-5-yl)
-Pyridin-3-yl] -allyl} -amide 1) 6-Hydroxy-pyridine-3-carboxylic acid {3
-[5-cyano-4- (4-methoxyphenyl) -2-
Synthesis of methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxy) of Example Phenyl) -2-methyl-6-
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 537 (MH +) 1H-NMR (CD3OD): 2.44 (3H, s), 3.75 (3H, s), 3.88 (2
H, br), 5.58 (1H, dt), 6.00 (2H, s), 6.24 (1H, d),
6.50-6.95 (6H, m), 7.23 (2H, d), 7.83-7.94 (2H,
m), 8.35 (1H, br)
【0361】2)6−ヒドロキシ−ピリジン−3−カル
ボン酸 {3−[4−(4−メトキシフェニル)−2−
メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−5−(1H−テトラゾール−5−イル)−ピリジ
ン−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 580 (MH+) 1H-NMR(DMSO-d6): 2.45 (3H, s), 3.63 (3H, s), 3.77
(2H, br), 5.57 (1H,dt), 6.05 (2H, s), 6.15 (1H,
d), 6.32 (1H, d), 6.52 (1H, dd), 6.70-6.90(6H, m),
7.74-7.89 (2H, m), 8.27 (1H, br t)2) 6-hydroxy-pyridine-3-carboxylic acid {3- [4- (4-methoxyphenyl) -2-
Synthesis of methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid of Example 3 − [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 580 (MH +) 1H-NMR (DMSO-d6): 2.45 (3H, s), 3.63 (3H, s), 3.77
(2H, br), 5.57 (1H, dt), 6.05 (2H, s), 6.15 (1H,
d), 6.32 (1H, d), 6.52 (1H, dd), 6.70-6.90 (6H, m),
7.74-7.89 (2H, m), 8.27 (1H, br t)
【0362】実施例101 1−{3−[4−(4−メ
トキシフェニル)−2−メチル−6−(3,4−メチレ
ンジオキシ−フェノキシ)−5−(1H−テトラゾール
−5−イル)−ピリジン−3−イル]−アリル}−3−
ピリジン−3−イル−ウレアの合成 1)1−{3−[5−シアノ−4−(4−メトキシフェ
ニル)−2−メチル−6−(3,4−メチレンジオキシ
−フェノキシ)−ピリジン−3−イル]−アリル}−3
−ピリジン−3−イル−ウレアの合成 ニコチン酸356mg(2.89mmol)をトルエン
5mlに溶かし、アジ化ジフェニルホスホリル927m
g(3.37mmol),トリエチルアミン341mg
(3.37mmol)を加え、80℃にて2時間攪拌し
た。その後3−[5−シアノ−4−(4−メトキシフェ
ニル)−2−メチル−6−(3,4−メチレンジオキシ
−フェノキシ)−ピリジン−3−イル]−アリル}−プ
ロプ−2−エン−1−アミン400g(0.963mm
ol)を80℃にて加え、さらに12時間攪拌した。反
応終了後、反応溶液に3規定塩酸を2ml加え、30分
間攪拌した。反応溶液に水を加え、酢酸エチルにて抽出
し有機層を無水硫酸マグネシウムで乾燥、減圧下濃縮し
た。残渣をカラムクロマトグラフィー(クロロホルム−
メタノール=20:1から10:1)にて精製し、表題
化合物を得た。 収量 390mg(0.728mmol) 収率 76
% MS (ESI, m/z) 536 (MH+) 1H-NMR(DMSO-d6): 2.41 (3H, s), 3.68 (2H, t), 3.73
(3H, s), 5.58 (1H, dt), 6.09 (2H, s), 6.17 (1H,
d), 6.34 (1H, br), 6.69 (1H, q), 6.93-7.33 (6H,
m), 7.86 (1H, br d), 8.11 (1H, br d), 8.51 (1H, br
d), 8.64 (1H, s)Example 101 1- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -Pyridin-3-yl] -allyl} -3-
Synthesis of pyridin-3-yl-urea 1) 1- {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -pyridine- 3-yl] -allyl} -3
Synthesis of -Pyridin-3-yl-urea 356 mg (2.89 mmol) of nicotinic acid was dissolved in 5 ml of toluene, and 927 m of diphenylphosphoryl azide was dissolved.
g (3.37 mmol), 341 mg of triethylamine
(3.37 mmol) was added and the mixture was stirred at 80 ° C. for 2 hours. Then 3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -prop-2-ene -1-amine 400 g (0.963 mm
ol) at 80 ° C. and further stirred for 12 hours. After completion of the reaction, 2 ml of 3N hydrochloric acid was added to the reaction solution, and the mixture was stirred for 30 minutes. Water was added to the reaction solution, extracted with ethyl acetate, and the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was subjected to column chromatography (chloroform-
Purification by methanol = 20: 1 to 10: 1) gave the title compound. Yield 390 mg (0.728 mmol) Yield 76
% MS (ESI, m / z) 536 (MH +) 1H-NMR (DMSO-d6): 2.41 (3H, s), 3.68 (2H, t), 3.73
(3H, s), 5.58 (1H, dt), 6.09 (2H, s), 6.17 (1H,
d), 6.34 (1H, br), 6.69 (1H, q), 6.93-7.33 (6H,
m), 7.86 (1H, br d), 8.11 (1H, br d), 8.51 (1H, br
d), 8.64 (1H, s)
【0363】2)1−{3−[4−(4−メトキシフェ
ニル)−2−メチル−6−(3,4−メチレンジオキシ
−フェノキシ)−5−(1H−テトラゾール−5−イ
ル)−ピリジン−3−イル]−アリル}−3−ピリジン
−3−イル−ウレアの合成 1−{3−[5−シアノ−4−(4−メトキシフェニ
ル)−2−メチル−6−(3,4−メチレンジオキシ−
フェノキシ)−ピリジン−3−イル]−アリル}−3−
ピリジン−3−イル−ウレア200mg(0.373m
mol)をトルエン10mlに溶解しアジ化ナトリウム
145mg(2.24mmol)、塩化トリ−n−ブチ
ルスズ486mg(1.49mmol)から作成したア
ジ化トリ−n−ブチルスズを加え2日間加熱環流した。
反応終了後30%塩酸−エタノールを加えさらに室温に
て攪拌した。減圧下溶媒を留去し、残渣を酢酸エチルに
溶解し飽和食塩水で洗浄した。有機層を無水硫酸マグネ
シウムで乾燥し減圧下溶媒を留去した。得られた残渣を
酢酸エチルで洗浄し、得られた残留物をオクタドデシル
(ODS)基化学結合型シリカゲルを充填剤とする逆相
高速液体クロマトグラフィーに付し、トリフルオロ酢酸
を0.1%含有する(v/v)水−アセトニトリルの混
合溶媒で溶出し、目的物のフラクションを凍結乾燥する
ことにより表題化合物を得た。 収量 1.04g(2.27mmol) 収率 19.
4% MS (ESI, m/z) 579 (MH+) 1H-NMR(CD3OD): 2.50 (3H, s), 3.60 (3H, s), 3.80 (2
H, d), 5.63 (1H, dt), 5.96 (2H, s), 6.27 (1H, d),
6.48-6.95 (7H, m), 7.87 (1H, q), 8.20 (1H,d), 8.37
(1H, d), 9.13 (1H, s)2) 1- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl)- Synthesis of pyridin-3-yl] -allyl-3-pyridin-3-yl-urea 1- {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4 -Methylenedioxy-
[Phenoxy) -pyridin-3-yl] -allyl} -3-
200 mg of pyridin-3-yl-urea (0.373 m
mol) was dissolved in 10 ml of toluene, and tri-n-butyltin azide prepared from 145 mg (2.24 mmol) of sodium azide and 486 mg (1.49 mmol) of tri-n-butyltin chloride was added thereto, and the mixture was refluxed for 2 days.
After completion of the reaction, 30% hydrochloric acid-ethanol was added, and the mixture was further stirred at room temperature. The solvent was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate and washed with saturated saline. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was washed with ethyl acetate, and the obtained residue was subjected to reversed-phase high-performance liquid chromatography using octadodecyl (ODS) group chemically bonded silica gel as a filler to give trifluoroacetic acid in an amount of 0.1%. The mixture was eluted with a mixed solvent of (v / v) water-acetonitrile, and the target compound fraction was lyophilized to give the title compound. Yield 1.04 g (2.27 mmol) Yield 19.
4% MS (ESI, m / z) 579 (MH +) 1H-NMR (CD3OD): 2.50 (3H, s), 3.60 (3H, s), 3.80 (2
H, d), 5.63 (1H, dt), 5.96 (2H, s), 6.27 (1H, d),
6.48-6.95 (7H, m), 7.87 (1H, q), 8.20 (1H, d), 8.37
(1H, d), 9.13 (1H, s)
【0364】実施例102 ピリジン−4−カルボン酸
{3−[4−(4−メトキシフェニル)−2−メチル−
6−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル]−アリル}−アミド の合成 1)ピリジン−4−カルボン酸 {3−[5−シアノ−
4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 521 (MH+) 1H−NMR(CDCl3): 2.44 (3H,
s), 3.73 (3H, s), 4.00 (2
H, t), 5.49 (1H, dt), 6.0
1 (2H, s), 6.27 (1H, br
d), 6.62−6.81 (3H, m), 6.
91 (2H, d), 7,22 (2H, d),
7.48 (2H, d), 8.71 (2H,
d)Example 102 Pyridine-4-carboxylic acid {3- [4- (4-methoxyphenyl) -2-methyl-
6- (3,4-methylenedioxy-phenoxy) -5
Synthesis of (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide 1) Pyridin-4-carboxylic acid {3- [5-cyano-
4- (4-methoxyphenyl) -2-methyl-6-
Synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl) -2 of Example] -Methyl-6-
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 521 (MH +) 1H-NMR (CDCl3): 2.44 (3H,
s), 3.73 (3H, s), 4.00 (2
H, t), 5.49 (1H, dt), 6.0
1 (2H, s), 6.27 (1H, br)
5. d), 6.62-6.81 (3H, m),
91 (2H, d), 7, 22 (2H, d),
7.48 (2H, d), 8.71 (2H, d)
d)
【0365】2)ピリジン−4−カルボン酸 {3−
[4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−5−(1
H−テトラゾール−5−イル)−ピリジン−3−イル]
−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミドの合成に準じて合成した。 MS (ESI, m/z) 564 (MH+) 1H-NMR(CD3OD): 2.50 (3H, s), 3.61 (3H, s), 4.00 (2
H, br), 5.65 (1H, br), 5.96 (2H, s), 6.30-6.95 (8
H, m), 8.12 (2H, br), 8.92 (2H, br)2) Pyridine-4-carboxylic acid {3-
[4- (4-methoxyphenyl) -2-methyl-6-
(3,4-methylenedioxy-phenoxy) -5- (1
H-tetrazol-5-yl) -pyridin-3-yl]
Synthesis of -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
According to the synthesis of methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide. Synthesized. MS (ESI, m / z) 564 (MH +) 1H-NMR (CD3OD): 2.50 (3H, s), 3.61 (3H, s), 4.00 (2
H, br), 5.65 (1H, br), 5.96 (2H, s), 6.30-6.95 (8
H, m), 8.12 (2H, br), 8.92 (2H, br)
【0366】実施例103 2、6−ジメトキシ−ピ
リジン−3−カルボン酸{3−[4−(4−メトキシフ
ェニル)−2−メチル−6−(3,4−メチレンジオキ
シ−フェノキシ)−5−(1H−テトラゾール−5−イ
ル)−ピリジン−3−イル]−アリル}−アミド の合成 1)2,6−ジメトキシ−ピリジン−3−カルボン酸
{3−[5−シアノ−4−(4−メトキシフェニル)−
2−メチル−6−(3,4−メチレンジオキシ−フェノ
キシ)−ピリジン−3−イル]−アリル}−アミドの合
成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 581 (MH+) 1H-NMR(CDCl3): 2.47 (3H, s), 3.74 (3H, s), 3.97 (3
H, s), 4.03 (5H, br), 5.61 (1H, dt), 6.00 (2H, s),
6.22 (1H, d), 6.44 (1H, d), 6.64-6.82 (3H, m), 6.
90 (2H, d), 7.24 (2H, d), 7.64 (1H, br t), 8.37 (1
H, d)Example 103 2,6-Dimethoxy-pyridine-3-carboxylic acid {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5 Synthesis of-(1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide 1) 2,6-dimethoxy-pyridine-3-carboxylic acid
{3- [5-cyano-4- (4-methoxyphenyl)-
Synthesis of 2-methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4 -Methoxyphenyl) -2-methyl-6-
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 581 (MH +) 1H-NMR (CDCl3): 2.47 (3H, s), 3.74 (3H, s), 3.97 (3
H, s), 4.03 (5H, br), 5.61 (1H, dt), 6.00 (2H, s),
6.22 (1H, d), 6.44 (1H, d), 6.64-6.82 (3H, m), 6.
90 (2H, d), 7.24 (2H, d), 7.64 (1H, brt), 8.37 (1
H, d)
【0367】2)2,6−ジメトキシ−ピリジン−3−
カルボン酸 {3−[4−(4−メトキシフェニル)−
2−メチル−6−(3,4−メチレンジオキシ−フェノ
キシ)−5−(1H−テトラゾール−5−イル)−ピリ
ジン−3−イル]−アリル}−アミドの合成 実施例 DL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 624 (MH+) 1H-NMR(CD3OD): 2.50 (3H, s), 3.56 (3H, s), 3.98 (5
H, br s), 4.03 (3H,s), 5.66 (1H, dt), 5.96 (2H,
s), 6.29 (1H, d), 6.43-6.52 (2H, m), 6.62-6.78 (4
H, m), 6.90 (2H, d), 8.17 (1H, d)2) 2,6-dimethoxy-pyridine-3-
Carboxylic acid {3- [4- (4-methoxyphenyl)-
Synthesis of 2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Example DL-pyroglutamic acid 3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 624 (MH +) 1H-NMR (CD3OD): 2.50 (3H, s), 3.56 (3H, s), 3.98 (5
H, br s), 4.03 (3H, s), 5.66 (1H, dt), 5.96 (2H,
s), 6.29 (1H, d), 6.43-6.52 (2H, m), 6.62-6.78 (4
H, m), 6.90 (2H, d), 8.17 (1H, d)
【0368】実施例104 2−メチル安息香酸{3−
[4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−5−(1
H−テトラゾール−5−イル)−ピリジン−3−イル]
−アリル}−アミド の合成 1)2−メチル安息香酸 {3−[5−シアノ−4−
(4−メトキシフェニル)−2−メチル−6−(3,4
−メチレンジオキシ−フェノキシ)−ピリジン−3−イ
ル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 534 (MH+) 1H-NMR(CDCl3): 2.37 (3H, s), 2.46 (3H, s), 3.74 (3
H, s), 4.00 (2H, t),5.55 (1H, dt), 5.70 (1H, br),
6.00 (2H, s), 6.26 (1H, d), 6.64-6.81 (3H, m), 6.9
4 (2H, d), 7.16-7.35 (6H, m)Example 104 2-Methylbenzoic acid {3-
[4- (4-methoxyphenyl) -2-methyl-6-
(3,4-methylenedioxy-phenoxy) -5- (1
H-tetrazol-5-yl) -pyridin-3-yl]
Synthesis of -allyl} -amide 1) 2-Methylbenzoic acid {3- [5-cyano-4-
(4-methoxyphenyl) -2-methyl-6- (3,4
Synthesis of -Methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6 of Example −
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 534 (MH +) 1H-NMR (CDCl3): 2.37 (3H, s), 2.46 (3H, s), 3.74 (3
H, s), 4.00 (2H, t), 5.55 (1H, dt), 5.70 (1H, br),
6.00 (2H, s), 6.26 (1H, d), 6.64-6.81 (3H, m), 6.9
4 (2H, d), 7.16-7.35 (6H, m)
【0369】2)2−メチル安息香酸 {3−[4−
(4−メトキシフェニル)−2−メチル−6−(3,4
−メチレンジオキシ−フェノキシ)−5−(1H−テト
ラゾール−5−イル)−ピリジン−3−イル]−アリ
ル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 577 (MH+) 1H-NMR(CD3OD): 2.31 (3H, s), 2.52 (3H, s), 3.67 (3
H, s), 3.93 (2H, brd), 5.68 (1H, dt), 5.96 (2H,
s), 6.32 (1H, d), 6.48-6.63 (2H, m), 6.75-6.79 (3
H, m), 6.96 (2H, d), 7.10-7.31 (4H, m)2) 2-Methylbenzoic acid {3- [4-
(4-methoxyphenyl) -2-methyl-6- (3,4
Synthesis of -methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 577 (MH +) 1H-NMR (CD3OD): 2.31 (3H, s), 2.52 (3H, s), 3.67 (3
H, s), 3.93 (2H, brd), 5.68 (1H, dt), 5.96 (2H,
s), 6.32 (1H, d), 6.48-6.63 (2H, m), 6.75-6.79 (3
H, m), 6.96 (2H, d), 7.10-7.31 (4H, m)
【0370】実施例105 2−フルオロ安息香酸{3
−[4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−5−(1
H−テトラゾール−5−イル)−ピリジン−3−イル]
−アリル}−アミド の合成 1)2−フルオロ安息香酸 {3−[5−シアノ−4−
(4−メトキシフェニル)−2−メチル−6−(3,4
−メチレンジオキシ−フェノキシ)−ピリジン−3−イ
ル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 538(MH+) 1H-NMR(CDCl3): 2.46 (3H, s), 3.74 (3H, s), 4.05 (2
H, t), 5.56 (1H, dt), 6.00 (2H, s), 6.27 (1H, d),
6.58-6.81 (4H, m), 6.92 (2H, d), 7.11 (1H,dd), 7.2
2-7.29 (3H, m), 7.42-7.52 (1H, m), 8.04 (1H, td)Example 105 2-Fluorobenzoic acid {3
-[4- (4-methoxyphenyl) -2-methyl-6-
(3,4-methylenedioxy-phenoxy) -5- (1
H-tetrazol-5-yl) -pyridin-3-yl]
Synthesis of -allyl} -amide 1) 2-Fluorobenzoic acid {3- [5-cyano-4-
(4-methoxyphenyl) -2-methyl-6- (3,4
Synthesis of -Methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6 of Example −
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 538 (MH +) 1H-NMR (CDCl3): 2.46 (3H, s), 3.74 (3H, s), 4.05 (2
H, t), 5.56 (1H, dt), 6.00 (2H, s), 6.27 (1H, d),
6.58-6.81 (4H, m), 6.92 (2H, d), 7.11 (1H, dd), 7.2
2-7.29 (3H, m), 7.42-7.52 (1H, m), 8.04 (1H, td)
【0371】2)2−フルオロ安息香酸 {3−[4−
(4−メトキシフェニル)−2−メチル−6−(3,4
−メチレンジオキシ−フェノキシ)−5−(1H−テト
ラゾール−5−イル)−ピリジン−3−イル]−アリ
ル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 581 (MH+) 1H-NMR(CD3OD): 2.51 (3H, s), 3.62 (3H, s), 3.95 (2
H, d), 5.65 (1H, dt), 5.96 (2H, s), 6.33 (1H, s),
6.49-6.78 (5H, m), 6.93 (2H, d), 7.14-7.28(2H, m),
7.50-7.64 (2H, m)2) 2-Fluorobenzoic acid {3- [4-
(4-methoxyphenyl) -2-methyl-6- (3,4
Synthesis of -methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 581 (MH +) 1H-NMR (CD3OD): 2.51 (3H, s), 3.62 (3H, s), 3.95 (2
H, d), 5.65 (1H, dt), 5.96 (2H, s), 6.33 (1H, s),
6.49-6.78 (5H, m), 6.93 (2H, d), 7.14-7.28 (2H, m),
7.50-7.64 (2H, m)
【0372】実施例106 2−トリフルオロメチル安
息香酸{3−[4−(4−メトキシフェニル)−2−メ
チル−6−(3,4−メチレンジオキシ−フェノキシ)
−5−(1H−テトラゾール−5−イル)−ピリジン−
3−イル]−アリル}−アミド の合成 1)2−トリフルオロメチル安息香酸 {3−[5−シ
アノ−4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−ピリジ
ン−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 588 (MH+) 1H-NMR(CDCl3): 2.47 (3H, s), 3.77 (3H, s), 4.01 (2
H, t), 5.56 (1H, dt), 5.67 (1H, br), 6.01 (2H, s),
6.26 (1H, d), 6.64-6.82 (3H, m), 6.94 (2H, d), 7.
24 (2H, d), 7.36-7.71 (4H, m)Example 106 2-trifluoromethylbenzoic acid {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy)
-5- (1H-tetrazol-5-yl) -pyridine-
Synthesis of 3-yl] -allyl} -amide 1) 2-trifluoromethylbenzoic acid {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6
Synthesis of-(3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl)-of Example] 2-methyl-6
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 588 (MH +) 1H-NMR (CDCl3): 2.47 (3H, s), 3.77 (3H, s), 4.01 (2
H, t), 5.56 (1H, dt), 5.67 (1H, br), 6.01 (2H, s),
6.26 (1H, d), 6.64-6.82 (3H, m), 6.94 (2H, d), 7.
24 (2H, d), 7.36-7.71 (4H, m)
【0373】2)2−トリフルオロメチル安息香酸
{3−[4−(4−メトキシフェニル)−2−メチル−
6−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 631 (MH+) 1H-NMR(CD3OD): 2.52 (3H, s), 3.69 (3H, s), 3.93 (2
H, d), 5.68 (1H, dt), 5.96 (2H, s), 6.33 (1H, d),
6.49-6.63 (2H, m), 6.75-6.81 (3H, m), 6.98(2H, d),
7.24-7.27 (1H, m), 7.60-7.88 (3H, m)2) 2-trifluoromethylbenzoic acid
{3- [4- (4-methoxyphenyl) -2-methyl-
6- (3,4-methylenedioxy-phenoxy) -5
Synthesis of (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 631 (MH +) 1H-NMR (CD3OD): 2.52 (3H, s), 3.69 (3H, s), 3.93 (2
H, d), 5.68 (1H, dt), 5.96 (2H, s), 6.33 (1H, d),
6.49-6.63 (2H, m), 6.75-6.81 (3H, m), 6.98 (2H, d),
7.24-7.27 (1H, m), 7.60-7.88 (3H, m)
【0374】実施例107 3−トリフルオロメチル安
息香酸{3−[4−(4−メトキシフェニル)−2−メ
チル−6−(3,4−メチレンジオキシ−フェノキシ)
−5−(1H−テトラゾール−5−イル)−ピリジン−
3−イル]−アリル}−アミド の合成 1)3−トリフルオロメチル安息香酸 {3−[5−シ
アノ−4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−ピリジ
ン−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 588 (MH+) 1H-NMR(CDCl3): 2.45 (3H, s), 3.71 (3H, s), 4.02 (2
H, t), 5.51 (1H, dt), 6.01 (2H, s), 6.09 (1H, br),
6.28 (1H, d), 6.63-6.81 (3H, m), 6.90 (2H, d), 7.
22 (2H, d), 7.57 (1H, t), 7.78 (1H, q), 7.96 (1H,
s)Example 107 3-trifluoromethylbenzoic acid {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy)
-5- (1H-tetrazol-5-yl) -pyridine-
Synthesis of 3-yl] -allyl} -amide 1) 3-trifluoromethylbenzoic acid {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6
Synthesis of-(3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl)-of Example] 2-methyl-6
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 588 (MH +) 1H-NMR (CDCl3): 2.45 (3H, s), 3.71 (3H, s), 4.02 (2
H, t), 5.51 (1H, dt), 6.01 (2H, s), 6.09 (1H, br),
6.28 (1H, d), 6.63-6.81 (3H, m), 6.90 (2H, d), 7.
22 (2H, d), 7.57 (1H, t), 7.78 (1H, q), 7.96 (1H,
s)
【0375】2)3−トリフルオロメチル安息香酸
{3−[4−(4−メトキシフェニル)−2−メチル−
6−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 631 (MH+) 1H−NMR(CD3OD): 2.49 (3H,
s), 3.52 (3H, s), 3.95 (2
H, br), 5.64 (1H, dt), 5.
96 (2H, s), 6.30 (1H, d),
6.47−6.92 (7H, m), 7.62−
8.04 (4H, m), 8.70 (1H, b
r)2) 3-trifluoromethylbenzoic acid
{3- [4- (4-methoxyphenyl) -2-methyl-
6- (3,4-methylenedioxy-phenoxy) -5
Synthesis of (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 631 (MH +) 1H-NMR (CD3OD): 2.49 (3H,
s), 3.52 (3H, s), 3.95 (2
H, br), 5.64 (1H, dt), 5.
96 (2H, s), 6.30 (1H, d),
6.47-6.92 (7H, m), 7.62-
8.04 (4H, m), 8.70 (1H, b
r)
【0376】実施例108 2、5−ジフルオロ安息香
酸{3−[4−(4−メトキシフェニル)−2−メチル
−6−(3,4−メチレンジオキシ−フェノキシ)−5
−(1H−テトラゾール−5−イル)−ピリジン−3−
イル]−アリル}−アミド の合成 1)2,5−ジフルオロ安息香酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 556 (MH+) 1H-NMR(CDCl3): 2.46 (3H, s), 3.76 (3H, s), 4.04 (2
H, br), 5.54 (1H, dt), 6.00 (2H, s), 6.25 (1H, d),
6.64-6.81 (3H, m), 6.92 (2H, d), 7.10-7.26 (4H,
m), 7.70-7.76 (1H, m)Example 108 2,5-Difluorobenzoic acid {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5]
-(1H-tetrazol-5-yl) -pyridin-3-
Synthesis of yl] -allyl} -amide 1) 2,5-difluorobenzoic acid {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6-
Synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl) -2 of Example] -Methyl-6-
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 556 (MH +) 1H-NMR (CDCl3): 2.46 (3H, s), 3.76 (3H, s), 4.04 (2
H, br), 5.54 (1H, dt), 6.00 (2H, s), 6.25 (1H, d),
6.64-6.81 (3H, m), 6.92 (2H, d), 7.10-7.26 (4H,
m), 7.70-7.76 (1H, m)
【0377】2)2,5−ジフルオロ安息香酸 {3−
[4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−5−(1
H−テトラゾール−5−イル)−ピリジン−3−イル]
−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 599 (MH+) 1H-NMR(CDCl3): 2.50 (3H, s), 3.66 (3H, s), 4.02 (2
H, br), 5.55 (1H, dt), 5.97 (2H, s), 6.27 (1H, d),
6.51-6.78 (5H, m), 6.92 (2H, d), 6.95-7.19 (2H,
m), 7.67 (1H, br)2) 2,5-difluorobenzoic acid {3-
[4- (4-methoxyphenyl) -2-methyl-6-
(3,4-methylenedioxy-phenoxy) -5- (1
H-tetrazol-5-yl) -pyridin-3-yl]
Synthesis of -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 599 (MH +) 1H-NMR (CDCl3): 2.50 (3H, s), 3.66 (3H, s), 4.02 (2
H, br), 5.55 (1H, dt), 5.97 (2H, s), 6.27 (1H, d),
6.51-6.78 (5H, m), 6.92 (2H, d), 6.95-7.19 (2H,
m), 7.67 (1H, br)
【0378】実施例109 4−トリフルオロメトキシ
安息香酸{3−[4−(4−メトキシフェニル)−2−
メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−5−(1H−テトラゾール−5−イル)−ピリジ
ン−3−イル]−アリル}−アミド の合成 1)4−トリフルオロメトキシ安息香酸 {3−[5−
シアノ−4−(4−メトキシフェニル)−2−メチル−
6−(3,4−メチレンジオキシ−フェノキシ)−ピリ
ジン−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 604 (MH+) 1H-NMR(CDCl3): 2.46 (3H, s), 3.75 (3H, s), 4.02 (2
H, t), 5.49 (1H, dt), 5.80 (1H, br), 6.02 (1H, d),
6.29 (1H, d), 6.64-6.82 (3H, m), 6.94 (2H, d), 7.
23-7.29 (4H, m), 7.68 (2H, d)Example 109 4-trifluoromethoxybenzoic acid {3- [4- (4-methoxyphenyl) -2-
Synthesis of methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide 1) 4-trifluoromethoxybenzoic acid {3- [5-
Cyano-4- (4-methoxyphenyl) -2-methyl-
Synthesis of 6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl) of Example] -2-methyl-6-
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 604 (MH +) 1H-NMR (CDCl3): 2.46 (3H, s), 3.75 (3H, s), 4.02 (2
H, t), 5.49 (1H, dt), 5.80 (1H, br), 6.02 (1H, d),
6.29 (1H, d), 6.64-6.82 (3H, m), 6.94 (2H, d), 7.
23-7.29 (4H, m), 7.68 (2H, d)
【0379】2)4−トリフルオロメトキシ安息香酸
{3−[4−(4−メトキシフェニル)−2−メチル−
6−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 647 (MH+) 1H-NMR(CDCl3): 2.50 (3H, s), 3.62 (3H, s), 3.98 (2
H, br d), 5.55 (1H,dt), 5.96 (2H, s), 6.28 (1H,
d), 6.51-6.76 (5H, m), 6.92 (2H, d), 7.26 (2H, d),
7.72 (2H, d)2) 4-trifluoromethoxybenzoic acid
{3- [4- (4-methoxyphenyl) -2-methyl-
6- (3,4-methylenedioxy-phenoxy) -5
Synthesis of (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 647 (MH +) 1H-NMR (CDCl3): 2.50 (3H, s), 3.62 (3H, s), 3.98 (2
H, br d), 5.55 (1H, dt), 5.96 (2H, s), 6.28 (1H,
d), 6.51-6.76 (5H, m), 6.92 (2H, d), 7.26 (2H, d),
7.72 (2H, d)
【0380】実施例110 4−トリフルオロメチル安
息香酸{3−[4−(4−メトキシフェニル)−2−メ
チル−6−(3,4−メチレンジオキシ−フェノキシ)
−5−(1H−テトラゾール−5−イル)−ピリジン−
3−イル]−アリル}−アミド の合成 1)4−トリフルオロメチル安息香酸 {3−[5−シ
アノ−4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−ピリジ
ン−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 588 (MH+) 1H-NMR(CDCl3): 2.45 (3H,s), 3.72 (3H, s), 4.03 (2
H, t), 5.50 (1H, dt),5.90 (1H, br), 6.01 (2H, s),
6.29 (1H, d), 6.63-6.82 (3H, m), 6.92 (2H,d), 7.23
(2H, d), 7.72 (4H, q)Example 110 4-trifluoromethylbenzoic acid {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy)
-5- (1H-tetrazol-5-yl) -pyridine-
Synthesis of 3-yl] -allyl} -amide 1) 4-trifluoromethylbenzoic acid {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6
Synthesis of-(3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl)-of Example] 2-methyl-6
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 588 (MH +) 1H-NMR (CDCl3): 2.45 (3H, s), 3.72 (3H, s), 4.03 (2
H, t), 5.50 (1H, dt), 5.90 (1H, br), 6.01 (2H, s),
6.29 (1H, d), 6.63-6.82 (3H, m), 6.92 (2H, d), 7.23
(2H, d), 7.72 (4H, q)
【0381】2)4−トリフルオロメチル安息香酸
{3−[4−(4−メトキシフェニル)−2−メチル−
6−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 631 (MH+) 1H-NMR(DMSO-d6): 2.46 (3H, s), 3.55(3H, s), 3.85
(2H, br), 5.64 (1H, dt), 6.05 (2H, s), 6.20 (1H,
d), 6.51-6.90 (7H, m), 7.86 (4H, q), 8.74 (1H, br)2) 4-trifluoromethylbenzoic acid
{3- [4- (4-methoxyphenyl) -2-methyl-
6- (3,4-methylenedioxy-phenoxy) -5
Synthesis of (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 631 (MH +) 1H-NMR (DMSO-d6): 2.46 (3H, s), 3.55 (3H, s), 3.85
(2H, br), 5.64 (1H, dt), 6.05 (2H, s), 6.20 (1H,
d), 6.51-6.90 (7H, m), 7.86 (4H, q), 8.74 (1H, br)
【0382】実施例111 3−フルオロ安息香酸{3
−[4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−5−(1
H−テトラゾール−5−イル)−ピリジン−3−イル]
−アリル}−アミド の合成 1)3−フルオロ安息香酸 {3−[5−シアノ−4−
(4−メトキシフェニル)−2−メチル−6−(3,4
−メチレンジオキシ−フェノキシ)−ピリジン−3−イ
ル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 538 (MH+) 1H-NMR(CDCl3): 2.44 (3H,s), 3.74 (3H, s), 4.00 (2
H, t), 5.50 (1H, dt),6.01 (2H, s), 6.26 (1H, d),
6.63-6.81 (3H, m), 6.92 (2H, d), 7.15-7,28(3H, m),
7.36-7.41 (3H, m)Example 111 3-Fluorobenzoic acid {3
-[4- (4-methoxyphenyl) -2-methyl-6-
(3,4-methylenedioxy-phenoxy) -5- (1
H-tetrazol-5-yl) -pyridin-3-yl]
Synthesis of -allyl} -amide 1) 3-Fluorobenzoic acid {3- [5-cyano-4-
(4-methoxyphenyl) -2-methyl-6- (3,4
Synthesis of -Methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6 of Example −
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 538 (MH +) 1H-NMR (CDCl3): 2.44 (3H, s), 3.74 (3H, s), 4.00 (2
H, t), 5.50 (1H, dt), 6.01 (2H, s), 6.26 (1H, d),
6.63-6.81 (3H, m), 6.92 (2H, d), 7.15-7,28 (3H, m),
7.36-7.41 (3H, m)
【0383】2)3−フルオロ安息香酸 {3−[4−
(4−メトキシフェニル)−2−メチル−6−(3,4
−メチレンジオキシ−フェノキシ)−5−(1H−テト
ラゾール−5−イル)−ピリジン−3−イル]−アリ
ル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 581 (MH+) 1H-NMR(DMSO-d6): 2.46 (3H, s), 3.60 (3H, s), 3.85
(2H, t), 5.63 (1H, dt), 6.05 (2H, s), 6.20 (1H,
d), 6.54 (1H, dd), 6.71-6.76 (3H, m), 6.88-6.93 (3
H, m), 7.36-7.52 (4H, m), 8.62 (1H, br t)2) 3-Fluorobenzoic acid {3- [4-
(4-methoxyphenyl) -2-methyl-6- (3,4
Synthesis of -methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 581 (MH +) 1H-NMR (DMSO-d6): 2.46 (3H, s), 3.60 (3H, s), 3.85
(2H, t), 5.63 (1H, dt), 6.05 (2H, s), 6.20 (1H,
d), 6.54 (1H, dd), 6.71-6.76 (3H, m), 6.88-6.93 (3
H, m), 7.36-7.52 (4H, m), 8.62 (1H, br t)
【0384】実施例112 2−メチル−ピリジン−3
−カルボン酸{3−[4−(4−メトキシフェニル)−
2−メチル−6−(3,4−メチレンジオキシ−フェノ
キシ)−5−(1H−テトラゾール−5−イル)−ピリ
ジン−3−イル]−アリル}−アミド の合成 1)2−メチル−ピリジン−3−カルボン酸 {3−
[5−シアノ−4−(4−メトキシフェニル)−2−メ
チル−6−(3,4−メチレンジオキシ−フェノキシ)
−ピリジン−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成に準じて合成し
た。 MS (ESI, m/z) 535 (MH+) 1H-NMR(CDCl3): 2.47 (3H,s), 2.60 (3H, s), 3.76 (3
H, s), 4.02 (2H, t),5.54 (1H, dt), 5.63 (1H, br),
6.02 (2H, s), 6.13 (1H, d), 6.64-6.82 (3H,m), 6.94
(2H, d), 7.14 (1H, dd), 7,24 (2H, d), 8.55 (1H, d
d)Example 112 2-Methyl-pyridine-3
-Carboxylic acid {3- [4- (4-methoxyphenyl)-]
Synthesis of 2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide 1) 2-Methyl-pyridine -3-carboxylic acid {3-
[5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy)
Synthesis of -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6-methyl-6
It was synthesized according to the synthesis of (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 535 (MH +) 1H-NMR (CDCl3): 2.47 (3H, s), 2.60 (3H, s), 3.76 (3
H, s), 4.02 (2H, t), 5.54 (1H, dt), 5.63 (1H, br),
6.02 (2H, s), 6.13 (1H, d), 6.64-6.82 (3H, m), 6.94
(2H, d), 7.14 (1H, dd), 7,24 (2H, d), 8.55 (1H, d
d)
【0385】2)2−メチル−ピリジン−3−カルボン
酸 {3−[4−(4−メトキシフェニル)−2−メチ
ル−6−(3,4−メチレンジオキシ−フェノキシ)−
5−(1H−テトラゾール−5−イル)−ピリジン−3
−イル]−アリル}−アミド の合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成に準じて合成した。 MS (ESI, m/z) 578 (MH+) 1H-NMR(CD3OD): 2.52 (3H, s), 2.67 (3H, s), 3.68 (3
H, s), 3.99 (2H, br), 5.69 (1H, dt), 5.97 (2H, s),
6.34 (1H, d), 6.49-6.64 (2H, m), 6.76-6.80 (3H,
m), 6.97 (2H, d), 7.69 (1H, t), 8.04 (1H, d), 8.65
(1H, d)2) 2-Methyl-pyridine-3-carboxylic acid {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy)-
5- (1H-tetrazol-5-yl) -pyridine-3
Synthesis of -yl] -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. MS (ESI, m / z) 578 (MH +) 1H-NMR (CD3OD): 2.52 (3H, s), 2.67 (3H, s), 3.68 (3
H, s), 3.99 (2H, br), 5.69 (1H, dt), 5.97 (2H, s),
6.34 (1H, d), 6.49-6.64 (2H, m), 6.76-6.80 (3H,
m), 6.97 (2H, d), 7.69 (1H, t), 8.04 (1H, d), 8.65
(1H, d)
【0386】実施例113 N−{3−[4−(4−メ
トキシフェニル)−2−メチル−6−(3,4−メチレ
ンジオキシ−フェノキシ)−5−(1H−テトラゾール
−5−イル)−ピリジン−3−イル]−アリル}−オキ
ザラミド エチルエステルの合成 3−[4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル] −プロプ−2−エン−1−アミン73.0mg
(0.159mmol)を塩化メチレンに溶解し、クロ
ログリオキシル酸エチルエステル33.0mg(0.2
39mmol)を加え、室温にて3時間攪拌した。減圧
下溶媒を留去して、得られた残渣を水、アセトニトリル
にて洗浄し、表題化合物を得た。 MS (ESI, m/z) 559 (MH+) 1H-NMR(DMSO-d6): 1.26 (3H, t), 2.43 (3H, s), 3.69
(5H, br), 4.21 (2H,q), 5.49 (1H, dt), 6.05 (2H,
s), 6.16 (1H, d), 6.53 (1H, q), 6.75-6.80 (3H, m),
6.88-6.91 (3H, m), 8.93 (1H, br t)Example 113 N- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) Synthesis of -pyridin-3-yl] -allyl} -oxalamide ethyl ester 3- [4- (4-methoxyphenyl) -2-methyl-6
-(3,4-methylenedioxy-phenoxy) -5-
(1H-tetrazol-5-yl) -pyridin-3-yl] -prop-2-en-1-amine 73.0 mg.
(0.159 mmol) was dissolved in methylene chloride, and chloroglyoxylic acid ethyl ester 33.0 mg (0.23 mmol) was dissolved.
39 mmol) and stirred at room temperature for 3 hours. The solvent was distilled off under reduced pressure, and the obtained residue was washed with water and acetonitrile to obtain the title compound. MS (ESI, m / z) 559 (MH +) 1H-NMR (DMSO-d6): 1.26 (3H, t), 2.43 (3H, s), 3.69
(5H, br), 4.21 (2H, q), 5.49 (1H, dt), 6.05 (2H,
s), 6.16 (1H, d), 6.53 (1H, q), 6.75-6.80 (3H, m),
6.88-6.91 (3H, m), 8.93 (1H, br t)
【0387】実施例114 1−{3−[4−(4−メ
トキシフェニル)−2−メチル−6−(3,4−メチレ
ンジオキシ−フェノキシ)−5−(1H−テトラゾール
−5−イル)−ピリジン−3−イル]−アリル}−3−
フェニル−チオウレアの合成 3−[4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル] −プロプ−2−エン−1−アミン54.0mg
(0.118mmol)をジオキサン溶解し、フェニル
イソチオシアネート19.0mg(0.141mmo
l)を加え、100℃にて3時間攪拌した。減圧下溶媒
を留去して、得られた残渣を酢酸エチルに溶解し、有機
層を無水硫酸マグネシウムで乾燥、減圧下濃縮した。残
渣をカラムクロマトグラフィー(クロロホルム−メタノ
ール=100:1から10:1)にて精製し、表題化合
物を得た。 MS (ESI, m/z) 594 (MH+) 1H-NMR(CD3OD): 2.51 (3H, s), 3.70 (3H, s), 4.17 (2
H, br d), 5.65 (1H,dt), 5.96 (2H, s), 6.25 (1H,
d), 6.48-6.63 (2H, m), 6.75-6.81 (3H, m), 6.97 (2
H, d), 7.17-7.22 (3H, m), 7.32-7.37 (2H, m)Example 114 1- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -Pyridin-3-yl] -allyl} -3-
Synthesis of phenyl-thiourea 3- [4- (4-methoxyphenyl) -2-methyl-6
-(3,4-methylenedioxy-phenoxy) -5-
(1H-tetrazol-5-yl) -pyridin-3-yl] -prop-2-en-1-amine 54.0 mg.
(0.118 mmol) was dissolved in dioxane, and 19.0 mg (0.141 mmol) of phenylisothiocyanate was dissolved.
l) was added and the mixture was stirred at 100 ° C for 3 hours. The solvent was distilled off under reduced pressure, and the obtained residue was dissolved in ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was purified by column chromatography (chloroform-methanol = 100: 1 to 10: 1) to obtain the title compound. MS (ESI, m / z) 594 (MH +) 1H-NMR (CD3OD): 2.51 (3H, s), 3.70 (3H, s), 4.17 (2
H, br d), 5.65 (1H, dt), 5.96 (2H, s), 6.25 (1H,
d), 6.48-6.63 (2H, m), 6.75-6.81 (3H, m), 6.97 (2
H, d), 7.17-7.22 (3H, m), 7.32-7.37 (2H, m)
【0388】実施例115 1−{3−[4−(4−メ
トキシフェニル)−2−メチル−6−(3,4−メチレ
ンジオキシ−フェノキシ)−5−(1H−テトラゾール
−5−イル)−ピリジン−3−イル]−アリル}−3−
ピリジン−4−イル−ウレアの合成 3−[4−(4−メトキシフェニル)−2−メチル−6
−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル] −プロプ−2−エン−1−アミン150mg(0.
327mmol)をジオキサン溶解し、ピリジン−4−
カルバミン酸 フェニルエステル105mg(0.49
1mmol)を加え、100℃にて24時間攪拌した。
減圧下溶媒を留去して、得られた残留物をオクタドデシ
ル(ODS)基化学結合型シリカゲルを充填剤とする逆
相高速液体クロマトグラフィーに付し、トリフルオロ酢
酸を0.1%含有する(v/v)水−アセトニトリルの
混合溶媒で溶出し、目的物のフラクションを凍結乾燥す
ることにより表題化合物を得た。 収量 85mg(0.147mmol) 収率 45% MS (ESI, m/z) 579 (MH+) 1H-NMR(CD3OD): 2.50 (3H, s), 3.62 (3H, s), 3.81 (2
H, d), 5.62 (1H, dt), 5.97 (2H, s), 6.28 (1H, d),
6.48-6.63 (2H, m), 6.71-6.79 (3H, m), 6.94(2H, d),
7.89 (2H, d), 8.45 (2H, d)Example 115 1- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -Pyridin-3-yl] -allyl} -3-
Synthesis of pyridin-4-yl-urea 3- [4- (4-methoxyphenyl) -2-methyl-6
-(3,4-methylenedioxy-phenoxy) -5-
(1H-tetrazol-5-yl) -pyridin-3-yl] -prop-2-en-1-amine 150 mg (0.
327 mmol) was dissolved in dioxane, and pyridine-4-
Carbamic acid phenyl ester 105 mg (0.49
1 mmol) and stirred at 100 ° C. for 24 hours.
The solvent was distilled off under reduced pressure, and the obtained residue was subjected to reversed-phase high-performance liquid chromatography using octadodecyl (ODS) group chemically bonded silica gel as a filler, containing 0.1% of trifluoroacetic acid. (V / v) The mixture was eluted with a mixed solvent of water-acetonitrile, and the target compound was lyophilized to give the title compound. Yield 85 mg (0.147 mmol) Yield 45% MS (ESI, m / z) 579 (MH +) 1H-NMR (CD3OD): 2.50 (3H, s), 3.62 (3H, s), 3.81 (2
H, d), 5.62 (1H, dt), 5.97 (2H, s), 6.28 (1H, d),
6.48-6.63 (2H, m), 6.71-6.79 (3H, m), 6.94 (2H, d),
7.89 (2H, d), 8.45 (2H, d)
【0389】実施例116 1−{3−[4−(4−メ
トキシフェニル)−2−メチル−6−(3,4−メチレ
ンジオキシ−フェノキシ)−5−(1H−テトラゾール
−5−イル)−ピリジン−3−イル]−アリル}−3−
ピラジン−2−イル−ウレアの合成 ピラジン−2−カルボン酸60.9mg(0.491m
mol)をトルエン10mlに溶かし、アジ化ジフェニ
ルホスホリル72.5mg(0.589mmol),ト
リエチルアミン59.6mg(0.589mmol)を
加え、80℃にて2時間攪拌した。その後3−[4−
(4−メトキシフェニル)−2−メチル−6−(3,4
−メチレンジオキシ−フェノキシ)−5−(1H−テト
ラゾール−5−イル)−ピリジン−3−イル] −プロプ
−2−エン−1−アミン150mg(0.327mmo
l)を80℃にて加え、さらに12時間攪拌した。反応
終了後減圧下溶媒を留去して、得られた残留物をオクタ
ドデシル(ODS)基化学結合型シリカゲルを充填剤と
する逆相高速液体クロマトグラフィーに付し、トリフル
オロ酢酸を0.1%含有する(v/v)水−アセトニト
リルの混合溶媒で溶出し、目的物のフラクションを凍結
乾燥することにより表題化合物を得た。 収量 32mg(0.0552mmol) 収率 17
% MS (ESI, m/z) 580 (MH+) 1H-NMR(CD3OD): 2.50 (3H, s), 3.59 (3H, s), 3.89 (2
H, br), 5.62 (1H, dt), 5.96 (2H, s), 6.25-6.93 (8
H, m), 8.13 (2H, d), 8.50 (1H, s)Example 116 1- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -Pyridin-3-yl] -allyl} -3-
Synthesis of pyrazin-2-yl-urea 60.9 mg of pyrazine-2-carboxylic acid (0.491 m
mol) was dissolved in 10 ml of toluene, 72.5 mg (0.589 mmol) of diphenylphosphoryl azide and 59.6 mg (0.589 mmol) of triethylamine were added, and the mixture was stirred at 80 ° C. for 2 hours. Then 3- [4-
(4-methoxyphenyl) -2-methyl-6- (3,4
-Methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -prop-2-en-1-amine 150 mg (0.327 mmol
1) was added at 80 ° C., and the mixture was further stirred for 12 hours. After completion of the reaction, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to reversed-phase high-performance liquid chromatography using octadodecyl (ODS) group chemically bonded silica gel as a packing material. % Of (v / v) mixed solvent of water-acetonitrile, and the target compound was lyophilized to obtain the title compound. Yield 32 mg (0.0552 mmol) Yield 17
% MS (ESI, m / z) 580 (MH +) 1H-NMR (CD3OD): 2.50 (3H, s), 3.59 (3H, s), 3.89 (2
H, br), 5.62 (1H, dt), 5.96 (2H, s), 6.25-6.93 (8
H, m), 8.13 (2H, d), 8.50 (1H, s)
【0390】実施例117 N−{3−[4−(4−メ
トキシフェニル)−2−メチル−6−(3,4−メチレ
ンジオキシ−フェノキシ)−5−(1H−テトラゾール
−5−イル)−ピリジン−3−イル]−アリル}−2−
トリクロロ−アセトアミドの合成 1)N−{3−[5−シアノ−4−(4−メトキシフェ
ニル)−2−メチル−6−(3,4−メチレンジオキシ
−フェノキシ)−ピリジン−3−イル]−アリル}−2
−トリクロロ−アセトアミドの合成 3−[5−シアノ−4−(4−メトキシフェニル)−2
−メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−ピリジン−3−イル]−アリル}−プロプ−2−
エン−1−アミン200g(0.481mmol)をジ
オキサン10mlに溶解し、ヘキサクロロアセトン19
1mg(0.722mmol)を加え100℃にて3時
間攪拌した。減圧下溶媒を留去し、残渣を酢酸エチルに
溶解し水、飽和食塩水で洗浄した。有機層を無水硫酸マ
グネシウムで乾燥し減圧下溶媒を留去した。得られた残
渣をシリカゲルカラムクロマトグラフィー(ヘキサン−
酢酸エチル=3:1)で精製し表題化合物を得た。 収量 240mg(0.428mmol) 収率 8
9.0% MS (ESI, m/z) 560 (MH+) 1H-NMR(CDCl3): 2.44 (3H,s), 3.85 (3H, s), 3.92 (2
H, br), 5.46 (1H, dt), 6.01 (2H, s), 6.29 (1H, d),
6.59-6.82 (4H, m), 6.97 (2H, d), 7.23 (2H,d),Example 117 N- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -Pyridin-3-yl] -allyl} -2-
Synthesis of trichloro-acetamide 1) N- {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -Allyl} -2
Synthesis of 3-trichloro-acetamide 3- [5-cyano-4- (4-methoxyphenyl) -2
-Methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -prop-2-
200 g (0.481 mmol) of ene-1-amine was dissolved in 10 ml of dioxane, and hexachloroacetone 19 was dissolved.
1 mg (0.722 mmol) was added, and the mixture was stirred at 100 ° C. for 3 hours. The solvent was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate and washed with water and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (hexane-
Purification by ethyl acetate (3: 1) gave the title compound. Yield 240 mg (0.428 mmol) Yield 8
9.0% MS (ESI, m / z) 560 (MH +) 1H-NMR (CDCl3): 2.44 (3H, s), 3.85 (3H, s), 3.92 (2
H, br), 5.46 (1H, dt), 6.01 (2H, s), 6.29 (1H, d),
6.59-6.82 (4H, m), 6.97 (2H, d), 7.23 (2H, d),
【0391】2)N−{3−[4−(4−メトキシフェ
ニル)−2−メチル−6−(3,4−メチレンジオキシ
−フェノキシ)−5−(1H−テトラゾール−5−イ
ル)−ピリジン−3−イル]−アリル}−2−トリクロ
ロ−アセトアミドの合成 N−{3−[5−シアノ−4−(4−メトキシフェニ
ル)−2−メチル−6−(3,4−メチレンジオキシ−
フェノキシ)−ピリジン−3−イル]−アリル}−2−
トリクロロ−アセトアミド240mg(0.428mm
ol)をアジ化トリ−n−ブチルスズ568mg(1.
71mmol)を加え2日間加熱環流した。反応終了後
4規定塩酸−ジオキサン、酢酸エチル加えて析出してく
る結晶を濾過した。得られた結晶をシリカゲルカラムク
ロマトグラフィー(クロロホルム−メタノール=20:
1)で精製し表題化合物を得た。 収量 160mg(0.265mmol) 収率 6
2.0% MS (ESI, m/z) 603 (MH+) 1H-NMR(CD3OD): 2.49 (3H,s), 3.75 (3H, s), 3.86 (2
H, d), 5.58 (1H, dt),5.96 (1H, s), 6.28 (1H, d),
6.48-6.63 (2H, m) , 6.75-6.81 (3H, m), 6.93(2H, d)2) N- {3- [4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl)- Synthesis of pyridin-3-yl] -allyl} -2-trichloro-acetamide N- {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy) −
Phenoxy) -pyridin-3-yl] -allyl {-2-
240 mg of trichloro-acetamide (0.428 mm
ol) with 568 mg of tri-n-butyltin azide (1.
(71 mmol) and refluxed under heating for 2 days. After completion of the reaction, 4N hydrochloric acid-dioxane and ethyl acetate were added, and the precipitated crystals were filtered. The obtained crystals were subjected to silica gel column chromatography (chloroform-methanol = 20:
Purification in 1) gave the title compound. Yield 160 mg (0.265 mmol) Yield 6
2.0% MS (ESI, m / z) 603 (MH +) 1H-NMR (CD3OD): 2.49 (3H, s), 3.75 (3H, s), 3.86 (2
H, d), 5.58 (1H, dt), 5.96 (1H, s), 6.28 (1H, d),
6.48-6.63 (2H, m), 6.75-6.81 (3H, m), 6.93 (2H, d)
【0392】実施例118 5−ブロモフラン−2−カ
ルボン酸 {3−[4−(4−メトキシフェニル)−2
−メチル−6−(3,4−メチレンジオキシ−フェノキ
シ)−5−(1H−テトラゾール−5−イル)−ピリジ
ン−3−イル]−アリル}−アミドの合成 1)5−ブロモ−フラン−2−カルボン酸 {3−[5
−シアノ−4−(4−メトキシフェニル)−2−メチル
−6−(3,4−メチレンジオキシ−フェノキシ)−ピ
リジン−3−イル]−アリル}−アミドの合成 実施例のDL−ピログルタミン酸 {3−[5−シアノ
−4−(4−メトキシフェニル)−2−メチル−6−
(3,4−メチレンジオキシ−フェノキシ)−ピリジン
−3−イル]−アリル}−アミドの合成と同様に合成し
た。 MS (ESI, m/z) 590 (MH+) 1H-NMR(CDCl3): 2.45 (3H, s), 3.81 (3H, s), 3.96 (2
H, t), 5.49 (1H, dt), 6.00 (2H, s), 6.17-6.28 (2
H, m), 6.45 (1H, d), 6.64-6.82 (3H, m), 6.94-7.05
(3H, m), 7.23 (1H, dt)Example 118 5-Bromofuran-2-carboxylic acid {3- [4- (4-methoxyphenyl) -2]
Synthesis of -methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide 1) 5-bromo-furan- 2-carboxylic acid {3- [5
Synthesis of -cyano-4- (4-methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid of the example {3- [5-cyano-4- (4-methoxyphenyl) -2-methyl-6-
(3,4-Methylenedioxy-phenoxy) -pyridin-3-yl] -allyl} -amide. MS (ESI, m / z) 590 (MH +) 1H-NMR (CDCl3): 2.45 (3H, s), 3.81 (3H, s), 3.96 (2
H, t), 5.49 (1H, dt), 6.00 (2H, s), 6.17-6.28 (2
H, m), 6.45 (1H, d), 6.64-6.82 (3H, m), 6.94-7.05
(3H, m), 7.23 (1H, dt)
【0393】2)5−ブロモフラン−2−カルボン酸
{3−[4−(4−メトキシフェニル)−2−メチル−
6−(3,4−メチレンジオキシ−フェノキシ)−5−
(1H−テトラゾール−5−イル)−ピリジン−3−イ
ル]−アリル}−アミド の合成 実施例のDL−ピログルタミン酸 {3−[4−(4−
メトキシフェニル)−2−メチル−6−(3,4−メチ
レンジオキシ−フェノキシ)−5−(1H−テトラゾー
ル−5−イル)−ピリジン−3−イル]−アリル}−ア
ミド の合成と同様に合成した。 1H-NMR (CD3OD): 2.49 (3H, s), 3.66 (3H, s), 3.85
(2H, br d), 5.55 (1H,dt), 5.96 (2H, s), 6.28 (1H,
d), 6.48-6.62 (3H, m), 6.70 (2H, d), 6.76(1H, d),
6.91 (2H, dt), 7.02 (1H, d)2) 5-bromofuran-2-carboxylic acid
{3- [4- (4-methoxyphenyl) -2-methyl-
6- (3,4-methylenedioxy-phenoxy) -5
Synthesis of (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide DL-pyroglutamic acid {3- [4- (4-
Methoxyphenyl) -2-methyl-6- (3,4-methylenedioxy-phenoxy) -5- (1H-tetrazol-5-yl) -pyridin-3-yl] -allyl} -amide Synthesized. 1H-NMR (CD3OD): 2.49 (3H, s), 3.66 (3H, s), 3.85
(2H, br d), 5.55 (1H, dt), 5.96 (2H, s), 6.28 (1H,
d), 6.48-6.62 (3H, m), 6.70 (2H, d), 6.76 (1H, d),
6.91 (2H, dt), 7.02 (1H, d)
【0394】上記で合成した化合物を下記表に示す。The compounds synthesized above are shown in the following table.
【0395】[0395]
【表1】 [Table 1]
【0396】[0396]
【表2】 [Table 2]
【0397】[0397]
【表3】 [Table 3]
【0398】[0398]
【表4】 [Table 4]
【0399】[0399]
【表5】 [Table 5]
【0400】[0400]
【表6】 [Table 6]
【0401】[0401]
【表7】 [Table 7]
【0402】[0402]
【表8】 [Table 8]
【0403】[0403]
【表9】 [Table 9]
【0404】[0404]
【表10】 [Table 10]
【0405】[0405]
【表11】 [Table 11]
【0406】[0406]
【表12】 [Table 12]
【0407】[0407]
【表13】 [Table 13]
【0408】[0408]
【表14】 [Table 14]
【0409】[0409]
【表15】 [Table 15]
【0410】エンドセリン受容体に対する本発明の化合
物の抑制活性を下記の試験行程を使用して示すことがで
きる。The inhibitory activity of the compounds of the present invention on endothelin receptors can be demonstrated using the following test procedure.
【0411】(試験例)エンドセリンー1拮抗活性 エンドセリンー1拮抗活性は、放射性リガンドを[12
5I]エンドセリンー1とし、また受容体に豚心室筋膜
を用いた受容体結合反応により上記ピリジン誘導体の阻
害活性を測定した。(Test Example) Endothelin-1 antagonistic activity Endothelin-1 antagonistic activity was determined by activating the radioligand with [12
5I] endothelin-1 and the inhibitory activity of the pyridine derivative was measured by a receptor binding reaction using porcine ventricular fascia as a receptor.
【0412】1)ブタ心室筋膜調製法 屠殺直後のブタ心臓を購入し、心室のみを取り出した。
表層の血管部分等を取り除いた後細かく切り、緩衝液A
(20mM NaHCO3,0.1mM PMSF,1
mM EDTA)を加えてホモジナイザーで3回ホモジ
ネートした。ホモジネートを遠心(1000g×10m
in,4℃)にかけ、その沈殿物を再度遠心し上清を得
た。先ほどの上清と合わせてさらに遠心(35000g
×20min,4℃)し沈殿を得た。この沈殿物を緩衝
液B(50mM Tris/HCl(pH7.4),
0.1mM フェニルメタンスルホニル フルオライド
(以下PMSFと略す),1mM エチレンジアミン四
酢酸(以下EDTAと略す))を加えホモジナイザーで
ホモジネート後、遠心(35000g×20min,4
℃)をかけ沈殿を得た。この沈殿物を緩衝液Bを加えて
再びホモジネート後、0.2g/2mlになるよう緩衝
液Bで希釈分注した。これをレセプターを含む膜画分と
して、使用時まで−80℃で凍結保存した。1) Method for Preparing Porcine Ventricular Fascia The pig heart immediately after sacrifice was purchased, and only the ventricle was taken out.
After removing the surface blood vessel portion and the like, cut finely, buffer A
(20 mM NaHCO3, 0.1 mM PMSF, 1
mM EDTA) and homogenized three times with a homogenizer. Centrifuge the homogenate (1000g × 10m
in, 4 ° C.), and the precipitate was centrifuged again to obtain a supernatant. Further centrifuge (35,000 g)
× 20 min, 4 ° C.) to obtain a precipitate. This precipitate was washed with buffer B (50 mM Tris / HCl (pH 7.4),
0.1 mM phenylmethanesulfonyl fluoride (hereinafter abbreviated as PMSF) and 1 mM ethylenediaminetetraacetic acid (hereinafter abbreviated as EDTA) were added, homogenized with a homogenizer, and then centrifuged (35,000 g × 20 min, 4 μm).
° C) to obtain a precipitate. The precipitate was added with buffer B, homogenized again, and diluted and dispensed with buffer B to 0.2 g / 2 ml. This was frozen and stored at −80 ° C. until use as a membrane fraction containing the receptor.
【0413】2)受容体結合反応 放射リガンドとして[125I]エンドセリンー1(比
活性81.4TBq/mmol,濃度2870KBq/
ml,NEN社製)200μlをレセプター膜画分20
0μlと各検体200μl(緩衝液C(50mM トリ
ス(ヒドロキシメチル)アミノメタン(以下Trisと
略す)/HCl(pH7.4),0.1mM PMS
F,1mM EDTA,0.1%ウシ血清アルブミン
(以下BSAと略す))に溶かしたもの)に加え、37
℃にて90分間攪拌した。セルハーベスターにG/FB
グラスフィルターをセットし、ハーベスターでグラスフ
ィルター上に捕捉した蛋白を氷冷した緩衝液Cで3回洗
浄することにより、反応を終了させた。フィルター上に
残存するアイソトープ量をγカウンターにて、測定時間
1分間でγ線を測定した。なお、非特異的結合量は0.
1μMの非放射性エンドセリンー1を用いて測定した。2) Receptor binding reaction [125I] endothelin-1 (specific activity 81.4 TBq / mmol, concentration 2870 KBq /
200 μl) of the receptor membrane fraction 20
0 μl and 200 μl of each sample (buffer C (50 mM tris (hydroxymethyl) aminomethane (hereinafter abbreviated as Tris) / HCl (pH 7.4), 0.1 mM PMS
F, 1 mM EDTA, 0.1% bovine serum albumin (hereinafter abbreviated as BSA)) and 37
Stirred at 90 ° C. for 90 minutes. G / FB for cell harvester
A glass filter was set, and the reaction was terminated by washing the protein captured on the glass filter with a harvester three times with ice-cold buffer C. The amount of isotope remaining on the filter was measured for γ-ray with a γ-counter for a measurement time of 1 minute. The amount of non-specific binding was 0.1.
The measurement was performed using 1 μM of non-radioactive endothelin-1.
【0414】このように測定したピリジン誘導体の阻害
活性を表1に示す。なおpIC50値は化合物非存在下
での[125I]エンドセリンー1の特異的結合をコン
トロールとし、化合物存在下での特異的結合量を50%
減少させるのに必要な濃度の負の対数値で示した。The inhibitory activities of the pyridine derivatives thus measured are shown in Table 1. The pIC50 value was determined based on the specific binding of [125I] endothelin-1 in the absence of the compound as a control, and the specific binding amount in the presence of the compound was 50%.
Shown as the negative logarithmic value of the concentration required to reduce.
【0415】[0415]
【表16】 [Table 16]
【0416】表16から明らかな如く新規ピリジン誘導
体は優れたエンドセリンー1拮抗活性を示した。As is clear from Table 16, the novel pyridine derivatives exhibited excellent endothelin-1 antagonistic activity.
【0417】[0417]
【0418】本発明の新規ピリジン誘導体は優れたエン
ドセリンー1拮抗活性を示した。従って本発明の新規ピ
リジン誘導体は高血圧症、レイノー病、心筋梗塞、狭心
症、脳梗塞、脳血管攣縮、動脈硬化、冠動脈再狭窄、気
管支喘息、胃潰瘍、急性肝不全、糖尿病、前立腺肥大、
エンドキシンショック、多臓器不全、播種性血管内凝
固、急性腎不全、シクロスポリン誘発の腎障害などの治
療薬に利用できる。The novel pyridine derivative of the present invention exhibited excellent endothelin-1 antagonistic activity. Therefore, the novel pyridine derivative of the present invention is hypertensive, Raynaud's disease, myocardial infarction, angina, cerebral infarction, cerebral vasospasm, arteriosclerosis, coronary restenosis, bronchial asthma, gastric ulcer, acute liver failure, diabetes, prostatic hypertrophy,
It can be used as a therapeutic drug for endoxin shock, multiple organ failure, disseminated intravascular coagulation, acute renal failure, cyclosporine-induced renal damage, and the like.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 31/44 ADD A61K 31/44 ADD ADP ADP AED AED 31/47 ABU 31/47 ABU 31/505 ABN 31/505 ABN 31/535 ABX 31/535 ABX C07D 405/04 213 C07D 405/04 213 405/12 213 405/12 213 405/14 213 405/14 213 409/14 213 409/14 213 413/14 213 413/14 213 417/14 213 417/14 213 (72)発明者 内田 裕久 神奈川県川崎市川崎区鈴木町1−1 味の 素株式会社中央研究所内──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code Agency reference number FI Technical display location A61K 31/44 ADD A61K 31/44 ADD ADP ADP AED AED 31/47 ABU 31/47 ABU 31/505 ABN 31/505 ABN 31/535 ABX 31/535 ABX C07D 405/04 213 C07D 405/04 213 405/12 213 405/12 213 405/14 213 405/14 213 409/14 213 409/14 213 413/14 213 413/14 213 417/14 213 417/14 213 (72) Inventor Hirohisa Uchida 1-1, Suzukicho, Kawasaki-ku, Kawasaki-shi, Kanagawa Prefecture Ajinomoto Co., Inc.
Claims (5)
導体またはその医薬的に許容しうる塩。 【化1】 [式中、R1、R2、R3、R4及びR5はそれぞれ同じで
も異なっても良く、またいずれか二つが結合して環を構
成しても良く、水素原子、ハロゲン原子、水酸基、アミ
ノ基、ニトロ基、低級アルキル基、低級アルコキシ基、
低級アルケニル基、低級アルキルアミノ基、低級アルキ
ルチオ基、低級アルカノイル基、ヒドロキシ低級アルキ
ル基、ヒドロキシ低級アルコキシ基、ヒドロキシ低級ア
ルケニル基、ハロゲノ低級アルキル基、ハロゲノ低級ア
ルコキシ基、ハロゲノ低級アルケニル基、アリール低級
アルコキシ基、又はアロイル基のいずれかを表し、R6
は酸性官能基を表し、R7、R8、R9、R10及びR11は
それぞれ同じでも異なっても良く、またいずれか二つが
結合して環を構成しても良く、水素原子、ハロゲン原
子、水酸基、アミノ基、ニトロ基、低級アルキル基、低
級アルコキシ基、低級アルケニル基、低級アルキルアミ
ノ基、低級アルキルチオ基、低級アルカノイル基、ヒド
ロキシ低級アルキル基、ヒドロキシ低級アルコキシ基、
ヒドロキシ低級アルケニル基、ハロゲノ低級アルキル
基、ハロゲノ低級アルコキシ基、ハロゲノ低級アルケニ
ル基、アリール低級アルコキシ基、又はアロイル基のい
ずれかを表し、R12は水素原子、ハロゲン原子、水酸
基、アミノ基、ニトロ基、低級アルキル基、低級アルコ
キシ基、低級アルケニル基、低級アルキルアミノ基、低
級アルキルチオ基、低級アルカノイル基、ヒドロキシ低
級アルキル基、ヒドロキシ低級アルコキシ基、ヒドロキ
シ低級アルケニル基、ハロゲノ低級アルキル基、ハロゲ
ノ低級アルコキシ基、ハロゲノ低級アルケニル基、アリ
ール低級アルコキシ基、アロイル基、アリール基、ヘテ
ロアリール基、又はヘテロサイクリルカルボニル基のい
ずれかを表す。また、Xは下式(2)〜(5)のいずれ
かを表し、 【化2】 (但し、R13、R14、及びR15はそれぞれ同じでも異な
っていても良く、水素原子又は低級アルキル基を表
す。) Yは下式(6)〜(9)のいずれかを表し、 【化3】 (但し、R16、R17、及びR18はそれぞれ同じでも異な
っていても良く、水素原子又は低級アルキル基のいずれ
かを表す。) Zは水素原子、水酸基、カルボキシル基、低級アルコキ
シカルボニル基、アリールオキシカルボニル基、ヘテロ
アリールオキシカルボニル基、アルキルカルバモイル
基、アリールカルバモイル基、ヘテロアリールカルバモ
イル基、アミノ基、アルキルアミノ基、アリールアミノ
基、ヘテロアリールアミノ基、アシルアミノ基又は下式
(10)〜(15)のいずれかを表す。 【化4】 (但し、R19、R20、R21、R22、R23、R24、R25、
R26、R27、及びR28はそれぞれ同じでも異なっていて
も良く、水素原子、低級アルキル基、アリール基、ヘテ
ロアリール基のいずれかを表す、なお、ここでR19及び
R20、R21及びR22、R21及びR23、R22及びR23、又
はR25及びR26は結合して環を構成しても良い。)mは
0か1の整数を、nは0〜3の整数を表す。]1. A pyridine derivative represented by the following general formula (1) or a pharmaceutically acceptable salt thereof. Embedded image [Wherein, R 1 , R 2 , R 3 , R 4 and R 5 may be the same or different, and any two may be combined to form a ring, and include a hydrogen atom, a halogen atom, a hydroxyl group , Amino group, nitro group, lower alkyl group, lower alkoxy group,
Lower alkenyl group, lower alkylamino group, lower alkylthio group, lower alkanoyl group, hydroxy lower alkyl group, hydroxy lower alkoxy group, hydroxy lower alkenyl group, halogeno lower alkyl group, halogeno lower alkoxy group, halogeno lower alkenyl group, aryl lower alkoxy group, or represents one of the aroyl group, R 6
Represents an acidic functional group, and R 7 , R 8 , R 9 , R 10 and R 11 may be the same or different, and any two may be bonded to form a ring; Atom, hydroxyl group, amino group, nitro group, lower alkyl group, lower alkoxy group, lower alkenyl group, lower alkylamino group, lower alkylthio group, lower alkanoyl group, hydroxy lower alkyl group, hydroxy lower alkoxy group,
Represents a hydroxy lower alkenyl group, a halogeno lower alkyl group, a halogeno lower alkoxy group, a halogeno lower alkenyl group, an aryl lower alkoxy group, or an aroyl group, and R 12 represents a hydrogen atom, a halogen atom, a hydroxyl group, an amino group, a nitro group. A lower alkyl group, a lower alkoxy group, a lower alkenyl group, a lower alkylamino group, a lower alkylthio group, a lower alkanoyl group, a hydroxy lower alkyl group, a hydroxy lower alkoxy group, a hydroxy lower alkenyl group, a halogeno lower alkyl group, and a halogeno lower alkoxy group , A halogeno lower alkenyl group, an aryl lower alkoxy group, an aroyl group, an aryl group, a heteroaryl group, or a heterocyclylcarbonyl group. X represents any of the following formulas (2) to (5); (However, R 13 , R 14 , and R 15 may be the same or different and each represents a hydrogen atom or a lower alkyl group.) Y represents any of the following formulas (6) to (9); Chemical formula 3] (However, R 16 , R 17 and R 18 may be the same or different and each represents a hydrogen atom or a lower alkyl group.) Z is a hydrogen atom, a hydroxyl group, a carboxyl group, a lower alkoxycarbonyl group, Aryloxycarbonyl group, heteroaryloxycarbonyl group, alkylcarbamoyl group, arylcarbamoyl group, heteroarylcarbamoyl group, amino group, alkylamino group, arylamino group, heteroarylamino group, acylamino group or the following formulas (10) to ( 15). Embedded image (However, R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 ,
R 26 , R 27 , and R 28 may be the same or different and each represents a hydrogen atom, a lower alkyl group, an aryl group, or a heteroaryl group, where R 19, R 20 , and R 21 And R 22 , R 21 and R 23 , R 22 and R 23 , or R 25 and R 26 may combine to form a ring. M) represents an integer of 0 or 1, and n represents an integer of 0 to 3. ]
O3H、PO3H2、テトラゾール−5−イル基、スルホ
ンアミド基、2−オキソ−3H−1、2、3、5−オキ
サチアジアゾール−4−イル基、又は5−オキソ−4H
−1、2、4−オキサジアゾール−3−イル基のいずれ
かである請求項1記載のピリジン誘導体またはその医薬
的に許容しうる塩。2. The acidic functional group of R 6 is a carboxyl group, S
O 3 H, PO 3 H 2 , tetrazol-5-yl group, a sulfonamido group, 2-oxo-3H-1,2,3,5- oxathiadiazol-4-yl group, or a 5-oxo -4H
The pyridine derivative according to claim 1, which is any of a -1,2,4-oxadiazol-3-yl group, or a pharmaceutically acceptable salt thereof.
はテトラゾール−5−イル基である請求項1記載のピリ
ジン誘導体またはその医薬的に許容しうる塩。3. The pyridine derivative according to claim 1, wherein the acidic functional group of R 6 is a carboxyl group or a tetrazol-5-yl group, or a pharmaceutically acceptable salt thereof.
れR17及びR18がいずれも水素原子である請求項3記載
のピリジン誘導体またはその医薬的に許容しうる塩。4. The pyridine derivative or the pharmaceutically acceptable salt thereof according to claim 3, wherein m = n = 1, Y is represented by the formula (9), and R 17 and R 18 are both hydrogen atoms. .
たはその医薬的に許容しうる塩を有効成分とするエンド
セリン拮抗剤。5. An endothelin antagonist comprising the pyridine derivative according to claim 1 or a pharmaceutically acceptable salt thereof as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9378297A JPH1029979A (en) | 1996-04-12 | 1997-04-11 | New pyridine derivative |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8-91272 | 1996-04-12 | ||
JP9127296 | 1996-04-12 | ||
JP9378297A JPH1029979A (en) | 1996-04-12 | 1997-04-11 | New pyridine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH1029979A true JPH1029979A (en) | 1998-02-03 |
Family
ID=26432723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9378297A Pending JPH1029979A (en) | 1996-04-12 | 1997-04-11 | New pyridine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH1029979A (en) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001139550A (en) * | 1999-11-17 | 2001-05-22 | Shionogi & Co Ltd | New use of amide compound |
WO2003024441A1 (en) * | 2001-09-14 | 2003-03-27 | Shionogi & Co., Ltd. | Novel use of tricyclic compound |
EP1780196A3 (en) * | 2001-12-10 | 2007-05-09 | Amgen, Inc | Pyridine derivatives for use as vanilloid receptor ligands |
US7335672B2 (en) | 2004-09-13 | 2008-02-26 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
JP2009530248A (en) * | 2006-03-15 | 2009-08-27 | オルソー−マクニール−ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 1,4-Disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
JP2011526287A (en) * | 2008-06-26 | 2011-10-06 | レスバーロジックス コーポレイション | Method for producing quinazolinone derivative |
US8106051B2 (en) | 2001-09-14 | 2012-01-31 | Shionogi & Co., Ltd. | Utilities of amide compounds |
US8691849B2 (en) | 2008-09-02 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
US8691813B2 (en) | 2008-11-28 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
US8906939B2 (en) | 2007-03-07 | 2014-12-09 | Janssen Pharmaceuticals, Inc. | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
US8937060B2 (en) | 2009-05-12 | 2015-01-20 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US8946205B2 (en) | 2009-05-12 | 2015-02-03 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
US9012448B2 (en) | 2010-11-08 | 2015-04-21 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
US9067891B2 (en) | 2007-03-07 | 2015-06-30 | Janssen Pharmaceuticals, Inc. | 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors |
US9085577B2 (en) | 2009-05-12 | 2015-07-21 | Janssen Pharmaceuticals, Inc. | 7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US9114138B2 (en) | 2007-09-14 | 2015-08-25 | Janssen Pharmaceuticals, Inc. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones |
US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US9708315B2 (en) | 2013-09-06 | 2017-07-18 | Janssen Pharmaceutica Nv | 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors |
US9765119B2 (en) | 2001-10-19 | 2017-09-19 | Aurinia Pharmaceuticals Inc. | Cyclosporine analogue mixtures and their use as immunomodulating agents |
US10106542B2 (en) | 2013-06-04 | 2018-10-23 | Janssen Pharmaceutica Nv | Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors |
US10537573B2 (en) | 2014-01-21 | 2020-01-21 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US11369606B2 (en) | 2014-01-21 | 2022-06-28 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
-
1997
- 1997-04-11 JP JP9378297A patent/JPH1029979A/en active Pending
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001139550A (en) * | 1999-11-17 | 2001-05-22 | Shionogi & Co Ltd | New use of amide compound |
US8106051B2 (en) | 2001-09-14 | 2012-01-31 | Shionogi & Co., Ltd. | Utilities of amide compounds |
WO2003024441A1 (en) * | 2001-09-14 | 2003-03-27 | Shionogi & Co., Ltd. | Novel use of tricyclic compound |
USRE48226E1 (en) | 2001-10-19 | 2020-09-29 | Aurinia Pharmaceuticals Inc. | Cyclosporine analogue mixtures and their use as immunomodulating agents |
US10472394B2 (en) | 2001-10-19 | 2019-11-12 | Aurinia Pharmaceuticals Inc. | Cyclosporine analogue mixtures and their use as immunomodulating agents |
US9765119B2 (en) | 2001-10-19 | 2017-09-19 | Aurinia Pharmaceuticals Inc. | Cyclosporine analogue mixtures and their use as immunomodulating agents |
EP1780196A3 (en) * | 2001-12-10 | 2007-05-09 | Amgen, Inc | Pyridine derivatives for use as vanilloid receptor ligands |
US7335672B2 (en) | 2004-09-13 | 2008-02-26 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
US9266834B2 (en) | 2006-03-15 | 2016-02-23 | Janssen Pharmaceuticals, Inc. | 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
US8841323B2 (en) | 2006-03-15 | 2014-09-23 | Janssen Pharmaceuticals, Inc. | 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
JP2009530248A (en) * | 2006-03-15 | 2009-08-27 | オルソー−マクニール−ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 1,4-Disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
US8906939B2 (en) | 2007-03-07 | 2014-12-09 | Janssen Pharmaceuticals, Inc. | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
US9067891B2 (en) | 2007-03-07 | 2015-06-30 | Janssen Pharmaceuticals, Inc. | 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors |
US9132122B2 (en) | 2007-09-14 | 2015-09-15 | Janssen Pharmaceuticals, Inc. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones |
US11071729B2 (en) | 2007-09-14 | 2021-07-27 | Addex Pharmaceuticals S.A. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones |
US9114138B2 (en) | 2007-09-14 | 2015-08-25 | Janssen Pharmaceuticals, Inc. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones |
JP2011526287A (en) * | 2008-06-26 | 2011-10-06 | レスバーロジックス コーポレイション | Method for producing quinazolinone derivative |
US8691849B2 (en) | 2008-09-02 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
US8691813B2 (en) | 2008-11-28 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
US8937060B2 (en) | 2009-05-12 | 2015-01-20 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US9085577B2 (en) | 2009-05-12 | 2015-07-21 | Janssen Pharmaceuticals, Inc. | 7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US9226930B2 (en) | 2009-05-12 | 2016-01-05 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US8946205B2 (en) | 2009-05-12 | 2015-02-03 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US9737533B2 (en) | 2009-05-12 | 2017-08-22 | Janssen Pharmaceuticals. Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US10071095B2 (en) | 2009-05-12 | 2018-09-11 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders |
US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
US9012448B2 (en) | 2010-11-08 | 2015-04-21 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US10106542B2 (en) | 2013-06-04 | 2018-10-23 | Janssen Pharmaceutica Nv | Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors |
US10584129B2 (en) | 2013-06-04 | 2020-03-10 | Janssen Pharmaceuticals Nv | Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors |
US9708315B2 (en) | 2013-09-06 | 2017-07-18 | Janssen Pharmaceutica Nv | 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors |
US10537573B2 (en) | 2014-01-21 | 2020-01-21 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US11103506B2 (en) | 2014-01-21 | 2021-08-31 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US11369606B2 (en) | 2014-01-21 | 2022-06-28 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US12048696B2 (en) | 2014-01-21 | 2024-07-30 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH1029979A (en) | New pyridine derivative | |
US9290450B2 (en) | Compounds and methods for treating inflammatory and fibrotic disorders | |
US7446222B2 (en) | Phenyl compounds | |
EP0548934A1 (en) | Benzamide derivatives | |
SK10012003A3 (en) | Quinazolines as inhibitors MMP-13, process of preparation and use thereof | |
CZ216399A3 (en) | Heterocyclic compounds containing nitrogen and pharmaceutical composition containing thereof | |
EA010568B1 (en) | 2,6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists | |
CA2014760A1 (en) | Chemical compounds | |
KR19990022327A (en) | N-heteroaryl-pyridine sulfonamide derivatives and their use as endothelin antagonists | |
US4125618A (en) | Novel substituted pyridines, their preparation and pharmaceutical use | |
SE465269B (en) | 1,4-DIHYDROPYRIDINE DERIVATIVES AND SALTS THEREOF, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE | |
US8153647B2 (en) | Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics | |
US7232821B2 (en) | (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives | |
HU180081B (en) | Process for producing hystamine antagonic 2-amino-pirimidone derivatives | |
US20090227591A1 (en) | Cyclopentene compounds | |
US20080275053A1 (en) | Heterocyclyl Compounds | |
JPH05202054A (en) | Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridine | |
US20060128684A1 (en) | Anthranilic acid amide derivatives and their pharmaceutical use | |
US4234590A (en) | Thiosubstituted pyridines | |
US20080234335A1 (en) | Cyclohexene Compounds | |
JPH06220044A (en) | Benzamide derivative | |
KR101128372B1 (en) | 1H-pyridin-2-one derivatives | |
US4251663A (en) | Thiosubstituted pyridines | |
WO1999036408A1 (en) | Novel pyrimidine derivatives | |
JPH0441143B2 (en) |